<SEC-DOCUMENT>0001688757-21-000045.txt : 20210506
<SEC-HEADER>0001688757-21-000045.hdr.sgml : 20210506
<ACCEPTANCE-DATETIME>20210506160416
ACCESSION NUMBER:		0001688757-21-000045
CONFORMED SUBMISSION TYPE:	10-Q
PUBLIC DOCUMENT COUNT:		84
CONFORMED PERIOD OF REPORT:	20210331
FILED AS OF DATE:		20210506
DATE AS OF CHANGE:		20210506

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			ESTABLISHMENT LABS HOLDINGS INC.
		CENTRAL INDEX KEY:			0001688757
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		IRS NUMBER:				981436377

	FILING VALUES:
		FORM TYPE:		10-Q
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38593
		FILM NUMBER:		21897642

	BUSINESS ADDRESS:	
		STREET 1:		PO BOX 3140, COMMERCE HOUSE
		STREET 2:		WICKHAMS CAY 1, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110
		BUSINESS PHONE:		50624342400

	MAIL ADDRESS:	
		STREET 1:		PO BOX 3140, COMMERCE HOUSE
		STREET 2:		WICKHAMS CAY 1, ROAD TOWN
		CITY:			TORTOLA
		STATE:			D8
		ZIP:			VG1110
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-Q
<SEQUENCE>1
<FILENAME>esta-20210331.htm
<DESCRIPTION>10-Q
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2021 Workiva--><!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25,d:1ffd384b299d487fa5b14f13003c56d4--><html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:country="http://xbrl.sec.gov/country/2020-01-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:esta="http://establishmentlabs.com/20210331" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:srt="http://fasb.org/srt/2020-01-31" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>esta-20210331</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:CountryRegion" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMS0xLTEtMS0w_72a1cb71-aced-4595-9e3a-c90782b25fa1">506</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:CityAreaCode" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMi0xLTEtMS0w_f5abdbca-6127-4183-b97c-8308361db706">24</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:LocalPhoneNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMy0xLTEtMS0w_640e0397-b2f0-4ed9-a8ce-dc67e122a933">34 2400</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt:datemonthdayen" name="dei:CurrentFiscalYearEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yMi0xLTEtMS0w_7cc26fc9-5c1b-416a-b6da-d3c0172acafd">December 31</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:AmendmentFlag" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yMy0xLTEtMS0w_33dfd91e-69a3-4d69-a3c1-ee74f7697f53">false</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityCentralIndexKey" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yNC0xLTEtMS0w_a6719743-96d5-4e6f-b4da-1b41ca093044">0001688757</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:DocumentFiscalYearFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8zMi0xLTEtMS0w_f8c12ece-fdbb-4903-87d3-72b59358f05f">2021</ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:DocumentFiscalPeriodFocus" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8zMy0xLTEtMS0w_fe401401-e50c-4cee-9dd8-c974a824219b">Q1</ix:nonNumeric><ix:nonNumeric contextRef="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b">P5Y</ix:nonNumeric><ix:nonNumeric contextRef="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94">P2Y</ix:nonNumeric><ix:nonFraction unitRef="segment" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzIzL2ZyYWc6OGY1YjViYjA0OWFjNGY1NjkyNWFkNDNjZjRmZWZkOWIvdGV4dHJlZ2lvbjo4ZjViNWJiMDQ5YWM0ZjU2OTI1YWQ0M2NmNGZlZmQ5Yl80OTQ3ODAyMzI1MTU2_22e54002-68f8-49aa-a3a8-1b94cfd75ce3">one</ix:nonFraction><ix:nonFraction unitRef="segment" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="0" format="ixt-sec:numwordsen" name="us-gaap:NumberOfOperatingSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzIzL2ZyYWc6OGY1YjViYjA0OWFjNGY1NjkyNWFkNDNjZjRmZWZkOWIvdGV4dHJlZ2lvbjo4ZjViNWJiMDQ5YWM0ZjU2OTI1YWQ0M2NmNGZlZmQ5Yl80OTQ3ODAyMzI1MTU2_78018be4-7f3a-443d-ab4c-4d364c999fc2">one</ix:nonFraction><ix:nonNumeric contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" name="us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzE1L2ZyYWc6MTgxZGYxMzhjYzIwNDgyNGI0ODc4ZjIzZjk5NTYxNjkvdGFibGU6MWY5MDY5MGFlY2UwNDk2MWE3OWQ0Y2EzNjVlNTg0YWIvdGFibGVyYW5nZToxZjkwNjkwYWVjZTA0OTYxYTc5ZDRjYTM2NWU1ODRhYl8xLTAtMS0xLTE1MDI_bae51b41-1f29-44f1-97ca-43f30d817cc7">us-gaap:AccruedLiabilitiesCurrent</ix:nonNumeric><ix:nonNumeric contextRef="ia91fb86dcab548bc9e44e800b0fe1b3a_D20210101-20210331" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzU1OA_84b51ed7-33dc-4765-9c9e-ef71511b6db7">P1Y</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="esta-20210331.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:context id="i518b1d7c980a42fcbaee9300b5097f76_I20210505"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-05-05</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="i220c6103ff954277ae7622703799d5e7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib16374b323b64d7eb6f72c7a60281d29_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i99d366567ea04542ae012abac0572301_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="usdPerShare"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit><xbrli:context id="i27dba17eccf84c9498625bbb25746d84_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id69290453e57482aa28d8af7f2da3e28_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icfc0d371d9dd4ebab9502457b3b27e7a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5553b0e30a6b47359efbe2db3fd9d04d_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i13e571bed5bb4c89b0b49d66d7bcbf02_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6f7657c1342467f9d573a50f47b9d88_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9a6b7f3567044b68b1e616d124468d00_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3a0ab61152174dbdaa572644ecc6b59b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia3ba1914f323451f89eb5903cdba7731_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d4a80508a874fea812a9bf34453045f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9b7a1e0a518244cc92beac16b86bacf4_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie486adfced4149c7b72ce4eb4e0c316c_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i362d2bbbd4e448569b56bbaee1759caa_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i51349f298359423dbbd0501a71ab38ef_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7788fd91dc6d471fa4673c7a9251123e_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="iadc48570b61b405a97585b09fb39f436_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i176f5f3fed6946c0a3f5a48340d39eb9_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1541abdbaa374948b1b9a005046d4619_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4f1c51ee57d844558ea1135f49bae5c0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="icbae770df24748ea9b96a10664c50302_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i572345c645984642a2707a36a0be8636_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i592974b4edd4462d8c0a59600b23a746_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1dd6b5f4c6e54f6da671c43da519f1b0_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd5a00be8cba48418ad7288e78d73ae7_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:unit id="facility"><xbrli:measure>esta:facility</xbrli:measure></xbrli:unit><xbrli:unit id="number"><xbrli:measure>xbrli:pure</xbrli:measure></xbrli:unit><xbrli:context id="i8bd19aab21a94b07b796f48b84ac115a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic9ea8ba03f124881b6cb4934a8317cf3_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d40f566ba694c62a29ae89f751ed9ee_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:LongLivedAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i081fde0d54924d748cd0047a247aca91_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:LongLivedAssetsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib1162e78c15d49bb9ac650a48748dcd6_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:MajorCustomersAxis">esta:CustomerOneMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i73eb050084884d97aabea10fa887eb00_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9c4421ada28146c7bd79ce446cfd0743_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:InventoryRawMaterialsPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i68ae26916d1344978f6c5489277d557b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1425d844a2054eb1874c578463f2cd02_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:InventoryRawMaterialsPurchasesMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i05b2ab81a8424def8cac4bbd46817c34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7eb8031bfbf744fd8a075ed851059c67_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i004b7705a98e4c32b860182a8c4f08b3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i3b07bb856af64942a2e4ba6539ed0b99_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ib3ef82464d324a3a9122d68d6f8222d4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4beb3e97e88a46229246ffae5ae38b10_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d50b891602a40ae8475374170cd88a9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0f90130bb6ee4c95851406f50fa32310_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i60a99d33ac56428badf4fa77635987cc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:AsiaPacificAndMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id8f4d7ebd44a431298ec2a860ec67dc5_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:AsiaPacificAndMiddleEastMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic1895da228434d8c86601eebd0eb076b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01fdfa1c7b87456c91b44f087364d012_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:OtherGeographicalAreasMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="segment"><xbrli:measure>esta:segment</xbrli:measure></xbrli:unit><xbrli:unit id="reportingunit"><xbrli:measure>esta:reportingunit</xbrli:measure></xbrli:unit><xbrli:context id="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id3996f92cc944a339de5caa40d1800d5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29eb930880f043a89583c6fc57efa900_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ife4026763f654a77bc94bbe390a2fc4a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9f0ae59c23484eb780355e39397ef553_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i160d575ddcb0470f83ed19730eb5fb61_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iab56151cd6614657ab84386f1061d9c5_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieb8e6e4dd99449fb88bbbca0acc2862b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i43b3f0124f284ee699ac3fd4d34805b2_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2121ef462b904bc38a4a252ab9b29bcd_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i98c64154fe544ca7bd6cee9aadcc28ef_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if284ebc70ba8430c827c84cea2ebd7c0_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id5bc7817e64f42009391e541e0bed5b9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4df511fe868145bb8de184fd4579130b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic63ccb3e5f68497baa493ee0a27489ff_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1811e0f3590c40d0b8b5264bef9323fa_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib89a316782de4b9aa036ee79cbb8a6a8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia40ff3845c404ee89df2259094867ea7_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i873ca24dbc894b9e8daab00025293c33_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if0cce1c6c85749738e3b59dc105867e4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifd06ef7b1af0422c93f821f4a2f4cdce_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6dc8ae01d3fd43de87978f967915da5f_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic96c2ad8891740878a37a78c477c68e5_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3162e9ed932d412fb094be4a89be74cb_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0c230954c47a42a2a8f3f7a01264f32a_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i689c07f08f64464b9f3b1686974bd26c_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9dca6d717b2a43bcb02a10e44f07718f_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7d0ffc41700c443db6b4f0218c08c5f9_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia584179cdecd4217be8aa815f6592f34_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d86c11463554b5dae342b3e252588bc_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14be8b6604984469ba137e25363566e7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ifcfcfc5c853545cfb75ef591c4c89c42_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i49c86d6704eb428f9ade6dcef7f7c2ba_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i01b3a59d508e48d9b117f28aeb5c7264_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3edec611128b4e3ab3d4aa78897c8d21_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i89fb77590e764015b6a150b0c8ffe09d_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i9fa0089fc31649e58eec8035eada66ac_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6997f7df2347466ab6eff3ece39e0830_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i78118302909b42fe814d72c9776a9be6_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i3c454b81cfb24c619a23bb42c3d8fd20_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6494d630a4134e7bab16b46694c01385_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i059a7469f92d475985e17381b3f435bf_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i089cb2848143463d8c43064f3bebf723_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id15204a07aef47d79b3d1359d3d2298a_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic2100b1681d141eb80d0946f6fecde49_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="id757366e4d8c40e7a89ea6fdd3bf8800_D20200101-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i95331fe2443f47f2a92a6d7d257f21c3_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ifa130603b0d34bcaba896c6b2fbc06e8_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4e9b5f5e5662468497f5df0724ed1d00_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id0a4ea3cfc9b4f2d86192db4068663ca_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i71bb3412c07447beaadc22f1358a2b26_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i790092f6c06c4e31b55aa091e6e08ed8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idaea600f2d8040ed846ffa50db817b73_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1ddf079de41d4d389e34c1fe33bd8373_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie0f77adbac95434d9b0d6d9480e92d51_I20170831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i9330e02904744171946200efc674cd7f_I20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i830e948888774878a6aef7ca1259e422_I20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-08-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-01</xbrli:startDate><xbrli:endDate>2017-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia6941f5711ff453faf70724a85877a15_D20190801-20190831"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-01</xbrli:startDate><xbrli:endDate>2019-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i059114baa58f4872bbfdcb04e021af01_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputProbabilityOfChangeInControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i14303ccbd1cf4882a177c1af2b917801_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputProbabilityOfChangeInControlMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i27da2686b48242f7a22212016aa9bccb_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputInterestRateVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i31a7c4a5a5f04c84a1769a691fe0f9e8_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputInterestRateVolatilityMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i86193100685843efbbbb39fedddbac34_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputMarketYieldRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if774d5d7adbc4aac92f6d23ce833114e_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputMarketYieldRateMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia29fed8a4345411c9e198ad402e4bf12_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i7ca4bc90ca3d4e5a87867faec60ebc94_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i210e77df9d574a529b2c2f319b1dee8b_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6d2f8614a7724e108142603cacaa1bb9_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i35ee0f70fefa4c82929e447a5cec9bb3_I20191231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibe39498f97ab4942a773e100eed6a382_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i90151a15234f4bf594dddc4ccebc3bac_I20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i366040d3254b4edebd0cb69800364ef1_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ibc537e3dcd364e198a3715d83f0505b5_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i5aed9212cd444c949bd6daaee2b29e84_I20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i6b2546ff36954e819bb93630aa88e260_I20170824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:AmendedMadrynCreditAgreementMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia833a43aacd04fb58829b20141aedaf6_I20170824"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermAMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-08-24</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ied61c55aaefd4fa6ab4618839ed979f0_D20171031-20171031"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB1Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-10-31</xbrli:startDate><xbrli:endDate>2017-10-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1f9be83f245489ba3f93a2a2970a743_D20171215-20171215"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB2Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2017-12-15</xbrli:startDate><xbrli:endDate>2017-12-15</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icb1b1b6522f146e2a92e6845b3354b0e_I20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB3Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="iefa578fa70ce4695a1914cbd8fad0ccd_I20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-06-17</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i56705c8ada8c45b8893dfc488df6e515_D20190812-20190812"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB3AndB4Member</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-08-12</xbrli:startDate><xbrli:endDate>2019-08-12</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i15ac743227854d2c9afe9117722a0e53_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="if0313e61c81e4ee8a20a20c25abd823f_D20190101-20190616"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-06-16</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="idd8ee19aeac5495bb1e420bf7d180a2b_D20190617-20190617"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-06-17</xbrli:startDate><xbrli:endDate>2019-06-17</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i709a73d169864a389bd4608c3299e861_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i0007a8ee0a3a4436b52008e19adf5975_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i759011d78d1d4884b0ec06f0e36e3637_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i0f4c0806d8b045fd8478b54e30beab7e_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id90136f7b3494c6a9628a63b0d9d7b06_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i1bd2c2bf38844a08b1d34482f0bd0b6d_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5f2199649ba74639a58014d05b0e0980_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i4983eb1dc3b54e3da8367f9521c63168_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i84d60646549649c5b45c4a188e368335_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i13079f6ba18c4ea6bd64156a196823ad_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ia2caa5751cee42809a8237b7da9369d9_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i2fa6b9cdd0424fd2946a54b840e1d4fb_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i247e8da1272d441ea7089934a2671ae9_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="idc6ad514225b434ea180652c54cb7361_I20170331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2017-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ieda0ffc7bc7d4fa4861317378b2356ed_I20181231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2018-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2019-01-01</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i87fb0387087841b6b020b35c3bc5ad74_D20190101-20190101"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2019-01-01</xbrli:startDate><xbrli:endDate>2019-01-01</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia1ec09e636ce49e4903a5f3d5ac3e7c7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i986acae19ce84fab8f8d01f4ded6532e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1f351807ee89478e92c86e857311533d_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie71a900e3d434bcab7ea26baa565deb4_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ie0fdf8bc2e1e409db1472911b124d683_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i15b02aa6633a436480804341634e94d3_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i478c73ce4642455cba1f5dffb0d3782a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic68469141fd244179893ceb45866a4a1_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia2edc59bec53490994496014ae3b59a2_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic6df5fcf8c8343ea957122278a45e96b_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ia91fb86dcab548bc9e44e800b0fe1b3a_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="ic880ec3a676b4f12a08eb325a02676fa_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i2bfc12cdfee24225bc3c5d74083ada83_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i695c26f28c134a87811302e003a58006_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">esta:EmployeeAndNonemployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i07c8793eb73f4c988ba24cd20e54c766_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">esta:EmployeeAndNonemployeeStockOptionMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i99e5a665c04f40eca5f9a0b3a98ca5a4_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="icbb360d504184d689fa5022115013737_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4915579cae994b35a1b781ee5e5104d7_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i52d7890a8568427a9a9331d06f4f7f6e_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-03-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="i8874a1e19376447fbb0ebf1b8cb9d361_I20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2020-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="id7adeaf0b41a4c8289f265e3a67c7204_I20210331"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2021-03-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2016-01-01</xbrli:startDate><xbrli:endDate>2016-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="if841a633a7064c10a7ea55273d751563_I20161231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:instant>2016-12-31</xbrli:instant></xbrli:period></xbrli:context><xbrli:context id="i29f43ea253394bd380b244709b366727_D20201201-20201231"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001688757</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2020-12-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i1ffd384b299d487fa5b14f13003c56d4_1"></div><div style="min-height:18pt;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:14pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:DocumentType" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDUw_c69bf5f3-8dd6-4a7f-b565-66b1c96865ca">10-Q</ix:nonNumeric></span></div><div style="margin-bottom:3pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">(Mark One)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:11pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentQuarterlyReport" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDUy_a1f6df08-f49b-4ee9-8de8-900a2d71c821">&#9746;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the quarterly period ended <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt:datemonthdayyearen" name="dei:DocumentPeriodEndDate" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMjI_6706ef66-8207-4726-8a37-abfb3932696a">March&#160;31, 2021</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">OR</span></div><div><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:DocumentTransitionReport" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ2_2da1a388-edae-4848-bc5c-bb2bec27bf5f">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">TRANSITION</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="margin-bottom:6pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the transition period from ___________ to ___________</span></div><div style="margin-bottom:12pt;padding-left:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Commission File Number: <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityFileNumber" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ3_c27a18dc-f624-480f-bf03-620f891562fd">001-38593</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:15pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityRegistrantName" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ4_7eb6f545-6b09-4b6f-aa64-64e23809bf7e">Establishment Labs Holdings Inc.</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Exact name of Registrant as specified in its charter)</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.861%"><tr><td style="width:1.0%"></td><td style="width:45.214%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.271%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:45.215%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:edgarprovcountryen" name="dei:EntityIncorporationStateCountryCode" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8wLTAtMS0xLTA_f5fa9a07-a149-4a68-9c70-c1b97b2f3a4d">British Virgin Islands</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-top:1pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">State or Other Jurisdiction of </span></div><div style="margin-top:1pt;padding-left:7.87pt;padding-right:7.87pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Incorporation or Organization</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">I.R.S. Employer Identification No.</span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityAddressAddressLine1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF80_217a8512-fa59-4f42-90d0-ceb97416729b">Building B15 and 25</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityAddressAddressLine2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF83_66d44191-08dc-4733-a4c6-f59f037885d4">Coyol Free Zone</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityAddressCityOrTown" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF8xMA_71377024-5328-4d1c-beaa-a31e7bf83bd5">Alajuela</ix:nonNumeric></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:countrynameen" name="dei:EntityAddressCountry" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF8xMw_498ccf5d-29e3-4315-ade6-bda71b2e094f">Costa Rica</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not applicable</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Address of Principal Executive Offices</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6.75pt;padding-right:6.75pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Zip Code</span></div></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:18.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">+506 2434 2400</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:120%">Registrant&#8217;s Telephone Number, Including Area Code</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Not applicable</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Former Name, Former Address and Former Fiscal Year, if Changed Since Last Report</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;margin-top:15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant (1)&#160;has filed all reports required to be filed by Section&#160;13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12&#160;months (or for such shorter period that the registrant was required to file such reports), and (2)&#160;has been subject to such filing requirements for the past 90&#160;days.&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityCurrentReportingStatus" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ5_a54a2c86-0d0f-4d06-b96d-e3f1f954bd98">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule&#160;405 of Regulation&#160;S-T (&#167;&#160;232.405 of this chapter) during the preceding 12&#160;months (or for such shorter period that the registrant was required to submit such files).&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:EntityInteractiveDataCurrent" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQz_04449dc7-74df-480a-9e51-e87ada32cdec">Yes</ix:nonNumeric>&#160;</span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:400;line-height:120%">&#9746;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;&#160;No </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:8pt;font-weight:700;line-height:120%">&#9744;</span></div><div style="margin-bottom:9pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of &#8220;large accelerated filer,&#8221; &#8220;accelerated filer,&#8221; &#8220;smaller reporting company,&#8221; and &#8220;emerging growth company&#8221; in Rule 12b-2 of the Exchange Act. </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Large&#160;accelerated&#160;filer&#160;&#9744;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Accelerated filer</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#160;&#9744;</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:entityfilercategoryen" name="dei:EntityFilerCategory" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18xLTAtMS0xLTQzNjYvdGV4dHJlZ2lvbjo5MzRmNmQ4MzM4Njk0NzVmODA1ZTRhMTgwZmRhN2UyNF80OTQ3ODAyMzI1MDQw_e9a99c9b-00a1-4c5a-b13a-1824793efc31">Non-accelerated filer</ix:nonNumeric>&#160;&#9746;</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Smaller&#160;reporting&#160;company&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntitySmallBusiness" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18xLTItMS0xLTAvdGV4dHJlZ2lvbjpjM2ExOTM3ZDM0OTk0YmFlYTJjNTZjYTZmYzk2MDM2ZV8zMA_cca1e270-8a8a-4eac-bd97-fda6aab8b830">&#9746;</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Emerging growth company&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityEmergingGrowthCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18yLTAtMS0xLTAvdGV4dHJlZ2lvbjphZjFmMDFkMWM4YjA0MjAwOWFiMDUxNDgyMDJhM2M2MV8yOA_450c2f70-07a9-44eb-abb3-112f6ece7f8a">&#9746;</ix:nonNumeric></span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.&#160; <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityExTransitionPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDU0_864b29e3-b524-404b-aba0-34954ce0a449">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is a shell company (as defined in Rule&#160;12b-2 of the Act).&#160;&#160;Yes&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:boolballotbox" name="dei:EntityShellCompany" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ0_1a22a992-f84c-455c-b397-54ec41e8205f">&#9744;</ix:nonNumeric>&#160;&#160;No &#9746;</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act: </span></div><div><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Trading symbol</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:Security12bTitle" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTAtMS0xLTA_b2350373-d4a0-450e-83b9-37e7a3a2f97d">Common Shares, No Par Value</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:TradingSymbol" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTEtMS0xLTA_613a571d-87a5-46cc-9865-99495ff14ad8">ESTA</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">The <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="dei:SecurityExchangeName" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTItMS0xLTAvdGV4dHJlZ2lvbjozOTdjMTc2MjA1NzY0ZDZlYTJhNTllNmU2OWRlODE0ZV84_d330aaec-173a-41bf-abde-20161ca53787">NASDAQ</ix:nonNumeric> Capital Market</span></div></td></tr></table></div><div style="margin-bottom:6pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">The number of the registrant&#8217;s common shares outstanding as of May 5, 2021 was <ix:nonFraction unitRef="shares" contextRef="i518b1d7c980a42fcbaee9300b5097f76_I20210505" decimals="INF" format="ixt:numdotdecimal" name="dei:EntityCommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQx_5d267636-135c-46f4-874d-d7ac6c2667ad">23,687,808</ix:nonFraction>.</span></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_7"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:12pt;margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:7.828%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:81.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Page</span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_10">Explanatory Note</a></span></div></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_10">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_10">Special Note about Forward-Looking Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_10">1</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_13">Part&#160;I. Financial Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_13">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_13">Condensed Consolidated Financial Statements - Unaudited</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_13">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_16">Condensed Consolidated Balance Sheets as of March 31, 2021 and December&#160;31, 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_16">2</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_19">Condensed Consolidated Statements of Operations for the Three Months Ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_19">3</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_22">Condensed Consolidated Statements of Comprehensive Loss for the Three Months Ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_22">4</a></span></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_25">Condensed Consolidated Statements of Shareholders&#8217; Equity for the Three Months Ended March 31, 2021 and  2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_25">5</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_28">Condensed Statements of Cash Flows for the Three Months Ended March 31, 2021 and 2020</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_28">6</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_31">Notes to the Condensed Consolidated Financial Statements</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_31">8</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_76">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_76">Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_76">33</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_115">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_115">Quantitative and Qualitative Disclosures About Market Risk</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_115">45</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_118">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_118">Controls and Procedures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_118">45</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_121">Part II. Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_121">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_124">Item 1.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_124">Legal Proceedings</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_124">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_127">Item 1A.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_127">Risk Factors</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_127">47</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_130">Item 2.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_130">Recent Sales of Unregistered Securities and Use of Proceeds</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_130">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_133">Item 3.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_133">Defaults Upon Senior Securities</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_133">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_136">Item 4.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_136">Mine Safety Disclosure</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_136">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_139">Item 5.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_139">Other Information</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_139">87</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_142">Item 6.</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_142">Exhibits and Financial Statement Schedules</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_142">87</a></span></div></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_145">Signatures</a></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_145">88</a></span></div></td></tr></table></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">i</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_10"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXPLANATORY NOTE </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In this report, unless the context indicates otherwise, the terms &#8220;Establishment Labs,&#8221; &#8220;Company,&#8221; &#8220;we&#8221;, &#8220;us&#8221; and &#8220;our&#8221; refer to Establishment Labs Holdings Inc., a British Virgin Islands entity, and its consolidated subsidiaries. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We own, or have rights to, trademarks and trade names that we use in connection with the operation of our business, including Establishment Labs and our logo as well as other brands such as Motiva Implants, SilkSurface/SmoothSilk, VelvetSurface, ProgressiveGel, TrueMonobloc, BluSeal, Divina, Ergonomix, Ergomonix2, Ergonomix2 Diamond, Motiva MIA and MotivaImagine, among others. Other trademarks and trade names appearing in this report are the property of their respective owners. Solely for your convenience, some of the trademarks and trade names referred to in this report are listed without the &#174; and TM symbols, but we will assert, to the fullest extent under applicable law, our rights to our trademarks and trade names.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SPECIAL NOTE ABOUT FORWARD-LOOKING STATEMENTS </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This report contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;). You can find many (but not all) of these statements by looking for words such as &#8220;approximates,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;would,&#8221; &#8220;may&#8221; or other similar expressions in this report. Any statements that refer to projections of our future financial or operating performance, anticipated trends in our business (including the impact of the COVID-19 outbreak), our goals, strategies, focus and plans, and other characterizations of future events or circumstances, including statements expressing general optimism about future operating results, are forward-looking statements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We claim the protection of the safe harbor contained in the Private Securities Litigation Reform Act of 1995. We caution investors that any forward-looking statements presented in this report, or that we may make orally or in writing from time to time, are expressions of our beliefs and expectations based on currently available information at the time such statements are made. Such statements are based on assumptions, and the actual outcome will be affected by known and unknown risks, trends, uncertainties and factors that are beyond our control. Although we believe that our assumptions are reasonable, they are not guarantees of future performance, and some will inevitably prove to be incorrect. As a result, our actual future results may differ from our expectations, and those differences may be material. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Factors that could cause or contribute to these differences include, among others, those risks and uncertainties discussed under the sections contained in this Form 10-Q entitled &#8220;Part I, Item 2. Management&#8217;s Discussion and Analysis of Financial Condition and Results of Operations,&#8221; &#8220;Part I, Item 3. Quantitative and Qualitative Disclosures about Market Risk,&#8221; and &#8220;Part II, Item 1A. Risk Factors&#8221;, and our other filings with the Securities and Exchange Commission. The risks included in those documents are not exhaustive, and additional factors could adversely affect our business and financial performance. We operate in a very competitive and rapidly changing environment. New risk factors emerge from time to time, and it is not possible for us to predict all such risk factors, nor can we assess the impact of all such risk factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are not undertaking any obligation to update any forward-looking statements. Accordingly, investors should use caution in relying on past forward-looking statements, which are based on known results and trends at the time they are made, to anticipate future results or trends.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_13"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Balance Sheets</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share data)</span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART I. FINANCIAL INFORMATION</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. FINANCIAL STATEMENTS</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_16"></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.400%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.252%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Unaudited)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cash</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNS0xLTEtMS0w_9cca0165-5370-4b77-9970-9580eaa273ad">77,950</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Cash" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNS0zLTEtMS0w_24ad9f79-a981-4ec2-91a6-34b304c02980">84,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts receivable, net of allowance for doubtful accounts of $<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0wLTEtMS0wL3RleHRyZWdpb246MmExNjU4ZDdiOTJmNGUwNTg4NTQyMTk4M2I2ZDFlOWZfNjc_ae1c299d-3d10-4c73-a6bc-bcb878e72311">1,121</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0wLTEtMS0wL3RleHRyZWdpb246MmExNjU4ZDdiOTJmNGUwNTg4NTQyMTk4M2I2ZDFlOWZfNzQ_9bc7aa9c-63c9-4077-8e29-b0439604fbfd">1,143</ix:nonFraction></span></div></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0xLTEtMS0w_d7808043-6784-4b0a-b89f-8553a1ba8a9b">23,777</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableNetCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0zLTEtMS0w_4e8c9160-f233-456f-a644-84fbb5fee6a6">19,127</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inventory, net</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNy0xLTEtMS0w_c51ba677-c8d3-463b-a1f7-08837e5f0f1b">22,377</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNy0zLTEtMS0w_60de96c7-f43a-4526-b275-5eb5821f664d">23,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOC0xLTEtMS0w_2bbefca3-540c-46cd-a01a-62d84c26f221">4,194</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PrepaidExpenseAndOtherAssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOC0zLTEtMS0w_e51151c0-0b7b-4d75-bdde-2be80a05bfd4">5,439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current assets</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOS0xLTEtMS0w_14c693e6-cb90-464a-92f0-a1fe33a6727a">128,298</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AssetsCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOS0zLTEtMS0w_a853cae5-32ee-495d-8be8-69cf87a30b27">132,299</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term assets:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Property and equipment, net of accumulated depreciation</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTEtMS0xLTEtMA_8b234edb-7bdf-4ec7-9fd7-e0d6f7875cde">16,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTEtMy0xLTEtMA_014cc911-1c33-47d8-8ef5-28b4270807d3">16,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Goodwill</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTItMS0xLTEtMA_b11b9cdf-18f5-472a-b5ec-08deff9b90ab">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTItMy0xLTEtMA_b60b0951-f27c-46e5-b9f4-1994d9d831fb">465</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Intangible assets, net of accumulated amortization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTMtMS0xLTEtMA_89e76878-b487-452a-8f2c-6770c7e5a8e5">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTMtMy0xLTEtMA_239330c7-3bb1-472e-8e94-7fa4ec84dd8f">4,148</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Right-of-use operating lease assets, net</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMS0xLTEtNDA_9bfdd304-0cd1-45e8-b7ae-90e3b2a420f2">2,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMy0xLTEtNTg_106bea3b-9dad-464a-80d0-e99871abcfbb">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other non-current assets</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMS0xLTEtMA_70dd55f0-b9fd-424f-bdfe-af84a34c7e5d">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:OtherAssetsNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMy0xLTEtMA_09a46261-758a-4434-8865-2a663782329f">664</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total assets</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTYtMS0xLTEtMA_d10eea5e-a4f3-4278-aff6-6238ec16778d">152,349</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Assets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTYtMy0xLTEtMA_420723a3-b884-44cc-af64-249a9ee64a4c">156,388</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Liabilities and shareholders&#8217; equity</span></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Current liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accounts payable</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTktMS0xLTEtMA_f3ac84af-6f21-4c6c-839b-974e1381ee44">8,994</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTktMy0xLTEtMA_08b6bf68-e7c6-4188-9dce-0df44cebf171">9,722</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjAtMS0xLTEtMA_7f240c9a-1881-440b-9f4c-4f9c8a053920">14,408</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjAtMy0xLTEtMA_d88aed1d-0350-4f80-8083-929730b3cb27">14,532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities, short-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjEtMS0xLTEtMA_8aea8ff2-1ca6-4a43-8e72-a25ea164450a">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjEtMy0xLTEtMA_5b6e4ce7-bc68-489e-b2d4-850d05e163d6">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total current liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjItMS0xLTEtMA_24e891d4-291b-4d01-9cd4-8ce414c5ab9b">24,833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjItMy0xLTEtMA_2693e081-8726-4062-9282-1f8c670194ce">25,900</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Long-term liabilities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Note payable, Madryn, net of debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjQtMS0xLTEtMA_662c6692-e696-47f5-90e7-c310e293c4d2">50,305</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebtNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjQtMy0xLTEtMA_23e3d664-d4ed-4de0-ab96-df5f3a8081e1">49,832</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Madryn put option</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d366567ea04542ae012abac0572301_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMS0xLTEtMA_7d73786f-66b0-4e39-99d0-2e5389d5fe8e"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMS0xLTEtMA_e4f1ffd1-4aae-46e1-8d1e-80d9343ee31c">1,210</ix:nonFraction></ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMy0xLTEtMA_f903eb47-e665-4331-abe7-01d28e4cecc0">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating lease liabilities, non-current</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMS0xLTEtNjg_76045df7-35a2-4a8e-99aa-7484c0d17f2b">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMy0xLTEtNjQ_e2f556db-6f4f-4473-bb8c-34773dd78044">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other liabilities, long-term</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjYtMS0xLTEtMA_c500af28-e7c7-43c1-97ed-d091f3b3c78c">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjYtMy0xLTEtMA_b26bdda8-eeb4-402b-b500-93c0b0a27300">2,332</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMS0xLTEtMA_ae2a192c-0daf-403c-b038-f1e4ffc94b7a">79,798</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Liabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMy0xLTEtMA_adcde8c1-a6a2-4a1a-bdbe-5285c5953c85">81,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Commitments and contingencies (Note 13)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjgtMS0xLTEtMA_7e9c190b-b860-429f-b31b-266f2cec3613"></ix:nonFraction></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" xsi:nil="true" name="us-gaap:CommitmentsAndContingencies" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjgtMy0xLTEtMA_a23b3c4f-62c4-4a8b-aa5a-d7efb9783c9b"></ix:nonFraction></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Shareholders&#8217; equity:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Common shares - zero par value, unlimited amount authorized; <ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzY1_fea9dc35-31c0-420d-b26d-83f20fb4cf63">24,094,051</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzcy_d674b4c5-db63-4510-97b0-6bb9c9ce1cb7">23,925,789</ix:nonFraction> shares issued at March 31, 2021 and December 31, 2020, respectively; <ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzE0OA_76b2ff02-b315-4bdc-aaaf-28f6d228c438">23,685,981</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzE1NQ_4ffcc7e8-e0b2-4404-a934-4e2371c27e73">23,517,719</ix:nonFraction> shares outstanding at March 31, 2021 and December 31, 2020, respectively</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMS0xLTEtMA_45b5560b-da56-45df-bac4-53d522d43575">215,358</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CommonStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMy0xLTEtMA_3c4117ac-919e-4d88-9ffd-92621a4cf62f">213,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Additional paid-in-capital</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzEtMS0xLTEtMA_f21aa9e5-b038-4568-b0f3-d77b4eb492ab">28,427</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AdditionalPaidInCapital" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzEtMy0xLTEtMA_7715ef92-a9d1-458e-b3ee-efe451e08e01">26,717</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Treasury shares, at cost, <ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjFiZWRkN2U5NTk5ZDRlY2NhYTE3OTliYmY3MWYzZmU2XzMw_2b1d5f8c-4bfb-4f79-9f62-b4bee099322f"><ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockShares" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjFiZWRkN2U5NTk5ZDRlY2NhYTE3OTliYmY3MWYzZmU2XzMw_2b929161-97d5-4b24-a1ff-c1f07d5aba41">408,070</ix:nonFraction></ix:nonFraction> shares held at March 31, 2021 and December 31, 2020</span></div></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMS0xLTEtMA_22e16da7-a64f-4cdc-a791-7fa5092e9482">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:TreasuryStockValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMy0xLTEtMA_d283ac66-c25f-48f0-897a-f3daec9f0d01">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated deficit</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzMtMS0xLTEtMA_183da65b-f33d-43d7-b4b2-3cf62302a93c">172,194</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:RetainedEarningsAccumulatedDeficit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzMtMy0xLTEtMA_4c9fa4aa-9f97-4169-bcae-3b49b0c0f65d">165,246</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Accumulated other comprehensive income</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzQtMS0xLTEtMA_d70930a2-5eda-449c-a3ac-16ad9c3caba6">3,814</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzQtMy0xLTEtMA_c5e6949e-6cf9-42a3-814c-43c0a83c60b3">2,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total shareholders&#8217; equity</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzUtMS0xLTEtMA_f28b2724-6df4-4ba3-bf2c-31d3bc442836">72,551</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzUtMy0xLTEtMA_7ace3179-38e4-462b-8071-78000c8a692d">74,961</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total liabilities and shareholders&#8217; equity</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzYtMS0xLTEtMA_16184dac-de3a-4d82-b71f-3f03280c47ec">152,349</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LiabilitiesAndStockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzYtMy0xLTEtMA_1fcee1d8-8c80-4436-9ae4-4a7420dbfe84">156,388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">2</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_19"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Operations</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands, except share and per share data)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.685%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.763%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.764%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMy02LTEtMS0w_f8b8885f-cc18-4a2e-84ce-a607396bd805">30,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMy04LTEtMS0w_4c7a90bb-b732-4c34-86be-f6ca32dff340">24,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNC02LTEtMS0w_919b523e-fc5b-4596-b79e-186604c32089">10,246</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CostOfRevenue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNC04LTEtMS0w_1bd3867d-e9fa-43f5-b20f-33e24deab0a5">9,003</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNS02LTEtMS0w_d6648089-2e20-4c2a-ad06-238d082a69c7">20,090</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:GrossProfit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNS04LTEtMS0w_677771f3-4218-4965-80e0-00310f81768f">15,478</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNy02LTEtMS0w_b8673451-c3c2-4a31-97b5-96cde059aa41">18,138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNy04LTEtMS0w_97abf68e-b7f2-4fcc-b1ba-f02e52469a27">18,984</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOC02LTEtMS0w_cedb8f6a-0a70-41bc-8dc1-683648f4d6b2">4,048</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ResearchAndDevelopmentExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOC04LTEtMS0w_71419a1f-6ed0-4e1f-8670-4d74b3991281">4,199</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOS02LTEtMS0w_2c81a7b9-d2fa-4c4a-a9fc-70a1ac1c5e15">22,186</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingExpenses" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOS04LTEtMS0w_46b58cbd-9572-471f-ad06-c6edd6e77eff">23,183</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTAtNi0xLTEtMA_a836e76b-a826-4950-a9e9-486babd46d0c">2,096</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OperatingIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTAtOC0xLTEtMA_bcc380f3-eeb3-46ec-92b5-2b3c1e43f8a1">7,705</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest income</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTEtNi0xLTEtMA_5d357525-0681-427f-8077-b723175c23b4">4</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:InvestmentIncomeInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTEtOC0xLTEtMA_a74756c1-5d63-4da0-822c-25e95e5a5fa1">8</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTItNi0xLTEtMA_4c1f532f-33e5-431f-bf22-efce1856134a">2,195</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTItOC0xLTEtMA_0c8a14c5-5f90-4533-9bdd-611b94e8d431">2,146</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTMtNi0xLTEtMA_3875b5a6-3d9d-475c-b540-04816a6585fb">230</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:GainLossOnDerivativeInstrumentsNetPretax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTMtOC0xLTEtMA_4daeb9b9-872d-4c01-8a3c-994225d8ebdc">1,929</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTQtNi0xLTEtMA_f820fa4d-5397-4ea9-9b90-c1835c7fe31a">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTQtOC0xLTEtMA_4ade64c4-826b-4b2e-8051-b6f5e74871c1">440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTYtNi0xLTEtMA_34cafbce-c035-4f20-b15c-bb7c6183c066">2,726</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:OtherNonoperatingIncomeExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTYtOC0xLTEtMA_20aabfd8-ed54-4e8f-a56a-a30bff9a8404">6,190</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTctNi0xLTEtMA_58f03211-1c77-4411-ac71-9b24821c2952">6,783</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTctOC0xLTEtMA_f778499b-a93f-4646-a306-03e503665782">17,522</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTgtNi0xLTEtMA_dc03a3f7-e89a-4b16-9440-88c8f7444202">165</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncomeTaxExpenseBenefit" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTgtOC0xLTEtMA_3e117403-47e3-4dfa-9a60-61c8a34168e2">231</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktNi0xLTEtMA_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktNi0xLTEtMA_e52cb721-7370-454d-94fa-56383aa1257a">6,948</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktOC0xLTEtMA_ef1bacbe-ecde-4483-9a94-2223bfbb2136">17,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Basic and diluted net loss per share</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjEtNi0xLTEtMA_94b15bb6-65a4-4361-bd75-95873be68845">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjEtOC0xLTEtMA_8d61c6f8-d664-480a-943f-67808af75935">0.79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Weighted average outstanding shares used for basic and diluted net loss per share</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjMtNi0xLTEtMA_3b8f333e-0fdf-492c-a099-5e0bce6ef8ee">23,827,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjMtOC0xLTEtMA_f667509d-60dd-48cb-a123-b1786cf8d5a7">22,456,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_22"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt;text-align:center"><span><br/></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Comprehensive Loss</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:75.536%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.465%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.211%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended<br/>March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy01LTEtMS0w_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy01LTEtMS0w_e52cb721-7370-454d-94fa-56383aa1257a">6,948</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy03LTEtMS0w_ef1bacbe-ecde-4483-9a94-2223bfbb2136">17,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive income:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Foreign currency translation gain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNS01LTEtMS0w_e25006af-ab58-43ff-905f-f9b78539959e">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNS03LTEtMS0w_f34fd8c0-dfc3-4c0d-a132-b0c8f8fd5347">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other comprehensive gain</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNi01LTEtMS0w_44743d93-6b51-4536-839c-30d96688c0d5">941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNi03LTEtMS0w_4bbc407b-ac7c-4d30-891e-0607630b9dee">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Comprehensive loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNy01LTEtMS0w_78f9d283-1342-4ddd-8ae1-305786817bac">6,007</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ComprehensiveIncomeNetOfTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNy03LTEtMS0w_47d882eb-191d-4f3c-a8f9-7dc9352fa0f4">14,932</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">4</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_25"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statement of Shareholders&#8217; Equity</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited) (In thousands, except share data)</span></div><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.780%"><tr><td style="width:1.0%"></td><td style="width:27.361%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.251%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.581%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.349%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.260%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:2pt solid #000000;padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i27dba17eccf84c9498625bbb25746d84_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMi0xLTEtMA_dcbda8be-5b45-4ae7-9510-dfee6ae6d1c5">23,925,789</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i27dba17eccf84c9498625bbb25746d84_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtNC0xLTEtMA_82518856-da83-4715-b78f-0e38a45d2a21">213,471</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTAtMS0xLTA_24018275-e642-435f-b31f-c7c112a4ce95">408,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTItMS0xLTA_83f5fc1c-e836-4491-8710-deaa1c56c030">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id69290453e57482aa28d8af7f2da3e28_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTQtMS0xLTA_da9df87d-d27e-4ab8-b9d0-44b782d29c81">26,717</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icfc0d371d9dd4ebab9502457b3b27e7a_I20201231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTYtMS0xLTA_ceafce51-a349-428d-b062-fe31d96a280c">165,246</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5553b0e30a6b47359efbe2db3fd9d04d_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTgtMS0xLTA_833a3605-ee9c-40f1-bb28-bc4d3541cec8">2,873</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMjAtMS0xLTA_6afe24e0-b850-457f-8125-e23c6055afce">74,961</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtMi0xLTEtMA_26d16370-6845-48ff-b835-edee23e1a9ec">163,034</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtNC0xLTEtMA_6bd30098-3a17-4fb0-98b4-c2678f1c4a89">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtMjAtMS0xLTA_cf6bf953-a8e4-48fd-8f1e-6c495e4d1bcd">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMi0xLTEtMA_7bd5adc7-d50e-4819-b158-7741f13fec1b">5,939</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtNC0xLTEtMA_7f30bcc8-a45d-4558-aeb1-a36448edd713">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMTQtMS0xLTA_26524b8e-d5ce-461d-8807-04d4b0c49b08">1,750</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMjAtMS0xLTA_63a04672-0729-4f06-99eb-91347da11c69">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares withheld to cover income tax obligation upon vesting of restricted stock</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="INF" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMi0xLTEtMA_702d0bb1-9745-4cea-880b-be10a9671e67">711</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtNC0xLTEtMA_b5097b36-8386-4d02-bb46-a6848d8fd2db">1</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMTQtMS0xLTA_21874a20-7b3b-4b80-96e1-7096119f834c">40</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMjAtMS0xLTA_20a12df1-12ec-4ead-bd55-e94b78d98f5b">41</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation gain</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i13e571bed5bb4c89b0b49d66d7bcbf02_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjMtMTgtMS0xLTA_daf3a213-ecd1-4755-bd52-2adfaca7627f">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjMtMjAtMS0xLTA_c658ece6-c9dd-4c04-b519-25fe989356c5">941</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMTYtMS0xLTA_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMTYtMS0xLTA_e52cb721-7370-454d-94fa-56383aa1257a">6,948</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMjAtMS0xLTA_6d5f90a8-c1ed-48b4-b8bc-64751471be74">6,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ic6f7657c1342467f9d573a50f47b9d88_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMi0xLTEtMA_194ab096-4b5b-4bcd-8fcc-a0da57ecc097">24,094,051</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic6f7657c1342467f9d573a50f47b9d88_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtNC0xLTEtMA_b8ecb4b9-3cc0-406b-9a96-dbc4a592402b">215,358</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9a6b7f3567044b68b1e616d124468d00_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTAtMS0xLTA_a6cd1da4-ed83-46a7-8bc8-9d671b5c35ef">408,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9a6b7f3567044b68b1e616d124468d00_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTItMS0xLTA_be594475-f1da-4cae-99c6-ac6131f609de">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i3a0ab61152174dbdaa572644ecc6b59b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTQtMS0xLTA_27383593-c1f6-436e-9d9d-7be45a82682d">28,427</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia3ba1914f323451f89eb5903cdba7731_I20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTYtMS0xLTA_0bff2281-135b-4bac-9ece-ec8893ee4492">172,194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7d4a80508a874fea812a9bf34453045f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTgtMS0xLTA_65b1644b-fd3d-426a-bdaa-9df45f28bd54">3,814</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMjAtMS0xLTA_e04bc652-d7f2-44f9-ab90-2f7550e6ab40">72,551</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:27.518%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.233%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.562%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.348%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.238%"></td><td style="width:0.1%"></td></tr><tr style="height:12pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Common Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Treasury Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Additional<br/>Paid-In<br/>Capital</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated<br/>Deficit</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Accumulated Other Comprehensive Income</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Total</span></td></tr><tr style="height:17pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at January 1, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMi0xLTEtMA_3802998b-032f-41c6-9ae7-6d77c0b1c4ef">21,057,040</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtNC0xLTEtMA_df92a522-1ec5-4c6a-beef-2081d9a83c1a">147,688</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9b7a1e0a518244cc92beac16b86bacf4_I20191231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTAtMS0xLTA_a68a59ef-5c53-46d9-ac18-525818ee8bfe">408,070</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9b7a1e0a518244cc92beac16b86bacf4_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTItMS0xLTA_3eb3fa22-1551-4795-a13e-4e23da017bdf">2,854</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie486adfced4149c7b72ce4eb4e0c316c_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTQtMS0xLTA_b4e40bfe-854c-44e5-8666-104026ceb46f">21,214</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i362d2bbbd4e448569b56bbaee1759caa_I20191231" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTYtMS0xLTA_8dbadfc4-191f-42c9-b2b3-a086f7603424">127,125</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i51349f298359423dbbd0501a71ab38ef_I20191231" decimals="-3" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTgtMS0xLTA_02571e2a-555d-44b9-a122-867ef0dc242d">691</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7788fd91dc6d471fa4673c7a9251123e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMjAtMS0xLTA_01aa80ca-6e87-4372-96ff-f8425f936236">39,614</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Issuance of common stock, net of underwriters&#8217; discount and issuance costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesNewIssues" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtMi0xLTEtMA_7ed43b93-7e48-4614-a245-0bdac7529a68">2,628,571</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtNC0xLTEtMA_43aea9c5-d910-47d8-b5cc-5ced75197595">63,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueNewIssues" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtMjAtMS0xLTA_910cfb6a-6b9d-407c-acf1-1e3ba63b231d">63,855</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Stock option exercises</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctMi0xLTEtMA_6ee3622c-79e3-439b-ab27-09defc5c83dc">39,723</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctNC0xLTEtMA_beea7853-fd5b-4914-8c4c-d608c711248c">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctMjAtMS0xLTA_ba1d2762-8c08-4a7a-82bb-31add82e78cf">181</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Share-based compensation</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMi0xLTEtMA_1e8dedb7-9fe3-4b59-9cd1-252b3d6dc103">11,062</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="-3" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktNC0xLTEtMA_049798ef-8408-4427-a5ac-128155125e72">11</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iadc48570b61b405a97585b09fb39f436_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMTQtMS0xLTA_241260b9-d8af-439d-af56-752b81aa8dc8">1,618</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMjAtMS0xLTA_c9c6f0d8-23a1-4a01-a754-a221db1541ab">1,629</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Shares withheld to cover income tax obligation upon vesting of restricted stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMi0xLTEtMA_a7bf8690-15b4-4076-9338-221472666c9c">1,383</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtNC0xLTEtMA_cc6499d6-2630-4bc6-bb3b-0ee3c87e5763">1</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="iadc48570b61b405a97585b09fb39f436_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMTQtMS0xLTA_20cde836-a252-4688-b0df-5c9996e7237b">33</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMjAtMS0xLTA_40624edb-53fa-4e8b-9408-065f03d514d7">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Foreign currency translation gain</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i176f5f3fed6946c0a3f5a48340d39eb9_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjEtMTgtMS0xLTA_b92e4bfe-aacb-4f05-8981-f7a7e517880c">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjEtMjAtMS0xLTA_713997ff-a464-44d4-9cc6-2664f79e23aa">2,821</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i1541abdbaa374948b1b9a005046d4619_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjItMTYtMS0xLTA_b10dd5d8-09c2-456c-b588-e3e076f2feb7">17,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjItMjAtMS0xLTA_225661ce-6f62-4393-8c09-3cc88b3676a4">17,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance at March 31, 2020</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4f1c51ee57d844558ea1135f49bae5c0_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMi0xLTEtMA_2b77b2f3-0d6c-4f54-aa8f-a6c86d25fd23">23,735,013</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4f1c51ee57d844558ea1135f49bae5c0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtNC0xLTEtMA_68260f4c-2a9a-4f7d-aa79-5569095f400a">211,734</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="icbae770df24748ea9b96a10664c50302_I20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:SharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTAtMS0xLTA_d2ef4dd7-5e53-4cbd-a58c-383553577d6d">408,070</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="icbae770df24748ea9b96a10664c50302_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTItMS0xLTA_47a94026-1583-48c4-bd50-86d65b68da37">2,854</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i572345c645984642a2707a36a0be8636_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTQtMS0xLTA_98049d12-6dcd-4d24-acd5-0634fda4fd53">22,799</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i592974b4edd4462d8c0a59600b23a746_I20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTYtMS0xLTA_6f254417-707c-4726-873f-4f42d2edcf9c">144,878</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1dd6b5f4c6e54f6da671c43da519f1b0_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTgtMS0xLTA_8f1230bb-8ce6-4749-aa6f-e428987514d0">3,512</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">$</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5a00be8cba48418ad7288e78d73ae7_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:StockholdersEquity" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMjAtMS0xLTA_32dfa984-99cc-45e5-869a-859c168b6efc">90,313</ix:nonFraction></span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;border-bottom:3pt double #000;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">5</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_28"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:69.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.762%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows from operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNC0yLTEtMS0w_25818941-a9ca-4993-ac53-b9c0e5408b50">6,948</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNC00LTEtMS0w_777258f6-e5ec-41ad-92b1-577905794c11">17,753</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Adjustments to reconcile net loss to net cash used in operating activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="esta:DepreciationandAmortizationExcludingDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNi0yLTEtMS0w_082000ef-a154-464a-a759-1f343987e9c7">908</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="esta:DepreciationandAmortizationExcludingDebtDiscountPremium" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNi00LTEtMS0w_eb7e3ba1-aaf4-48a6-80f4-9f1d0c6dba44">833</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Provision for doubtful accounts</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNy0yLTEtMS0w_81e1fc28-a391-418e-96c2-70d7d7d5af55">6</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:ProvisionForDoubtfulAccounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNy00LTEtMS0w_2e2850d8-b03e-4173-99d0-ecfa99cbcd07">599</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Provision for inventory obsolescence</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOC0yLTEtMS0w_7088837a-faba-442e-a4c0-54e33f6c149c">93</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:InventoryWriteDown" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOC00LTEtMS0w_68f207ba-d88d-46d2-a021-bd7662d6787b">137</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Share-based compensation </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOS0yLTEtMS0w_e3126c8c-0e31-4394-b967-06f04ed1bed6">1,756</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOS00LTEtMS0w_e785db8a-8e15-4625-b5e1-d26eb26916b9">1,629</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Loss from disposal of property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTAtMi0xLTEtMA_91e14270-9627-474d-af12-25a0ce485e76">20</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:GainLossOnSaleOfPropertyPlantEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTAtNC0xLTEtMA_45c07d7d-6f8f-4f45-a442-9647d2154453">5</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unrealized foreign currency loss, net</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTItMi0xLTEtMA_012fed3c-fb81-44f9-bb73-4cc088a8c2ea">3,030</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossUnrealized" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTItNC0xLTEtMA_fe7b367c-8530-4d6b-a528-6e35995012ca">5,845</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Amortization of right-to-use asset</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtMi0xLTEtMTUz_0774db73-306d-4077-87e8-2108bed774f8">101</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtNC0xLTEtMTQ5_779e6c36-5259-42e7-bd82-8271d383dc27">79</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Change in fair value of derivative instruments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtMi0xLTEtMA_1d157645-0a69-417a-8b1e-6ffdf1984942">230</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:UnrealizedGainLossOnDerivatives" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtNC0xLTEtMA_3840ea84-b89f-400b-a785-598dae57aee2">1,929</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTQtMi0xLTEtMA_7f7663e4-c555-4f61-9886-970cefc9087f">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTQtNC0xLTEtMA_cb9355c3-98e2-4672-bc51-5d7ed8c19512">440</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Amortization of debt discount</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTUtMi0xLTEtMA_21e30d6a-0a38-43a9-9ee0-94df8fd0fd77">474</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:AmortizationOfFinancingCostsAndDiscounts" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTUtNC0xLTEtMA_dd6c2150-0b80-4f3d-8c1c-ae74b97c717b">388</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Changes in operating assets and liabilities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts receivable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTctMi0xLTEtMA_fc1d1951-1fed-4c38-acd5-ea90255ce638">5,218</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsReceivable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTctNC0xLTEtMA_2f51a331-22b2-41b5-ae48-c543e3a9ffb1">171</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Inventory</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTgtMi0xLTEtMA_3fde4dad-1267-4c90-9162-35ab8aece067">698</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInInventories" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTgtNC0xLTEtMA_ffa20f9a-5af6-432e-a19d-bdc864697961">438</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Prepaid expenses and other current assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTktMi0xLTEtMA_9d6144f9-f2c1-4732-b159-719d56d7b092">1,217</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTktNC0xLTEtMA_7e25ddd8-1f04-483e-916f-f7a064d88b1f">660</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjAtMi0xLTEtMA_ff0de94c-8436-48b8-acba-b44cf05595b7">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:IncreaseDecreaseInOtherNoncurrentAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjAtNC0xLTEtMA_0d905490-7295-40ba-804e-10ad908e4e2c">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accounts payable</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjEtMi0xLTEtMA_4e6edb18-71fa-4576-9fb3-0fee132856fa">617</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccountsPayable" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjEtNC0xLTEtMA_2cc573b4-6ce3-4fba-b017-fa513a0c3421">366</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Accrued liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjItMi0xLTEtMA_7b9dcc6c-d512-48a0-87aa-538b44d192c6">158</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInAccruedLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjItNC0xLTEtMA_d57a302d-afdf-4139-85c5-62176157b21b">40</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="esta:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtMi0xLTEtMTYx_9c060bf8-61b4-48cf-b37a-b5ed1e4eddc8">95</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="esta:IncreaseDecreaseInOperatingLeaseLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtNC0xLTEtMTU3_441686db-ebce-4806-90eb-818a3a6ae553">70</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Other liabilities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjMtMi0xLTEtMA_41c01b48-01b9-48b6-a4b1-875efc3390eb">221</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncreaseDecreaseInOtherOperatingLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjMtNC0xLTEtMA_318484f7-f793-4116-bcb2-6cc9e044ae13">4</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in operating activities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtMi0xLTEtMA_64519fe8-8894-4c09-b1be-51ce9b58a452">6,554</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInOperatingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtNC0xLTEtMA_d0f5f2fe-e47f-456a-87a5-4f1500fcb986">6,802</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows from investing activities:</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Purchases of property and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjYtMi0xLTEtMA_b9c51d84-ec55-4f7a-a2af-f05c7ec06a3e">804</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsToAcquirePropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjYtNC0xLTEtMA_4666d558-6b10-4860-9e55-eac0b13cdf91">687</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash used in asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="esta:PaymentstoAcquireAssetsIncludingReceivablesHeld" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjctMi0xLTEtMA_d5e8153b-0a36-4715-a327-c37442784859">434</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="esta:PaymentstoAcquireAssetsIncludingReceivablesHeld" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjctNC0xLTEtMA_8e7bdb36-0acc-4f2f-9099-75450b540019">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cost incurred for intangible assets</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjgtMi0xLTEtMA_d5e8baee-7b95-4ebb-b94f-98ad937a8452">294</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsToAcquireIntangibleAssets" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjgtNC0xLTEtMA_f98217ad-a003-45bf-8132-b688cddc4fb3">262</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash used in investing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzAtMi0xLTEtMA_04a6f99b-dfb1-4d5d-96b9-98b931a1fbad">1,532</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:NetCashProvidedByUsedInInvestingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzAtNC0xLTEtMA_fcebc8c6-ecbe-4c4a-815f-ff88d1dcb414">949</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash flows from financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Repayments on finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzgtMi0xLTEtMA_67f3af5b-1e53-4210-999f-2eb4aeaacf18">55</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzgtNC0xLTEtMA_92ffa02e-d00c-4ab1-accf-af62078b3b5e">76</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from issuance of common shares, net of underwriters&#8217; discount and issuance costs</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDAtMi0xLTEtMA_cfba3eb2-1d73-42ee-8aad-d8a60f2af7c7">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfCommonStock" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDAtNC0xLTEtMA_97921494-9c14-4258-9544-783d276f5166">63,855</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Proceeds from stock option exercises</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDMtMi0xLTEtMA_b3ec5d0e-f70b-4dc8-b73e-df525e265241">1,882</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:ProceedsFromStockOptionsExercised" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDMtNC0xLTEtMA_b21fd8d1-295e-45d1-9609-a97ac7e3f583">181</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Tax&#160;payments&#160;related&#160;to&#160;shares&#160;withheld&#160;upon&#160;vesting of&#160;restricted&#160;stock</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDUtMi0xLTEtMA_3cb87e0d-0ca6-4e97-98d8-29b02a0bdf3e">41</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDUtNC0xLTEtMA_63b5ad01-9511-42b7-b456-cbf44762ede7">34</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net cash provided by financing activities</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDYtMi0xLTEtMA_c1fc2adc-2c88-43f9-bc1c-905db00c8f01">1,786</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:NetCashProvidedByUsedInFinancingActivities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDYtNC0xLTEtMA_5cbd592a-9219-4577-9f64-c0d23174d13c">63,926</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDctMi0xLTEtMA_d056f35d-0951-4f01-a81f-2715dec611c1">273</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" name="us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDctNC0xLTEtMA_ea3dff9b-7824-44ad-9ac3-3e3f6f9400ee">234</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Net (decrease)/increase in cash</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDgtMi0xLTEtMA_99699d7e-1010-427a-8f7e-8346aa6398f4">6,573</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDgtNC0xLTEtMA_f24b2a05-7137-47ba-9669-4d4e69e2891c">55,941</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash at beginning of period</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDktMi0xLTEtMA_607634bf-d8c8-42b9-9bef-064368ef579f">84,523</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i7788fd91dc6d471fa4673c7a9251123e_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDktNC0xLTEtMA_d293f4c9-0833-4741-a7f1-541d860a9e96">37,655</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash at end of period</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTAtMi0xLTEtMA_0c039126-1dd6-4210-8571-9bb15017b8e6">77,950</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifd5a00be8cba48418ad7288e78d73ae7_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTAtNC0xLTEtMA_94302f37-1858-4740-8514-62e1e4ef2d8d">93,596</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:3pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Condensed Consolidated Statements of Cash Flows</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(In thousands)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:69.689%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.762%"></td><td style="width:0.1%"></td></tr><tr style="height:6pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Supplemental disclosures:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for interest</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTQtMi0xLTEtMA_7f4f6561-2b27-40af-aeb5-aacc54f27cc4">1,710</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InterestPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTQtNC0xLTEtMA_e5a582c3-1ea4-49a5-a654-bf05e36dfcb6">1,734</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Cash paid for income taxes</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTUtMi0xLTEtMA_7add73d6-2e4a-4841-a678-7120227e8e1b">10</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:IncomeTaxesPaidNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTUtNC0xLTEtMA_1370e330-7e65-46b4-a7bd-d9c967a66f6c">1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Supplemental disclosures of non-cash investing and financing activities:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Unpaid balance for property and equipment</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTgtMi0xLTEtMA_e1d1f1f4-cd3c-479b-9933-d0925b70065c">143</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:CapitalExpendituresIncurredButNotYetPaid" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTgtNC0xLTEtMA_c05bdcda-09b3-4abb-865e-5769595d1fef">395</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">Consideration payable related to asset acquisition</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="esta:NoncashConsiderationPayableRelatedtoAssetAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNjQtMi0xLTEtMA_c7d4b5a6-0311-4a68-bd7d-160721e41818">407</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8.5pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="esta:NoncashConsiderationPayableRelatedtoAssetAcquisition" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNjQtNC0xLTEtMA_91d7515d-b0b2-4b6e-a6f5-94402092cc00">1,257</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying notes are an integral part of these condensed consolidated financial statements.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">7</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_31"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="text-align:center"><span><br/></span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_34"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNC9mcmFnOmIyMWE2MDhhNTA5ZDRkOTI4MWQ2NjNhYjlkNTc4YzdjL3RleHRyZWdpb246YjIxYTYwOGE1MDlkNGQ5MjgxZDY2M2FiOWQ1NzhjN2NfMzUzOQ_c3fe1ba1-4f3d-4a84-a2a2-a73b6b7f41db" continuedAt="i1dc5572f1ee24b32af795ec47feec131" escape="true">Formation and Business of the Company</ix:nonNumeric></span></div><ix:continuation id="i1dc5572f1ee24b32af795ec47feec131" continuedAt="id1f8ca62e8e14fb187a51018a1fb80f0"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formation and Business of the Company</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishment Labs Holdings Inc. and its wholly owned subsidiaries (collectively &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) is a global company that manufactures and markets innovative medical devices for aesthetic and reconstructive plastic surgery. The Company was established in the British Virgin Islands on October 9, 2013, at which time Establishment Labs, S.A., the Costa Rican manufacturing company, was reincorporated as a wholly-owned subsidiary. As of March&#160;31, 2021, the Company also has wholly-owned subsidiaries in the United States (JAMM Technologies, Inc. and Motiva USA LLC), Brazil (Establishment Labs Produtos para Saude Ltda), Belgium (European Distribution Center Motiva BVBA), France (Motiva Implants France SAS), Sweden (Motiva Nordica AB), Switzerland (JEN-Vault AG), the United Kingdom (Motiva Implants UK Limited), Italy (Motiva Italy S.R.L), Spain (Motiva Implants Spain, S.L.), Austria (Motiva Austria GmbH), Germany (Motiva Germany GmbH) and Argentina (Motiva Argentina S.R.L). Substantially all of the Company&#8217;s revenues are derived from the sale of silicone gel-filled breast implants, branded as Motiva Implants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The main manufacturing activities are conducted at <ix:nonFraction unitRef="facility" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="esta:NumberOfManufacturingFacilities" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNC9mcmFnOmIyMWE2MDhhNTA5ZDRkOTI4MWQ2NjNhYjlkNTc4YzdjL3RleHRyZWdpb246YjIxYTYwOGE1MDlkNGQ5MjgxZDY2M2FiOWQ1NzhjN2NfMTIyNw_102708b5-2a50-48f0-a59e-9bf14ebc45d2">two</ix:nonFraction> manufacturing facilities in Costa Rica. In 2010, the Company began operating under the Costa Rica free zone regime (R&#233;gimen de Zona Franca), which provides for reduced income tax and other tax obligations pursuant to an agreement with the Costa Rican authorities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are approved for sale in Europe, the Middle East, Latin America, and Asia. The Company sells its products internationally through a combination of distributors and direct sales to customers. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is pursuing regulatory approval to commercialize its products in the United States. The Company received approval for an investigational device exemption, or IDE, from the FDA in March 2018 to initiate a clinical trial in the United States for its Motiva Implants. In August 2019, we completed all patient surgeries for the IDE aesthetic cohorts, which include primary augmentation and revision. As of March&#160;31, 2021, we are continuing to enroll subjects in the remaining reconstruction cohorts. </span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id1f8ca62e8e14fb187a51018a1fb80f0">The Company has been expanding its global operations through a series of acquisitions and establishing wholly-owned subsidiaries. In November 2015, the Company purchased certain assets from Magna Equities I, LLC and established its wholly-owned subsidiary, JAMM Technologies, Inc., in the United States. In January 2016, the Company purchased a distribution company in Brazil to support the application to sell its products in Brazil. In March 2016, the Company purchased a storage and distribution company in Belgium to support its continued growth in Europe. In September 2016, the Company purchased a distribution company in France, and it also established a wholly-owned subsidiary in Switzerland. In November 2017, the Company acquired certain assets from Femiline AB and established its wholly-owned subsidiary in Sweden, Motiva Nordica AB. During 2018, the Company established wholly-owned subsidiaries in the United Kingdom and Italy and purchased certain assets from Menke Med GmbH, Motiva Matrix Spain, S.L. and Belle Health Ltd. In 2019, the Company purchased certain assets from AFS Medical GMBH and established wholly-owned subsidiaries in Austria, Spain and Germany. In 2020, the Company established a wholly-owned subsidiary in Argentina and purchased certain assets from Orion Trading SRL for the Italian operations.</ix:continuation> </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_37"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:SignificantAccountingPoliciesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDI_de341e2c-cb49-465d-a10f-00d95cbecf17" continuedAt="i596c3971f856403fa0722ba4681a931c" escape="true">Summary of Significant Accounting Policies</ix:nonNumeric></span></div><ix:continuation id="i596c3971f856403fa0722ba4681a931c" continuedAt="i4d7c3ffec2824644b71a43cf7e38df58"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s significant accounting policies during the&#160;three months ended March&#160;31, 2021 as compared to the significant accounting policies described in Note 2 of the &#8220;Notes to Consolidated Financial Statements&#8221; in the Company&#8217;s audited consolidated financial statements as of December&#160;31, 2020 and 2019 and for the years then ended. Below are those policies with current period updates.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:BasisOfAccountingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTY_6e550028-9c72-4ecd-b945-ad25e83c12b7" continuedAt="i7ae8e73efa6a44748f1d18caa2feffc8" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ConsolidationPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODQ_7e3016bf-9405-4b15-aa01-bdf93ca14ed6" continuedAt="i19ee8dae7bdb4590bf7f3a1612dc88fb" escape="true">The accompanying condensed consolidated financial statements and related financial information should be read </ix:nonNumeric></span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i4d7c3ffec2824644b71a43cf7e38df58" continuedAt="i4e1f1cfdd8d14347b1f26a7cfcefa472"><ix:continuation id="i19ee8dae7bdb4590bf7f3a1612dc88fb" continuedAt="iab7671bec21e401288720124e1ac14ff"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7ae8e73efa6a44748f1d18caa2feffc8" continuedAt="if309fa81825546c5bc3bf9358363e4cf">in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#8217;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.</ix:continuation></span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="esta:ScheduleOfConsolidatedEntitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTE_4c14027c-e59b-46fa-889c-4ddf690d7e29" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the Company&#8217;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.394%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.406%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporation/Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs, S.A. (Costa Rica)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2004</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva USA, LLC (USA)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JAMM Technologies, Inc. (USA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs Produtos par Saude Ltda (Brazil)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Distribution Center Motiva BVBA (Belgium)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants France SAS (France)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 12, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JEN-Vault AG (Switzerland)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Nordica AB (Sweden)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants UK Limited (the United Kingdom)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Italy S.R.L (Italy)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants Spain, S.L. (Spain)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 3, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Austria GmbH (Austria)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 14, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Germany GmbH (Germany)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Argentina S.R.L (Argentina)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iab7671bec21e401288720124e1ac14ff">All intercompany accounts and transactions have been eliminated in consolidation.</ix:continuation> </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:continuation id="if309fa81825546c5bc3bf9358363e4cf" continuedAt="id45e4a8d3d4345a1b5cce2a134c0b836">Unaudited Interim Condensed Consolidated Financial Information</ix:continuation></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id45e4a8d3d4345a1b5cce2a134c0b836">The accompanying interim condensed consolidated financial statements as of March&#160;31, 2021 and for the three months ended March&#160;31, 2021 and 2020, and the related interim information contained within the notes to the condensed consolidated financial statements, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments which are necessary to state fairly the Company&#8217;s financial position as of March&#160;31, 2021, and the results of its operations and cash flows for the three months ended March&#160;31, 2021 and 2020. Such adjustments are of a normal and recurring nature. The results for the three months ended March&#160;31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year 2021, or for any future period.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:SegmentReportingPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjc_235dc418-70da-40a1-802e-d8636d795bef" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic regions in which the Company operates.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i4e1f1cfdd8d14347b1f26a7cfcefa472" continuedAt="i1112ccbe92d942a68749408a59d53056"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="esta:GeographicConcentrationsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTc_a73b96d4-d9bc-47cb-b591-c5896615fc79" continuedAt="iba7ea696ed5d4296a0886a43b5cfebce" escape="true">Geographic Concentrations </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iba7ea696ed5d4296a0886a43b5cfebce">The Company derives all its revenues from sales to customers in Europe, the Middle East, Latin America, and Asia, and has not yet received approval to sell its products in the United States.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021 and 2020 Brazil accounted for <ix:nonFraction unitRef="number" contextRef="i8bd19aab21a94b07b796f48b84ac115a_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzU0MQ_472d3b6d-46e5-4386-b77a-79908c844a6d">10.6</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="ic9ea8ba03f124881b6cb4934a8317cf3_D20200101-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEyMTc3Mg_9670a174-26d6-4a51-b839-67d18d0dfa6e">10.0</ix:nonFraction>% of consolidated revenue, respectively, and no other individual country exceeded 10% of consolidated revenue, on a ship-to destination basis. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s consolidated total assets, including cash and tangible assets, is held in the United States. The Company&#8217;s long-lived assets, which primarily consist of property and equipment and intangible assets located in Costa Rica represented </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonFraction unitRef="number" contextRef="i2d40f566ba694c62a29ae89f751ed9ee_D20210101-20210331" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEwMzkwNQ_58fd6a70-4296-4cd4-9e2d-cd2f3ee58e65">78</ix:nonFraction>% and <ix:nonFraction unitRef="number" contextRef="i081fde0d54924d748cd0047a247aca91_D20200101-20201231" decimals="2" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEwMzkxOA_767e9794-7941-402d-8b02-7014ca8ca4e4">80</ix:nonFraction>% </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the total long-lived assets as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:UseOfEstimates" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDA_54d1b758-1014-48bd-9c14-2582e7dbc379" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the condensed </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets&#8217; useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ConcentrationRiskCreditRisk" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTI_42e70db4-3c62-494d-a3ce-f00c725c65a0" continuedAt="id8e78cac5aab432894e120920b6df690" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. Balances in the Company&#8217;s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s revenues were derived from the sale of Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, no customer accounted for more than 10% of the Company&#8217;s revenue. <ix:nonFraction unitRef="number" contextRef="ib1162e78c15d49bb9ac650a48748dcd6_D20200101-20201231" decimals="3" format="ixt-sec:numwordsen" name="us-gaap:ConcentrationRiskPercentage1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM3NzAxNw_1a3e128b-24b2-43b6-a7fb-f8184a68fdac">No</ix:nonFraction> customer accounted for more than 10% of the Company&#8217;s trade accounts receivable balance as of March&#160;31, 2021 or </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, the Company had purchases of $<ix:nonFraction unitRef="usd" contextRef="i73eb050084884d97aabea10fa887eb00_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI1NQ_f88bf559-aba9-4931-b077-4b33823c7405">4.3</ix:nonFraction> million, or <ix:nonFraction unitRef="number" contextRef="i9c4421ada28146c7bd79ce446cfd0743_D20210101-20210331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI2Mg_5652849d-093e-4c74-abc3-2f000fa03a48">55.8</ix:nonFraction>% of total purchases, and $<ix:nonFraction unitRef="usd" contextRef="i68ae26916d1344978f6c5489277d557b_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:PaymentsToSuppliers" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI4OQ_3890c3e3-ea52-4ebc-a3eb-54e877a4e58d">5.0</ix:nonFraction>&#160;million, or <ix:nonFraction unitRef="number" contextRef="i1425d844a2054eb1874c578463f2cd02_D20200101-20200331" decimals="3" name="us-gaap:ConcentrationRiskPercentage1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI5Ng_48af9be9-2396-4d42-b5ab-79be16a4fb49">64.9</ix:nonFraction>% of total purchases, respectively, from NuSil. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had an outstanding balance owed to this vendor of $<ix:nonFraction unitRef="usd" contextRef="i05b2ab81a8424def8cac4bbd46817c34_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjQyNA_140dd637-76bd-4a43-843b-c8f3d6fa9b71">1.6</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i7eb8031bfbf744fd8a075ed851059c67_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsPayableTradeCurrent" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjQzMQ_3f2a5132-c768-4e3a-a1e6-de555356b9ae">1.3</ix:nonFraction> million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company&#8217;s current and potential future products, uncertainty of market acceptance of the Company&#8217;s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="id8e78cac5aab432894e120920b6df690">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</ix:continuation> </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i1112ccbe92d942a68749408a59d53056" continuedAt="ief1add90fbc94e9e83ebd9edae4365bc"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus, or COVID-19, as a pandemic which has spread globally, including locations where the Company does business. This outbreak caused a material disruption of the operations of the Company and its suppliers and customers in fiscal 2020 and resulted in delayed clinical trial enrollment within the reconstruction cohorts of its IDE clinical trial in the United States. However, the impact from the COVID-19 outbreak has not had a material effect on the Company&#8217;s liquidity or financial position. The full extent of any future impact of the continuing outbreak, related business and travel restrictions and changes to behavior intended to reduce its spread are uncertain and continues to evolve globally. Management continues to monitor the impact that the COVID-19 pandemic is having on the Company, the breast aesthetics and reconstruction market and the economies in which the Company operates. The Company anticipates that its future results of operations, including the results for 2021 could be materially impacted by the COVID-19 outbreak. However, given the speed and frequency of continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the potential impact to the results of its operations. To the extent that the Company&#8217;s customers continue to be materially and adversely impacted by the COVID-19 outbreak, this could materially interrupt the Company&#8217;s business operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzE_9c440d36-a2a9-4b1c-80a4-682bfdd3c138" continuedAt="i612cc552898d495c9d5a0163383bf8fd" escape="true">Cash </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i612cc552898d495c9d5a0163383bf8fd">The Company&#8217;s cash consists of cash maintained in checking and interest-bearing accounts. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents.</ix:continuation> The Company held <ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfOTI0NA_0f6391ce-b425-4b1c-9efa-dbddeec2bc11"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:CashEquivalentsAtCarryingValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfOTI0NA_84627d40-95ec-4229-8a90-f50393270f40">no</ix:nonFraction></ix:nonFraction> cash equivalents as of March&#160;31, 2021 or </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTM_41e4963a-f83a-4414-891f-0bc3d5f365c3" continuedAt="i7e408a60ffeb448494c8cb3ea9aecb49" escape="true">Accounts Receivable and Allowance for Doubtful Accounts</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7e408a60ffeb448494c8cb3ea9aecb49">Accounts receivable is stated at invoice value less estimated allowances for returns and doubtful accounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from customers&#8217; inability to make required payments. In evaluating the Company&#8217;s ability to collect outstanding receivable balances, the Company considers various factors including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition. In cases where there are circumstances that may impair a specific customer&#8217;s ability to meet its financial obligations, an allowance is recorded against amounts due, which reduces the net recognized receivable to the amount reasonably believed to be collectible.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:InventoryPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTQ_dc321365-c944-4136-bfe8-ff2698a1ac52" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory and Cost of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost to purchase or manufacture the inventory or the net realizable value of such inventory. Cost is determined using the standard cost method which approximates actual costs using the first-in, first-out basis. The Company regularly reviews inventory quantities considering actual losses, projected future demand, and remaining shelf life to record a provision for excess and slow-moving inventory. An inventory reserve of $<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTA2NzQ_86759702-7960-47ca-b1b5-d7d3b30b600b">1.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InventoryValuationReserves" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTA2ODE_d392099a-ad0c-44b6-a73b-34ac4832649b">1.6</ix:nonFraction> million has been recorded as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of inventory transferred to the customer in cost of revenue when revenue is recognized.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:LesseeLeasesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM3NzAxMg_f0f93d1b-276d-4ad2-aec3-16f296ec9500" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at the inception date of the contract. The Company has elected an expedient to account for each separate lease component and its associated non-lease components as a single lease component for the majority of its asset classes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. The Company recognizes lease liabilities and right-of-use, or ROU, assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ief1add90fbc94e9e83ebd9edae4365bc" continuedAt="ia7fc518cfa404e588081cac163972e8e"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:RevenueFromContractWithCustomerPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjU_9a35e2c5-e2c8-4c98-8ea2-6d11867721dd" continuedAt="i88a522cc8f964fdaabf051397a46e281" escape="true">Shipping and Handling Costs</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i88a522cc8f964fdaabf051397a46e281" continuedAt="ie34b1fe230d0469facf0c3551874745b">Shipping and handling costs are expensed as incurred and are included in selling, general and administrative, or SG&amp;A, expenses.</ix:continuation> For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020, shipping and handling costs were </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i004b7705a98e4c32b860182a8c4f08b3_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTExNzQ_301596e8-72ee-4105-859a-7f73e272efa0">1.2</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i3b07bb856af64942a2e4ba6539ed0b99_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:SellingGeneralAndAdministrativeExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTExODE_0e351792-175b-48a6-80d0-5649e6077793">0.8</ix:nonFraction>&#160;million, respectively.</span></div><ix:continuation id="ie34b1fe230d0469facf0c3551874745b" continuedAt="i9b89fe5bccfc4fd9a84be157616ddd9b"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to sales of products to distributors or directly to customers in markets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where it has regulatory approval, net of discounts and allowances. The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, Revenue from Contracts with Customers. ASC 606 requires the Company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to the sales of products to distributors at the time of shipment of the product, which represents the point in time when the distributor has taken ownership and assumed the risk of loss and the required revenue recognition criteria are satisfied. The Company&#8217;s distributors are obligated to pay within specified terms regardless of when, or if, they sell the products. The Company&#8217;s contracts with distributors typically do not contain right of return or price protection and have no post-delivery obligations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when title to the product and risk of loss transfer to customers, provided there are no remaining performance obligations required of the Company or any written matters requiring customer acceptance. The Company allows for the return of product from direct customers in certain regions in limited instances within <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:durwordsen" name="esta:RevenueFromContractWithCustomerProductReturnPeriod" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTI3ODQ_fb6e594f-7e59-4415-8de1-d9687c01c2c4">fifteen days</ix:nonNumeric> after the original sale and records estimated sales returns as a reduction of sales in the same period revenue is recognized. Appropriate reserves are established for anticipated sales returns based on historical experience, recent gross sales and any notification of pending returns. Actual sales returns in any future period are inherently uncertain and thus may differ from the estimates. If actual sales returns differ significantly from the estimates, an adjustment to revenue in the current or subsequent period is recorded. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an allowance of <ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt-sec:numwordsen" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTMyODU_37384c52-66d5-4ce4-bfe2-3580b2d27751">zero</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTMyOTI_f1de219e-9c11-4331-8c79-395cf547f6e7">54,000</ix:nonFraction> was recorded for product returns, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s revenue is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For these products, revenue is recognized at the time the Company is notified by the consignee that the product has been implanted, not when the consigned products are delivered to the consignee&#8217;s warehouse. </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:DisaggregationOfRevenueTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNDk_25581737-0705-4b52-ac02-d499e7189b9f" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was generated in these primary geographic markets:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:68.096%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.395%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib3ef82464d324a3a9122d68d6f8222d4_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNC02LTEtMS0w_8698a40c-7017-462c-90e6-f6226b473b56">12,693</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4beb3e97e88a46229246ffae5ae38b10_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNC04LTEtMS0w_43e9d18b-1c76-4502-929e-4a6373ea8236">9,779</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d50b891602a40ae8475374170cd88a9_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNS02LTEtMS0w_33f86e18-bea9-4f06-9ba0-98d7ca828c8d">8,001</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0f90130bb6ee4c95851406f50fa32310_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNS04LTEtMS0w_24c9a323-2529-4d2d-960c-32fd432c56c7">7,141</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific/Middle East</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i60a99d33ac56428badf4fa77635987cc_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNi02LTEtMS0w_aa969814-b5c9-4e66-8a07-58c7b7b96d40">9,495</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id8f4d7ebd44a431298ec2a860ec67dc5_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNi04LTEtMS0w_b746a314-95b0-4ed0-977a-c429d9d79cbb">7,471</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic1895da228434d8c86601eebd0eb076b_D20210101-20210331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNy02LTEtMS0w_8c1fa2bf-7aaa-46fa-bb5a-a6e15ef839f7">147</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i01fdfa1c7b87456c91b44f087364d012_D20200101-20200331" decimals="-3" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNy04LTEtMS0w_35355a74-b65b-47e3-833f-33b665ed37f0">90</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfOC02LTEtMS0w_b844f77d-45c1-4787-a296-b5b457ab5432">30,336</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfOC04LTEtMS0w_9a49da3f-99e2-4dc8-b709-1645bffa64ea">24,481</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a limited warranty for the shelf life of the product, which is <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:durwordsen" name="esta:RevenueFromContractWithCustomerProductShelfLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTM4MzQ_6ee8643d-8e7f-4247-a689-9c453cce0353">five years</ix:nonNumeric> from the time of manufacture. Estimated warranty obligations are recorded at the time of sale. The Company also offers a warranty to patients in the event of rupture and a replacement program for capsular contracture events, provided certain registration requirements are met. Revenue for extended warranties is recognized ratably over the term of the agreement. To date, these warranty and program costs have been de minimis. The Company will continue to evaluate the warranty reserve policies for adequacy considering claims history.</span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia7fc518cfa404e588081cac163972e8e" continuedAt="ib81f4e256c7d4449921daa3185cbd23d"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i9b89fe5bccfc4fd9a84be157616ddd9b">Deferred revenue primarily consists of payments received in advance of meeting revenue recognition criteria. The Company has received payments from distributors to provide distribution exclusivity within a geographic area and recognizes deferred revenue on a ratable basis over the term of such contractual distribution relationship. Additionally, the Company has received payments from customers in direct markets prior to surgical implantation and recognizes deferred revenue at the time the Company is notified by the customer that the product has been implanted. For all arrangements, any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue and included in &#8220;Other liabilities, long-term&#8221; on the condensed consolidated balance sheets (see Note 3).</ix:continuation></span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ResearchAndDevelopmentExpensePolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODA_dac01270-0633-4119-b36e-aa84f5f7bb5a" continuedAt="i99862fd18cfa46619a76fd25800d658e" escape="true"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to research and development, or R&amp;D, activities are expensed as incurred. R&amp;D costs primarily include personnel costs, materials, clinical expenses, regulatory expenses, product development, consulting services, and outside research activities, all of which are directly related to research and development activities. </span></div></ix:nonNumeric><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i99862fd18cfa46619a76fd25800d658e">The Company estimates IDE clinical trial expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations that conduct and manage clinical trials on its behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly.</ix:continuation> </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjg_bc904f42-625e-4745-9999-dd53604c1652" continuedAt="if8cb2be4b24a4bc7b69218e5f5e727b6" escape="true">Selling, General and Administrative Expenses</ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="if8cb2be4b24a4bc7b69218e5f5e727b6">SG&amp;A expenses include sales and marketing costs, payroll and related benefit costs, insurance expenses, shipping and handling costs, legal and professional fees and administrative overhead.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:PropertyPlantAndEquipmentPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjE_d62d9a0d-6abe-46c1-b2f3-c247a056bf55" continuedAt="i7a45f0bfcfab454c8c2605b3c1b071e3" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;margin-top:4.05pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization.</span></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:0.1pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i7a45f0bfcfab454c8c2605b3c1b071e3">Following the exercise of its option to purchase its manufacturing facility in June 2019, the Company depreciates the owned building on a straight-line basis over <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY2MTg_23e1d17f-c9d5-42f1-ad7c-d4f68a70eda1">50</ix:nonNumeric> years of useful life. Depreciation of property and equipment is computed using the straight-line method over the assets&#8217; estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b">five</span> to <ix:nonNumeric contextRef="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:PropertyPlantAndEquipmentUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3NzQ_12fd4b86-4ac0-4386-9b6b-bfa85d2d90d4">ten years</ix:nonNumeric>. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the remaining lease term after factoring expected renewal periods. Upon retirement or disposal of assets, the costs and related accumulated depreciation are eliminated from the accounts and any gain or loss is recognized in operations. Maintenance and repairs are expensed as incurred. Substantially all of the Company&#8217;s manufacturing operations and related property and equipment is located in Costa Rica.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjY_e305f131-4b4b-4833-9746-ecf27d0f95b8" continuedAt="ic95ebea8c34249bca61baaba407781a3" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the excess of the acquisition purchase price over the net fair value of the tangible and identifiable intangible assets acquired and liabilities assumed as goodwill. In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company tests goodwill for impairment annually during the fourth quarter of each year and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with the annual impairment test for goodwill, the Company elected the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it was more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test is performed. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the Company's assessment that it has only <ix:nonFraction unitRef="segment" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportableSegments" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTgyODE_cd7275cc-decc-4611-a607-d7c831ac45c8">one</ix:nonFraction> reporting segment, the Company has determined that it has only <ix:nonFraction unitRef="reportingunit" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:NumberOfReportingUnits" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTgzNDc_912b51ab-6f96-49aa-8187-ba8559f3649a">one</ix:nonFraction> reporting unit and tests goodwill for impairment at the entity level using the two-step process required by ASC 350. In the first step, the Company compares the carrying amount of the reporting unit to the fair value of the enterprise. If the fair value of the enterprise exceeds the carrying value, goodwill is not considered impaired and no further testing is required. If the carrying value of the enterprise exceeds the fair value, goodwill is potentially impaired, and the second step of the impairment test must be performed. In the second step, the Company compares the implied fair value of the goodwill, as defined by ASC 350, to its carrying amount to determine the impairment loss, if any.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes certain costs related to intangible assets, such as patents, trademarks and software </span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ib81f4e256c7d4449921daa3185cbd23d" continuedAt="i217d561244eb4185824927bc3e50ec42"><div><ix:continuation id="ic95ebea8c34249bca61baaba407781a3" continuedAt="iecbf243b3c91444ca3a4519e5aa359a3"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">development costs. The Company follows the provisions of ASC 350-40, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Use Software </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for determining whether computer software is internal-use software and on accounting for the proceeds of computer software originally developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of software development and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.</span></ix:continuation></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"><ix:continuation id="iecbf243b3c91444ca3a4519e5aa359a3">The Company records purchased intangible assets at their respective estimated fair values at the date of acquisition. Purchased finite-lived intangible assets are being amortized using the straight-line method over their remaining estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94">two</span> to <ix:nonNumeric contextRef="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxODA_be2f7bdb-43a4-4cee-906c-b67281c38570">fifteen years</ix:nonNumeric>. The Company evaluates the remaining useful lives of intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining estimated amortization period. The Company tests indefinite-lived intangible assets for impairment on at least an annual basis and whenever circumstances suggest the assets may be impaired. If indicators of impairment are present, the Company evaluates the carrying value of the intangible assets in relation to estimates of future undiscounted cash flows. The Company also evaluates the remaining useful life of an indefinite-lived intangible asset to determine whether events and circumstances continue to support an indefinite useful life.</ix:continuation> </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, there was <ix:nonFraction unitRef="usd" contextRef="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:GoodwillAndIntangibleAssetImpairment" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjA5MzU_e2c0e650-6e23-49c3-b24f-2b377248be5e">no</ix:nonFraction> impairment of goodwill or intangible assets based on the qualitative assessments performed by the Company. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTU_b62fb2de-7a5c-4918-aa32-69c32c858618" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:6pt;margin-top:4.4pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were <ix:nonFraction unitRef="usd" contextRef="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjE5OTI_41a35aec-3cb1-4608-aa6f-b5114d3626b2"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt-sec:numwordsen" name="us-gaap:AssetImpairmentCharges" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjE5OTI_bfcbc271-9dbb-4758-a798-550e92712e6f">no</ix:nonFraction></ix:nonFraction> impairment charges, or changes in estimated useful lives recorded d</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the year ended December&#160;31, 2020. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-lived</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset values may not be recoverable.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:DerivativesEmbeddedDerivatives" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTg_9186de92-b63b-4ada-83ff-d83db2eec0a2" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Embedded Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 6).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note&#160;5).</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:DebtPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzU_89773d43-fdb4-4595-819f-50ab28dabb38" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs and Debt Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in connection with the issuance of new debt are capitalized. Capitalizable debt issuance costs paid to third parties and debt discounts, net of amortization, are recorded as a reduction to the long-term debt balance on the condensed consolidated balance sheets. Amortization expense on capitalized debt issuance costs and debt discounts related to loans are calculated using the effective interest method over the term of the loan commitment and is recorded as interest expense in the condensed consolidated statements of operations.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:IncomeTaxPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzY_3a4965fc-a5fc-4898-a02b-6116ca8f10a0" continuedAt="i75f887bed3df4352b0fc9574067ce8a8" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:4.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events, enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">14</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i217d561244eb4185824927bc3e50ec42" continuedAt="ia971277fb2f8427faa54e3bbf38de3fb"><ix:continuation id="i75f887bed3df4352b0fc9574067ce8a8"><div style="margin-bottom:6pt;margin-top:4.09pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.</span></div><div style="margin-bottom:6pt;margin-top:4.34pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.</span></div></ix:continuation><div style="margin-bottom:6pt;margin-top:4.34pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material uncertain tax positions in fiscal 2020 and for the three months ended March&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDE_03efaf11-7119-46ca-a47d-7873b02fa5a5" continuedAt="i11cfb97a57f74bfca78ce5c1f7fc5346" escape="true">Foreign Currency </ix:nonNumeric></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i11cfb97a57f74bfca78ce5c1f7fc5346">The financial statements of the Company&#8217;s foreign subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, stockholders&#8217; equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries&#8217; accounts are included in &#8220;Accumulated other comprehensive income&#8221; as equity in the condensed consolidated balance sheet. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within &#8220;Other expense, net&#8221; in the condensed consolidated statement of operations.</ix:continuation> For the three months ended March&#160;31, 2021 and March&#160;31, 2020, foreign currency transaction loss amounted to $<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjYxNzM_5f1a0dfe-5ff8-4e5d-8871-9070ceeafe12">2.7</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-5" sign="-" format="ixt:numdotdecimal" name="us-gaap:ForeignCurrencyTransactionGainLossBeforeTax" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTExODI0MA_76e446cb-d13b-4fad-baaa-d020eba71bc3">6.2</ix:nonFraction>&#160;million, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ComprehensiveIncomePolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODk_1e06b92e-5a7f-42fc-b6c4-b9978e9c7546" continuedAt="i6fb1c65ce4b741b0af1fdc95381b5157" escape="true">Comprehensive Loss</ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i6fb1c65ce4b741b0af1fdc95381b5157">The Company&#8217;s comprehensive loss consists of net loss and foreign currency translation adjustments arising from the consolidation of the Company&#8217;s foreign subsidiaries.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjM_3457dab9-f5ff-4ca6-9602-8347a72a3c37" continuedAt="i32d0adbf286c41ce881feaa271c44e06" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all share-based awards in accordance with the provisions of ASC 718, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Share-based awards granted include stock options, restricted stock units, or RSUs, and restricted stock awards, or RSAs. Share-based compensation expense for stock options and RSAs granted to employees is measured at the grant date based on the fair value of the awards and is recognized as an expense ratably on a straight-line basis over the requisite service period. The fair value of options to purchase shares granted to employees is estimated on the grant date using the Black-Scholes option valuation model. </span></div></ix:nonNumeric><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i32d0adbf286c41ce881feaa271c44e06">The calculation of share-based compensation expense requires the Company to make assumptions and judgments about the variables used in the Black-Scholes model, including the expected term, expected volatility of the underlying common shares, risk-free interest rate and dividends.</ix:continuation> </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:EarningsPerSharePolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDQ_7ef40cb6-f478-4741-a485-492f29b0b897" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share </span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted-average number of shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted-average number of shares and potentially </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilutive </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities outstanding for the period. For purposes of the diluted net loss per share calculation, any shares issuable upon exercise of warrants, stock options and non-vested restricted stock outstanding under the Company&#8217;s equity plan are potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for periods where the Company reported a net loss because including the dilutive securities would be anti-dilutive.</span></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:PriorPeriodReclassificationAdjustmentDescription" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM5Mzc2MQ_bf27b55b-04dd-4983-9a5a-e07388a7d045" continuedAt="i8281188eddd84e73a8ca9a4f666e0b1d" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of ASU No. 2016-02, </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effective January 1, 2020, using the modified retrospective </span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia971277fb2f8427faa54e3bbf38de3fb" continuedAt="ia5828e2722e045e5838dcd80a88c6552"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8281188eddd84e73a8ca9a4f666e0b1d">approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the three months ended March 31, 2020.</ix:continuation></span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTI_5ffe565b-e662-4229-a7c8-7198f64728cd" continuedAt="i7a6cfbdd899345b4ab4cdbc53ea3d2cc" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, the Company meets the definition of an emerging growth company, and has elected the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. The Company will remain an emerging growth company until the earliest of (1)&#160;the last day of its first fiscal year (a)&#160;following the fifth anniversary of the completion of our initial public offering, (b)&#160;in which we have total annual gross revenue of at least $1.07 billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (2)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following recent accounting pronouncements issued by the FASB, could have a material effect on our financial statements:</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements. The modifications removed the following disclosure requirements: (i) the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy; (ii) the policy for timing of transfers between levels; and (iii) the valuation processes for Level 3 fair value measurements. This ASU added the following disclosure requirements: (i) the changes in unrealized gains and losses for the period included in other comprehensive income, or OCI, for recurring Level 3 fair value measurements held at the end of the reporting period; and (ii) the range and weighted average of significant observable inputs used to develop Level 3 fair value measurements. This update is effective for non-public entities for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-13 on January 1, 2021. As the requirements of this literature are disclosure only, ASU 2018-13 did not impact our financial condition or results of operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect the updated standard will have on its consolidated financial statements and footnote disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for nonpublic business entities and emerging growth companies for fiscal years after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company is </span></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ia5828e2722e045e5838dcd80a88c6552"><ix:continuation id="i7a6cfbdd899345b4ab4cdbc53ea3d2cc"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently assessing the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and footnote disclosures.</span></div></ix:continuation></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_40"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:SupplementalBalanceSheetDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTEwNQ_90de81c5-af6f-419a-8c3f-8a21d72b166d" continuedAt="id78aa21be5ad4484a6ab26807ae1a644" escape="true">Balance Sheet Accounts</ix:nonNumeric></span></div><ix:continuation id="id78aa21be5ad4484a6ab26807ae1a644" continuedAt="i6f41cff2d2c143e58420de2f2dd3a391"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, Net</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfInventoryCurrentTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTEwNw_3893673a-165b-455f-8821-a20e7c5fa571" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNC0yLTEtMS0w_0c041c22-6e15-4dd4-9ecb-47a72ce13fcf">6,105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryRawMaterialsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNC00LTEtMS0w_22f93afe-1f12-4e62-9156-df28cd6adf3d">5,450</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNS0yLTEtMS0w_0abe736d-4c5d-4371-84c0-9e067aca0a68">1,625</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryWorkInProcessNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNS00LTEtMS0w_feaa918e-8196-484b-9b6e-e1a40e115f66">1,121</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNi0yLTEtMS0w_9338a288-6e8f-4048-996b-094c85908d36">14,647</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryFinishedGoodsNetOfReserves" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNi00LTEtMS0w_e1fac797-f335-4944-8060-23f8880cccb7">16,639</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNy0yLTEtMS0w_ad728bc9-92ef-4863-96bb-618f5c75765b">22,377</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:InventoryNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNy00LTEtMS0w_cdd0e95f-ad46-42c6-8ab1-5e44538e7f83">23,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, $<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMjc0ODc3OTA3MDgyOA_3d288022-4966-4506-b604-bca09f9b90c2">2.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMjc0ODc3OTA3MDc5Mw_da44fb49-9609-474a-9613-4a5d2f732275">2.0</ix:nonFraction>&#160;million of inventory was on consignment, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:6pt;text-align:center"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:PropertyPlantAndEquipmentTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExMg_fc21191a-97a0-43e0-9b6f-917bc4601a69" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id3996f92cc944a339de5caa40d1800d5_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNC0yLTEtMS0w_b30c7e7b-9621-4b27-8c23-cc415a154c27">9,494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i29eb930880f043a89583c6fc57efa900_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNC00LTEtMS0w_eeb3a37c-67cf-49e7-8a82-e25c7a6c79af">9,232</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ife4026763f654a77bc94bbe390a2fc4a_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNS0yLTEtMS0w_ed92bcb7-8652-4491-b1bd-c0cf08d378ec">6,456</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9f0ae59c23484eb780355e39397ef553_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNS00LTEtMS0w_28fe6c0e-5024-415b-ae69-eeed2a6af713">6,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i160d575ddcb0470f83ed19730eb5fb61_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNi0yLTEtMS0w_5dcaad98-ba62-4bd5-bb60-bc9b85b300e1">4,268</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="iab56151cd6614657ab84386f1061d9c5_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNi00LTEtMS0w_f522635e-637a-41eb-b09d-b8d54ef7095a">4,092</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ieb8e6e4dd99449fb88bbbca0acc2862b_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNy0yLTEtMS0w_991867dc-993a-4ca3-a92c-927d4f3c14e8">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i43b3f0124f284ee699ac3fd4d34805b2_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNy00LTEtMS0w_8d06e913-5ea3-4a67-adbe-ce5953a1b451">2,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2121ef462b904bc38a4a252ab9b29bcd_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOC0yLTEtMS0w_d8d72e00-90be-4f63-b9e5-2f399b7faf5c">2,025</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i98c64154fe544ca7bd6cee9aadcc28ef_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOC00LTEtMS0w_d77fa928-bcad-486e-8925-a9ddaaa34642">2,065</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="if284ebc70ba8430c827c84cea2ebd7c0_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOS0yLTEtMS0w_0bd0d017-e96b-4910-938e-3cd2f4f207aa">802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id5bc7817e64f42009391e541e0bed5b9_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOS00LTEtMS0w_85a82f9b-7ed7-4511-ac37-92b438c77733">802</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4df511fe868145bb8de184fd4579130b_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTAtMi0xLTEtMA_d8d02ade-526f-41fb-a35d-e0d1b751855c">395</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic63ccb3e5f68497baa493ee0a27489ff_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTAtNC0xLTEtMA_a2561ca0-f043-4425-bc16-45f459a40907">399</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1811e0f3590c40d0b8b5264bef9323fa_I20210331" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTEtMi0xLTEtMA_f0076fff-09ee-47a8-9450-f5f83bb9efe1">579</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib89a316782de4b9aa036ee79cbb8a6a8_I20201231" decimals="-3" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTEtNC0xLTEtMA_1d5b2937-593e-4cdb-9a03-dafa5b39ea41">317</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTItMi0xLTEtMA_262227f6-9608-464e-9866-6ffcf7ca91d5">26,491</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTItNC0xLTEtMA_4a2c5386-d89f-4fe8-b979-494f82f9b5a2">25,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTMtMi0xLTEtMA_bff810b9-fdeb-4362-9c39-9ac1c5b9ab1f">10,170</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTMtNC0xLTEtMA_36ce76b8-e0bb-432c-a3e9-d61be06120f9">9,633</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTQtMi0xLTEtMA_bc507ac7-246a-4a52-a9d0-d8501ac8e955">16,321</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:PropertyPlantAndEquipmentNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTQtNC0xLTEtMA_7c05d967-3dc6-4455-83c7-8611c6acc019">16,202</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></ix:nonNumeric></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2021 and 2020, depreciation and amortization expense related to property and equipment was $<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="esta:DepreciationAndAmortizationPropertyPlantAndEquipment" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMzAz_9ad83a7a-99de-4e94-9435-b934689f3dc0">0.6</ix:nonFraction>&#160;million.</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt"><ix:continuation id="i6f41cff2d2c143e58420de2f2dd3a391" continuedAt="ibcdd28113de84653a19a99c222501e8f"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into finance leases relating to equipment and vehicles and recorded the fair value of the lease payments on the initial contract date and is amortizing the assets over the term of the leases. As of each of March&#160;31, 2021 and December&#160;31, 2020, the gross asset value for capital lease assets was $<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNjE2_e16b3507-95d3-45c5-ad88-5337a95bd84c"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNjE2_ec41aa9c-67ff-4e23-8cd8-5dfef04cbcca">1.4</ix:nonFraction></ix:nonFraction> million. Depreciation expense for assets under finance leases was $<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNzk2_57d957df-ee22-423b-811e-12b5780225be">43,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:Depreciation" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfODAz_3347c9ef-779f-4820-88e4-b98caf8313c2">20,000</ix:nonFraction> for the three months ended March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></ix:continuation></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">18</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ibcdd28113de84653a19a99c222501e8f"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExMw_efb15e47-d4c4-421c-882e-9d6dc873ec36" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:AccruedBonusesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNS0yLTEtMS0w_04339c1c-a9fe-44b8-825a-707fc1dcf5bc">971</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedBonusesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNS00LTEtMS0w_83ac1939-24a6-4e19-8e4f-8458a030fa06">2,406</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNi0yLTEtMS0w_971ce965-c16b-48e9-8285-efa0c546da99">3,619</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedSalariesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNi00LTEtMS0w_2597996e-a369-4acb-a1c8-570ea07887bd">2,781</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus feature of stock option grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="esta:AccruedStockOptionGrantBonusCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNy0yLTEtMS0w_850ead52-d35b-4536-b83a-b0c21abfee51">6,605</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="esta:AccruedStockOptionGrantBonusCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNy00LTEtMS0w_84d0374b-5f8e-4382-8c9d-875e5409736b">5,992</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS0yLTEtMS0xNDAz_35757bd0-2415-45c0-b35b-274ebc918217">986</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS00LTEtMS0xNDAx_ebd7b0ff-7451-4b06-89a5-c969b31e8515">788</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS0yLTEtMS0w_3afc7730-6d9f-4d26-9507-67504ae2a2ef">648</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:AccruedSalesCommissionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS00LTEtMS0w_fe39050d-a2b0-41f1-ac48-6f9811ba3916">628</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and legal services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTAtMi0xLTEtMA_4218a4da-7207-4bd2-b822-f292407db915">469</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:AccruedProfessionalFeesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTAtNC0xLTEtMA_363340ab-1c8f-4a0c-95bd-06730184a426">439</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term minimum lease payments under finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTEtMi0xLTEtMA_6777688e-d866-425b-abff-349432e57966">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTEtNC0xLTEtMA_43d5e7d2-1c14-42c9-97e8-c0ce1c90bf2a">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTItMi0xLTEtMA_a030ad39-d672-48dd-a828-c498fbfa95ef">236</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:ProductWarrantyAccrualClassifiedCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTItNC0xLTEtMA_ec0b91e3-1975-408e-9fa4-8a2a7295de93">237</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advisory board and board of director related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTMtMi0xLTEtMA_20988a82-0a7e-4b83-be5f-aacbbab47ecb">70</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTMtNC0xLTEtMA_90e05065-869c-40cb-9d98-67921a504387">80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTQtMi0xLTEtMA_8a7f3285-5114-47d4-ace6-5f51277542f2">699</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherAccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTQtNC0xLTEtMA_7f6e4b73-8b2c-4326-ae46-b3b70fd83971">1,021</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTUtMi0xLTEtMA_25323d03-b3c4-4ea8-ae9e-5e85cf259bd4">14,408</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AccruedLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTUtNC0xLTEtMA_51b1ced3-3301-498f-a63f-72ae306c3bf2">14,532</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Short-Term</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:OtherCurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExNA_4b6f9a1d-cfed-49d8-9ae6-8c9625dee6e5" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, short-term consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNi0yLTEtMS0w_f634d675-d6ea-4b6c-8493-be1d583281a5">1,024</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNi00LTEtMS0w_cd0f2f0f-ba69-442b-acb5-b5e9b18e709f">1,214</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="esta:CashPayableForAssetAcquisitionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNy0yLTEtMS0w_a883d4ab-e4a4-47e3-b7f9-ab98e146628b">407</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="esta:CashPayableForAssetAcquisitionCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNy00LTEtMS0w_5cb65e73-1b7f-4e7e-badb-64701188807d">432</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfOC0yLTEtMS0w_519c8f86-3b6f-4e65-958b-37534b7cc216">1,431</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfOC00LTEtMS0w_c435d496-56d1-4737-ad42-a0507ee6ba72">1,646</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:24pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Long-Term</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:OtherNoncurrentLiabilitiesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExNg_05b16856-88f5-437c-8a91-2098a28b9709" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, long-term consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.947%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.632%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.633%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNS0yLTEtMS0w_c7868bbb-6bc7-4e88-ac43-00e9a21f7fd7">1,778</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ContractWithCustomerLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNS00LTEtMS0w_78866aca-ef39-412c-b5a1-241de74d6527">1,860</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:zerodash" name="esta:CashPayableForAssetAcquisitionNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNi0yLTEtMS0w_31286f04-25f1-49b7-9f52-5365f6e69166">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="esta:CashPayableForAssetAcquisitionNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNi00LTEtMS0w_24c54d64-1e12-44cb-9056-51ecce824d85">425</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNy0yLTEtMS0w_0a5c2dd2-8422-4499-a32a-61c31765b0d0">42</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:OtherSundryLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNy00LTEtMS0w_b4b2eae9-473d-4bf7-8a33-50ea2eb88a10">47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfOC0yLTEtMS0w_a2579d76-0feb-4e91-8aa2-d1dae9a0864d">1,820</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OtherLiabilitiesNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfOC00LTEtMS0w_30bda811-999a-4147-8c3d-3ebdeb879246">2,332</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_43"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">4. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMA_bbb636da-980a-4791-986b-7ae80de24837" continuedAt="i2ff757e0332e4425bfd57edcc09e16bd" escape="true">Goodwill and Other Intangible Assets</ix:nonNumeric></span></div><ix:continuation id="i2ff757e0332e4425bfd57edcc09e16bd" continuedAt="i2ab49762271041e286b1966250440b20"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. Intangible assets resulting from the acquisitions of entities accounted for using the acquisition method of accounting are recorded at the estimated fair value of the assets acquired. Purchased intangibles include certain patents and license rights, 510(k) authorization by the FDA to sell a medical device and other intangible assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill and most intangibles at March&#160;31, 2021 are the result of acquisitions of certain assets formerly owned by VeriTeQ Corporation in November 2015, Femiline AB in November 2017 and Orion Trading S.r.l in August 2020 and business acquisitions of Establishment Labs Brasil Productos para Saude Ltda. in January 2016, European Distribution Center Motiva BVBA in March 2016 and Motiva Implants France in September 2016. Finite-lived intangibles are amortized over their estimated useful lives based on expected future benefit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the intangibles acquired, the Company capitalized certain patent and license rights as identified intangibles based on patent and license rights agreements entered into over the past several years. Additionally, the Company capitalized certain software development costs.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfGoodwillTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMw_ba088167-6128-47da-b01f-85157634d54a" escape="true"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the carrying amount of goodwill during the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"></td><td style="width:48.450%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.876%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.025%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.548%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.880%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Impairment Losses</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC0xLTEtMS0w_39747bba-4a8b-4070-9edf-42203a23f626">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillAcquiredDuringPeriod" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC0zLTEtMS0w_fc405c74-b9a3-46b2-968e-703812707736">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:GoodwillImpairmentLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC01LTEtMS0w_e1fdbb89-5837-4be8-b20a-66b4d4e0e498">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:Goodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC03LTEtMS0w_c952b508-59db-47c6-984d-092450db94d1">465</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQxNg_a5aff0fa-8c1f-4019-843e-002242596f5c" continuedAt="ic0155a63aad5472a8de3652d7e812190" escape="true"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMQ_a97e303d-3cb5-450e-bd59-93fedb9975a4" continuedAt="ief503cb6b6e8483fbf21fc83efc0f1b2" escape="true"><div style="margin-top:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.798%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC0xLTEtMS0w_9ac3cd78-352d-42a5-b3c3-26770a9db528">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC0zLTEtMS0w_c52828e5-f07f-4800-aa89-057bcf987c48">994</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC01LTEtMS0w_9119be9c-1ec7-47de-a2e0-438d25c49d44">742</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i873ca24dbc894b9e8daab00025293c33_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC03LTEtMS0wL3RleHRyZWdpb246ZTU3NmYxNTYzOGJkNGE4N2IwMThlOGU2Mjk1Y2U2OTFfNA_5a1fa7d1-0aa5-4b07-81fb-c9f41bc5101e">7</ix:nonNumeric>-<ix:nonNumeric contextRef="if0cce1c6c85749738e3b59dc105867e4_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC03LTEtMS0wL3RleHRyZWdpb246ZTU3NmYxNTYzOGJkNGE4N2IwMThlOGU2Mjk1Y2U2OTFfNw_871b2136-f99b-446e-89b7-bdc125c38dd4">12</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS0xLTEtMS0w_1c5ceb2d-7055-498b-bbbe-f21cc67efe7a">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS0zLTEtMS0w_cadcc137-4049-4e71-b726-0dcf6cad1091">1,452</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS01LTEtMS0w_128a0841-a923-4efe-a7e1-72a0e037c22b">581</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ifd06ef7b1af0422c93f821f4a2f4cdce_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS03LTEtMS0wL3RleHRyZWdpb246YmEyOTAyMzUxOTJjNDVmNzk5NjhmMTIzZjk5MjQxMGJfNA_c7915113-8220-4ad9-803f-72318a867449">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i6dc8ae01d3fd43de87978f967915da5f_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS03LTEtMS0wL3RleHRyZWdpb246YmEyOTAyMzUxOTJjNDVmNzk5NjhmMTIzZjk5MjQxMGJfNw_f0ede5ba-bf87-4669-9763-01f7cbe7b8b6">10</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi0xLTEtMS0w_211457c0-9829-47ac-a9a3-60d03cd08f11">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi0zLTEtMS0w_c63af029-b77f-4298-9209-e5adf88176cc">203</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi01LTEtMS0w_c3886ff2-2171-4c23-911a-4b4c82bce036">364</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3162e9ed932d412fb094be4a89be74cb_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi03LTEtMS0w_79b48356-9495-4299-8e70-9e512e4baad8">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy0xLTEtMS0w_640b7637-8c2d-43bc-b334-87d8b4b1e13b">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy0zLTEtMS0w_1446e55a-6023-4807-9e8a-cfc8ffb95cd6">47</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy01LTEtMS0w_a577f480-7a84-4f2c-bce1-7eda2a790aef">15</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i689c07f08f64464b9f3b1686974bd26c_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy03LTEtMS0w_545518e8-94f6-4a05-8034-bce568e32c7e">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC0xLTEtMS0w_fb42e4cf-1b6a-4a76-b734-850fa18bbb58">2,497</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC0zLTEtMS0w_5f8a1e44-7032-4d36-abd8-7531b0140c57">411</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC01LTEtMS0w_b553f08b-bcb9-4c69-83f0-38c86eeee486">2,086</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i7d0ffc41700c443db6b4f0218c08c5f9_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC03LTEtMS0wL3RleHRyZWdpb246NjY5MDU0MWNiNzk0NGFkNGFiMTJhY2QxYmU2ZTAxNDNfNA_1987ef7d-9682-4e39-9709-0922a0cfb239">2</ix:nonNumeric>-<ix:nonNumeric contextRef="ia584179cdecd4217be8aa815f6592f34_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC03LTEtMS0wL3RleHRyZWdpb246NjY5MDU0MWNiNzk0NGFkNGFiMTJhY2QxYmU2ZTAxNDNfNw_f67149e9-3bb5-4542-b496-12c168c48171">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS0xLTEtMS0w_c3df0494-7a64-4d0c-aa30-59ca3329077e">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS0zLTEtMS0w_cdd23276-2418-4d25-a768-742b230e49ab">28</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS01LTEtMS0w_50949f68-90d9-4709-9909-1e567cea53a8">47</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i14be8b6604984469ba137e25363566e7_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS03LTEtMS0wL3RleHRyZWdpb246NTRiMzE1ZTNjM2I1NDA1M2EwNTg3MTVkMGE0YmI1NzlfNA_a15dd763-fba3-46a4-afdc-3fb968df9198">2</ix:nonNumeric>-<ix:nonNumeric contextRef="ifcfcfc5c853545cfb75ef591c4c89c42_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS03LTEtMS0wL3RleHRyZWdpb246NTRiMzE1ZTNjM2I1NDA1M2EwNTg3MTVkMGE0YmI1NzlfNw_04394aaa-a368-4862-a51a-ad67b9ff51d3">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTAtMS0xLTEtMA_6dd55665-f762-4e83-9acf-254e9ec5319f">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTAtNS0xLTEtMA_1e25b6cd-f0bd-446f-ade7-b2af5e45d9d3">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtMS0xLTEtMA_6553f6e6-ca66-4b56-a650-2b2fc3e61175">7,261</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtMy0xLTEtMA_e63af0b0-b2a5-484e-a281-f93c46cfe81f">3,135</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtNS0xLTEtMA_89e76878-b487-452a-8f2c-6770c7e5a8e5">4,126</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">20</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i2ab49762271041e286b1966250440b20" continuedAt="iede485d47b594066870c68d06dff9dc8"><ix:continuation id="ic0155a63aad5472a8de3652d7e812190"><ix:continuation id="ief503cb6b6e8483fbf21fc83efc0f1b2"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:50.989%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.885%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.798%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC0xLTEtMS0w_2ea19b55-3d14-4cf7-a30f-ee183656dea2">1,736</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC0zLTEtMS0w_9b7d0163-8e1c-4973-8b2e-37d207cfe5a2">951</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC01LTEtMS0w_adc1a719-2f2a-487e-a604-41fc9a49bbbc">785</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i49c86d6704eb428f9ade6dcef7f7c2ba_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC03LTEtMS0wL3RleHRyZWdpb246ZDc5NDZhZjM1NWMwNGFjNDg1Mzc4MGU3MjIxNTMyZjFfNA_c76a2852-1baf-44e4-88ed-c31370ba732b">7</ix:nonNumeric>-<ix:nonNumeric contextRef="i01b3a59d508e48d9b117f28aeb5c7264_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC03LTEtMS0wL3RleHRyZWdpb246ZDc5NDZhZjM1NWMwNGFjNDg1Mzc4MGU3MjIxNTMyZjFfNw_37acd7e5-061b-40c7-a07d-ef331c777fb5">12</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS0xLTEtMS0w_bf9dfa5e-e793-4471-a75d-6c4ee473f17c">2,033</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS0zLTEtMS0w_2045fb1d-ba91-4a48-9f03-d054417a924d">1,297</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS01LTEtMS0w_30f94ad0-124a-4895-bf0d-66725cb47a07">736</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3edec611128b4e3ab3d4aa78897c8d21_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS03LTEtMS0wL3RleHRyZWdpb246YzEyYmZhNjRmNzI1NDRkZThiMjgxOGE0MGUyOTk3ZDdfNA_1bc13ef9-b726-44b1-82a8-916b92da46fd">4</ix:nonNumeric>-<ix:nonNumeric contextRef="i89fb77590e764015b6a150b0c8ffe09d_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS03LTEtMS0wL3RleHRyZWdpb246YzEyYmZhNjRmNzI1NDRkZThiMjgxOGE0MGUyOTk3ZDdfNw_56e1bd78-6efc-4ff3-b560-2dd714a77b26">10</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi0xLTEtMS0w_a3683243-8a35-4f54-8793-b5783f0f4fbf">567</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi0zLTEtMS0w_73e8095d-726a-46b5-93a1-61a6e7bbb712">194</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi01LTEtMS0w_2b91a785-651e-45a3-9889-690e4f146eec">373</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6997f7df2347466ab6eff3ece39e0830_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi03LTEtMS0w_5e9e8de3-889f-4a8f-9bda-6464f9219112">15</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78118302909b42fe814d72c9776a9be6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy0xLTEtMS0w_2114c47b-78e9-41e1-ae05-14b538ea1cbc">62</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i78118302909b42fe814d72c9776a9be6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy0zLTEtMS0w_800771b0-f8db-4e72-a824-5afd66584cda">46</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i78118302909b42fe814d72c9776a9be6_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy01LTEtMS0w_0d82d358-6d67-4abc-a1b4-8ba857ca50b7">16</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i3c454b81cfb24c619a23bb42c3d8fd20_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy03LTEtMS0w_6184952a-e40b-48b8-82b6-0864388fe3d3">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6494d630a4134e7bab16b46694c01385_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC0xLTEtMS0w_f996fb44-ffb5-44fa-8e63-eda0dc933376">2,203</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i6494d630a4134e7bab16b46694c01385_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC0zLTEtMS0w_2cd07d2c-6bdf-4042-96db-a9d199f154ae">302</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i6494d630a4134e7bab16b46694c01385_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC01LTEtMS0w_7180d6a1-9048-4d11-bf04-fcbad854e022">1,901</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i059a7469f92d475985e17381b3f435bf_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC03LTEtMS0wL3RleHRyZWdpb246ODQ5ZmFhNWI1ZjIwNDRkZjk0NWVlZTAyM2EwY2RkNmVfNA_c8fe93da-e47f-4b69-ba6a-c8ccf9bf7cf7">2</ix:nonNumeric>-<ix:nonNumeric contextRef="i089cb2848143463d8c43064f3bebf723_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC03LTEtMS0wL3RleHRyZWdpb246ODQ5ZmFhNWI1ZjIwNDRkZjk0NWVlZTAyM2EwY2RkNmVfNw_40bedc60-e19c-49c2-98b9-30334876b18d">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsGross" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS0xLTEtMS0w_7d701462-797a-40c5-8936-172d3e062713">75</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS0zLTEtMS0w_be0f5be6-38d9-46bc-ac54-5b15a55a1954">29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS01LTEtMS0w_1f41c879-1f4f-4e30-92e3-34f2aa38df2b">46</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic2100b1681d141eb80d0946f6fecde49_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS03LTEtMS0wL3RleHRyZWdpb246OGJjNjM4NzUyODZkNGU5NDg2NmY0OTQ4NGFhYzQyNmZfNA_44a26e9e-8d9a-4631-adb7-187fe770b721">2</ix:nonNumeric>-<ix:nonNumeric contextRef="id757366e4d8c40e7a89ea6fdd3bf8800_D20200101-20201231" format="ixt-sec:duryear" name="us-gaap:FiniteLivedIntangibleAssetUsefulLife" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS03LTEtMS0wL3RleHRyZWdpb246OGJjNjM4NzUyODZkNGU5NDg2NmY0OTQ4NGFhYzQyNmZfNw_f051e0d3-b079-41f4-aac9-a42abbc40efc">5</ix:nonNumeric></span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTAtMS0xLTEtMA_4f1791df-87a6-4a9f-8912-2d1ee537692c">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTAtNS0xLTEtMA_0eb22213-621a-4a2c-9f81-78d883e16a6e">291</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsGrossExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtMS0xLTEtMA_4278f520-dce7-4fa4-8f6a-0308cecf462a">6,967</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtMy0xLTEtMA_1a27bd5c-565d-4801-80e0-d067c928b846">2,819</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:IntangibleAssetsNetExcludingGoodwill" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtNS0xLTEtMA_0b79c88b-c20f-483e-b439-586a2c8a0f9e">4,148</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:continuation></ix:continuation><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization expense associated with intangible assets was $<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMTc3NA_880ed0c2-19bb-42ae-846d-99d2009c9d92">0.3</ix:nonFraction>&#160;million and $<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AmortizationOfIntangibleAssets" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMTc4MQ_bf670809-fdff-43c6-b824-77c47b2ddff7">0.2</ix:nonFraction>&#160;million for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2021 and 2020, respectively</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Non-product related amortization is recorded in SG&amp;A while product related amortization is recorded in cost of revenue.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQxOA_840a6b6b-6f77-46c2-b52e-1e66cd655aec" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the amortization expense related to identifiable intangible assets, with definite useful lives, in future periods is expected to be as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.209%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfMi0yLTEtMS0w_2f27bf3e-0622-4c5d-861f-bcc3bbe8105c">868</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfMy0yLTEtMS0w_f91c1f66-b878-4ba4-a026-143af9c38c27">875</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNC0yLTEtMS0w_87a7108c-29bf-438f-ab1c-83dfe00e0a3d">617</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNS0yLTEtMS0w_b7d9a709-003a-44b6-9d4f-5ca210446d63">592</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNi0yLTEtMS0w_0e78bb37-8f65-4efe-b426-a28d2c92c4ae">393</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="esta:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNy0yLTEtMS0w_49ae9ade-7c97-4393-90df-5c046794aa2c">490</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FiniteLivedIntangibleAssetsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfOC0yLTEtMS0w_e0adcef3-92f7-4c29-9a30-6cbfb78215aa">3,835</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iede485d47b594066870c68d06dff9dc8">The Company evaluates the recoverability of goodwill and indefinite-lived intangible assets annually and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.</ix:continuation> </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_46"></div><div style="margin-bottom:3pt;margin-top:15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">5.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:FairValueDisclosuresTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4NA_ec8b9e16-bfad-4bc5-a9d5-0b969e6ad4ae" continuedAt="i84bd9df50b014130a9daaaebc04f0724" escape="true">Fair Value Measurements</ix:nonNumeric></span></div><ix:continuation id="i84bd9df50b014130a9daaaebc04f0724" continuedAt="iab0395e7a3e840bf87599e51b2641acf"><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s cash, accounts receivable and accounts payable approximate fair value due to the short-term nature of these items. Contingent equity consideration and embedded derivatives that qualify for liability treatment are carried at fair value and re-measured at each reporting period. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">21</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="iab0395e7a3e840bf87599e51b2641acf" continuedAt="ic85288b7d7f746b186820135b4cfbe7a"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the use of observable inputs and minimize the use of unobservable inputs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows: </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level I&#160;&#160;&#160;&#160;Unadjusted quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level II&#160;&#160;&#160;&#160;Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level III Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. </span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4Nw_d1f73543-c67e-4892-a744-3a7857a65fb8" escape="true"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy at period end: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:53.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.798%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i95331fe2443f47f2a92a6d7d257f21c3_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi0xLTEtMS0w_fe1f4fb9-306f-4e3e-9e9d-076b15f6be00">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ifa130603b0d34bcaba896c6b2fbc06e8_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi0zLTEtMS0w_2d6295f8-2617-4b53-ab0e-04e411dd6bad">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i4e9b5f5e5662468497f5df0724ed1d00_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi01LTEtMS0w_1f0fbd2d-7d6c-4742-8cd9-1554c3081985">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="id0a4ea3cfc9b4f2d86192db4068663ca_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi03LTEtMS0w_c67eafec-b47b-4eeb-b66e-199a03c9c811">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:53.079%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.798%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i71bb3412c07447beaadc22f1358a2b26_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi0xLTEtMS0w_09c9a2f8-0635-401a-835a-5690f9a043c3">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i790092f6c06c4e31b55aa091e6e08ed8_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi0zLTEtMS0w_c494c94b-fa9b-4e62-95ff-91b41596a3aa">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="idaea600f2d8040ed846ffa50db817b73_I20201231" decimals="-3" format="ixt:zerodash" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi01LTEtMS0w_3f5ade11-516a-4b2b-95d0-4352a755e2b6">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1ddf079de41d4d389e34c1fe33bd8373_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DerivativeLiabilities" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi03LTEtMS0w_f64cbbf6-87ea-4a59-a071-25f3f8a2995b">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement of derivatives is based on significant inputs not observed in the market and thus represents a Level 3 measurement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders (see Note 6). The Company determined that the Madryn Credit Agreement contained put options related to early redemption mandatory prepayment terms in case of change in control or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $<ix:nonFraction unitRef="usd" contextRef="ie0f77adbac95434d9b0d6d9480e92d51_I20170831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjQzOQ_56b18e3d-53c3-4b13-b886-87e7b72daab4">15.1</ix:nonFraction> million for these identified embedded derivatives as a debt discount on the original commitment date. An additional $<ix:nonFraction unitRef="usd" contextRef="i9330e02904744171946200efc674cd7f_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjU1MA_3a005fc6-df5e-4ad2-8cc1-1835e951569f">5.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i830e948888774878a6aef7ca1259e422_I20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjU1Nw_1182e89f-3702-4fe4-9528-529e990c9891">1.6</ix:nonFraction> million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $<ix:nonFraction unitRef="usd" contextRef="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjY4OQ_532518ef-d23e-4c28-9f50-abe4c68cae8c">10.0</ix:nonFraction> million in the fourth quarter of fiscal 2017 and $<ix:nonFraction unitRef="usd" contextRef="ia6941f5711ff453faf70724a85877a15_D20190801-20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromIssuanceOfDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjczMw_a58a72a2-9197-4149-a932-bc2ae8f22b34">25.0</ix:nonFraction> million in August 2019 (see Note 6). The Company revalued the options as of each reporting period and recorded the change in the fair value in the consolidated statement of operations as other income or expense.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation of the embedded derivatives is complex and requires interest rate simulation, capturing optimal decision making process as interest rate fluctuates and estimating the resultant bond valuation and the resultant pay-off to the option holder. The Company estimated the fair value of the embedded redemption options based on a &#8220;with&#8221; and &#8220;without&#8221; approach using the Black-Derman-Toy model, a form of the Binomial Lattice Model that captures interest rate variability and the prepayment optionality. The Binomial Lattice Model allows for the possibility of exercise before the end of the option&#8217;s life and considers future interest rates, volatility and other data with </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ic85288b7d7f746b186820135b4cfbe7a"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regards to the Company&#8217;s credit rating and credit spread. The value of the embedded derivatives was based on the difference between the &#8220;with&#8221; and &#8220;without&#8221; analysis. The probability of a change in control occurring was determined to be <ix:nonFraction unitRef="number" contextRef="i059114baa58f4872bbfdcb04e021af01_I20201231" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMzc4Mw_260cf02c-7444-4887-b880-48e5e384c053"><ix:nonFraction unitRef="number" contextRef="i14303ccbd1cf4882a177c1af2b917801_I20210331" decimals="2" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMzc4Mw_5419c860-9bb4-4673-807b-3f145191fdb9">50</ix:nonFraction></ix:nonFraction>% (cumulative probability through the maturity date) at March&#160;31, 2021 and December&#160;31, 2020.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4OQ_d24f103f-b92d-437c-afa5-2856beee4e5a" escape="true"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used the following assumptions to value Madryn derivatives:</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put Option Liability </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:74.011%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.971%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.973%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate volatility</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i27da2686b48242f7a22212016aa9bccb_I20210331" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMi0zLTEtMS0w_9fc55ca0-298c-4944-a376-0fd55856935b">20.9</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i31a7c4a5a5f04c84a1769a691fe0f9e8_I20201231" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMi01LTEtMS0w_5aca937e-4a3b-4ff5-a0ab-58691c52e3c3">19.7</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market yield rate</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i86193100685843efbbbb39fedddbac34_I20210331" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMy0zLTEtMS0w_d16da57d-9873-419f-ad12-09555b9953af">7.3</ix:nonFraction>%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="if774d5d7adbc4aac92f6d23ce833114e_I20201231" decimals="3" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMy01LTEtMS0w_a791022d-6e10-4d9a-92d3-4487d8bc1422">7.9</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia29fed8a4345411c9e198ad402e4bf12_I20210331" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNC0zLTEtMS0w_983b6ec2-3b1c-4b7a-9c5b-8549ddc340c5">4.57</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i7ca4bc90ca3d4e5a87867faec60ebc94_I20201231" decimals="INF" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNC01LTEtMS0w_645903dd-744c-4c21-a3b1-f3d244c20363">4.82</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i210e77df9d574a529b2c2f319b1dee8b_I20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNS0zLTEtMS0w_bf73a870-3476-4c4c-939d-ef19e66019d2">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6d2f8614a7724e108142603cacaa1bb9_I20201231" decimals="INF" format="ixt:zerodash" name="us-gaap:DerivativeLiabilityMeasurementInput" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNS01LTEtMS0w_4d73e9f0-d9da-4318-ac86-238998084950">&#8212;</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates are based, in part, on subjective assumptions and could differ materially in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the three months ended March&#160;31, 2021 or during the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the debt redemption feature liability includes the estimated market rate (credit spread and risk-free rate) and volatility.&#160;The higher/lower the estimated volatility, the higher/lower the value of the debt redemption feature liability. The higher/lower the estimated market rate, the higher/lower the value of the debt redemption feature liability.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4Mw_bef55998-7950-4b11-958b-7e7b8ac6984e" escape="true"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:80.447%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.609%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Put Option Liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i35ee0f70fefa4c82929e447a5cec9bb3_I20191231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMi0xMC0xLTEtMA_7d3b40f4-c44b-4c73-9764-71f718bcb1e4">3,072</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ibe39498f97ab4942a773e100eed6a382_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfNC0xMC0xLTEtMA_24fd3032-1b98-4f53-aebb-52072c2bbc9e">1,929</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i90151a15234f4bf594dddc4ccebc3bac_I20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfNy0xMC0xLTEtMA_3d00bdea-b95f-4b41-b3ac-97bc5d23a708">5,001</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i366040d3254b4edebd0cb69800364ef1_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfOS0xMC0xLTEtMA_7188a5c2-0e48-4a53-a4e1-e51fb2510517">1,440</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="ibc537e3dcd364e198a3715d83f0505b5_D20210101-20210331" decimals="-3" sign="-" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMTEtMTAtMS0xLTA_981d07c7-93bd-41c7-a93f-22d93ab42dd4">230</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i99d366567ea04542ae012abac0572301_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMTMtMTAtMS0xLTA_592d1543-973f-4695-8da6-8951feef36eb">1,210</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_49"></div><div style="margin-bottom:3pt;margin-top:21pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">6.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:DebtDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDkyNw_c2892bf6-58f2-4628-88ec-9acbc76e4360" continuedAt="iee4e211315654619841946fa57a7d3d8" escape="true">Debt</ix:nonNumeric></span></div><ix:continuation id="iee4e211315654619841946fa57a7d3d8" continuedAt="i77e0f83144d24b37874123af1bff3f2c"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Madryn Debt</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders. On June 17, 2019, the Madryn Credit Agreement was amended to lower the interest rate on the outstanding debt facilities, provide for </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i77e0f83144d24b37874123af1bff3f2c" continuedAt="i469921263809480dbf4bc78a604331b9"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$<ix:nonFraction unitRef="usd" contextRef="i5aed9212cd444c949bd6daaee2b29e84_I20190617" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzUw_a6fda9a4-4504-4013-bc3b-7ec831e24ff5">25.0</ix:nonFraction> million of new term loan commitments, decrease the amount of the prepayment penalties, remove all principal payments and extend the maturity date and repayment from September 30, 2023 to September 30, 2025. On August 5, 2020, the Company amended the Madryn Credit Agreement to adjust the minimum product revenue milestone previously applicable to December 31, 2020 to September 31, 2021 and to add Motiva Implants UK Limited, Motiva Implants France SAS, Motiva Implants Spain, S.L. and Motiva Germany GmbH, wholly-owned subsidiaries of the Company, as guarantors to the Madryn Credit Agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement, as amended, provides for a term loan in a maximum principal amount of $<ix:nonFraction unitRef="usd" contextRef="i6b2546ff36954e819bb93630aa88e260_I20170824" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTAzOQ_1faf2068-13a7-4caf-a3a0-df8f9c48b28a">65.0</ix:nonFraction> million, $<ix:nonFraction unitRef="usd" contextRef="ia833a43aacd04fb58829b20141aedaf6_I20170824" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTA0Mw_427d2200-e12b-46ca-a2a2-a46eb70ce885">30.0</ix:nonFraction> million (Term A) of which became available upon signing and was subsequently borrowed by the Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to amending the Madryn Credit Agreement on June 17, 2019, the Company&#8217;s ability to borrow the remaining term loans under the Madryn Credit Agreement was subject to the Company achieving certain revenue milestones. The Company met milestones sufficient to borrow and borrowed an additional $<ix:nonFraction unitRef="usd" contextRef="ied61c55aaefd4fa6ab4618839ed979f0_D20171031-20171031" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTQzNQ_65706fec-d10e-4787-93b0-4a2ae53bae71">5.0</ix:nonFraction> million (Term B-1) on October 31, 2017 and $<ix:nonFraction unitRef="usd" contextRef="ia1f9be83f245489ba3f93a2a2970a743_D20171215-20171215" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTQ3Mw_ad5b8105-c373-4973-8422-f57cd009b2c2">5.0</ix:nonFraction> million (Term B-2) on December 15, 2017, increasing the total outstanding principal balance to $<ix:nonFraction unitRef="usd" contextRef="i9330e02904744171946200efc674cd7f_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTU2Mw_618a5d6b-9684-457e-942d-7babd155adb4">40.0</ix:nonFraction> million as of December 31, 2017.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the June 2019 amendment, the Company became eligible to borrow an additional $<ix:nonFraction unitRef="usd" contextRef="icb1b1b6522f146e2a92e6845b3354b0e_I20190617" decimals="INF" format="ixt:numdotdecimal" name="esta:LineOfCreditFacilityAdditionalBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTY4MA_4aa1a5c0-65cb-4b43-87b4-37922916ebdc">10.0</ix:nonFraction> million (Term B-3) and $<ix:nonFraction unitRef="usd" contextRef="iefa578fa70ce4695a1914cbd8fad0ccd_I20190617" decimals="INF" format="ixt:numdotdecimal" name="esta:LineOfCreditFacilityAdditionalBorrowingCapacity" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTY5OA_0e2d343d-83a5-49ad-9eb6-4f02bb73765e">15.0</ix:nonFraction> million (Term B-4) on or before September 30, 2019 and December 31, 2019, respectively. The Company borrowed the available funds under both tranches equal to $<ix:nonFraction unitRef="usd" contextRef="i56705c8ada8c45b8893dfc488df6e515_D20190812-20190812" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTg1MQ_308675c4-dffb-44fb-9fc6-770781358444">25.0</ix:nonFraction> million on August 12, 2019, bringing up the total outstanding principal balance to $<ix:nonFraction unitRef="usd" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTkyOQ_aff31062-d5b6-4307-ad9c-e014a693909d">65.0</ix:nonFraction> million as of March&#160;31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Madryn Credit Agreement, the Company and certain of its subsidiaries granted a security interest in substantially all of their respective assets, including, without limitation, intellectual property, and pledges of certain shares of the Company&#8217;s subsidiaries, subject to certain excluded collateral exceptions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement contains customary affirmative and negative covenants, including, but not limited to, restrictions on the ability of the Company and its subsidiaries to incur additional indebtedness, create liens, make certain investments, make restricted payments, enter into or undertake certain liquidations, mergers, consolidations or acquisitions and dispose of assets or subsidiaries. In addition, the Madryn Credit Agreement requires the Company to maintain minimum revenues and liquidity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the effectiveness of the June 17, 2019 amendment, borrowings under the Madryn Credit Agreement bore interest at a rate equal to 3-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="if0313e61c81e4ee8a20a20c25abd823f_D20190101-20190616" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMjk0Mg_dc3d30a0-884a-4ec7-ac6b-3bb7d2bc7fb2">11.0</ix:nonFraction>% per annum. As of the amendment on June 17, 2019, borrowings under the Madryn Credit Agreement bear interest at a rate equal to 3-month LIBOR plus <ix:nonFraction unitRef="number" contextRef="idd8ee19aeac5495bb1e420bf7d180a2b_D20190617-20190617" decimals="INF" name="us-gaap:DebtInstrumentBasisSpreadOnVariableRate1" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzA5MQ_d17dcb52-3a49-4d52-8de7-9069d23f4b3e">8.0</ix:nonFraction>% per annum provided that no default has occurred. In an event of a default, the interest would increase by an additional <ix:nonFraction unitRef="number" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="INF" name="esta:DebtInstrumentDefaultInterestRateIncrease" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzIxNA_e6720460-7c0e-4ef6-a032-18d467605e7f">4.0</ix:nonFraction>% per annum. The effective interest rate under the amended Madryn Credit Agreement is <ix:nonFraction unitRef="number" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="3" name="us-gaap:DebtInstrumentInterestRateEffectivePercentage" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzMwMQ_3e52ed20-2e40-4e17-905b-c7454555ae78">18.4</ix:nonFraction>%, and the weighted average interest rate was approximately <ix:nonFraction unitRef="number" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="3" name="us-gaap:DebtWeightedAverageInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzM2Mg_095e8081-1f87-4a82-9e4d-cf8292b25869">10.6</ix:nonFraction>% at March&#160;31, 2021. The Company incurred $<ix:nonFraction unitRef="usd" contextRef="i709a73d169864a389bd4608c3299e861_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzQwMA_16de6a90-5665-4d21-b947-b8e747facb80"><ix:nonFraction unitRef="usd" contextRef="i0007a8ee0a3a4436b52008e19adf5975_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:InterestExpenseDebt" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzQwMA_a221c6e5-e292-4e43-bc88-ea486d39820b">1.7</ix:nonFraction></ix:nonFraction> million in interest expense in connection with Madryn Credit Agreement during each of the three months ended March&#160;31, 2021 and 2020. No principal payments are due on the term loans until the final maturity date on September 30, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determined that the Madryn Credit Agreement contained put options which are mandatory repayment provisions related to liquidity events or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $<ix:nonFraction unitRef="usd" contextRef="ie0f77adbac95434d9b0d6d9480e92d51_I20170831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDA1MQ_33920679-7e4e-443a-a029-cf2016be9726">15.1</ix:nonFraction> million for these embedded derivatives as a debt discount on the original commitment date in August 2017. An additional $<ix:nonFraction unitRef="usd" contextRef="i9330e02904744171946200efc674cd7f_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDE2Ng_ece01014-3c53-4bbf-89b5-d740f5d39e71">5.0</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i830e948888774878a6aef7ca1259e422_I20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscount" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDE3Mw_1ec79ffc-14ef-4383-a143-48c2340954a7">1.6</ix:nonFraction> million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $<ix:nonFraction unitRef="usd" contextRef="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDMwNQ_bc6756f0-1571-4f9e-9a43-23732eed20c9">10.0</ix:nonFraction> million in the fourth quarter of fiscal 2017 and $<ix:nonFraction unitRef="usd" contextRef="ia6941f5711ff453faf70724a85877a15_D20190801-20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ProceedsFromLinesOfCredit" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDM0OQ_ecf93593-21c7-45b6-9695-cacfff7afab1">25.0</ix:nonFraction>&#160;million in August 2019. The Company revalues the embedded derivatives as of each reporting period and records the change in the fair value in the consolidated statement of operations as other income or expense (see Note 5). The Company also incurred legal expenses of $<ix:nonFraction unitRef="usd" contextRef="i9330e02904744171946200efc674cd7f_I20171231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDYxMg_f2407641-94b2-419c-89d7-b2b92f48bd62">1.3</ix:nonFraction> million in 2017 and $<ix:nonFraction unitRef="usd" contextRef="i830e948888774878a6aef7ca1259e422_I20190831" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:DeferredFinanceCostsNet" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDY1NQ_1ab876ff-8264-4eab-92ef-6b33a0cac678">0.3</ix:nonFraction> million in August 2019, which were recorded as a debt discount and are being amortized over the term of the Madryn Credit Agreement. </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i469921263809480dbf4bc78a604331b9"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfDebtInstrumentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDkyNQ_2ef84c5f-133e-45e7-8702-e7884b82d224" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded Madryn debt on the balance sheet as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.304%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNC0xLTEtMS0w_e7f689bd-0e07-414b-a199-c488596aeb86">65,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentCarryingAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNC0zLTEtMS0w_9ba0c0a5-b3f9-4e3b-94e5-f40e1ecd44f7">65,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNy0xLTEtMS0w_527b1381-f50f-4b01-a86b-1310b897e2e6">14,695</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNy0zLTEtMS0w_00e8aca8-cf96-46f7-ac7b-bffaa805a1fa">15,168</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of Madryn debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfOC0xLTEtMS0w_35b594bc-38b1-435a-b69f-20b780b30554">50,305</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LongTermDebt" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfOC0zLTEtMS0w_1e41bbff-59fb-436e-aae2-74fefa8656eb">49,832</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company is in compliance with all financial debt covenants.</span></div></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_52"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">7. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:LesseeFinanceLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Ng_052620b3-b62c-4810-80bc-69a7ed620fb2" continuedAt="if901497d9b564807b2d46d3fd524f5d6" escape="true"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:LesseeOperatingLeasesTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Ng_deaf924d-ce0d-43f3-b0a8-fd16e2d47675" continuedAt="i291dfedbaf294b6eb08d6e9e25099f64" escape="true">Leases</ix:nonNumeric></ix:nonNumeric></span></div><ix:continuation id="if901497d9b564807b2d46d3fd524f5d6" continuedAt="ic3c94717d0194f8297d7ea624393d1a2"><ix:continuation id="i291dfedbaf294b6eb08d6e9e25099f64" continuedAt="ic26a25d20bf948dd883da9807b68c2f9"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease liabilities and ROU assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When the rate implicit to the lease cannot be readily determined, the Company utilizes its incremental borrowing rate in determining the present value of the future lease payments. Lease liabilities are accreted each period and reduced for payments. The ROU asset also includes other adjustments, such as for the effects of escalating rents, rent abatements or initial lease costs. The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. For finance leases, the ROU asset depreciates on a straight-line basis over the shorter of the lease term or useful life of the ROU asset and the lease liability accretes interest based on the interest method using the discount rate determined at lease commencement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for facilities and office space as well as finance leases for equipment and vehicles. Operating lease assets and the related lease liabilities are included within the ROU assets&#8212;operating leases. The determination of whether an arrangement is, or contains, a lease is performed at the inception of the arrangement. The Company has operating and finance leases for certain facilities, office space, equipment, and vehicles to be used in its operations, with remaining lease terms ranging from monthly to <ix:nonNumeric contextRef="i759011d78d1d4884b0ec06f0e36e3637_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeFinanceLeaseTermOfContract1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfMzI5ODUzNDg4OTc1Mw_18e4ea17-64a2-4fa2-801f-8e1178199fce"><ix:nonNumeric contextRef="i759011d78d1d4884b0ec06f0e36e3637_I20210331" format="ixt-sec:duryear" name="us-gaap:LesseeOperatingLeaseTermOfContract" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfMzI5ODUzNDg4OTc1Mw_f5975e0b-69b8-4831-9e6f-6f50b5005c71">8</ix:nonNumeric></ix:nonNumeric> years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for additional years. These optional periods have not been considered in the determination of the ROU or lease liabilities associated with these leases as management did not consider it reasonably certain it would exercise the options. Short-term leases, which have an initial term of 12 months or less, are not recorded in the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements do not contain any termination options, material residual value guarantees, material bargain purchase options or material restrictive covenants. The Company does not have any lease transactions with related parties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:LeaseCostTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Nw_92ad5841-7d33-4c0e-baa8-82499990fb53" continuedAt="ic6b55b3818e1401396b675a1fc79cd26" escape="true">Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:</ix:nonNumeric></span></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="ic3c94717d0194f8297d7ea624393d1a2" continuedAt="i729caf83e25842bb9302c227798a370f"><ix:continuation id="ic26a25d20bf948dd883da9807b68c2f9" continuedAt="ic1f18bbcb41a438cbbdae356da254d19"><div style="margin-bottom:6pt"><ix:continuation id="ic6b55b3818e1401396b675a1fc79cd26" continuedAt="i7dfc9ad6bd734526b77d7b441b4d4995"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfMi0yLTEtMS0xNDMx_7bfe1778-391e-4584-83b1-a1d17fd4dfef">167</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:OperatingLeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfMi00LTEtMS0xNDMz_28c18821-3eaa-460a-b5ab-359d76860f8c">150</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNS0yLTEtMS0xNDM1_5c17577c-752d-466f-a38f-954e27948a46">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeaseInterestExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNS00LTEtMS0xNDM3_6e85b043-f5fc-4d1c-804d-626d76a9b49e">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNi0yLTEtMS0xNDM1_59f1da80-429c-4d3a-8b30-37f5bf72d380">35</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAssetAmortization" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNi00LTEtMS0xNDM3_866d3d08-3e06-48a9-8011-b585bc1e0fcd">20</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNy0yLTEtMS0xNDM1_4b457aa3-3ca8-4603-a113-a116e9f02e6d">38</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:LeaseCost" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNy00LTEtMS0xNDM3_22854254-19d2-450d-b6c9-bdc6d8d27571">26</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td></tr></table></ix:continuation></div><div style="margin-bottom:6pt"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="esta:AssetsAndLiabilitiesLesseeTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2OA_f6e81251-1a00-4578-9735-6afbd9c5debd" escape="true"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Supplemental balance sheet information</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNC0yLTEtMS0xNDI5_505d4eda-4a1e-4a91-baaa-36723e926aba">2,511</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNC00LTEtMS0xNDI5_9e23d688-dcbe-4dbf-8dba-882ac8cbb441">2,610</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNS0yLTEtMS0xNDI5_a563f92f-be61-4f03-8ed5-cc8e61aee0b7">986</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:OperatingLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNS00LTEtMS0xNDI5_7fe4c4fb-edf9-47b2-91b6-f98ac45cc218">788</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNi0yLTEtMS0xNDI5_b7491f87-e5a3-4e05-b4b3-e5cf867ea488">1,630</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNi00LTEtMS0xNDI5_4e9876a2-1d6b-44aa-b4a8-6fd60f84568b">1,923</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNy0yLTEtMS0xNDI5_253337d6-cd46-4ee8-a000-34d2ebba8990">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNy00LTEtMS0xNDI5_9a8e1e6f-fdbd-43ae-a771-f9e54e3e7533">2,711</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTAtMi0xLTEtMTQyOQ_3294c7ef-6905-4203-b0af-5666069c4d62">278</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:FinanceLeaseRightOfUseAsset" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTAtNC0xLTEtMTQyOQ_c82f99b1-796b-45c4-a8be-c734fc61f6f0">313</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTEtMi0xLTEtMTQyOQ_aa495aca-7098-4061-9695-a34da3f91b76">105</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityCurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTEtNC0xLTEtMTQyOQ_ee5bf5e9-ad29-4aaa-8f60-11995d422793">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - long-term</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTItMi0xLTEtMTQyOQ_ab96d305-d451-4e4b-99a3-314b332028f5">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiabilityNoncurrent" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTItNC0xLTEtMTQyOQ_86012b10-f11f-4920-b813-93b1e9b2b341">28</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTMtMi0xLTEtMTQyOQ_90f4a327-3dbe-4e2b-9d32-9fcf8612f364">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTMtNC0xLTEtMTQyOQ_c9b4b3fb-f805-48d6-9e04-1e3b279d1631">188</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTYtMi0xLTEtMzUxNA_22557f85-3d33-4012-a323-140e1112ee64">5.9</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" format="ixt-sec:duryear" name="us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTYtNC0xLTEtMTQyOQ_a718b2e9-320e-4411-8080-5aeecc7ba678">6.2</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTctMi0xLTEtNDA5MA_077243fa-6c22-47eb-aa15-f4e05b881d09">0.8</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" format="ixt-sec:duryear" name="us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTctNC0xLTEtMTQyOQ_9895201d-f12d-44a3-827b-f16b88f5be17">1.0</ix:nonNumeric></span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate (%)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjAtMi0xLTEtNDA5MA_3c85f093-d21a-4641-9db2-6dfcd929a87c">10.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="3" name="us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjAtNC0xLTEtMTQyOQ_450eb337-d9b4-4499-b079-7333f71942b2">10.5</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjEtMi0xLTEtNDA5MA_8dc934bd-bd01-4a6a-8976-74882335dd07">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="3" name="us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjEtNC0xLTEtMTQyOQ_38cc1c2b-8826-4437-9e62-38d36d174cab">9.1</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></ix:nonNumeric></div></ix:continuation></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i729caf83e25842bb9302c227798a370f"><ix:continuation id="ic1f18bbcb41a438cbbdae356da254d19"><div style="margin-bottom:6pt"><ix:continuation id="i7dfc9ad6bd734526b77d7b441b4d4995"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfMy0yLTEtMS0xNDI3_64fba255-7ef2-492e-ba50-a5fcbbba77da">160</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:OperatingLeasePayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfMy00LTEtMS0xNDI3_f0edd5a8-79e0-4a8e-92dc-f642c4303283">137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNC0yLTEtMS0xNDI3_cca27c29-bc3a-4dba-938c-b2cab877797a">3</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeaseInterestPaymentOnLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNC00LTEtMS0xNDI3_774054c3-5cee-4caa-87ab-75ccba79e2f8">6</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNS0yLTEtMS0xNDI3_0ba51772-18df-4825-90be-6db65167a6ba">55</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" name="us-gaap:FinanceLeasePrincipalPayments" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNS00LTEtMS0xNDI3_e7f3056a-c67b-482a-8e17-77fef3669d00">76</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOC0yLTEtMS0xNDI3_b0def68f-5382-46aa-b807-e6106bfa1e8d">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOC00LTEtMS0xNDI3_d637d611-904e-4da7-994c-66bd7924dbe2">&#8212;</ix:nonFraction>&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOS0yLTEtMS0xNDI3_0da3d640-bbd5-4f72-89f9-2c7ad086b431">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:zerodash" name="us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOS00LTEtMS0xNDI3_6980fcdb-4313-4af9-8934-184e6a865e2e">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></ix:continuation></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA3MA_08795870-2c3a-4026-b998-1d7ccb816bb2" escape="true"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA3MA_6080baeb-f3ed-46f8-854e-bc6529cde8e8" escape="true"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.654%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.396%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.655%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMy0yLTEtMS0xNDIz_c3bf8caf-e234-4b48-a135-4b53d477bdb8">494</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMy00LTEtMS0xNDI1_9b03d44d-1b93-408f-987b-d0c09a5e2056">109</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNC0yLTEtMS0xNDIz_4768b75c-859b-4b21-a18c-1650cd79f4b8">594</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNC00LTEtMS0xNDI1_2db1d23d-de09-4e73-9dac-15c2f3dcef06">29</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNS0yLTEtMS0xNDIz_8239c462-de3f-44cc-8572-929b0afd2142">565</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNS00LTEtMS0xNDI1_2eadcbcc-1717-46ca-9f6e-c6bb807bf7f8">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNi0yLTEtMS0xNDIz_2bbc627e-e225-439e-89cd-57e2cfbb2908">532</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNi00LTEtMS0xNDI1_6e26d171-c286-48ce-af9d-a04787ba7549">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNy0yLTEtMS0xNDIz_585ee086-03b4-400e-8301-76ff1f5513c3">449</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNy00LTEtMS0xNDI1_4e5b7516-cd64-4dfd-b84a-6f76cccbdfde">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOC0yLTEtMS0xNDIz_076f79e7-1bc0-41d1-b94f-5ff76ec16158">878</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:zerodash" name="us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOC00LTEtMS0xNDI1_ab2818b0-9558-4765-abc7-f908b051f760">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOS0yLTEtMS0xNDIz_d1134fb2-af4f-4312-b5a6-7321b8a06287">3,512</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityPaymentsDue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOS00LTEtMS0xNDI1_f6d33330-670a-4c25-953a-65433fc04962">138</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amount of lease payments representing interest</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTAtMi0xLTEtMTQyMw_822c82af-9aed-4dfa-a17f-443183a0d687">896</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTAtNC0xLTEtMTQyNQ_f228a73d-3427-4bd2-ba94-7aae761e8e82">5</ix:nonFraction>)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:OperatingLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTEtMi0xLTEtMTQyMw_22e41746-63de-4c0f-9fcf-ce0b0e6c6dcf">2,616</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" name="us-gaap:FinanceLeaseLiability" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTEtNC0xLTEtMTQyNQ_9eb8ca86-df46-4617-b9d6-d21a5c046214">133</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:nonNumeric></ix:continuation></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_55"></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">8.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:StockholdersEquityNoteDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfNTEw_7e31536b-0c16-4124-895b-c1af963c17aa" continuedAt="ib58a38fa3e224831811f8ebc1cbafa7e" escape="true">Shareholders&#8217; Equity</ix:nonNumeric></span></div><ix:continuation id="ib58a38fa3e224831811f8ebc1cbafa7e" continuedAt="i8a50ddbcadac4a6a9e3b8dcdb11ed363"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Memorandum of Association and Articles of Association, or Articles, in effect as of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and December&#160;31, 2020, the Company had authorized an unlimited number of common shares with no par value.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjE2_5736161f-6ea9-4703-848c-8efc77e31d75">24,094,051</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesIssued" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjIz_707611d2-e463-4b33-83da-92bc3efdf638">23,925,789</ix:nonFraction> common shares, respectively, were issued and <ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjcx_6208fb15-876f-40dc-8ee0-4e5e171441da">23,685,981</ix:nonFraction> and <ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjc4_7ddc69ff-3010-4961-9215-47c28561e260">23,517,719</ix:nonFraction> common shares, respectively, were outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company granted stock options to employees and contractors (see Note 10).</span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i8a50ddbcadac4a6a9e3b8dcdb11ed363" continuedAt="i404ff2dbdd51427785195aa99e5415a1"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfStockByClassTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfNTE0_5996e527-42f0-440c-84fd-22767f716b6b" escape="true"><div style="margin-bottom:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had reserved common shares for future issuances as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.263%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNC0xLTEtMS0w_39ddd3c2-df0a-4703-bc2a-69659174aa21">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="id90136f7b3494c6a9628a63b0d9d7b06_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNC0zLTEtMS0w_c6dea6ad-9cca-4d29-b2be-0fc9e4cd43a9">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i1bd2c2bf38844a08b1d34482f0bd0b6d_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNS0xLTEtMS0w_b931cbd2-1e4a-4e48-81b4-394c49322aa7">2,161,165</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i5f2199649ba74639a58014d05b0e0980_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNS0zLTEtMS0w_35a69292-7753-41a3-807a-5f8763f8b9fa">2,012,960</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNi0xLTEtMS0w_2ccfa72b-4b7c-437a-b6de-0d9949400723">2,079,873</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4983eb1dc3b54e3da8367f9521c63168_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNi0zLTEtMS0w_42342afb-5628-4e60-a145-379421fe8691">1,641,112</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84d60646549649c5b45c4a188e368335_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNy0xLTEtMS0w_3da25a5f-6283-4077-94ee-5d7c3bfb1825">42,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNy0zLTEtMS0w_e626be60-285d-4cf1-8cf9-e70c8105ef89">48,624</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ia2caa5751cee42809a8237b7da9369d9_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOC0xLTEtMS0w_5e3cc439-5ce9-4811-956c-3eeca76fcb73">661,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2fa6b9cdd0424fd2946a54b840e1d4fb_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOC0zLTEtMS0w_7f561cb3-682e-4345-be20-cb83ca845633">474,000</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOS0xLTEtMS0w_d41b12db-e921-44cb-9b7b-37b5fdd42a4d">4,950,223</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOS0zLTEtMS0w_2be476b4-2290-451e-9f89-61c1f79bbcf0">4,182,196</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"></td></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_58"></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">9.&#160;&#160;&#160;&#160;<ix:continuation id="i404ff2dbdd51427785195aa99e5415a1" continuedAt="ic05ac3353c694964876ed96d79a65fbb">Warrants </ix:continuation></span></div><ix:continuation id="ic05ac3353c694964876ed96d79a65fbb"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued warrants for the purchase of <ix:nonFraction unitRef="shares" contextRef="i247e8da1272d441ea7089934a2671ae9_I20170331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfNzU_2d6edb75-597e-4d8b-917d-5e302a2c8f70">145,000</ix:nonFraction> Class B ordinary shares to parties related to Rockport Ventures, with a fixed exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="idc6ad514225b434ea180652c54cb7361_I20170331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMTc0_9346ddcc-baf3-48ee-8af9-6c22db6bdbd4">3.80</ix:nonFraction> per share.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, no warrants were exercised. <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMzYz_f4515b80-1f48-418a-a39c-3ffbd0e1a80c" continuedAt="i4d55582b3b6b43df9ba9b6903bea282e" escape="true">As of each of March&#160;31, 2021 and December&#160;31, 2020, <ix:nonFraction unitRef="shares" contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMjcy_df9629a1-2af0-4a99-861c-6b9cf15d2628"><ix:nonFraction unitRef="shares" contextRef="id90136f7b3494c6a9628a63b0d9d7b06_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMjcy_e084e9bd-7e80-44bc-aff8-b21befed2c38">5,500</ix:nonFraction></ix:nonFraction> warrants to purchase the Company&#8217;s common shares were outstanding and exercisable: </ix:nonNumeric></span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><ix:continuation id="i4d55582b3b6b43df9ba9b6903bea282e"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"></td><td style="width:13.079%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.795%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:17.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:16.362%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.258%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.989%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.546%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.083%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Holder</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In Connection With</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant&#160;to Purchase</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockport</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ClassOfWarrantOrRightOutstanding" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RhYmxlOjE3MWRlYWZlMjhhMTRkMjJhZTUwNGJjZmRiM2ViZjFkL3RhYmxlcmFuZ2U6MTcxZGVhZmUyOGExNGQyMmFlNTA0YmNmZGIzZWJmMWRfMi04LTEtMS0w_daa34a81-a979-4408-8ce6-b79508676e19">5,500</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331" decimals="INF" name="us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RhYmxlOjE3MWRlYWZlMjhhMTRkMjJhZTUwNGJjZmRiM2ViZjFkL3RhYmxlcmFuZ2U6MTcxZGVhZmUyOGExNGQyMmFlNTA0YmNmZGIzZWJmMWRfMi0xMC0xLTEtMA_7dd4e55e-3f8f-4ba6-82db-b513448e48c4">3.80</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/28/2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></ix:continuation></div></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_61"></div><div style="margin-bottom:3pt;margin-top:15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">10. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0MQ_82601962-d0de-4791-82a8-e84101074565" continuedAt="ib91f115df1514abcade467094571cd74" escape="true">Share-Based Compensation</ix:nonNumeric></span></div><ix:continuation id="ib91f115df1514abcade467094571cd74" continuedAt="if1cc2bbda0d74a9086a5fbf26f08baaa"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, the Board of Directors approved and adopted the 2015 Equity Incentive Plan, or 2015 Plan. Pursuant to the 2015 Plan, the Company has granted RSAs and stock options to Board of Directors, employees and consultants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Board of Directors terminated the 2015 Plan and approved the 2018 Equity Incentive Plan, or the 2018 Plan, with an initial reserve of <ix:nonFraction unitRef="shares" contextRef="ieda0ffc7bc7d4fa4861317378b2356ed_I20181231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockCapitalSharesReservedForFutureIssuance" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMzkx_63e68f82-4ced-4c7a-b131-860ca355b2d1">1,500,000</ix:nonFraction> common shares. Under the 2018 Plan, the Company may grant stock options, equity appreciation rights, and restricted shares and restricted share units. If an award granted under the 2018 Plan expires, terminates, is unexercised, or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares become available for further awards under the 2018 Plan. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the &#8220;evergreen&#8221; provision contained in the 2018 Plan, the number of common shares reserved for issuance under the 2018 Plan automatically increases on first day of each fiscal year, commencing on January 1, 2019, in an amount equal to the least of (1) <ix:nonFraction unitRef="shares" contextRef="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101" decimals="INF" format="ixt:numdotdecimal" name="esta:IncreaseInCommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTE1MA_7d159225-d28f-4d39-90f2-4fd38060018e">750,000</ix:nonFraction> shares, (2) <ix:nonFraction unitRef="number" contextRef="i87fb0387087841b6b020b35c3bc5ad74_D20190101-20190101" decimals="INF" name="esta:CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTE2NQ_2970d93a-57ad-4eef-9664-f0c41729ce50">4</ix:nonFraction>% of the total number of the Company&#8217;s common shares outstanding on the last day of the preceding fiscal year, or (3) a number of common shares as may be determined by the Company&#8217;s Board of Directors prior to any such increase date. On each of January 1, 2019, 2020 and 2021 the number of common shares authorized for issuance increased automatically by <ix:nonFraction unitRef="shares" contextRef="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101" decimals="INF" format="ixt:numdotdecimal" name="esta:IncreaseInCommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTQ5OQ_2f5ae2a3-c8cd-492b-85ba-ca0e8159567a">750,000</ix:nonFraction> shares in accordance with the evergreen provision, increasing the number of common shares reserved under the 2018 Plan to <ix:nonFraction unitRef="shares" contextRef="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:CommonStockSharesAuthorized" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTY0MQ_67314a2b-da59-4953-9eec-e0548d5dd11f">3,750,000</ix:nonFraction> as of March 31, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Ng_99e543e8-37a1-4f5f-9d0f-73f0295b931c" continuedAt="i806a6d47ef0f4179b2b3276b8302eaa1" escape="true">During the periods presented, the Company recorded the following share-based compensation expense for stock </ix:nonNumeric></span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="if1cc2bbda0d74a9086a5fbf26f08baaa" continuedAt="i57d65dfb7c344f44bf5ace4ba192c003"><ix:continuation id="i806a6d47ef0f4179b2b3276b8302eaa1"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options and restricted stock awards: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:73.602%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:10.804%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.806%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ia1ec09e636ce49e4903a5f3d5ac3e7c7_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNS02LTEtMS0w_8735b2e1-d5ea-48f8-b099-b8cf18c6fbc7">1,146</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i986acae19ce84fab8f8d01f4ded6532e_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNS04LTEtMS0w_e222368d-71e5-4e45-8422-3fa46434efee">1,307</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i1f351807ee89478e92c86e857311533d_D20210101-20210331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNi02LTEtMS0w_1f089a39-967b-4896-a4de-d22875b4daba">611</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ie71a900e3d434bcab7ea26baa565deb4_D20200101-20200331" decimals="-3" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNi04LTEtMS0w_58d0b743-fe62-493d-9336-917053f2e172">322</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNy02LTEtMS0w_942700d8-f476-468a-881a-1252ec98a99b">1,757</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNy04LTEtMS0w_bdcecfa1-39d7-4318-ba14-726045651374">1,629</ix:nonFraction></span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:continuation><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Mw_573980d3-a1b6-431e-ac49-0ffa0dc6925f" escape="true"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.553%"><tr><td style="width:1.0%"></td><td style="width:52.263%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:1.0%"></td><td style="width:9.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.811%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.547%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.816%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItNC0xLTEtMA_7a9cc3d7-0986-46e0-a8a2-bb9955ccdfcb">2,012,960</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItNi0xLTEtMA_cd40a378-d2d4-4c46-b97f-96ed0fe0582e">16.71</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItOC0xLTEtMA_bcae6f8f-90ab-422a-8730-a15574ad30aa">7.75</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItMTAtMS0xLTA_f10bfe0c-164a-420d-8a56-3095fc3626bd">42,126</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (weighted-average fair value of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjk5ODY0NjU0NWRlNTQzNzViOTE4N2NlY2E5NWZmNTk0XzQ0_8f348e3f-72fe-4c78-9b56-b984ebf1c49d">38.55</ix:nonFraction> per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtNC0xLTEtMA_edfe4a7b-16b5-4b59-9a02-b6887af27a06">347,239</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtNi0xLTEtMA_57b88594-78a4-42df-b6a5-795aad7a4540">68.97</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTQtNC0xLTEtMA_b93f5081-f28e-4c18-bc11-d50646e1095e">163,034</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTQtNi0xLTEtMA_0b5e9c16-24b3-4652-bdc5-494adcb0d0e6">11.54</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTUtNC0xLTEtMA_2ba11e5c-8934-4b95-a3fd-43854340d6a6">36,000</ix:nonFraction>)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTUtNi0xLTEtMA_291ae026-95fb-4096-834f-a5911fe21313">18.51</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtNC0xLTEtMA_859fcbb4-90e3-4375-8933-e66a6e8123e4">2,161,165</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtNi0xLTEtMA_1b7ee25d-5f00-4c9c-99d7-28496fa14191">25.47</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtOC0xLTEtMA_8429a3ec-9935-4177-b002-f92374c14a03">7.94</ix:nonNumeric></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-3" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtMTAtMS0xLTA_201e319c-0ca7-412c-b69e-b553266b20e9">82,375</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTgxOQ_22e842a6-7d7e-4505-bb7c-57767f6ea38c">857,094</ix:nonFraction> options were vested and exercisable with weighted-average exercise price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTg5OA_3c88a04d-161c-4bfb-9b95-ab23c8964129">12.22</ix:nonFraction>&#160;per share and a total aggregate intrinsic value of $<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTk1Mg_8121a6c6-d356-484d-8fe8-d3f5424174fd">43.1</ix:nonFraction>&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, <ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTk4Nw_2e76a316-c0d2-4cd9-bc1b-c86186052574">163,034</ix:nonFraction> options were exercised at a weighted-average price of $<ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjA0NA_ecec9830-6229-4f52-8504-ecb68ae4feb9">11.54</ix:nonFraction> per share. The intrinsic value of the options exercised during the three months ended March&#160;31, 2021 and 2020 was $<ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjEzNw_d6ad1c90-e898-4f40-b32a-5e8c06f42aa1">7.3</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMzI5ODUzNDg5MTgxOQ_bf3ac2e0-1e4b-44e2-87a7-2bfb1c351fe1">0.4</ix:nonFraction>&#160;million, respectively. Upon the exercise of stock options, the Company issued new shares from its authorized shares.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, unrecognized compensation expense was $<ix:nonFraction unitRef="usd" contextRef="i220c6103ff954277ae7622703799d5e7_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjI4MA_7a007f78-d7f2-4e29-bd38-1b49ba67a7af">19.0</ix:nonFraction> million related to stock options granted to employees and Board of Directors and $<ix:nonFraction unitRef="usd" contextRef="ie0fdf8bc2e1e409db1472911b124d683_I20210331" decimals="-5" format="ixt:numdotdecimal" name="esta:NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjM1Ng_177a4da6-1100-4db6-a05c-14e40cff1372">2.5</ix:nonFraction> million related to stock options granted to consultants. The weighted-average period over which such compensation expense will be recognized is <ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" format="ixt-sec:duryear" name="esta:EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjQ5NQ_7afe58f2-3878-40bc-8f4e-6b868a9ba33a">2.5</ix:nonNumeric> years. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options Granted to Employees </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for employees is based on the grant date fair value. The Company recognizes compensation expense for all share-based awards ratably on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of <ix:nonNumeric contextRef="i15b02aa6633a436480804341634e94d3_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjgxNA_a531427d-2cb5-415f-b43b-026bb37eef2f">four years</ix:nonNumeric>. During the three months ended March&#160;31, 2021 and 2020, the Company recognized $<ix:nonFraction unitRef="usd" contextRef="i15b02aa6633a436480804341634e94d3_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjg3OQ_55a6d348-1e4b-4ba0-8855-7733c334925b">1.1</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i478c73ce4642455cba1f5dffb0d3782a_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AllocatedShareBasedCompensationExpense" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjg4Ng_579343de-a8af-498a-8d1e-82a7ec9ea6a9">0.6</ix:nonFraction> million, respectively, of share-based compensation expense for stock options granted to employees.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option valuation model to value options granted to employees and consultants, which requires the use of highly subjective assumptions to determine the fair value of share-based awards. The assumptions used in the Company&#8217;s option-pricing model represent management&#8217;s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment. If factors change and different assumptions are used, the Company&#8217;s share-based compensation expense could be materially different in the future. The assumptions and estimates that the Company uses in the Black-Scholes model are as follows: </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Fair Value of Common Shares.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Following the Company&#8217;s IPO in 2018, the closing price of the Company&#8217;s publicly-traded common shares on the date of grant is used as the fair value of the shares. Prior to the </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i57d65dfb7c344f44bf5ace4ba192c003" continuedAt="i3c17aded54e34155b1de50d4066b977c"><div style="margin-bottom:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPO, the fair value of ordinary shares was estimated on a periodic basis by the Company&#8217;s Board of Directors, with the assistance of an independent third-party valuation firm.&#160;The Board of Directors intended all options granted to be exercisable at a price per share not less than the estimated per share fair value of the shares underlying those options on the date of grant.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Risk-Free Interest Rate.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company bases the risk-free interest rate used in the Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with a term equivalent to that of the term of the options for each option group on the measurement date.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Term.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For employee stock options, the expected term represents the period that the Company&#8217;s share-based awards are expected to be outstanding. Because of the limitations on the sale or transfer of the Company&#8217;s shares during the period the Company was a privately held company, the Company does not believe its historical exercise pattern is indicative of the pattern it will experience as a publicly traded company. The Company consequently uses the Staff Accounting Bulletin 110, or SAB 110, simplified method to calculate the expected term of employee stock options, which is the average of the contractual term and vesting period. The Company plans to continue to use the SAB 110 simplified method until it has sufficient trading history as a publicly traded company. For consultant stock options, the term used is equal to the remaining contractual term on the measurement date.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Volatility.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company determines the price volatility based on the historical volatilities of industry peers as it does not have sufficient trading history for its shares. Industry peers consist of several public companies in the medical device industry with comparable characteristics, including revenue growth, operating model and working capital requirements. The Company intends to continue to consistently apply this process using the same or a similar peer group of public companies until a sufficient amount of historical information regarding the volatility of its own shares becomes available, or unless circumstances change such that the identified peer companies are no longer similar, in which case other suitable peer companies whose common share prices are publicly available would be utilized in the calculation. The volatility is calculated based on the term on the measurement date.</span></div><div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Dividend Yield.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The expected dividend assumption is based on the Company&#8217;s current expectations about its anticipated dividend policy. The Company has no expectation that it will declare dividends on its common shares, and therefore has used an expected dividend yield of zero.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Nw_930d983c-44cb-4443-9fc0-4942936f56e8" continuedAt="ieb450d4584624e0bb6d0b312834e91fd" escape="true"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to employees was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.050%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.399%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.761%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfMy0yLTEtMS0wL3RleHRyZWdpb246MjBiY2RlMDUzNzUxNGQ1YmIxZDE4OWYyOWQwMGE1ZmJfOQ_5b658956-7779-4fd2-80b2-134779161526">60</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfMy00LTEtMS0wL3RleHRyZWdpb246NDg2MjFkNjU4ZWRhNDBkYmI3MzNlOTA4Nzc3ODlhOTdfNA_fd6987f5-2db4-4a75-8a39-648474597ac2">55</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQxMTExMDQ2N2M0NDkxNmEwYzI2N2EzOGE2YmIxNjNfNA_380c5721-80ed-47cb-b581-b3dfccc8ab81">0.7</ix:nonFraction>% - <ix:nonFraction unitRef="number" contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQxMTExMDQ2N2M0NDkxNmEwYzI2N2EzOGE2YmIxNjNfOQ_261c2346-5ff9-4eb9-8d1a-1ecd0370588b">1.1</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC00LTEtMS0wL3RleHRyZWdpb246ZjhhYjVhNGM4Njc1NDM1M2E2NmFiOTI0NWNhMDZhYThfNA_42f0697d-0209-4c25-8a0f-5fa2fca8e4ab">1.5</ix:nonFraction>%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNS0yLTEtMS0w_bdfd26cc-22d1-4c85-957c-490b01f04528">6.25</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNS00LTEtMS0w_399bb030-2c4a-4331-be80-a342320dbdd9">6.25</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNi0yLTEtMS0w_94350bc5-258a-4d46-85d6-0f152aff1c28">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNi00LTEtMS0w_f4a780a2-0d26-46c1-ae46-35e9e907c032">&#8212;</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options Granted to Non-Employees </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to stock options granted to non-employees is recognized as the stock options are earned using an accelerated attribution method. The Company believes that the estimated fair value of the stock options is more readily measurable than the fair value of the services rendered. For the three months ended March&#160;31, 2021 and 2020, the Company recognized expense of $<ix:nonFraction unitRef="usd" contextRef="ia2edc59bec53490994496014ae3b59a2_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzExOA_4b9af80c-79d0-4080-b0aa-064911d22bf6">0.5</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="ic6df5fcf8c8343ea957122278a45e96b_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzEyNQ_58663800-7adf-4831-a3e1-d1b4f9bb89f8">0.8</ix:nonFraction> million, respectively, for stock options granted to consultants. </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><ix:continuation id="i3c17aded54e34155b1de50d4066b977c" continuedAt="i8b07db37be1d4f948dc18f9f958408bb"><ix:continuation id="ieb450d4584624e0bb6d0b312834e91fd"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:68.497%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.356%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.357%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfMy0yLTEtMS0wL3RleHRyZWdpb246MTcxNDNjZDA0MDBiNDI3ZGE4ZWJkYTlhYmNjNjFmMmJfOQ_af9bca82-ae3a-4798-b526-44c9038b0051">60</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfMy00LTEtMS0w_abb8aa70-26b4-4e9d-8c5f-cd6260427a98">56</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQ0ZTNiYjEzMGNkNGIwM2E0NTQzZDU1YTkzNzgwMDlfOQ_af9b6725-f955-4cad-89f0-d78c76e5a2dc">1.6</ix:nonFraction>%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331" decimals="3" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNC00LTEtMS0w_2f27ff71-ac8c-4ea0-a3bc-70d8068ad806">1.6</ix:nonFraction>%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNS0yLTEtMS0w_932ae5bb-4cf6-445f-8e49-b678221f124a">10</ix:nonNumeric></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331" format="ixt-sec:duryear" name="us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNS00LTEtMS0w_8904b399-188f-42b3-b236-e2d48b028c2c">10</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNi0yLTEtMS0w_72f1e511-ff31-4b97-9df0-8d2fdc29dd7e">&#8212;</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="number" contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" scale="-2" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNi00LTEtMS0w_48e3ccc4-fe63-4578-b686-b83a67b1756e">&#8212;</ix:nonFraction></span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div></ix:continuation><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each vested RSA entitles the holder to be issued one common share. These awards vest according to a vesting schedule determined by the Compensation Committee of the Company&#8217;s Board of Directors, generally over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzU1OA_84b51ed7-33dc-4765-9c9e-ef71511b6db7">one</span> to <ix:nonNumeric contextRef="ic880ec3a676b4f12a08eb325a02676fa_D20210101-20210331" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0NQ_a82cf4cf-bc61-47b6-9941-b26ec49e35e7">four year</ix:nonNumeric> period.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0MA_ba424f3d-c5b2-4057-8740-61f274889596" escape="true"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents RSA activity for fiscal 2021:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.519%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.846%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.847%"></td><td style="width:0.1%"></td></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTAtMi0xLTEtMA_a7e12373-c27f-4ef7-8e81-16a1f106f6d9">48,624</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTAtNC0xLTEtMA_bf55b0bf-5222-4136-b34d-df1b18dbadd4">11.32</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTEtMi0xLTEtMA_1e5cc610-4f1e-4f04-86fb-428352636b20">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTEtNC0xLTEtMA_9a56ae78-8530-4fac-be2c-9373abf5d2bd">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="shares" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTItMi0xLTEtMA_0e8e143e-8128-4f75-b425-b9fb8be402a8">5,939</ix:nonFraction>)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTItNC0xLTEtMA_b08cb203-9b95-4524-b202-582d219c763e">13.31</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="INF" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTMtMi0xLTEtMA_47c1124d-07b3-44f0-a412-d66fb5200f51">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="2" format="ixt:zerodash" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTMtNC0xLTEtMA_ee684605-9368-4bea-aadc-d14715d7be56">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i84d60646549649c5b45c4a188e368335_I20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTQtMi0xLTEtMA_56c56fe5-7c04-4384-80be-d3aa1b6266d1">42,685</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usdPerShare" contextRef="i84d60646549649c5b45c4a188e368335_I20210331" decimals="2" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTQtNC0xLTEtMA_13a95c2c-4b9d-4fa1-8423-224b1e3d58ab">11.04</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div style="margin-bottom:6pt;margin-top:24pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock is the grant date market value of common shares. The Company recognizes share-based compensation expense related to restricted stock using a straight-line method over the vesting term of the awards. The share-based compensation expense for RSAs that vested during the three months ended March&#160;31, 2021 and 2020, was $<ix:nonFraction unitRef="usd" contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzk3Nw_8d4032e8-990f-480e-a8ac-16885b443f56">0.2</ix:nonFraction> million and $<ix:nonFraction unitRef="usd" contextRef="i2bfc12cdfee24225bc3c5d74083ada83_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzk4NA_eb471c99-3353-4947-ada0-b763f9a7dec3">0.1</ix:nonFraction> million, respectively, which was calculated based on the market value of the Company&#8217;s common shares on the applicable date of vesting.</span></div></ix:continuation><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i8b07db37be1d4f948dc18f9f958408bb">As of March&#160;31, 2021, the Company had unrecognized share-based compensation cost of approximately $<ix:nonFraction unitRef="usd" contextRef="i84d60646549649c5b45c4a188e368335_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODE5Mg_7c7c34b3-4d2a-4802-8488-6d5d2d54d086">0.3</ix:nonFraction> million associated with unvested restricted stock awards. This cost is expected to be recognized over a weighted-average period of approximately <ix:nonNumeric contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331" format="ixt-sec:duryear" name="us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODMzMg_47fe8328-1c35-4f70-9e7e-b2c49ea2335f">0.5</ix:nonNumeric> years.</ix:continuation> </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">31</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_67"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">11.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:EarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTAy_e5a72520-1386-4e89-9b0d-f175d8c16fcf" continuedAt="i3a8c30c3da464d7380ba4a4e04a96202" escape="true">Net Loss Per Share</ix:nonNumeric></span></div><ix:continuation id="i3a8c30c3da464d7380ba4a4e04a96202"><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTAz_60b0834a-df31-4e19-88c0-faff227b2904" escape="true"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share for the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.138%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.036%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.038%"></td><td style="width:0.1%"></td></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi01LTEtMS0w_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"><ix:nonFraction unitRef="usd" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi01LTEtMS0w_e52cb721-7370-454d-94fa-56383aa1257a">6,948</ix:nonFraction></ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="-3" sign="-" format="ixt:numdotdecimal" name="us-gaap:NetIncomeLoss" scale="3" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi03LTEtMS0w_ef1bacbe-ecde-4483-9a94-2223bfbb2136">17,753</ix:nonFraction>)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used for basic and diluted earnings per share</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfOC01LTEtMS0w_3b8f333e-0fdf-492c-a099-5e0bce6ef8ee">23,827,137</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfOC03LTEtMS0w_f667509d-60dd-48cb-a123-b1786cf8d5a7">22,456,365</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfMTItNS0xLTEtMA_d5c0fd0d-3446-4868-803a-7b5afacd668a">0.29</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usdPerShare" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="2" sign="-" name="us-gaap:EarningsPerShareBasicAndDiluted" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfMTItNy0xLTEtMA_cc7a9a60-7e42-4301-afdc-4a2222f2e66a">0.79</ix:nonFraction>)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:18pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and dilutive share equivalents outstanding for the period, determined using the treasury-share method and the as-if converted method, for convertible securities, if inclusion of these is dilutive</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company reports a net loss</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, diluted net loss per share is the same as basic net loss per share for those periods because including the dilutive securities would be anti-dilutive.</span></div><ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTA2_7049fff6-7c3e-440d-bcd1-7ad0ac532d26" escape="true"><div style="margin-bottom:9pt;margin-top:8.3pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:67.203%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.376%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.377%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i695c26f28c134a87811302e003a58006_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNC0xLTEtMS0w_4154eda3-24b7-40a0-9226-37398045162d">1,900,825</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i07c8793eb73f4c988ba24cd20e54c766_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNC0zLTEtMS0w_a16b9bfc-e5e7-4535-a5d7-bd7df2b42978">1,632,871</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i99e5a665c04f40eca5f9a0b3a98ca5a4_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNS0xLTEtMS0w_fb737923-92dc-463c-a855-b1fa670eaf64">42,685</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="icbb360d504184d689fa5022115013737_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNS0zLTEtMS0w_641fdab5-f634-4094-9be4-5b1ad2649708">108,472</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i4915579cae994b35a1b781ee5e5104d7_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNi0xLTEtMS0w_877227bf-e7a8-43b7-9f84-7c88697b927f">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i52d7890a8568427a9a9331d06f4f7f6e_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNi0zLTEtMS0w_561fec8f-5f31-41ab-bd09-184377931c07">5,500</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNy0xLTEtMS0w_957a5b51-adfb-4561-8d4d-356461cbe4fd">1,949,010</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="shares" contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331" decimals="0" format="ixt:numdotdecimal" name="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNy0zLTEtMS0w_4697708f-f838-4d51-b64a-20f605627afa">1,746,843</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div></ix:nonNumeric></ix:continuation><div id="i1ffd384b299d487fa5b14f13003c56d4_70"></div><div style="margin-bottom:6pt;margin-top:15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12.&#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:RelatedPartyTransactionsDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTU1OA_1c710b80-7298-4691-aa63-314f12bc10bf" continuedAt="i04be0e8c64d2460cb6bbd4aafcef16a8" escape="true">Related Party Transactions</ix:nonNumeric></span></div><ix:continuation id="i04be0e8c64d2460cb6bbd4aafcef16a8" continuedAt="iee13aa5a0e0642d085f88519d95ed39d"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2021 and 2020, the Company recorded revenue of $<ix:nonFraction unitRef="usd" contextRef="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfOTA_8a26a421-2ce2-4849-b4bf-2dac6a105c6d"><ix:nonFraction unitRef="usd" contextRef="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:RevenueFromRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfOTA_90e94c7d-a301-4d2e-bfcf-70a2276e9142">0.2</ix:nonFraction></ix:nonFraction> million for product sales to Herramientas Medicas, S.A., a distribution company owned by a family member of the Chief Executive Officer of the Company. Accounts receivable owed to the Company from this distribution company amounted to approximately $<ix:nonFraction unitRef="usd" contextRef="i8874a1e19376447fbb0ebf1b8cb9d361_I20201231" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzQx_7c62fdbf-8e2e-4477-9acd-1219cf636ad6"><ix:nonFraction unitRef="usd" contextRef="id7adeaf0b41a4c8289f265e3a67c7204_I20210331" decimals="-5" format="ixt:numdotdecimal" name="us-gaap:AccountsReceivableRelatedParties" scale="6" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzQx_88966b81-1c4a-4ffa-afb8-b6b741629db6">0.2</ix:nonFraction></ix:nonFraction> million for each of March&#160;31, 2021 and December&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the Company entered into a scientific board advisory agreement with Dr. Manuel Enrique Chac&#243;n Quir&#243;s, the brother of our Chief Executive Officer, Juan Jos&#233; Chac&#243;n Quir&#243;s, pursuant to which Dr. Chac&#243;n Quir&#243;s joined the Company&#8217;s Scientific Advisory Board, provided general scientific advice, and served as a clinical investigator, among other services. In exchange for these services, Dr. Chac&#243;n Quir&#243;s was granted options to purchase </span></div></ix:continuation><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:9pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div><div style="margin-bottom:9pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ESTABLISHMENT LABS HOLDINGS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Notes to Condensed Consolidated Financial Statements </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(Unaudited)</span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="iee13aa5a0e0642d085f88519d95ed39d" continuedAt="i07ca485f0bba42f986830a4e6f5238a5"><ix:nonFraction unitRef="shares" contextRef="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfNzUz_4d1f5fce-b995-4fb5-be82-bc90dd237025">20,580</ix:nonFraction> shares. The grant vested over <ix:nonNumeric contextRef="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfNzc3_58e73340-68b0-41cd-bb66-99093bce7e70">four years</ix:nonNumeric> in equal annual installments. Dr. Chac&#243;n Quir&#243;s resigned from the Company&#8217;s Scientific Advisory Board in November 2019.</ix:continuation></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:continuation id="i07ca485f0bba42f986830a4e6f5238a5">In 2016, the Company also entered into a separate agreement with Dr.&#160;Chac&#243;n Quir&#243;s to maintain his clinic in Costa Rica as a MotivaImagine Excellence Center and to host and train physicians in the use of the Company products in relevant procedures, among other services, in exchange for cash reimbursement of up to $<ix:nonFraction unitRef="usd" contextRef="if841a633a7064c10a7ea55273d751563_I20161231" decimals="INF" format="ixt:numdotdecimal" name="esta:RelatedPartyTransactionCashReimbursementPerDayForServices" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTE5OA_fbc4fd85-791c-4986-afc2-4e5d347acec6">4,500</ix:nonFraction> per day that such services are rendered. In December 2020, Dr. Chac&#243;n Quir&#243;s was granted options to purchase <ix:nonFraction unitRef="shares" contextRef="i29f43ea253394bd380b244709b366727_D20201201-20201231" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzI5ODUzNDg4NTU0NA_6aae8238-392f-4299-8e22-cb752ab9e369">22,068</ix:nonFraction> shares vesting over <ix:nonNumeric contextRef="i29f43ea253394bd380b244709b366727_D20201201-20201231" format="ixt-sec:durwordsen" name="us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzI5ODUzNDg4NTU1MQ_1a14f182-6e13-4f29-a2e8-2101ee26fcb2">four years</ix:nonNumeric> in equal annual installments, provided that he continues to provide these services at such times. During the three months ended March&#160;31, 2021 and 2020, the Company paid Dr. Chac&#243;n Quir&#243;s approximately $<ix:nonFraction unitRef="usd" contextRef="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTUwOQ_a482b48b-1e4c-4520-8949-679bbafaaa50">93,000</ix:nonFraction> and $<ix:nonFraction unitRef="usd" contextRef="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331" decimals="INF" format="ixt:numdotdecimal" name="us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" scale="0" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTUxNg_72900c13-0b42-4d77-813f-3a5ffa4f7de3">20,000</ix:nonFraction>, respectively, for services rendered.</ix:continuation> </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_1333"></div><div style="margin-bottom:3pt;margin-top:15pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">13. &#160;&#160;&#160;&#160;<ix:nonNumeric contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331" name="us-gaap:CommitmentsAndContingenciesDisclosureTextBlock" id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzMzL2ZyYWc6ZTA0YjhiYmY0MDQ2NDU1YjliYzY4N2IwNTg4OWMwNzcvdGV4dHJlZ2lvbjplMDRiOGJiZjQwNDY0NTViOWJjNjg3YjA1ODg5YzA3N180OTQ3ODAyMzI4NzU3_ff9dd3ca-8ae7-4475-a3e0-7fa2e3e96074" continuedAt="id3b18cc9a18141aa89fb8d4796d19e50" escape="true">Commitments and Contingencies</ix:nonNumeric></span></div><ix:continuation id="id3b18cc9a18141aa89fb8d4796d19e50"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual or disclosure at March&#160;31, 2021 and 2020 except for contingent equity consideration related to past asset acquisitions as of March 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Indemnification</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</span></div></ix:continuation><div style="margin-bottom:6pt"><span><br/></span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_76"></div><div style="margin-bottom:12pt;margin-top:3pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. MANAGEMENT&#8217;S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">You should read the following discussion and analysis of our financial condition and results of operations together with the condensed consolidated financial statements and related notes that are included elsewhere in this Quarterly Report on Form&#160;10-Q. This discussion contains forward-looking statements based upon current expectations that involve risks and uncertainties. Our actual results may differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under &#8220;Risk Factors,&#8221; set forth in Part II, Item 1A of this Quarterly Report on Form&#160;10-Q.&#160;See &#8220;Special Note Regarding Forward-Looking Statements&#8221; below.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Forward-Looking Statements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">The information in this discussion contains forward-looking statements and information within the meaning of Section 27A of the Securities Act and Section 21E of the Exchange Act, which are subject to the &#8220;safe harbor&#8221; created by those sections. These forward-looking statements include, but are not limited to, statements concerning the impact of the COVID-19 outbreak, our strategy, future operations, future financial position, future revenues, projected costs, prospects and plans and objectives of management. The words &#8220;anticipates,&#8221; &#8220;believes,&#8221; &#8220;estimates,&#8221; &#8220;expects,&#8221; &#8220;intends,&#8221; &#8220;may,&#8221; &#8220;plans,&#8221; &#8220;projects,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">identifying words. We may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements and you should not place undue reliance on our forward-looking statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Actual results or events could differ materially from the plans, intentions and expectations disclosed in the forward-looking statements that we make. These forward-looking statements involve risks and uncertainties that could cause our actual results to differ materially from those in the forward-looking statements, including, without limitation, the risks set forth in Part II, Item 1A, &#8220;Risk Factors&#8221; in this Quarterly Report on Form 10-Q and in our other filings with the SEC. The forward-looking statements are applicable only as of the date on which they are made, and we do not assume any obligation to update any forward-looking statements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These risks and uncertainties arise from (among other factors):</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our expectations and estimates concerning future financial performance, financing plans and the impact of competition;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the impact that the COVID-19 pandemic may have with respect to deferrals of procedures using our products, disruptions or restrictions on the ability of many of our employees and of third parties on which we rely to work effectively, and temporary closures of our facilities and of the facilities of our customers and suppliers; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">the full extent to which the COVID-19 pandemic will, directly or indirectly, impact our business, results of operations and financial condition, including our sales, expenses, supply chain integrity, manufacturing capability, research and development activities, clinical activities, and employee-related compensation, including as a result of (1) a resurgence in COVID-19 transmission and infection after the loosening of &#8220;stay at home&#8221; restrictions or resumption of surgical procedures, (2) actions required or recommended to contain or treat COVID-19, in light of any or all of the foregoing or other as-yet unanticipated developments, and (3) the direct and indirect economic impact, both domestically and abroad, of COVID-19 as a result of any or all of the foregoing, including actions taken by local, state, national and international governmental agencies, whether such impact affects customers, suppliers, or markets generally, all of which currently are highly uncertain; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to continue to invest in medical education and training, product development, and/or sales and commercial marketing initiatives at levels sufficient to drive future revenue growth;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected expenses and delay and our ability to manage timelines and costs related to manufacturing our products including as a result of litigation or developing and supporting the full commercial launch of new products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to obtain additional debt and equity financing to fund capital expenditures and working capital requirements and acquisitions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to complete acquisitions, integrate operations post-acquisition and maintain relationships with customers of acquired entities; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to support the safety and efficacy of our products with long-term clinical data; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">existing and future regulations affecting our business, both in the United States and internationally, and enforcement of those regulations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to protect our intellectual property, including unpatented trade secrets, and to operate without infringing or misappropriating the proprietary rights of others; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">general economic and business conditions, in both domestic and international markets; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">other risk factors described in our other SEC filings, including in the section entitled &#8220;Risk Factors&#8221; of our Annual Report on Form 10-K for the year ended December 31, 2020 .</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">These factors should not be construed as exhaustive and should be read in conjunction with the other cautionary statements included in this report.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">34</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_79"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Overview</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our line of silicone gel-filled breast implants, branded as Motiva Implants, is the centerpiece of our MotivaImagine medical technology platform. Our post-market surveillance data (which was not generated in connection with a United Stated Food and Drug Administration, or FDA, pre-market approval, or PMA, study but was self collected rather than collected at mandatory follow-ups) and published third-party data indicates that Motiva Implants show low rates of adverse events (including rupture, capsular contracture, and safety related reoperations) that we believe compare favorably with those of our competitors. We believe the proprietary technologies that differentiate our Motiva Implants enable improved safety and aesthetic outcomes and drive our revenue growth. Our MotivaImagine platform enables surgical techniques that we promote as Motiva designed surgeries. We have developed other complementary products and services on our MotivaImagine platform, which are aimed at further enhancing patient outcomes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have devoted a majority of our resources since inception to developing our Motiva Implants, which we began selling in October 2010. We have incurred net losses in each year since inception, and we have financed our operations primarily through equity financings and debt financings. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our revenue for the three months ended March&#160;31, 2021 and 2020 was $30.3 million and $24.5 million, respectively, an increase of $5.9 million, or 23.9%. Net losses were $6.9 million for the three months ended March&#160;31, 2021 as compared to $17.8 million for the three months ended March&#160;31, 2020. As of March&#160;31, 2021 we had an accumulated deficit of $172.2 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our cash balance as of March&#160;31, 2021 was $78.0 million. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are pursuing proposals related to the expansion of our manufacturing facilities and corporate offices in the Coyol Free Zone in Costa Rica. The initial $35.3 million project estimate includes approximately 170,000 square feet of facility space and would initially increase our manufacturing capacity by approximately 400,000 units per year, and potentially increase capacity by 800,000 units with an additional incremental $4.6 million investment in manufacturing equipment. Currently we are in the design phase and anticipate to breaking ground in the second quarter of 2021. All plans are subject to final approval by the Board of Directors and the negotiation and execution of definitive agreements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have made and continue to make significant investments in additional manufacturing capacity, marketing, customer service, and a direct sales force in certain territories like Brazil and several countries in Europe in order to drive and support further adoption of our Motiva Implants. We expect that we will continue to incur losses at least in the near term as we expand our organization to support planned sales growth, while also continuing to invest in research and development of our products, clinical trials to enable regulatory approval in the United States, and in other commercialization efforts. We also expect to incur significant additional expenditures as a public company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had 638 employees. Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees, advisors and consultants. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel through the granting of share-based and cash-based compensation awards, in order to increase stockholder value and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus, or COVID-19, as a pandemic which has spread globally, including locations where we do business. This outbreak caused a material disruption of our operations and our suppliers and customers in fiscal 2020 and resulted in delayed clinical trial enrollment within the reconstruction cohorts. However, the impact from the COVID-19 outbreak has not had a material effect on our liquidity or financial position. The full extent of any future impact of the continuing outbreak, related business and travel restrictions and changes to behavior intended to reduce its spread are uncertain and continues to evolve globally. Management continues to monitor the impact that the COVID-19 pandemic is having on our operations, the breast aesthetics and reconstruction market and the economies in which we operate. We do not anticipate that our future results of operations, including the results for 2021 will be materially impacted by the COVID-19 outbreak. However, given the speed and frequency of continuously evolving developments with respect to this pandemic, we cannot reasonably estimate the magnitude of the potential impact to the results of </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our operations. To the extent that our customers continue to be materially and adversely impacted by the COVID-19 outbreak, this could materially interrupt our business operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these and other factors, we expect to continue to incur net losses in the intermediate term and may need to raise additional capital through equity and debt financings in order to fund our operations. Our operating results may fluctuate on a quarterly or annual basis in the future, and our growth or operating results may not be consistent with predictions made by securities analysts, if any. If we are unable to achieve our revenue growth objectives, we may not be able to achieve profitability.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_82"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Components of Results of Operations</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We commenced sales of our Motiva Implants in October 2010 and these products have historically accounted for the majority of our revenues. Sales of our Motiva breast implants accounted for over 97% of our revenues for the three months ended March&#160;31, 2021, and we expect our revenues to continue to be driven primarily by sales of these products. We primarily derive revenue from sales of our Motiva Implants to two types of customers: (1) medical distributors and (2) direct sales to physicians, hospitals, and clinics.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We recognize revenue related to the sales of products at the time of shipment, except for a portion of our direct sales revenue that is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For consignment sales, revenue is recognized at the time we are notified by the consignee that the product has been implanted. Our contracts with distributors do not typically contain right of return or price protection and have no post-delivery obligations.</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our revenue to increase as we enter new markets, expand awareness of our products in existing markets, and grow our distributor network and direct sales force. We also expect our revenue to fluctuate from quarter to quarter due to a variety of factors, including seasonal fluctuations in demand for Motiva Implants. We are also affected by foreign currency fluctuations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue and Gross Margin</span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our implants are manufactured at our two facilities in Costa Rica. Cost of revenue is primarily the cost of silicone but also includes other raw materials, packaging, components, quality assurance, labor costs, as well as manufacturing and overhead expenses. Cost of revenue also includes depreciation expense for production equipment, and amortization of certain intangible assets. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We calculate gross margin as revenue less cost of revenue for a given period divided by revenue. Our gross margin may fluctuate from period to period depending, in part, on the efficiency and utilization of our manufacturing facilities, targeted pricing programs, and sales volume based on geography, customer and product type.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Sales, General and Administrative </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sales, general and administrative, or SG&amp;A, expenses primarily consist of compensation, including salary, share-based compensation and employee benefits for our sales and marketing personnel, and for administrative personnel that support our general operations such as information technology, executive management, financial accounting, customer service, and human resources personnel. SG&amp;A expenses also includes costs attributable to marketing, sales support, travel, legal services, financial audit fees, insurance costs, and consulting services. We expect to incur additional SG&amp;A expenses in connection with being a public company, which may increase further when we are no longer able to rely on the &#8220;emerging growth company&#8221; exemption we are afforded under the Jumpstart Our Business Startups Act of 2012, or JOBS Act. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our SG&amp;A expenses to continue to increase in absolute dollars for the foreseeable future as our business grows and we continue to invest in our sales, marketing, medical education, training and general administration resources to build our corporate infrastructure. However, we expect our SG&amp;A expenses to decrease as a percentage of our revenue over the long term, although our SG&amp;A expenses may fluctuate from period to period due to the timing of expenses related to our sales and marketing campaigns. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">36</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Research and Development </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our research and development, or R&amp;D, activities primarily consist of engineering and research programs associated with our products under development, as well as R&amp;D activities associated with our clinical development activities. Our R&amp;D expenses primarily consist of compensation, including salary, share-based compensation and employee benefits for our R&amp;D and clinical personnel. We also incur significant expenses for supplies, development prototypes, design and testing, clinical study costs and product regulatory and consulting expenses. </span></div><div style="margin-bottom:6pt;margin-top:4.5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect our R&amp;D expenses to continue to increase in absolute dollars and as a percentage of revenue for the foreseeable future as we continue to advance our products under development, as well as initiate and prepare for additional clinical studies. We received an approval of an investigational device exemption, or IDE, from the FDA in March 2018 to initiate a clinical trial and enrolled the first patient in April 2018. In August 2019, we completed all patient surgeries for the IDE aesthetic cohorts, which include primary augmentation and revision augmentation. As of March&#160;31, 2021, we successfully completed enrollment in the revision reconstruction sub-cohort and we are continuing to enroll subjects in the remaining reconstruction cohorts. Although we continue to activate trial sites and secure Institutional Review Board approvals, the COVID-19 pandemic has delayed enrollment in the reconstruction cohorts for our IDE clinical trial, which could add at least six months to our planned regulatory timeline. We plan to enroll 800 patients in the study across 40 sites in the United States, Germany and Sweden. The results of the study are expected to support a pre-market approval, or PMA, submission to the FDA. We estimate that total costs for this IDE clinical trial will be between $30.0 million and $40.0 million over ten years. We also have other products under development for which we may be required to conduct clinical trials in future periods in order to receive regulatory approval to market these products. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense consists primarily of cash and non-cash interest related to outstanding debt and amortization of debt discounts. As of March&#160;31, 2021, we had $65.0 million in outstanding principal. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Derivative Instruments </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of derivative instruments consists of changes in the fair value of the put and call option liabilities associated with outstanding debt instruments. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Contingent Consideration</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of contingent consideration consists of changes in the fair value of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">contingent equity consideration related to past asset acquisitions</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, Net</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net primarily consists of foreign currency gains/losses and interest income.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Tax Expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Income tax expense consists primarily of income taxes in foreign jurisdictions in which we conduct business. Due to our history of losses, with the exception of Belgium, we maintain a full valuation allowance for deferred tax assets including net operating loss carry-forwards, R&amp;D tax credits, capitalized R&amp;D and other book versus tax differences.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Business Update Regarding COVID-19 </span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has presented a substa</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ntial public health and economic challenge around the world and has materially and adversely affected our business in fiscal 2020. We continue to closely monitor developments related to the COVID-19 pandemic and our decisions will continue to be driven by the health and well-being of our employees, our distributor and plastic surgeon customers, and their patients while maintaining operations to support our customers and their patients in the near-term.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Surgery Deferrals:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> From late March 2020 to mid-May 2020, among other impacts on our business related to the pandemic, plastic surgeons and their patients deferred surgical procedures in which our products otherwise could have been used, including surgeries for our clinical trial participants. This decrease in demand for our products recovered to varying degrees in the latter half of May and into June 2020, though still below pre-pandemic levels though the rest of fiscal 2020, as certain geographies reopened </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">after an initial improvement in COVID-19 infection rates and allowed plastic surgeons to resume providing procedures. However, the impact from the COVID-19 outbreak in fiscal 2020 has not had a material effect on the Company&#8217;s liquidity or financial position. During the first quarter of 2021, we saw an increase in surgical activity as women&#8217;s interest in plastic surgery exceeded pre-pandemic levels, and most geographies modified procedures to mitigate infection risk to allow returning to normalized operating levels. However, if a resurgence of infections is observed, we may see continued volatility through at least the duration of the pandemic as geographies respond to current local conditions. The duration of further deferrals of surgical procedures, the magnitude of such deferrals, the timing and extent of the economic impact of the pandemic, and the pace at which the economy recovers therefrom, cannot be determined at this time. We continue to work closely with our plastic surgeon customers, distributors and suppliers to navigate through this unforeseen event while maintaining flexible operations and investing for future growth.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Operations:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Our sales, marketing and research and development efforts have continued since the outbreak of the pandemic. However, the pandemic has adversely affected our business despite the steps taken to mitigate its impact. To protect the safety, health and well-being of our employees, distributor and plastic surgeon customers, and communities, we implemented preventative measures including travel restrictions and requiring all office-based employees to work from home, except for those related to manufacturing and select others, as permitted under governmental orders. </span></div><div style="margin-bottom:6pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing, distribution and supply chain has largely been uninterrupted, but could be disrupted as a result of the pandemic due to staffing shortages, production slowdowns, stoppages, or disruptions in delivery systems.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Cost Containment: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We continue to carefully manage expenses and cash spend to preserve liquidity and we initiated actions to generate savings in areas such as travel, events and consulting. Production at our manufacturing locations has been reduced based on our current forecasts and at the end of June 2020, we reduced our manufacturing headcount by approximately 70 positions. As the demand for our products rebounded, we have rehired some manufacturing personnel.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">2020 Results: </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Given that the onset of COVID-19 occurred toward the end of the first quarter of 2020, our total revenue for the second quarter of 2020 was significantly lower compared to the same period in 2019. Our revenue for the third and fourth quarters of 2020, however, recovered and was comparable or exceeded the revenue in corresponding quarters of fiscal 2019. The first quarter of 2021 resulted in record quarterly revenue, which points to the recovering global business environment and normalizing medical protocols as countries manage new COVID-19 infections.</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Outlook:</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> At this time, the full extent of the impact of the COVID-19 pandemic on our business, financial condition and results of operations is uncertain and cannot be predicted with reasonable accuracy and will depend on future developments that are also uncertain and cannot be predicted with reasonable accuracy. However, management does not expect future results of operations to be materially impacted by the COVID-19 pandemic.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For additional information on the various risks posed by the COVID-19 pandemic on our business, financial condition and results of operations, please see Item 1A. Risk Factors in this report.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_85"></div><hr style="page-break-after:always"/><div style="min-height:90pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Consolidated Results of Operations</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">The following tables set forth our results of operations for the periods presented, in dollars:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:71.221%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.995%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.996%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited) (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,138&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,984&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,048&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,186&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,183&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss from operations</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,096)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(7,705)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,195)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,146)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of derivative instruments</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">230&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,929)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value of contingent consideration</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other expense, net</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,722)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,182)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loss before income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,783)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,522)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Provision for income taxes</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(165)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(231)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 30.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_91"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Comparison of the Three Months Ended March&#160;31, 2021 and 2020 </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:70.775%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.590%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.591%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited) (in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Revenue</span></div></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,481&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cost of revenue</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,246&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,003&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross profit</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20,090&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,478&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Gross margin</span></div></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63.2&#160;</span></td><td style="background-color:#ffffff;border-top:3pt double #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue increased $5.9 million, or 23.9%, to $30.3 million for the three months ended March&#160;31, 2021 as compared to $24.5 million for the three months ended March&#160;31, 2020. The increase was primarily due to the global economies recovering from the COVID-19 pandemic declared in March 2020 that resulted in multiple geographies experiencing restrictions on elective surgical procedures and a shut-down or slow down in business activity deemed to be non-essential. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cost of Revenue and Gross Margin</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Cost of revenue increased $1.2 million, or 13.8%, to $10.2 million for the three months ended March&#160;31, 2021 compared to $9.0 million for the three months ended March&#160;31, 2020. The increase in cost of revenue is in line with the increase in revenue due to the economic recovery from the COVID-19 pand</span><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">emic</span><span style="background-color:#ffffff;color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The gross margin increased to 66.2% for the three months ended March&#160;31, 2021 compared to 63.2% for the three months ended March&#160;31, 2020, primarily due to the benefit of geographic mix, greater operating efficiencies, and enhanced manufacturing planning capabilities.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Operating Expenses</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"></td><td style="width:70.435%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.759%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.545%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.761%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited) (in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating expenses:</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,138&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,984&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,048&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,199&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating expenses</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,186&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,183&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Sales, General and Administrative Expense</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expense decreased $0.8 million, or 4.5%, to $18.1 million for the three months ended March&#160;31, 2021, compared to $19.0 million for the three months ended March&#160;31, 2020. The decrease in SG&amp;A was primarily due to a $0.8 million decrease in consulting fees and a $0.3&#160;million decrease in personnel and related costs, partially offset by a $0.5&#160;million increase in commissions.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development Expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">R&amp;D expense decreased $0.2 million, or 3.6%, to $4.0 million for the three months ended March&#160;31, 2021, compared to $4.2 million for the three months ended March&#160;31, 2020. The decrease in R&amp;D expense was primarily due to a $0.4&#160;million decrease in expenditures related to our IDE clinical trial in the United States, primarily consisting of fees to third parties to manage the clinical trial, partially offset by a $0.3&#160;million increase in personnel cost.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Interest Expense</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interest expense remained consistent at $2.2 million for the three months ended March&#160;31, 2021, compared to </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$2.1 million for the three months ended March&#160;31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Derivative Instruments </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Change in fair value of derivative instruments for the three months ended March&#160;31, 2021 resulted in a gain of $0.2 million, compared to a loss of $1.9 million for the three months ended March&#160;31, 2020. The change in fair value of derivative instruments was due to changes in the fair value of Madryn derivatives embedded in the Madryn Credit Agreement we entered into in August 2017. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Change in Fair Value of Contingent Consideration</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The liability related to the contingent consideration was extinguished in the third quarter of 2020 when the remaining contingently-issuable shares were issued.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provision for Income Taxes</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provision for income taxes decreased $66,000, or 28.6%, to $165,000 for the three months ended March&#160;31, 2021, compared to $231,000 for the three months ended March&#160;31, 2020. The change in the provision for income taxes is primarily due to decreased pre-tax income in certain foreign jurisdictions.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Expense, Net</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other expense, net decreased $3.5 million to $2.7 million for the three months ended March&#160;31, 2021, compared to $6.2 million for the three months ended March&#160;31, 2020. The decrease was primarily due to the foreign currency fluctuations of Brazilian real and the euro as compared to the U.S. dollar in fiscal 2020 and 2021, resulting in a foreign currency transaction loss of $2.7 million as of March&#160;31, 2021, compared to $6.2&#160;million for the three months ended March&#160;31, 2020.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_94"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Liquidity and Capital Resources</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had an accumulated deficit of $172.2 million. Since our inception, we have generated losses and expect to continue to generate losses in the intermediate term. We have financed our operations through a combination of equity financings and debt financings, and from cash generated from operations, primarily from the collection of accounts receivable resulting from sales. Our historical cash outflows have primarily been associated with cash used for operating activities such as expansion of our sales and marketing and distributor infrastructure, investing in inventory, R&amp;D activities, asset acquisitions, capital improvements and other working capital needs. As of March&#160;31, 2021 and December&#160;31, 2020, we had cash of $78.0 million and $84.5 million, respectively. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 3, 2020, we completed a public follow-on offering and received net proceeds of $63.9</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">million, after deducting underwriting discounts and expenses. During the three months ended March&#160;31, 2021, the Company also received $1.9&#160;million from the exercise of stock options.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The global economy continues to be impacted by the COVID-19 pandemic, the ultimate extent and duration of which is not presently known, and our liquidity may be negatively impacted. As a result, we have taken significant actions to minimize the operational and financial impacts of the COVID-19 pandemic, including adjusting our cost structure, reducing discretionary capital and operating expenditures and improving working capital management in order to preserve our financial flexibility and liquidity position. We believe that our available cash and cash from operations will be sufficient to satisfy our liquidity requirements for at least the next 12 months. Our liquidity assumptions may prove to be incorrect, and we could utilize our available financial resources sooner than we currently expect. Our future capital requirements will depend on many factors, including:</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the degree and rate of market adoption of our products;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the cost and timing of our regulatory activities, especially the IDE clinical trial to obtain regulatory approval for our Motiva Implants in the United States;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the emergence of new competing technologies and products;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the costs of R&amp;D activities we undertake to develop and expand our products;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the costs of commercialization activities, including sales, marketing and manufacturing; </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the level of working capital required to support our growth; and</span></div><div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our need for additional personnel, information technology or other operating infrastructure to support our growth and operations as a public company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to raise additional capital to execute our business plan. If we are unable to raise additional capital when desired, or on terms acceptable to us, our business, results of operations, and financial condition would be adversely affected. </span></div><div style="margin-bottom:3pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash Flows </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the primary sources and uses of cash for each of the periods presented below:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:74.644%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.655%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.544%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.657%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(unaudited) (in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net cash provided by (used in):</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating activities</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,554)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,802)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Investing activities</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,532)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(949)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing activities</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">63,926&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Effect of exchange rate changes on cash</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(273)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(234)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net (decrease) increase in cash</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,573)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,941&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">42</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Operating Activities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities of $6.6 million for the three months ended March&#160;31, 2021 was comprised of a net loss of $6.9 million and a $0.2 million change in fair value of financial instruments, partially offset by $3.0 million of unrealized foreign currency loss, $1.8 million of share-based compensation expense, $0.9 million of non-cash depreciation expense, $0.5 million of non-cash interest expense due to accretion of debt discounts, and a $0.1 million change in provision for inventory obsolescence, as well as changes in operating assets and liabilities of $5.8 million.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in operating activities of $6.8 million for the three months ended March 31, 2020 was comprised of net loss of $17.8 million, partially offset by $5.8 million unrealized foreign currency loss, $1.9 million change in fair value of financial instruments, $1.6 million of share-based compensation expense, $0.8 million of non-cash depreciation expense, and $0.4 million of non-cash interest expense due to accretion of debt discounts, as well as changes in operating assets and liabilities of $32,000.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Used in Investing Activities </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities of $1.5 million for the three months ended March&#160;31, 2021 primarily consisted of $0.8 million in purchases of property and equipment, $0.4 million of cash paid for past asset acquisitions and $0.3 million of purchases of intangibles.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash used in investing activities of $0.9 million for the three months ended March 31, 2020 primarily consisted of $0.7 million in purchases of property and equipment and $0.3 million purchases of intangibles.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Net Cash Provided by Financing Activities</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities of $1.8 million for the three months ended March&#160;31, 2021 primarily consisted of $1.9 million in proceeds received for stock option exercises, which were partially offset by $55,000 in repayment on finance leases and a $41,000 tax payment related to shares withheld upon vesting of restricted stock. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Net cash provided by financing activities of $63.9 million for the three months ended March 31, 2020 primarily reflected $63.9 million in proceeds received from the issuance of common shares in the follow-on public offering, net of underwriters&#8217; discount and issuance costs, $0.2 million in proceeds received for stock option exercises, which were partially offset by $0.1 million in repayment on finance leases and a $34,000 tax payment related to shares withheld upon vesting of restricted stock.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_97"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Indebtedness</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Madryn Debt</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2017, we entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders. On June 17, 2019, the Madryn Credit Agreement was amended to lower the interest rate on the outstanding debt facilities, provide for $25.0 million of new term loan commitments, decrease the amount of the prepayment penalties, remove all principal payments and extend the maturity date and repayment from September 30, 2023 to September 30, 2025. On August 5, 2020, we amended the Madryn Credit Agreement to adjust the minimum product revenue milestone previously applicable to December 31, 2020 to September 31, 2021 and to add Motiva Implants UK Limited, Motiva Implants France SAS, Motiva Implants Spain, S.L. and Motiva Germany GmbH, our wholly-owned subsidiaries, as guarantors to the Madryn Credit Agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement, as amended, provides for a term loan in a maximum principal amount of $65.0 million, $30.0 million (Term A) of which became available to us upon signing and was subsequently borrowed.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to amending the Madryn Credit Agreement on June 17, 2019, our ability to borrow the remaining term loans under the Madryn Credit Agreement was subject to our achievement of certain revenue milestones. We met milestones sufficient to borrow and borrowed an additional $5.0 million (Term B-1) on October 31, 2017 and $5.0 million (Term B-2) on December 15, 2017, increasing the total outstanding principal balance to $40.0 million as of December 31, 2017.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the June 2019 amendment, we became eligible to borrow an additional $10.0 million (Term B-3) and $15.0 million (Term B-4) on or before September 30, 2019 and December 31, 2019, respectively. We borrowed the available funds under both tranches equal to $25.0&#160;million on August 12, 2019, bringing up the total outstanding principal balance to $65.0 million as of March&#160;31, 2021.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Madryn Credit Agreement, the Company and certain of its subsidiaries granted a security interest in substantially all of their respective assets, including, without limitation, intellectual property, and pledges of certain shares of the Company&#8217;s subsidiaries, subject to certain excluded collateral exceptions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement contains customary affirmative and negative covenants, including, but not limited to, restrictions on the ability of the Company and its subsidiaries to incur additional indebtedness, create liens, make certain investments, make restricted payments, enter into or undertake certain liquidations, mergers, consolidations or acquisitions and dispose of assets or subsidiaries. In addition, the Madryn Credit Agreement requires us to maintain minimum revenues and liquidity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the effectiveness of the June 17, 2019 amendment, borrowings under the Madryn Credit Agreement bore interest at a rate equal to 3-month LIBOR plus 11.0% per annum. As of the amendment on June 17, 2019, borrowings under the Madryn Credit Agreement bear interest at a rate equal to 3-month LIBOR plus 8.0% per annum provided that no default has occurred. In an event of a default, the interest would increase by an additional 4.0% per annum. The effective interest rate under the amended Madryn Credit Agreement is 18.4%, and the weighted average interest rate was approximately 10.6% at March&#160;31, 2021. The Company incurred $1.7 million in interest expense in connection with Madryn Credit Agreement during each of the three months ended March&#160;31, 2021 and in 2020, respectively. No principal payments are due on the term loans until the final maturity date on September 30, 2025.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also determined that the Madryn Credit Agreement contained put options which are mandatory repayment provisions related to liquidity events or an event of default and a call option related to voluntary repayment option. We allocated a fair value of $15.1 million for these embedded derivatives as a debt discount on the original commitment date in August 2017. An additional $5.0 million and $1.6 million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $10.0 million in the fourth quarter of fiscal 2017 and $25.0&#160;million in August 2019. We revalue the embedded derivatives as of each reporting period and records the change in the fair value in the consolidated statement of operations as other income or expense (see Note 5). We also incurred legal expenses of $1.3 million in 2017 and $0.3 million in August 2019, which were recorded as a debt discount and are being amortized over the term of the Madryn Credit Agreement. </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_100"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Contractual Obligations and Commitments </span></div><div style="margin-bottom:6pt;text-align:justify"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our contractual obligations have not changed materially from those included in the Form 10-K filed with the SEC on March 15, 2021.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_103"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Off-Balance Sheet Arrangements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:174%">As of March&#160;31, 2021 and December&#160;31, 2020, we did not have any off-balance sheet arrangements. </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_106"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">JOBS Act Accounting Election</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The JOBS Act permits an &#8220;emerging growth company&#8221; such as us to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to take advantage of certain exemptions from various public company reporting requirements including following private company effective dates for new or revised accounting standards.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_109"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Critical Accounting Policies, Significant Judgments and Use of Estimates</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This discussion and analysis of our financial condition and results of operations is based on our consolidated financial statements, which have been prepared in accordance with the generally accepted accounting principles in the United States of America, or GAAP. The preparation of these consolidated financial statements requires us to make estimates and judgments that affect the reported amounts of assets and liabilities, revenue and expenses, and the disclosure of contingent assets and liabilities. Our estimates are based on our historical experience and on various other assumptions that we believe to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities. Actual results may differ from these estimates. We believe that the critical accounting policies discussed below are essential to understanding our historical and future performance, as these policies relate to the more significant areas involving management&#8217;s estimates and judgments.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We identified certain critical accounting policies that affect certain of our more significant estimates and assumptions used in preparing our consolidated financial statements in the Form 10-K filed with the SEC on </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Contents</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March 15, 2021. We have not made any material changes to these policies as previously disclosed in the Form 10-K.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will directly or indirectly impact our business, results of operations and financial condition, including sales, operational expenses, manufacturing, research and development costs, IDE clinical trial enrollment and related costs, and employee-related compensation, will depend on future developments that are highly uncertain, including as a result of new information that may emerge concerning COVID-19 and the actions taken to contain it or treat COVID-19, as well as the economic impact on local, regional, national and international customers and markets. We have made estimates of the impact of COVID-19 within our financial statements and there may be changes to those estimates in future periods. Actual results may differ from these estimates.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_112"></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Accounting Pronouncements</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please refer to Note 2 - &#8220;Summary of Significant Accounting Policies&#8221; in the notes to the unaudited condensed consolidated financial statements included in this Form 10-Q for information on recent accounting pronouncements and the expected impact on our unaudited condensed consolidated financial statements.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_115"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3: QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Interest Rate Risk</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We had cash of $78.0 million and $84.5 million as of March&#160;31, 2021 and December&#160;31, 2020, respectively. We manage our cash portfolio for operating and working capital purposes. Our cash balances are held in bank checking accounts, and we believe that we do not have any material exposure to changes in the fair value of our cash portfolio as a result of changes in interest rates. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Foreign Currency Exchange Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To date, the majority of our revenue has been denominated in U.S. dollars, Brazilian reals and euros. Some of our operating expenses are subject to fluctuations due to changes in foreign currency exchange rates, particularly changes in the euro and Brazilian real. Fluctuations in foreign currency exchange rates may cause us to recognize transaction gains and losses in our consolidated statements of operations. For the three months ended March&#160;31, 2021, foreign currency transaction loss amounted to $2.7 million primarily related to the remeasurement of transactions denominated in the U.S. dollar into the Brazilian real and the euro as part of the financial reporting consolidation process under GAAP. The Brazilian real has been experiencing a weakening since December 31, 2017 as compared to the U.S. dollar. We have not engaged in any foreign currency hedging activities. As our international operations grow, we will continue to reassess our approach to managing the risks relating to fluctuations in foreign currency exchange rates. During the year ended December&#160;31, 2020, the effect of an immediate 10% adverse change in foreign exchange rates on foreign-denominated accounts as of December&#160;31, 2020 would have had an impact of approximately 9.9% on revenues and would have impacted our net loss by a commensurate amount.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Inflation Risk</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not believe that inflation had a significant impact on our results of operations for any periods presented in our consolidated financial statements.</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_118"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. CONTROLS AND PROCEDURES</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Evaluation of disclosure controls and procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the end of the period covered by this Quarterly Report on From 10-Q, our management, with the participation of our Chief Executive Officer and Chief Financial Officer, have evaluated the effectiveness of our disclosure controls and procedures as of the end of the period covered by this quarterly report. Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended) are designed to ensure that information required to be disclosed by a company in the reports that it files or submits under the Exchange Act is (i) recorded, processed, summarized and reported within the time periods specified in the SEC&#8217;s rules and forms and (ii) accumulated and communicated to the Company&#8217;s management, including its principal executive officer and principal financial officer, as appropriate to allow timely decisions regarding required disclosure. Based on the evaluation of our disclosure controls and procedures, our Chief Executive Officer and Chief Financial Officer concluded that, due to a material weakness in internal control </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">45</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span><br/></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">over financial reporting, our disclosure controls and procedures were not effective as of the end of the period covered by this quarterly report at the reasonable assurance level.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Material Weakness in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We disclosed in our Annual Report on Form 10-K for the year ended December 31, 2020, that the following material weakness in our internal control over financial reporting existed as of December 31, 2020: a lack of adequate review over the manual consolidation process, resulting in an audit adjustment, or the Material Weakness.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Plan for Remediation of the Material Weakness</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have implemented and are continuing to implement a number of measures to address the Material Weakness identified as of December 31, 2020. We improved policies and procedures and designed and documented more effective controls that addressed the relevant risks in order to remediate the previously identified Material Weakness in addition to engaging a third-party consulting firm to assist us with the continuing implementation of SAP, which is a global information technology solution designed to address, among other items, the elements which gave rise to the Material Weakness. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Changes in Internal Control over Financial Reporting</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other than with respect to the remediation efforts discussed above, there was no change in our internal control over financial reporting that occurred during the period covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. Although we have altered some work routines due to the COVID-19 pandemic, the changes in our work environment, including remote work arrangements, have not materially impacted our internal controls over financial reporting and have not adversely affected the Company&#8217;s ability to maintain operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Limitations on Effectiveness of Controls and Procedures</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our disclosure controls and procedures and internal control over financial reporting are designed to provide reasonable assurance of achieving the desired control objectives. Our management recognizes that any control system, no matter how well designed and operated, is based upon certain judgments and assumptions and cannot provide absolute assurance that its objectives will be met. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply judgment in evaluating the benefits of possible controls and procedures relative to their costs. Similarly, an evaluation of controls cannot provide absolute assurance that misstatements due to error or fraud will not occur or that all control issues and instances of fraud, if any, have been detected.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">46</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_121"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PART II. OTHER INFORMATION</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_124"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1. LEGAL PROCEEDINGS</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are currently not a party to any material legal proceedings, but from time-to-time may become involved in legal proceedings arising in the ordinary course of our business activities. </span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_127"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 1A. RISK FACTORS </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investing in our common shares involves a high degree of risk. The following risk factors describe circumstances or events that could have a negative effect on our business, financial condition or operating results. You should consider the following risks carefully, together with all the other information in this Quarterly Report on Form&#160;10-Q, including our consolidated financial statements and notes thereto, before you invest in our common shares. If any of the following risks occur, our business, financial condition, or operating results, could be adversely affected. As a result, the trading price of our common shares could decline, and you could lose part or all of your investment. Additional risks and uncertainties not currently known to us or that we currently believe are not material could also impair our business, financial condition or operating results.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Summary Risk Factors</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our business is subject to numerous risks and uncertainties that you should consider before investing in our company, as fully described below. The principal factors and uncertainties that make investing in our company risky include, among others:</span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The COVID-19 pandemic has, and may for the foreseeable future, materially and adversely affected our business and our financial results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">There is no guarantee that the FDA or non-U.S. regulatory agencies will grant approval for our current or future products, and failure to obtain regulatory approvals in the United States and other international jurisdictions, or revocation of approvals in those jurisdictions, will prevent us from marketing our products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Even if clinical trials demonstrate acceptable safety and efficacy for Motiva Implants in some patient populations, the FDA or similar regulatory authorities outside the United States may not approve the marketing of Motiva Implants or may approve it with restrictions on the label, which could have a material adverse effect on our business, financial condition, results of operations and growth prospects. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">In certain large markets, we engage in direct sales efforts. We may fail to maintain and develop our direct sales force, and our revenues and financial outcomes could suffer as a result. Furthermore, our direct sales personnel may not effectively sell our products.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">If we are unable to train plastic surgeons on the safe, effective and appropriate use of our products and designed surgeries, we may be unable to achieve our expected growth.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We have a limited operating history and may face difficulties encountered by companies early in their commercialization in competitive and rapidly evolving markets. </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Our business depends on maintaining our brand and ongoing customer demand for our products and services, and a significant reduction in sentiment or demand could affect our results of operations.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Any disruption at our existing facilities could adversely affect our business and operating results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants. If this supplier were to increase prices for this raw material over time or experience interruptions in its ability to supply us with this raw material, our business, financial condition and results of operations could be adversely affected.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Negative publicity, product defects and any resulting litigation concerning our products or our competitors&#8217; products could harm our reputation and reduce demand for silicone breast implants, either of which could negatively impact our financial results.</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Recent news coverage has called into question the long-term safety of breast implants and reports of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) linked to our competitors&#8217; products which have led to regulatory actions regarding macrotextured devices in several countries and the worldwide recall of one of our competitor&#8217;s macrotextured implants and tissue expanders. These events may lead to a reduction in the demand for silicone breast implants and could adversely affect our business.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risk Related to COVID-19</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The COVID-19 pandemic has, and may for the foreseeable future, materially and adversely affected our business and our financial results.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The COVID-19 pandemic has materially and adversely impacted our business and we expect the impact to continue through at least the duration of the pandemic as regions respond to local conditions. To date, the impact includes: </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the deferral of procedures using our products; </span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">disruptions or restrictions on the ability of many of our employees and of third parties on which we rely, to work effectively, including &#8220;stay-at-home&#8221; orders and similar government actions; and</span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">temporary closures of our facilities and of the facilities of our customers and suppliers.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As jurisdictions throughout the world continue to respond to the pandemic, the degree of the foregoing impacts may increase in scope or magnitude or we may experience additional adverse effects in one or more regions. Any other outbreaks of contagious diseases or other adverse public health developments in countries where we operate or where our customers or suppliers are located could also have a material and adverse effect on our business, financial condition and results of operations. </span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to the COVID-19 pandemic, surgeons and their patients have been, and in certain regions continue to be, required, or are choosing, to defer elective procedures in which our products otherwise could be used, and many facilities that specialize in the procedures in which our products otherwise could be used have temporarily closed and in some cases continue to be temporarily closed or operating at reduced hours. In addition, even after the pandemic subsides or governmental orders no longer prohibit or recommend against performing such procedures, patients may continue to defer such procedures due to personal concerns. Further, facilities at which our products typically are used may not reopen or, even if they reopen, patients may elect to have procedures performed at facilities that are, or are perceived to be, lower-risk, such as private surgery centers, and our products may not be approved at such facilities, and we may be unable to have our products approved for use at such facilities on a timely basis, or at all. The effect of the pandemic on the broader economy could also negatively affect demand for elective procedures using our products, both in the near- and long-term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Workforce limitations and travel restrictions resulting from government actions taken to contain the spread of COVID-19 have and will continue to adversely affect almost every aspect of our business. If a significant percentage of our workforce, or of the workforce of third parties on which we rely, cannot work, including because of illness or travel or government restrictions, our operations will be negatively affected. Because of government restrictions and social distancing guidelines in many countries around the world, there is an increased reliance on working from home for our workforce and on the workforce of third parties on which we rely. For example, most of our sales personnel and third party agents currently are working largely using virtual and online engagement tools and tactics, which may be less effective than our typical in-person sales and marketing programs. In addition, we reduced access to our hands-on surgeon trainings, which, in turn, adversely impacted our ability to educate and train surgeons on the proper use of our products, which may make surgeons less comfortable using, and therefore less likely to use, our products. We expect that &#8220;stay-at-home&#8221; orders will also limit our ability to develop, and therefore launch, the products we believe will drive our future revenue growth on the timelines we anticipated previously, or at all, and could also delay the planned launch of products in 2021 and beyond. It may also cause us not to submit required filings on our previous time tables, including with the FDA, or other regulatory bodies, both in the U.S. and outside the U.S. The continued spread of COVID-19 has adversely impacted our IDE clinical trial operations in the United States, including our ability to recruit and retain patients and principal investigators and site staff who, as healthcare providers, have heightened exposure to COVID-19. In addition, changes impacting workforce function at the FDA and other regulatory bodies, as well as changes impacting workforce function at the facilities at which we seek to have new products approved for use, could adversely impact the timing of when our new products are cleared for marketing and approved for use, either of which would adversely impact the timing of our ability to sell these new products and would have a material and adverse effect on our revenue growth.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, disruptions in the manufacture and distribution of our products or in our supply chain may occur as a result of the COVID-19 pandemic, including for the reasons above, or other events that result in staffing shortages, production slowdowns, stoppages, or disruptions in delivery systems, any of which could materially </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and adversely affect our ability to manufacture or distribute our products, or to obtain the raw materials and supplies necessary to manufacture and distribute our products, in a timely manner, or at all.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may also experience other unknown adverse impacts from the COVID-19 pandemic that cannot be predicted. For example, hospitals and other facilities at which we sell our products may renegotiate their purchase prices, including as a result of, or the perception that they may be suffering, financial difficulty as a result of the pandemic. Similarly, facilities at which we seek to sell our products in the future may require price reductions relative to the price at which we previously expected to sell our products. Reduction in the prices at which we sell products to existing customers may have a material and adverse effect on our future financial results and reductions in the prices at which we expected to sell products would have a material and adverse effect on our expectations for revenue growth.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, the global capital markets experienced, and we expect will continue to experience, disruption and volatility due to the COVID-19 pandemic, adversely impacting access to capital not only for us, but also for our customers and suppliers who need access to capital. Their inability to access capital in a timely manner, or at all, could adversely impact demand for our products and/or adversely impact our ability to manufacture or supply our products, any of which could have a material and adverse effect on our business. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The full extent to which the COVID-19 pandemic will, directly or indirectly, impact our business, results of operations and financial condition, including our sales, expenses, supply chain integrity, manufacturing capability, research and development activities, and employee-related compensation, is currently highly uncertain and cannot be predicted with reasonable accuracy at this time and will depend on future developments that are also highly uncertain and cannot be predicted with reasonable accuracy at this time, including, without limitation: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">new information that may emerge concerning COVID-19, its contagiousness or virulence; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">resurgences in COVID-19 transmission and infection following the easing or lifting of &#8220;stay-at-home&#8221; or other restrictions or following resumption of surgical procedures, whether as a result thereof, as a result of reinfection, as a result of a delay in the emergence of symptoms following infection (or reinfection) by COVID-19, or as a result of COVID-19&#8217;s ability to lay dormant following infection (or reinfection), and the adverse impact the foregoing may have on our business and financial condition, including because of the adverse impact on patients&#8217; willingness to undergo procedures in which our products could be used; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actions required or recommended to contain or treat COVID-19, in light of any or all of the foregoing or other as-yet unanticipated developments, whether related to COVID-19 directly or indirectly; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the direct and indirect economic impact, both domestically and abroad, of the COVID-19 pandemic as a result of any or all of the foregoing, including actions taken by local, state, national and international governmental agencies, whether such impact affects customers, suppliers, or markets generally.</span></div><div><span><br/></span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unfavorable global economic conditions could adversely affect our business, financial condition or results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our results of operations could be adversely affected by general conditions in the global economy and in the global financial markets. The global financial crisis caused extreme volatility and disruptions in the capital and credit markets. A severe or prolonged economic downturn, could result in a variety of risks to our business, including general economic pressure on our customers&#8217; patients. Elective aesthetic procedures are less of a priority than other items for those patients that have lost their jobs, are furloughed, have reduced work hours or have to allocate their cash to other priorities.&#160;A weak or declining economy could also strain our manufacturers or suppliers, possibly resulting in supply disruption, or cause our customers or distributors to delay making payments for our products. Any of the foregoing could harm our business and we cannot anticipate all of the ways in which the economic climate and financial market conditions could adversely affect our business.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to the Development and Commercialization of Our Products </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to incur losses for the foreseeable future, and our ability to achieve and maintain profitability depends on the commercial success of our Motiva Implants, which accounted for approximately 98% and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">94% of our revenues for the years ended December 31, 2020 and 2019, respectively, and we expect our revenues to continue to be driven primarily by sales of these products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred losses to date and expect to continue to incur losses for the foreseeable future. Sales of our Motiva Implants accounted for approximately 98% and 94% of our revenues for the years ended December 31, 2020 and December 31, 2019, respectively, and we expect our revenues to continue to be driven primarily by sales of these products. In order to achieve and sustain profitability, our revenues from these products will need to grow beyond the levels we have achieved in the past. If physicians and/or patients do not perceive our products to be competitive in features and safety when compared to other products in the market, or if demand for our Motiva Implants or for breast implants in general decreases, we may fail to achieve sales levels that provide for future profitability. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully market Motiva Implants and our other current and future offerings depends on numerous factors, including but not limited to: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the outcomes of current and future clinical studies of Motiva Implants, including our ongoing IDE clinical trial, to demonstrate our products&#8217; value in improving safety outcomes and/or patient satisfaction;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">acceptance of Motiva Implants as safe and effective by patients, caregivers and the medical community; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">an acceptable safety profile of Motiva Implants in the global market; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">whether key thought leaders in the medical community accept that such clinical studies are sufficiently meaningful to influence their or their patients&#8217; choices of product; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintenance of our existing regulatory approvals and expansion of the geographies in which we have regulatory approvals;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">designing commercially viable processes at a scale sufficient to meet anticipated demand at an adequate cost of manufacturing, and that are compliant with ISO 13485 Quality Management System requirements and/or good manufacturing practice, or GMP, requirements, as set forth in the FDA&#8217;s Quality System Regulation, Brazilian and other international regulations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our success in educating physicians and patients about the benefits, administration and use of Motiva Implants; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the availability, perceived advantages, relative cost, relative safety and relative efficacy of alternative and competing treatments; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the willingness of patients to pay out-of-pocket for breast augmentation and reconstruction procedures in the absence of coverage and reimbursement for such procedures;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our internal sales and marketing organization and the sales forces of our distributors; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">continued demand for breast augmentation and reconstruction procedures using silicone implants, which may be adversely affected by events involving either our products or those of our competitors, including FDA warnings to patients regarding Breast Implant-Associated Anaplastic Large Cell Lymphoma, or BIA-ALCL.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some of these factors are beyond our control. If we are unable to continue to commercialize Motiva Implants and our other products, or unable to obtain a partner to commercialize them, we may not be able to produce any incremental revenues related to Motiva Implants and our other products. This would result in an adverse effect on our business, financial condition, results of operations and growth prospects. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">There is no guarantee that the FDA or non-U.S. regulatory agencies will grant approval for our current or future products, and failure to obtain regulatory approvals in the United States and other international jurisdictions, or revocation of approvals in those jurisdictions, will prevent us from marketing our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We intend to seek additional distribution and marketing partners for Motiva Implants and may market specific products only in international markets. We have obtained a CE Mark for Motiva Implants and are therefore authorized to sell in the EU; however, in order to market in regions such as the Asia Pacific region and many other jurisdictions, we must obtain separate regulatory approvals. The approval procedures vary among countries and can involve additional clinical testing, and the time required to obtain approvals may differ from that required to </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">50</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">obtain the CE Mark or FDA approval. Moreover, clinical studies or manufacturing processes conducted in one country may not be accepted by regulatory authorities in other countries. Approval by the FDA does not ensure approval by regulatory authorities in other countries, and approval by one or more international regulatory authorities does not ensure approval by regulatory authorities in other countries or by the FDA. However, a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in others. An international regulatory approval process may include all of the risks associated with obtaining FDA approval. We may not obtain international regulatory approvals on a timely basis, if at all. We may not be able to file for regulatory approvals and, even if we file, we may not receive necessary approvals to commercialize our products in any market.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Before obtaining regulatory approval for the sale of a planned product, we may be required to conduct extensive preclinical and clinical studies to demonstrate the safety and efficacy of our planned products in human patients. Clinical studies can be expensive, difficult to design and implement, can take many years to complete, and are uncertain as to outcome. A failure of one or more of our clinical studies could occur at any stage of testing. In connection with the initiation of a clinical study in the United States, we filed an IDE application in 2017, which was approved in March 2018 and our first patient was enrolled in April 2018. Our ongoing U.S. IDE trial may take longer to enroll than anticipated, may be stopped for unforeseen safety issues or may not be successful in meeting its endpoints, in which case our U.S. regulatory pathway would require subsequent additional clinical trials.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Numerous unforeseen events during, or as a result of, preclinical and clinical studies could occur, which would delay or prevent our ability to receive regulatory approval or commercialize Motiva Implants or any of our planned products, including the following: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">clinical studies may produce negative or inconclusive results, and we may decide, or regulators may require us, to conduct additional clinical studies or abandon product development programs;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the number of patients required for clinical studies may be larger than we anticipate, enrollment in these clinical studies may be insufficient or slower than we anticipate, or patients may drop out of these clinical studies at a higher rate than we anticipate;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the cost of clinical studies may be greater than we anticipate;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">third-party contractors may fail to comply with regulatory requirements or meet their contractual obligations to us in a timely manner, or at all;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we might suspend or terminate clinical studies of our planned products for various reasons, including a finding that our planned products have unanticipated serious side effects or other unexpected characteristics, or that the study subjects are being exposed to unacceptable health risks;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators may not approve our proposed clinical development plans;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators or independent institutional review boards, or IRBs, may not authorize us or our investigators to commence a clinical study or conduct a clinical study at a prospective study site;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators or IRBs may require that we, or our investigators, suspend or terminate clinical studies for various reasons, including noncompliance with regulatory requirements;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators may determine that the clinical data submitted to support our request for approval is unreliable or incomplete as a result of any number of factors, including potential financial bias associated with equity holdings in the Company by study investigators, or significant payments by the Company to study investigators for consulting work, which may result in regulators requesting further data analysis or other confirmatory studies to be performed, or determining the data does not support regulatory approval;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators in countries where Motiva Implants are currently marketed may require that we suspend commercial distribution if there is noncompliance with regulatory requirements or safety concerns;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulators in countries where Motiva Implants are currently marketed may suspend commercial distribution of silicone breast implants due to safety or other concerns generally applicable to the product category;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the supply or quality of our planned products or other materials necessary to conduct clinical studies of our planned products may be insufficient or inadequate; and/or</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the enactment of new regulatory requirements in Europe under the new Medical Device Regulation may make approval times longer and standards more difficult to pass.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we, or any future collaboration partner, are required to conduct additional clinical trials or other testing of Motiva Implants or any planned products, those clinical studies or other testing may not be successfully completed. Additionally, if the results of these studies or tests are not positive, or if they raise safety concerns, we may: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be delayed in obtaining marketing approvals for Motiva Implants or our planned products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">not obtain marketing approval at all; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain approval for indications that are not as broad as intended; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">have a product removed from the market after obtaining marketing approval; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to additional post-marketing testing requirements; and/or </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">be subject to restrictions on how the product is distributed or used. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we obtain regulatory approvals or clearances in a jurisdiction, our products may be removed from the market due to a variety of factors, including adverse events, recalls, suspension of regulatory clearance to sell, or other factors. For example, during the summer of 2016 while we were transitioning from one notified body to another, our CE Mark for Motiva Implants was temporarily not in force. We expect that the initial U.S. approval will be subject to a lengthy and expensive follow-up period, during which we must monitor patients enrolled in clinical studies and collect data on their safety outcomes. Even if FDA approval is obtained, FDA has authority to impose postmarket approval conditions, which can include (i) restrictions on device&#8217;s sale, distribution, or use, (ii) continuing evaluation of the device&#8217;s safety and efficacy, (iii) additional warning/hazard labeling requirements, (iv) significant record management, (v) periodic reporting requirements, and (vi) any other requirements the FDA determines necessary to provide reasonable assurance of the device&#8217;s safety and effectiveness. Completion of this follow-up study, in a manner which results in data sufficient to maintain FDA approval, is subject to multiple risks, many of which are outside of our control. These include, but are not limited to, our ability to fund the ongoing study from our operations or via additional fundraising; study participants&#8217; willingness and ability to return for follow-up study visits; and maintenance of a suitable study database over a long period of time. Even if completed and appropriately evaluated, the study follow-up may reveal safety or other issues that impact the approved labeling or may result in withdrawal of Motiva Implants from the marketplace in the United States or elsewhere. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Although we launched Motiva Implants commercially in October 2010 and have sold approximately 1.6 million units to date in various countries outside the United States, we do not have as much post-market surveillance data as our competitors and may not have clearly identified all possible or actual risks of our products. Furthermore, if our clinical trials do not produce patient data that compares favorably with breast implants that are already on the market, physicians and patients may opt to not use our products, and our business would suffer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our product development costs will also increase if we experience delays to our clinical trials or approvals. We do not know whether any clinical studies will begin as planned, will need to be restructured, or will be completed on schedule, or at all. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Significant clinical study delays could allow our competitors to bring products to market before we do, which would impair our ability to commercialize our planned products and harm our business and results of operations. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Negative publicity, product defects and any resulting litigation concerning our products or our competitors&#8217; products could harm our reputation and reduce demand for silicone breast implants, either of which could negatively impact our financial results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The responses of potential patients, physicians, the news media, legislative and regulatory bodies and others to information about complications or alleged complications of our products, or products liability litigation against us or our competitors, could result in negative publicity and could materially reduce market acceptance of our products. These responses or any investigations and potential resulting negative publicity may have a material adverse effect on our business and reputation and negatively impact our financial condition, results of operations or the market price of our common shares. In addition, significant negative publicity could result in an increased number of product liability claims against us.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">In certain large markets, we engage in direct sales efforts. We may fail to maintain and develop our direct sales force, and our revenues and financial outcomes could suffer as a result. Furthermore, our direct sales personnel may not effectively sell our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have established a direct sales force for our business in Brazil, and we have implemented a direct sales strategy in several European countries. We have hired and will need to retain and motivate a significant number of sales and marketing personnel in order to support our anticipated growth in these countries. There is significant competition for quality personnel experienced in such activities, including from companies with greater financial resources than ours. If we are not successful in our efforts to continue recruiting, retaining, and motivating such personnel, we may not be able to increase our revenues, or we may increase our expenses in greater measure than our revenues, negatively impacting our operating results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are also working on creating a direct sales structure and strategy in certain markets. We are working to put in place the correct legal and business structures to comply with taxation and operational requirements. These structures may not ultimately be implemented or, if implemented, be successful or effective and may not be able to increase our revenues or improve our gross margins. In addition, our expenses or tax related costs may increase in greater measure than our revenues, negatively impacting our operating results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, our sales force may operate independently with limited day-to-day oversight from management. They may engage in sales practices that increase certain risks to our business, including the risk of scrutiny from regulatory authorities and the risk that we violate health care or anti-corruption regulations in one or more countries. These and other independent actions may result in unexpected costs, publicity that might impair our reputation or revenues, litigation in various jurisdictions, and/or sanctions. Any of these could impair the trading price of our shares and adversely impact our results.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">A substantial proportion of our sales are through exclusive distributors, and we do not have direct control over the efforts these distributors may use to sell our products. If our relationships with these third-party distributors deteriorate, or if these third-party distributors fail to sell our products or engage in activities that harm our reputation, or fail to adhere to medical device regulations, our financial results may be negatively affected.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Historically, our sales model has been to sell primarily through distributors rather than through our own sales force, with the notable exception of Brazil and several European countries where we are selling directly, but, in the future, we may utilize a hybrid sales model that includes both distributors and a direct sales effort. We believe that our reliance on distributors improves the economics of our business, as we do not carry the high fixed costs of a direct sales force in many of the countries in which our Motiva Implants are sold. If we are unable to maintain or enter into such distribution arrangements on acceptable terms, or at all, we may not be able to successfully commercialize our products in certain countries. Furthermore, distributors can choose the level of effort that they apply to selling our products relative to others in their portfolio. The selection, training, and compensation of a distributors&#8217; sales personnel are within their control rather than our own and may vary significantly in quality from distributor to distributor. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, although our contract terms require our distributors to comply with all applicable laws regarding the sale of our products, including anti-competition, anti-money laundering, and sanctions laws, we may not be able to ensure proper compliance. If our distributors fail to effectively market and sell our products in full compliance with applicable laws, our results of operations and business may suffer.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to train plastic surgeons on the safe, effective and appropriate use of our products and designed surgeries, we may be unable to achieve our expected growth.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">An important part of our sales process includes educating plastic surgeons about the benefits and advantages of our Motiva Implants and MotivaImagine products as well as training them on the safe and appropriate use of our products. As part of our effort to educate and train plastic surgeons through our MotivaEDGE educational platform, we completed 126 and 244 medical training sessions worldwide during 2020 and 2019, respectively. If we are unable to train potential new plastic surgeon customers at these medical training sessions, we may be unable to achieve our expected growth. Although since the outbreak of the global COVID-19 pandemic we have offered virtual training sessions through our MotivaEDGE platform, the limited ability to train surgeons in-person may harm our ability to properly train surgeons on our products.</span></div><div><span style="color:#0094ff;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"> </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">53</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is critical to the success of our commercialization efforts to train a sufficient number of plastic surgeons and provide them with adequate instructions in the appropriate use of our products and designed surgeries. This training process may take longer than expected and may therefore affect our ability to grow our business. Following completion of training, we rely on the trained plastic surgeons to advocate for our products and designed surgeries in the marketplace. Convincing plastic surgeons to dedicate the time and focus necessary for adequate training is challenging, and we cannot provide any assurances that we will be successful in these efforts. If plastic surgeons are not properly trained, they may misuse or ineffectively use our products or designed surgeries. This may also result in, among other things, unsatisfactory patient outcomes, patient injury, negative publicity or lawsuits against us, any of which could have an adverse effect on our business and reputation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we need to ensure that plastic surgeons are sufficiently educated regarding our implants. For example, many metal implants, such as screws or artificial joints, produce an artifact when magnetic resonance imaging, or MRI, is used to image the area in which the object resides. Our QInside Safety Technology microtransponder embedded in certain Motiva Implants contains metal and causes an artifact that can affect breast cancer screening using MRI, and this artifact is not present in other imaging modalities such as breast ultrasound and film or digital mammography. It is important that we educate physicians and patients on the risks associated with MRI artifacts and how to mitigate them if they choose to utilize Motiva Implants that contain a QInside microtransponder. If we fail to educate physicians and patients about any of these factors, they may make decisions regarding Motiva Implants without full knowledge of the risks and benefits or may view our Motiva Implants negatively. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have a limited operating history and may face difficulties encountered by companies early in their commercialization in competitive and rapidly evolving markets. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Motiva Implants have been marketed in countries outside of the United States since October 2010, and as such, we have a limited operating history upon which to evaluate our business and forecast our future net sales and operating results. In assessing our business prospects, you should consider the various risks and difficulties frequently encountered by companies early in their commercialization in competitive markets, particularly companies that develop and sell medical devices. These risks include our ability to:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">implement and execute our business strategy;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expand and improve the productivity of our direct sales force, distributors and marketing programs to grow sales of our products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">increase awareness of our brands and build loyalty among plastic surgeons and patients;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">manage expanding operations;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">respond effectively to competitive pressures and developments;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">enhance our existing products and develop new products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">maintain and obtain regulatory clearance or approval of our existing products and commercialize new products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">respond to changing regulations associated with medical devices across all geographies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">perform clinical trials with respect to our existing products and any new products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">attract, retain and motivate qualified personnel in various areas of our business; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">obtain and maintain coverage and adequate levels of reimbursement for our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Due to our limited operating history, we may not have the institutional knowledge or experience to be able to effectively address these and other risks that we may face. In addition, we may not be able to develop insights into trends that could emerge and negatively affect our business and may fail to respond effectively to those trends. As a result of these or other risks, we may not be able to execute key components of our business strategy, and our business, financial condition and operating results may suffer.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Motiva Implants are not currently approved for commercial sale in the United States. Obtaining such approval is costly and time consuming, and we may not obtain the regulatory approval required to sell our products in the United States. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Neither we, nor any future collaboration partner, can commercialize Motiva Implants in the United States without first obtaining regulatory approval for the product from the FDA. In the EU and other countries, we previously obtained a CE Mark, before making Motiva Implants available for commercial sale. FDA guidance on silicone breast implants mandates approval via the PMA process. Extensive preclinical and clinical testing will be required to support the PMA. At least one well-controlled clinical trial is required for approval, such as the one we began in April 2018, which will require us to commit significant financial and personnel resources. Additionally, we will be required to commit to significant and costly post-approval requirements, which will include follow-up of our clinical trial patients for up to ten years, creation of a patient registry, and/or other studies, and implementation of training programs for physicians. We may be unable to fund, enroll, or complete such trials in a timely fashion, or at all, and we may have an insufficient number of enrolled patients follow up as instructed. The results of clinical studies may not be favorable enough to support marketing approval in the United States, or may raise other questions (pertaining, for example, to product safety or effectiveness) that jeopardizes our current approvals for sale in other territories. The FDA approval process will take at least several years to complete, and FDA approval may never be obtained. We must also demonstrate that our manufacturing facilities, processes and controls are adequate to support FDA approval and that our clinical investigators complied with good clinical practices in the conduct of the clinical trial for our Motiva Implants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Furthermore, FDA regulatory approval is not a guarantee, and the filing and approval process itself is expensive and may take several years. The FDA also has substantial discretion in the approval process. Despite the time and expense exerted, failure may occur at any stage, and we could encounter problems that cause us to abandon or repeat clinical studies, including our ongoing IDE clinical trial that commenced in April 2018. The FDA can delay, limit, or deny approval of a product candidate for many reasons, including, but not limited, to: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a product candidate may not be deemed to be safe and effective; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">FDA officials may not find the data from clinical and preclinical studies sufficient; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA may not approve our or our suppliers&#8217; processes or facilities; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA may consider clinical studies inadequate and the data inadequate if, among other things, appropriate steps have not been taken in the design, conduct, reporting and analysis of the studies to minimize bias; or </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the FDA may change its approval policies or adopt new regulations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Motiva Implants, or our future products, fail to demonstrate safety and efficacy in further clinical studies that may be required for U.S. approval, or do not gain regulatory approval, our business and results of operations will be harmed. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, obtaining regulatory approval for marketing of our products in one country does not ensure we will be able to obtain regulatory approval in other countries, while a failure or delay in obtaining regulatory approval in one country may have a negative effect on the regulatory process in other countries. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if clinical trials demonstrate acceptable safety and efficacy for Motiva Implants in some patient populations, the FDA or similar regulatory authorities outside the United States may not approve the marketing of Motiva Implants or may approve it with restrictions on the label, which could have a material adverse effect on our business, financial condition, results of operations and growth prospects. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible the FDA or similar regulatory authorities may not consider the results of our clinical trials to be sufficient for approval of Motiva Implants for our desired indications for use. Guidance issued by the FDA in 2006 suggests that a single well-controlled study is required for approval of a new silicone breast implant. The FDA may nonetheless require that we conduct additional clinical studies, possibly using a different clinical study design. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, even if the FDA or other regulatory authorities approve the marketing of Motiva Implants, the approval may include additional restrictions on the label that could make Motiva Implants less attractive to physicians and patients compared to other products that may be approved for broader indications, which could limit potential sales of Motiva Implants. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">55</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we fail to obtain FDA or other regulatory approval of Motiva Implants, or if the approval is narrower than what we seek, it could impair our ability to realize value from Motiva Implants, and therefore may have a material adverse effect on our business, financial condition, results of operations and growth prospects. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to compete effectively against our competitors, many of whom have greater resources than we have, our revenues and results of operations may be negatively affected.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Alternatives exist for Motiva Implants and for our other products, and we will likely face competition with respect to any planned products that we may seek to develop or commercialize in the future from major pharmaceutical companies, specialty pharmaceutical companies, medical device companies and biotechnology companies worldwide. There are several large pharmaceutical and biotechnology companies that currently market silicone breast implants. We also face competition from manufacturers of saline-filled breast implants, and we see emerging competition from non-implant breast augmentation techniques such as hyaluronic acid injection and novel fat grafting methodologies. Any of these may present competitive barriers to Motiva Implants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our leading competitors are large, multi-national companies with significant resources and capabilities. Three of these companies, Sientra, Inc., Mentor Worldwide LLC (a division of Johnson &amp; Johnson), and Allergan plc (recently acquired by AbbVie Inc.), have conducted large prospective clinical studies that started in the United States in 2002, 2000 and 1998, respectively, and they use this data extensively to promote their products. This can put us at a disadvantage when promoting our products to physicians and patients, even outside the United States. In addition, the significant financial and staff resources and brand recognition that our competitors possess mean they may be able to compete with us regardless of the differentiating features of our products. If we are not successful in capturing market share, even outside the United States, or if physicians or patients do not perceive our products to be safer or more favorable, our revenues and/or our operating margins may be significantly impaired.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, manufacturers of competitive products may reduce prices for their competing products in an effort to gain or retain market share and undermine the value proposition that Motiva Implants might otherwise be able to offer to customers. Potential competitors also include academic institutions, government agencies and other public and private research organizations that conduct research, seek patent protection and establish collaborative arrangements for research, development, manufacturing and commercialization. These competitors may develop new technologies that are superior to our products or replace silicone.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Smaller or early stage companies may also prove to be significant competitors, particularly through collaborative arrangements with large and established companies. These third parties may compete with us in recruiting and retaining qualified technical and management personnel, establishing clinical study sites and patient registrations for clinical studies, as well as in acquiring technologies complementary to, or necessary for, our programs.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Pricing pressure from customers and our competitors may impact our ability to sell our products at prices necessary to support our current business strategies and future expansion.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The industry environment for silicone implants and complementary products in certain international markets is price sensitive. In these markets, or in the United States if we are successful in obtaining the required regulatory approval to sell in the U.S. market, our competitors may adopt aggressive pricing strategies to intensify the competitive pricing pressure for breast implants. If we are not successful in educating customers or third-party payors on the differentiation of our Motiva Implants as compared to our competitors&#8217; products, customers may choose our competitors&#8217; products. Additionally, as more competitors introduce products that compete with ours, we may face additional pricing pressure that would adversely impact our future results.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our business depends on maintaining our brand and ongoing customer demand for our products and services, and a significant reduction in sentiment or demand could affect our results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends on the reputation of our brands, which depends on factors such as the safety and quality of our products, our communication activities, including marketing and education efforts, and our management of our customer experience. Maintaining, promoting and positioning our brands is important to expanding our customer base. This will depend largely on the success of our education and marketing efforts and our ability to provide a consistent, high-quality customer experience. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may need to make substantial investments in the areas of education and marketing in order to maintain and enhance our brands. Ineffective marketing, negative publicity, significant discounts by our competitors, product defects and related liability litigation, failure to obtain regulatory clearance for our products, counterfeit products, </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">56</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">unfair labor practices and failure to protect the intellectual property rights in our brands are some of the potential threats to the strength of our business. To protect our brands&#8217; status, we may need to make substantial expenditures to mitigate the impact of such threats. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe that maintaining and enhancing our brands in the countries in which we currently sell our products, and in new countries where we have limited brand recognition, is important to expanding our customer base. If we are unable to maintain or enhance the strength of our brands in the countries in which we currently sell our products and in new countries, then our growth strategy could be adversely affected.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any disruption at our existing facilities could adversely affect our business and operating results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our headquarters are located in Costa Rica, and all of our main manufacturing activities are conducted in two ISO-13485 and GMP compliant manufacturing facilities in Costa Rica through Establishment Labs, S.A. Despite our efforts to maintain and safeguard our manufacturing facilities, including acquiring insurance and adopting maintenance and health and safety protocols, vandalism, terrorism or a natural or other disaster, such as earthquake, volcanic activity, fire or flood, could damage or destroy our inventory of finished goods, cause substantial delays in our operations and manufacturing, result in the loss of key information and cause us to incur additional expenses. Our insurance may not cover our losses in any particular case. In addition, regardless of the level of insurance coverage, damage to our facilities may have an adverse effect on our business, financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If changes in the economy and/or consumer spending, consumer preference and other trends reduce consumer demand for our products, our sales and profitability would suffer.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to the risks arising from adverse changes in general economic and market conditions. Certain elective procedures, including breast augmentation, are typically not covered by insurance. Adverse changes in the economy may cause consumers to reassess their spending choices, which could have an adverse effect on consumer spending, reduce the demand for these surgeries, and therefore have an adverse effect on our revenues. Furthermore, consumer preferences and trends may shift due to a variety of factors, including changes in demographic and social trends, public health initiatives and product innovations, which may reduce consumer demand for our products.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have made multiple acquisitions in the past, and in the future we may acquire other businesses or form joint ventures or make investments in other companies or technologies. If we are not successful in integrating these businesses, as well as identifying and controlling risks associated with the past operations of these businesses, we may incur significant costs, receive penalties or other sanctions from various regulatory agencies, and/or incur significant diversions of management time and attention. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe our business growth will be enhanced if we continually seek opportunities to enhance and broaden our product offerings. As part of our business strategy, we may pursue acquisitions or licenses of assets, or acquisitions of businesses. We also may pursue strategic alliances and joint ventures that leverage our core technology and industry experience to expand our product offerings or sales and distribution resources. We have acquired companies and/or assets and licensed assets in a variety of countries, including Brazil and several European countries. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may do more of these types of transactions in the future and may also form strategic alliances and joint ventures. We may not be able to find suitable partners or acquisition candidates, and we may not be able to complete such transactions on favorable terms, if at all. If we make any acquisitions, we may not be able to integrate these acquisitions successfully into our existing business, and we could assume unknown or contingent liabilities. Any future acquisitions also could result in significant write-offs or the incurrence of debt and contingent liabilities, any of which could have an adverse effect on our financial condition, results of operations and cash flows. Integration of an acquired company may also disrupt ongoing operations and require management resources that would otherwise focus on developing our existing business. We may experience losses related to investments in other companies, which could have a negative effect on our results of operations. We may not identify or complete these transactions in a timely manner, on a cost-effective basis, or at all, and we may not realize the anticipated benefits of any acquisition, license, strategic alliance or joint venture. To finance such a transaction, we may choose to issue common shares as consideration, which would dilute the ownership of our shareholders. If the price of our common shares is low or volatile, we may not be able to acquire other companies or fund a joint venture project using our shares as consideration. Alternatively, it may be necessary for us to raise </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">57</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">additional funds for acquisitions through public or private financings. Additional funds may not be available on terms that are favorable to us, or at all. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not know whether we will be able to successfully integrate any acquired business, product or technology. The success of any given acquisition may depend on our ability to retain any key employees related thereto, and we may not be successful at retaining or integrating such key personnel. Integrating any business, product or technology we acquire could be expensive and time-consuming, disrupt our ongoing business, impact our liquidity, and/or distract our management. If we are unable to integrate any acquired businesses, products or technologies effectively, our business may suffer. Whether as a result of unsuccessful integration, unanticipated costs, including those associated with assumed liabilities and indemnification obligations, negative accounting impact, or other factors, we may not realize the economic benefits we anticipate from acquisitions. In addition, any amortization or charges resulting from the costs of acquisitions could increase our expenses. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may be subject to substantial warranty or product liability claims or other litigation in the ordinary course of business that may adversely affect our business, financial condition and operating results.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We face an inherent risk of product liability exposure related to the sale of Motiva Implants and any planned products in clinical studies. The marketing, sale and use of Motiva Implants and our planned products could lead to the filing of product liability claims against us if someone alleges that our products failed to perform as designed or caused significant adverse events in patients. We may also be subject to liability for a misunderstanding of, or inappropriate reliance upon, the information we provide. If we cannot successfully defend ourselves against claims that Motiva Implants or our planned products caused injuries, we may incur substantial liabilities. Regardless of merit or eventual outcome, liability claims may result in: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">decreased demand for any planned products we may develop; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injury to our reputation and significant negative media attention; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">withdrawal of patients from clinical studies or cancellation of studies; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">significant costs to defend the related litigation and distraction to our management team; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">substantial monetary awards to plaintiffs; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">loss of revenue; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the inability to commercialize any products that we may develop. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently hold $25 million in product liability insurance coverage, which may not be adequate to cover all liabilities we may incur. Insurance coverage is increasingly expensive. We may not be able to maintain insurance coverage at a reasonable cost or in an amount adequate to satisfy any liability that may arise. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our success depends, in part, on our ability to continue to enhance our existing products and services and develop or commercialize new products and services that respond to customer needs and preferences, which we expect will require us to incur significant expenses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In recent years, we have incurred significant costs in connection with the development of Motiva Implants, the MotivaImagine platform, including the Divina 3D simulation system, and other products and services. We expect our research and development expenses to increase significantly in 2021 and beyond, as we continue with our IDE clinical trial in the United States. We will also incur significant expenses to expand our sales and marketing organization to support sales of Motiva Implants, including but not limited to a direct sales force in Brazil and several European countries, as well as MotivaImagine products outside the United States and Canada. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may not be able to compete effectively with our competitors, and ultimately satisfy the needs and preferences of our customers, unless we can continue to enhance existing products and develop or acquire new innovative products and services. Product development requires the investment of significant financial, technological and other resources. Product improvements and new product introductions also require significant planning, design, development and testing at the product and manufacturing process levels. We may not be able to timely or effectively develop product improvements or new products and services. Likewise, we may not be able to acquire new products on terms that are acceptable to us, or at all. Furthermore, in most countries, we need to obtain regulatory approval in order to market and sell our products, which may limit our ability to act quickly in scaling commercialization in those countries, including the United States. Our competitors&#8217; new products may beat our products to market, be more effective or safer or have new features, obtain better market acceptance or render </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">58</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">our products and services obsolete. Any new or modified products and services that we develop may not receive regulatory clearance or approval, or achieve market acceptance or otherwise generate any meaningful sales or profits for us. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The loss of members of our executive management team or other employees could adversely affect our business. </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Our success in implementing our business strategy depends largely on the skills, experience and performance of members of our executive management team and other key employees, including Juan Jos&#233; Chac&#243;n Quir&#243;s, our Chief Executive Officer, Salvador Dada, our Chief Operating Officer, Roberto de Mezerville, our Chief Technology Officer and Renee M. Gaeta, our Chief Financial Officer. The collective efforts of each of these persons, and others working with them as a team, are critical as we continue to develop our tests and technologies and pursue our research and development and sales programs. As a result of the difficulty in locating qualified new management and other key employees, the loss or incapacity of existing members of our executive management team could adversely affect our operations. If we were to lose one or more key employees, we could experience difficulties in finding qualified successors, competing effectively, developing our technologies and implementing our business strategy. As we previously disclosed, Mr. Dada is currently on a medical leave of absence, and although we are managing his absence in the short-term, we will be required to find a highly-skilled replacement for him if his leave continues longer-term, and such search may take a material amount of time and effort. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">We do not have &#8220;key person&#8221; life insurance on our senior executives, and the loss of any of the key team members would have a negative impact to our business and financial results. In addition, the job market in Costa Rica and other locations in which we operate has recently become more competitive and we are competing for talent with major multinational corporations which have significantly more resources than us, and we may find new difficulties in retaining our most talented employees.</span></div><div><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, we rely on collaborators, consultants and advisors, including scientific and clinical advisors, to assist us in formulating our research and development and commercialization strategy. Our collaborators, consultants and advisors are generally employed by employers other than us and may have commitments under agreements with other entities that may limit their availability to us. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our failure to adequately protect personal information in compliance with evolving legal requirements could harm our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the ordinary course of our business, we collect and store sensitive data, including legally protected patient health information, credit card information and personally identifiable information. We collect this kind of information on our customers for purposes of servicing potential warranty claims and for post-marketing safety vigilance. These data protection and privacy-related laws and regulations are evolving and may result in ever-increasing regulatory and public scrutiny and escalating levels of enforcement and sanctions. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of state, federal and international laws protecting the privacy and security of health information and personal data. As part of the American Recovery and Reinvestment Act 2009, or ARRA, Congress amended the privacy and security provisions of the Health Insurance Portability and Accountability Act, or HIPAA. HIPAA imposes limitations on the use and disclosure of an individual&#8217;s protected health information by certain health care providers, health care clearinghouses, and health insurance plans, collectively referred to as covered entities, that involve the creation, use, maintenance or disclosure of protected health information. The HIPAA amendments also impose compliance obligations and corresponding penalties for non-compliance on individuals and entities that provide services to health care providers and other covered entities, collectively referred to as business associates. Most recently, on December 10, 2020, HHS issued a Notice of Proposed Rulemaking, which if finalized, would make changes to some of HIPAA&#8217;s regulatory requirements, which would impact us, to the extent we are a business associate. ARRA also made significant increases in the penalties for improper use or disclosure of an individual&#8217;s protected health information under HIPAA and extended enforcement authority to state attorneys general. The amendments also create notification requirements for individuals whose protected health information has been inappropriately accessed or disclosed, notification requirements to federal regulators and in some cases, notification to local and national media. Notification is not required under HIPAA if the health information that is improperly used or disclosed is deemed secured in accordance with encryption or other standards developed by the U.S. Department of Health and Human Services, or HHS. Most states have laws requiring notification of affected individuals and state regulators in the event of a breach of personal information, which is a broader class of information than the protected health information protected by HIPAA. Many state laws </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">59</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">impose significant data security requirements, such as encryption or mandatory contractual terms to ensure ongoing protection of personal information. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, even when HIPAA does not apply, according to the FTC, failing to take appropriate steps to keep consumers&#8217; personal information secure constitutes unfair acts or practices in or affecting commerce in violation of Section 5(a) of the FTCA, 15 U.S.C &#167; 45(a). The FTC expects a company&#8217;s data security measures to be reasonable and appropriate in light of the sensitivity and volume of consumer information it holds, the size and complexity of its business, and the cost of available tools to improve security and reduce vulnerabilities. Medical data is considered sensitive data that merits stronger safeguards. The FTC&#8217;s guidance for appropriately securing consumers&#8217; personal information is similar to what is required by the HIPAA Security Rule.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many foreign countries and governmental bodies, including the EU, Canada, Australia and other relevant jurisdictions, have laws and regulations concerning the collection and use of personal or sensitive data obtained from their residents or by businesses operating within their jurisdiction. For example, the European Commission recently adopted the General Data Protection Regulation, or the GDPR, effective on May 25, 2018, that supersedes current EU data protection legislation, imposes more stringent EU data protection requirements and provides for greater penalties for noncompliance. The GDPR applies to any company established in the EU as well as to those outside the EU if they collect and use personal data in connection with the offering goods or services to individuals in the EU or the monitoring of their behavior. The GDPR enhances data protection obligations for processors and controllers of personal data, including, for example, expanded disclosures about how personal information is to be used, limitations on retention of information, mandatory data breach notification requirements and onerous new obligations on services providers. Non-compliance with the GDPR can trigger steep fines of up to &#8364;20 million or 4% of total worldwide annual revenues, whichever is higher. Given the breadth and depth of changes in data protection obligations, meeting the GDPR&#8217;s requirements requires time, resources and a review of the technology and systems currently in use against the GDPR&#8217;s requirements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may be at risk of enforcement actions taken by certain EU data protection authorities while we continue to build our business practices to ensure that all transfers of personal data to us from the European Economic Area are conducted in compliance with all applicable regulatory obligations, the guidance of data protection authorities and evolving best practices. We may find it necessary to establish systems to maintain personal data originating from the EU in the European Economic Area, which may involve substantial expense and may cause us to need to divert resources from other aspects of our business, all of which may adversely affect our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our failure to comply with applicable laws and regulations, or to protect such data, could result in enforcement actions against us, including fines, imprisonment of company officials and public censure, claims for damages by end-customers and other affected individuals, damage to our reputation and loss of goodwill, any of which could harm on our operations, financial performance, and business. Evolving and changing definitions of personal data and personal information, within the European Union, the United States, and elsewhere, may limit or inhibit our ability to operate or expand our business, including limiting strategic partnerships that may involve the sharing of data. Moreover, if the relevant laws and regulations change, or are interpreted and applied in a manner that is inconsistent with our data practices or the operation of our products, we may need to expend resources in order to change our business operations, data practices, or the manner in which our products operate. Even the perception of privacy concerns, whether or not valid, may harm our reputation and inhibit adoption of our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are in the process of obtaining cyber liability insurance; however, there is the risk that the limits we obtain may not cover the total loss experienced in the event of a data security incident, including the financial loss, legal costs, and business and reputational harm, particularly if there is an interruption to our systems. Additionally, there is the risk of a data privacy or security incident by an employee, which may expose us to liability. If personal information of our customers or employees is misappropriated, our reputation with our customers and employees may be injured resulting in loss of business and/or morale, and we may incur costs to remediate possible injury to our customers and employees or be required to pay fines or take other action with respect to judicial or regulatory actions arising out of such incidents.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Continued international expansion of our business will expose us to business, regulatory, political, operational, financial and economic risks associated with doing business internationally. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our products are commercially available in more than 80 countries, and we operate subsidiaries in the United States, Costa Rica, Brazil, and several European countries. Our business strategy contemplates continued international expansion, including partnering with medical device distributors, and introducing Motiva Implants and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">60</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">other planned products outside the United States. The sale and shipment of our products internationally, as well as the purchase of components from international sources, subjects us to potential trade, import and export, and customs regulations and laws.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Compliance with these regulations and laws is costly and exposes us to penalties for non-compliance. Any failure to comply with applicable legal and regulatory obligations could impact us in a variety of ways that include, but are not limited to, significant criminal, civil and administrative penalties, including imprisonment of individuals, fines and penalties, denial of export or import privileges, seizure of shipments, restrictions on certain business activities and exclusion or debarment from government contracting. Also, the failure to comply with applicable legal and regulatory obligations could result in the disruption of our shipping, marketing and sales activities. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, several of the countries in which we sell our products or conduct our operations are, to some degree, subject to political, economic or social instability. Doing business in Costa Rica and other countries outside the United States involves a number of other risks, including: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with the free zone regime regulations under which the manufacturing sites operate;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">different regulatory requirements for device approvals in international markets; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">multiple, conflicting and changing laws and regulations such as tariffs and tax laws, export and import restrictions, employment laws, regulatory requirements and other governmental approvals, permits and licenses;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">potential failure by us or our distributors to obtain and/or maintain regulatory approvals for the sale or use of our products in various countries; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">difficulties in managing global operations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">logistics and regulations associated with shipping products, including infrastructure conditions and transportation delays; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">limits on our ability to penetrate international markets if our distributors do not execute successfully; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">governmental price controls, differing reimbursement regimes and other market regulations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">financial risks, such as longer payment cycles, difficulty enforcing contracts and collecting accounts receivable, and exposure to currency exchange rate fluctuations; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">reduced protection for intellectual property rights, or lack of them in certain jurisdictions, forcing more reliance on our trade secrets, if available; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">economic weakness, political and economic instability, including wars, terrorism and political unrest, outbreak of disease, boycotts, curtailment of trade and other business restrictions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the British exit from the EU, including with respect to its effect on the value of the British pound relative to other currencies;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with the Foreign Corrupt Practices Act, including its books and records provisions and its anti-bribery provisions, by maintaining accurate information and control over sales activities and distributors&#8217; activities; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to comply with restrictions on the ability of companies to do business in foreign countries, including restrictions on foreign ownership of telecommunications providers imposed by the U.S. Office of Foreign Assets Control;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">unexpected changes in tariffs, trade barriers and regulatory requirements; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">compliance with tax, employment, immigration and labor laws; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">taxes, including withholding of payroll taxes; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">currency fluctuations, which could result in increased operating expenses and reduced revenue, and other obligations incident to doing business in another country; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">workforce uncertainty in countries where labor unrest is more common than in the United States; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">production shortages resulting from any events affecting raw material supply or manufacturing capabilities abroad; and </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">61</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">business and shipping interruptions resulting from natural or other disasters including earthquakes, volcanic activity, hurricanes, floods and fires.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any of these risks, if encountered, could harm our future international expansion and operations and, consequently, have an adverse effect on our financial condition, results of operations and cash flows. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to satisfy data protection, security, privacy, and other government- and industry-specific requirements, our business could be harmed.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are a number of data protection, security, privacy and other government- and industry-specific requirements, including those that require companies to notify individuals of data security incidents involving certain types of personal data. Security compromises experienced by other companies, by our customers or by us may lead to public disclosures, which could harm our reputation, erode customer confidence in the effectiveness of our security measures, negatively impact our other products and our ability to attract new customers. As we expand into new regions, we will need to comply with new requirements. If we cannot comply or if we incur a violation in one or more of these requirements, our growth could be adversely impacted, and we could incur significant liability.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Fluctuations in insurance costs and availability, and future insurance requirements could adversely affect our profitability or our risk management profile.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We hold a number of insurance policies, including product liability insurance, directors&#8217; and officers&#8217; liability insurance, general liability insurance, property insurance and workers&#8217; compensation insurance. If the costs of maintaining adequate insurance coverage increase significantly in the future, our operating results could be adversely affected. Likewise, if any of our current insurance coverage should become unavailable to us or become economically impractical, we would be required to operate our business without indemnity from commercial insurance providers. If we operate our business without insurance, we could be responsible for paying claims or judgments against us that would have otherwise been covered by insurance, which would adversely affect our results of operations or financial condition. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Commercial success of Motiva Implants in the United States or elsewhere depends on our ability to accurately forecast customer demand and manufacture sufficient quantities of product in the implant sizes that patients and physicians request, and to manage inventory effectively and the failure to do so could have a material adverse effect on our business, financial condition, results of operations and growth prospects.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Manufacturing of silicone breast implants requires costly capital equipment and a highly skilled workforce. There is a significant lead time to build and certify a new manufacturing facility. Until 2017, we had one manufacturing facility in Costa Rica, and we experienced inventory shortages from time-to-time that impaired our ability to meet market demand. In March 2017, our second manufacturing facility, also located in Costa Rica, became operational, and we received certification under the multi-country MDSAP protocol and began shipping saleable product. Although we believe our new, larger manufacturing facility, in combination with our first facility, will give us adequate manufacturing capacity to meet demand for at least the next two years, we have, in the past, been unable to fill all incoming orders to meet growing demand. In addition, if we obtain FDA approval, we will likely need to obtain additional manufacturing capacity prior to any commercialization of our Motiva Implants in the United States. If demand increases faster than we expect, or if we are unable to produce the quantity of goods that we expect with our current facilities, we may not be able to grow revenue at an optimal rate. There may be other negative effects from supply shortages, including loss of our reputation in the marketplace and a negative impact on our relationships with our distributors. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On the other hand, if demand for our products declines, or if market supply surpasses demand, we may not be able to reduce manufacturing expenses or overhead costs proportionately. We have invested significantly in our manufacturing capacity in order to vertically integrate our business. If an increase in supply outpaces the increase in market demand, or if demand decreases, the resulting oversupply could adversely impact our sales and result in the underutilization of our manufacturing capacity, higher inventory carrying costs and associated working capital, changes in revenue mix, and/or price erosion, any of which would lower our margins and adversely impact our financial results. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">62</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counterfeit products may be represented as ours, which could compete with our genuine products and may also expose us to risks associated with adverse events and product liability.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We routinely see counterfeit versions of our major competitor&#8217;s branded products in the marketplace, and we have recently become aware of potential counterfeiting of our Motiva Implants. This is particularly common in emerging markets, where sensitivity to price is higher and regulatory enforcement is under-resourced. These counterfeit products are typically manufactured with significantly lower quality than the products they are claimed to be, and in some cases may be manufactured with silicones that are not medical grade. They may expose patients to significant adverse event risks, and there is a risk that certain adverse events with counterfeit products may be attributed to our genuine products. This could reduce demand for our products, result in negative publicity, or otherwise impact our business and the price of our shares.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to the Operation of Our Business </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Various factors outside our direct control, including the reliance on single-source suppliers, may adversely affect manufacturing and supply of our Motiva Implants and other products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently manufacture Motiva Implants at our facilities in the Coyol Free Zone, Alajuela, Costa Rica, under the multi-country MDSAP protocol. Our Divina scanners are manufactured by contract manufacturers from components sourced globally, with final assembly in Alajuela, Costa Rica. Our QInside Safety Technology microtransponders are manufactured by contract manufacturers with final testing and packaging at a manufacturing supplier facility in Regensburg, Germany, with additional inspection of the units at our facilities in Coyol, Costa Rica, prior to approval for inclusion in Motiva Implants. If demand for our current products and our planned products increases more rapidly than we anticipate, or if we secure regulatory approval to commercialize our products in additional geographies, we will need to either expand our manufacturing capabilities or outsource to other manufacturers. The manufacture of these products in compliance with ISO standards and the FDA&#8217;s regulations requires significant expertise and capital investment, including the development of advanced manufacturing techniques and process controls. Manufacturers of medical device products often encounter difficulties in production, including difficulties with production costs and yields, quality control, quality assurance testing, shortages of qualified personnel, as well as compliance with strictly enforced FDA requirements, other federal and state regulatory requirements, and foreign regulations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently purchase components for the Divina scanners and QInside Safety Technology microtransponders under purchase orders and do not have long-term contracts with most of the suppliers of the materials included in these products. We rely on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in our Motiva Implants as well as other products that we manufacture under contract to other customers. See the risk factor below titled &#8220;We rely on a single-source, third-party supplier for medical-grade silicone, which is the primary raw material used in these products. If this supplier were to increase prices for these raw materials over time or experience interruptions in their ability to supply us with this raw material, our business, financial condition and results of operations could be adversely affected.&#8221; In addition, the suppliers of certain packaging components and the surgical tools that we sell with Motiva Implants, including the cannulas, retractors, and insertion sleeves, are all purchased by us from single-source suppliers. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our single-source and other suppliers were to delay or stop producing our components, or if the prices they charge us were to increase significantly, or if they elected not to sell to us at all or on commercially reasonable terms, we would need to identify and initiate relationships with alternative suppliers, if possible. We could experience delays in manufacturing our products or the interruption of the availability of Motiva Implants or our other products for sale, while finding another acceptable supplier, which would impact our business, financial condition and results of operations. Even if such alternative suppliers are available on commercially reasonable terms, the changes could also result in increased costs associated with qualifying the new materials and in increased operating costs. Further, any prolonged disruption in a supplier&#8217;s operations could have a significant negative impact on our ability to manufacture and deliver products in a timely manner and as a result, our business, financial condition and results of operations could be adversely affected. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The manufacturing, sterilization and distribution of our Motiva Implants and other products are technically challenging. Changes that our suppliers may make, or additional requirements from regulatory agencies, are outside of our direct control and can have an impact on our processes, on quality, and on the successful delivery of products to our customers. Mistakes and mishandling are not uncommon and can affect supply and delivery. Some of these risks include:</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">63</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">failure to complete sterilization on time or in compliance with the required regulatory standards;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">transportation and import and export risk, particularly given the global nature of our supply and distribution chains;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">delays in analytical results or failure of analytical techniques that we depend on for quality control and release of products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">natural or other disasters, labor disputes, financial distress, lack of raw material supply, issues with facilities and equipment or other forms of disruption to business operations affecting our manufacturer or its suppliers;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">latent defects that may become apparent after products have been released and that may result in a recall of such products;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contamination of our raw materials or manufactured products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">inclusion of vendors of raw materials not in compliance with ISO-13485 requirements.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As referenced above in this risk factor, some of the components used in our Motiva Implants and our other products are currently single-sourced, and substitutes for these components might not be obtained easily or may require substantial redesign or manufacturing modifications related to our specifications or due to regulatory requirements. Any significant problem experienced by one of our single-source suppliers may result in a delay or interruption in the supply of components or products to us because the number of third-party manufacturers with the necessary manufacturing and regulatory expertise and facilities is limited and certification of a new supplier may be complex and time consuming. Any delay or interruption would likely lead to a delay or interruption in our manufacturing or distribution operations and/or adversely affect our ability to sell Motiva Implants. The inclusion of substitute components or products must meet our specifications and could require us to qualify the new supplier with the appropriate regulatory authorities. The added time and cost to arrange for alternative suppliers could have a material adverse effect on our business. New manufacturers of any current or planned product would be required to qualify under applicable regulatory requirements and would need to have sufficient rights under applicable intellectual property laws to the design and method of manufacturing the planned product. Obtaining the necessary FDA or international approvals or other qualifications under applicable regulatory requirements and ensuring non-infringement of third-party intellectual property rights could result in a significant interruption of supply and could require the new manufacturer to bear significant additional costs that may be passed on to us.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We expect to significantly increase the size of our organization; as a result, we may encounter difficulties in managing our growth, which could disrupt our operations and/or increase our net losses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, we had 638 employees. Unless it is necessary for us to continue to make reductions to our workforce as a cost management strategy due to the impact of the global COVID-19 pandemic on our business, over the next several years, we expect to experience significant growth in the number of our employees and the scope of our operations, principally in the areas of manufacturing, regulatory affairs, clinical and sales and marketing, and particularly as we prepare our operations in the anticipation of obtaining approval from the FDA to commercialize our Motiva Implants in the United States. We also intend to continue to improve our operational, financial and management controls, reporting systems and procedures, which may require additional personnel. Such growth could place a strain on our administrative and operational infrastructure, and/or our managerial abilities, and we may not be able to make improvements to our management information and control systems in an efficient or timely manner. We may discover deficiencies in existing systems and controls. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of these employees will be in countries outside of our corporate headquarters, which adds additional complexity. To manage our anticipated future growth, we must continue to implement and improve our managerial, operational and financial systems, expand our facilities and continue to recruit and train additional qualified personnel. We may not be able to effectively manage these activities. The physical expansion of our operations may lead to significant costs and may divert our management and business development resources. Future growth would impose significant added responsibilities on members of management, including: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">managing our clinical trials effectively, which we anticipate being conducted at numerous clinical sites; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">identifying, recruiting, maintaining, motivating and integrating additional employees with the expertise and experience we will require, in multiple countries; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">64</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">managing our internal development efforts effectively while complying with our contractual obligations to licensors, licensees, contractors and other third parties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">managing additional relationships with various distributors, suppliers, and other third parties; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">improving our managerial, development, operational and finance reporting systems and procedures; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">expanding our facilities. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our failure to accomplish any of these tasks could prevent us from growing successfully. Any inability to manage growth could delay the execution of our business plans or disrupt our operations. We may also be exposed or subject to additional unforeseen or undisclosed liabilities as well as increased levels of indebtedness.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on third parties to conduct certain components of our clinical studies, and those third parties may not perform satisfactorily, including failing to meet deadlines for the completion of such studies, which could interfere with or delay our ability to get regulatory approval or commercialize our products.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on third parties, such as contract research organizations, or CROs, clinical data management organizations, medical institutions and clinical investigators, to perform various functions for our clinical trials. Our reliance on these third parties for clinical development activities reduces our control over these activities but does not relieve us of our responsibilities. We remain responsible for ensuring that each of our clinical studies is conducted in accordance with the general investigational plan and protocols for the study. Moreover, the International Council for Harmonization, or ICH, and the FDA require us to comply with standards, commonly referred to as good clinical practices, for conducting, recording and reporting the results of clinical studies to ensure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of patients in clinical studies are protected. Furthermore, these third parties may also have relationships with other entities, some of which may be our competitors. If these third parties do not successfully carry out their contractual duties, meet expected deadlines or conduct our clinical studies in accordance with regulatory requirements or our stated protocols, we will not be able to obtain, or may be delayed in obtaining, regulatory approvals for our planned products and will not be able to, or may be delayed in our efforts to, successfully commercialize our planned products. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our operations involve hazardous materials and we and third parties with whom we contract must comply with environmental laws and regulations, which can be expensive and restrict how we do business, and could expose us to liability if our use of such hazardous materials causes injury.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our manufacturing processes currently require the controlled use of potentially harmful chemicals, including highly flammable solvents. We cannot eliminate the risk of accidental contamination or injury to employees or third parties from the use, storage, handling or disposal of these materials. In the event of contamination or injury, we could be held liable for any resulting damages, and any liability could exceed our resources or any applicable insurance coverage we may have. Additionally, we are subject to, on an ongoing basis, federal, state and local laws and regulations governing the use, storage, handling and disposal of these materials and specified waste products. These are particularly stringent in California, where NuSil, one of our key suppliers, is located. The cost of compliance with these laws and regulations may become significant and could have an adverse effect on our financial condition, results of operations and cash flows. In the event of an accident or if we otherwise fail to comply with applicable regulations, we could lose our permits or approvals or be held liable for damages or penalized with fines.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Any future distribution or commercialization agreements we may enter into with respect to our current or planned products may place the development of these products outside our control, or may otherwise be on terms unfavorable to us.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may enter into additional distribution or commercialization agreements with third parties with respect to our current or planned products, for commercialization in or outside the United States. Our likely collaborators for any distribution, marketing, licensing or other collaboration arrangements include large and mid-size medical device and diagnostic companies, regional and national medical device and diagnostic companies, and distribution or group purchasing organizations. We will have limited control over the amount and timing of resources that our collaborators dedicate to the development or commercialization of our planned products. Our ability to generate revenue from these arrangements will depend in part on our collaborators&#8217; abilities to successfully perform the functions assigned to them in these arrangements.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">65</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Collaborations may be terminated and, if terminated, may result in a need for additional capital to pursue further development or commercialization of the applicable planned products. Collaborators may own or co-own intellectual property covering our products that results from our collaboration with them. In such cases, we would not have the exclusive right to commercialize such intellectual property. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any termination or disruption of collaborations could result in delays in the development of planned products, increases in our costs to develop the planned products or the termination of development of a planned product. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our results of operations could be affected by fluctuations in currency rates.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We present our results of operations in U.S. dollars, which is our reporting currency. However, as of December&#160;31, 2020, the majority of our revenues are denominated in currencies other than the U.S. dollar - primarily the British pound, the euro, and the Brazilian real. As of December&#160;31, 2020, the majority of our expenses are denominated in U.S. dollars or in Costa Rican colones, which are linked to the U.S. dollar. In the future, we expect to have significant revenues and expenses denominated in these non-U.S. currencies. As such, unfavorable fluctuations in currency exchange rates could have an adverse effect on our results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Because our consolidated financial statements are presented in U.S. dollars, we must translate revenues, expenses and income, as well as assets and liabilities, into U.S. dollars at exchange rates in effect during or at the end of each reporting period. Therefore, changes in the value of the U.S. dollar in relation to the British pound, the euro, and the Brazilian real will affect our revenues, operating income and the value of balance sheet items originally denominated in other currencies. These changes would cause our growth in consolidated earnings stated in U.S. dollars to be higher or lower than our growth in local currency when compared against other periods. We do not currently engage in currency hedging arrangements to protect us from fluctuations in the exchange rates of the euro and other currencies in relation to the U.S. dollar (and/or from inflation of such currencies), and we may be exposed to material adverse effects from such movements. We cannot predict any future trends in rates of inflation or exchange rates of other currencies against the U.S. dollar, and there can be no assurance that any contractual provisions will offset their impact, or that any future currency hedging activities will be successful.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have significant exposure to the economic and political situations in emerging market countries, and developments in these countries could materially impact our financial results, or our business more generally.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Many of the countries in which our products are sold are emerging markets. Our global growth strategy contemplates the expansion of our existing sales activities in Latin America, Europe, the Middle East, and Asia-Pacific region as well as North America. Our exposure to emerging markets has increased in recent years, as have the number and importance of our distributor arrangements. Economic and political developments in Brazil and other emerging markets, including economic crises, currency inflation, or political instability, have had in the past, and may have in the future, a material adverse effect on our financial condition and results of operations. Moreover, as these markets continue to grow, competitors may seek to enter these markets and existing market participants will likely try to aggressively protect or increase their market shares. Increased competition may result in price reductions, reduced margins and our inability to gain or hold market share, which could have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Exposure to United Kingdom political developments, including the outcome of its withdrawal from membership in the European Union, could be costly and difficult to comply with and could seriously harm our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, a referendum was held in the U.K. which resulted in a majority voting in favor of the U.K. withdrawing from the E.U. (commonly referred to as &#8220;Brexit&#8221;). Pursuant to legislation approved by the U.K. Parliament and the E.U. Parliament in January 2020, the U.K. withdrew from the E.U. with effect from 11 p.m. (GMT) on January 31, 2020 on the terms of a withdrawal agreement agreed between the U.K. and the E.U. in October 2019. On December 24, 2020, the U.K. and E.U. agreed to a trade deal, or the Trade and Cooperation Agreement, which was ratified by the U.K. on December 30, 2020. The Trade and Cooperation Agreement is subject to formal approval by the European Parliament and the Council of the European Union before it comes into effect and has been applied provisionally since January 1, 2021. There are still a number of areas of uncertainty in connection with the future of the U.K. and its relationship with the E.U. and the application and interpretation of the Trade and Cooperation Agreement, and Brexit related matters may take several years to be clarified and resolved. For example, because a significant proportion of the regulatory framework in the U.K. is </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">66</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently derived from E.U. directives and regulations, Brexit could result in material changes to the regulatory regime applicable to many of our current operations. Although the Trade and Cooperation Agreement offers U.K. and E.U. companies preferential access to each other&#8217;s markets, ensuring imported goods will be free of tariffs and quotas, economic relations between the U.K. and the E.U. will now be on more restricted terms than existed previously. Therefore, at this time, we cannot predict the impact that the Trade and Cooperation Agreement and any future agreements contemplated under the terms of the Trade and Cooperation Agreement will have on our on our future business efforts to commercialize our products in the U.K. and E.U. Accordingly, it is possible that new terms of the Trade and Cooperation Agreement may adversely affect our operations and financial results. We are currently in the process of evaluating our own risks and uncertainties to ascertain what financial, trade, regulatory and legal implications the Trade and Cooperation Agreement could have on our operations in the U.K. and otherwise. Finally, uncertainty surrounding Brexit has contributed to recent fluctuations in the U.K. economy as a whole which could experience future disruptions. As a result, Brexit could cause financial and capital markets within and outside the U.K. or the E.U. to constrict, thereby negatively impacting our ability to finance our U. K. operations which could also have an adverse effect on our results of operations and financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These developments, or the perception that any of them could occur, may adversely affect European and worldwide economic and market conditions, significantly reduce global market liquidity and restrict the ability of key market participants to operate in certain financial markets and could contribute to instability in global financial and foreign exchange markets, including increased volatility in interest rates and foreign exchange rates. The potential impacts could adversely impact other global economies, and in particular, the European economy, a region which accounted for approximately 44% and 40% of our total revenues for the year ended December 31, 2020 and 2019, respectively. In the first quarter of 2019, we completed the migration of our CE Mark certificates, originally issued by BSI UK Notified Body, to BSI Group The Netherlands B.V., which is a European Notified Body designated in The Netherlands. We continue to actively monitor the ongoing potential impacts of Brexit and will seek to minimize its impact on our business through review of our existing regulatory requirements, contractual arrangements and obligations, particularly in the European region. Any of these effects of Brexit, among others, could adversely affect our business, business opportunities, results of operations, financial condition and cash flows.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Almost one year after it was introduced to the House of Commons, the Medical Devices Bill was granted Royal Assent on February 11, 2021, becoming law as the Medicines and Medical Devices Act 2021. The purpose of the Act is to create a structure for the UK Government to legislate for updates or amendments to the existing laws on human and veterinary medicine, clinical trials, and medical devices. We will need to comply with the Act on a going forward basis.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The political situation in the United States can affect the ability of our company to conduct business in certain areas or countries if new trade conditions are imposed or enforced by the U.S. government.</span></div><div style="margin-bottom:6pt"><span style="background-color:#ffffff;color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There could be negative consequences to our company&#8217;s revenue if the U.S. government unexpectedly changes its trade policies towards determined geographies or countries. These policy changes can include such things as trade barriers, which serve to limit or prevent international trade. The U.S. government may request additional funds or tariffs in exchange for the right to export items into the country. Tariffs or quotas may be used to protect domestic producers from foreign competition. Changes may include the modification or withdrawal of free trade agreements already in place. This also can have a large effect on the profits of our company because it either cuts revenues as a result of a tax on imports/exports or restricts the amount of revenues that can be earned.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Our Financial Condition and Capital Requirements </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have incurred net operating losses in the past and expect to incur net operating losses for the foreseeable future. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have incurred net operating losses since our inception, and we continue to incur significant research and development and general and administrative expenses related to our operations. We do not expect to be profitable in 2020, and in future years we expect to incur significant research and development expenses related to, among other things, the IDE clinical study of Motiva Implants in the United States. Investment in medical device product development, particularly clinical studies, is highly speculative. It entails substantial upfront capital expenditures and significant risk that any potential planned product will fail to demonstrate adequate accuracy or clinical utility. We may not be profitable for some time. As of March&#160;31, 2021, we had an accumulated deficit of $172.2 million. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">67</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We expect that our future financial results will depend primarily on our success in launching, selling and supporting Motiva Implants and other products that are part of our MotivaImagine platform. This will require us to be successful in a range of activities, including manufacturing, marketing, and selling Motiva Implants. We may not succeed in these activities and may never generate revenue that is sufficient to be profitable in the future. Even if we are profitable, we may not be able to sustain or increase profitability on a quarterly or annual basis. Our failure to achieve sustained profitability would depress the value of our company and could impair our ability to raise capital, expand our business, diversify our planned products, market our current and planned products, or continue our operations. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may need additional funds to support our operations, and such funding may not be available to us on acceptable terms, or at all, which would force us to delay, reduce or suspend our planned development and commercialization efforts. Raising additional capital may subject us to unfavorable terms, cause dilution to our existing shareholders, restrict our operations, or require us to relinquish rights to our products and technologies.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our operations have consumed substantial amounts of cash since our inception, and we expect to incur significant expenses in connection with our planned research, development and product commercialization efforts. We believe that our available cash and cash from operations will be sufficient to satisfy our liquidity requirements for at least the next 12 months. If our available cash resources, net proceeds from our follow-on public offering and anticipated cash flow from operations are insufficient to satisfy our liquidity requirements, we may seek to sell equity or convertible debt securities, enter into a credit facility or another form of third-party funding, or seek other debt financing. However, we are subject to restrictive covenants under the Madryn Credit Agreement which restrict our ability to incur additional debt. Any failure to raise the funds necessary to support our operations may force us to delay, reduce or suspend our planned clinical trials, research and development programs, or other commercialization efforts.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">To the extent that we raise additional capital through the sale of equity or convertible debt securities, your ownership may be diluted, and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a shareholder. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take certain actions, such as incurring additional debt, making capital expenditures or declaring dividends. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If we raise additional funds through collaborations, strategic collaborations or partnership, or marketing, distribution or licensing arrangements with third parties, we may be required to do so at an earlier stage than would otherwise be ideal and/or may have to limit valuable rights to our intellectual property, technologies, products, or future revenue streams, or grant licenses or other rights on terms that are not favorable to us. Furthermore, any additional fundraising efforts may divert our management from their day-to-day activities, which may adversely affect our ability to develop and commercialize our products.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Our Business and Our Industry </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We rely on a single-source, third-party supplier for medical-grade long-term implantable silicone, which is the primary raw material used in our Motiva Implants. If this supplier were to increase prices for this raw material over time or experience interruptions in its ability to supply us with this raw material, our business, financial condition and results of operations could be adversely affected.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We rely on NuSil, as the sole supplier of medical-grade silicone used in our Motiva Implants as well as other products that we manufacture under contract to other customers. To our knowledge, NuSil is the only supplier of such raw materials with the appropriate filings with the FDA and other regulatory bodies to enable the manufacturing of products with our requirements. NuSil supplies our major competitors with raw material as well, and at least two of these are larger-volume customers of NuSil than we are. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If NuSil becomes unable or unwilling to supply sufficient quantities of medical-grade silicone of the specifications required for our products, we may not be able to replace this supply source quickly, or at all. Similarly, they may become unable or unwilling to manufacture our needed raw materials in compliance with regulatory requirements, or their manufacturing facilities may not be able to maintain compliance with regulatory requirements. Any replacement supplier would have to be qualified with the relevant regulatory authorities, which is an expensive and time-consuming process during which we may experience an interruption in our manufacturing operations. We may also be unsuccessful in negotiating favorable terms with such a supplier. Any of these contingencies would likely affect the financial results of our operations and may have a negative impact on our share price. In </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">68</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">particular, if we are not able to establish a replacement vendor for our medical-grade silicone, we would be unable to manufacture our Motiva Implants as well as other products that we manufacture under contract to other customers until such time as a replacement vendor is identified, which would likely significantly affect the financial results of our operations and have a significantly negative impact on our share price.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our current supply agreement with NuSil expires in December 2021. There can be no assurance that NuSil will agree to continue to supply us with medical-grade silicone following the expiration of our contract on terms that are acceptable to us, or at all. This would have a material adverse effect on our business, financial condition, and results of operations for the reasons set forth above.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our relationship with NuSil involves other risks, including but not limited to the following:</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it may not be able, or willing, to manufacture silicone raw materials with our agreed-upon specifications;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it may not be able, or willing, to manufacture our needed raw materials in compliance with regulatory requirements, or our its manufacturing facilities may not be able to maintain compliance with regulatory requirements;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it may not be able to supply sufficient quantities of each raw material quickly enough for us to respond to rapid increases in demand;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it may unintentionally convey information to our competitors that is helpful in understanding our proprietary compositions and other trade secrets of our manufacturing processes;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be subject to price fluctuations if we fail to meet certain minimum order requirements, or if our existing contract expires or is renegotiated;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">it may lose access to critical services and components, resulting in interruption in manufacture or shipment of medical-grade silicone;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">its facilities may be affected by earthquakes, wildfires, mud slides or other natural disasters, which could delay or impede production of our raw materials;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">we may be required to obtain regulatory approvals related to any change in our supply chain;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NuSil may wish to discontinue supply of products to us due to its existing relationships with our competitors;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NuSil may stop supply and claim ownership of intellectual property on materials associated with future products; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">NuSil or its parent entity may encounter financial or other hardships unrelated to our demand for products, which could negatively impact their ability to fulfill our orders and support our regulatory approvals.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Negative publicity concerning our products or our competitors&#8217; products could harm our reputation and reduce demand for silicone breast implants, either of which could impact our financial results and/or share price.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The silicone breast implant industry has been the focus of significant regulatory and media scrutiny. Silicone breast implants were removed from the U.S. marketplace for a period in the 1990s and 2000s related to safety concerns. Certain patient advocacy groups exist to publicize real and perceived health risks associated with silicone breast implants and plastic surgery generally. Recently, some breast implant patients have begun to self-identify and report various symptoms that they believe are related to their breast implants; they refer to these symptoms as Breast Implant Illness, or BII, but BII is not an official medical diagnosis. Additionally, the activities of legislative bodies, regulatory agencies, physician organizations, and other groups may lead to publicity around the real and perceived risks to patients from silicone implants. Any of these could reduce patient demand for our products, or could, even in the absence of a change in demand, negatively impact our share price. In addition, activity of this type could result in an increase in the number or size of product liability claims, which would adversely affect our business, financial results, and/or the price of our shares.</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent news coverage has called into question the long-term safety of breast implants and reports of breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) linked to our competitors&#8217; products which have led to regulatory actions regarding macrotextured devices in several countries and the worldwide recall of one of our competitor&#8217;s macrotextured implants and tissue expanders. These events </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">69</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">may lead to a reduction in the demand for silicone breast implants and could adversely affect our business.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Women with breast implants have reported higher rates, as compared to the general population, of BIA-ALCL, an uncommon type of cancer affecting cells of the immune system. In January 2011, the FDA indicated that there was a possible association between certain saline and silicone gel-filled breast implants and higher rates of BIA-ALCL, with the causal links neither yet understood nor confirmed. In March 2015, France&#8217;s National Cancer Institute, or NCI, noted that there is a clearly established link between ALCL and certain breast implants, which is referred to as breast implant-associated ALCL, or BIA-ALCL. The NCI noted in that report that most of the reported cases occurred in women with textured implants.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the FDA updated its advisory on BIA-ALCL and subsequently requested all breast implant manufacturers to revise their physician and patient labeling with the most current information.&#160;The August 2017 update described BIA-ALCL as &#8220;rare&#8221; and stated &#8220;we have strengthened our understanding of this condition and concur with the&#160;World Health Organization designation&#160;of BIA-ALCL as a rare T-cell lymphoma that can develop following breast implants. The exact number of cases remains difficult to determine due to&#160;significant limitations in world-wide reporting and lack of global implant sales data. At this time, most data suggest that BIA-ALCL occurs more frequently following implantation of breast implants with textured surfaces rather than those with smooth surfaces.&#8221; The FDA noted it does not recommend prophylactic breast implant removal in a patient without symptoms or other abnormalities.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2018, the FDA further updated its advisory on BIA-ALCL stating &#8220;we are reporting that we are aware of 414&#160;total cases of BIA-ALCL. Additionally, studies reported in medical literature estimate that the lifetime risk of developing BIA-ALCL for patients with textured breast implants ranges from 1 in 3,817 to 1 in 30,000.&#8221;&#160;The FDA noted that the update did not change the agency&#8217;s recommendation and that choosing to obtain a breast implant is a personal decision that patients and providers should make with the most complete information available. In the fourth quarter of 2018, following the non-renewal of its textured breast implant CE Mark licenses in Europe, Allergan plc suspended sales of textured breast implants in Europe and withdrew its remaining textured breast implants on the market within Europe.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 6, 2019, the FDA further reported that as of September 2018, the agency had received a total of 660 total medical device reports regarding BIA-ALCL cases since 2010. Of the 660 reports, the FDA&#8217;s analysis suggested that there are 457 unique cases of BIA-ALCL, including nine patient deaths.&#160;Additionally, on February 12, 2019, Health Canada confirmed that as of January 1, 2019, it had received reports of 22 confirmed and 22 suspected Canadian cases of BIA-ALCL and that it would be updating its safety review of BIA-ALCL in Spring 2019. In April 2019, the Agence Nationale de Securite du Medicament et des Produits de Sante, or ANSM, the regulatory authority in France, announced that 59 cases of BIA-ALCL had been reported in France since 2011 and banned several types of macrotextured and polyurethane implants linked to BIA-ALCL.&#160;Between February and September 2019, authorities from Australia, Colombia, Canada, South Korea and Singapore announced similar bans.&#160;</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In July 2019, the FDA requested that Allergan plc recall its Biocell</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> textured implants in the U.S. market and Allergan subsequently announced the global recall of its Biocell</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> textured breast implants and tissue expanders. In the FDA announcement, it noted that it had reviewed 573 unique cases globally of BIA-ALCL, including 33 patient deaths, of which 12 of the 13 known deaths were attributed to Biocell</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> implants. The FDA further noted that it will continue to monitor the incidence of BIA-ALCL across other textured and smooth breast implants and tissue expanders as well as other devices intended for use in the breast.&#160;The FDA subsequently identified the recall as a Class I recall in September 2019 and stated that use of the recalled devices may cause serious injuries and death. As the BIA-ALCL risk continues to become more highly publicized, this could have a significant negative impact on demand for breast implants globally, including our Motiva Implants. In September 2020, the FDA released finalized guidance on breast implant labeling recommendations, including the addition of a boxed warning, a patient decision checklist, material and device descriptions, implant rupture screening recommendations and a patient device card.</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, FDA updated its analysis of medical device reports of breast implant illness and breast implant associated lymphoma. In this update, the FDA updated the table on the agency&#8217;s BIA-ALCL webpage to include a total of 733 unique cases and 36 patient deaths globally, which reflect an increase of 160 new cases and 3 deaths since the early-July, 2019 update.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">70</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We do not produce the types of rough textured implants that have been involved in these reports. To date, no cases of BIA-ALCL have been reported in patients with Motiva Implants. Furthermore, there have been no reported cases of BIA-ALCL in patients with smooth implants with no history of previously having a textured device.&#160;Future clinical studies or clinical experience may indicate that breast implants expose potentially genetically predisposed patients to greater risks of BIA-ALCL, which may reduce demand for silicone implants generally, expose us to product liability claims, as well as to class actions and other lawsuits. These impacts may occur in the absence of any specific linkage with our products. Moreover, if cases of BIA-ALCL or other complications are discovered in the future and/or are reported in patients with Motiva Implants, we could be subject to mandatory product recalls, suspension or withdrawal of our regulatory licensure for sale in one or more countries, and significant legal liability. Any of these may have an adverse effect on our business or operating results, or a negative impact on our share price.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Intellectual Property </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are unable to protect the confidentiality of our trade secrets, the value of our technology could be materially adversely affected, harming our business and competitive position. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to our patented technology and products, we rely upon confidential proprietary information, including trade secrets, unpatented know-how, technology and other proprietary information, to develop and maintain our competitive position. Any disclosure to or misappropriation by third parties of our confidential proprietary information could enable competitors to quickly duplicate or surpass our technological achievements, thus eroding our competitive position in the market. We seek to protect our confidential proprietary information, in part, by confidentiality agreements with our employees and our collaborators and consultants. We also have agreements with our employees and selected consultants that obligate them to assign their inventions to us. These agreements are designed to protect our proprietary information, however, we cannot be certain that our trade secrets and other confidential information will not be disclosed or that competitors will not otherwise gain access to our trade secrets, or that technology relevant to our business will not be independently developed by a person that is not a party to such an agreement. Furthermore, if the employees, consultants or collaborators that are parties to these agreements breach or violate the terms of these agreements, we may not have adequate remedies for any such breach or violation, and we could lose our trade secrets through such breaches or violations. Further, our trade secrets could be disclosed, misappropriated or otherwise become known or be independently discovered by our competitors. In addition, intellectual property laws in foreign countries may not protect trade secrets and confidential information to the same extent as the laws of the United States. If we are unable to prevent disclosure of the intellectual property related to our technologies to third parties, we may not be able to establish or maintain a competitive advantage in our market, which would harm our ability to protect our rights and have an adverse effect on our business. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we are not able to obtain and maintain intellectual property protection for our products and technologies, or if the scope of our patents is not sufficiently broad, we may not be able to effectively maintain our market leading technology position.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our success depends in large part on our ability to obtain and maintain patent and other intellectual property protection in the United States and in other countries with respect to our proprietary technology and products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The patent position of medical device and diagnostic companies generally is highly uncertain and involves complex legal and factual questions for which legal principles remain unresolved. In recent years, patent rights have been the subject of significant litigation. As a result, the issuance, scope, validity, enforceability and commercial value of the patent rights we rely on are highly uncertain. Pending and future patent applications may not result in patents being issued which protect our technology or products or which effectively prevent others from commercializing competitive technologies and products. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of the patents we rely on or narrow the scope of our patent protection. The laws of other countries may not protect our rights to the same extent as the laws of the U.S. Publications of discoveries in the scientific literature often lag behind the actual discoveries, and patent applications in the United States and other jurisdictions are typically not published until 18 months after filing, or in some cases not at all. Therefore, we cannot be certain that we were the first to make the inventions claimed in our patents or pending patent applications, or that we or were the first to file for patent protection of such inventions. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if the patent applications we rely on issue as patents, they may not issue in a form that will provide us with any meaningful protection, prevent competitors from competing with us or otherwise provide us with any </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">71</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">competitive advantage. Our competitors may be able to circumvent our patents by developing similar or alternative technologies or products in a non-infringing manner. The issuance of a patent is not conclusive as to its scope, validity or enforceability, and the patents we rely on may be challenged in the courts or patent offices in the United States and abroad. Such challenges may result in patent claims being narrowed, invalidated or held unenforceable, which could limit our ability to stop or prevent us from stopping others from using or commercializing similar or identical technology and products, or limit the duration of the patent protection of our technology and products. Given the amount of time required for the development, testing and regulatory review of new planned products, patents protecting such products might expire before or shortly after such products are commercialized. As a result, our patent portfolio may not provide us with sufficient rights to exclude others from commercializing products similar or identical to ours or otherwise provide us with a competitive advantage. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may not be able to protect or enforce our intellectual property rights throughout the world. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filing, prosecuting and defending patents on all of our planned products throughout the world may be prohibitively expensive to us. Competitors may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export otherwise infringing products to territories where we have patent protection but where enforcement is not as strong as in the United States. These products may compete with our products in jurisdictions where we do not have any issued patents and our patent claims or other intellectual property rights may not be effective or sufficient to prevent them from so competing. Many companies have encountered significant problems in protecting and defending intellectual property rights in international jurisdictions. The legal systems of certain countries, particularly certain developing countries, do not favor the enforcement of patents and other intellectual property protection, which could make it difficult for us to stop the infringement of our patents or marketing of competing products in violation of our proprietary rights generally. Proceedings to enforce our patent rights in foreign jurisdictions could result in substantial cost and divert our efforts and attention from other aspects of our business. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We may become involved in legal proceedings to protect or enforce our intellectual property rights, which could be expensive, time consuming, or unsuccessful.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Competitors may infringe or otherwise violate the patents we rely on, or our other intellectual property rights. To counter infringement or unauthorized use, we may be required to file infringement claims, which can be expensive and time-consuming. Any claims that we assert against perceived infringers could also provoke these parties to assert counterclaims against us alleging that we infringe their intellectual property rights. In addition, in an infringement proceeding, a court may decide that a patent we are asserting is invalid or unenforceable, or may refuse to stop the other party from using the technology at issue on the grounds that the patents we are asserting do not cover the technology in question. An adverse result in any litigation proceeding could put one or more patents at risk of being invalidated or interpreted narrowly. Furthermore, because of the substantial amount of discovery required in connection with intellectual property litigation, there is a risk that some of our confidential information could be compromised by disclosure during this type of litigation. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Interference or derivation proceedings provoked by third parties or brought by the U.S. Patent and Trademark Office, or USPTO, or any other patent authority may be necessary to determine the priority of inventions or other matters of inventorship with respect to patents and patent applications. We may become involved in proceedings, including oppositions, interferences, derivation proceedings, inter partes reviews, patent nullification proceedings, or re-examinations, challenging our patent rights or the patent rights of others, and the outcome of any such proceedings are highly uncertain. An adverse determination in any such proceeding could reduce the scope of, or invalidate, important patent rights, allow third parties to commercialize our technology or products and compete directly with us, without payment to us, or result in our inability to manufacture or commercialize products without infringing third-party patent rights. Our business also could be harmed if a prevailing party does not offer us a license on commercially reasonable terms, if any license is offered at all. Litigation or other proceedings may fail and, even if successful, may result in substantial costs and distract our management and other employees. We may also become involved in disputes with others regarding the ownership of intellectual property rights. If we are unable to resolve these disputes, we could lose valuable intellectual property rights. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if resolved in our favor, litigation or other legal proceedings relating to intellectual property claims may cause us to incur significant expenses and could distract our technical or management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the market price of our common shares. Such litigation or </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">72</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">proceedings could substantially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. Uncertainties resulting from the initiation and continuation of intellectual property litigation or other proceedings could have an adverse effect on our ability to compete in the marketplace. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our internal computer systems, or those used by third parties which we rely on, may fail or suffer security breaches.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Despite the implementation of security measures, our internal computer systems, or those used by third parties which we rely on, are vulnerable to damage from computer viruses and unauthorized access, malware, natural disasters, fire, terrorism, war and telecommunication, electrical failures, cyber-attacks or cyber-intrusions over the Internet, attachments to emails, persons inside our organization, or persons with access to systems inside our organization. The risk of a security breach or disruption, particularly through cyber-attacks or cyber intrusion, including by computer hackers, foreign governments, and cyber terrorists, has generally increased as the number, intensity and sophistication of attempted attacks and intrusions from around the world have increased. While we have not experienced any such material system failure or security breach to our knowledge to date, if such an event were to occur and cause interruptions in our operations, it could result in a material disruption of our development programs and our business operations. For example, the loss of data from completed, ongoing or future studies could result in delays in our regulatory approval efforts and significantly increase our costs to recover or reproduce the data. To the extent that any disruption or security breach were to result in a loss of, or damage to, our data or applications, or inappropriate disclosure of confidential or proprietary information, we could incur liability and the further development and commercialization of our current and future products could be delayed.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The medical device industry is characterized by patent litigation and we could become subject to litigation that could be costly, result in the diversion of management's time and efforts, require us to pay damages or prevent us from marketing our existing or future products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Patent litigation is prevalent in the medical device and diagnostic sectors. Our commercial success depends in part upon our ability and that of our distributors, contract manufacturers, and suppliers to manufacture, market and sell our planned products, and to use our proprietary technologies without infringing, misappropriating or otherwise violating the proprietary rights or intellectual property of third parties. We may become party to, or be threatened with, future adversarial proceedings or litigation regarding intellectual property rights with respect to our products and technology. Third parties may assert infringement claims against us based on existing or future intellectual property rights. If we are found to infringe a third-party&#8217;s intellectual property rights, we could be required to obtain a license from such third-party to continue developing and marketing our products and technology. We may also elect to enter into such a license in order to settle pending or threatened litigation. However, we may not be able to obtain any required license on commercially reasonable terms, or at all. Even if we were able to obtain a license, it could be non-exclusive, thereby giving our competitors access to the same technologies licensed to us and could require us to pay significant royalties and other fees. We could be forced, including by court order, to cease commercializing the infringing technology or product. In addition, we could be found liable for monetary damages. A finding of infringement could prevent us from commercializing our planned products in commercially important territories, or force us to cease some of our business operations, which could harm our business. Many of our employees were previously employed at, and many of our current advisors and consultants are employed by, universities or other biotechnology, medical device or pharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees, advisors and consultants do not use the proprietary information or know-how of others in their work for us, we may be subject to claims that we, or these employees, have used or disclosed intellectual property, including trade secrets or other proprietary information, of any such employee&#8217;s former employer. These and other claims that we have misappropriated the confidential information or trade secrets of third parties can have a similar negative impact on our business to the infringement claims discussed above. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Even if we are successful in defending against intellectual property claims, litigation or other legal proceedings relating to such claims may cause us to incur significant expenses, and could distract our technical and management personnel from their normal responsibilities. In addition, there could be public announcements of the results of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, it could have a substantial adverse effect on the price of our common shares. Such litigation or proceedings could substantially increase our operating losses and reduce our resources available for development activities. We may not have sufficient financial or other resources to adequately </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">73</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conduct such litigation or proceedings. Some of our competitors may be able to sustain the costs of such litigation or proceedings more effectively than we can because of their substantially greater financial resources. Uncertainties resulting from the initiation and continuation of litigation or other intellectual property related proceedings could have a material adverse effect on our ability to compete in the marketplace. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment and other requirements imposed by governmental patent agencies, and our patent protection could be reduced or eliminated for non-compliance with these requirements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodic maintenance fees, renewal fees, annuity fees and various other governmental fees on patents or applications will be due to be paid by us to the USPTO and various governmental patent agencies outside of the United States in several stages over the lifetime of the patents or applications. The USPTO and various non-U.S. governmental patent agencies require compliance with a number of procedural, documentary, fee payment and other similar provisions during the patent application process. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. However, there are situations in which noncompliance can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, our competitors might be able to use our technologies and this circumstance would have a material adverse effect on our business. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with our obligations in our intellectual property agreements, we could lose intellectual property rights that are important to our business. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are a party, and expect to become party in the future, to certain intellectual property agreements that impose various diligence, milestone payment, royalty, insurance and other obligations on us. If we fail to comply with these obligations, any licensor may have the right to terminate such agreements, in which event we may not be able to develop and market any product that is covered by such agreements. Termination of such agreements, or reduction or elimination of our rights under such agreements, may result in our having to negotiate new or reinstated arrangements on less favorable terms, or our not having sufficient intellectual property rights to operate our business. The occurrence of such events could harm our business and financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The risks described elsewhere in this Quarterly Report on Form&#160;10-Q pertaining to our intellectual property rights also apply to any intellectual property rights that we may license, and any failure by us or any future licensor to obtain, maintain, defend and enforce these rights could have a material adverse effect on our business. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Government Regulation </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The regulatory approval process is expensive, time consuming and uncertain, and may prevent us from obtaining approvals for the commercialization of Motiva Implants or our planned products. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The research, testing, manufacturing, labeling, approval, selling, import, export, marketing and distribution of medical devices are subject to extensive regulation by the FDA and other regulatory authorities in the United States and other countries, where regulations differ from country to country. Our products are registered to be sold in more than 80 countries, but we are not permitted to market our planned products in the United States until we receive the requisite approval or clearance from the FDA. We have not submitted an application or received marketing approval for Motiva Implants or any planned products in the United States. Obtaining PMA approval for sale of a medical device from the FDA can be a lengthy, expensive and uncertain process. In addition, failure to comply with FDA and other applicable U.S. and foreign regulatory requirements may subject us to administrative or judicially imposed sanctions, including the following: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">warning letters; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">civil or criminal penalties and fines; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">injunctions; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension or withdrawal of regulatory approval; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">suspension of any ongoing clinical studies; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">voluntary or mandatory product recalls and publicity requirements; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">refusal to accept or approve applications for marketing approval of new devices or supplements to approved applications filed by us; </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">74</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">restrictions on operations, including costly new manufacturing requirements; or </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">seizure or detention of our products or import bans. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to receiving approval to commercialize any of our planned products in the United States or abroad, we may be required to demonstrate with substantial evidence from preclinical and well-controlled clinical studies, and to the satisfaction of the FDA or other regulatory authorities abroad, that such planned products are safe and effective for their intended uses. Results from preclinical studies and clinical studies can be interpreted in different ways. Even if we believe the preclinical or clinical data for our planned products are promising, such data may not be sufficient to support approval by the FDA and other regulatory authorities. Administering any of our planned products to humans may produce undesirable side effects, which could interrupt, delay or cause suspension of clinical studies of our planned products and result in the FDA or other regulatory authorities denying approval of our planned products for any or all targeted indications. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Regulatory approval from the FDA is not guaranteed, and the approval process is expensive and may take several years. The FDA also has substantial discretion in the approval process. Despite the time and expense exerted, failure can occur at any stage, and we could encounter problems that cause us to abandon or repeat clinical studies, or perform additional preclinical studies and clinical studies. The number of preclinical studies and clinical studies that will be required for FDA approval varies depending on the planned product, the indication that the planned product is designed to address and the regulations applicable to any particular planned product. The FDA can delay, limit or deny approval of a planned product for many reasons, including, but not limited to, the following: </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">a planned product or one or more of its features may not be deemed safe or effective; </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">FDA officials may not find the data from preclinical studies and clinical studies sufficient; </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the FDA might not approve our manufacturing or our third-party supplier&#8217;s processes or facilities; or </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the FDA may change its approval policies or adopt new regulations. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If Motiva Implants or any planned products fail to demonstrate safety and efficacy in preclinical and clinical studies or do not gain regulatory approval, our business and results of operations will be harmed. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Even if we receive regulatory approval for a planned product, we will be subject to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense and subject us to penalties if we fail to comply with applicable regulatory requirements. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When a regulatory approval is obtained, the approved product and its manufacturer are subject to continual review by the FDA or non-U.S. regulatory authorities. Our regulatory approval for Motiva Implants, as well as any regulatory approval that we receive for Motiva Implants or for any planned products may be subject to limitations on the indicated uses for which the product may be marketed. Future approvals may contain requirements for potentially costly post-marketing follow-up studies to monitor the safety and efficacy of the approved product. In addition, we are subject to extensive and ongoing regulatory requirements by the FDA and other regulatory authorities with regard to the labeling, packaging, adverse event reporting, storage, advertising, promotion and recordkeeping for our products. In addition, we are required to comply with regulations regarding the manufacture of Motiva Implants, which include requirements related to quality control and quality assurance as well as the corresponding maintenance of records and documentation. Further, regulatory authorities must inspect these manufacturing facilities and determine they are in compliance with FDA good manufacturing practice requirements as set forth in the Quality System Regulation, or QSR, before the products can be approved. These facilities are subject to continual review and periodic inspections by the FDA and other regulatory authorities for compliance with QSR regulations. If we or a third-party discover previously unknown problems with a product, such as adverse events of unanticipated severity or frequency, or problems with the facility where the product is manufactured, a regulatory authority may impose restrictions on that product, the manufacturer or us, including requiring withdrawal of the product from the market or suspension of manufacturing. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If we fail to comply with health care regulations, we could face substantial penalties and our business, operations and financial condition could be adversely affected. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain federal and state health care laws and regulations pertaining to fraud and abuse and patients&#8217; rights are and will be applicable to our business. If we are approved by the FDA to market our products in the United States, we could be subject to health care fraud and abuse and patient privacy regulation by both the federal government </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">75</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and the states in which we conduct our business. The regulations that may affect our ability to operate include, without limitation: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal Anti-Kickback Statute, which prohibits, among other things, any person from knowingly and willfully offering, soliciting, receiving or providing remuneration, directly or indirectly, in exchange for or to induce either the referral of an individual for, or the purchase, order or recommendation of, any good or service for which payment may be made under federal health care programs, such as the Medicare and Medicaid programs; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal physician self-referral law, commonly known as the Stark Law, which prohibits, among other things, physicians who have a financial relationship, including an investment, ownership or compensation relationship with an entity, from referring Medicare and Medicaid patients to that entity for designated health services, unless an exception applies. Similarly, entities may not bill Medicare, Medicaid or any other party for services furnished pursuant to a prohibited referral. Unlike the federal Anti-Kickback Statute, the Stark Law is a strict liability statute, meaning that all of the requirements of a Stark Law exception must be met in order to be compliant with the law;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal civil and criminal false claims and civil monetary penalties laws, including beneficiary inducement laws, and the federal False Claims Act, which prohibits, among other things, individuals or entities from knowingly presenting, or causing to be presented, false claims, or knowingly using false statements, to obtain payment from the federal government; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, which prohibits, executing a scheme to defraud any health care benefit program or making false statements relating to health care matters; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the federal transparency requirements under the PPACA which requires certain manufacturers of drugs, devices, biologics and medical supplies to annual report to the HHS information related to physician payments and other transfers of value made to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act, which governs the conduct of certain electronic health care transactions and protects the security and privacy of protected health information; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state law equivalents of each of the above federal laws, such as anti-kickback, transparency and false claims laws which may apply to items or services reimbursed by any third-party payor, including commercial insurers, as well as state post-marketing compliance laws; and</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">state laws governing the privacy and security of health information in certain circumstances, many of which differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PPACA, among other things, amended the intent requirement of the federal Anti-Kickback Statute and criminal health care fraud statutes. A person or entity no longer needs to have actual knowledge of this statute or specific intent to violate it. In addition, the PPACA provides that the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the federal False Claims Act. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Similar regulations would also apply to our business in countries where we have started direct sales operations, like Brazil and several others within the European Union, where they have different regulations at European and national levels. There is a high degree of complication in complying with the different levels of regulation and the singular differences in the different countries and markets.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is possible that some of our business practices could be subject to challenge by one or more of these laws. These laws are often open to a variety of interpretations by the regulatory authorities that enforce them, in addition to courts. This makes it difficult to anticipate all potential challenges to our business practices and increases the potential risk that we may be found to be in violation of one of these laws. The enforcement of these laws may include investigations, prosecutions, convictions, monetary settlements, exclusion from participation in Medicare, Medicaid and other federal healthcare programs, individual imprisonment, additional reporting and government oversight. If we become subject to a corporate integrity agreement or similar agreement to resolve allegations of non-compliance with these laws and the curtailment or restructuring of our operations. Often, to avoid the threat of treble damages and penalties under the False Claims Act, which in 2020 were $11,665 to </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">76</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$23,331 per false claim, companies will resolve allegations in a settlement without admitting liability to avoid the potential treble damages. Any such settlement could materially affect our business, financial operations, and reputation. Further, any such penalties or curtailment or restructuring of our operations could adversely affect our ability to operate our business and our financial results. Any action against us for violation of these laws, even if we successfully defend against it, could cause us to incur significant legal expenses and divert our management&#8217;s attention from the operation of our business. Moreover, achieving and sustaining compliance with applicable federal, state or international privacy, security and fraud laws may prove costly. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have obtained the authorization to distribute our products in regions/countries such as Europe and Brazil through the certification of our Quality System by the corresponding regulatory entities. Failing to demonstrate that our Quality System is in place, that consistently and systematically ensures compliance with regulations from such regions/countries might imply losing the certifications and as such, the rights to freely distribute the products which would adversely impact the Company&#8217;s revenue and reputation.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Health care reform measures could hinder or prevent our planned products&#8217; commercial success. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the United States, there have been, and we expect there will continue to be, a number of legislative and regulatory changes to the health care system in ways that could affect our future revenue and future profitability and the future revenue and future profitability of our potential customers. Federal and state lawmakers regularly propose and, at times, enact legislation that could result in significant changes to the health care system, some of which are intended to contain or reduce the costs of medical products and services. For example, one of the most significant health care reform measures in decades, the Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act, or PPACA, was enacted in 2010. The PPACA contains a number of provisions, including those governing enrollment in federal health care programs, reimbursement changes and fraud and abuse measures, all of which will impact existing government health care programs and will result in the development of new programs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Some provisions of the PPACA have yet to be implemented, and there have been judicial and Congressional challenges to certain aspects of the PPACA, as well as recent efforts by the Trump administration to repeal or replace certain aspects of the PPACA. Furthermore, the Tax Cuts and Jobs Act passed in December of 2017 included a provision that would repeal one of the primary pillars of the law, the PPACA&#8217;s individual mandate penalty that essentially assessed a monetary penalty or fine on certain individuals who fail to maintain qualifying health coverage for all or part of a year. Congress may consider other legislation to repeal or replace elements of the PPACA on a provision-by-provision basis. We cannot assure you that the PPACA, as currently enacted or as amended in the future, will not adversely affect our business and financial results and we cannot predict how future federal or state legislative or administrative changes relating to health care reform will affect our business. Most recently, under President Biden, the Department of Justice dropped support of two Supreme Court cases challenging PPACA in addition to a case before the U.S. Court of Appeals for the Fifth Circuit. On January 28, 2021, President Biden signed an executive orders to expand access to PPACA coverage, stating that it is the &#8220;policy&#8221; of the Biden administration to protect and strengthen the PPACA and directing agencies to consider suspending, revising, or rescinding actions related to President Trump&#8217;s executive orders that are inconsistent with this policy position. However, other legislators continue efforts to repeal and replace other elements of the PPACA. While the ultimate outcome of PPACA is not yet known, any changes that result in price controls reduce access to and reimbursement for care or add additional regulations may have an adverse effect on our financial condition and results of operations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We cannot predict the impact that such actions against the PPACA or other health care reform under the Biden administration will have on our business, and there is uncertainty as to what healthcare programs and regulations may be implemented or changed at the federal and/or state level in the United States, or the effect of any future legislation or regulation. However, it is possible that such initiatives could have an adverse effect on our ability to obtain approval and/or successfully commercialize products in the United States in the future. For example, any changes that reduce, or impede the ability to obtain, reimbursement for the type of products we intend to commercialize in the United States (or our products more specifically, if approved) or reduce medical procedure volumes could adversely affect our business plan to introduce our products in the United States.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, other legislative changes have been proposed and adopted since the PPACA was enacted. For example, the Budget Control Act of 2011, among other things, created the Joint Select Committee on Deficit Reduction to recommend proposals for spending reductions to Congress. The Joint Select Committee did not achieve a targeted deficit reduction of at least $1.2 trillion for the years 2013 through 2021, which triggered the </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">77</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">legislation&#8217;s automatic reduction to several government programs, including aggregate reductions to Medicare payments to providers of up to 2%&#160;per fiscal year, starting in 2013, which, due to subsequent legislative amendments to the statute, including the Bipartisan Budget Act of 2018, will remain in effect through 2027 unless additional Congressional action is taken. We cannot predict whether any additional legislative changes will affect our business. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There likely will continue to be legislative and regulatory proposals at the federal and state levels directed at containing or lowering the cost of health care. We cannot predict the initiatives that may be adopted in the future or their full impact. The continuing efforts of the government, insurance companies, managed care organizations and other payors of health care services to contain or reduce costs of health care may adversely affect: </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our ability to set a price that we believe is fair for our products; </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">our ability to generate revenue and achieve or maintain profitability; and </span></div><div style="margin-bottom:6pt;text-indent:18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the availability of capital. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Ownership of Our Securities </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our share price may be volatile, and purchasers of our securities could incur substantial losses.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our common shares have only recently become publicly traded, and we expect that the price of our common shares will likely be volatile. The securities markets in general, and the market for biotechnology and medical device companies in particular, have experienced extreme volatility that has often been unrelated to the operating performance of particular companies. Additionally, the lack of an active market may impair the value of our common shares, or your ability to sell your shares at the time you wish to sell them or at a price that you consider reasonable. Although our common shares are listed on the Nasdaq Capital Market, if we fail to satisfy the continued listing standards, we could be de-listed, which would negatively impact the price of our common shares. The market price for our shares may be influenced by many factors, including the following: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability to successfully commercialize, and realize revenues from sales of, Motiva Implants; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">the success of competitive products or technologies; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">results of clinical studies of Motiva Implants or planned products or those of our competitors; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">regulatory or legal developments in the United States and other countries, especially changes in laws or regulations applicable to our products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">introductions and announcements of new products by us, our commercialization partners, or our competitors, and the timing of these introductions or announcements; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actions taken by regulatory agencies with respect to our products, clinical studies, manufacturing processes or sales and marketing terms; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">variations in our financial results or those of companies that are perceived to be similar to us; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the success of our efforts to acquire or in-license additional products or planned products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments concerning our collaborations, including but not limited to those with our sources of manufacturing supply and our commercialization partners; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments concerning our ability to bring our manufacturing processes to scale in a cost-effective manner; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or capital commitments; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">developments or disputes concerning patents or other proprietary rights, including patents, litigation matters and our ability to obtain patent protection for our products; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our ability or inability to raise additional capital and the terms on which we raise it; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the recruitment or departure of key personnel; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">changes in the structure of health care payment systems; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">negative shifts in the economy effecting the number of aesthetic breast procedures;</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">78</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">market conditions in the pharmaceutical and biotechnology sectors; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">actual or anticipated changes in earnings estimates or changes in securities analyst recommendations regarding our common shares, other comparable companies or our industry generally; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">trading volume of our common shares; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">sales of our common shares by us or our shareholders; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the impact of the COVID-19 pandemic;</span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">general economic, industry and market conditions; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the other risks described in this &#8220;Risk Factors&#8221; section. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These broad market and industry factors may harm the market price of our common shares, regardless of our operating performance. In the past, following periods of volatility in the market, securities class-action litigation has often been instituted against companies. Such litigation, if instituted against us, could result in substantial costs and diversion of management&#8217;s attention and resources, which could adversely affect our business, financial condition, results of operations and growth prospects. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If securities or industry analysts do not publish research, or publish inaccurate or unfavorable research, about our business, our common share price and trading volume could decline. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The trading market for our common shares will depend, in part, on the research and reports that securities or industry analysts publish about us or our business. Securities and industry analysts do not currently, and may never, publish research on our company. If no securities or industry analysts commence coverage of our company, the trading price for our common shares would likely be negatively impacted. In the event securities or industry analysts initiate coverage, if one or more of the analysts who cover us downgrade our common shares or publish inaccurate or unfavorable research about our business, our share price would likely decline. In addition, if our operating results fail to meet the forecast of analysts, our share price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our common shares could decrease, which might cause our share price and trading volume to decline. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We have identified a material weakness in our internal control over financial reporting as of December 31, 2019 and may identify additional material weaknesses in the future that may cause us to fail to meet our reporting obligations or result in material misstatements of our consolidated financial statements. If we fail to remedy our material weakness, or if we fail to establish and maintain effective control over financial reporting, our ability to accurately and timely report our financial results could be adversely affected. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our management is responsible for establishing and maintaining adequate internal control over financial reporting. Internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements in accordance with U.S. generally accepted accounting principles. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of annual or interim financial statements will not be prevented or detected on a timely basis. Prior to the completion of our IPO, we were a private company with limited accounting and compliance personnel and other resources to address our internal control over financial reporting. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the preparation and audit of our 2019 financial statements, we had one material weakness. It was determined that we did not perform an adequate review over the manual consolidation process, resulting in audit adjustments. We have implemented and are continuing to implement a number of measures to address the material weakness; however, there is no guarantee that we will be able to remediate the material weakness on a timely basis, or at all.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If our remedial measures are insufficient to address the material weakness, or if additional material weaknesses or significant deficiencies in our internal control are discovered or occur in the future, it may materially adversely affect our ability to report our financial condition and results of operations in a timely and accurate manner and impact investor confidence in our Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The actions we have taken are subject to continued review, supported by confirmation and testing by management as well as audit committee oversight. While we have implemented a plan to remediate this material weakness, we cannot assure you that we will be able to remediate it, which could impair our ability to accurately </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">79</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and timely report our consolidated financial position, results of operations, or cash flows. Our failure to remediate the material weakness identified above or the identification and remediation of additional material weaknesses in the future, could adversely affect our ability to report financial information, including our filing of quarterly or annual reports with the SEC on a timely and accurate basis. Moreover, our failure to remediate the material weakness identified above or the identification of additional material weaknesses, could prohibit us from producing timely and accurate consolidated financial statements, which may adversely affect our share price and we may be unable to maintain compliance with Nasdaq listing requirements. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We continue to incur significant costs as a result of operating as a public company, and our management is required to devote substantial time to new compliance initiatives. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a public company, we incur significant legal, accounting and other expenses that we did not incur as a private company. We are subject to the reporting requirements of the Exchange Act, the other rules and regulations of the Securities and Exchange Commission, or SEC, and the rules and regulations of Nasdaq. The expenses that are required in order to adequately prepare for being a public company are material, and compliance with the various reporting and other requirements applicable to public companies require considerable time and attention of management. For example, the Sarbanes-Oxley Act and the rules of the SEC and national securities exchanges have imposed various requirements on public companies, including requiring establishment and maintenance of effective disclosure and financial controls. Our management and other personnel devote a substantial amount of time to these compliance initiatives. These rules and regulations continue to increase our legal and financial compliance costs and make some activities more time-consuming and costly. For example, these rules and regulations make it more difficult and more expensive for us to obtain director and officer liability insurance, and we may be required to accept reduced policy limits on coverage or incur substantial costs to maintain the same or similar coverage. The impact of these events could also make it more difficult for us to attract and retain qualified personnel to serve on our Board of Directors, our board committees, or as executive officers. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Sarbanes-Oxley Act requires, among other things, that we maintain effective internal control over financial reporting and disclosure controls and procedures. In particular, we must perform system and process evaluation and testing of our internal control over financial reporting to allow management to report on the effectiveness of our internal control over financial reporting, as required by Section&#160;404 of the Sarbanes-Oxley Act, beginning with our second annual report on Form 10-K. In addition, we will be required to have our independent registered public accounting firm attest to the effectiveness of our internal control over financial reporting beginning with our annual report on Form 10-K following the date on which we are no longer an emerging growth company or a smaller reporting company. Our compliance with Section&#160;404 of the Sarbanes-Oxley Act will require that we incur substantial accounting expense and expend significant management efforts. We currently do not have an internal audit group, and we will need to hire additional accounting and financial staff with appropriate public company experience and technical accounting knowledge. If we are not able to comply with the requirements of Section&#160;404 in a timely manner, or if we or our independent registered public accounting firm identify deficiencies in our internal control over financial reporting that are deemed to be material weaknesses, the market price of our shares could decline and we could be subject to sanctions or investigations by Nasdaq, the SEC or other regulatory authorities, which would require additional financial and management resources. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our ability to successfully implement our business plan and comply with Section&#160;404 requires us to be able to prepare timely and accurate financial statements. We expect that we will need to continue to improve existing, and implement new operational and financial systems, procedures and controls to manage our business effectively. Any delay in the implementation of, or disruption in the transition to, new or enhanced systems, procedures or controls, may cause our operations to suffer and we may be unable to conclude that our internal control over financial reporting is effective and to obtain an unqualified report on internal controls from our auditors as required under Section&#160;404 of the Sarbanes-Oxley Act. This, in turn, could have an adverse impact on trading prices for our common shares, and could adversely affect our ability to access the capital markets. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our directors and principal shareholders continue to maintain the ability to control or significantly influence all matters submitted to shareholders for approval. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, our executive officers, directors and shareholders who own more than 5% of our outstanding common shares, in the aggregate, assuming the exercise of all options held by such persons, beneficially owned shares representing approximately 50.9% of our common shares. As a result, if these shareholders were to choose to act together, they would be able to control or significantly influence all matters submitted to our shareholders for approval, as well as our management and affairs. For example, these </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">80</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">shareholders, if they choose to act together, will control or significantly influence the election of directors and approval of any merger, consolidation or sale of all or substantially all of our assets. This concentration of voting power could delay or prevent an acquisition of our company on terms that other shareholders may desire. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Discontinuation of preferential tax treatments we currently enjoy or other unfavorable changes in tax law could result in additional compliance obligations and costs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Discontinuation of preferential tax treatments we currently enjoy or other unfavorable changes in tax law could result in additional compliance obligations and costs. We are currently the beneficiary of a tax holiday in Costa Rica pursuant to which we are subject to a tax at a 0% rate. However, there can be no assurance that we will continue to qualify for or receive such favorable tax treatment. If we fail to maintain such favorable tax treatment we may be subject to tax in Costa Rica at a significantly higher rate.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Tax authorities may disagree with our positions and conclusions regarding certain tax positions, resulting in unanticipated costs, taxes or non-realization of expected benefits.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A tax authority may disagree with tax positions that we have taken, which could result in increased tax liabilities. For example, the U.S. Internal Revenue Service or another tax authority could challenge the amounts paid between our affiliated companies pursuant to our intercompany arrangements and transfer pricing policies. A tax authority may take the position that material income tax liabilities, interest and penalties are payable by us, in which case, we expect that we might contest such assessment. Contesting such an assessment may be lengthy and costly and if we were unsuccessful in disputing the assessment, the implications could increase our anticipated effective tax rate, where applicable. In addition, we may be subject to additional tax liabilities, which could materially and adversely affect our business, financial condition and results of operations. The application, interpretation and enforcement value-added tax, or VAT, and other taxes and related regulations applicable to medical device companies is complex and evolving.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are a multinational organization faced with increasingly complex tax issues in many jurisdictions, and changes in tax laws or their application to the operation of our business could adversely impact our operating results and our business. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We conduct operations in multiple jurisdictions, and we are subject to certain taxes, including income, sales and use, employment, value added and other taxes, in the United States and other jurisdictions in which we do business. A change in the tax laws in the jurisdictions in which we do business, including an increase in tax rates or an adverse change in the treatment of an item of income or expense, possibly with retroactive effect, could result in a material increase in the amount of taxes we incur. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our determination of our tax liability is subject to review by applicable U.S. and foreign tax authorities. Any adverse outcome of such a review could harm our operating results and financial condition. The determination of our worldwide provision for income taxes and other tax liabilities requires significant judgment and, in the ordinary course of business, there are many transactions and calculations where the ultimate tax determination is complex and uncertain. Moreover, as a multinational business, we have subsidiaries that engage in many intercompany transactions in a variety of tax jurisdictions where the ultimate tax determination is complex and uncertain. The taxing authorities of the jurisdictions in which we operate may challenge our methodologies, which could impact our financial position and operating results. Historically, we have allocated some of our employees&#8217; and contractors&#8217; time across multiple business entities in the international jurisdictions in which we operate. If it were determined that we had misclassified our employees&#8217; or contractors&#8217; employment status or certain of our expenditures under local laws, we may be subjected to penalties or be required to pay withholding taxes for, extend employee benefits to, provide compensation for unpaid overtime to, or otherwise incur substantially greater expenses with respect to such employees and contractors.&#160;Any of the foregoing circumstances could have a material adverse impact on our operating results and financial condition.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are periodically reviewed and audited by tax authorities with respect to income and non-income taxes. Tax authorities may disagree with certain positions we have taken, and we may have exposure to additional income and non-income tax liabilities which could have an adverse effect on our operating results and financial condition. Such authorities could impose additional taxes, interest and penalties, claim that various withholding requirements apply to us or our subsidiaries or assert that benefits of tax treaties are not available to us or our subsidiaries. In addition, our future effective tax rates could be favorably or unfavorably affected by changes in tax rates, changes in the valuation of our deferred tax assets or liabilities, the effectiveness of our tax planning strategies, or changes in tax laws or their interpretation. Such changes could have an adverse impact on our financial condition. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">81</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a result of these and other factors, the ultimate amount of tax obligations owed may differ from the amounts recorded in our financial statements and any such difference may harm our operating results in future periods in which we change our estimates of our tax obligations or in which the ultimate tax outcome is determined. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We are an &#8220;emerging growth company,&#8221; and a &#8220;smaller reporting company,&#8221; and we cannot be certain if the reduced reporting requirements applicable to emerging growth companies or smaller reporting companies will make our common shares less attractive to investors.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are an &#8220;emerging growth company,&#8221; as defined in the Jumpstart Our Business Startups Act, or the JOBS Act, which was enacted in April 2012 and a &#8220;smaller reporting company&#8221; under the Securities Exchange Act of 1934, or the Exchange Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section&#160;404 of the Sarbanes-Oxley Act of 2002, or the Sarbanes-Oxley Act, reduced disclosure obligations regarding executive compensation in our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and shareholder approval of any golden parachute payments not previously approved. We could be an emerging growth company for up to five years, although circumstances could cause us to lose that status earlier. We will remain an emerging growth company until the earlier of (1)&#160;the last day of the fiscal year following the fifth anniversary of the completion of our IPO, (2)&#160;the last day of the fiscal year in which we have total annual gross revenue of at least $1.07 billion, (3) the date on which we are deemed to be a large accelerated filer, which means the market value of our common shares that is held by non-affiliates exceeds $700 million as of the prior June&#160;30th, and (4)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period. We will remain a smaller reporting company until we have a public float, or value attributable to stock held by nonaffiliates, of at least $250 million, as measured on or prior to June 30th. After we are no longer an emerging growth company and for as long as we remain a smaller reporting company, we will remain eligible for certain exemptions, including not being required to comply with the auditor attestation requirements of Section 404 of the Sarbanes-Oxley Act and reduced disclosure obligations regarding executive compensation, but we will be required to hold a nonbinding advisory vote on executive compensation and obtain stockholder approval of golden parachute payments. We cannot predict if investors will find our common shares less attractive because we may rely on these exemptions. If some investors find our common shares less attractive as a result, there may be a less active trading market for our common shares and our share price may suffer or be more volatile. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the JOBS Act, emerging growth companies can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. We have&#160;elected&#160;to take advantage of the extension of time to comply with new or revised financial accounting standards available under Section 102(b) of the JOBS Act. </span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our ability to use net operating losses to offset future taxable income and certain other tax attributes may be subject to certain limitations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Federal and California laws impose restrictions on the utilization of net operating loss carryforwards and research and development credit carryforwards in the event of a change in ownership of the Company, which constitutes an &#8220;ownership change&#8221; as defined by Internal Revenue Code Sections 382 and 383.&#160;Generally, an ownership change occurs if the percentage of the value of the shares that are owned by one or more direct or indirect &#8220;five percent shareholders&#8221; increases by more than 50% over their lowest ownership percentage at any time during the applicable testing period. If we have experienced an &#8220;ownership change&#8221; at any time since our&#160;formation, we may already be subject to limitations on our ability to utilize our existing net operating losses and other tax attributes. We have not experienced an ownership change in the past that would materially impact the availability of its net operating losses and tax credits. Nevertheless, future changes in our share ownership, which may be outside of our control, may trigger an &#8220;ownership change&#8221; and, consequently, Section 382 and 383 limitations. We have not completed a Section 382 and 383 analysis to determine if an ownership change has occurred. Until such analysis is completed, we cannot be sure that the full amount of the existing net operating loss carryforwards will be available to us, even if we do generate taxable income before their expiration. In addition, under the newly enacted U.S. federal income tax law, federal net operating losses incurred in 2018 and in future years may be carried forward indefinitely, but the deductibility of such federal net operating losses is limited.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">82</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Provisions in our amended and restated memorandum and articles of association and under British Virgin Islands law could make an acquisition of us more difficult and may prevent attempts by our shareholders to replace or remove our current management. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Provisions in our amended and restated memorandum and articles of association may discourage, delay or prevent a merger, acquisition or other change in control of us that shareholders may consider favorable, including transactions in which shareholders might otherwise receive a premium for their shares. These provisions could also limit the price that investors might be willing to pay in the future for our common shares, thereby depressing the market price of our common shares. In addition, these provisions may frustrate or prevent any attempts by our shareholders to replace or remove our current management by making it more difficult for shareholders to replace members of our Board of Directors. Because our Board of Directors is responsible for appointing the members of our management team, these provisions could in turn affect any attempt by our shareholders to replace current members of our management team. Among others, these provisions include the following: </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Board of Directors is divided into three classes with staggered three-year terms which may delay or prevent a change of our management or a change in control; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Board of Directors has the right to elect directors to fill a vacancy created by the expansion of our Board of Directors or the resignation, death or removal of a director, which will prevent shareholders from being able to fill vacancies on our Board of Directors; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our shareholders are not be able to act by written consent, as a result, a holder, or holders, controlling a majority of our shares are not be able to take certain actions other than at annual shareholders&#8217; meetings or special shareholders&#8217; meetings; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our amended and restated memorandum and articles of association do not allow cumulative voting in the election of directors, which limits the ability of minority shareholders to elect director candidates; </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">amendments of our amended and restated memorandum and articles of association will require the approval of shareholders holding 66 2/3% of our outstanding voting shares (unless amended by the Board of Directors); </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our shareholders are required to provide advance notice and additional disclosures in order to nominate individuals for election to our Board of Directors or to propose matters that can be acted upon at a shareholders&#8217; meeting, which may discourage or deter a potential acquiror from conducting a solicitation of proxies to elect the acquiror&#8217;s own slate of directors or otherwise attempting to obtain control of our company; and </span></div><div style="margin-bottom:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">our Board of Directors is able to issue, without shareholder approval, preferred shares with voting or other rights or preferences that could impede the success of any attempt to acquire us. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moreover, because we are incorporated in the British Virgin Islands, we are governed by the provisions of BVI Business Companies Act, 2004, as amended, or the BVI Act, which provide for different shareholder rights than a Delaware corporation. See, for example, the risk factor titled &#8220;Rights of shareholders under British Virgin Islands law differ from those under U.S. law, and, accordingly, you may have fewer protections as a shareholder.&#8221;</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Our employment agreements with our executive officers may require us to pay severance benefits to any of those persons who are terminated in connection with a change in control of us, which could harm our financial condition or results. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain of our executive officers are parties to employment agreements that contain change in control and severance provisions providing for aggregate cash payments of up to approximately $2.5 million for severance and other benefits and acceleration of vesting of share options in the event of a termination of employment in connection with a change in control of our company. The accelerated vesting of options could result in dilution to our existing shareholders and harm the market price of our common shares. The payment of these severance benefits could harm our financial condition and results. In addition, these potential severance payments may discourage or prevent third parties from seeking a business combination with our company. </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">83</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Because we do not anticipate paying any cash dividends on our common shares in the foreseeable future, capital appreciation, if any, will be our shareholders&#8217; sole source of gain. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We currently intend to retain all our future earnings, if any, to finance the growth and development of our business. In addition, the terms of existing or any future debt agreements may preclude us from paying dividends. For example, our credit agreement and guaranty with Madryn restricts our ability to pay dividends. As a result, capital appreciation, if any, of our common shares will be our shareholders&#8217; sole source of gain for the foreseeable future. </span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">U.S. holders of our common shares may suffer adverse tax consequences if we are characterized as a passive foreign investment company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A non-U.S. corporation will be classified as a passive foreign investment company, or PFIC, for U.S. federal income tax purposes, in any taxable year in which either (1) at least 75% of its gross income is passive income; or (2) at least 50% of the average quarterly value of its total gross assets is attributable to assets that produce &#8220;passive income&#8221; or are held for the production of passive income. Based on the project composition of our income and valuation of our assets, we do not believe we were a PFIC in 2019, and we do not expect to be a PFIC for our current taxable year or to become one in the future. However, because our PFIC status is subject to a number of uncertainties, neither we nor our tax advisors can provide any assurances regarding our PFIC status. If we are a PFIC for any taxable year during which a U.S. holder holds our common shares, the U.S. holder may be subject to adverse tax consequences. U.S. investors should consult their advisors regarding the application of these rules and the availability of any potential elections. See &#8220;Material British Virgin Island and U.S. Federal Income Tax Considerations.&#8221;</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">If a United States person is treated as owning at least 10% of our common shares, such holder may be subject to adverse U.S. federal income tax consequences.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a United States person is treated as owning (directly, indirectly, or constructively) at least 10% of the value or voting power of our ordinary shares, such person may be treated as a &#8220;United States shareholder&#8221; with respect to each &#8220;controlled foreign corporation&#8221; in our group (if any). We may become a controlled foreign corporation. In addition, because our group includes one or more U.S. subsidiaries, certain of our non-U.S. subsidiaries could be treated as controlled foreign corporations (regardless of whether or not we are treated as a controlled foreign corporation). A U.S. shareholder of a controlled foreign corporation may be required to report annually and include in its U.S. taxable income its pro rata share of &#8220;Subpart F income,&#8221; &#8220;global intangible low-taxed income,&#8221; and investments in U.S. property by controlled foreign corporations, regardless of whether we make any distributions. An individual that is a U.S. shareholder with respect to a controlled foreign corporation generally would not be allowed certain tax deductions or foreign tax credits that would be allowed to a U.S. shareholder that is a U.S. corporation. Failure to comply with these reporting obligations may subject a U.S. shareholder to significant monetary penalties and may prevent the statute of limitations with respect to such shareholder&#8217;s U.S. federal income tax return for the year for which reporting was due from starting. We cannot provide any assurances that we will assist investors in determining whether we or any of our non-U.S. subsidiaries is treated as a controlled foreign corporation or whether any investor is treated as a U.S. shareholder with respect to any such controlled foreign corporation or furnish to any U.S. shareholders information that may be necessary to comply with the aforementioned reporting and tax paying obligations. A U.S. investor should consult its advisors regarding the potential application of these rules to an investment in our common shares.</span></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Risks Related to Being a British Virgin Islands Company</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Rights of shareholders under British Virgin Islands law differ from those under U.S. law, and, accordingly, you may have fewer protections as a shareholder.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate affairs are governed by our amended and restated memorandum and articles of association, the BVI Act, and the common law of the British Virgin Islands. The rights of shareholders to take legal action against our directors, actions by minority shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are to a large extent governed by the common law of the British Virgin Islands and by the BVI Act. The common law of the British Virgin Islands is derived in part from comparatively limited judicial precedent in the British Virgin Islands as well as from English common law, which has persuasive, but not binding, authority on a court in the British Virgin Islands. The rights of our shareholders and the fiduciary responsibilities of our directors under British Virgin Islands law are not as clearly established as they would be under statutes or judicial precedents in some jurisdictions in the United States. In particular, the British Virgin Islands has a less developed </span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">84</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">body of securities laws as compared to the United States, and some states (such as Delaware) have more fully developed and judicially interpreted bodies of corporate law. As a result of the foregoing, holders of our ordinary shares may have more difficulty in protecting their interests through actions against our management, directors or major shareholders than they would as shareholders of a U.S. company.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">British Virgin Islands companies may not be able to initiate shareholder derivative actions, thereby depriving shareholders of one avenue to protect their interests.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">British Virgin Islands companies may not have standing to initiate a shareholder derivative action in a federal court of the United States. The circumstances in which any such action may be brought, and the procedures and defenses that may be available in respect of any such action, may result in the rights of shareholders of a British Virgin Islands company being more limited than those of shareholders of a company organized in the United States. Accordingly, shareholders may have fewer alternatives available to them if they believe that corporate wrongdoing has occurred. The British Virgin Islands courts are also unlikely to recognize or enforce judgments of courts in the United States based on certain liability provisions of U.S. securities law, or to impose liabilities based on certain liability provisions of the U.S. securities laws that are penal in nature, in original actions brought in the British Virgin Islands. There is no statutory recognition in the British Virgin Islands of judgments obtained in the United States, although the courts of the British Virgin Islands will generally recognize and enforce the non-penal judgment of a non-U.S. court of competent jurisdiction without retrial on the merits. This means that even if shareholders were to sue us successfully, they may not be able to recover anything to make up for the losses suffered.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">British Virgin Islands law differs from the laws in effect in the United States, and U.S. investors may have difficulty enforcing civil liabilities against us, our directors or members of senior management.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our amended and restated memorandum and articles of association, we may indemnify and hold our directors harmless against all claims and suits brought against them, subject to limited exceptions. Furthermore, to the extent allowed by law, the rights and obligations among or between us, any of our current or former directors, officers and employees and any current or former shareholder will be governed exclusively by the laws of the British Virgin Islands and subject to the jurisdiction of the British Virgin Islands courts, unless those rights or obligations do not relate to or arise out of their capacities as such. Although there is doubt as to whether U.S. courts would enforce these provisions in an action brought in the United States, under U.S. securities laws, these provisions could make judgments obtained outside of the British Virgin Islands more difficult to enforce against our assets in the British Virgin Islands or jurisdictions that would apply British Virgin Islands law.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">The laws of the British Virgin Islands provide limited protection for minority shareholders, so minority shareholders will have limited or no recourse if they are dissatisfied with the conduct of our affairs.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the laws of the British Virgin Islands, there is limited statutory law for the protection of minority shareholders other than the provisions of the BVI Act dealing with shareholder remedies, as summarized under &#8220;Description of Share Capital-Shareholders&#8217; Rights Under British Virgin Islands Law Generally.&#8221; One protection under statutory law is that shareholders may bring an action to enforce the constituent documents of a British Virgin Islands company and are entitled to have the affairs of the Company conducted in accordance with the BVI Act and the amended and restated memorandum and articles of association of the Company. As such, if those who control the Company have disregarded the requirements of the BVI Act or the provisions of our amended and restated memorandum and articles of association, then the courts will likely grant relief. Generally, the areas in which the courts will intervene are the following: (i) an act complained of which is illegal&#894; (ii) acts that constitute oppression, unfair discrimination or unfair prejudice against the minority where the wrongdoers control the Company&#894; (iii) acts that infringe on the personal rights of the shareholders, such as the right to vote&#894; and (iv) acts where we have not complied with provisions requiring approval of a special or extraordinary majority of shareholders, which are more limited than the rights afforded to minority shareholders under the laws of many states in the United States.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">85</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:11pt;font-weight:700;line-height:120%">General Risk Factors</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Legal proceedings may significantly harm our business.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">From time to time, we may become involved in litigation or other proceedings in the ordinary course of business. It is possible that such litigation or proceedings may significantly harm our future results of operations or financial condition due to expenses we may incur to defend ourselves or the ramifications of an adverse decision. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">We could be subject to securities class action litigation.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the past, securities class action litigation has often been instituted against companies whose securities have experienced periods of volatility in market price. Securities litigation brought against us following volatility in the price of our ordinary shares, regardless of the merit or ultimate results of such litigation, could result in substantial costs, which would hurt our financial condition and results of operations and divert management&#8217;s attention and resources from our business.</span></div><div style="margin-bottom:6pt"><span><br/></span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">86</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_130"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 2. RECENT SALES OF UNREGISTERED SECURITIES AND USE OF PROCEEDS</span></div><div style="margin-bottom:9pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_133"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 3. DEFAULTS UPON SENIOR SECURITIES</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_136"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 4. MINE SAFETY DISCLOSURES</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_139"></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 5. OTHER INFORMATION</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None</span></div><div id="i1ffd384b299d487fa5b14f13003c56d4_142"></div><div style="-sec-extract:summary;margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ITEM 6. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES</span></div><div style="margin-bottom:12pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(a) &#160;&#160;&#160;&#160;Exhibits.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:98.511%"><tr><td style="width:1.0%"></td><td style="width:7.510%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.555%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:64.156%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:24.279%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Exhibits </span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Description</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline">Incorporation by Reference</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit311q12021.htm">Certification of Principal Executive Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit312q12021.htm">Certification of Principal Financial Officer pursuant to Securities Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">32.1*</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit321q12021.htm">Certification of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.</a></span></div></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.INS</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Instance Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.SCH</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Schema Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.CAL</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Calculation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.DEF</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Definition Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.LAB</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Label Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">101.PRE</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Inline XBRL Taxonomy Extension Presentation Linkbase Document</span></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)</span></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%">* The certifications filed as Exhibits 32.1 are not deemed &#8220;filed&#8221; for purposes of Section 18 of the Securities Exchange Act of 1934 and are not to be incorporated by reference into any filing of the Company under the Securities Exchange Act of 1933 or the Securities Exchange Act of 1934, whether made before or after the date hereof irrespective of any general incorporation by reference language contained in any such filing, except to the extent that the registrant specifically incorporates it by reference</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">.</span></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="-sec-extract:summary;margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">87</span></div></div></div><div id="i1ffd384b299d487fa5b14f13003c56d4_145"></div><hr style="page-break-after:always"/><div style="min-height:54pt;width:100%"><div style="margin-bottom:6pt"><span style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline"><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">Table of Content</a><a style="color:#0000ff;font-family:'Arial',sans-serif;font-size:9pt;font-weight:400;line-height:120%;text-decoration:underline" href="#i1ffd384b299d487fa5b14f13003c56d4_7">s</a></span></div></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:6pt;text-align:center"><span><br/></span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.786%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.114%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:6.638%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:35.062%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-top:10pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ESTABLISHMENT LABS HOLDINGS INC.</span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;/s/ Juan Jos&#233; Chac&#243;n Quir&#243;s</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juan Jos&#233; Chac&#243;n Quir&#243;s</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Executive Officer and Director</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Executive Officer)</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#160;/s/ Renee M. Gaeta</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renee M. Gaeta</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Principal Financial Officer and Chief Accounting Officer)</span></td></tr></table></div><div style="height:54pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">88</span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.1
<SEQUENCE>2
<FILENAME>exhibit311q12021.htm
<DESCRIPTION>EX-31.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="i09faae9aae9c4b8d9d763e86bf762e1e_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exhibit&#160;31.1</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">I, Juan Jose Chacon Quiros, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Establishment Labs Holdings Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.983%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.407%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Juan Jos&#233; Chac&#243;n Quir&#243;s</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Juan Jos&#233; Chac&#243;n Quir&#243;s</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Chief Executive Officer and Director</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">(Principal Executive Officer)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31.2
<SEQUENCE>3
<FILENAME>exhibit312q12021.htm
<DESCRIPTION>EX-31.2
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="ieae77bd002064c4fb74562ef9f57d5b6_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">Exhibit&#160;31.2</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:700;line-height:120%">PURSUANT TO SECTION&#160;302 OF THE SARBANES-OXLEY ACT OF 2002</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">I, Renee M. Gaeta, certify that&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;I have reviewed this quarterly report on Form&#160;10-Q of Establishment Labs Holdings Inc.&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules&#160;13a-15(e)&#160;and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13(a)-15(f) and 15d-15(f)) for the registrant and have&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared&#59;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles&#59;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">c.&#160;&#160;&#160;&#160;Evaluated the effectiveness of the registrant&#8217;s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">d.&#160;&#160;&#160;&#160;Disclosed in this report any change in the registrant&#8217;s internal control over financial reporting that occurred during the registrant&#8217;s most recent fiscal quarter (the registrant&#8217;s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant&#8217;s internal control over financial reporting&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;The registrant&#8217;s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant&#8217;s auditors and the audit committee of the registrant&#8217;s board of directors (or persons performing the equivalent functions)&#58;</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">a.&#160;&#160;&#160;&#160;All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant&#8217;s ability to record, process, summarize and report financial information&#59; and</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:justify;text-indent:22.5pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">b.&#160;&#160;&#160;&#160;Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant&#8217;s internal control over financial reporting.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:5.951%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:50.662%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.087%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Date&#58;</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Renee M. Gaeta</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:100%">Renee M. Gaeta</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">Chief Financial Officer</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:120%">(Principal Financial and Accounting Officer)</font></div></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32.1
<SEQUENCE>4
<FILENAME>exhibit321q12021.htm
<DESCRIPTION>EX-32.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2021 Workiva -->
<title>Document</title></head><body><div id="iee2c8a318998407d9f40776f3498f952_1"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Exhibit&#160;32.1</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PURSUANT TO 18 U.S.C. SECTION&#160;1350,</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">AS ADOPTED PURSUANT TO</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECTION&#160;906 OF THE SARBANES&#8209;OXLEY ACT OF&#160;2002</font></div><div style="text-align:center"><font><br></font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirement set forth in Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. &#167;1350),</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-weight:400;line-height:120%">Juan Jose Chacon Quiros</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as Chief Executive Officer, and Renee M. Gaeta, as Chief Financial Officer, of Establishment Labs Holdings Inc. (the &#8220;Company&#8221;), hereby certifies that to the best of his and her knowledge&#58;</font></div><div style="margin-bottom:10pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The Company&#8217;s Quarterly Report on Form&#160;10&#8209;Q for the period ended March&#160;31, 2021, to which this Certification is attached as Exhibit 32.1 (the &#8220;Report&#8221;), fully complies with the requirements of Section&#160;13(a) or 15(d) of the Exchange Act&#59; and</font></div><div style="margin-bottom:13pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:24.34pt">The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.</font></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:6.432%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:49.541%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:40.727%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Juan Jos&#233; Chac&#243;n Quir&#243;s</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Juan Jos&#233; Chac&#243;n Quir&#243;s</font></div><div style="margin-bottom:1pt"><font><br></font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Chief Executive Officer and Director</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(Principal Executive Officer)</font></td></tr><tr style="height:14pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:9pt;text-indent:-6.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date&#58;</font></div></td><td colspan="3" style="padding:2px 1pt 2px 10pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">May 6, 2021</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Renee M. Gaeta</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="margin-bottom:1pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Renee M. Gaeta</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">Chief Financial Officer</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9.5pt;font-style:italic;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</font></td></tr></table></div><div style="margin-top:18pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This certification accompanies the Form&#160;10-Q to which it relates, is not deemed filed with the Securities and Exchange Commission and is not to be incorporated by reference into any filing of Establishment Labs Holdings Inc. under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended (whether made before or after the date of the Form&#160;10-Q), irrespective of any general incorporation language contained in such filing. </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#160;</font></div><div style="margin-bottom:8pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>esta-20210331.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:esta="http://establishmentlabs.com/20210331" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://establishmentlabs.com/20210331">
  <xs:import namespace="http://fasb.org/srt/2020-01-31" schemaLocation="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd"/>
  <xs:import namespace="http://fasb.org/us-gaap/2020-01-31" schemaLocation="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd"/>
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd"/>
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/country/2020-01-31" schemaLocation="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2020-01-31" schemaLocation="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esta-20210331_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esta-20210331_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esta-20210331_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="esta-20210331_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://establishmentlabs.com/role/Cover">
        <link:definition>0001001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedBalanceSheets" roleURI="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets">
        <link:definition>1001002 - Statement - Condensed Consolidated Balance Sheets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ConsolidatedBalanceSheetsParenthetical" roleURI="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical">
        <link:definition>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofOperations" roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations">
        <link:definition>1003004 - Statement - Condensed Consolidated Statements of Operations</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofComprehensiveIncomeLoss" roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss">
        <link:definition>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementofShareholdersEquity" roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity">
        <link:definition>1005006 - Statement - Condensed Consolidated Statement of Shareholders&#8217; Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CondensedConsolidatedStatementsofCashFlows" roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows">
        <link:definition>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FormationandBusinessoftheCompany" roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompany">
        <link:definition>2101101 - Disclosure - Formation and Business of the Company</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FormationandBusinessoftheCompanyDetails" roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails">
        <link:definition>2402401 - Disclosure - Formation and Business of the Company (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPolicies" roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies">
        <link:definition>2103102 - Disclosure - Summary of Significant Accounting Policies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesPolicies" roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies">
        <link:definition>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesTables" roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables">
        <link:definition>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesNarrativeDetails" roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails">
        <link:definition>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails">
        <link:definition>2407403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccounts" roleURI="http://establishmentlabs.com/role/BalanceSheetAccounts">
        <link:definition>2108103 - Disclosure - Balance Sheet Accounts</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsTables" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsTables">
        <link:definition>2309302 - Disclosure - Balance Sheet Accounts (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsInventoryDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails">
        <link:definition>2410404 - Disclosure - Balance Sheet Accounts - Inventory (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsPropertyandEquipmentDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails">
        <link:definition>2411405 - Disclosure - Balance Sheet Accounts - Property and Equipment (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsNarrativeDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails">
        <link:definition>2412406 - Disclosure - Balance Sheet Accounts - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsAccruedLiabilitiesDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails">
        <link:definition>2413407 - Disclosure - Balance Sheet Accounts - Accrued Liabilities (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsOtherLiabilitiesShortTermDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails">
        <link:definition>2414408 - Disclosure - Balance Sheet Accounts - Other Liabilities, Short-Term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="BalanceSheetAccountsOtherLiabilitiesLongTermDetails" roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails">
        <link:definition>2415409 - Disclosure - Balance Sheet Accounts - Other Liabilities, Long-Term (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssets" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets">
        <link:definition>2116104 - Disclosure - Goodwill and Other Intangible Assets</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsTables" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables">
        <link:definition>2317303 - Disclosure - Goodwill and Other Intangible Assets (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsGoodwillDetails" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails">
        <link:definition>2418410 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
        <link:definition>2419411 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsNarrativeDetails" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails">
        <link:definition>2420412 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails">
        <link:definition>2421413 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurements" roleURI="http://establishmentlabs.com/role/FairValueMeasurements">
        <link:definition>2122105 - Disclosure - Fair Value Measurements</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsTables" roleURI="http://establishmentlabs.com/role/FairValueMeasurementsTables">
        <link:definition>2323304 - Disclosure - Fair Value Measurements (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsFVonaRecurringBasisDetails" roleURI="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails">
        <link:definition>2424414 - Disclosure - Fair Value Measurements - FV on a Recurring Basis (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsNarrativeDetails" roleURI="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails">
        <link:definition>2425415 - Disclosure - Fair Value Measurements - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsDerivativesDetails" roleURI="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails">
        <link:definition>2426416 - Disclosure - Fair Value Measurements - Derivatives (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="FairValueMeasurementsLevel3FinancialInstrumentsDetails" roleURI="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails">
        <link:definition>2427417 - Disclosure - Fair Value Measurements - Level 3 Financial Instruments (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Debt" roleURI="http://establishmentlabs.com/role/Debt">
        <link:definition>2128106 - Disclosure - Debt</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtTables" roleURI="http://establishmentlabs.com/role/DebtTables">
        <link:definition>2329305 - Disclosure - Debt (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtNarrativeDetails" roleURI="http://establishmentlabs.com/role/DebtNarrativeDetails">
        <link:definition>2430418 - Disclosure - Debt - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="DebtScheduleofMadrynDebtDetails" roleURI="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails">
        <link:definition>2431419 - Disclosure - Debt - Schedule of Madryn Debt (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Leases" roleURI="http://establishmentlabs.com/role/Leases">
        <link:definition>2132107 - Disclosure - Leases</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesTables" roleURI="http://establishmentlabs.com/role/LeasesTables">
        <link:definition>2333306 - Disclosure - Leases (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesNarrativeDetails" roleURI="http://establishmentlabs.com/role/LeasesNarrativeDetails">
        <link:definition>2434420 - Disclosure - Leases - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseCostDetails" roleURI="http://establishmentlabs.com/role/LeasesLeaseCostDetails">
        <link:definition>2435421 - Disclosure - Leases - Lease Cost (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalBalanceSheetInformationDetails" roleURI="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails">
        <link:definition>2436422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesSupplementalCashFlowsDetails" roleURI="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails">
        <link:definition>2437423 - Disclosure - Leases - Supplemental Cash Flows (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturityDetails" roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails">
        <link:definition>2438424 - Disclosure - Leases - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="LeasesLeaseMaturityDetails_1" roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1">
        <link:definition>2438424 - Disclosure - Leases - Lease Maturity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquity" roleURI="http://establishmentlabs.com/role/ShareholdersEquity">
        <link:definition>2139108 - Disclosure - Shareholders' Equity</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityTables" roleURI="http://establishmentlabs.com/role/ShareholdersEquityTables">
        <link:definition>2340307 - Disclosure - Shareholders' Equity (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityNarrativeDetails" roleURI="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails">
        <link:definition>2441425 - Disclosure - Shareholders' Equity - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="ShareholdersEquityReservedOrdinarySharesDetails" roleURI="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails">
        <link:definition>2442426 - Disclosure - Shareholders' Equity - Reserved Ordinary Shares (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="Warrants" roleURI="http://establishmentlabs.com/role/Warrants">
        <link:definition>2143109 - Disclosure - Warrants</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsTables" roleURI="http://establishmentlabs.com/role/WarrantsTables">
        <link:definition>2344308 - Disclosure - Warrants (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsNarrativeDetails" roleURI="http://establishmentlabs.com/role/WarrantsNarrativeDetails">
        <link:definition>2445427 - Disclosure - Warrants - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="WarrantsWarrantDetails" roleURI="http://establishmentlabs.com/role/WarrantsWarrantDetails">
        <link:definition>2446428 - Disclosure - Warrants - Warrant (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensation" roleURI="http://establishmentlabs.com/role/SharebasedCompensation">
        <link:definition>2147110 - Disclosure - Share-based Compensation</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationTables" roleURI="http://establishmentlabs.com/role/SharebasedCompensationTables">
        <link:definition>2348309 - Disclosure - Share-based Compensation (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationNarrativeDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails">
        <link:definition>2449429 - Disclosure - Share-based Compensation - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockOptionsandRestrictedStockDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails">
        <link:definition>2450430 - Disclosure - Share-based Compensation - Stock Options and Restricted Stock (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockOptionsDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails">
        <link:definition>2451431 - Disclosure - Share-based Compensation - Stock Options (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockOptionGrantedtoEmployeesDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails">
        <link:definition>2452432 - Disclosure - Share-based Compensation - Stock Option Granted to Employees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails">
        <link:definition>2453433 - Disclosure - Share-based Compensation - Stock Options Granted to Non-employees (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="SharebasedCompensationRestrictedStockActivityDetails" roleURI="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails">
        <link:definition>2454434 - Disclosure - Share-based Compensation - Restricted Stock Activity (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShare" roleURI="http://establishmentlabs.com/role/NetLossPerShare">
        <link:definition>2155111 - Disclosure - Net Loss Per Share</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareTables" roleURI="http://establishmentlabs.com/role/NetLossPerShareTables">
        <link:definition>2356310 - Disclosure - Net Loss Per Share (Tables)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareBasicandDilutedDetails" roleURI="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails">
        <link:definition>2457435 - Disclosure - Net Loss Per Share - Basic and Diluted (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" roleURI="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails">
        <link:definition>2458436 - Disclosure - Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactions" roleURI="http://establishmentlabs.com/role/RelatedPartyTransactions">
        <link:definition>2159112 - Disclosure - Related Party Transactions</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="RelatedPartyTransactionsNarrativeDetails" roleURI="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails">
        <link:definition>2460437 - Disclosure - Related Party Transactions - Narrative (Details)</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:roleType id="CommitmentsandContingencies" roleURI="http://establishmentlabs.com/role/CommitmentsandContingencies">
        <link:definition>2161113 - Disclosure - Commitments and Contingencies</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" abstract="false" name="FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermB2Member" abstract="true" name="MadrynCreditAgreementTermB2Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_CashPayableForAssetAcquisitionCurrent" abstract="false" name="CashPayableForAssetAcquisitionCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_SummaryOfSignificantAccountingPoliciesLineItems" abstract="true" name="SummaryOfSignificantAccountingPoliciesLineItems" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_DepreciationandAmortizationExcludingDebtDiscountPremium" abstract="false" name="DepreciationandAmortizationExcludingDebtDiscountPremium" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" abstract="true" name="RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_AssetsAndLiabilitiesLesseeTableTextBlock" abstract="false" name="AssetsAndLiabilitiesLesseeTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="esta_CustomerOneMember" abstract="true" name="CustomerOneMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_NumberOfManufacturingFacilities" abstract="false" name="NumberOfManufacturingFacilities" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:integerItemType"/>
  <xs:element id="esta_RevenueFromContractWithCustomerProductShelfLife" abstract="false" name="RevenueFromContractWithCustomerProductShelfLife" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="esta_LongLivedAssetsMember" abstract="true" name="LongLivedAssetsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_InventoryRawMaterialsPurchasesMember" abstract="true" name="InventoryRawMaterialsPurchasesMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_AmendedMadrynCreditAgreementMember" abstract="true" name="AmendedMadrynCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_NuSilTechnologyLLCMember" abstract="true" name="NuSilTechnologyLLCMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" abstract="false" name="AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_PatentsAndLicensingAgreementsMember" abstract="true" name="PatentsAndLicensingAgreementsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" abstract="false" name="NoncashConsiderationPayableRelatedtoAssetAcquisition" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_OtherGeographicalAreasMember" abstract="true" name="OtherGeographicalAreasMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_RelatedPartyTransactionCashReimbursementPerDayForServices" abstract="false" name="RelatedPartyTransactionCashReimbursementPerDayForServices" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermB1Member" abstract="true" name="MadrynCreditAgreementTermB1Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_GeographicConcentrationsPolicyPolicyTextBlock" abstract="false" name="GeographicConcentrationsPolicyPolicyTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermB3AndB4Member" abstract="true" name="MadrynCreditAgreementTermB3AndB4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" abstract="false" name="CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="esta_DepreciationAndAmortizationPropertyPlantAndEquipment" abstract="false" name="DepreciationAndAmortizationPropertyPlantAndEquipment" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_AccruedStockOptionGrantBonusCurrent" abstract="false" name="AccruedStockOptionGrantBonusCurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_RevenueFromContractWithCustomerProductReturnPeriod" abstract="false" name="RevenueFromContractWithCustomerProductReturnPeriod" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="esta_A510kAuthorizationMember" abstract="true" name="A510kAuthorizationMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_ConsultantMember" abstract="true" name="ConsultantMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_EmployeeAndNonemployeeStockOptionMember" abstract="true" name="EmployeeAndNonemployeeStockOptionMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_WeightedAverageRemainingLeaseTermAbstract" abstract="true" name="WeightedAverageRemainingLeaseTermAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_DebtInstrumentDefaultInterestRateIncrease" abstract="false" name="DebtInstrumentDefaultInterestRateIncrease" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="num:percentItemType"/>
  <xs:element id="esta_MeasurementInputProbabilityOfChangeInControlMember" abstract="true" name="MeasurementInputProbabilityOfChangeInControlMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_IncreaseDecreaseInOperatingLeaseLiabilities" abstract="false" name="IncreaseDecreaseInOperatingLeaseLiabilities" nillable="true" xbrli:periodType="duration" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_LeasesWeightedAverageDiscountRateAbstract" abstract="true" name="LeasesWeightedAverageDiscountRateAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_MeasurementInputInterestRateVolatilityMember" abstract="true" name="MeasurementInputInterestRateVolatilityMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_IncreaseInCommonStockSharesAuthorized" abstract="false" name="IncreaseInCommonStockSharesAuthorized" nillable="true" xbrli:periodType="instant" substitutionGroup="xbrli:item" type="xbrli:sharesItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermB4Member" abstract="true" name="MadrynCreditAgreementTermB4Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_LineOfCreditFacilityAdditionalBorrowingCapacity" abstract="false" name="LineOfCreditFacilityAdditionalBorrowingCapacity" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_EquityIncentivePlan2018Member" abstract="true" name="EquityIncentivePlan2018Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_AsiaPacificAndMiddleEastMember" abstract="true" name="AsiaPacificAndMiddleEastMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_MadrynCreditAgreementMember" abstract="true" name="MadrynCreditAgreementMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_CashPayableForAssetAcquisitionNoncurrent" abstract="false" name="CashPayableForAssetAcquisitionNoncurrent" nillable="true" xbrli:periodType="instant" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" abstract="false" name="EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:durationItemType"/>
  <xs:element id="esta_CashFlowLesseeAbstract" abstract="true" name="CashFlowLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermAMember" abstract="true" name="MadrynCreditAgreementTermAMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" abstract="false" name="PaymentstoAcquireAssetsIncludingReceivablesHeld" nillable="true" xbrli:periodType="duration" xbrli:balance="credit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_MeasurementInputMarketYieldRateMember" abstract="true" name="MeasurementInputMarketYieldRateMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" abstract="true" name="FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="xbrli:stringItemType"/>
  <xs:element id="esta_MadrynCreditAgreementTermB3Member" abstract="true" name="MadrynCreditAgreementTermB3Member" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
  <xs:element id="esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" abstract="false" name="NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" nillable="true" xbrli:periodType="instant" xbrli:balance="debit" substitutionGroup="xbrli:item" type="xbrli:monetaryItemType"/>
  <xs:element id="esta_SummaryOfSignificantAccountingPoliciesTable" abstract="true" name="SummaryOfSignificantAccountingPoliciesTable" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrldt:hypercubeItem" type="xbrli:stringItemType"/>
  <xs:element id="esta_ScheduleOfConsolidatedEntitiesTableTextBlock" abstract="false" name="ScheduleOfConsolidatedEntitiesTableTextBlock" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:textBlockItemType"/>
  <xs:element id="esta_RockportWarrantsMember" abstract="true" name="RockportWarrantsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="nonnum:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>6
<FILENAME>esta-20210331_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://establishmentlabs.com/role/Cover" xlink:type="simple" xlink:href="esta-20210331.xsd#Cover"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/Cover" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_92c7ea17-cc07-4db3-9bdc-028acedeed04" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:to="loc_us-gaap_CommonStockValue_92c7ea17-cc07-4db3-9bdc-028acedeed04" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_dd9f38e1-16d4-4f9a-a2d5-9200a7437e73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:to="loc_us-gaap_AdditionalPaidInCapital_dd9f38e1-16d4-4f9a-a2d5-9200a7437e73" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_9e4d1207-a21f-4b83-b5cc-ea4904c72ec3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:to="loc_us-gaap_TreasuryStockValue_9e4d1207-a21f-4b83-b5cc-ea4904c72ec3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d98eaf0d-9425-45f1-8803-cb49716d7408" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_d98eaf0d-9425-45f1-8803-cb49716d7408" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_49aec80d-5cdc-42c5-aa5a-b3883d2de303" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_StockholdersEquity_a3a3389e-e639-4e48-89b7-034f7dbfe78f" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_49aec80d-5cdc-42c5-aa5a-b3883d2de303" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_ed6a8ca3-c88b-4a0a-a3c6-39227ba17fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_c76a6e09-5705-42ae-9aa2-8f823e8a58dd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ed6a8ca3-c88b-4a0a-a3c6-39227ba17fdd" xlink:to="loc_us-gaap_Cash_c76a6e09-5705-42ae-9aa2-8f823e8a58dd" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_e1658e6d-d5b2-4c68-bdec-9db7bfcbf82a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ed6a8ca3-c88b-4a0a-a3c6-39227ba17fdd" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_e1658e6d-d5b2-4c68-bdec-9db7bfcbf82a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_90a37fb9-aa26-4701-9abc-a3f23b38b794" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ed6a8ca3-c88b-4a0a-a3c6-39227ba17fdd" xlink:to="loc_us-gaap_InventoryNet_90a37fb9-aa26-4701-9abc-a3f23b38b794" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_75ee084a-b6ad-4e5e-b586-df27b0c37512" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AssetsCurrent_ed6a8ca3-c88b-4a0a-a3c6-39227ba17fdd" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_75ee084a-b6ad-4e5e-b586-df27b0c37512" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_b6500211-b825-4f70-81a6-0265ed1d4484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_1c082849-536a-4781-bf67-6043f35a400f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b6500211-b825-4f70-81a6-0265ed1d4484" xlink:to="loc_us-gaap_Liabilities_1c082849-536a-4781-bf67-6043f35a400f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_14c4ad91-ce52-44c2-ad82-056b71490345" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b6500211-b825-4f70-81a6-0265ed1d4484" xlink:to="loc_us-gaap_CommitmentsAndContingencies_14c4ad91-ce52-44c2-ad82-056b71490345" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_b1f08ab8-4d0c-4f22-bd0c-29e167bae3ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity_b6500211-b825-4f70-81a6-0265ed1d4484" xlink:to="loc_us-gaap_StockholdersEquity_b1f08ab8-4d0c-4f22-bd0c-29e167bae3ad" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d0b5e2e7-8a6a-4366-8e06-8e11278812dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:to="loc_us-gaap_LiabilitiesCurrent_d0b5e2e7-8a6a-4366-8e06-8e11278812dc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_35ecdcf8-e807-461a-8bea-b76aee856bbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_35ecdcf8-e807-461a-8bea-b76aee856bbb" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_abc82fe3-9a75-41f8-8260-2263da1b0600" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_abc82fe3-9a75-41f8-8260-2263da1b0600" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e47eb568-bbbe-42e3-96bd-86cbb89e6d9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_e47eb568-bbbe-42e3-96bd-86cbb89e6d9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_2314340f-6b28-49c2-a927-a8ca394194ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Liabilities_b3c27220-3dfa-49db-a60e-e76d8a0efe0f" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_2314340f-6b28-49c2-a927-a8ca394194ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_b98549cd-f325-48ac-a338-8489e81e42ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_068b438f-5d5c-4a7c-8820-0796ea3edc2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b98549cd-f325-48ac-a338-8489e81e42ca" xlink:to="loc_us-gaap_AccountsPayableCurrent_068b438f-5d5c-4a7c-8820-0796ea3edc2c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_00f94a18-54d8-43bd-b80b-f31427b119b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b98549cd-f325-48ac-a338-8489e81e42ca" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_00f94a18-54d8-43bd-b80b-f31427b119b6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_6290cce7-b956-41a8-add4-af85fae140f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LiabilitiesCurrent_b98549cd-f325-48ac-a338-8489e81e42ca" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_6290cce7-b956-41a8-add4-af85fae140f3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_33c497b7-7198-459e-86ae-e533b6ca7c99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_AssetsCurrent_33c497b7-7198-459e-86ae-e533b6ca7c99" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_9988d3f6-db95-478f-ba63-b2205be32d5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_9988d3f6-db95-478f-ba63-b2205be32d5b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_2519972b-689c-479e-aaa5-c32881a3b727" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_Goodwill_2519972b-689c-479e-aaa5-c32881a3b727" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd755ad0-f37f-48f8-a438-b1d985011eee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_dd755ad0-f37f-48f8-a438-b1d985011eee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_c47db478-8e4e-4c6b-bece-27cd09da9292" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_c47db478-8e4e-4c6b-bece-27cd09da9292" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_8e1b460f-51f6-403b-9b26-429c44835cf6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_Assets_035b0e98-aa47-4e4e-ac9c-af8430bfe4dc" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_8e1b460f-51f6-403b-9b26-429c44835cf6" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="esta-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_85590ecc-4fd8-4ab1-adba-fddb53c35fbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f184b36-815c-4d1b-9b03-4739f9aab96b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_85590ecc-4fd8-4ab1-adba-fddb53c35fbe" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_7f184b36-815c-4d1b-9b03-4739f9aab96b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_bafa1408-5816-49e8-990e-4158fbe7c615" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingExpenses_85590ecc-4fd8-4ab1-adba-fddb53c35fbe" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_bafa1408-5816-49e8-990e-4158fbe7c615" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_fed82a69-10a1-4d01-9db8-4ec5b231eb81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9a584c0e-7671-44b1-b90b-6ca88f7538df" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fed82a69-10a1-4d01-9db8-4ec5b231eb81" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_9a584c0e-7671-44b1-b90b-6ca88f7538df" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_fb842cb1-f541-44e1-8d21-1b72db429934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetIncomeLoss_fed82a69-10a1-4d01-9db8-4ec5b231eb81" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_fb842cb1-f541-44e1-8d21-1b72db429934" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_63996661-df61-4541-80ee-b6f650b37064" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_OperatingIncomeLoss_63996661-df61-4541-80ee-b6f650b37064" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_86c40fa7-8bcc-455b-a53d-169640088951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_InvestmentIncomeInterest_86c40fa7-8bcc-455b-a53d-169640088951" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_b1bb0329-a7e3-4be4-9b56-f5cbfb92b9c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_InterestExpense_b1bb0329-a7e3-4be4-9b56-f5cbfb92b9c8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_09452c4b-1139-4562-b3c6-d77a84b10c94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_09452c4b-1139-4562-b3c6-d77a84b10c94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_030529d7-98d1-4cf5-a5af-3edfd631e30b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="5" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_030529d7-98d1-4cf5-a5af-3edfd631e30b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_04a3c915-6134-452d-b6fd-734261e22099" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_6cdcd1ae-1282-4603-80e7-a09b490c67fe" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_04a3c915-6134-452d-b6fd-734261e22099" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_04aebd3f-0d34-4b07-8b0e-d0a29ca3df7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e8047eb-e492-4c97-8b00-53345f567394" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_04aebd3f-0d34-4b07-8b0e-d0a29ca3df7c" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_5e8047eb-e492-4c97-8b00-53345f567394" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_f6bcf115-bdf1-4094-a4d8-768ad6c831db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_GrossProfit_04aebd3f-0d34-4b07-8b0e-d0a29ca3df7c" xlink:to="loc_us-gaap_CostOfRevenue_f6bcf115-bdf1-4094-a4d8-768ad6c831db" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_f7e3f2d4-47b0-4bdb-ac8c-5eb819e0ec37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_c600dc36-369e-4791-991d-a3356999b658" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f7e3f2d4-47b0-4bdb-ac8c-5eb819e0ec37" xlink:to="loc_us-gaap_GrossProfit_c600dc36-369e-4791-991d-a3356999b658" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_c58ddda9-e1d8-467d-810f-84beffcfc1a4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingIncomeLoss_f7e3f2d4-47b0-4bdb-ac8c-5eb819e0ec37" xlink:to="loc_us-gaap_OperatingExpenses_c58ddda9-e1d8-467d-810f-84beffcfc1a4" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fb29a46-99e5-4ba6-b25f-0b56c185d3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1313912a-bb95-41b2-8e47-ff9865dfb4fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1fb29a46-99e5-4ba6-b25f-0b56c185d3db" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1313912a-bb95-41b2-8e47-ff9865dfb4fa" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_a63b66c1-4712-435f-af85-a7dacc19fc2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_877b301e-2cb0-4b01-8a0b-b0eed21e1e1c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a63b66c1-4712-435f-af85-a7dacc19fc2d" xlink:to="loc_us-gaap_NetIncomeLoss_877b301e-2cb0-4b01-8a0b-b0eed21e1e1c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05787066-423f-4bec-a5e4-4cd09cc1d142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax_a63b66c1-4712-435f-af85-a7dacc19fc2d" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_05787066-423f-4bec-a5e4-4cd09cc1d142" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementofShareholdersEquity"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_97acbc74-0d74-45b4-bb2b-c65050fe9c47" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_NetIncomeLoss_97acbc74-0d74-45b4-bb2b-c65050fe9c47" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_a4f7f3fe-5973-4134-b22d-31dce3189a7c" xlink:href="esta-20210331.xsd#esta_DepreciationandAmortizationExcludingDebtDiscountPremium"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_a4f7f3fe-5973-4134-b22d-31dce3189a7c" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_8cb0f496-6625-48ff-8b13-2123cb783519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_8cb0f496-6625-48ff-8b13-2123cb783519" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_d7cc5c3f-6363-4d48-aad4-d2ba25aa8463" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_InventoryWriteDown_d7cc5c3f-6363-4d48-aad4-d2ba25aa8463" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_f0c42ca6-1c89-4dfa-81af-4ef6116e6cf8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_ShareBasedCompensation_f0c42ca6-1c89-4dfa-81af-4ef6116e6cf8" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d6947c70-56c7-4647-bd13-a5c81d69c01a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:calculationArc order="6" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_d6947c70-56c7-4647-bd13-a5c81d69c01a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8580df8b-d4b9-4331-8fe6-ca84ae9c22fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:calculationArc order="7" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_8580df8b-d4b9-4331-8fe6-ca84ae9c22fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6b59c94d-06e7-48dc-8f7d-3dc9a3046c8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_6b59c94d-06e7-48dc-8f7d-3dc9a3046c8f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_6957fc25-5d81-4164-bfb4-c8566214aa1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:calculationArc order="9" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_6957fc25-5d81-4164-bfb4-c8566214aa1d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07f1884a-9cb5-4f24-b689-9c498d9b633d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_07f1884a-9cb5-4f24-b689-9c498d9b633d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fc531bf6-8424-4241-8699-b6a04dccd2e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:calculationArc order="11" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_fc531bf6-8424-4241-8699-b6a04dccd2e9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b9c4100f-aee1-46fb-9025-b50c0c0dd287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:calculationArc order="12" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_b9c4100f-aee1-46fb-9025-b50c0c0dd287" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_9832a9b0-f94f-4354-a566-481f674767f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:calculationArc order="13" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_9832a9b0-f94f-4354-a566-481f674767f5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5f4fe49c-b7c7-4b3a-8849-0d603d6470f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:calculationArc order="14" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_5f4fe49c-b7c7-4b3a-8849-0d603d6470f4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e6a0429a-42f2-45af-ad57-c67f17cb2e7f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:calculationArc order="15" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_e6a0429a-42f2-45af-ad57-c67f17cb2e7f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_185d8b0c-9be8-4153-bacf-fcaefdf0ca51" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:calculationArc order="16" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_185d8b0c-9be8-4153-bacf-fcaefdf0ca51" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9496edc8-a54f-4fc9-bb79-163d7ed5d57e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:calculationArc order="17" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_9496edc8-a54f-4fc9-bb79-163d7ed5d57e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities_8a5b349b-0cd7-4404-bfdb-4ec3cb898b84" xlink:href="esta-20210331.xsd#esta_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:calculationArc order="18" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities_8a5b349b-0cd7-4404-bfdb-4ec3cb898b84" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fedd79b5-e040-420e-95a9-044640ca7b9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:calculationArc order="19" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_5fc53542-5b82-4904-8a7e-535c42ccd772" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_fedd79b5-e040-420e-95a9-044640ca7b9f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdbe96b6-e67e-4260-ae1f-3f00f2271016" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_e41979f7-cf89-4de1-b81e-4c9bbd5ffcf4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdbe96b6-e67e-4260-ae1f-3f00f2271016" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_e41979f7-cf89-4de1-b81e-4c9bbd5ffcf4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d9eddb53-5b53-47f2-bb33-3e75a8ec706e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdbe96b6-e67e-4260-ae1f-3f00f2271016" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_d9eddb53-5b53-47f2-bb33-3e75a8ec706e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_7d2b181d-3742-4653-bd0b-5131835748da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdbe96b6-e67e-4260-ae1f-3f00f2271016" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_7d2b181d-3742-4653-bd0b-5131835748da" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bc999916-50ad-48c7-981f-ca1820ea948b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:calculationArc order="4" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_cdbe96b6-e67e-4260-ae1f-3f00f2271016" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_bc999916-50ad-48c7-981f-ca1820ea948b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_448ff659-6fe5-4a7a-81eb-1dc29d323cc7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ad98207a-9e34-46ee-a68f-4322029208c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:calculationArc order="1" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_448ff659-6fe5-4a7a-81eb-1dc29d323cc7" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_ad98207a-9e34-46ee-a68f-4322029208c4" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_82b6d23a-2692-4382-bb9c-77d618cb8f16" xlink:href="esta-20210331.xsd#esta_PaymentstoAcquireAssetsIncludingReceivablesHeld"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_448ff659-6fe5-4a7a-81eb-1dc29d323cc7" xlink:to="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_82b6d23a-2692-4382-bb9c-77d618cb8f16" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3d83dbdb-02f7-4a4d-b6ba-4344c770479f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:calculationArc order="3" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_448ff659-6fe5-4a7a-81eb-1dc29d323cc7" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_3d83dbdb-02f7-4a4d-b6ba-4344c770479f" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8d79f2ba-4d51-4daa-8929-3c9619a235c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f5160499-8dd4-4a07-a5bb-242fabdc1a9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8d79f2ba-4d51-4daa-8929-3c9619a235c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_f5160499-8dd4-4a07-a5bb-242fabdc1a9e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5f26a536-4c6c-4dab-b2d0-d708b1d04013" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8d79f2ba-4d51-4daa-8929-3c9619a235c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_5f26a536-4c6c-4dab-b2d0-d708b1d04013" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_783715bc-58fe-44ac-b68d-2d75d7691188" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8d79f2ba-4d51-4daa-8929-3c9619a235c2" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_783715bc-58fe-44ac-b68d-2d75d7691188" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edce4a5a-c61c-4578-abda-d0ccd33a53b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_8d79f2ba-4d51-4daa-8929-3c9619a235c2" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_edce4a5a-c61c-4578-abda-d0ccd33a53b0" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompany"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccounts"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsInventoryDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_9abe1f9b-4a8b-45b9-b0ed-3f19aab3547b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7c1a64d4-d741-440e-8f27-135669a58fea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9abe1f9b-4a8b-45b9-b0ed-3f19aab3547b" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_7c1a64d4-d741-440e-8f27-135669a58fea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2c6c41b4-61f9-4e34-a99b-04981bc16ae0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9abe1f9b-4a8b-45b9-b0ed-3f19aab3547b" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_2c6c41b4-61f9-4e34-a99b-04981bc16ae0" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_af9ef8aa-a520-4e8e-a56d-0091f44c7752" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_InventoryNet_9abe1f9b-4a8b-45b9-b0ed-3f19aab3547b" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_af9ef8aa-a520-4e8e-a56d-0091f44c7752" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsPropertyandEquipmentDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d2f0b70d-5536-4f4b-8b66-4df89243ce53" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_c762a736-f2e9-40e4-9769-df03d58f53ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d2f0b70d-5536-4f4b-8b66-4df89243ce53" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_c762a736-f2e9-40e4-9769-df03d58f53ee" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_65ea5d7d-6d89-498a-9f95-d1d7df7d0240" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet_d2f0b70d-5536-4f4b-8b66-4df89243ce53" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_65ea5d7d-6d89-498a-9f95-d1d7df7d0240" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsAccruedLiabilitiesDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_bae808f8-0c16-467f-970c-76f1aa77b0a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_AccruedBonusesCurrent_bae808f8-0c16-467f-970c-76f1aa77b0a9" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_1ce0c665-eb28-4188-9164-0d621b4e090d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_AccruedSalariesCurrent_1ce0c665-eb28-4188-9164-0d621b4e090d" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AccruedStockOptionGrantBonusCurrent_ebcfe433-9439-41c5-8f9f-7fdd3a8079c5" xlink:href="esta-20210331.xsd#esta_AccruedStockOptionGrantBonusCurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_esta_AccruedStockOptionGrantBonusCurrent_ebcfe433-9439-41c5-8f9f-7fdd3a8079c5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_efde95f9-a83f-484b-8209-9f7426aa3701" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_efde95f9-a83f-484b-8209-9f7426aa3701" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_3e6fc3da-eea8-4761-bca7-682016c0c3cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_3e6fc3da-eea8-4761-bca7-682016c0c3cc" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_7053ab73-9547-4db5-906c-0d832f6b3907" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_7053ab73-9547-4db5-906c-0d832f6b3907" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_0d72aa32-b8ed-421c-b69c-fe554cf687c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="7" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_0d72aa32-b8ed-421c-b69c-fe554cf687c3" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_4d6bfb5d-44fd-4c41-92a5-976b29c5b70a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:calculationArc order="8" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_4d6bfb5d-44fd-4c41-92a5-976b29c5b70a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_143b3484-8fd9-437c-ab1f-50bb8f590fb5" xlink:href="esta-20210331.xsd#esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent"/>
    <link:calculationArc order="9" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_143b3484-8fd9-437c-ab1f-50bb8f590fb5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a3f5d3d3-6390-4b6e-b000-6e58cb2db3c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:calculationArc order="10" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent_312508f3-3a8a-4921-9941-fa0cce694e8f" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_a3f5d3d3-6390-4b6e-b000-6e58cb2db3c2" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesShortTermDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_7afbf4e6-ec8b-445b-9bc2-7b21400cc8c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2c14ef87-f7a8-4aa9-8c01-eb7b4217f543" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7afbf4e6-ec8b-445b-9bc2-7b21400cc8c8" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_2c14ef87-f7a8-4aa9-8c01-eb7b4217f543" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionCurrent_488ff332-f6b3-4e0c-ac48-ec8f1d9e3961" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionCurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent_7afbf4e6-ec8b-445b-9bc2-7b21400cc8c8" xlink:to="loc_esta_CashPayableForAssetAcquisitionCurrent_488ff332-f6b3-4e0c-ac48-ec8f1d9e3961" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesLongTermDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_02f4775a-5db8-4a16-80e6-037f0acc2c25" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a604a721-f0b5-4cfc-b8f0-587624bec44a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_02f4775a-5db8-4a16-80e6-037f0acc2c25" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_a604a721-f0b5-4cfc-b8f0-587624bec44a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionNoncurrent_32af5baa-1866-4f26-a761-538f985020a2" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_02f4775a-5db8-4a16-80e6-037f0acc2c25" xlink:to="loc_esta_CashPayableForAssetAcquisitionNoncurrent_32af5baa-1866-4f26-a761-538f985020a2" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_fff1e0a0-e9a3-4009-bbf8-9d860049d934" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent_02f4775a-5db8-4a16-80e6-037f0acc2c25" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_fff1e0a0-e9a3-4009-bbf8-9d860049d934" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b664d2cd-0924-4f4e-bb6e-46379489d344" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_73a9a7e7-f0b8-441d-bd99-aa8a3a154fc6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b664d2cd-0924-4f4e-bb6e-46379489d344" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_73a9a7e7-f0b8-441d-bd99-aa8a3a154fc6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1738d50-24c4-43e3-bbfa-257a6b8f1a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_b664d2cd-0924-4f4e-bb6e-46379489d344" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_c1738d50-24c4-43e3-bbfa-257a6b8f1a94" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_db832905-1c70-4f28-a55c-88a1495a86ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c5fd2108-1767-4f74-92f2-6f515ec39fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_db832905-1c70-4f28-a55c-88a1495a86ca" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_c5fd2108-1767-4f74-92f2-6f515ec39fdf" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322f0ffe-28cf-4b8a-ae04-e1fff217e0f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_db832905-1c70-4f28-a55c-88a1495a86ca" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_322f0ffe-28cf-4b8a-ae04-e1fff217e0f7" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_919094fc-4f98-470a-b5a3-25456480ebff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_919094fc-4f98-470a-b5a3-25456480ebff" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35a1d494-9aab-4e7d-ac64-3cfca7bbc2d7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_35a1d494-9aab-4e7d-ac64-3cfca7bbc2d7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8cbd4054-8734-43d3-b3ba-8cde74c1f765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_8cbd4054-8734-43d3-b3ba-8cde74c1f765" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_22513a59-0971-48aa-94b2-fc672e180c0b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_22513a59-0971-48aa-94b2-fc672e180c0b" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58e128e3-1907-44d2-87d9-d3f434ce85fe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_58e128e3-1907-44d2-87d9-d3f434ce85fe" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_795b9ef5-a071-417f-b428-9475c4aab98e" xlink:href="esta-20210331.xsd#esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet_7befc3b3-1bd5-4d5e-a1a5-67c1414cc7b1" xlink:to="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_795b9ef5-a071-417f-b428-9475c4aab98e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurements"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsFVonaRecurringBasisDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsDerivativesDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsLevel3FinancialInstrumentsDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Debt" xlink:type="simple" xlink:href="esta-20210331.xsd#Debt"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/Debt" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtTables" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/DebtTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtScheduleofMadrynDebtDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_0e3e1163-1627-406e-9eff-d418ba29b909" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_5f48cfee-97ee-4b51-beaf-b412aa18ab9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_0e3e1163-1627-406e-9eff-d418ba29b909" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_5f48cfee-97ee-4b51-beaf-b412aa18ab9a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_336092d0-bdbd-46ca-bd31-e1f479954e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:calculationArc order="2" weight="-1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LongTermDebt_0e3e1163-1627-406e-9eff-d418ba29b909" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_336092d0-bdbd-46ca-bd31-e1f479954e26" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Leases" xlink:type="simple" xlink:href="esta-20210331.xsd#Leases"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/Leases" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseCostDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_42371268-af19-4a84-bb57-842df2eb50e5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_a13c69c9-0895-42ee-bc4d-8867cc7925e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_42371268-af19-4a84-bb57-842df2eb50e5" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_a13c69c9-0895-42ee-bc4d-8867cc7925e7" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1721f993-1798-4d04-aa2e-57efe23c430e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LeaseCost_42371268-af19-4a84-bb57-842df2eb50e5" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_1721f993-1798-4d04-aa2e-57efe23c430e" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_9b3216f8-fbd3-427c-be05-7700e4c08dbb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_55f4f580-121b-4d10-8f6c-a616727d5bce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9b3216f8-fbd3-427c-be05-7700e4c08dbb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_55f4f580-121b-4d10-8f6c-a616727d5bce" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f6a830b7-4707-4398-a89f-d600d062a06a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_OperatingLeaseLiability_9b3216f8-fbd3-427c-be05-7700e4c08dbb" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_f6a830b7-4707-4398-a89f-d600d062a06a" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_c4c0d050-c1b5-43f1-ab87-767a1524b0fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_47196b1c-d7c7-4454-9de2-50dfb8a96936" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_c4c0d050-c1b5-43f1-ab87-767a1524b0fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_47196b1c-d7c7-4454-9de2-50dfb8a96936" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5a56caaf-2d59-48e2-865f-03ef2906f213" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiability_c4c0d050-c1b5-43f1-ab87-767a1524b0fa" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_5a56caaf-2d59-48e2-865f-03ef2906f213" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalCashFlowsDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseMaturityDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_59a1cd15-4826-4197-b795-a2e358993a50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_59a1cd15-4826-4197-b795-a2e358993a50" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_32e82b27-971e-4ae2-8103-7a0d89c626a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_32e82b27-971e-4ae2-8103-7a0d89c626a6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5167d471-2956-4068-89ec-18c49efa438e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_5167d471-2956-4068-89ec-18c49efa438e" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_01e28938-1266-4cfc-8b88-c364f3d5d404" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_01e28938-1266-4cfc-8b88-c364f3d5d404" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7274d2c3-2e30-4e33-8a53-c2650ecbcf46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_7274d2c3-2e30-4e33-8a53-c2650ecbcf46" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_264362a7-079f-4af9-9ad9-2fb62e23f2ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_688611e7-2ed5-4c29-8426-d362d06eb7ac" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_264362a7-079f-4af9-9ad9-2fb62e23f2ea" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3d848d9e-c1a5-4206-86e8-54f10c402662" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_3d848d9e-c1a5-4206-86e8-54f10c402662" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cfa2fed7-f5b0-4cbd-931d-e18b036a6ca5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_cfa2fed7-f5b0-4cbd-931d-e18b036a6ca5" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_951a2b58-5ed0-4959-b1a6-44a8a9e9a773" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:calculationArc order="3" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_951a2b58-5ed0-4959-b1a6-44a8a9e9a773" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_95d6a45f-e1f1-4d35-9d28-7d57893030c6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:calculationArc order="4" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_95d6a45f-e1f1-4d35-9d28-7d57893030c6" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_87f14561-84a3-4970-aa6e-ac4138f02767" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:calculationArc order="5" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_87f14561-84a3-4970-aa6e-ac4138f02767" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd95bf2d-b11e-4995-ae9a-75e3d0456534" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:calculationArc order="6" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_11e41333-59e3-4822-b174-ceebbb1173ed" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_bd95bf2d-b11e-4995-ae9a-75e3d0456534" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseMaturityDetails_1"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d07b5d2-579e-4986-9c84-e617a0790205" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_99d97ccc-5838-494c-9494-193d1c245c11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d07b5d2-579e-4986-9c84-e617a0790205" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_99d97ccc-5838-494c-9494-193d1c245c11" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_3ac78205-8b83-4c39-8ed9-4c8a511be922" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_3d07b5d2-579e-4986-9c84-e617a0790205" xlink:to="loc_us-gaap_OperatingLeaseLiability_3ac78205-8b83-4c39-8ed9-4c8a511be922" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_8cfb75ef-c50c-4967-8e49-1da07ae255e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f970a3b8-e403-48bd-8618-26b1e4f1bfca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:calculationArc order="1" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_8cfb75ef-c50c-4967-8e49-1da07ae255e2" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_f970a3b8-e403-48bd-8618-26b1e4f1bfca" xlink:type="arc"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_daf25367-e688-4529-8770-8bf784e8eb3b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:calculationArc order="2" weight="1.0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/summation-item" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_8cfb75ef-c50c-4967-8e49-1da07ae255e2" xlink:to="loc_us-gaap_FinanceLeaseLiability_daf25367-e688-4529-8770-8bf784e8eb3b" xlink:type="arc"/>
  </link:calculationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquity"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityReservedOrdinarySharesDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Warrants" xlink:type="simple" xlink:href="esta-20210331.xsd#Warrants"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/Warrants" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/WarrantsTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsWarrantDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensation"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsandRestrictedStockDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionGrantedtoEmployeesDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationRestrictedStockActivityDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShare"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareTables"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareBasicandDilutedDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactions"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="esta-20210331.xsd#CommitmentsandContingencies"/>
  <link:calculationLink xlink:role="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="extended"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>esta-20210331_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Cover" xlink:type="simple" xlink:href="esta-20210331.xsd#Cover"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/Cover" xlink:type="extended" id="id10a544801094e6fbec3c4136bac466f_Cover"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended" id="i5e6d0f6d89844417b148c0d138f91109_CondensedConsolidatedBalanceSheets"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="esta-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended" id="i9c488fb1eae7462c9e91062059008d8a_ConsolidatedBalanceSheetsParenthetical"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended" id="i681dca6c60c04f4297879efb9631b828_CondensedConsolidatedStatementsofOperations"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended" id="i37cdf5a49920416194c5b7db2f27dae6_CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementofShareholdersEquity"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="extended" id="ia2ca2dfe67354eb4945a6fc80f615b74_CondensedConsolidatedStatementofShareholdersEquity">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f761ccf2-75ee-47f2-b747-3701d2169809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_SharesIssued_f761ccf2-75ee-47f2-b747-3701d2169809" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0723e6c1-531b-48c3-ad3e-a2143342acd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockholdersEquity_0723e6c1-531b-48c3-ad3e-a2143342acd1" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1c12c7e0-e113-48e5-9292-b5dff51deb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1c12c7e0-e113-48e5-9292-b5dff51deb24" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d53c5b14-d5cb-4d85-baba-c141cc54f233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d53c5b14-d5cb-4d85-baba-c141cc54f233" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0b52b223-e732-4ed7-b375-50b14dceff66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0b52b223-e732-4ed7-b375-50b14dceff66" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3574e274-4374-4add-8e0c-ab76836ffaf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3574e274-4374-4add-8e0c-ab76836ffaf7" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b80224d1-47ff-4027-bf21-b821e1431c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b80224d1-47ff-4027-bf21-b821e1431c86" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3d83ef71-432d-4111-a8fd-40e31089baa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3d83ef71-432d-4111-a8fd-40e31089baa0" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bb7d5492-f532-4a0d-9bb4-753d2f0c3f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bb7d5492-f532-4a0d-9bb4-753d2f0c3f95" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4bef9c74-8ac3-4427-966f-b283b428f084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4bef9c74-8ac3-4427-966f-b283b428f084" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5378f890-fee3-4e3f-b41e-b2b85a451eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5378f890-fee3-4e3f-b41e-b2b85a451eb4" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2a52a77-6483-4fcc-a4d4-c9d9ee98fa52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_NetIncomeLoss_c2a52a77-6483-4fcc-a4d4-c9d9ee98fa52" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9dfa4a56-e99e-472e-9cc6-e2ea6d3a63f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_130d94ca-47b2-460f-a3c2-4f713b94918a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:to="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_b29209da-a7b4-4cf8-b633-37cb70846054_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:to="loc_us-gaap_EquityComponentDomain_b29209da-a7b4-4cf8-b633-37cb70846054_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:to="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dd8a7d32-85f5-48ca-95cd-638ff6ae8a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_CommonStockMember_dd8a7d32-85f5-48ca-95cd-638ff6ae8a80" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7a4968c0-1ab0-4003-ac99-72c9c91e1cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_TreasuryStockMember_7a4968c0-1ab0-4003-ac99-72c9c91e1cc4" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9d07635b-9408-42ce-9fcb-ddd99091bc55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9d07635b-9408-42ce-9fcb-ddd99091bc55" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cbef17a8-04a5-4197-ae8e-cd67436100e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_RetainedEarningsMember_cbef17a8-04a5-4197-ae8e-cd67436100e2" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a04c8472-bf1d-40e0-a048-734be4d14074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a04c8472-bf1d-40e0-a048-734be4d14074" xlink:type="arc" order="4"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended" id="id07adcbf5b98462d91b0c2a0c8d1c2d8_CondensedConsolidatedStatementsofCashFlows"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompany"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="extended" id="i1a22c780907341ab9d5ed6cab5b94fa0_FormationandBusinessoftheCompany"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended" id="i44c5fae1d30d410387cd48ba1008b99f_FormationandBusinessoftheCompanyDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended" id="ic074e14d9f654d2bab9a16b1616fb630_SummaryofSignificantAccountingPolicies"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended" id="if7521181e8a649d698e02643e6aec078_SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended" id="ifc923e3ada0d4f0b8b5bdaf94e2cd802_SummaryofSignificantAccountingPoliciesTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended" id="i05f07f23c58043cb8fbd5678cd70d246_SummaryofSignificantAccountingPoliciesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_68383ebe-a435-454f-a35e-1c80c4b0e940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfOperatingSegments_68383ebe-a435-454f-a35e-1c80c4b0e940" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_fafd517e-664c-4399-94b0-d616d4740f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_fafd517e-664c-4399-94b0-d616d4740f0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers_0253a633-f823-4cb3-8a6e-ba556806cbeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_PaymentsToSuppliers_0253a633-f823-4cb3-8a6e-ba556806cbeb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_6e45b9dc-23bb-4947-997b-84816d8a57b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_6e45b9dc-23bb-4947-997b-84816d8a57b5" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_79f05af8-7293-4686-b81d-89df8ad8f207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_79f05af8-7293-4686-b81d-89df8ad8f207" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_a19aaf06-d762-47f6-9bc1-cd14f2cf7105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_InventoryValuationReserves_a19aaf06-d762-47f6-9bc1-cd14f2cf7105" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efcb51f9-fae8-4a4a-94d5-fa764c6a95f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efcb51f9-fae8-4a4a-94d5-fa764c6a95f9" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod_48d0ba9e-5902-4bc8-b61e-dfaf7df11cc4" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductReturnPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod_48d0ba9e-5902-4bc8-b61e-dfaf7df11cc4" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_8274ec60-2fdb-4daf-ad1b-036a8787f9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_8274ec60-2fdb-4daf-ad1b-036a8787f9b5" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductShelfLife_c9c17f44-734c-4d5c-aa71-0e3b4c6c16b6" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductShelfLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_esta_RevenueFromContractWithCustomerProductShelfLife_c9c17f44-734c-4d5c-aa71-0e3b4c6c16b6" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8b33a81-0165-4ddb-a423-1b1d6682ed58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8b33a81-0165-4ddb-a423-1b1d6682ed58" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8b2eb2b9-a3fd-4272-82b8-e2546f7494e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfReportableSegments_8b2eb2b9-a3fd-4272-82b8-e2546f7494e0" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_076a329f-3226-4a65-b0e4-426d9b9faf50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfReportingUnits_076a329f-3226-4a65-b0e4-426d9b9faf50" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_08e259a1-ed11-42e0-93c5-9aaab97104ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_08e259a1-ed11-42e0-93c5-9aaab97104ca" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1bb512ff-2380-401d-ba26-95bc1a541fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1bb512ff-2380-401d-ba26-95bc1a541fe1" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_92e1cdc7-e2db-431d-b0bc-e8c7c1010974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_AssetImpairmentCharges_92e1cdc7-e2db-431d-b0bc-e8c7c1010974" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_edbae19a-1047-4ba0-ae96-e3b299ce69b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_edbae19a-1047-4ba0-ae96-e3b299ce69b6" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6046f02-40c6-4d9a-a973-6b8f43b7924c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6046f02-40c6-4d9a-a973-6b8f43b7924c" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_21f4461b-5cd6-4dcb-b51e-fb6e6aea1048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_OperatingLeaseLiability_21f4461b-5cd6-4dcb-b51e-fb6e6aea1048" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:to="loc_srt_NameOfMajorCustomerDomain_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:to="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CustomerOneMember_bbab3334-f195-46eb-8183-7c3716b75497" xlink:href="esta-20210331.xsd#esta_CustomerOneMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:to="loc_esta_CustomerOneMember_bbab3334-f195-46eb-8183-7c3716b75497" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_934ec598-05f8-40c1-9f2a-636a229610cf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_934ec598-05f8-40c1-9f2a-636a229610cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4a171c16-dad6-46c9-bdc0-fb081f5ce634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_us-gaap_SalesRevenueNetMember_4a171c16-dad6-46c9-bdc0-fb081f5ce634" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_InventoryRawMaterialsPurchasesMember_44f3daf3-a036-4e6b-9cb4-f750912777fd" xlink:href="esta-20210331.xsd#esta_InventoryRawMaterialsPurchasesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_esta_InventoryRawMaterialsPurchasesMember_44f3daf3-a036-4e6b-9cb4-f750912777fd" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LongLivedAssetsMember_3786fea7-5fb7-42be-b459-d147ffacfb0a" xlink:href="esta-20210331.xsd#esta_LongLivedAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_esta_LongLivedAssetsMember_3786fea7-5fb7-42be-b459-d147ffacfb0a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_d487afd3-debf-45e2-b92d-b972d4460a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_d487afd3-debf-45e2-b92d-b972d4460a13" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8e93038d-f76b-4e09-a318-1cd77e1a04d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8e93038d-f76b-4e09-a318-1cd77e1a04d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_b0a15d48-164f-4741-910d-68d53707ae99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_b0a15d48-164f-4741-910d-68d53707ae99" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_c122aff6-d615-4e4c-933f-0e37e9c9efbb_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:to="loc_srt_SegmentGeographicalDomain_c122aff6-d615-4e4c-933f-0e37e9c9efbb_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:to="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_9f58aa59-1898-4416-9f11-8bec9829bbf7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_BR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:to="loc_country_BR_9f58aa59-1898-4416-9f11-8bec9829bbf7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_f9023d53-d46a-46fe-a654-7ea8705695f2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:to="loc_country_CR_f9023d53-d46a-46fe-a654-7ea8705695f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8de86c12-ec40-4623-ad20-e2e4f90c8c81_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8de86c12-ec40-4623-ad20-e2e4f90c8c81_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NuSilTechnologyLLCMember_c80562ed-2ef1-4670-bddc-c897d7fad3b1" xlink:href="esta-20210331.xsd#esta_NuSilTechnologyLLCMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:to="loc_esta_NuSilTechnologyLLCMember_c80562ed-2ef1-4670-bddc-c897d7fad3b1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_323c1f02-c319-4b86-8572-c2f5a66734db_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:to="loc_srt_ProductsAndServicesDomain_323c1f02-c319-4b86-8572-c2f5a66734db_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:to="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_7618ddcf-23b5-4a4b-84bc-e92d4a3bd4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:to="loc_us-gaap_ShippingAndHandlingMember_7618ddcf-23b5-4a4b-84bc-e92d4a3bd4cc" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_1050c85b-0529-4f92-b826-7f0690611a35_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:to="loc_srt_RangeMember_1050c85b-0529-4f92-b826-7f0690611a35_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:to="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1699d788-ffb8-4a27-9aa7-633a46b701dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:to="loc_srt_MinimumMember_1699d788-ffb8-4a27-9aa7-633a46b701dd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03c055a4-c241-4cf4-8f7c-07af43816950" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:to="loc_srt_MaximumMember_03c055a4-c241-4cf4-8f7c-07af43816950" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended" id="i0e325c5af13144fb968a865f67e3ff41_SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c94bee4-6514-44b5-947b-bdf645ba83e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c94bee4-6514-44b5-947b-bdf645ba83e1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:to="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_11e1394f-6ac3-45a0-ad49-a5f15938c712_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:to="loc_srt_SegmentGeographicalDomain_11e1394f-6ac3-45a0-ad49-a5f15938c712_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:to="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_3ec0c2dc-1fd2-4101-9a62-d9c3e77fc90d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_srt_EuropeMember_3ec0c2dc-1fd2-4101-9a62-d9c3e77fc90d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_c7394501-c004-4dde-ad0a-c0828c6437c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_srt_LatinAmericaMember_c7394501-c004-4dde-ad0a-c0828c6437c7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AsiaPacificAndMiddleEastMember_81cee04a-449d-4033-8617-ecf3bd3d2e57" xlink:href="esta-20210331.xsd#esta_AsiaPacificAndMiddleEastMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_esta_AsiaPacificAndMiddleEastMember_81cee04a-449d-4033-8617-ecf3bd3d2e57" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_OtherGeographicalAreasMember_46d41451-4553-4831-b1a8-3d7eea89b9cd" xlink:href="esta-20210331.xsd#esta_OtherGeographicalAreasMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_esta_OtherGeographicalAreasMember_46d41451-4553-4831-b1a8-3d7eea89b9cd" xlink:type="arc" order="3"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccounts"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="extended" id="id39ddfc769854d18885bd045190448fa_BalanceSheetAccounts"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="extended" id="i85b4860d491b42caad20b95cb2fbc4f7_BalanceSheetAccountsTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsInventoryDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="extended" id="ic40a39817e5d4084b9cbec5c75c585f7_BalanceSheetAccountsInventoryDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsPropertyandEquipmentDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="extended" id="i884b7b64c32b4ec8b29aafa07cdb1b70_BalanceSheetAccountsPropertyandEquipmentDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0394b123-88a9-4b4b-acca-6f508ccb9f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0394b123-88a9-4b4b-acca-6f508ccb9f01" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d791710c-0f6e-4cfe-962d-ef14e29eb793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d791710c-0f6e-4cfe-962d-ef14e29eb793" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d8bed431-be46-4e28-9274-89f7404d4b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d8bed431-be46-4e28-9274-89f7404d4b61" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef6b6769-44ca-41e9-8584-d7e8f23e723b_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_ef6b6769-44ca-41e9-8584-d7e8f23e723b_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_fd981a43-f3d6-411b-9fbe-8aa6743ca5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_fd981a43-f3d6-411b-9fbe-8aa6743ca5eb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_6535a8e2-2b88-42cd-82c8-1e223a8e7a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_BuildingImprovementsMember_6535a8e2-2b88-42cd-82c8-1e223a8e7a46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d1fd04ab-d227-4e0a-83a6-00a86fbe4674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d1fd04ab-d227-4e0a-83a6-00a86fbe4674" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_0cb00056-d1db-4b67-ae62-6869a2bc6d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_BuildingMember_0cb00056-d1db-4b67-ae62-6869a2bc6d55" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b57853d6-3553-49d2-81f2-240fb8742c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b57853d6-3553-49d2-81f2-240fb8742c8d" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_c78df011-7557-48a7-a962-0bd82a9b4991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_LandMember_c78df011-7557-48a7-a962-0bd82a9b4991" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_8b464e49-639b-4e50-b347-1e46d8a48d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_VehiclesMember_8b464e49-639b-4e50-b347-1e46d8a48d63" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_0d7b22bc-0145-44be-9682-51c8e7b63a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_ConstructionInProgressMember_0d7b22bc-0145-44be-9682-51c8e7b63a5b" xlink:type="arc" order="7"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="extended" id="ie033040b577a4571b7378c9661039de0_BalanceSheetAccountsNarrativeDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsAccruedLiabilitiesDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="extended" id="ia753d535471444c78d106495540d3315_BalanceSheetAccountsAccruedLiabilitiesDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesShortTermDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="extended" id="ie59ba26e514042abb5371000e02f0354_BalanceSheetAccountsOtherLiabilitiesShortTermDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesLongTermDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="extended" id="i16c80fce6e1443df9a034642ceec8549_BalanceSheetAccountsOtherLiabilitiesLongTermDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended" id="i35b656aa21224443bdc923b88aee2345_GoodwillandOtherIntangibleAssets"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended" id="iaeb169ab18c4475fb876f03b2b096b2b_GoodwillandOtherIntangibleAssetsTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended" id="i79b1a59139914318a0bed5a032c318f6_GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended" id="i3a120156ec254aceb9b8b633b7a83c97_GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0c754ce8-ed24-4ee0-aba2-2cd41a810288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0c754ce8-ed24-4ee0-aba2-2cd41a810288" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a5d59704-3526-4fd8-b5d8-18caf240074a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a5d59704-3526-4fd8-b5d8-18caf240074a" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d595d177-91ed-49bc-adf4-cb2842e022e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d595d177-91ed-49bc-adf4-cb2842e022e9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_06686d51-cfa1-4ffa-80f4-8de75e2bae31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_06686d51-cfa1-4ffa-80f4-8de75e2bae31" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_17fa9261-f5d5-429a-8d7e-1ff97cc82bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_17fa9261-f5d5-429a-8d7e-1ff97cc82bec" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f0f94bdf-6fe6-40c2-9020-fcb8111c7cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f0f94bdf-6fe6-40c2-9020-fcb8111c7cb1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cb14cc25-90af-4c25-8cdc-b3ffdd08acbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cb14cc25-90af-4c25-8cdc-b3ffdd08acbc" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_879ae3d4-25e6-47e5-8270-9905704dd0f0_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_879ae3d4-25e6-47e5-8270-9905704dd0f0_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PatentsAndLicensingAgreementsMember_a43387f6-036e-4632-af7f-d988fd966565" xlink:href="esta-20210331.xsd#esta_PatentsAndLicensingAgreementsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_esta_PatentsAndLicensingAgreementsMember_a43387f6-036e-4632-af7f-d988fd966565" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_04ee4b6e-4c8f-4023-8603-7bd49b2d97d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_04ee4b6e-4c8f-4023-8603-7bd49b2d97d9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_A510kAuthorizationMember_7065612d-27bd-419e-a71c-0ee561216c58" xlink:href="esta-20210331.xsd#esta_A510kAuthorizationMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_esta_A510kAuthorizationMember_7065612d-27bd-419e-a71c-0ee561216c58" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d56a1b0b-4467-4e85-ac77-55b123214fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d56a1b0b-4467-4e85-ac77-55b123214fe1" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_1c4131c6-cae1-4075-b2c3-578818a8ce24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_1c4131c6-cae1-4075-b2c3-578818a8ce24" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_746504db-9f06-4936-8e92-c7d30da08c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_746504db-9f06-4936-8e92-c7d30da08c0c" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:to="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:to="loc_srt_RangeMember_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:to="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b5bca8c-20ba-4397-b14b-9185f5232f72" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:to="loc_srt_MinimumMember_1b5bca8c-20ba-4397-b14b-9185f5232f72" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f4787b29-6814-4418-9d4a-06694460948f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:to="loc_srt_MaximumMember_f4787b29-6814-4418-9d4a-06694460948f" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended" id="idd4a0f5b8e2b4367976237ac94bdbde8_GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended" id="i215c86f75fe84ae1b0925e155431a301_GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurements"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="extended" id="i2db53acfd6ff48ecbc8544ccbeaabf29_FairValueMeasurements"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="extended" id="i7c59f90823c049968673d09fdb1ed425_FairValueMeasurementsTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsFVonaRecurringBasisDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="extended" id="ia0491489be764007a1f66fed8248dde5_FairValueMeasurementsFVonaRecurringBasisDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_3bd03b76-0736-4ca2-940d-d363dd944736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:to="loc_us-gaap_DerivativeLiabilities_3bd03b76-0736-4ca2-940d-d363dd944736" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_d7351adb-a276-4080-a516-5c3d00177f94_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_d7351adb-a276-4080-a516-5c3d00177f94_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4f7b24fc-d7db-4d98-958a-a6da7f6d88d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4f7b24fc-d7db-4d98-958a-a6da7f6d88d3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_17dba4ee-1566-4704-b343-5b54624d077e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_17dba4ee-1566-4704-b343-5b54624d077e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d40464b1-8d77-4c36-9dfc-d11d768f96f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d40464b1-8d77-4c36-9dfc-d11d768f96f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eebadc0b-f4cf-4974-901f-fc52e4a9b94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eebadc0b-f4cf-4974-901f-fc52e4a9b94b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_522c1c4f-1b77-448d-8d5f-c6af72463ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_522c1c4f-1b77-448d-8d5f-c6af72463ec8" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended" id="i0ca626b1d91f4bef93e1671a1a5eda35_FairValueMeasurementsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_3f3b8aca-70f3-4937-b868-8acf0d896edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_3f3b8aca-70f3-4937-b868-8acf0d896edd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_532350d6-8a42-4c36-b3df-2bafeae12061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_532350d6-8a42-4c36-b3df-2bafeae12061" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_aa537b42-7e2b-4e0a-9778-55a92056afa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_aa537b42-7e2b-4e0a-9778-55a92056afa3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_c34e19c9-7cc0-4d87-93bc-5e53aaf41c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_c34e19c9-7cc0-4d87-93bc-5e53aaf41c74" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_44749bdb-a9a0-47c9-835c-ec461ca31fa3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_44749bdb-a9a0-47c9-835c-ec461ca31fa3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_577a2c89-5654-41da-90f0-ef7d0a6cad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:to="loc_us-gaap_LineOfCreditMember_577a2c89-5654-41da-90f0-ef7d0a6cad8c" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_dd36e7e9-7a04-494d-af03-029ed033560a" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:to="loc_esta_MadrynCreditAgreementMember_dd36e7e9-7a04-494d-af03-029ed033560a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_51a408d0-4ce1-43f6-9715-33c86fa9f410_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_51a408d0-4ce1-43f6-9715-33c86fa9f410_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputProbabilityOfChangeInControlMember_c910f7d4-d161-4b90-9af0-2b5f454b409d" xlink:href="esta-20210331.xsd#esta_MeasurementInputProbabilityOfChangeInControlMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:to="loc_esta_MeasurementInputProbabilityOfChangeInControlMember_c910f7d4-d161-4b90-9af0-2b5f454b409d" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsDerivativesDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="extended" id="if043cfe53b274f88bb0f829e3122b97d_FairValueMeasurementsDerivativesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1c3e8821-bc0e-4e53-9ca4-86365f5ac787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1c3e8821-bc0e-4e53-9ca4-86365f5ac787" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_fee608c5-c353-4b31-b4f5-4b5f1c0977f2_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_fee608c5-c353-4b31-b4f5-4b5f1c0977f2_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputInterestRateVolatilityMember_92b56e24-3e05-4b7d-b82b-8762e698bda6" xlink:href="esta-20210331.xsd#esta_MeasurementInputInterestRateVolatilityMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_esta_MeasurementInputInterestRateVolatilityMember_92b56e24-3e05-4b7d-b82b-8762e698bda6" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputMarketYieldRateMember_1b413eb2-05d1-49f4-9cae-418f939babd9" xlink:href="esta-20210331.xsd#esta_MeasurementInputMarketYieldRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_esta_MeasurementInputMarketYieldRateMember_1b413eb2-05d1-49f4-9cae-418f939babd9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_acac7859-0ef1-4dc9-8c77-471308d7003b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_acac7859-0ef1-4dc9-8c77-471308d7003b" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_95c2a526-25be-43a9-9ca6-5831d923ac9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_95c2a526-25be-43a9-9ca6-5831d923ac9f" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43204dd8-ebf2-4a78-845f-6d4da542c803_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_43204dd8-ebf2-4a78-845f-6d4da542c803_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_1bdf600c-ffde-42ac-8022-b2569ef85270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PutOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:to="loc_us-gaap_PutOptionMember_1bdf600c-ffde-42ac-8022-b2569ef85270" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsLevel3FinancialInstrumentsDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="extended" id="id840668c8171494fa0ce90c9acb7c86a_FairValueMeasurementsLevel3FinancialInstrumentsDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0ad608c6-b10f-48e5-9c37-05e4dda94bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0ad608c6-b10f-48e5-9c37-05e4dda94bb5" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6d6cec8-7505-48a1-aac9-bb09ece95c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6d6cec8-7505-48a1-aac9-bb09ece95c50" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2f7a05b5-0a5f-48e8-819d-c147ddc6b89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b4b6e6d2-763d-41fb-a041-4cabad48a689_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_b4b6e6d2-763d-41fb-a041-4cabad48a689_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_696bec61-6511-44c3-81ca-f194888543fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PutOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:to="loc_us-gaap_PutOptionMember_696bec61-6511-44c3-81ca-f194888543fc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Debt" xlink:type="simple" xlink:href="esta-20210331.xsd#Debt"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/Debt" xlink:type="extended" id="id2e147d458984a5fa2316b181a708cdc_Debt"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtTables" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/DebtTables" xlink:type="extended" id="i517487a6fa724c85ae3cdce13a9703cf_DebtTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="extended" id="icfbe03076b2b4e8e8a356286acc1f867_DebtNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a9e52c60-2a38-43f5-9d15-2b022be8b953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a9e52c60-2a38-43f5-9d15-2b022be8b953" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_78911a84-ecf4-441a-af31-264360112adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_78911a84-ecf4-441a-af31-264360112adb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4f5f52e9-758e-40d6-bf2c-51e91178fa9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4f5f52e9-758e-40d6-bf2c-51e91178fa9c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_3a3c8c18-78ae-4c2c-baf3-e7e63cd31380" xlink:href="esta-20210331.xsd#esta_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_3a3c8c18-78ae-4c2c-baf3-e7e63cd31380" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3461541e-95b1-487f-837c-1c6335206674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3461541e-95b1-487f-837c-1c6335206674" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DebtInstrumentDefaultInterestRateIncrease_fb87b65e-a9c7-4b01-b8d8-ca38d073f754" xlink:href="esta-20210331.xsd#esta_DebtInstrumentDefaultInterestRateIncrease"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_esta_DebtInstrumentDefaultInterestRateIncrease_fb87b65e-a9c7-4b01-b8d8-ca38d073f754" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f93d2e40-efbb-4d99-bfa6-e336a38422af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f93d2e40-efbb-4d99-bfa6-e336a38422af" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_47741217-5bf2-4b53-8db6-f4d21901f2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_47741217-5bf2-4b53-8db6-f4d21901f2fa" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_cda14f3a-0ebe-491d-871c-a8ebc2f9e63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_InterestExpenseDebt_cda14f3a-0ebe-491d-871c-a8ebc2f9e63a" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_853ad253-9ba0-4ff8-ad3c-f0d8b5cbb90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_853ad253-9ba0-4ff8-ad3c-f0d8b5cbb90e" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6159b85b-5394-442a-9be3-2220a3200e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6159b85b-5394-442a-9be3-2220a3200e12" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e5c1c9d4-7358-446b-9ae3-39fda145ea76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e5c1c9d4-7358-446b-9ae3-39fda145ea76" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_144578bf-4731-4e68-96e4-f1dffb9f3e09_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_144578bf-4731-4e68-96e4-f1dffb9f3e09_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_29730f7e-bfcf-41d4-a92e-5a93d574a0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:to="loc_us-gaap_LineOfCreditMember_29730f7e-bfcf-41d4-a92e-5a93d574a0ca" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_ecae9158-69b0-4ca7-9d28-b279fd2227a3_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_ecae9158-69b0-4ca7-9d28-b279fd2227a3_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_5d1bbee3-dbfb-42b3-8994-49ac6a2c1edd" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementMember_5d1bbee3-dbfb-42b3-8994-49ac6a2c1edd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AmendedMadrynCreditAgreementMember_4a396280-5226-4d14-b71e-8ea8ad2c498a" xlink:href="esta-20210331.xsd#esta_AmendedMadrynCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_AmendedMadrynCreditAgreementMember_4a396280-5226-4d14-b71e-8ea8ad2c498a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermAMember_56a7d394-a6bd-4aa5-ab2c-a9630e199927" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermAMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermAMember_56a7d394-a6bd-4aa5-ab2c-a9630e199927" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB1Member_49d9b11f-cb78-4387-ab90-689a6167ce3c" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB1Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB1Member_49d9b11f-cb78-4387-ab90-689a6167ce3c" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB2Member_483832ab-6a13-4cd4-9d54-0c688ca4e3c2" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB2Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB2Member_483832ab-6a13-4cd4-9d54-0c688ca4e3c2" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3AndB4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3Member_f0f74f71-f6bd-4990-a28a-a6d0fae187c9" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:to="loc_esta_MadrynCreditAgreementTermB3Member_f0f74f71-f6bd-4990-a28a-a6d0fae187c9" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB4Member_ac8b3fd8-6b6a-4867-8f60-9793f49543ef" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB4Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:to="loc_esta_MadrynCreditAgreementTermB4Member_ac8b3fd8-6b6a-4867-8f60-9793f49543ef" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_1e4c3e06-98b8-4b1e-a983-4379f99f5316_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:to="loc_us-gaap_VariableRateDomain_1e4c3e06-98b8-4b1e-a983-4379f99f5316_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:to="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_52ef3ad1-1a70-442a-b2c3-ae935b307556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_52ef3ad1-1a70-442a-b2c3-ae935b307556" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtScheduleofMadrynDebtDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="extended" id="i1cae8e15d6cf445c961d059fc511d52a_DebtScheduleofMadrynDebtDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_087038f9-8c88-44d1-9b0d-a479512d5e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_087038f9-8c88-44d1-9b0d-a479512d5e26" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_75920964-01d2-47ce-b8a4-15b0b37ffa73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_75920964-01d2-47ce-b8a4-15b0b37ffa73" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1a039e4b-2c6d-41ab-8d16-3747067a9668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_LongTermDebt_1a039e4b-2c6d-41ab-8d16-3747067a9668" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_3d14f244-0fd6-4b15-b9ab-0f150660fa6c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_3d14f244-0fd6-4b15-b9ab-0f150660fa6c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_fca8f93c-f52f-463c-9067-84fa2a204015" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:to="loc_esta_MadrynCreditAgreementMember_fca8f93c-f52f-463c-9067-84fa2a204015" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_2db0aed1-f802-45bd-a9bc-ff300480aa27_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_2db0aed1-f802-45bd-a9bc-ff300480aa27_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_90baed68-dfde-489d-9e93-dfc776d74bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:to="loc_us-gaap_LineOfCreditMember_90baed68-dfde-489d-9e93-dfc776d74bdc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Leases" xlink:type="simple" xlink:href="esta-20210331.xsd#Leases"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/Leases" xlink:type="extended" id="if41c7b15cff141599a2da7369410ccfe_Leases"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesTables" xlink:type="extended" id="i88c7bacf5dd34cd893595579a0935d2b_LeasesTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="extended" id="i65274bc6a0394a5296cc3b427e9d5fe3_LeasesNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dcd2b5d9-8fbb-4326-8782-0406587bfacb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dcd2b5d9-8fbb-4326-8782-0406587bfacb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_133b8396-6037-4385-9688-97fe8abccc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_133b8396-6037-4385-9688-97fe8abccc91" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:to="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_18bcbb77-3a08-4e38-8d18-93a3b25b1194_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:to="loc_srt_RangeMember_18bcbb77-3a08-4e38-8d18-93a3b25b1194_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:to="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac41f7bd-2b0e-4bcb-ba72-1c075faeb867" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:to="loc_srt_MaximumMember_ac41f7bd-2b0e-4bcb-ba72-1c075faeb867" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseCostDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="extended" id="i3c3e97fd80914bec9d5f0947abfb10cd_LeasesLeaseCostDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended" id="i29f1beba543e4821ab08c26e20789675_LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalCashFlowsDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="extended" id="i5c71f8d6847d449e889b703868dfe769_LeasesSupplementalCashFlowsDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseMaturityDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="extended" id="ia85aa9a5606c4e45bbd13dc66afcee3c_LeasesLeaseMaturityDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquity"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="extended" id="i8ca5351a39f7458fa20c8c6e85b38ba1_ShareholdersEquity"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="extended" id="i534d167459ea4b14bf602e8c175cefce_ShareholdersEquityTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended" id="i033fd1e7bb87467f820da6a611170002_ShareholdersEquityNarrativeDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityReservedOrdinarySharesDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="extended" id="i02ac11659430406f9913738ea7d7f169_ShareholdersEquityReservedOrdinarySharesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e3f85c68-c448-482a-b0d7-1de7d5fb8632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e3f85c68-c448-482a-b0d7-1de7d5fb8632" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_e9e3fa28-ec22-4dba-b345-85781a913593_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_e9e3fa28-ec22-4dba-b345-85781a913593_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_20e23298-34af-4c89-a09e-18925dd0b741" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:to="loc_esta_RockportWarrantsMember_20e23298-34af-4c89-a09e-18925dd0b741" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6520d4d3-ebdd-4462-8592-c32716d3bde4_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_6520d4d3-ebdd-4462-8592-c32716d3bde4_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08a7a861-0493-4528-b4b9-54b0438a1721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08a7a861-0493-4528-b4b9-54b0438a1721" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_40aa1122-4e4f-4972-9a9a-ccab028c616c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_RestrictedStockMember_40aa1122-4e4f-4972-9a9a-ccab028c616c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a14894c8-9af9-411b-bab7-491a85ab8e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_EmployeeStockMember_a14894c8-9af9-411b-bab7-491a85ab8e8c" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:to="loc_us-gaap_PlanNameDomain_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:to="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EquityIncentivePlan2018Member_79b88cd8-6509-4c56-ae10-fa292cc303cc" xlink:href="esta-20210331.xsd#esta_EquityIncentivePlan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:to="loc_esta_EquityIncentivePlan2018Member_79b88cd8-6509-4c56-ae10-fa292cc303cc" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Warrants" xlink:type="simple" xlink:href="esta-20210331.xsd#Warrants"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/Warrants" xlink:type="extended" id="i6a2592bce349421aab1c33454415c199_Warrants"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/WarrantsTables" xlink:type="extended" id="i8566e9498215427bb6e776e947788b21_WarrantsTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="extended" id="i384d94c4266441fe857ae51afeb8bd17_WarrantsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ddcc43be-5744-4f0f-91d6-768b0d7f4738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ddcc43be-5744-4f0f-91d6-768b0d7f4738" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_72fa8c60-9692-4213-aadf-7f0eb5853e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_72fa8c60-9692-4213-aadf-7f0eb5853e0e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a8c3d1e2-640c-4ff4-ab0c-0e51857fbddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a8c3d1e2-640c-4ff4-ab0c-0e51857fbddb" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_b62991eb-3f44-486a-bc0c-4f5372a0e5c1" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:to="loc_esta_RockportWarrantsMember_b62991eb-3f44-486a-bc0c-4f5372a0e5c1" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:to="loc_us-gaap_ClassOfStockDomain_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:to="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_3481a071-4b6b-42b8-97c7-272769e1ae74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:to="loc_us-gaap_CommonClassBMember_3481a071-4b6b-42b8-97c7-272769e1ae74" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsWarrantDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="extended" id="i18245002e2264fc4b86d5464fef16988_WarrantsWarrantDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3a87ea3-916d-4931-ad5a-35673354b79a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3a87ea3-916d-4931-ad5a-35673354b79a" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70572702-31d8-4940-8980-42f246335158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70572702-31d8-4940-8980-42f246335158" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_c542c7f0-26e0-4ddd-b98f-16a0d5e24f15" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:to="loc_esta_RockportWarrantsMember_c542c7f0-26e0-4ddd-b98f-16a0d5e24f15" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensation"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="extended" id="i739054205f964cd9b9a88fb761f72074_SharebasedCompensation"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="extended" id="ifc08c8ed009841529e324ae0f21e4064_SharebasedCompensationTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended" id="i2ee44f22a39e47eeb65e61921f8c1a82_SharebasedCompensationNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ddbd865e-c091-4439-b342-bb7c2ce23cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ddbd865e-c091-4439-b342-bb7c2ce23cd3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseInCommonStockSharesAuthorized_6cd2d524-1098-485a-90f8-ff611dc15c7d" xlink:href="esta-20210331.xsd#esta_IncreaseInCommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_IncreaseInCommonStockSharesAuthorized_6cd2d524-1098-485a-90f8-ff611dc15c7d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_d97f488b-696c-49ed-869d-adc1431e8851" xlink:href="esta-20210331.xsd#esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_d97f488b-696c-49ed-869d-adc1431e8851" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5a445f2f-03bc-452c-918f-67dd4187c0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5a445f2f-03bc-452c-918f-67dd4187c0f3" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_763e1191-39a0-4fcd-9a79-411c8f098b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_763e1191-39a0-4fcd-9a79-411c8f098b67" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ea789ae-bcbd-4bf2-92a3-57b0bb8dc89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ea789ae-bcbd-4bf2-92a3-57b0bb8dc89b" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_05b3c24b-350b-4967-96e6-ca7832e7366e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_05b3c24b-350b-4967-96e6-ca7832e7366e" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_920e1faf-4663-4f3c-a73f-7fb4051c4c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_920e1faf-4663-4f3c-a73f-7fb4051c4c9f" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_86e691f2-4fc3-40c4-8b47-e0cd7baeae19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_86e691f2-4fc3-40c4-8b47-e0cd7baeae19" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_66f334b4-e007-450c-836d-4aa0146094f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_66f334b4-e007-450c-836d-4aa0146094f4" xlink:type="arc" order="9"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f9725e38-ac47-4d5b-8dd9-160afac4fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f9725e38-ac47-4d5b-8dd9-160afac4fd0d" xlink:type="arc" order="10"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_632d6934-cd70-4924-ac67-7804becf654a" xlink:href="esta-20210331.xsd#esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_632d6934-cd70-4924-ac67-7804becf654a" xlink:type="arc" order="11"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_81937270-7907-4db8-9b07-687e89ac78ad" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_81937270-7907-4db8-9b07-687e89ac78ad" xlink:type="arc" order="12"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bb1d62dc-3400-4c15-a805-0c0da6e9ffa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bb1d62dc-3400-4c15-a805-0c0da6e9ffa3" xlink:type="arc" order="13"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_daad070e-9e73-49f2-83b7-0234ff5bb38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_daad070e-9e73-49f2-83b7-0234ff5bb38c" xlink:type="arc" order="14"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_acb44f87-90db-496a-b65e-89b2fbdd3655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_acb44f87-90db-496a-b65e-89b2fbdd3655" xlink:type="arc" order="15"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7ae9768b-450b-4ae7-9d2e-36a989ff298f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7ae9768b-450b-4ae7-9d2e-36a989ff298f" xlink:type="arc" order="16"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_87e30720-9ec9-4b3e-ba81-cadda8425388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_87e30720-9ec9-4b3e-ba81-cadda8425388" xlink:type="arc" order="17"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2d90f8e4-1516-4cf3-bc3f-a42c3fad7e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2d90f8e4-1516-4cf3-bc3f-a42c3fad7e6c" xlink:type="arc" order="18"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_27dfbf13-3132-432b-b8c8-f8b43b58108c_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:to="loc_us-gaap_PlanNameDomain_27dfbf13-3132-432b-b8c8-f8b43b58108c_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:to="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EquityIncentivePlan2018Member_f29b8f3e-986e-4008-96fe-3dda46a3ae84" xlink:href="esta-20210331.xsd#esta_EquityIncentivePlan2018Member"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:to="loc_esta_EquityIncentivePlan2018Member_f29b8f3e-986e-4008-96fe-3dda46a3ae84" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_9eee54e2-a658-403e-904f-9779a673f2e8_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_9eee54e2-a658-403e-904f-9779a673f2e8_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ConsultantMember_4aeddd5d-cbfc-4fa1-8aef-c44458b2eca5" xlink:href="esta-20210331.xsd#esta_ConsultantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:to="loc_esta_ConsultantMember_4aeddd5d-cbfc-4fa1-8aef-c44458b2eca5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_76ed17b4-44a1-49df-94f6-6b69353a49cf_default" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:to="loc_srt_RangeMember_76ed17b4-44a1-49df-94f6-6b69353a49cf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:to="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e0ad611c-b363-480c-af3d-1c7d7d591a57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:to="loc_srt_MinimumMember_e0ad611c-b363-480c-af3d-1c7d7d591a57" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_605e6eb0-cee7-4ba8-95c4-8ec2a6f08af2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:to="loc_srt_MaximumMember_605e6eb0-cee7-4ba8-95c4-8ec2a6f08af2" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_147b16e9-d020-4878-8bc8-8ccd07819aef_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_147b16e9-d020-4878-8bc8-8ccd07819aef_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2bc62ac7-4c70-4648-a775-8d359b99f184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2bc62ac7-4c70-4648-a775-8d359b99f184" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0525f350-5cab-4b7d-82c4-07e6a7a36306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:to="loc_us-gaap_RestrictedStockMember_0525f350-5cab-4b7d-82c4-07e6a7a36306" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsandRestrictedStockDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="extended" id="i561bbcf5c80e49e6b5b830032f4db1b5_SharebasedCompensationStockOptionsandRestrictedStockDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_901b2a74-3687-4256-9274-35547b3edeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_901b2a74-3687-4256-9274-35547b3edeba" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_184175b7-0a44-4b4e-bca7-0df51b13459d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_184175b7-0a44-4b4e-bca7-0df51b13459d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e74c1f62-fd37-43d8-98a3-93f95ec267f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e74c1f62-fd37-43d8-98a3-93f95ec267f5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a7defe0c-1a3c-4f71-8385-e9ef5e51edbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a7defe0c-1a3c-4f71-8385-e9ef5e51edbd" xlink:type="arc" order="1"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="extended" id="i0f5f463f9bd447ffbb07f5054e53336e_SharebasedCompensationStockOptionsDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionGrantedtoEmployeesDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="extended" id="id3144eadde6d40f19982c1e50bb9d0db_SharebasedCompensationStockOptionGrantedtoEmployeesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3922f128-55ba-48e9-bfec-e6b3f3901ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3922f128-55ba-48e9-bfec-e6b3f3901ea5" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c50fea69-d538-4917-907f-b93633a4b59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c50fea69-d538-4917-907f-b93633a4b59e" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_42fe6030-195a-457c-bd5d-a08f90d6d6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_42fe6030-195a-457c-bd5d-a08f90d6d6ab" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dabb47a8-5515-4bd2-aed2-5d56d432b4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dabb47a8-5515-4bd2-aed2-5d56d432b4bb" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ba163c93-b2af-41fa-8276-093a0ec78f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ba163c93-b2af-41fa-8276-093a0ec78f2c" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_25f61cb4-578b-4a5f-9c6e-d1ad5fa665f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_25f61cb4-578b-4a5f-9c6e-d1ad5fa665f0" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:to="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_bb3a0ee5-84af-4e25-ad18-58e120930c33_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:to="loc_us-gaap_GranteeStatusDomain_bb3a0ee5-84af-4e25-ad18-58e120930c33_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:to="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_22a028ea-3dc5-4d19-b705-9b291cfa7982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_22a028ea-3dc5-4d19-b705-9b291cfa7982" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:to="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa45322e-350c-483d-af3a-f5c6c37e7e7e_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_fa45322e-350c-483d-af3a-f5c6c37e7e7e_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cebfd483-f109-48d3-8702-593f0ea0ad7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cebfd483-f109-48d3-8702-593f0ea0ad7a" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="extended" id="ieb53ad957d7545f8a509ae0a5c18a535_SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c950aa1c-8ec3-47da-b6b1-086ba8f2fbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c950aa1c-8ec3-47da-b6b1-086ba8f2fbe3" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_132a0fcd-e48e-4e52-b53f-09a3a11248ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_132a0fcd-e48e-4e52-b53f-09a3a11248ee" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_eba982f7-0120-40e0-94d0-89d9ab798fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_eba982f7-0120-40e0-94d0-89d9ab798fa9" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8a21d987-eb48-48bc-8555-25896c5cdf44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8a21d987-eb48-48bc-8555-25896c5cdf44" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_01a8ed16-6a61-4b74-9538-a01926b662bf_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:to="loc_us-gaap_GranteeStatusDomain_01a8ed16-6a61-4b74-9538-a01926b662bf_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:to="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_641f129b-4ac8-4828-9eae-d17bbd906fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_641f129b-4ac8-4828-9eae-d17bbd906fdd" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8a46589-3d01-4a6a-ab84-0d6f469389a7_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_f8a46589-3d01-4a6a-ab84-0d6f469389a7_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_460ed450-735a-4e07-8367-ad5119927ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:to="loc_us-gaap_EmployeeStockOptionMember_460ed450-735a-4e07-8367-ad5119927ed7" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1139f385-ede4-42d9-87f5-00ddc14c88d9_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_1139f385-ede4-42d9-87f5-00ddc14c88d9_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ConsultantMember_ec5d33c1-e580-4040-8933-6cf429694fd0" xlink:href="esta-20210331.xsd#esta_ConsultantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:to="loc_esta_ConsultantMember_ec5d33c1-e580-4040-8933-6cf429694fd0" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationRestrictedStockActivityDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="extended" id="i11a487b0ffb94dd09eaded4539cc9479_SharebasedCompensationRestrictedStockActivityDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e416bf6-df48-440a-823f-5264c242e139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e416bf6-df48-440a-823f-5264c242e139" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c9e4c78-3f06-4db0-af9a-c78352c00fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c9e4c78-3f06-4db0-af9a-c78352c00fdf" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e5ddcf4-b6b5-4945-83db-36a05cf3b321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e5ddcf4-b6b5-4945-83db-36a05cf3b321" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_845dabbb-b616-4ca9-b28a-c497eae545f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_845dabbb-b616-4ca9-b28a-c497eae545f1" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f066ece6-dc2f-4f1d-9fcd-70e7222b837b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3b971a6-e480-4600-b50a-06c70a579ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3b971a6-e480-4600-b50a-06c70a579ec6" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_860b524e-cc7b-4929-ba4b-922b774f79ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_860b524e-cc7b-4929-ba4b-922b774f79ea" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2482065e-184d-4492-ba8f-c0de5513b287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2482065e-184d-4492-ba8f-c0de5513b287" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eaa56693-2078-4ecb-a97a-d0b484cba026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eaa56693-2078-4ecb-a97a-d0b484cba026" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7b41a56d-3825-4c94-a45c-b610e5c75082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:to="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69ca708e-d15e-4e80-9a1f-f7bce7bf604d_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_69ca708e-d15e-4e80-9a1f-f7bce7bf604d_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_628d3f27-0451-45c5-ba0c-4507e119f358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:to="loc_us-gaap_RestrictedStockMember_628d3f27-0451-45c5-ba0c-4507e119f358" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShare"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="extended" id="i2f54a3eb11fa4bab9e078ab3d4172bea_NetLossPerShare"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareTables"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="extended" id="ib305ad556e6b463c9b016b09c34f95b2_NetLossPerShareTables"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareBasicandDilutedDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="extended" id="ida671938f3284524861430ee890337c7_NetLossPerShareBasicandDilutedDetails"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended" id="i0712538f309e4b21a5357de0590358e6_NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc478710-57fd-440c-9055-2ea6c9f2cfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc478710-57fd-440c-9055-2ea6c9f2cfeb" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7e3a28fd-bd04-44fd-8566-811f008a8399_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_7e3a28fd-bd04-44fd-8566-811f008a8399_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonemployeeStockOptionMember_af15b9a2-5d54-42a3-b319-8cf2ecc31525" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonemployeeStockOptionMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_esta_EmployeeAndNonemployeeStockOptionMember_af15b9a2-5d54-42a3-b319-8cf2ecc31525" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7bf90861-25d6-41c3-a789-3ff8b0838d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7bf90861-25d6-41c3-a789-3ff8b0838d4a" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_89e46528-b50c-4f3e-a66e-9635b66589d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_us-gaap_WarrantMember_89e46528-b50c-4f3e-a66e-9635b66589d2" xlink:type="arc" order="2"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactions"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="extended" id="ifbb09a5bfc854827bfe97584568da776_RelatedPartyTransactions"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended" id="ia8ad58c7eecd4aa0b825e1fbd918ba1e_RelatedPartyTransactionsNarrativeDetails">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_a1ff34f4-ec84-4d05-a645-e7192dc90d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_RevenueFromRelatedParties_a1ff34f4-ec84-4d05-a645-e7192dc90d89" xlink:type="arc" order="0"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_b5e8cdb1-31b5-4017-9cab-11cbca6b34a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_b5e8cdb1-31b5-4017-9cab-11cbca6b34a1" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ce80882-d866-4ceb-96e0-88dbb1eb8dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ce80882-d866-4ceb-96e0-88dbb1eb8dad" xlink:type="arc" order="2"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e9bb613-d31b-4a4c-bd5e-1aba95658dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e9bb613-d31b-4a4c-bd5e-1aba95658dc0" xlink:type="arc" order="3"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_5c4add36-e533-4b9d-8831-d674c2b59d3b" xlink:href="esta-20210331.xsd#esta_RelatedPartyTransactionCashReimbursementPerDayForServices"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_5c4add36-e533-4b9d-8831-d674c2b59d3b" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8495c8df-be16-44f4-bd8b-a56c613c0710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8495c8df-be16-44f4-bd8b-a56c613c0710" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:type="arc" order="1" xbrldt:closed="true" xbrldt:contextElement="segment"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_c6a8f35a-23a3-4606-bc19-69b4cd21cf49_default" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:to="loc_us-gaap_RelatedPartyDomain_c6a8f35a-23a3-4606-bc19-69b4cd21cf49_default" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:to="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:type="arc" order="1"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_ddd64cc9-3cb4-4ab2-80c8-497d74069d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:to="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_ddd64cc9-3cb4-4ab2-80c8-497d74069d8f" xlink:type="arc" order="0"/>
  </link:definitionLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="esta-20210331.xsd#CommitmentsandContingencies"/>
  <link:definitionLink xlink:role="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="extended" id="i82313fb6fe084388a5f02966ce04d4bf_CommitmentsandContingencies"/>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>8
<FILENAME>esta-20210331_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_a8db03c6-b579-4656-8ace-d2a95d67aea0_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_32fcd60b-3542-42df-b2ae-f058cfe6d2f5_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_41ef7bfc-17ef-4cc9-8790-a6471c131a04_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_e9a7b859-dfd3-4e81-9bbf-c0e0a65b2673_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other expense, net</link:label>
    <link:label id="lab_us-gaap_OtherNonoperatingIncomeExpense_label_en-US" xlink:label="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Nonoperating Income (Expense)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNonoperatingIncomeExpense" xlink:to="lab_us-gaap_OtherNonoperatingIncomeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_3da740b5-17f4-4650-a276-2e16eb6debf3_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_0df434d3-55c3-4362-b39d-4d3d1b57474e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_d50be914-c23c-4561-ab1c-9cae4e60f21f_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grants in period (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_ddeff043-f59b-4c5c-ad46-5fa7d9d5e63f_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:to="lab_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_AccruedStockOptionGrantBonusCurrent_cde7f9aa-534a-4a32-9417-aa7bab6eccd8_terseLabel_en-US" xlink:label="lab_esta_AccruedStockOptionGrantBonusCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Bonus feature of stock option grants</link:label>
    <link:label id="lab_esta_AccruedStockOptionGrantBonusCurrent_label_en-US" xlink:label="lab_esta_AccruedStockOptionGrantBonusCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Stock Option Grant Bonus, Current</link:label>
    <link:label id="lab_esta_AccruedStockOptionGrantBonusCurrent_documentation_en-US" xlink:label="lab_esta_AccruedStockOptionGrantBonusCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Stock Option Grant Bonus, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AccruedStockOptionGrantBonusCurrent" xlink:href="esta-20210331.xsd#esta_AccruedStockOptionGrantBonusCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_AccruedStockOptionGrantBonusCurrent" xlink:to="lab_esta_AccruedStockOptionGrantBonusCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockMember_0cb87299-fd5e-4ed5-add3-975191b6d2eb_terseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Shares</link:label>
    <link:label id="lab_us-gaap_TreasuryStockMember_label_en-US" xlink:label="lab_us-gaap_TreasuryStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockMember" xlink:to="lab_us-gaap_TreasuryStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_1f864f13-26f6-4a0e-ba4a-ba5212f24159_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Valuation allowances and reserves, amount</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Asset, Allowance for Credit Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:to="lab_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_c63908c7-6092-4be8-a670-90adf2f43c7f_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_4262c3d6-c2cf-415c-a1fe-089901e32995_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;3</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel3Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel3Member" xlink:to="lab_us-gaap_FairValueInputsLevel3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock_ee63d331-ee43-4a5b-9d5a-eb15c2b11c61_terseLabel_en-US" xlink:label="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentrations</link:label>
    <link:label id="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentrations, Policy [Policy Text Block]</link:label>
    <link:label id="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock_documentation_en-US" xlink:label="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentrations, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:href="esta-20210331.xsd#esta_GeographicConcentrationsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:to="lab_esta_GeographicConcentrationsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWriteDown_b04b06f0-5bae-4c68-8026-a893aaa735d5_verboseLabel_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for inventory obsolescence</link:label>
    <link:label id="lab_us-gaap_InventoryWriteDown_label_en-US" xlink:label="lab_us-gaap_InventoryWriteDown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Write-down</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWriteDown" xlink:to="lab_us-gaap_InventoryWriteDown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_03a07b1f-4e14-4e24-9261-4800de680f97_terseLabel_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair value of options</link:label>
    <link:label id="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_label_en-US" xlink:label="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Embedded Derivative, Fair Value of Embedded Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:to="lab_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_country_CR_3c202be2-590f-4c43-ac5b-467126c98f5c_terseLabel_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:label id="lab_country_CR_label_en-US" xlink:label="lab_country_CR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">COSTA RICA</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_CR" xlink:to="lab_country_CR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_b1f44c54-0c70-4293-84cf-770084593224_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeLeasesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Leases [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeasesPolicyTextBlock" xlink:to="lab_us-gaap_LesseeLeasesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_0ed3ea7e-6885-4277-9213-4e21388dc371_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases from related party</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Expenses from Transactions with Related Party</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:to="lab_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_d06d8f42-a928-4522-b74f-556b30b71497_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_05759050-58cc-4120-a4b3-ddc06c93f178_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeMember_de279f42-4e41-4a2f-89b7-2cee07d968f5_terseLabel_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:label id="lab_srt_RangeMember_label_en-US" xlink:label="lab_srt_RangeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeMember" xlink:to="lab_srt_RangeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_b9944d1c-9869-4156-a8fc-4e866fb0ee5e_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditMember_0ae255fa-3243-4813-b52d-c35649163396_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit</link:label>
    <link:label id="lab_us-gaap_LineOfCreditMember_label_en-US" xlink:label="lab_us-gaap_LineOfCreditMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditMember" xlink:to="lab_us-gaap_LineOfCreditMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_02d06abc-dd97-4129-b5ca-f12214c64300_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_f6d68d9d-5223-4385-a667-09ab62f0f8b8_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_c108782b-0e89-4d59-992a-69de06e19992_terseLabel_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warranty reserve</link:label>
    <link:label id="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent_label_en-US" xlink:label="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Warranty Accrual, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:to="lab_us-gaap_ProductWarrantyAccrualClassifiedCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_6a600c9b-165d-4449-845f-143956a5d54c_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional amount borrowed</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfDebt_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfDebt" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_0a89e723-4045-490c-bc41-152261a6ddbf_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_b090dde4-da91-4d42-823e-66002b8e00fa_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible assets, net of accumulated amortization</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_a331dce6-cbad-4e28-b57b-7971981adbb3_totalLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_a6f03e38-e2f5-4021-9e7f-c841037fa943_terseLabel_en-US" xlink:label="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense of stock options to non-employees</link:label>
    <link:label id="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Stock Options</link:label>
    <link:label id="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_documentation_en-US" xlink:label="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Stock Options</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:href="esta-20210331.xsd#esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:to="lab_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_283a2dfc-264f-4e75-9c80-8b56c76e9bbf_terseLabel_en-US" xlink:label="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immediate Family Member of Management or Principal Owner</link:label>
    <link:label id="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_label_en-US" xlink:label="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Immediate Family Member of Management or Principal Owner [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:to="lab_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_e51185a0-6d42-4823-a0a4-2d621acf1747_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Changes in operating assets and liabilities:</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_66d9fd46-a3ed-407f-8911-aad3bfc1ff4e_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, ROU asset, before accumulated amortization</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, before Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_cebc212f-29f1-413f-9c22-3476fce81729_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from operations</link:label>
    <link:label id="lab_us-gaap_OperatingIncomeLoss_label_en-US" xlink:label="lab_us-gaap_OperatingIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Income (Loss)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingIncomeLoss" xlink:to="lab_us-gaap_OperatingIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_74648db4-7989-4751-acd5-40587cc573df_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current liabilities</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrent" xlink:to="lab_us-gaap_LiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_db76b72d-4d01-481c-bdf7-6db2f16ac826_terseLabel_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_label_en-US" xlink:label="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid Expense and Other Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:to="lab_us-gaap_PrepaidExpenseAndOtherAssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_04d7347e-0426-4ec0-9b7d-ef545eba5f37_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_114fd194-4979-4310-8df1-f9070f991200_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateDomain_f464c230-66a0-480f-bdfa-91bb7a509384_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:label id="lab_us-gaap_VariableRateDomain_label_en-US" xlink:label="lab_us-gaap_VariableRateDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateDomain" xlink:to="lab_us-gaap_VariableRateDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_ab457dfa-ec07-40dc-9bf5-5262b0238ec0_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Professional and legal services</link:label>
    <link:label id="lab_us-gaap_AccruedProfessionalFeesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Professional Fees, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedProfessionalFeesCurrent" xlink:to="lab_us-gaap_AccruedProfessionalFeesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VariableRateAxis_18055a10-df4a-4507-9da8-5de678b7e4f0_terseLabel_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:label id="lab_us-gaap_VariableRateAxis_label_en-US" xlink:label="lab_us-gaap_VariableRateAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Variable Rate [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VariableRateAxis" xlink:to="lab_us-gaap_VariableRateAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_3cefeb83-efcf-4bec-bce5-b47c54789d36_terseLabel_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_label_en-US" xlink:label="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:to="lab_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_a83dcb21-5c28-4157-9964-15162ed1cd84_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and contingencies (Note 13)</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingencies_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingencies" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingencies" xlink:to="lab_us-gaap_CommitmentsAndContingencies" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_bdf64953-fcc3-4d1d-919c-754bb2ea55ef_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_69b8a490-490f-452e-bdaf-8d44a3cbb377_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld to cover income tax obligation upon vesting of restricted stock</link:label>
    <link:label id="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Decrease for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsAbstract_6172733a-45f5-42bf-a216-bc587b4677c0_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:label id="lab_us-gaap_AssetsAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsAbstract" xlink:to="lab_us-gaap_AssetsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_ecce2c5b-fc67-4dde-b1c4-c02d17fdb5ea_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:to="lab_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_LongLivedAssetsMember_700a2e83-105a-4857-a3f9-971dd9d2d0ab_terseLabel_en-US" xlink:label="lab_esta_LongLivedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets</link:label>
    <link:label id="lab_esta_LongLivedAssetsMember_label_en-US" xlink:label="lab_esta_LongLivedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets [Member]</link:label>
    <link:label id="lab_esta_LongLivedAssetsMember_documentation_en-US" xlink:label="lab_esta_LongLivedAssetsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-lived Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LongLivedAssetsMember" xlink:href="esta-20210331.xsd#esta_LongLivedAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_LongLivedAssetsMember" xlink:to="lab_esta_LongLivedAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_52e0d1c6-7c62-412e-b283-2fd70cc88afa_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vesting period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_3f1c0557-6c58-4da3-9f64-724bd82d6bbc_terseLabel_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:label id="lab_us-gaap_AccountingPoliciesAbstract_label_en-US" xlink:label="lab_us-gaap_AccountingPoliciesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounting Policies [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountingPoliciesAbstract" xlink:to="lab_us-gaap_AccountingPoliciesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_97878eba-29db-4954-abb5-b37ea59efb29_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_807f82aa-f613-442c-85be-e07b7cfe43f0_terseLabel_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and fixtures</link:label>
    <link:label id="lab_us-gaap_FurnitureAndFixturesMember_label_en-US" xlink:label="lab_us-gaap_FurnitureAndFixturesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Furniture and Fixtures [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FurnitureAndFixturesMember" xlink:to="lab_us-gaap_FurnitureAndFixturesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_245b6e4c-21cc-4ff8-9c56-8281309e97f2_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_0bc6d50a-40d7-4ce1-ad9f-75dc4161cc15_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vested (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_2b4b7869-a9c0-4816-a638-74c0f8301276_terseLabel_en-US" xlink:label="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional borrowing capacity</link:label>
    <link:label id="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_label_en-US" xlink:label="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Additional Borrowing Capacity</link:label>
    <link:label id="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_documentation_en-US" xlink:label="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line Of Credit Facility, Additional Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:href="esta-20210331.xsd#esta_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:to="lab_esta_LineOfCreditFacilityAdditionalBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeasePayments_e2d8b001-bf12-466c-8f37-0b736084a0a4_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeasePayments_label_en-US" xlink:label="lab_us-gaap_OperatingLeasePayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeasePayments" xlink:to="lab_us-gaap_OperatingLeasePayments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_5661fda5-642b-4e86-906c-55543b1c8e6f_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_AccountsPayableCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableCurrent" xlink:to="lab_us-gaap_AccountsPayableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_e511e8c7-3538-4c3b-82d6-d4eef1708cd7_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsAccumulatedDeficit_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings (Accumulated Deficit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:to="lab_us-gaap_RetainedEarningsAccumulatedDeficit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_2798eb17-9974-4ce1-ac9d-80d5936e6522_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-use operating lease assets, net</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAsset" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCountry_49fa6428-a397-432f-9a87-4d00fb1fc135_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:label id="lab_dei_EntityAddressCountry_label_en-US" xlink:label="lab_dei_EntityAddressCountry" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Country</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCountry" xlink:to="lab_dei_EntityAddressCountry" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_3a8ca50b-6819-4bef-a47f-2cb6f3c374be_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commissions</link:label>
    <link:label id="lab_us-gaap_AccruedSalesCommissionCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Sales Commission, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalesCommissionCurrent" xlink:to="lab_us-gaap_AccruedSalesCommissionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_2e000bd9-d2a1-409a-9098-aa71d0ec52e9_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt discount</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_af6a7f32-8799-4334-bb6e-68cf525d6f30_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonClassBMember_5263da79-72d0-46a4-ba14-7de1eb2c1e1f_terseLabel_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B</link:label>
    <link:label id="lab_us-gaap_CommonClassBMember_label_en-US" xlink:label="lab_us-gaap_CommonClassBMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Class B [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonClassBMember" xlink:to="lab_us-gaap_CommonClassBMember" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock_9f08181f-f914-4b2f-8f7a-ebbb514734e7_terseLabel_en-US" xlink:label="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:label id="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock_label_en-US" xlink:label="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee [Table Text Block]</link:label>
    <link:label id="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock_documentation_en-US" xlink:label="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:href="esta-20210331.xsd#esta_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:to="lab_esta_AssetsAndLiabilitiesLesseeTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_66395d5b-915e-449e-962a-79d10029a672_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_635cdfad-7889-44dd-b7e0-308a5cb42b16_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_5eb63f7c-f176-4c0a-bd9f-07de00a3717c_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_d1c7266d-afd7-4da8-a083-b4428b0c24e8_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MajorCustomersAxis_8052f64f-7150-4fe4-b97a-4b39422eb642_terseLabel_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:label id="lab_srt_MajorCustomersAxis_label_en-US" xlink:label="lab_srt_MajorCustomersAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MajorCustomersAxis" xlink:to="lab_srt_MajorCustomersAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_427d048d-f20e-4463-9f2f-cf1f9254c515_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value by Liability Class [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_1cd87199-ca1f-4a5f-b949-981bf9dfc9b1_terseLabel_en-US" xlink:label="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash reimbursement per day for services</link:label>
    <link:label id="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_label_en-US" xlink:label="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Reimbursement Per Day For Services</link:label>
    <link:label id="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_documentation_en-US" xlink:label="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction, Cash Reimbursement Per Day For Services</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:href="esta-20210331.xsd#esta_RelatedPartyTransactionCashReimbursementPerDayForServices"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:to="lab_esta_RelatedPartyTransactionCashReimbursementPerDayForServices" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_CashFlowLesseeAbstract_65656d27-c6cf-4340-a548-4dcb1e8e7375_terseLabel_en-US" xlink:label="lab_esta_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for amounts included in the measurement of lease liabilities</link:label>
    <link:label id="lab_esta_CashFlowLesseeAbstract_label_en-US" xlink:label="lab_esta_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee [Abstract]</link:label>
    <link:label id="lab_esta_CashFlowLesseeAbstract_documentation_en-US" xlink:label="lab_esta_CashFlowLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashFlowLesseeAbstract" xlink:href="esta-20210331.xsd#esta_CashFlowLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_CashFlowLesseeAbstract" xlink:to="lab_esta_CashFlowLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_e008c325-4f5f-42f5-af60-6e8d670a83c1_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxPolicyTextBlock" xlink:to="lab_us-gaap_IncomeTaxPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCost_3d14f46e-5c7c-4ca3-903a-5dca12834b0d_totalLabel_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease costs</link:label>
    <link:label id="lab_us-gaap_LeaseCost_label_en-US" xlink:label="lab_us-gaap_LeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCost" xlink:to="lab_us-gaap_LeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpenses_dcf66198-5a79-4e01-bf5c-8dbf97b058e5_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total operating expenses</link:label>
    <link:label id="lab_us-gaap_OperatingExpenses_label_en-US" xlink:label="lab_us-gaap_OperatingExpenses" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpenses" xlink:to="lab_us-gaap_OperatingExpenses" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingMember_f56a337f-d188-4300-8117-e12ab0cdb642_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building</link:label>
    <link:label id="lab_us-gaap_BuildingMember_label_en-US" xlink:label="lab_us-gaap_BuildingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingMember" xlink:to="lab_us-gaap_BuildingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_9254affa-c8e5-4df2-a84c-e20c24066a0a_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive income:</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_0b5117df-a671-4a2f-b640-3e35d36970df_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in control</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_9628e1b9-b111-493c-9f72-8d55d7b16e2f_verboseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilityMeasurementInput_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Measurement Input</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilityMeasurementInput" xlink:to="lab_us-gaap_DerivativeLiabilityMeasurementInput" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_bd6fb4cf-151e-4a5f-8eae-feea63f06781_terseLabel_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Noncurrent Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_c9df5053-ba0a-47ee-8c1d-9410ee2e30c9_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, long-term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_6cb47bfa-8f59-4af5-a3b0-3ec3575fab94_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, long term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_3d2c2d00-8313-4bb3-a8ed-2c97e4cad88c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited/canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_0061f1c6-21c8-4d6b-b711-ffdcdccd38a3_negatedLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Repayments on finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_dd4f8e68-29d6-445a-b985-d81ef09b87f3_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financing cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeasePrincipalPayments_label_en-US" xlink:label="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Principal Payments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeasePrincipalPayments" xlink:to="lab_us-gaap_FinanceLeasePrincipalPayments" xlink:type="arc" order="1"/>
    <link:label id="lab_country_BR_f9319ea1-277c-4ff6-9f1a-2706272aa103_terseLabel_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Brazil</link:label>
    <link:label id="lab_country_BR_label_en-US" xlink:label="lab_country_BR" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">BRAZIL</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_BR"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_country_BR" xlink:to="lab_country_BR" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_42ef90bb-f160-4d55-810b-1d746e73eb4c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByLiabilityClassAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liability Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis" xlink:to="lab_us-gaap_FairValueByLiabilityClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_dc128708-b907-402b-bbb8-c60a15c294b9_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Work in process</link:label>
    <link:label id="lab_us-gaap_InventoryWorkInProcessNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Work in Process, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:to="lab_us-gaap_InventoryWorkInProcessNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_022b12c4-4a44-473d-a363-55f974ef37ab_terseLabel_en-US" xlink:label="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_label_en-US" xlink:label="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, After Year Four</link:label>
    <link:label id="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_documentation_en-US" xlink:label="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite Lived Intangible Assets, Amortization Expense, After Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:href="esta-20210331.xsd#esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:to="lab_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_83fb795d-4840-4e7a-a884-72a342bfee41_terseLabel_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of exchange rate changes on cash</link:label>
    <link:label id="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryNet_6daa41a7-e439-48d0-9bee-854099f8a7f7_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_54a05457-9114-4d00-9fb5-6a3f2a5e3679_totalLabel_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, net</link:label>
    <link:label id="lab_us-gaap_InventoryNet_label_en-US" xlink:label="lab_us-gaap_InventoryNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryNet" xlink:to="lab_us-gaap_InventoryNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0ad9cbf4-c928-4ba1-92fd-2deff00bbc17_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer, Excluding Assessed Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_6d5f42ab-c501-47b3-befc-82bd41fbd4cd_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementFrequencyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain" xlink:to="lab_us-gaap_FairValueMeasurementFrequencyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_6f8a71c5-5b64-4cd8-8d8e-02a490d45a7f_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration risk (as a percent)</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskPercentage1_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskPercentage1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskPercentage1" xlink:to="lab_us-gaap_ConcentrationRiskPercentage1" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_SegmentGeographicalDomain_5ced3f1e-22b1-4fad-a8ff-173c51811a8e_terseLabel_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:label id="lab_srt_SegmentGeographicalDomain_label_en-US" xlink:label="lab_srt_SegmentGeographicalDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_SegmentGeographicalDomain" xlink:to="lab_srt_SegmentGeographicalDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MeasurementInputMarketYieldRateMember_d8d9cbb0-d30c-479e-9aee-4624af2263af_terseLabel_en-US" xlink:label="lab_esta_MeasurementInputMarketYieldRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Market yield rate</link:label>
    <link:label id="lab_esta_MeasurementInputMarketYieldRateMember_label_en-US" xlink:label="lab_esta_MeasurementInputMarketYieldRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Yield Rate [Member]</link:label>
    <link:label id="lab_esta_MeasurementInputMarketYieldRateMember_documentation_en-US" xlink:label="lab_esta_MeasurementInputMarketYieldRateMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Market Yield Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputMarketYieldRateMember" xlink:href="esta-20210331.xsd#esta_MeasurementInputMarketYieldRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MeasurementInputMarketYieldRateMember" xlink:to="lab_esta_MeasurementInputMarketYieldRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementLineItems_d101ae40-1a0a-436f-ad85-d6824d1320f4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:label id="lab_us-gaap_StatementLineItems_label_en-US" xlink:label="lab_us-gaap_StatementLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementLineItems" xlink:to="lab_us-gaap_StatementLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_18cef713-528a-4fd3-8a38-6dcd52e031cb_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockDomain_b4e9f1b0-70ea-479e-978b-1c4fb572da2a_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfStockDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockDomain" xlink:to="lab_us-gaap_ClassOfStockDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_OtherGeographicalAreasMember_e649a463-d303-48b4-b653-9e2484981e8c_terseLabel_en-US" xlink:label="lab_esta_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_esta_OtherGeographicalAreasMember_label_en-US" xlink:label="lab_esta_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:label id="lab_esta_OtherGeographicalAreasMember_documentation_en-US" xlink:label="lab_esta_OtherGeographicalAreasMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Geographical Areas [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_OtherGeographicalAreasMember" xlink:href="esta-20210331.xsd#esta_OtherGeographicalAreasMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_OtherGeographicalAreasMember" xlink:to="lab_esta_OtherGeographicalAreasMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_5c6b0e44-a01a-4592-a9e0-727386efe714_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Numerator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_b60bfde9-762b-47d1-9207-a17a361f1542_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeDomain_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeDomain" xlink:to="lab_us-gaap_MeasurementInputTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementTable_89e1565b-73a4-40d8-b0a7-d7161496dfbc_terseLabel_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:label id="lab_us-gaap_StatementTable_label_en-US" xlink:label="lab_us-gaap_StatementTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementTable" xlink:to="lab_us-gaap_StatementTable" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_RangeAxis_cfec8813-2654-43b5-b224-4de932a1f5c5_terseLabel_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:label id="lab_srt_RangeAxis_label_en-US" xlink:label="lab_srt_RangeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statistical Measurement [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_RangeAxis" xlink:to="lab_srt_RangeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_17ff3e88-7708-4dce-9a94-807df6df6d9f_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of right-to-use asset</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Right-of-Use Asset, Amortization Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:to="lab_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_RockportWarrantsMember_19730602-fc9e-4416-9eac-9786c41eb6db_terseLabel_en-US" xlink:label="lab_esta_RockportWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockport Warrants</link:label>
    <link:label id="lab_esta_RockportWarrantsMember_label_en-US" xlink:label="lab_esta_RockportWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockport Warrants [Member]</link:label>
    <link:label id="lab_esta_RockportWarrantsMember_documentation_en-US" xlink:label="lab_esta_RockportWarrantsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Rockport Warrants [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_RockportWarrantsMember" xlink:to="lab_esta_RockportWarrantsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_efbf99f7-5da3-43a9-aff3-11d1e5ed5431_terseLabel_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities</link:label>
    <link:label id="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Current Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_OtherCurrentLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_aff85745-7d3a-454d-9fa6-c861f60d1024_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn put option</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:to="lab_us-gaap_DerivativeLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_9dc4708b-9635-4072-a756-4980d6b4ee58_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise price of warrants (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_c9798feb-2ef4-4734-b80e-34c0751a03c4_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercise Price (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Exercise Price of Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:to="lab_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_a6b638e9-c9c7-4bf4-b418-344a17aac371_verboseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted net loss per share (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_3e7d26d4-990b-4c32-92fd-4044504ee211_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basic and diluted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDiluted" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntitySmallBusiness_6a6e6011-2825-441e-958d-d49c21701dbf_terseLabel_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:label id="lab_dei_EntitySmallBusiness_label_en-US" xlink:label="lab_dei_EntitySmallBusiness" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Small Business</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntitySmallBusiness" xlink:to="lab_dei_EntitySmallBusiness" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_0c0e1ad1-f363-48c2-9133-b0ece633ec73_terseLabel_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation</link:label>
    <link:label id="lab_us-gaap_ConsolidationPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consolidation, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConsolidationPolicyTextBlock" xlink:to="lab_us-gaap_ConsolidationPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_54000cc8-2e08-4bf1-b8c0-766c6e622a9a_terseLabel_en-US" xlink:label="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, capital shares reserved for future issuance, increase (decrease), percent</link:label>
    <link:label id="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_label_en-US" xlink:label="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Increase (Decrease), Percent</link:label>
    <link:label id="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_documentation_en-US" xlink:label="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance, Increase (Decrease), Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:href="esta-20210331.xsd#esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:to="lab_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_bf4e0aa7-e430-4ee8-903e-05287e88abc2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_LatinAmericaMember_46388080-5ead-41ab-86d9-808b68227dcb_terseLabel_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America</link:label>
    <link:label id="lab_srt_LatinAmericaMember_label_en-US" xlink:label="lab_srt_LatinAmericaMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Latin America [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_LatinAmericaMember" xlink:to="lab_srt_LatinAmericaMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a889a082-4bc8-4a49-879e-3a742509459d_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Stockholders' Equity [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:to="lab_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_103afafc-b693-4628-8ecc-ce0d9255b08d_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureTextBlock" xlink:to="lab_us-gaap_DebtDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_e46e21df-b924-4d62-bad1-1234597cca50_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:to="lab_us-gaap_FairValueMeasurementsFairValueHierarchyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_e9c2b198-ce57-4642-a919-f1eb3b6d4b0f_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from issuance of ordinary shares, net of issuance costs</link:label>
    <link:label id="lab_us-gaap_ProceedsFromIssuanceOfCommonStock_label_en-US" xlink:label="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Issuance of Common Stock</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:to="lab_us-gaap_ProceedsFromIssuanceOfCommonStock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CostOfRevenue_aa251bdc-5013-4959-bce3-404990c00227_terseLabel_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of revenue</link:label>
    <link:label id="lab_us-gaap_CostOfRevenue_label_en-US" xlink:label="lab_us-gaap_CostOfRevenue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost of Revenue</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CostOfRevenue" xlink:to="lab_us-gaap_CostOfRevenue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_db0bcc4e-def7-4fa2-8e90-9033dd04fd71_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillRollForward_e36a5269-765e-45de-bbe9-bbb9f55aa221_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_GoodwillRollForward_label_en-US" xlink:label="lab_us-gaap_GoodwillRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillRollForward" xlink:to="lab_us-gaap_GoodwillRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_07034069-ef30-49c2-b9a1-239909a3c800_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_03e2380f-792c-4879-97bd-5ea1e3ca0ec1_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Basic and Diluted Earnings Per Share</link:label>
    <link:label id="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_c0fbf493-a95f-4603-9677-3bab41aee3d2_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Major Class Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_591518c8-5f6e-46ac-ad57-1c7201f9d0d9_periodStartLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_58746391-2f8a-4d51-b7a8-e4253a04fd3c_periodEndLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_9069715f-c750-4c5e-b621-12d53468df14_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeasesTextBlock" xlink:to="lab_us-gaap_LesseeFinanceLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_9f3f6650-1d41-4f28-9f01-c9c6d426dfa9_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpensePolicy_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpensePolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_49c584bf-e8ab-44d1-805d-d53f7007ff83_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Non-employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonemployee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementNonemployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_9177c211-d32e-4a79-a7be-5702aaf4e3af_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherAccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherAccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_014af6bc-e9ff-4652-a867-3ea422aa98e5_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Balance Sheet Accounts</link:label>
    <link:label id="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Balance Sheet Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:to="lab_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_4415837c-a37b-426a-becb-075559f229dc_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in operating activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0bab923a-09f9-41b7-877a-a7530fa81b60_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyDomain_27aed30c-4e6a-4e3f-b674-a14420bfebed_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyDomain_label_en-US" xlink:label="lab_us-gaap_RelatedPartyDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyDomain" xlink:to="lab_us-gaap_RelatedPartyDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_b8543c6f-17f2-40f8-a48d-31247880ae62_terseLabel_en-US" xlink:label="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="esta-20210331.xsd#esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_9b368216-1537-4e70-86b0-0cb2f7471652_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByMeasurementFrequencyAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Frequency [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:to="lab_us-gaap_FairValueByMeasurementFrequencyAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_396cb240-7582-40ce-a676-12fe72c17d76_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reporting units</link:label>
    <link:label id="lab_us-gaap_NumberOfReportingUnits_label_en-US" xlink:label="lab_us-gaap_NumberOfReportingUnits" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reporting Units</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportingUnits" xlink:to="lab_us-gaap_NumberOfReportingUnits" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_a7ba30a6-869a-4c85-90b5-96c5577a9479_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionLineItems_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transaction [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems" xlink:to="lab_us-gaap_RelatedPartyTransactionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_4330c929-4a6a-4220-ad79-bfc713991b29_terseLabel_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable and Allowance for Doubtful Accounts</link:label>
    <link:label id="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_label_en-US" xlink:label="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:to="lab_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_2354a5c3-2897-4730-ad20-da14c90f3ac2_terseLabel_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:label id="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_label_en-US" xlink:label="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instruments [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:to="lab_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_34c6f9e5-b309-4999-b6f0-0179771b42b7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets by Major Class [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_b5460ebb-fc83-41e9-9ec6-a89710ac2e61_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_0dd37073-411c-4578-91ed-ed5159809f51_terseLabel_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash equivalents</link:label>
    <link:label id="lab_us-gaap_CashEquivalentsAtCarryingValue_label_en-US" xlink:label="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Equivalents, at Carrying Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashEquivalentsAtCarryingValue" xlink:to="lab_us-gaap_CashEquivalentsAtCarryingValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_6bdab3ec-524f-43dd-9848-5b033d52c709_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeFinanceLeaseTermOfContract1_label_en-US" xlink:label="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Finance Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:to="lab_us-gaap_LesseeFinanceLeaseTermOfContract1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_7af195f5-f47c-4e80-b1e6-e079448819b1_terseLabel_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unpaid balance for property and equipment</link:label>
    <link:label id="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid_label_en-US" xlink:label="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capital Expenditures Incurred but Not yet Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:to="lab_us-gaap_CapitalExpendituresIncurredButNotYetPaid" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_StatementGeographicalAxis_5b2bd8bf-009f-4926-8d99-0acdb51f0041_terseLabel_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:label id="lab_srt_StatementGeographicalAxis_label_en-US" xlink:label="lab_srt_StatementGeographicalAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographical [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_StatementGeographicalAxis" xlink:to="lab_srt_StatementGeographicalAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_9241ec78-e81e-4cae-bfe0-ff25933eb3f1_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense of stock options granted</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_988f11cf-6477-4062-9323-c411b77b9265_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfCashFlowsAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Cash Flows [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract" xlink:to="lab_us-gaap_StatementOfCashFlowsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_01451b0e-d00e-4f94-a139-b03577d151b6_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockMember_1392fd55-f17b-4f7e-8fd0-299d5e0c0e98_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ESPP</link:label>
    <link:label id="lab_us-gaap_EmployeeStockMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockMember" xlink:to="lab_us-gaap_EmployeeStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_752fbd20-171e-4f80-8608-072310c6c44e_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationAxis_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationAxis" xlink:to="lab_us-gaap_IncomeStatementLocationAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_5ad15207-7c62-49c0-abcc-3c9a0d6a233c_terseLabel_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Allowance for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_label_en-US" xlink:label="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:to="lab_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_425a6658-1ac9-4a33-ae93-6244997205d0_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedDividendRateMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Dividend Rate [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:to="lab_us-gaap_MeasurementInputExpectedDividendRateMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_5abae45a-19bc-4994-84aa-5afec9a508d6_terseLabel_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding (in shares)</link:label>
    <link:label id="lab_dei_EntityCommonStockSharesOutstanding_label_en-US" xlink:label="lab_dei_EntityCommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Common Stock, Shares Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCommonStockSharesOutstanding" xlink:to="lab_dei_EntityCommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_dcd60ab2-a20d-47cb-9413-d5a04304e51f_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementLocationDomain_label_en-US" xlink:label="lab_us-gaap_IncomeStatementLocationDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement Location [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementLocationDomain" xlink:to="lab_us-gaap_IncomeStatementLocationDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_a053a733-5585-4da1-a152-0eb9c0cbf586_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_1bf6ef68-31c3-4a81-9cc3-8e9803a9fc75_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from financing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_19d4a9fd-cfdc-42ff-9a18-fa90ef0a97fc_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Sales, general and administrative</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpense_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_2edc5f7b-5687-4389-9f17-024511806c21_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Performance bonus</link:label>
    <link:label id="lab_us-gaap_AccruedBonusesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedBonusesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Bonuses, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedBonusesCurrent" xlink:to="lab_us-gaap_AccruedBonusesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_cd3c74c0-1b1d-424f-9198-0c5e539c09a8_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of intangible assets</link:label>
    <link:label id="lab_us-gaap_AmortizationOfIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfIntangibleAssets" xlink:to="lab_us-gaap_AmortizationOfIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_caeb9ee0-45af-4819-ac6b-1e209b109271_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost</link:label>
    <link:label id="lab_us-gaap_LeaseCostTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LeaseCostTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lease, Cost [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseCostTableTextBlock" xlink:to="lab_us-gaap_LeaseCostTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_43597c85-7dc4-4d0f-a1b0-adbd157fad09_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityTable_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityTable" xlink:to="lab_us-gaap_LineOfCreditFacilityTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_16008d61-a109-4b8b-bf70-091fa52b6652_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_39d2efb0-935f-4d2a-a50b-cc3dd4f60e9c_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_f2d0d126-825e-4efb-907a-76e29e04e65e_terseLabel_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other non-current assets</link:label>
    <link:label id="lab_us-gaap_OtherAssetsNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherAssetsNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Assets, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherAssetsNoncurrent" xlink:to="lab_us-gaap_OtherAssetsNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameAxis_dbcf4578-a482-4759-b444-41169fb8bca3_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:label id="lab_us-gaap_PlanNameAxis_label_en-US" xlink:label="lab_us-gaap_PlanNameAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameAxis" xlink:to="lab_us-gaap_PlanNameAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_d069b6ca-4a17-4087-918b-e879861c37fe_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_c879598d-6b20-4cae-9207-a48555672820_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating cash outflows from finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Payment on Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:to="lab_us-gaap_FinanceLeaseInterestPaymentOnLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Assets_adcf113a-cd58-4e2e-991b-95a90c1a3f37_totalLabel_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total assets</link:label>
    <link:label id="lab_us-gaap_Assets_label_en-US" xlink:label="lab_us-gaap_Assets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Assets" xlink:to="lab_us-gaap_Assets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_5e5f05ef-07fc-4b9b-95b3-536835b041f2_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:to="lab_us-gaap_RelatedPartyTransactionsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_47a45014-a3ec-48f3-bf74-b355c51bf12b_terseLabel_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory on consignment</link:label>
    <link:label id="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_label_en-US" xlink:label="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:to="lab_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpenseDebt_38094428-d334-4736-b0f2-914e5561e4a0_terseLabel_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpenseDebt_label_en-US" xlink:label="lab_us-gaap_InterestExpenseDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense, Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpenseDebt" xlink:to="lab_us-gaap_InterestExpenseDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_1e846582-5628-473f-bdeb-7f8beef9e4ca_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_ae1c70da-b3b3-4e1f-9cbb-f829df22873f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_dc80c14e-b31c-4d09-acad-0b4f23ebe0da_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_b339946a-30fb-4bcc-b17b-5657f9b50c3d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Accrued Liabilities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition_f46f69c8-d8b7-4ee6-af06-72ddcfa9f913_terseLabel_en-US" xlink:label="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consideration payable related to asset acquisition</link:label>
    <link:label id="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition_label_en-US" xlink:label="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Consideration Payable Related to Asset Acquisition</link:label>
    <link:label id="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition_documentation_en-US" xlink:label="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Noncash Consideration Payable Related to Asset Acquisition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:href="esta-20210331.xsd#esta_NoncashConsiderationPayableRelatedtoAssetAcquisition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:to="lab_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_db92fe82-d79d-4b3a-b35d-f0ac5590817f_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Payment, Due [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:to="lab_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_d4f74ede-d6ff-47d5-bce5-5d46ce4f758a_totalLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNet_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_a5245974-c3ef-443f-9729-67806f38ab2e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average fair value (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PutOptionMember_4cb1c6bd-fed4-45b4-85ab-cbfb003153d4_terseLabel_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Option Liability</link:label>
    <link:label id="lab_us-gaap_PutOptionMember_label_en-US" xlink:label="lab_us-gaap_PutOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Put Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PutOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PutOptionMember" xlink:to="lab_us-gaap_PutOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities_b9a4afe8-3cbf-438f-b55c-55e553c179d9_terseLabel_en-US" xlink:label="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities_label_en-US" xlink:label="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:label id="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities_documentation_en-US" xlink:label="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) In Operating Lease Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:href="esta-20210331.xsd#esta_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:to="lab_esta_IncreaseDecreaseInOperatingLeaseLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_36986290-7f77-4672-b065-f26d5ec0890a_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_CustomerOneMember_38dfe3c7-e45e-4624-830c-4901dcacb087_terseLabel_en-US" xlink:label="lab_esta_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One</link:label>
    <link:label id="lab_esta_CustomerOneMember_label_en-US" xlink:label="lab_esta_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:label id="lab_esta_CustomerOneMember_documentation_en-US" xlink:label="lab_esta_CustomerOneMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer One [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CustomerOneMember" xlink:href="esta-20210331.xsd#esta_CustomerOneMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_CustomerOneMember" xlink:to="lab_esta_CustomerOneMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_87e5d728-e425-44c4-9707-67cdd631daeb_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightAxis_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis" xlink:to="lab_us-gaap_ClassOfWarrantOrRightAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_16db7f30-b8dd-444a-aeff-a9c1a3ddb410_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration of Credit Risk and Other Risks and Uncertainties</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskCreditRisk_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk, Credit Risk, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskCreditRisk" xlink:to="lab_us-gaap_ConcentrationRiskCreditRisk" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_cf7bad44-ae4c-48d0-b5ed-91b9ef9d73bf_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestExpense_9ee0914a-4f63-4d46-ae6f-793703e3ab7d_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_InterestExpense_label_en-US" xlink:label="lab_us-gaap_InterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestExpense" xlink:to="lab_us-gaap_InterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_43fa39f9-c1a8-40ee-82c5-3471ad6e36db_terseLabel_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherIntangibleAssetsMember_label_en-US" xlink:label="lab_us-gaap_OtherIntangibleAssetsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Intangible Assets [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherIntangibleAssetsMember" xlink:to="lab_us-gaap_OtherIntangibleAssetsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductOrServiceAxis_cd5e46e3-e7f8-4a57-9c02-6419abd2ca98_terseLabel_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:label id="lab_srt_ProductOrServiceAxis_label_en-US" xlink:label="lab_srt_ProductOrServiceAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductOrServiceAxis" xlink:to="lab_srt_ProductOrServiceAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Liabilities_06f534ed-b464-4fab-a787-12f770b376fd_totalLabel_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities</link:label>
    <link:label id="lab_us-gaap_Liabilities_label_en-US" xlink:label="lab_us-gaap_Liabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Liabilities" xlink:to="lab_us-gaap_Liabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_47ac5b8d-ce68-4387-9c35-1e77f792eeb5_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee unrecognized compensation expense, period for recognition</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_7794b0bc-4202-4c78-b41e-e237be56b960_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_8336dacd-6010-401d-9133-7eb8e55ff1e0_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Volatility</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_38872da4-8072-4744-833d-d64d61707b77_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_fb1cdeb9-badd-4da8-aef4-a9c9e4388a6d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Related Party Transactions, by Related Party [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:to="lab_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_9f8bdd85-3e55-41b1-bc4f-31dbaa027571_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Reserved Ordinary Shares for Future Issuances</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTextBlock" xlink:to="lab_us-gaap_ScheduleOfStockByClassTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_a0a3e63c-9076-4f5e-97c7-651a6b5125cb_terseLabel_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Commitments and Contingencies Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:to="lab_us-gaap_CommitmentsAndContingenciesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_671d97a5-54ff-495b-a276-c6220e40abb1_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;1</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel1Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel1Member" xlink:to="lab_us-gaap_FairValueInputsLevel1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_6b13a50d-3890-4ea9-8566-4f74b815f47c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInInventories_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInInventories" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Inventories</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInInventories" xlink:to="lab_us-gaap_IncreaseDecreaseInInventories" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_78db8aa3-c822-41a5-9d25-313d7854f4be_terseLabel_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average interest rate</link:label>
    <link:label id="lab_us-gaap_DebtWeightedAverageInterestRate_label_en-US" xlink:label="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Weighted Average Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtWeightedAverageInterestRate" xlink:to="lab_us-gaap_DebtWeightedAverageInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97f22b5a-849a-48d8-a55d-a42955875401_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring and Nonrecurring [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_48b5fd5e-407a-4b14-927e-1f487613180c_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts payable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsPayable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Payable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsPayable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c8252060-c43e-4c98-81f5-56685df421e1_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Awards</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_7612f2a7-b6f5-473c-ba77-85192d8c1c30_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Raw materials</link:label>
    <link:label id="lab_us-gaap_InventoryRawMaterialsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:to="lab_us-gaap_InventoryRawMaterialsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_5d80f0cd-dbb0-4dd2-bd6a-d7d151d711c4_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative instruments</link:label>
    <link:label id="lab_us-gaap_UnrealizedGainLossOnDerivatives_label_en-US" xlink:label="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized Gain (Loss) on Derivatives</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UnrealizedGainLossOnDerivatives" xlink:to="lab_us-gaap_UnrealizedGainLossOnDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_2b5af338-b776-4582-9e13-d6f73229436c_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentAxis" xlink:to="lab_us-gaap_DebtInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_9fc0481f-7896-4062-b6e7-ae78a9a61506_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-In Capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapitalMember_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid-in Capital [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapitalMember" xlink:to="lab_us-gaap_AdditionalPaidInCapitalMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_7326d4ff-49f9-44e3-b80a-f54808111668_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesNameDomain_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:to="lab_us-gaap_AntidilutiveSecuritiesNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_69b263e1-a3fa-43fd-976a-f12290190b4d_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term (in years)</link:label>
    <link:label id="lab_us-gaap_MeasurementInputExpectedTermMember_label_en-US" xlink:label="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Expected Term [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputExpectedTermMember" xlink:to="lab_us-gaap_MeasurementInputExpectedTermMember" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionNoncurrent_3065626d-caf5-4ba9-9e01-14f5164d3079_terseLabel_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payable for asset acquisitions</link:label>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionNoncurrent_label_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payable For Asset Acquisition, Noncurrent</link:label>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionNoncurrent_documentation_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payable For Asset Acquisition, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:to="lab_esta_CashPayableForAssetAcquisitionNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_dc83dd09-6501-4fcd-81e6-fc6bcf9e056f_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueLineItems_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems" xlink:to="lab_us-gaap_DisaggregationOfRevenueLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesTable_4a2a0355-6417-4e47-bfa3-35567306c0cf_terseLabel_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesTable_label_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesTable_documentation_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:to="lab_esta_SummaryOfSignificantAccountingPoliciesTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_82f20819-fc89-4ca6-ba74-6395bc92be91_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:label id="lab_us-gaap_ClassOfStockLineItems_label_en-US" xlink:label="lab_us-gaap_ClassOfStockLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfStockLineItems" xlink:to="lab_us-gaap_ClassOfStockLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_a206bd03-11d6-4b59-b92c-cf51e74499d5_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accrued Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInAccruedLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativeLiabilities_80e978f4-0df0-4ad2-9973-41fc266b5bdd_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn put option liability</link:label>
    <link:label id="lab_us-gaap_DerivativeLiabilities_label_en-US" xlink:label="lab_us-gaap_DerivativeLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivative Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativeLiabilities" xlink:to="lab_us-gaap_DerivativeLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_ec0e1257-0d6a-4240-b2b5-68585aa1eb29_terseLabel_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to reconcile net loss to net cash used in operating activities:</link:label>
    <link:label id="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesIssued_084c02f6-36c5-47a9-9391-192f599151fc_periodStartLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_2707a064-f449-4600-9ec3-1b2b104a38ed_periodEndLabel_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesIssued_label_en-US" xlink:label="lab_us-gaap_SharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesIssued" xlink:to="lab_us-gaap_SharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_76ae6960-f31f-4bd8-a2a8-b9cbc4bce966_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest expense</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseInterestExpense_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseInterestExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Interest Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseInterestExpense" xlink:to="lab_us-gaap_FinanceLeaseInterestExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_205ea278-0ffb-439e-806d-35705a55acfd_terseLabel_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and equipment</link:label>
    <link:label id="lab_us-gaap_MachineryAndEquipmentMember_label_en-US" xlink:label="lab_us-gaap_MachineryAndEquipmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Machinery and Equipment [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MachineryAndEquipmentMember" xlink:to="lab_us-gaap_MachineryAndEquipmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_742c6a7f-060c-430c-bcbe-17696400c6c3_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesOutstanding_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesOutstanding" xlink:to="lab_us-gaap_CommonStockSharesOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_4315bf0c-b980-4bd6-9cab-cefd743ca57a_totalLabel_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss before income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_label_en-US" xlink:label="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:to="lab_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_21d3bac2-0da1-4ef6-bdbf-c11656974f20_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price vested and exercisable (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_659fe2ca-27c2-4221-89fe-d4680cb5f550_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpense_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpense" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_bf6dea98-02b3-4ffa-b099-2648eacc6224_periodStartLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_3b313f7f-8a87-4484-9269-f699d500346f_periodEndLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options outstanding (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_7dd3856d-0e63-4269-83bc-3c0a29513720_terseLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss)</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:to="lab_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_a0e711d9-3e7b-4e4b-9645-b4f45cedd4be_terseLabel_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassifications</link:label>
    <link:label id="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription_label_en-US" xlink:label="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Reclassification, Comparability Adjustment [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:to="lab_us-gaap_PriorPeriodReclassificationAdjustmentDescription" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_7c6e89ee-461e-41df-b31c-a95c98e3bc60_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesAuthorized_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesAuthorized" xlink:to="lab_us-gaap_CommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_447989e6-87ff-4ec4-b7d3-3b57b7c844ec_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByTypeAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis" xlink:to="lab_us-gaap_ConcentrationRiskByTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_d31ff3ef-d130-4089-a141-31cc5e3f6740_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, gross</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentGross_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentGross" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_fc694ec4-24cb-47df-8a4c-dc708acb7a08_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from stock option exercises</link:label>
    <link:label id="lab_us-gaap_ProceedsFromStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromStockOptionsExercised" xlink:to="lab_us-gaap_ProceedsFromStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_aedf3621-6b75-46e1-8111-0e54cdf0be12_terseLabel_en-US" xlink:label="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized compensation expense period for recognition</link:label>
    <link:label id="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_label_en-US" xlink:label="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee And Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:label id="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_documentation_en-US" xlink:label="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee And Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:to="lab_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_7ddbcee1-bef3-4c46-a49a-cfa6db80eef8_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:label id="lab_us-gaap_IncomeStatementAbstract_label_en-US" xlink:label="lab_us-gaap_IncomeStatementAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Statement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeStatementAbstract" xlink:to="lab_us-gaap_IncomeStatementAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_e6b824c1-ee04-430a-afc9-397a133dc76a_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">AOCI Attributable to Parent [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_6b9802d3-3980-40d1-aa34-bba22e1b5d85_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities, non-current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_51a761a0-8e85-4e1a-acf4-2fef7f8bb3a7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_a8423d30-b165-438d-90cf-c5518df61545_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Prepaid expenses and other current assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Prepaid Expense and Other Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DerivativesEmbeddedDerivatives_d80b7c9e-2f1a-4957-9007-ef847e499cbf_terseLabel_en-US" xlink:label="lab_us-gaap_DerivativesEmbeddedDerivatives" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt and Embedded Derivatives</link:label>
    <link:label id="lab_us-gaap_DerivativesEmbeddedDerivatives_label_en-US" xlink:label="lab_us-gaap_DerivativesEmbeddedDerivatives" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Derivatives, Embedded Derivatives [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesEmbeddedDerivatives" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DerivativesEmbeddedDerivatives" xlink:to="lab_us-gaap_DerivativesEmbeddedDerivatives" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_f9f6e6ed-7519-4f26-9619-3a44ddd13487_terseLabel_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Restricted Stock</link:label>
    <link:label id="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Nonvested Restricted Stock Shares Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:to="lab_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_c39ee405-17fb-4348-a6a8-f01ca13c6dd9_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net unamortized debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:to="lab_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_UseOfEstimates_08d9c7e0-3247-408f-8ffd-09dcf84be61b_terseLabel_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates</link:label>
    <link:label id="lab_us-gaap_UseOfEstimates_label_en-US" xlink:label="lab_us-gaap_UseOfEstimates" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Use of Estimates, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_UseOfEstimates" xlink:to="lab_us-gaap_UseOfEstimates" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_5e0b9a4c-8636-4bf2-b155-cbd9e7e60d87_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current assets:</link:label>
    <link:label id="lab_us-gaap_AssetsCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrentAbstract" xlink:to="lab_us-gaap_AssetsCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_faac62ca-810a-4070-b483-184d9e5d5bba_terseLabel_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest income</link:label>
    <link:label id="lab_us-gaap_InvestmentIncomeInterest_label_en-US" xlink:label="lab_us-gaap_InvestmentIncomeInterest" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Investment Income, Interest</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InvestmentIncomeInterest" xlink:to="lab_us-gaap_InvestmentIncomeInterest" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_IncreaseInCommonStockSharesAuthorized_df06412a-2ca2-44a8-8a26-b8493b0263cd_terseLabel_en-US" xlink:label="lab_esta_IncreaseInCommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase in common stock, shares authorized (in shares)</link:label>
    <link:label id="lab_esta_IncreaseInCommonStockSharesAuthorized_label_en-US" xlink:label="lab_esta_IncreaseInCommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Common Stock, Shares Authorized</link:label>
    <link:label id="lab_esta_IncreaseInCommonStockSharesAuthorized_documentation_en-US" xlink:label="lab_esta_IncreaseInCommonStockSharesAuthorized" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase In Common Stock, Shares Authorized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseInCommonStockSharesAuthorized" xlink:href="esta-20210331.xsd#esta_IncreaseInCommonStockSharesAuthorized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_IncreaseInCommonStockSharesAuthorized" xlink:to="lab_esta_IncreaseInCommonStockSharesAuthorized" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_A510kAuthorizationMember_2c24b168-62a7-4567-a203-2a4053aaf2c7_terseLabel_en-US" xlink:label="lab_esta_A510kAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">510(k) authorization</link:label>
    <link:label id="lab_esta_A510kAuthorizationMember_label_en-US" xlink:label="lab_esta_A510kAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">510(k) Authorization [Member]</link:label>
    <link:label id="lab_esta_A510kAuthorizationMember_documentation_en-US" xlink:label="lab_esta_A510kAuthorizationMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">510(k) Authorization [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_A510kAuthorizationMember" xlink:href="esta-20210331.xsd#esta_A510kAuthorizationMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_A510kAuthorizationMember" xlink:to="lab_esta_A510kAuthorizationMember" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_40142f3f-b23a-4553-bd93-02c4abfbdae3_terseLabel_en-US" xlink:label="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advisory board and board of director related expenses</link:label>
    <link:label id="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_label_en-US" xlink:label="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advisory Board And Board Of Director Liabilities, Current</link:label>
    <link:label id="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_documentation_en-US" xlink:label="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Advisory Board And Board Of Director Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:href="esta-20210331.xsd#esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:to="lab_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_db59873a-df1b-4e20-b1fa-003efb6919e8_totalLabel_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive loss</link:label>
    <link:label id="lab_us-gaap_ComprehensiveIncomeNetOfTax_label_en-US" xlink:label="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Comprehensive Income (Loss), Net of Tax, Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ComprehensiveIncomeNetOfTax" xlink:to="lab_us-gaap_ComprehensiveIncomeNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_cf74da58-3c1b-494c-8ff0-43f2f36119fa_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_b4ccb78d-fe6f-41f4-9ad0-37747ac9b99e_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Dividend yield</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_e64a9b57-90a2-47cf-b84e-b415b727a214_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases of property and equipment</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:to="lab_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_05f42f1b-f350-41ed-8117-4d7ea0185be6_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_782e7a35-7c6d-4e09-a8cc-4ba5301ea765_terseLabel_en-US" xlink:label="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_label_en-US" xlink:label="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee [Abstract]</link:label>
    <link:label id="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_documentation_en-US" xlink:label="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Assets And Liabilities, Lessee</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:href="esta-20210331.xsd#esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:to="lab_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_8082342e-033f-435f-8afc-845636793d15_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_c56c18a2-e8b4-4dc3-a4a2-97abf6245412_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Other Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_AsiaPacificAndMiddleEastMember_904b7749-db47-4ef2-9576-5c1d56554202_terseLabel_en-US" xlink:label="lab_esta_AsiaPacificAndMiddleEastMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia-Pacific/Middle East</link:label>
    <link:label id="lab_esta_AsiaPacificAndMiddleEastMember_label_en-US" xlink:label="lab_esta_AsiaPacificAndMiddleEastMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific And Middle East [Member]</link:label>
    <link:label id="lab_esta_AsiaPacificAndMiddleEastMember_documentation_en-US" xlink:label="lab_esta_AsiaPacificAndMiddleEastMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asia Pacific and Middle East [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AsiaPacificAndMiddleEastMember" xlink:href="esta-20210331.xsd#esta_AsiaPacificAndMiddleEastMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_AsiaPacificAndMiddleEastMember" xlink:to="lab_esta_AsiaPacificAndMiddleEastMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_8645f658-bb00-49c9-9e8f-19f13e5bf1ce_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares reserved for future issuance (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_label_en-US" xlink:label="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Capital Shares Reserved for Future Issuance</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:to="lab_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_dcd6b1fa-cbde-47b7-84a3-0db7ff42f19d_terseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of derivative instruments</link:label>
    <link:label id="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_label_en-US" xlink:label="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Derivative Instruments, Net, Pretax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:to="lab_us-gaap_GainLossOnDerivativeInstrumentsNetPretax" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_d47fb11b-10ce-4844-b374-f66d0da13f8d_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_ebcc66f3-79cb-4960-a00f-fa305e0aa7f2_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTableTextBlock_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:to="lab_us-gaap_DisaggregationOfRevenueTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_b0518548-68b4-409a-9efa-6ab76fcaf184_terseLabel_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Assets</link:label>
    <link:label id="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:to="lab_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_cd6ea8e7-4ea7-40af-aec7-fcc6da7b9071_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, term of contract</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseTermOfContract_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Term of Contract</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:to="lab_us-gaap_LesseeOperatingLeaseTermOfContract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_c5e0575c-cf2e-4cc9-82b0-af0e47072947_terseLabel_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:label id="lab_us-gaap_DisaggregationOfRevenueTable_label_en-US" xlink:label="lab_us-gaap_DisaggregationOfRevenueTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Disaggregation of Revenue [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable" xlink:to="lab_us-gaap_DisaggregationOfRevenueTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_209cdc8f-d008-4792-b448-1219187ce5d6_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of inventory, current</link:label>
    <link:label id="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Inventory, Current [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfInventoryCurrentTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_a92e1bba-e8d4-4fe1-91ad-eda16e7077fc_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Cost by Plan [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_0b6d6c58-e7ea-4844-8a1f-93d8f8fe8562_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeDomain_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeDomain" xlink:to="lab_us-gaap_LongtermDebtTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensation_a3c1b61a-f5e5-4679-b05c-0a55c05597f2_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Noncash Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensation" xlink:to="lab_us-gaap_ShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_4a7298e7-85e1-4472-a7e4-6b1c43e4e945_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Tax&#160;payments&#160;related&#160;to&#160;shares&#160;withheld&#160;upon&#160;vesting of&#160;restricted&#160;stock</link:label>
    <link:label id="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payment, Tax Withholding, Share-based Payment Arrangement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_87c4d55b-8ac5-44ef-a768-c8c3b6d5f157_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Net (Excluding Goodwill) [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:to="lab_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_3eb7b0c5-fbc4-4edd-b8d6-291d8d11158c_terseLabel_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:label id="lab_us-gaap_MeasurementInputTypeAxis_label_en-US" xlink:label="lab_us-gaap_MeasurementInputTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_MeasurementInputTypeAxis" xlink:to="lab_us-gaap_MeasurementInputTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_c559aeda-c556-4bc8-a219-455762a2463e_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additions</link:label>
    <link:label id="lab_us-gaap_GoodwillAcquiredDuringPeriod_label_en-US" xlink:label="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Acquired During Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAcquiredDuringPeriod" xlink:to="lab_us-gaap_GoodwillAcquiredDuringPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_71e09198-fb76-4635-9caf-b15e70b0717f_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebt_b25d288f-1fe0-4a41-beb3-b7831a49e923_totalLabel_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net carrying value of Madryn debt</link:label>
    <link:label id="lab_us-gaap_LongTermDebt_label_en-US" xlink:label="lab_us-gaap_LongTermDebt" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebt" xlink:to="lab_us-gaap_LongTermDebt" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_170cdf3b-355a-4372-bb30-737e6d0307d2_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionLineItems_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems" xlink:to="lab_us-gaap_LesseeLeaseDescriptionLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_cd77e100-7066-42bb-b403-db4afbd6c8d3_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeasesTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Leases [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeasesTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeasesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToSuppliers_aad10ce9-cede-4546-9845-3708c9badf96_terseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliers" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases from suppliers</link:label>
    <link:label id="lab_us-gaap_PaymentsToSuppliers_label_en-US" xlink:label="lab_us-gaap_PaymentsToSuppliers" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Suppliers</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToSuppliers" xlink:to="lab_us-gaap_PaymentsToSuppliers" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_77d18c3d-930d-49f2-a347-69467389e79c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract" xlink:to="lab_us-gaap_FairValueDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_PatentsAndLicensingAgreementsMember_5cc330c8-c73e-4097-b93b-b139dd29002c_terseLabel_en-US" xlink:label="lab_esta_PatentsAndLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents and license rights</link:label>
    <link:label id="lab_esta_PatentsAndLicensingAgreementsMember_label_en-US" xlink:label="lab_esta_PatentsAndLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Licensing Agreements [Member]</link:label>
    <link:label id="lab_esta_PatentsAndLicensingAgreementsMember_documentation_en-US" xlink:label="lab_esta_PatentsAndLicensingAgreementsMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Patents And Licensing Agreements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PatentsAndLicensingAgreementsMember" xlink:href="esta-20210331.xsd#esta_PatentsAndLicensingAgreementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_PatentsAndLicensingAgreementsMember" xlink:to="lab_esta_PatentsAndLicensingAgreementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_174ae1b7-467d-4f4a-8334-12ffa9767b91_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_967b300f-7f3d-4220-89a3-7cb301a9833c_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer relationships</link:label>
    <link:label id="lab_us-gaap_CustomerRelationshipsMember_label_en-US" xlink:label="lab_us-gaap_CustomerRelationshipsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Relationships [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerRelationshipsMember" xlink:to="lab_us-gaap_CustomerRelationshipsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_0da69eea-33c0-4595-bef1-c173853021c0_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskByBenchmarkAxis_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:to="lab_us-gaap_ConcentrationRiskByBenchmarkAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_d07c9379-d458-47cf-968d-e97581af8cef_terseLabel_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementEquityComponentsAxis_label_en-US" xlink:label="lab_us-gaap_StatementEquityComponentsAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Components [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementEquityComponentsAxis" xlink:to="lab_us-gaap_StatementEquityComponentsAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockMember_6ab89901-b997-464a-9067-9ed55d945052_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock</link:label>
    <link:label id="lab_us-gaap_RestrictedStockMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockMember" xlink:to="lab_us-gaap_RestrictedStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_188a682b-c257-4493-9a3a-5227ec0f7052_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finished goods</link:label>
    <link:label id="lab_us-gaap_InventoryFinishedGoodsNetOfReserves_label_en-US" xlink:label="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Finished Goods, Net of Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:to="lab_us-gaap_InventoryFinishedGoodsNetOfReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_AmendedMadrynCreditAgreementMember_b99c4e73-0e46-47e7-83fa-78f95596b6ed_terseLabel_en-US" xlink:label="lab_esta_AmendedMadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Madryn Credit Agreement</link:label>
    <link:label id="lab_esta_AmendedMadrynCreditAgreementMember_label_en-US" xlink:label="lab_esta_AmendedMadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Madryn Credit Agreement [Member]</link:label>
    <link:label id="lab_esta_AmendedMadrynCreditAgreementMember_documentation_en-US" xlink:label="lab_esta_AmendedMadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amended Madryn Credit Agreement</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AmendedMadrynCreditAgreementMember" xlink:href="esta-20210331.xsd#esta_AmendedMadrynCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_AmendedMadrynCreditAgreementMember" xlink:to="lab_esta_AmendedMadrynCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_89b1329c-2dc8-4c68-a008-fe1e00fdc59c_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_8130d426-e503-4450-9fa1-06a311ba567f_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentNameDomain_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentNameDomain" xlink:to="lab_us-gaap_DebtInstrumentNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MinimumMember_1dbb7816-314a-4391-ab76-2675e6770620_terseLabel_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum</link:label>
    <link:label id="lab_srt_MinimumMember_label_en-US" xlink:label="lab_srt_MinimumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Minimum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MinimumMember" xlink:to="lab_srt_MinimumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LandMember_2e8cc1b3-eb53-453c-adaa-fc4f471c3dbf_terseLabel_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land</link:label>
    <link:label id="lab_us-gaap_LandMember_label_en-US" xlink:label="lab_us-gaap_LandMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Land [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LandMember" xlink:to="lab_us-gaap_LandMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_63428f2f-07bb-43cf-a40e-01fefa47fc85_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities - current</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiabilityCurrent" xlink:to="lab_us-gaap_OperatingLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_1e0775bd-7612-4175-8ab3-b1683f6ae3df_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation cost</link:label>
    <link:label id="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_label_en-US" xlink:label="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:to="lab_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_EuropeMember_bbcb4a8e-1372-476d-9f58-396a403820a7_terseLabel_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe</link:label>
    <link:label id="lab_srt_EuropeMember_label_en-US" xlink:label="lab_srt_EuropeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Europe [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_EuropeMember" xlink:to="lab_srt_EuropeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_2cfbc941-806a-4438-9642-9023250bab3d_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Finance Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_3064e95c-fb62-4708-90d1-9560511ba826_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_e3c2f507-040e-4269-a928-ce86fd656864_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited/canceled (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_cef25c5a-c976-4dbf-b9f9-322000c5d4de_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Employee Stock Options Valuation Assumptions</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_8f3c338f-867a-4b36-b334-b9014b5541bf_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payroll and related expenses</link:label>
    <link:label id="lab_us-gaap_AccruedSalariesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedSalariesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Salaries, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedSalariesCurrent" xlink:to="lab_us-gaap_AccruedSalariesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_140e10a5-35e2-44c0-9bfd-52817cb3a65e_terseLabel_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:label id="lab_dei_EntityInteractiveDataCurrent_label_en-US" xlink:label="lab_dei_EntityInteractiveDataCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Interactive Data Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityInteractiveDataCurrent" xlink:to="lab_dei_EntityInteractiveDataCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_5a7aa7b0-d0c5-4879-8bc4-2d3e46cb091b_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average exercise price of options exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_bc5cb92f-d532-4245-979f-fe23074278e7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_c95ff86f-1d21-4ae4-a561-f32e763fd90d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurements</link:label>
    <link:label id="lab_us-gaap_FairValueDisclosuresTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Disclosures [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueDisclosuresTextBlock" xlink:to="lab_us-gaap_FairValueDisclosuresTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_590be2e3-4618-4e51-83a7-d922c1f035c8_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from operating activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Operating Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_85962038-a30c-4d04-a30c-8cd59dde9319_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders' Equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_d1356e7c-3c17-410d-ac30-7dfc9891d987_verboseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Note Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:to="lab_us-gaap_StockholdersEquityNoteDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_666a32e5-14db-4f62-9c39-ebd53cbaebdd_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock Options</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option, Activity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_fa403a61-f156-4642-8fa6-2d744ad6a147_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2021 (remaining)</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_0d862606-0b5e-43d8-8718-b11b07ee6012_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:to="lab_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_2054aa74-55de-4330-8397-a1e04986dc39_terseLabel_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:label id="lab_srt_NameOfMajorCustomerDomain_label_en-US" xlink:label="lab_srt_NameOfMajorCustomerDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_NameOfMajorCustomerDomain" xlink:to="lab_srt_NameOfMajorCustomerDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_e1eb4f4a-d3f5-4af1-aa58-7ec388df210f_negatedTerseLabel_en-US" xlink:label="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash used in asset acquisitions</link:label>
    <link:label id="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_label_en-US" xlink:label="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Assets Including Receivables Held</link:label>
    <link:label id="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_documentation_en-US" xlink:label="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Assets Including Receivables Held</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:href="esta-20210331.xsd#esta_PaymentstoAcquireAssetsIncludingReceivablesHeld"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:to="lab_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment_127aea7b-ba91-4538-92f1-c67fac96d6a1_verboseLabel_en-US" xlink:label="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization expense</link:label>
    <link:label id="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization, Property, Plant And Equipment</link:label>
    <link:label id="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment_documentation_en-US" xlink:label="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation And Amortization, Property, Plant And Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:href="esta-20210331.xsd#esta_DepreciationAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_esta_DepreciationAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_eaf88824-af25-48da-b050-5d8c3f6945ed_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3Member_069ed058-23e6-444d-96d8-e23a82699995_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3Member_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3 [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3Member_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3Member" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermB3Member" xlink:to="lab_esta_MadrynCreditAgreementTermB3Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_470a438e-f5d2-4d2c-9aa2-41353c14e8ed_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightDomain_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain" xlink:to="lab_us-gaap_ClassOfWarrantOrRightDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_a7643264-53e0-41b1-a75f-5c9b6eb2cde4_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfStockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Stockholders' Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract" xlink:to="lab_us-gaap_StatementOfStockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_ec8c48c2-17df-4fe1-a36f-bf5724230ea8_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_1a385d81-d08b-4441-b004-8d5166f69e6b_terseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Operating Liabilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_7f939282-9445-40a3-a7bb-6894b77ded2b_terseLabel_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset impairment charges</link:label>
    <link:label id="lab_us-gaap_AssetImpairmentCharges_label_en-US" xlink:label="lab_us-gaap_AssetImpairmentCharges" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Asset Impairment Charges</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetImpairmentCharges" xlink:to="lab_us-gaap_AssetImpairmentCharges" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_1073d048-e367-496e-9550-0f29a2b4599d_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options vested and exercisable (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_0dc0f473-b071-49f9-a52d-33ae27bbef26_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted- Average Grant Date Fair Value</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_8e064599-08a1-4dd9-9072-fe95ec2cfff4_terseLabel_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Legal expenses</link:label>
    <link:label id="lab_us-gaap_DeferredFinanceCostsNet_label_en-US" xlink:label="lab_us-gaap_DeferredFinanceCostsNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DeferredFinanceCostsNet" xlink:to="lab_us-gaap_DeferredFinanceCostsNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_dd351884-b0ed-46f9-a935-9525496a2b9d_terseLabel_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling</link:label>
    <link:label id="lab_us-gaap_ShippingAndHandlingMember_label_en-US" xlink:label="lab_us-gaap_ShippingAndHandlingMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShippingAndHandlingMember" xlink:to="lab_us-gaap_ShippingAndHandlingMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_0f18136a-f078-497f-8823-72e8f66c9eb3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-Average Exercise Price</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_294cb2b4-4901-46bd-a22a-2b37aa5fac1f_terseLabel_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intangible Assets, Gross (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:to="lab_us-gaap_IntangibleAssetsGrossExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_066aa7b3-c821-4385-b5d7-fa6936245424_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of reportable segments</link:label>
    <link:label id="lab_us-gaap_NumberOfReportableSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfReportableSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Reportable Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfReportableSegments" xlink:to="lab_us-gaap_NumberOfReportableSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_3cc98139-b2f1-49d3-9ad0-11f2718e9526_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1d39d3b4-e87e-47c1-8ea7-ae720fc07040_terseLabel_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value of contingent consideration</link:label>
    <link:label id="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_label_en-US" xlink:label="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:to="lab_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_0c081e88-7b46-48ec-8540-1fd5842d7e0e_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Amount of lease payments representing interest</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Undiscounted Excess Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:to="lab_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_VehiclesMember_d14510d8-9462-42a7-beaa-e6c3a3841fe4_terseLabel_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles</link:label>
    <link:label id="lab_us-gaap_VehiclesMember_label_en-US" xlink:label="lab_us-gaap_VehiclesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Vehicles [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_VehiclesMember" xlink:to="lab_us-gaap_VehiclesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_bfaa6a0d-3a14-44e1-a7c9-215fd4b345eb_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Effective interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Interest Rate, Effective Percentage</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:to="lab_us-gaap_DebtInstrumentInterestRateEffectivePercentage" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_9ad281fd-98b7-485b-b9d5-a53ad098140a_terseLabel_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and development</link:label>
    <link:label id="lab_us-gaap_ResearchAndDevelopmentExpenseMember_label_en-US" xlink:label="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Research and Development Expense [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:to="lab_us-gaap_ResearchAndDevelopmentExpenseMember" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_f9360111-7c8a-427a-b85d-11c3bee4e88f_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_137a465b-549c-4c25-80a1-0d8f53bf4c74_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Impairment Losses</link:label>
    <link:label id="lab_us-gaap_GoodwillImpairmentLoss_label_en-US" xlink:label="lab_us-gaap_GoodwillImpairmentLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill, Impairment Loss</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillImpairmentLoss" xlink:to="lab_us-gaap_GoodwillImpairmentLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_f826cb1e-b42b-4bbf-9b56-3e45caac8646_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable, net of allowance for doubtful accounts of $1,121 and $1,143</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableNetCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableNetCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, after Allowance for Credit Loss, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableNetCurrent" xlink:to="lab_us-gaap_AccountsReceivableNetCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_5d6b6469-4c5d-4bbf-93bd-f57e3acadf3c_totalLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_689f44cc-178c-46ea-a1d6-70cd3fbff25e_terseLabel_en-US" xlink:label="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and amortization</link:label>
    <link:label id="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_label_en-US" xlink:label="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Excluding Debt Discount (Premium)</link:label>
    <link:label id="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_documentation_en-US" xlink:label="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation and Amortization, Excluding Debt Discount (Premium)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:href="esta-20210331.xsd#esta_DepreciationandAmortizationExcludingDebtDiscountPremium"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:to="lab_esta_DepreciationandAmortizationExcludingDebtDiscountPremium" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_b4ad29fd-3f9e-41ff-a115-685f877857ec_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk free interest rate, minimum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_be5e84ef-a657-4584-959a-03bc7ead5550_terseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transactions and Translations Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:to="lab_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_WeightedAverageRemainingLeaseTermAbstract_f79c3465-00d4-458f-bcf4-93b8eac37ae5_terseLabel_en-US" xlink:label="lab_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining lease term (years)</link:label>
    <link:label id="lab_esta_WeightedAverageRemainingLeaseTermAbstract_label_en-US" xlink:label="lab_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term [Abstract]</link:label>
    <link:label id="lab_esta_WeightedAverageRemainingLeaseTermAbstract_documentation_en-US" xlink:label="lab_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:href="esta-20210331.xsd#esta_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:to="lab_esta_WeightedAverageRemainingLeaseTermAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_f5641a9f-d886-47fa-85af-ccef3d08237d_terseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted average outstanding shares used for basic and diluted net loss per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_466f0937-c830-4649-bc9d-e71c2f11b8d9_verboseLabel_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted averave common shares used for basic and diluted earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_label_en-US" xlink:label="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted Average Number of Shares Outstanding, Basic and Diluted</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:to="lab_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_4c076cdd-fff3-4828-9bc2-63ef9b303a59_terseLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency translation gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Cash_089f61ed-a64c-4d57-9388-03be0f571007_terseLabel_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:label id="lab_us-gaap_Cash_label_en-US" xlink:label="lab_us-gaap_Cash" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Cash" xlink:to="lab_us-gaap_Cash" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Goodwill_f48296f4-ceb7-4375-a827-ea0c6676bd76_terseLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:label id="lab_us-gaap_Goodwill_72842495-f689-47fc-b177-a74675e5a1b7_periodStartLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_bf9140ce-b8dd-4b02-ab57-2bfa27f95669_periodEndLabel_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending Balance</link:label>
    <link:label id="lab_us-gaap_Goodwill_label_en-US" xlink:label="lab_us-gaap_Goodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Goodwill" xlink:to="lab_us-gaap_Goodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_ad1eca61-6a45-4d4e-90a5-ee16c399897d_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_61b1de5e-aa9d-4b40-8dc0-c21078ea3d6d_totalLabel_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other comprehensive gain</link:label>
    <link:label id="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_label_en-US" xlink:label="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:to="lab_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentTransitionReport_3022cb9b-5f79-4306-8ecc-cc52931b78db_terseLabel_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:label id="lab_dei_DocumentTransitionReport_label_en-US" xlink:label="lab_dei_DocumentTransitionReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Transition Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentTransitionReport" xlink:to="lab_dei_DocumentTransitionReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_WarrantMember_5da7438b-3238-4122-9015-2a858f95a2c0_terseLabel_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants to purchase common shares</link:label>
    <link:label id="lab_us-gaap_WarrantMember_label_en-US" xlink:label="lab_us-gaap_WarrantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_WarrantMember" xlink:to="lab_us-gaap_WarrantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_10411b4b-7fe4-43af-812f-de03628a980e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Warrants outstanding (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_f6f9cc5f-1503-46bc-bf01-07b386a6315e_verboseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightOutstanding_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Outstanding</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:to="lab_us-gaap_ClassOfWarrantOrRightOutstanding" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_bdcec712-3cbe-4189-a4d6-ced96ca96f6c_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Level&#160;2</link:label>
    <link:label id="lab_us-gaap_FairValueInputsLevel2Member_label_en-US" xlink:label="lab_us-gaap_FairValueInputsLevel2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Inputs, Level 2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueInputsLevel2Member" xlink:to="lab_us-gaap_FairValueInputsLevel2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CountryRegion_40ddda75-881a-436a-9a27-5ab7bd689a0b_terseLabel_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:label id="lab_dei_CountryRegion_label_en-US" xlink:label="lab_dei_CountryRegion" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Country Region</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CountryRegion" xlink:to="lab_dei_CountryRegion" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentQuarterlyReport_ddce60d4-deb5-42cb-adef-5b2b5e3726af_terseLabel_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:label id="lab_dei_DocumentQuarterlyReport_label_en-US" xlink:label="lab_dei_DocumentQuarterlyReport" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Quarterly Report</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentQuarterlyReport" xlink:to="lab_dei_DocumentQuarterlyReport" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_59139017-c95b-4fef-9589-6f6f8256ef04_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill</link:label>
    <link:label id="lab_us-gaap_ScheduleOfGoodwillTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Goodwill [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfGoodwillTextBlock" xlink:to="lab_us-gaap_ScheduleOfGoodwillTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_1a06fecf-5c52-467e-a245-f1fbff1495de_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited/canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_33767e86-7b20-44b4-98e5-89501c13e870_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_AccountsReceivableRelatedParties_label_en-US" xlink:label="lab_us-gaap_AccountsReceivableRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsReceivableRelatedParties" xlink:to="lab_us-gaap_AccountsReceivableRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityAbstract_47b38738-b595-4a71-b876-1698ae054bf6_terseLabel_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:label id="lab_us-gaap_EquityAbstract_label_en-US" xlink:label="lab_us-gaap_EquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityAbstract" xlink:to="lab_us-gaap_EquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_c2a60015-0470-4e7e-bd95-45b157034bd2_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:to="lab_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_f0c16483-047a-4c7b-93c5-caf0af075ab8_terseLabel_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures of non-cash investing and financing activities:</link:label>
    <link:label id="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:to="lab_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_5ec44b64-3490-4ea5-bd27-0d2a4df88683_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_3c037735-dac9-43d2-ab7b-dd32640380aa_terseLabel_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding balance owed</link:label>
    <link:label id="lab_us-gaap_AccountsPayableTradeCurrent_label_en-US" xlink:label="lab_us-gaap_AccountsPayableTradeCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Payable, Trade, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccountsPayableTradeCurrent" xlink:to="lab_us-gaap_AccountsPayableTradeCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_dc84bac7-2993-4d81-802c-9b658a773db4_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_b7244b0b-3715-4d6f-8c79-c16195761d36_terseLabel_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer concentration risk</link:label>
    <link:label id="lab_us-gaap_CustomerConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_CustomerConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Customer Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CustomerConcentrationRiskMember" xlink:to="lab_us-gaap_CustomerConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_b1b49cd0-87d0-4503-a7e0-fc95c24c85e5_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</link:label>
    <link:label id="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:to="lab_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_9df1c56c-8ef8-4315-9434-17b11f827e83_terseLabel_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building improvements</link:label>
    <link:label id="lab_us-gaap_BuildingImprovementsMember_label_en-US" xlink:label="lab_us-gaap_BuildingImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Building Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BuildingImprovementsMember" xlink:to="lab_us-gaap_BuildingImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_676b9935-7b97-4b22-b813-feb069021c05_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Term (in years)</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_2be51b19-2510-4dbb-8cfa-db6f792f203a_terseLabel_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of operating segments</link:label>
    <link:label id="lab_us-gaap_NumberOfOperatingSegments_label_en-US" xlink:label="lab_us-gaap_NumberOfOperatingSegments" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Operating Segments</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NumberOfOperatingSegments" xlink:to="lab_us-gaap_NumberOfOperatingSegments" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_8dec8149-e876-4cad-a868-9723a5d429f4_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_92c34903-16f0-4bef-805a-5b21bfa24ea0_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Forfeited/canceled (in shares)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_cac18f22-2215-46b5-981e-ee4ea25b7546_terseLabel_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_DebtDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_DebtDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtDisclosureAbstract" xlink:to="lab_us-gaap_DebtDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_6a5b613c-5e99-4846-9f0a-12487225d4c2_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock_cf54a49b-c731-49d0-8d75-633fe534e446_terseLabel_en-US" xlink:label="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Consolidated Entities</link:label>
    <link:label id="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock_label_en-US" xlink:label="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Consolidated Entities [Table Text Block]</link:label>
    <link:label id="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock_documentation_en-US" xlink:label="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule Of Consolidated Entities [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:href="esta-20210331.xsd#esta_ScheduleOfConsolidatedEntitiesTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:to="lab_esta_ScheduleOfConsolidatedEntitiesTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2b8991e6-8d75-4241-aec3-3e0d97ddb69b_terseLabel_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of debt discount</link:label>
    <link:label id="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts_label_en-US" xlink:label="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amortization of Debt Issuance Costs and Discounts</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:to="lab_us-gaap_AmortizationOfFinancingCostsAndDiscounts" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MeasurementInputProbabilityOfChangeInControlMember_f8986a3a-573c-4d54-bbb2-8cc0e0c9fee0_terseLabel_en-US" xlink:label="lab_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Change in Control</link:label>
    <link:label id="lab_esta_MeasurementInputProbabilityOfChangeInControlMember_label_en-US" xlink:label="lab_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability Of Change In Control [Member]</link:label>
    <link:label id="lab_esta_MeasurementInputProbabilityOfChangeInControlMember_documentation_en-US" xlink:label="lab_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Probability of Change in Control [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:href="esta-20210331.xsd#esta_MeasurementInputProbabilityOfChangeInControlMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:to="lab_esta_MeasurementInputProbabilityOfChangeInControlMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_c00c6635-6c0e-469a-9417-2aab04bb8694_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash provided by financing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Financing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInFinancingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryValuationReserves_5ddc2d91-c32a-44a1-8b78-da6fa03e05fb_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory valuation reserves</link:label>
    <link:label id="lab_us-gaap_InventoryValuationReserves_label_en-US" xlink:label="lab_us-gaap_InventoryValuationReserves" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory Valuation Reserves</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryValuationReserves" xlink:to="lab_us-gaap_InventoryValuationReserves" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_16634b5a-ff8d-49e2-ad5a-355b867a72cf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Aggregate intrinsic value of options vested and exercisable</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_456533e7-ad1b-4d63-ab05-db32318c9635_terseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrecognized share-based compensation cost of unvested RSAs</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_43c7c771-ef57-4ccd-a144-e108cc613285_verboseLabel_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation expense</link:label>
    <link:label id="lab_us-gaap_AllocatedShareBasedCompensationExpense_label_en-US" xlink:label="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Expense</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AllocatedShareBasedCompensationExpense" xlink:to="lab_us-gaap_AllocatedShareBasedCompensationExpense" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_9ea2e067-d3ff-4eb9-ace7-b00412cd2cd5_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Denominator:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockValue_486d9760-9b24-4fdc-912d-cc13cfaba95c_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common shares - zero par value, unlimited amount authorized; 24,094,051 and 23,925,789 shares issued at March 31, 2021 and December 31, 2020, respectively; 23,685,981 and 23,517,719 shares outstanding at March 31, 2021 and December 31, 2020, respectively</link:label>
    <link:label id="lab_us-gaap_CommonStockValue_label_en-US" xlink:label="lab_us-gaap_CommonStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Value, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockValue" xlink:to="lab_us-gaap_CommonStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_7e24043d-08f8-4058-89d3-3db4cff40504_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets Disclosure [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_0466d7f1-efaf-4f8d-8626-5213886d79e4_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalYearFocus_744d2659-782b-4c5c-90d0-b3cc6b319f46_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalYearFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalYearFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Year Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalYearFocus" xlink:to="lab_dei_DocumentFiscalYearFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dd2a571c-fc31-42f6-b03a-f2317ac4ab57_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2023</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_09698bab-48e3-439a-8d6c-6d4d98674640_terseLabel_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term assets:</link:label>
    <link:label id="lab_us-gaap_AssetsNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_AssetsNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract" xlink:to="lab_us-gaap_AssetsNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCurrentReportingStatus_d304447f-b0af-479f-9abe-588ad45dab94_terseLabel_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:label id="lab_dei_EntityCurrentReportingStatus_label_en-US" xlink:label="lab_dei_EntityCurrentReportingStatus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Current Reporting Status</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCurrentReportingStatus" xlink:to="lab_dei_EntityCurrentReportingStatus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_9dcaa1a0-fda7-431f-8b2a-6a0d7caeee2d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Four</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_abc069fd-9d4f-4835-b15a-fd34acca9147_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Change in fair value</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:to="lab_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_ConsultantMember_ff7c1385-2874-4f50-ba8a-a726fd3de548_terseLabel_en-US" xlink:label="lab_esta_ConsultantMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultant</link:label>
    <link:label id="lab_esta_ConsultantMember_label_en-US" xlink:label="lab_esta_ConsultantMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultant [Member]</link:label>
    <link:label id="lab_esta_ConsultantMember_documentation_en-US" xlink:label="lab_esta_ConsultantMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Consultant [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ConsultantMember" xlink:href="esta-20210331.xsd#esta_ConsultantMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_ConsultantMember" xlink:to="lab_esta_ConsultantMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_6f9dde66-5990-416f-9325-8591543f3e15_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerSharePolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerSharePolicyTextBlock" xlink:to="lab_us-gaap_EarningsPerSharePolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_ee18c231-6ebf-4bff-9374-affdcc028bb7_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based compensation (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_DebtInstrumentDefaultInterestRateIncrease_ec7f5155-5d2a-499a-add8-d03c92a5327b_terseLabel_en-US" xlink:label="lab_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Default interest rate</link:label>
    <link:label id="lab_esta_DebtInstrumentDefaultInterestRateIncrease_label_en-US" xlink:label="lab_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate Increase</link:label>
    <link:label id="lab_esta_DebtInstrumentDefaultInterestRateIncrease_documentation_en-US" xlink:label="lab_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Default Interest Rate Increase</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:href="esta-20210331.xsd#esta_DebtInstrumentDefaultInterestRateIncrease"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:to="lab_esta_DebtInstrumentDefaultInterestRateIncrease" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentTable_f4c4b779-bcd6-4727-b0da-d0b7e53b6d80_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentTable_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentTable" xlink:to="lab_us-gaap_DebtInstrumentTable" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementMember_2f36cd2a-c5ea-470f-b4fc-0aa3bf330b77_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementMember_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementMember_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementMember" xlink:to="lab_esta_MadrynCreditAgreementMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_65519177-809e-44ab-82d7-51c5e29725b3_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Granted (in dollars per share)</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_37e80782-ac10-4e0c-b740-a097acc15356_terseLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash flows from investing activities:</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_fbd42a7e-9a51-4e48-a671-54fd644ae075_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common stock, shares issued (in shares)</link:label>
    <link:label id="lab_us-gaap_CommonStockSharesIssued_label_en-US" xlink:label="lab_us-gaap_CommonStockSharesIssued" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock, Shares, Issued</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockSharesIssued" xlink:to="lab_us-gaap_CommonStockSharesIssued" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_b392577c-304a-4498-9cf3-ca001f087b66_terseLabel_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Issuance Costs and Debt Discounts</link:label>
    <link:label id="lab_us-gaap_DebtPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_DebtPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtPolicyTextBlock" xlink:to="lab_us-gaap_DebtPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_bca1f3dd-b145-464f-afda-37f14bc61abf_terseLabel_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of stock and warrants for services or claims</link:label>
    <link:label id="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_label_en-US" xlink:label="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of Stock and Warrants for Services or Claims</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:to="lab_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_ab29e75c-bed3-46f6-b338-cd9f16ebb3ca_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease, liability</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_9d5e5cc4-29c4-4cdc-be2f-fa735f533c5b_totalLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease liabilities</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_7e00c8af-f311-4433-a396-a4f14db35566_verboseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseLiability" xlink:to="lab_us-gaap_OperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_80798e3a-54ab-4d0f-bfe0-9fd803018481_terseLabel_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Note payable, Madryn, net of debt discount and issuance costs</link:label>
    <link:label id="lab_us-gaap_LongTermDebtNoncurrent_label_en-US" xlink:label="lab_us-gaap_LongTermDebtNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Excluding Current Maturities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongTermDebtNoncurrent" xlink:to="lab_us-gaap_LongTermDebtNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_533761e4-f408-44ee-9b36-d4a5d5b029cc_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts receivable</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInAccountsReceivable_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Accounts Receivable</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:to="lab_us-gaap_IncreaseDecreaseInAccountsReceivable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_1cc8a95d-3945-42a1-9ab6-e3b6484f3022_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentLineItems_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentLineItems" xlink:to="lab_us-gaap_DebtInstrumentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_886b508e-7a05-445d-bc1c-fe87727418b8_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Comprehensive Income [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:to="lab_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquity_b683011c-9078-451c-86f4-712bcc0c441a_totalLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_86575b47-0aa1-4448-9194-a0b388f02401_periodStartLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Beginning balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_a3859df3-3e1a-49b1-8008-047f2f91d4ab_periodEndLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Ending balance</link:label>
    <link:label id="lab_us-gaap_StockholdersEquity_label_en-US" xlink:label="lab_us-gaap_StockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquity" xlink:to="lab_us-gaap_StockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_EmployeeAndNonemployeeStockOptionMember_30ff2321-96fd-4082-a9f6-86dea571c484_terseLabel_en-US" xlink:label="lab_esta_EmployeeAndNonemployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase common shares</link:label>
    <link:label id="lab_esta_EmployeeAndNonemployeeStockOptionMember_label_en-US" xlink:label="lab_esta_EmployeeAndNonemployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee And Non-employee Stock Option [Member]</link:label>
    <link:label id="lab_esta_EmployeeAndNonemployeeStockOptionMember_documentation_en-US" xlink:label="lab_esta_EmployeeAndNonemployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee And Non-employee Stock Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonemployeeStockOptionMember" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonemployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_EmployeeAndNonemployeeStockOptionMember" xlink:to="lab_esta_EmployeeAndNonemployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_ba5487bb-e8ef-488f-b8d8-847ed4c130f6_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskTypeDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain" xlink:to="lab_us-gaap_ConcentrationRiskTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_9644e29b-62fe-450a-813f-4a9046755eeb_totalLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total liabilities and shareholders&#8217; equity</link:label>
    <link:label id="lab_us-gaap_LiabilitiesAndStockholdersEquity_label_en-US" xlink:label="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities and Equity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquity" xlink:to="lab_us-gaap_LiabilitiesAndStockholdersEquity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_119b4523-30b6-4567-909a-a36635ae90f3_terseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated other comprehensive income</link:label>
    <link:label id="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_label_en-US" xlink:label="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Other Comprehensive Income (Loss), Net of Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:to="lab_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_f21d03b3-00cc-45d5-98d2-ff16674f19e0_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_04f119c3-b263-465d-ab9a-8b9750759ed3_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:label id="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis_label_en-US" xlink:label="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value Hierarchy and NAV [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:to="lab_us-gaap_FairValueByFairValueHierarchyLevelAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_e6fd8b60-f295-444b-99de-1f1786a8ed1c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cost incurred for intangible assets</link:label>
    <link:label id="lab_us-gaap_PaymentsToAcquireIntangibleAssets_label_en-US" xlink:label="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Payments to Acquire Intangible Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:to="lab_us-gaap_PaymentsToAcquireIntangibleAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_190ef00e-17d3-4dbd-b0e2-b65400bfc507_terseLabel_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares issuable on vesting of restricted stock awards</link:label>
    <link:label id="lab_us-gaap_RestrictedStockUnitsRSUMember_label_en-US" xlink:label="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Restricted Stock Units (RSUs) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RestrictedStockUnitsRSUMember" xlink:to="lab_us-gaap_RestrictedStockUnitsRSUMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingLeaseCost_400874b1-5304-41a7-a310-c1921ab85132_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating lease expense cost</link:label>
    <link:label id="lab_us-gaap_OperatingLeaseCost_label_en-US" xlink:label="lab_us-gaap_OperatingLeaseCost" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Lease, Cost</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingLeaseCost" xlink:to="lab_us-gaap_OperatingLeaseCost" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_2bb85679-c31e-4c26-a832-65b85dcfb570_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2025</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, to be Paid, Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_9097f4e6-5d4f-42e4-88c8-0105b03810ab_terseLabel_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:label id="lab_us-gaap_FinancialInstrumentAxis_label_en-US" xlink:label="lab_us-gaap_FinancialInstrumentAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Financial Instrument [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinancialInstrumentAxis" xlink:to="lab_us-gaap_FinancialInstrumentAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductShelfLife_3790c7af-db13-40d1-a252-1a40f63a8618_terseLabel_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product shelf life</link:label>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductShelfLife_label_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Product Shelf Life</link:label>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductShelfLife_documentation_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Product Shelf Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductShelfLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:to="lab_esta_RevenueFromContractWithCustomerProductShelfLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_57bb054d-e30d-4a73-b259-aa4563d5fce3_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive securities excluded from computation of earnings per share (in shares)</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_7713dd3d-ee32-47d3-8a54-6bca8ebb7564_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityLineItems_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems" xlink:to="lab_us-gaap_LineOfCreditFacilityLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_692f7660-cc1e-4fac-b7f3-103fef74f91d_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Remaining Lease Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityExTransitionPeriod_264e3283-6b9c-4313-8ab5-c789d003559f_terseLabel_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:label id="lab_dei_EntityExTransitionPeriod_label_en-US" xlink:label="lab_dei_EntityExTransitionPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Ex Transition Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityExTransitionPeriod" xlink:to="lab_dei_EntityExTransitionPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_e6725e34-e56a-409f-967c-7817ed4fa3d6_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss from disposal of property and equipment</link:label>
    <link:label id="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_label_en-US" xlink:label="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gain (Loss) on Disposition of Property Plant Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:to="lab_us-gaap_GainLossOnSaleOfPropertyPlantEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_1758a5b2-d2b5-40d8-b72d-cabdd66294b3_verboseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated useful lives</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_a95e862f-0c4d-433d-8ca1-11295200dcd8_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Estimated Useful Lives</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Useful Life</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetUsefulLife" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EquityComponentDomain_7dd3384c-d877-4d62-b080-40206e24a229_terseLabel_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:label id="lab_us-gaap_EquityComponentDomain_label_en-US" xlink:label="lab_us-gaap_EquityComponentDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Component [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EquityComponentDomain" xlink:to="lab_us-gaap_EquityComponentDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusDomain_a6640b83-ad86-447d-915c-e3d4a93c6a38_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusDomain_label_en-US" xlink:label="lab_us-gaap_GranteeStatusDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusDomain" xlink:to="lab_us-gaap_GranteeStatusDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_5b38eb55-87de-40f9-8f09-98d943406e56_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other assets</link:label>
    <link:label id="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_label_en-US" xlink:label="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Increase (Decrease) in Other Noncurrent Assets</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:to="lab_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GrossProfit_d8504358-ccb4-44c5-bf79-75b0c4f01acc_totalLabel_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross profit</link:label>
    <link:label id="lab_us-gaap_GrossProfit_label_en-US" xlink:label="lab_us-gaap_GrossProfit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Profit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GrossProfit" xlink:to="lab_us-gaap_GrossProfit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_2bcd9c3d-5f48-45fa-87f8-9bc80109c1e9_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and equipment, net of accumulated depreciation</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_c622e060-f586-40f7-8c07-5d1484e684cb_totalLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, plant and equipment, net</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentNet_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentNet" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_906387f0-774e-4c37-9925-84ae073eda74_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2024</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year Three</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_8c0dbf9c-468c-4e8b-b875-fbac88c9628c_terseLabel_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in process</link:label>
    <link:label id="lab_us-gaap_ConstructionInProgressMember_label_en-US" xlink:label="lab_us-gaap_ConstructionInProgressMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Construction in Progress [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConstructionInProgressMember" xlink:to="lab_us-gaap_ConstructionInProgressMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_3eeb47dd-7684-4d0f-8f68-695ddf9ec4f5_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shipping and Handling Costs/Revenue Recognition</link:label>
    <link:label id="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Contract with Customer [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:to="lab_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_8352dad2-806c-41b8-a2ff-e5833867614b_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:label id="lab_us-gaap_LesseeLeaseDescriptionTable_label_en-US" xlink:label="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Lease, Description [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable" xlink:to="lab_us-gaap_LesseeLeaseDescriptionTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_95b998f4-3c41-4de8-bdf1-95563beee5bd_terseLabel_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation</link:label>
    <link:label id="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_label_en-US" xlink:label="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:to="lab_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetIncomeLoss_110965ca-9e8e-45a2-9040-679572f81bc0_totalLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_56819c8e-8989-4ed7-84db-6f59aa0eacbf_terseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_47e4afb1-1dad-4ce3-8dc8-188f714d40fd_verboseLabel_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net loss</link:label>
    <link:label id="lab_us-gaap_NetIncomeLoss_label_en-US" xlink:label="lab_us-gaap_NetIncomeLoss" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Income (Loss) Attributable to Parent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetIncomeLoss" xlink:to="lab_us-gaap_NetIncomeLoss" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_f9aebaea-385e-4b55-b519-c9588d2fe8f9_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities - long-term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_8d40bcee-6f4e-46c0-92dc-4d63fd064610_terseLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, short-term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_80b18b92-cd9e-48cc-bacd-e34efa524ebc_totalLabel_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other liabilities, short term</link:label>
    <link:label id="lab_us-gaap_OtherLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_OtherLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherLiabilitiesCurrent" xlink:to="lab_us-gaap_OtherLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_90c575f9-17c3-4237-b17e-fc6b56e083f6_terseLabel_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR)</link:label>
    <link:label id="lab_us-gaap_LondonInterbankOfferedRateLIBORMember_label_en-US" xlink:label="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">London Interbank Offered Rate (LIBOR) [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:to="lab_us-gaap_LondonInterbankOfferedRateLIBORMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeasesAbstract_label_en-US" xlink:label="lab_us-gaap_LeasesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeasesAbstract" xlink:to="lab_us-gaap_LeasesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_fe94f295-e2ee-4cfa-81db-c8833fe2fe60_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:to="lab_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_ab81bcc1-45df-4398-b287-2d337db52089_terseLabel_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:label id="lab_us-gaap_LongtermDebtTypeAxis_label_en-US" xlink:label="lab_us-gaap_LongtermDebtTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LongtermDebtTypeAxis" xlink:to="lab_us-gaap_LongtermDebtTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AssetsCurrent_9bf80708-465b-46e4-9211-5cc122539fe2_totalLabel_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total current assets</link:label>
    <link:label id="lab_us-gaap_AssetsCurrent_label_en-US" xlink:label="lab_us-gaap_AssetsCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Assets, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AssetsCurrent" xlink:to="lab_us-gaap_AssetsCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_ff2a9d12-d492-4f5c-8369-411687dbed79_terseLabel_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:label id="lab_dei_CurrentFiscalYearEndDate_label_en-US" xlink:label="lab_dei_CurrentFiscalYearEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current Fiscal Year End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CurrentFiscalYearEndDate" xlink:to="lab_dei_CurrentFiscalYearEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_c7fbefab-6cc5-4b04-b958-ebad0acd4174_terseLabel_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating expenses:</link:label>
    <link:label id="lab_us-gaap_OperatingExpensesAbstract_label_en-US" xlink:label="lab_us-gaap_OperatingExpensesAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating Expenses [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OperatingExpensesAbstract" xlink:to="lab_us-gaap_OperatingExpensesAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_aad30815-9133-41d8-ae6a-e95bfb8245b8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareAbstract" xlink:to="lab_us-gaap_EarningsPerShareAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_b3d52bcf-7a30-4824-bea9-a2093b6b71f4_terseLabel_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:label id="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_label_en-US" xlink:label="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:to="lab_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_a6340230-f08d-4dc9-a89a-ab2e08372f91_totalLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Total finance lease liabilities</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_d9ebdc4d-2246-4922-8231-661e23aa5faf_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Present value of future minimum lease payments</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiability_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiability" xlink:to="lab_us-gaap_FinanceLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_eda301b9-5cb5-4627-8874-fee982a9ce45_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Unrealized foreign currency loss, net</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), Unrealized</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossUnrealized" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_f6456d8f-5ab9-4e0e-ad8e-503cef2c1e21_terseLabel_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shareholders&#8217; equity:</link:label>
    <link:label id="lab_us-gaap_StockholdersEquityAbstract_label_en-US" xlink:label="lab_us-gaap_StockholdersEquityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stockholders' Equity Attributable to Parent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockholdersEquityAbstract" xlink:to="lab_us-gaap_StockholdersEquityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_7d917a9e-40a0-4574-8344-8c9a7bb83d1e_terseLabel_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of shares called by warrants (in shares)</link:label>
    <link:label id="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_label_en-US" xlink:label="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Warrant or Right, Number of Securities Called by Warrants or Rights</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:to="lab_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_29991ca0-09d4-4f61-b024-98378a1a0abb_terseLabel_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed technology</link:label>
    <link:label id="lab_us-gaap_DevelopedTechnologyRightsMember_label_en-US" xlink:label="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Developed Technology Rights [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DevelopedTechnologyRightsMember" xlink:to="lab_us-gaap_DevelopedTechnologyRightsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_2e3df31c-9137-467e-b5d4-9bc1b1fccdcf_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of Options Outstanding</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_72c7c207-334b-4076-8cce-06551bd2d6da_terseLabel_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:label id="lab_dei_DocumentFiscalPeriodFocus_label_en-US" xlink:label="lab_dei_DocumentFiscalPeriodFocus" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Fiscal Period Focus</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentFiscalPeriodFocus" xlink:to="lab_dei_DocumentFiscalPeriodFocus" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_97d7f809-a13f-4db9-a511-1442183db2a1_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and intangible asset impairment</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetImpairment_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Asset Impairment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetImpairment" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_e9335708-9259-41fc-ac53-dd63abf14722_terseLabel_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized software development costs</link:label>
    <link:label id="lab_us-gaap_SoftwareDevelopmentMember_label_en-US" xlink:label="lab_us-gaap_SoftwareDevelopmentMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Software Development [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SoftwareDevelopmentMember" xlink:to="lab_us-gaap_SoftwareDevelopmentMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_f70700be-87af-447d-8589-29fee74d0a96_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Thereafter</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, after Year Five</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_05428237-1d3a-43bc-915b-b5a393e4fb3c_terseLabel_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Deferred revenue</link:label>
    <link:label id="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent_label_en-US" xlink:label="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Contract with Customer, Liability, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:to="lab_us-gaap_ContractWithCustomerLiabilityNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_59d20de3-c8e8-4abe-a271-a2d5de54077e_terseLabel_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product Concentration Risk</link:label>
    <link:label id="lab_us-gaap_SupplierConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_SupplierConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplierConcentrationRiskMember" xlink:to="lab_us-gaap_SupplierConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MeasurementInputInterestRateVolatilityMember_521ae300-db30-4802-af79-597c7aeaa1b0_terseLabel_en-US" xlink:label="lab_esta_MeasurementInputInterestRateVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest rate volatility</link:label>
    <link:label id="lab_esta_MeasurementInputInterestRateVolatilityMember_label_en-US" xlink:label="lab_esta_MeasurementInputInterestRateVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Interest Rate Volatility [Member]</link:label>
    <link:label id="lab_esta_MeasurementInputInterestRateVolatilityMember_documentation_en-US" xlink:label="lab_esta_MeasurementInputInterestRateVolatilityMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Measurement Input, Interest Rate Volatility [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputInterestRateVolatilityMember" xlink:href="esta-20210331.xsd#esta_MeasurementInputInterestRateVolatilityMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MeasurementInputInterestRateVolatilityMember" xlink:to="lab_esta_MeasurementInputInterestRateVolatilityMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_b9c904de-380d-4447-a437-5c73919f8bb4_terseLabel_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental disclosures:</link:label>
    <link:label id="lab_us-gaap_SupplementalCashFlowInformationAbstract_label_en-US" xlink:label="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplemental Cash Flow Information [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract" xlink:to="lab_us-gaap_SupplementalCashFlowInformationAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_bdeca862-3a62-4b6e-9a13-aa787fd604de_terseLabel_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other</link:label>
    <link:label id="lab_us-gaap_OtherSundryLiabilitiesNoncurrent_label_en-US" xlink:label="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Other Sundry Liabilities, Noncurrent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:to="lab_us-gaap_OtherSundryLiabilitiesNoncurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFilerCategory_43e907e9-608a-457b-ad8a-4525ef4a4afa_terseLabel_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:label id="lab_dei_EntityFilerCategory_label_en-US" xlink:label="lab_dei_EntityFilerCategory" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Filer Category</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFilerCategory" xlink:to="lab_dei_EntityFilerCategory" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CommonStockMember_454fdb27-3381-4588-b17e-1bb28087e04d_terseLabel_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Shares</link:label>
    <link:label id="lab_us-gaap_CommonStockMember_label_en-US" xlink:label="lab_us-gaap_CommonStockMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Common Stock [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CommonStockMember" xlink:to="lab_us-gaap_CommonStockMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_e3611ada-56b9-4725-83c7-03afc32cb43b_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentLineItems_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_ProductsAndServicesDomain_0fd27a04-0045-48bd-8475-fbc4c87e2f9a_terseLabel_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:label id="lab_srt_ProductsAndServicesDomain_label_en-US" xlink:label="lab_srt_ProductsAndServicesDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product and Service [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_ProductsAndServicesDomain" xlink:to="lab_srt_ProductsAndServicesDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_5ebea9eb-967d-4e6a-a4ec-22d503ec70b0_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Type [Domain]</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-Lived Tangible Asset [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTypeDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_3eb52a62-14da-43f5-9f3a-057ab885ef8d_terseLabel_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:label id="lab_us-gaap_ConcentrationRiskBenchmarkDomain_label_en-US" xlink:label="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Concentration Risk Benchmark [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:to="lab_us-gaap_ConcentrationRiskBenchmarkDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_d8ce0544-2995-4f0f-a261-654232da09f7_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate, maximum</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_6d4eef6b-64fd-4700-9a92-a01879271314_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Weighted Average Discount Rate, Percent</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:to="lab_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_6a1ad8e3-08e5-4e49-b1b8-8b73b5a3ee4c_terseLabel_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk</link:label>
    <link:label id="lab_us-gaap_GeographicConcentrationRiskMember_label_en-US" xlink:label="lab_us-gaap_GeographicConcentrationRiskMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Geographic Concentration Risk [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GeographicConcentrationRiskMember" xlink:to="lab_us-gaap_GeographicConcentrationRiskMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_576e258d-61d7-4c1b-bf3a-13c6c2f5333d_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_4b411cec-42d2-4542-ad4a-2fedfeb2d254_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:label id="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_label_en-US" xlink:label="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Supplier [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:to="lab_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_56566738-049b-4e48-949a-eb5ee7630224_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Issuance of common stock (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Shares, New Issues</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesNewIssues" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_fc2b4fb3-9592-4450-a581-44dad83d93a5_terseLabel_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold improvements</link:label>
    <link:label id="lab_us-gaap_LeaseholdImprovementsMember_label_en-US" xlink:label="lab_us-gaap_LeaseholdImprovementsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leasehold Improvements [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LeaseholdImprovementsMember" xlink:to="lab_us-gaap_LeaseholdImprovementsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_9fbfb4e5-c566-45b4-bc47-a1230f246ae7_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Gross Carrying Amount</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsGross_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsGross" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_f5dcda22-c847-4a1b-bad1-a535c9fd9119_terseLabel_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue</link:label>
    <link:label id="lab_us-gaap_SalesRevenueNetMember_label_en-US" xlink:label="lab_us-gaap_SalesRevenueNetMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue Benchmark [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SalesRevenueNetMember" xlink:to="lab_us-gaap_SalesRevenueNetMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_7e0b05f2-754e-4cf8-9ae5-93a412e5ae30_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Net [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsNetAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_f0498117-9bd2-4b2a-b155-9292f56e524b_terseLabel_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for doubtful accounts</link:label>
    <link:label id="lab_us-gaap_ProvisionForDoubtfulAccounts_label_en-US" xlink:label="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accounts Receivable, Credit Loss Expense (Reversal)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProvisionForDoubtfulAccounts" xlink:to="lab_us-gaap_ProvisionForDoubtfulAccounts" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod_3fca6142-6279-43eb-83cd-652820938a4a_terseLabel_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Product return period</link:label>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod_label_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Product Return Period</link:label>
    <link:label id="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod_documentation_en-US" xlink:label="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue From Contract With Customer, Product Return Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductReturnPeriod"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:to="lab_esta_RevenueFromContractWithCustomerProductReturnPeriod" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_aa10f865-ae58-4a00-9b9e-7fe8c47b02bd_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Less: Accumulated depreciation and amortization</link:label>
    <link:label id="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_label_en-US" xlink:label="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:to="lab_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermAMember_8c7d5bd8-432f-45f2-8bfa-860c32fb133a_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermAMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term A</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermAMember_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermAMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term A [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermAMember_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermAMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term A [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermAMember" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermAMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermAMember" xlink:to="lab_esta_MadrynCreditAgreementTermAMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_deef1bba-a643-49a1-8a77-ce7f45947ff0_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercises (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_af566fbd-bdc4-4feb-a762-734b9b816f3e_verboseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of options exercised in period (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_cd5d498f-45c4-407c-b824-f46a824d3d5c_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Exercised (in shares)</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_2bd7e5e4-e36f-405d-9fa2-6d71eecf002a_terseLabel_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:label id="lab_us-gaap_RelatedPartyTransactionsAbstract_label_en-US" xlink:label="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Related Party Transactions [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract" xlink:to="lab_us-gaap_RelatedPartyTransactionsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_4e7c51a6-3a70-492e-b5b6-7f2db143e38d_totalLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net (decrease)/increase in cash</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_dbbb9cd8-4338-4c4b-90cf-67d8a8e9fc84_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease right-of-use assets</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseRightOfUseAsset_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Right-of-Use Asset, after Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseRightOfUseAsset" xlink:to="lab_us-gaap_FinanceLeaseRightOfUseAsset" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_NuSilTechnologyLLCMember_c60ce6f5-abfc-4b0b-b7de-b8872430939a_terseLabel_en-US" xlink:label="lab_esta_NuSilTechnologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NuSil Technology LLC</link:label>
    <link:label id="lab_esta_NuSilTechnologyLLCMember_label_en-US" xlink:label="lab_esta_NuSilTechnologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NuSil Technology LLC [Member]</link:label>
    <link:label id="lab_esta_NuSilTechnologyLLCMember_documentation_en-US" xlink:label="lab_esta_NuSilTechnologyLLCMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">NuSil Technology LLC [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NuSilTechnologyLLCMember" xlink:href="esta-20210331.xsd#esta_NuSilTechnologyLLCMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_NuSilTechnologyLLCMember" xlink:to="lab_esta_NuSilTechnologyLLCMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_ce68062e-ad0c-4a44-a870-b5661030d438_terseLabel_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity</link:label>
    <link:label id="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_label_en-US" xlink:label="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Lessee, Operating Lease, Liability, Maturity [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:to="lab_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_8b687c4d-cf6c-47d0-850e-d91a3657ef53_verboseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Options to purchase shares</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_d1ba63fa-9fc1-4c15-aa0b-d56be85c3005_terseLabel_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee Stock Option</link:label>
    <link:label id="lab_us-gaap_EmployeeStockOptionMember_label_en-US" xlink:label="lab_us-gaap_EmployeeStockOptionMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Option [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EmployeeStockOptionMember" xlink:to="lab_us-gaap_EmployeeStockOptionMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_0ae6ade3-a320-4120-9c62-0c0e95fa2185_terseLabel_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Presentation and Consolidation/Unaudited Interim Condensed Consolidated Financial Information</link:label>
    <link:label id="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Basis of Accounting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_BasisOfAccountingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_80b57ed8-76b4-4e80-b50d-41417ead4c74_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Employee</link:label>
    <link:label id="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember_label_en-US" xlink:label="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Employee [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:to="lab_us-gaap_ShareBasedPaymentArrangementEmployeeMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_4a018c43-e106-410d-9996-cf81ccc11b41_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Credit agreement interest rate</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Debt Instrument, Basis Spread on Variable Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:to="lab_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_78e164e8-c6da-40b4-9927-714e0afff87c_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Risk-free interest rate</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GranteeStatusAxis_71d5ab43-f163-401b-8946-e5c8b4f5c3c0_terseLabel_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:label id="lab_us-gaap_GranteeStatusAxis_label_en-US" xlink:label="lab_us-gaap_GranteeStatusAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Grantee Status [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GranteeStatusAxis" xlink:to="lab_us-gaap_GranteeStatusAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockShares_209d8302-f156-4386-91fc-83adc619dc36_verboseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury stock, shares held (in shares)</link:label>
    <link:label id="lab_us-gaap_TreasuryStockShares_label_en-US" xlink:label="lab_us-gaap_TreasuryStockShares" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Shares</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockShares" xlink:to="lab_us-gaap_TreasuryStockShares" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PlanNameDomain_657e4972-f992-46ed-acab-e8695a7272ca_terseLabel_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:label id="lab_us-gaap_PlanNameDomain_label_en-US" xlink:label="lab_us-gaap_PlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Plan Name [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PlanNameDomain" xlink:to="lab_us-gaap_PlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermB4Member_1f5f98d2-8320-4e6f-824a-c830261933a7_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-4</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB4Member_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-4 [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB4Member_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB4Member" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermB4Member" xlink:to="lab_esta_MadrynCreditAgreementTermB4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InterestPaidNet_d51c0a2f-812e-4e5f-aaf3-9a5f405dc409_terseLabel_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for interest</link:label>
    <link:label id="lab_us-gaap_InterestPaidNet_label_en-US" xlink:label="lab_us-gaap_InterestPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Interest Paid, Excluding Capitalized Interest, Operating Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InterestPaidNet" xlink:to="lab_us-gaap_InterestPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3AndB4Member_73868b3e-b578-4574-aacc-0fc53a493e5e_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3 And B-4</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3AndB4Member_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3 And B-4 [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB3AndB4Member_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-3 And B-4 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3AndB4Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:to="lab_esta_MadrynCreditAgreementTermB3AndB4Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_c1150431-9f48-48c1-b4fc-5a9da92991bf_terseLabel_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Operating leases</link:label>
    <link:label id="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_label_en-US" xlink:label="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-of-Use Asset Obtained in Exchange for Operating Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:to="lab_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_97393642-092b-48c7-bc20-e999dd9bd744_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Formation and Business of the Company</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_66a31775-0e87-4d5b-99d0-4018635474d9_terseLabel_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional paid-in-capital</link:label>
    <link:label id="lab_us-gaap_AdditionalPaidInCapital_label_en-US" xlink:label="lab_us-gaap_AdditionalPaidInCapital" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Additional Paid in Capital</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AdditionalPaidInCapital" xlink:to="lab_us-gaap_AdditionalPaidInCapital" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_6e4b547a-273d-42f3-a029-de410fa04c73_terseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Asset, Expected Amortization, Year One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_fc088b81-c468-4523-9412-bc178eec5979_terseLabel_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:label id="lab_us-gaap_StatementClassOfStockAxis_label_en-US" xlink:label="lab_us-gaap_StatementClassOfStockAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementClassOfStockAxis" xlink:to="lab_us-gaap_StatementClassOfStockAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_4b3c9362-f70b-4532-a0bb-cb9026275fcc_negatedLabel_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign currency transaction gain (loss)</link:label>
    <link:label id="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_label_en-US" xlink:label="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Foreign Currency Transaction Gain (Loss), before Tax</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:to="lab_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_EquityIncentivePlan2018Member_a349a8e1-4621-4f17-930d-d2945a66d826_terseLabel_en-US" xlink:label="lab_esta_EquityIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2018</link:label>
    <link:label id="lab_esta_EquityIncentivePlan2018Member_label_en-US" xlink:label="lab_esta_EquityIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2018 [Member]</link:label>
    <link:label id="lab_esta_EquityIncentivePlan2018Member_documentation_en-US" xlink:label="lab_esta_EquityIncentivePlan2018Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Equity Incentive Plan, 2018 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EquityIncentivePlan2018Member" xlink:href="esta-20210331.xsd#esta_EquityIncentivePlan2018Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_EquityIncentivePlan2018Member" xlink:to="lab_esta_EquityIncentivePlan2018Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_13b78235-1af9-4b76-af67-c1973257598d_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Fair Value, Off-balance Sheet Risks [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:to="lab_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_6aeffa5d-0956-4ebe-ba62-c9eddaf5a088_terseLabel_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory and Cost of Revenue</link:label>
    <link:label id="lab_us-gaap_InventoryPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_InventoryPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_InventoryPolicyTextBlock" xlink:to="lab_us-gaap_InventoryPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_07d9da31-4f3e-4ad7-a03a-3b8f4d3946d8_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Provision for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxExpenseBenefit_label_en-US" xlink:label="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Tax Expense (Benefit)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxExpenseBenefit" xlink:to="lab_us-gaap_IncomeTaxExpenseBenefit" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_NumberOfManufacturingFacilities_de56a786-f1e7-4891-b564-e59faa654edd_terseLabel_en-US" xlink:label="lab_esta_NumberOfManufacturingFacilities" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number of manufacturing facilities</link:label>
    <link:label id="lab_esta_NumberOfManufacturingFacilities_label_en-US" xlink:label="lab_esta_NumberOfManufacturingFacilities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturing Facilities</link:label>
    <link:label id="lab_esta_NumberOfManufacturingFacilities_documentation_en-US" xlink:label="lab_esta_NumberOfManufacturingFacilities" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Number Of Manufacturing Facilities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NumberOfManufacturingFacilities" xlink:href="esta-20210331.xsd#esta_NumberOfManufacturingFacilities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_NumberOfManufacturingFacilities" xlink:to="lab_esta_NumberOfManufacturingFacilities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_d030f208-4bdb-4f60-acdb-268a7200a79d_terseLabel_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash paid for income taxes</link:label>
    <link:label id="lab_us-gaap_IncomeTaxesPaidNet_label_en-US" xlink:label="lab_us-gaap_IncomeTaxesPaidNet" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Income Taxes Paid, Net</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IncomeTaxesPaidNet" xlink:to="lab_us-gaap_IncomeTaxesPaidNet" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_a0b62831-cdf8-439c-8ae2-bb2e22060e7c_periodStartLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodStartLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash at beginning of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_bc7b291c-52a3-4ed8-aaec-1521fa5b2c37_periodEndLabel_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/periodEndLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash at end of period</link:label>
    <link:label id="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_label_en-US" xlink:label="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:to="lab_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_4044cbd1-49a9-4eaa-8ba5-90d93f40d191_terseLabel_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property and Equipment</link:label>
    <link:label id="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Property, Plant and Equipment, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:to="lab_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_948dcb3d-ecf7-4e22-9ca3-2c8ed61bb6e7_terseLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_bcc0a99f-8f96-413a-b0a2-bcb53e8f65ac_totalLabel_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued liabilities</link:label>
    <link:label id="lab_us-gaap_AccruedLiabilitiesCurrent_label_en-US" xlink:label="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accrued Liabilities, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AccruedLiabilitiesCurrent" xlink:to="lab_us-gaap_AccruedLiabilitiesCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_LeasesWeightedAverageDiscountRateAbstract_f89332be-51f0-425c-978c-e438678ba194_terseLabel_en-US" xlink:label="lab_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average discount rate (%)</link:label>
    <link:label id="lab_esta_LeasesWeightedAverageDiscountRateAbstract_label_en-US" xlink:label="lab_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate [Abstract]</link:label>
    <link:label id="lab_esta_LeasesWeightedAverageDiscountRateAbstract_documentation_en-US" xlink:label="lab_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Leases, Weighted Average Discount Rate</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:href="esta-20210331.xsd#esta_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:to="lab_esta_LeasesWeightedAverageDiscountRateAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_f1c132a8-facf-401d-b234-f5989360aebe_verboseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Short-term minimum lease payments under finance leases</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_17d5606b-f970-4ddd-81d9-ba6c80e7a060_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance lease liabilities - short-term</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityCurrent_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityCurrent" xlink:to="lab_us-gaap_FinanceLeaseLiabilityCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_86721f3f-27c0-4be8-b206-cc00e41941c2_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems_97c5a25b-d592-4ffc-82dc-f445ffdb626b_terseLabel_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems_label_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary Of Significant Accounting Policies [Line Items]</link:label>
    <link:label id="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems_documentation_en-US" xlink:label="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">[Line Items] for Summary Of Significant Accounting Policies [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:to="lab_esta_SummaryOfSignificantAccountingPoliciesLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_45b584fc-7a2e-4bd0-80e2-a13dab84c177_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfStockByClassTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfStockByClassTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Stock by Class [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable" xlink:to="lab_us-gaap_ScheduleOfStockByClassTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_e1c83ee1-6f77-439c-9652-3104e7ebcf7a_verboseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Intrinsic value of options exercised in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_2124aaf5-2640-4c1c-b0d9-0a8f69b330d8_terseLabel_en-US" xlink:label="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">ROU assets obtained in exchange for new lease liabilities</link:label>
    <link:label id="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_label_en-US" xlink:label="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]</link:label>
    <link:label id="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_documentation_en-US" xlink:label="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Right-Of-Use Asset Obtained In Exchange For Lease Liability</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:href="esta-20210331.xsd#esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:to="lab_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_4decae4f-85b5-4036-9b78-d5a8e47d4183_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_f210778f-c10f-443a-bc38-f12dbf996076_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets</link:label>
    <link:label id="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Indefinite-Lived Intangible Assets [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:to="lab_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_ca0cd863-0b58-4a6a-83e4-cf83793749d7_terseLabel_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets</link:label>
    <link:label id="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Goodwill and Intangible Assets, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:to="lab_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_5eca95b6-cf6e-4713-addc-bb61289d9416_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:label id="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_label_en-US" xlink:label="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:to="lab_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_fdb0f4bd-c3ae-437a-949b-847f23d608e5_terseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Outstanding principal balance</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_fc9169e4-d439-4cdf-8526-0f99980f31d6_verboseLabel_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/verboseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Principal</link:label>
    <link:label id="lab_us-gaap_DebtInstrumentCarryingAmount_label_en-US" xlink:label="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term Debt, Gross</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_DebtInstrumentCarryingAmount" xlink:to="lab_us-gaap_DebtInstrumentCarryingAmount" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_91d9360e-a761-4a5a-94fc-bf551017e97c_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt</link:label>
    <link:label id="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock_label_en-US" xlink:label="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Long-term Debt Instruments [Table Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:to="lab_us-gaap_ScheduleOfDebtInstrumentsTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_Depreciation_449d4774-4115-40c9-ba8e-b080e1473202_terseLabel_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:label id="lab_us-gaap_Depreciation_label_en-US" xlink:label="lab_us-gaap_Depreciation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Depreciation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_Depreciation" xlink:to="lab_us-gaap_Depreciation" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_390bb841-8a1f-4aca-a16b-672bf4034c03_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_cf2f73a2-435d-4b9f-a6f6-533b184546e4_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_1d03b2a5-25dd-493f-987b-0b7f26acaa53_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_bffc24f5-7f90-40d1-9d00-7db8acf44b5b_terseLabel_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock option exercises</link:label>
    <link:label id="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_label_en-US" xlink:label="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Stock Issued During Period, Value, Stock Options Exercised</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:to="lab_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_734a87f3-1f19-402c-b723-3ad65cc581b9_terseLabel_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Capitalized patents and license rights not yet amortized</link:label>
    <link:label id="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_label_en-US" xlink:label="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Indefinite-lived Intangible Assets (Excluding Goodwill)</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:to="lab_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_d83f8029-d13d-4ce9-947a-1e76bd0fb149_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Finite-Lived Intangible Assets [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:to="lab_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_830429c2-c415-44f6-ba8e-516b1a4495e6_terseLabel_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses</link:label>
    <link:label id="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Selling, General and Administrative Expenses, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:to="lab_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_c4947a3e-2280-432c-9a5f-97f00de7895c_terseLabel_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum borrowing capacity</link:label>
    <link:label id="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_label_en-US" xlink:label="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Line of Credit Facility, Maximum Borrowing Capacity</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:to="lab_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_AwardTypeAxis_e3bd8e8f-c462-41b4-b775-63ffbd7a1226_terseLabel_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:label id="lab_us-gaap_AwardTypeAxis_label_en-US" xlink:label="lab_us-gaap_AwardTypeAxis" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_AwardTypeAxis" xlink:to="lab_us-gaap_AwardTypeAxis" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_bab0d0ae-99d9-4df6-b028-a92809b2f84b_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Amortization</link:label>
    <link:label id="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_label_en-US" xlink:label="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finite-Lived Intangible Assets, Accumulated Amortization</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:to="lab_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_457fa31a-84bd-49b9-bba7-3a32d0cf7444_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">RSAs vested in period</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue" xlink:type="arc" order="1"/>
    <link:label id="lab_srt_MaximumMember_415b5754-9570-4eca-b77f-189d433b57ac_terseLabel_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum</link:label>
    <link:label id="lab_srt_MaximumMember_label_en-US" xlink:label="lab_srt_MaximumMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Maximum [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_srt_MaximumMember" xlink:to="lab_srt_MaximumMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_bb7c2f9a-13f2-42e1-8364-3547278c3919_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:to="lab_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RetainedEarningsMember_7a429bd3-d7cf-4d5f-845b-5acfcc616cf4_terseLabel_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Accumulated Deficit</link:label>
    <link:label id="lab_us-gaap_RetainedEarningsMember_label_en-US" xlink:label="lab_us-gaap_RetainedEarningsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Retained Earnings [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RetainedEarningsMember" xlink:to="lab_us-gaap_RetainedEarningsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_3d3c9064-4253-4f7d-a4e1-ce31a4089d97_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:label id="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_label_en-US" xlink:label="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:to="lab_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_a422839b-758b-40dc-bfe4-e52bba8f9454_terseLabel_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Summary of Significant Accounting Policies</link:label>
    <link:label id="lab_us-gaap_SignificantAccountingPoliciesTextBlock_label_en-US" xlink:label="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Significant Accounting Policies [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:to="lab_us-gaap_SignificantAccountingPoliciesTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_9d4efd26-0d29-4fdf-ac60-f55f224685a8_totalLabel_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/totalLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net cash used in investing activities</link:label>
    <link:label id="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities_label_en-US" xlink:label="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Cash Provided by (Used in) Investing Activities</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:to="lab_us-gaap_NetCashProvidedByUsedInInvestingActivities" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_8ae8a661-5a83-4bc6-84e9-0ecd8c5e7793_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_83a4ed0d-5c52-49f4-807f-16c39d3000a8_terseLabel_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Weighted-average remaining contractual term</link:label>
    <link:label id="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_label_en-US" xlink:label="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:to="lab_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_9091ebf0-82ae-4945-b2f6-a03121e9c474_terseLabel_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:label id="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_label_en-US" xlink:label="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:to="lab_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_4c3ab957-4da2-4d37-8529-0454bd93bf28_terseLabel_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:label id="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_label_en-US" xlink:label="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Award Type [Domain]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:to="lab_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_3823740f-5a86-4c2d-a38f-354af9a0f075_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Long-term liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesNoncurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Noncurrent [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesNoncurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermB2Member_7e291d4c-2b74-4920-8a23-32ab1ae8020b_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB2Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-2</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB2Member_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB2Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-2 [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB2Member_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB2Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-2 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB2Member" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB2Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermB2Member" xlink:to="lab_esta_MadrynCreditAgreementTermB2Member" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_040698ae-41e6-41dc-ac1a-a2d19ae66929_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionCurrent_233f3dfd-9b02-4cd7-8e02-164bdcba409b_terseLabel_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash payable for asset acquisitions</link:label>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionCurrent_label_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payable For Asset Acquisition, Current</link:label>
    <link:label id="lab_esta_CashPayableForAssetAcquisitionCurrent_documentation_en-US" xlink:label="lab_esta_CashPayableForAssetAcquisitionCurrent" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cash Payable For Asset Acquisition, Current</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionCurrent" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionCurrent"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_CashPayableForAssetAcquisitionCurrent" xlink:to="lab_esta_CashPayableForAssetAcquisitionCurrent" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_InventoryRawMaterialsPurchasesMember_cbedda96-18bd-4a85-a46e-8a1f75226127_terseLabel_en-US" xlink:label="lab_esta_InventoryRawMaterialsPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Purchases</link:label>
    <link:label id="lab_esta_InventoryRawMaterialsPurchasesMember_label_en-US" xlink:label="lab_esta_InventoryRawMaterialsPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Purchases [Member]</link:label>
    <link:label id="lab_esta_InventoryRawMaterialsPurchasesMember_documentation_en-US" xlink:label="lab_esta_InventoryRawMaterialsPurchasesMember" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Inventory, Raw Materials, Purchases [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_InventoryRawMaterialsPurchasesMember" xlink:href="esta-20210331.xsd#esta_InventoryRawMaterialsPurchasesMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_InventoryRawMaterialsPurchasesMember" xlink:to="lab_esta_InventoryRawMaterialsPurchasesMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_98f4a362-f892-4709-9b2a-6ee22aeaff0a_terseLabel_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from related parties</link:label>
    <link:label id="lab_us-gaap_RevenueFromRelatedParties_label_en-US" xlink:label="lab_us-gaap_RevenueFromRelatedParties" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Revenue from Related Parties</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_RevenueFromRelatedParties" xlink:to="lab_us-gaap_RevenueFromRelatedParties" xlink:type="arc" order="1"/>
    <link:label id="lab_esta_MadrynCreditAgreementTermB1Member_eca1e741-b69a-4f3f-a203-aa3757b16e70_terseLabel_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB1Member" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-1</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB1Member_label_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB1Member" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-1 [Member]</link:label>
    <link:label id="lab_esta_MadrynCreditAgreementTermB1Member_documentation_en-US" xlink:label="lab_esta_MadrynCreditAgreementTermB1Member" xlink:role="http://www.xbrl.org/2003/role/documentation" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Madryn Credit Agreement - Term B-1 [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB1Member" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB1Member"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_esta_MadrynCreditAgreementTermB1Member" xlink:to="lab_esta_MadrynCreditAgreementTermB1Member" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_TreasuryStockValue_45931cb4-6f4e-4e3d-9d9a-c31c9c82da10_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury shares, at cost, 408,070 shares held at March 31, 2021 and December 31, 2020</link:label>
    <link:label id="lab_us-gaap_TreasuryStockValue_label_en-US" xlink:label="lab_us-gaap_TreasuryStockValue" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Treasury Stock, Value</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_TreasuryStockValue" xlink:to="lab_us-gaap_TreasuryStockValue" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_d55fdc3b-c508-491c-b49c-37979aaefbb8_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Net Loss Per Share</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareTextBlock_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share [Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareTextBlock" xlink:to="lab_us-gaap_EarningsPerShareTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_0ca91651-df51-4895-8782-11e48d3fff20_terseLabel_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:label id="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_label_en-US" xlink:label="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Organization, Consolidation and Presentation of Financial Statements [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:to="lab_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_93ac526a-e189-4f61-8079-63305974c825_terseLabel_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Current liabilities:</link:label>
    <link:label id="lab_us-gaap_LiabilitiesCurrentAbstract_label_en-US" xlink:label="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Liabilities, Current [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract" xlink:to="lab_us-gaap_LiabilitiesCurrentAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityShellCompany_bee6a3ed-412f-4f4a-8d57-a06dcb5a25ae_terseLabel_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:label id="lab_dei_EntityShellCompany_label_en-US" xlink:label="lab_dei_EntityShellCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Shell Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityShellCompany" xlink:to="lab_dei_EntityShellCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_5eea2df8-58bd-4281-85e0-893760bd8b80_terseLabel_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Measurements, Recurring</link:label>
    <link:label id="lab_us-gaap_FairValueMeasurementsRecurringMember_label_en-US" xlink:label="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Fair Value, Recurring [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FairValueMeasurementsRecurringMember" xlink:to="lab_us-gaap_FairValueMeasurementsRecurringMember" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_8b7778c3-e3df-483c-8bbe-945ca419b119_negatedTerseLabel_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)</link:label>
    <link:label id="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_label_en-US" xlink:label="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:to="lab_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_153fecd3-6376-42ad-9389-b0a9bf9bdaf6_terseLabel_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">2022</link:label>
    <link:label id="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_label_en-US" xlink:label="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Finance Lease, Liability, to be Paid, Year Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:to="lab_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_7982bb98-7594-4c3d-9b5d-e074105f1b6c_terseLabel_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segments</link:label>
    <link:label id="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Segment Reporting, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:to="lab_us-gaap_SegmentReportingPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_9613fdf3-ba15-4c7d-97f6-0cef8ca7fcc6_terseLabel_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Borrowings on credit facility</link:label>
    <link:label id="lab_us-gaap_ProceedsFromLinesOfCredit_label_en-US" xlink:label="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Proceeds from Lines of Credit</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_ProceedsFromLinesOfCredit" xlink:to="lab_us-gaap_ProceedsFromLinesOfCredit" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_419ca18f-ba9a-4d2b-9dca-77f9840d6047_terseLabel_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Recent Accounting Standards</link:label>
    <link:label id="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_label_en-US" xlink:label="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">New Accounting Pronouncements, Policy [Policy Text Block]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:to="lab_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_e8d4d58f-9409-468b-8dd8-4875789afb85_terseLabel_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:label id="lab_us-gaap_StatementOfFinancialPositionAbstract_label_en-US" xlink:label="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Statement of Financial Position [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract" xlink:to="lab_us-gaap_StatementOfFinancialPositionAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_1d4c6e87-771f-4ae6-836e-6fd97232f624_terseLabel_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Loss per share:</link:label>
    <link:label id="lab_us-gaap_EarningsPerShareBasicAbstract_label_en-US" xlink:label="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Earnings Per Share, Basic [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract" xlink:to="lab_us-gaap_EarningsPerShareBasicAbstract" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>9
<FILENAME>esta-20210331_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2021 Workiva-->
<!--r:16b977c7-1f25-4f85-8ae7-2403c7852cc7,g:ac86edbc-5373-43d7-b688-910e94887f25-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://establishmentlabs.com/role/Cover" xlink:type="simple" xlink:href="esta-20210331.xsd#Cover"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_ab02495a-98e9-4206-a6a8-7c7f5c82734e" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentType_ab02495a-98e9-4206-a6a8-7c7f5c82734e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentQuarterlyReport_9369e9a0-8e85-4659-9873-ee5c84e6a56a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentQuarterlyReport"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentQuarterlyReport_9369e9a0-8e85-4659-9873-ee5c84e6a56a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_6b8494d2-c4eb-40f1-87f6-90019f3a40a7" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentPeriodEndDate_6b8494d2-c4eb-40f1-87f6-90019f3a40a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentTransitionReport_5240d7fb-5bc4-4f88-a927-1730a50da698" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentTransitionReport"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentTransitionReport_5240d7fb-5bc4-4f88-a927-1730a50da698" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_80b65f70-7b84-4006-874b-506e76320249" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityFileNumber_80b65f70-7b84-4006-874b-506e76320249" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_f7b9dd72-b3d6-459c-b024-1ca3aaa0fe94" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityRegistrantName_f7b9dd72-b3d6-459c-b024-1ca3aaa0fe94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_e713f13d-f4e2-40f2-9861-e106042f4447" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityIncorporationStateCountryCode_e713f13d-f4e2-40f2-9861-e106042f4447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_5c3f72a0-1dd6-499d-867e-fca7a96f5ef5" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityAddressAddressLine1_5c3f72a0-1dd6-499d-867e-fca7a96f5ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_55306c21-659f-4d3f-a0ef-8a908ee35db4" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityAddressAddressLine2_55306c21-659f-4d3f-a0ef-8a908ee35db4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_c283e0e1-31f7-4417-b42a-c8dec3538b83" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityAddressCityOrTown_c283e0e1-31f7-4417-b42a-c8dec3538b83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCountry_bf98e4ff-7bbb-477b-ac4a-482ab635de27" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityAddressCountry"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityAddressCountry_bf98e4ff-7bbb-477b-ac4a-482ab635de27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CountryRegion_28629aac-1595-4151-b46e-9845edd14158" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CountryRegion"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_CountryRegion_28629aac-1595-4151-b46e-9845edd14158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_c1b9d367-8367-4d14-a328-151c2fbf8c29" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_CityAreaCode_c1b9d367-8367-4d14-a328-151c2fbf8c29" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_c9308139-b18a-4335-abd6-12f7890f6f30" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_LocalPhoneNumber_c9308139-b18a-4335-abd6-12f7890f6f30" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCurrentReportingStatus_70627564-2966-42a0-af91-09374b170ae9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCurrentReportingStatus"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityCurrentReportingStatus_70627564-2966-42a0-af91-09374b170ae9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityInteractiveDataCurrent_c050b44b-139b-411a-a8c6-857ce7842ab9" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityInteractiveDataCurrent"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityInteractiveDataCurrent_c050b44b-139b-411a-a8c6-857ce7842ab9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFilerCategory_3dc34ca8-0c11-4f74-b2a6-5875ed7fb324" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityFilerCategory"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityFilerCategory_3dc34ca8-0c11-4f74-b2a6-5875ed7fb324" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntitySmallBusiness_6f60f97a-0e6e-4319-9f85-6656a0cd7e27" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntitySmallBusiness"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntitySmallBusiness_6f60f97a-0e6e-4319-9f85-6656a0cd7e27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_2419e922-a779-41b6-8763-3f57dc4ce20f" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityEmergingGrowthCompany_2419e922-a779-41b6-8763-3f57dc4ce20f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityExTransitionPeriod_03de27ae-d8b5-4e72-825e-3a2cade8d8d8" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityExTransitionPeriod"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityExTransitionPeriod_03de27ae-d8b5-4e72-825e-3a2cade8d8d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityShellCompany_b1e002bb-2615-498e-9587-889e5c035798" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityShellCompany"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityShellCompany_b1e002bb-2615-498e-9587-889e5c035798" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_c38ab966-558a-4edd-8d05-09c9220b61b1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_Security12bTitle_c38ab966-558a-4edd-8d05-09c9220b61b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_f86f8623-f0de-4168-84ca-0a59262e411a" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_TradingSymbol_f86f8623-f0de-4168-84ca-0a59262e411a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_a98b7223-6412-47ed-9391-ab9cdc2df337" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_SecurityExchangeName_a98b7223-6412-47ed-9391-ab9cdc2df337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCommonStockSharesOutstanding_842f3d51-e2cf-45d2-9deb-4021e5b52e58" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCommonStockSharesOutstanding"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityCommonStockSharesOutstanding_842f3d51-e2cf-45d2-9deb-4021e5b52e58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CurrentFiscalYearEndDate_f8b9e387-8ed7-4ded-90ce-a39f54dc1236" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_CurrentFiscalYearEndDate"/>
    <link:presentationArc order="26" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_CurrentFiscalYearEndDate_f8b9e387-8ed7-4ded-90ce-a39f54dc1236" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_83350167-a46a-48e1-9f1f-d3d25f3f1429" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="27" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_AmendmentFlag_83350167-a46a-48e1-9f1f-d3d25f3f1429" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_9b269185-3cf3-4547-b9a6-24cffec318f1" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="28" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_EntityCentralIndexKey_9b269185-3cf3-4547-b9a6-24cffec318f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalYearFocus_3a47b467-3360-42cc-be9d-4a00fadc8681" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalYearFocus"/>
    <link:presentationArc order="29" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentFiscalYearFocus_3a47b467-3360-42cc-be9d-4a00fadc8681" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentFiscalPeriodFocus_cbcfb70a-b778-4414-a60c-32e6ce27045d" xlink:href="https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd#dei_DocumentFiscalPeriodFocus"/>
    <link:presentationArc order="30" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_6ac28ebc-33ca-44c3-893b-ca0bb4520a29" xlink:to="loc_dei_DocumentFiscalPeriodFocus_cbcfb70a-b778-4414-a60c-32e6ce27045d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedBalanceSheets"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_637481f2-2164-4102-a384-0182331c02ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsAbstract_3d4c45ca-9cd8-4759-bb9e-dde683176054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_637481f2-2164-4102-a384-0182331c02ce" xlink:to="loc_us-gaap_AssetsAbstract_3d4c45ca-9cd8-4759-bb9e-dde683176054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d4c45ca-9cd8-4759-bb9e-dde683176054" xlink:to="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Cash_6cf715c8-ac5d-433e-9a51-907f20f19314" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Cash"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:to="loc_us-gaap_Cash_6cf715c8-ac5d-433e-9a51-907f20f19314" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableNetCurrent_6ee45135-5915-4f73-9704-b692667d538d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableNetCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:to="loc_us-gaap_AccountsReceivableNetCurrent_6ee45135-5915-4f73-9704-b692667d538d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_50a2a6c2-450d-4dcf-bf83-3009c0b260f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:to="loc_us-gaap_InventoryNet_50a2a6c2-450d-4dcf-bf83-3009c0b260f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_188dd8ae-306f-4ba6-a9d3-121ea2fd18d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PrepaidExpenseAndOtherAssetsCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:to="loc_us-gaap_PrepaidExpenseAndOtherAssetsCurrent_188dd8ae-306f-4ba6-a9d3-121ea2fd18d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsCurrent_bbf3b832-7367-4e12-970e-8d7d0bd6c72d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsCurrentAbstract_4f05119f-2d63-4797-964a-fd77aa4fbc6f" xlink:to="loc_us-gaap_AssetsCurrent_bbf3b832-7367-4e12-970e-8d7d0bd6c72d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetsNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d4c45ca-9cd8-4759-bb9e-dde683176054" xlink:to="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_54e29dd7-64e0-44f8-87fc-b4cf2c2676b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_54e29dd7-64e0-44f8-87fc-b4cf2c2676b4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_c476a7e4-0820-4b94-8785-16fbac0dcb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:to="loc_us-gaap_Goodwill_c476a7e4-0820-4b94-8785-16fbac0dcb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3478c87-416b-4750-97fe-8f73f2b13af8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_b3478c87-416b-4750-97fe-8f73f2b13af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_eedd5a69-8daa-4864-9366-ced7ca0faf7c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_eedd5a69-8daa-4864-9366-ced7ca0faf7c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAssetsNoncurrent_a50d9fab-3dad-4e89-ac5d-a676cce1bf5d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAssetsNoncurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsNoncurrentAbstract_0a811104-7f48-4228-8aff-6cb5128127da" xlink:to="loc_us-gaap_OtherAssetsNoncurrent_a50d9fab-3dad-4e89-ac5d-a676cce1bf5d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Assets_cb81bf37-3414-4195-86db-11f889cf85c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Assets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AssetsAbstract_3d4c45ca-9cd8-4759-bb9e-dde683176054" xlink:to="loc_us-gaap_Assets_cb81bf37-3414-4195-86db-11f889cf85c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_637481f2-2164-4102-a384-0182331c02ce" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrentAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:to="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableCurrent_603951b2-5101-4f55-b96f-83ae7df6d435" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:to="loc_us-gaap_AccountsPayableCurrent_603951b2-5101-4f55-b96f-83ae7df6d435" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_a1e9de63-d4e2-4448-aeda-e8cecb43c6b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_a1e9de63-d4e2-4448-aeda-e8cecb43c6b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_04af6520-ebee-43d7-833b-c486fa07c669" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_04af6520-ebee-43d7-833b-c486fa07c669" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesCurrent_d4ae5b14-ed00-4ae7-aa48-97b7711f19b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesCurrentAbstract_18cd91e4-e362-44fb-a929-2ac7c10f9702" xlink:to="loc_us-gaap_LiabilitiesCurrent_d4ae5b14-ed00-4ae7-aa48-97b7711f19b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesNoncurrentAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:to="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebtNoncurrent_4e0b63da-7f67-41fc-a355-5eeb77cf2b28" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebtNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:to="loc_us-gaap_LongTermDebtNoncurrent_4e0b63da-7f67-41fc-a355-5eeb77cf2b28" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilitiesNoncurrent_40ee12c6-eb7f-4ab0-8aeb-d9454e96f373" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilitiesNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:to="loc_us-gaap_DerivativeLiabilitiesNoncurrent_40ee12c6-eb7f-4ab0-8aeb-d9454e96f373" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d81b4691-1d95-4045-808b-e4f04fcd6de0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_d81b4691-1d95-4045-808b-e4f04fcd6de0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_f45954eb-bf25-40c0-8c6d-327adf8e762f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_f45954eb-bf25-40c0-8c6d-327adf8e762f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Liabilities_00bc6372-2fdc-4655-a34c-3c9911fc97ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Liabilities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesNoncurrentAbstract_189a019c-264c-454a-acc5-745169457f0d" xlink:to="loc_us-gaap_Liabilities_00bc6372-2fdc-4655-a34c-3c9911fc97ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingencies_266df062-3918-4ca8-9399-8154c3f1c38d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingencies"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:to="loc_us-gaap_CommitmentsAndContingencies_266df062-3918-4ca8-9399-8154c3f1c38d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:to="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockValue_37acc46f-b213-45ba-a65d-d6accff6f227" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_CommonStockValue_37acc46f-b213-45ba-a65d-d6accff6f227" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapital_bfa81a71-197a-41f4-813a-8cb26614fa83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapital"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_AdditionalPaidInCapital_bfa81a71-197a-41f4-813a-8cb26614fa83" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockValue_2543b4d0-b84b-4768-a3c6-b23dfcb85b96" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_TreasuryStockValue_2543b4d0-b84b-4768-a3c6-b23dfcb85b96" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d8fcb85-06fb-4da6-9cc7-b28e5cb26a71" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsAccumulatedDeficit"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_RetainedEarningsAccumulatedDeficit_5d8fcb85-06fb-4da6-9cc7-b28e5cb26a71" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92cc8f96-4f60-41c5-85ff-7124d2b7fc8e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax_92cc8f96-4f60-41c5-85ff-7124d2b7fc8e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_7a5f46ff-225b-49bc-8ab8-bb9b4b725d85" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StockholdersEquityAbstract_9a9fb544-c011-4a68-b472-ea9c7dbf5ef9" xlink:to="loc_us-gaap_StockholdersEquity_7a5f46ff-225b-49bc-8ab8-bb9b4b725d85" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LiabilitiesAndStockholdersEquity_3afef20f-cd15-442c-97f3-a816037b696c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LiabilitiesAndStockholdersEquity"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LiabilitiesAndStockholdersEquityAbstract_579e0395-bbbb-4654-b144-6c81c8f9d216" xlink:to="loc_us-gaap_LiabilitiesAndStockholdersEquity_3afef20f-cd15-442c-97f3-a816037b696c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="simple" xlink:href="esta-20210331.xsd#ConsolidatedBalanceSheetsParenthetical"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfFinancialPositionAbstract_d79a477a-1b55-46ac-95ae-3426586061cd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfFinancialPositionAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d2b77663-3a2a-4b5f-b5f0-11bebf0b9699" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d79a477a-1b55-46ac-95ae-3426586061cd" xlink:to="loc_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent_d2b77663-3a2a-4b5f-b5f0-11bebf0b9699" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_c10ae8a0-8670-49d9-80cb-130bdbc3fa1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d79a477a-1b55-46ac-95ae-3426586061cd" xlink:to="loc_us-gaap_CommonStockSharesIssued_c10ae8a0-8670-49d9-80cb-130bdbc3fa1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6b288ed2-abd5-4a69-83be-b6b9eda92316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d79a477a-1b55-46ac-95ae-3426586061cd" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6b288ed2-abd5-4a69-83be-b6b9eda92316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockShares_e46e1450-12d1-4057-8c8c-4bf5b400ed6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockShares"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfFinancialPositionAbstract_d79a477a-1b55-46ac-95ae-3426586061cd" xlink:to="loc_us-gaap_TreasuryStockShares_e46e1450-12d1-4057-8c8c-4bf5b400ed6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofOperations"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0694d60b-3785-447e-bafb-c1762a0ec46f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_0694d60b-3785-447e-bafb-c1762a0ec46f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CostOfRevenue_d531f68e-b370-42be-8425-691dcfa39486" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CostOfRevenue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_CostOfRevenue_d531f68e-b370-42be-8425-691dcfa39486" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GrossProfit_b2eb81b1-072e-4b13-b77a-904dde26e0d4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GrossProfit"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_GrossProfit_b2eb81b1-072e-4b13-b77a-904dde26e0d4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpensesAbstract_d220d895-0c2b-493c-9773-837635e3e9d0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpensesAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_OperatingExpensesAbstract_d220d895-0c2b-493c-9773-837635e3e9d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_520ec364-8d22-4f9b-826f-dd7cc26655ec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d220d895-0c2b-493c-9773-837635e3e9d0" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_520ec364-8d22-4f9b-826f-dd7cc26655ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpense_d224c8df-d4ae-46d0-a4e4-6c9338829b86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d220d895-0c2b-493c-9773-837635e3e9d0" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpense_d224c8df-d4ae-46d0-a4e4-6c9338829b86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingExpenses_1ae1ec55-522f-48c8-9181-6071fb47789a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingExpenses"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingExpensesAbstract_d220d895-0c2b-493c-9773-837635e3e9d0" xlink:to="loc_us-gaap_OperatingExpenses_1ae1ec55-522f-48c8-9181-6071fb47789a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingIncomeLoss_5b0a25dc-8447-4b3a-a1e8-f92683a47ca2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingIncomeLoss"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_OperatingIncomeLoss_5b0a25dc-8447-4b3a-a1e8-f92683a47ca2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InvestmentIncomeInterest_f2d73aff-fe48-439f-8548-83912a9cb69d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InvestmentIncomeInterest"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_InvestmentIncomeInterest_f2d73aff-fe48-439f-8548-83912a9cb69d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpense_34d08ad7-f65b-4ea9-9b3a-410e286d7164" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_InterestExpense_34d08ad7-f65b-4ea9-9b3a-410e286d7164" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_c0fadf14-a056-4e6b-8eec-55b1f8d7f216" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnDerivativeInstrumentsNetPretax"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_GainLossOnDerivativeInstrumentsNetPretax_c0fadf14-a056-4e6b-8eec-55b1f8d7f216" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9a68cbf0-9c63-4334-8eda-5e02053a24f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_9a68cbf0-9c63-4334-8eda-5e02053a24f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNonoperatingIncomeExpense_63d9b7db-2f27-417d-b217-a10ed33a3138" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNonoperatingIncomeExpense"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_OtherNonoperatingIncomeExpense_63d9b7db-2f27-417d-b217-a10ed33a3138" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aeb7acc4-35d1-40ae-8510-1ff075201848" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_aeb7acc4-35d1-40ae-8510-1ff075201848" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxExpenseBenefit_5b08dcb4-bf39-4f35-9a76-deb00343d769" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxExpenseBenefit"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_IncomeTaxExpenseBenefit_5b08dcb4-bf39-4f35-9a76-deb00343d769" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c6d155f8-1b99-431c-a76b-47943853de87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_NetIncomeLoss_c6d155f8-1b99-431c-a76b-47943853de87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_7f0c86b7-d1c7-4b0b-803d-d8adc9b605c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_7f0c86b7-d1c7-4b0b-803d-d8adc9b605c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_e4a450d3-43a4-4c65-ac1a-7eb8352d601b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementAbstract_0c66182c-be46-47e1-a8c2-4bdf1b3c1533" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_e4a450d3-43a4-4c65-ac1a-7eb8352d601b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofComprehensiveIncomeLoss"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_520ab33d-ac62-44d5-a80b-a910ceff8cff" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_7912ddc7-831b-426a-aeff-6f6c8994341f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_520ab33d-ac62-44d5-a80b-a910ceff8cff" xlink:to="loc_us-gaap_NetIncomeLoss_7912ddc7-831b-426a-aeff-6f6c8994341f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91fc5660-47b1-4bcf-ace2-f90552b7fb15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_520ab33d-ac62-44d5-a80b-a910ceff8cff" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91fc5660-47b1-4bcf-ace2-f90552b7fb15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7a7b151c-765f-4285-bb7a-78f7b8edf090" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91fc5660-47b1-4bcf-ace2-f90552b7fb15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_7a7b151c-765f-4285-bb7a-78f7b8edf090" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_22b58207-a1f8-4171-9372-122eb1003cec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract_91fc5660-47b1-4bcf-ace2-f90552b7fb15" xlink:to="loc_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_22b58207-a1f8-4171-9372-122eb1003cec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomeNetOfTax_89efc575-086f-4f5a-9ea6-446bfda01023" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomeNetOfTax"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract_520ab33d-ac62-44d5-a80b-a910ceff8cff" xlink:to="loc_us-gaap_ComprehensiveIncomeNetOfTax_89efc575-086f-4f5a-9ea6-446bfda01023" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementofShareholdersEquity"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfStockholdersEquityAbstract_24929606-aebb-4a81-951f-2e2f28d7a5c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfStockholdersEquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfStockholdersEquityAbstract_24929606-aebb-4a81-951f-2e2f28d7a5c7" xlink:to="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementEquityComponentsAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:to="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityComponentDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementEquityComponentsAxis_b29209da-a7b4-4cf8-b633-37cb70846054" xlink:to="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockMember_dd8a7d32-85f5-48ca-95cd-638ff6ae8a80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_CommonStockMember_dd8a7d32-85f5-48ca-95cd-638ff6ae8a80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TreasuryStockMember_7a4968c0-1ab0-4003-ac99-72c9c91e1cc4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TreasuryStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_TreasuryStockMember_7a4968c0-1ab0-4003-ac99-72c9c91e1cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdditionalPaidInCapitalMember_9d07635b-9408-42ce-9fcb-ddd99091bc55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdditionalPaidInCapitalMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_AdditionalPaidInCapitalMember_9d07635b-9408-42ce-9fcb-ddd99091bc55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RetainedEarningsMember_cbef17a8-04a5-4197-ae8e-cd67436100e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RetainedEarningsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_RetainedEarningsMember_cbef17a8-04a5-4197-ae8e-cd67436100e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a04c8472-bf1d-40e0-a048-734be4d14074" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedOtherComprehensiveIncomeMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityComponentDomain_80d63787-2156-47fe-8dfc-6fd59d582e5e" xlink:to="loc_us-gaap_AccumulatedOtherComprehensiveIncomeMember_a04c8472-bf1d-40e0-a048-734be4d14074" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementTable_7ca609fb-79e8-4454-af02-a4c5bd19c965" xlink:to="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInStockholdersEquityRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementLineItems_81740cd5-acc1-43c6-8071-f90c058fe4f1" xlink:to="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_f761ccf2-75ee-47f2-b747-3701d2169809" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_SharesIssued_f761ccf2-75ee-47f2-b747-3701d2169809" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_0723e6c1-531b-48c3-ad3e-a2143342acd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockholdersEquity_0723e6c1-531b-48c3-ad3e-a2143342acd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1c12c7e0-e113-48e5-9292-b5dff51deb24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesNewIssues"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesNewIssues_1c12c7e0-e113-48e5-9292-b5dff51deb24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d53c5b14-d5cb-4d85-baba-c141cc54f233" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueNewIssues"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueNewIssues_d53c5b14-d5cb-4d85-baba-c141cc54f233" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0b52b223-e732-4ed7-b375-50b14dceff66" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_0b52b223-e732-4ed7-b375-50b14dceff66" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3574e274-4374-4add-8e0c-ab76836ffaf7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised_3574e274-4374-4add-8e0c-ab76836ffaf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b80224d1-47ff-4027-bf21-b821e1431c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation_b80224d1-47ff-4027-bf21-b821e1431c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3d83ef71-432d-4111-a8fd-40e31089baa0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation_3d83ef71-432d-4111-a8fd-40e31089baa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bb7d5492-f532-4a0d-9bb4-753d2f0c3f95" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation_bb7d5492-f532-4a0d-9bb4-753d2f0c3f95" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4bef9c74-8ac3-4427-966f-b283b428f084" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_4bef9c74-8ac3-4427-966f-b283b428f084" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5378f890-fee3-4e3f-b41e-b2b85a451eb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_5378f890-fee3-4e3f-b41e-b2b85a451eb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_c2a52a77-6483-4fcc-a4d4-c9d9ee98fa52" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_NetIncomeLoss_c2a52a77-6483-4fcc-a4d4-c9d9ee98fa52" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharesIssued_9dfa4a56-e99e-472e-9cc6-e2ea6d3a63f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharesIssued"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_SharesIssued_9dfa4a56-e99e-472e-9cc6-e2ea6d3a63f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquity_130d94ca-47b2-460f-a3c2-4f713b94918a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquity"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward_a8c40ecc-fde7-4551-b936-1f3978748d14" xlink:to="loc_us-gaap_StockholdersEquity_130d94ca-47b2-460f-a3c2-4f713b94918a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="simple" xlink:href="esta-20210331.xsd#CondensedConsolidatedStatementsofCashFlows"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementOfCashFlowsAbstract_c5758ae4-939f-41ed-b485-41c559cd8777" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementOfCashFlowsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementOfCashFlowsAbstract_c5758ae4-939f-41ed-b485-41c559cd8777" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_e810a83f-bb14-4a72-b97e-11219298f2e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_NetIncomeLoss_e810a83f-bb14-4a72-b97e-11219298f2e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_23000580-acda-47db-8454-b87952d37e01" xlink:href="esta-20210331.xsd#esta_DepreciationandAmortizationExcludingDebtDiscountPremium"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_esta_DepreciationandAmortizationExcludingDebtDiscountPremium_23000580-acda-47db-8454-b87952d37e01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProvisionForDoubtfulAccounts_1e132d50-f35f-4584-85d8-a1cb95f903f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProvisionForDoubtfulAccounts"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_ProvisionForDoubtfulAccounts_1e132d50-f35f-4584-85d8-a1cb95f903f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWriteDown_adc77dc4-6ddb-4354-8a08-be332bc62569" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWriteDown"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_InventoryWriteDown_adc77dc4-6ddb-4354-8a08-be332bc62569" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensation_9b5bfb5e-ff5c-4d09-a12a-d538eb335e82" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_ShareBasedCompensation_9b5bfb5e-ff5c-4d09-a12a-d538eb335e82" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c8b519c9-714e-44da-a3f4-4383e13bb824" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GainLossOnSaleOfPropertyPlantEquipment"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_GainLossOnSaleOfPropertyPlantEquipment_c8b519c9-714e-44da-a3f4-4383e13bb824" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c96f2720-ef0c-40ac-ac8a-5eff48e7e5d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossUnrealized"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossUnrealized_c96f2720-ef0c-40ac-ac8a-5eff48e7e5d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ae98d94f-9054-432b-b185-53332d348e4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense_ae98d94f-9054-432b-b185-53332d348e4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UnrealizedGainLossOnDerivatives_354001f5-bda9-467a-9e1e-3720a14193fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UnrealizedGainLossOnDerivatives"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_UnrealizedGainLossOnDerivatives_354001f5-bda9-467a-9e1e-3720a14193fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1a15106d-bd87-4d1a-8167-a89de6cd2e5a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1a15106d-bd87-4d1a-8167-a89de6cd2e5a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2101097b-7b4a-4eb6-8658-572a4dc467f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfFinancingCostsAndDiscounts"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract_353ecf12-0b7e-49b0-975b-dfc9b666dd1d" xlink:to="loc_us-gaap_AmortizationOfFinancingCostsAndDiscounts_2101097b-7b4a-4eb6-8658-572a4dc467f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc356731-7700-46af-b930-12f00fe937ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsReceivable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsReceivable_dc356731-7700-46af-b930-12f00fe937ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInInventories_b13b05f9-1229-4b5f-a9a9-8a4833a56997" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInInventories"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInInventories_b13b05f9-1229-4b5f-a9a9-8a4833a56997" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d96b1162-7663-414a-825b-ee9360f409eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_d96b1162-7663-414a-825b-ee9360f409eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9e8d235b-1e67-4b34-8e8c-ca5bd0a05bb4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherNoncurrentAssets"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets_9e8d235b-1e67-4b34-8e8c-ca5bd0a05bb4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a56d2301-edc1-4ded-a542-236a49125f55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccountsPayable"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccountsPayable_a56d2301-edc1-4ded-a542-236a49125f55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fec839ee-2497-4122-831c-8d3b186c7c60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInAccruedLiabilities"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInAccruedLiabilities_fec839ee-2497-4122-831c-8d3b186c7c60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities_6d5d0fa8-9963-4aec-b14f-7a0542031460" xlink:href="esta-20210331.xsd#esta_IncreaseDecreaseInOperatingLeaseLiabilities"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_esta_IncreaseDecreaseInOperatingLeaseLiabilities_6d5d0fa8-9963-4aec-b14f-7a0542031460" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6ea04001-f651-4a35-976e-83e9603273be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncreaseDecreaseInOtherOperatingLiabilities"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract_c669389e-82f4-404a-9826-96f82f37cc9e" xlink:to="loc_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities_6ea04001-f651-4a35-976e-83e9603273be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a2443fb-1776-49ff-b62b-ae5edc62d193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInOperatingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_NetCashProvidedByUsedInOperatingActivities_1a2443fb-1776-49ff-b62b-ae5edc62d193" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64638866-7087-452a-99d1-4763f1cdfdd9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquirePropertyPlantAndEquipment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:to="loc_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment_64638866-7087-452a-99d1-4763f1cdfdd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_cd0c51fd-5277-409f-818c-00897d7de783" xlink:href="esta-20210331.xsd#esta_PaymentstoAcquireAssetsIncludingReceivablesHeld"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:to="loc_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld_cd0c51fd-5277-409f-818c-00897d7de783" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToAcquireIntangibleAssets_885be851-3243-476c-8308-3f201292796b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToAcquireIntangibleAssets"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:to="loc_us-gaap_PaymentsToAcquireIntangibleAssets_885be851-3243-476c-8308-3f201292796b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9754b460-2ed6-4418-949a-eacbb5375039" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInInvestingActivities"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract_fa8c1a60-1818-418d-b95a-c7156fbfcb50" xlink:to="loc_us-gaap_NetCashProvidedByUsedInInvestingActivities_9754b460-2ed6-4418-949a-eacbb5375039" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_3dcaea0a-9945-4910-ad42-af8745ca2f09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_3dcaea0a-9945-4910-ad42-af8745ca2f09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_20a3cbd0-b896-4d88-9397-a0029a4b6519" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfCommonStock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfCommonStock_20a3cbd0-b896-4d88-9397-a0029a4b6519" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromStockOptionsExercised_b2315dbd-ad14-4060-aa26-21bd3ec9b629" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:to="loc_us-gaap_ProceedsFromStockOptionsExercised_b2315dbd-ad14-4060-aa26-21bd3ec9b629" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f15d15f6-2c4d-46ab-a082-a0c12795372b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:to="loc_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation_f15d15f6-2c4d-46ab-a082-a0c12795372b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_06033f2c-cd4b-4224-8486-d496f721aa1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetCashProvidedByUsedInFinancingActivities"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract_9fd1f0bf-bdf6-45fe-bcae-36c20968e447" xlink:to="loc_us-gaap_NetCashProvidedByUsedInFinancingActivities_06033f2c-cd4b-4224-8486-d496f721aa1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20e31e3c-eb0f-44a6-a9a5-eb74cf9fd8a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_20e31e3c-eb0f-44a6-a9a5-eb74cf9fd8a9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c8eec583-fad4-41e3-9938-f18267816495" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_c8eec583-fad4-41e3-9938-f18267816495" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a30cd55-4701-4d40-9fdf-5b8f71c24c2d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_4a30cd55-4701-4d40-9fdf-5b8f71c24c2d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_93049ec2-6a16-4fc0-ac49-0ee8c8748e7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_93049ec2-6a16-4fc0-ac49-0ee8c8748e7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalCashFlowInformationAbstract_a51697b4-33f6-45b5-ae2c-b39af519176c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalCashFlowInformationAbstract"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract_2de0215e-7e45-47ac-8c8b-c209c1a7e059" xlink:to="loc_us-gaap_SupplementalCashFlowInformationAbstract_a51697b4-33f6-45b5-ae2c-b39af519176c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestPaidNet_00fb50ea-773c-44f3-ae41-002bb5d17e9e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestPaidNet"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a51697b4-33f6-45b5-ae2c-b39af519176c" xlink:to="loc_us-gaap_InterestPaidNet_00fb50ea-773c-44f3-ae41-002bb5d17e9e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxesPaidNet_b6449d68-82ae-4139-8f3a-1b32844f2992" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxesPaidNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a51697b4-33f6-45b5-ae2c-b39af519176c" xlink:to="loc_us-gaap_IncomeTaxesPaidNet_b6449d68-82ae-4139-8f3a-1b32844f2992" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ec1470ec-bbad-4528-9d5a-4a10e1c6edb9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_SupplementalCashFlowInformationAbstract_a51697b4-33f6-45b5-ae2c-b39af519176c" xlink:to="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ec1470ec-bbad-4528-9d5a-4a10e1c6edb9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9e067c41-4279-48fd-8693-d531a5d2104f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CapitalExpendituresIncurredButNotYetPaid"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ec1470ec-bbad-4528-9d5a-4a10e1c6edb9" xlink:to="loc_us-gaap_CapitalExpendituresIncurredButNotYetPaid_9e067c41-4279-48fd-8693-d531a5d2104f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition_44c49b24-f556-4f6a-b9dc-eea1a2d6b7f3" xlink:href="esta-20210331.xsd#esta_NoncashConsiderationPayableRelatedtoAssetAcquisition"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract_ec1470ec-bbad-4528-9d5a-4a10e1c6edb9" xlink:to="loc_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition_44c49b24-f556-4f6a-b9dc-eea1a2d6b7f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompany"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompany" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b20baab-0211-432d-9875-4dab0f204193" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ed6d0033-42bf-462e-9341-b550425ffd7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_9b20baab-0211-432d-9875-4dab0f204193" xlink:to="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock_ed6d0033-42bf-462e-9341-b550425ffd7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FormationandBusinessoftheCompanyDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_806be5be-7459-4454-b6be-c7e082e0486a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NumberOfManufacturingFacilities_5c98383d-5304-4c55-964c-df58d6403c4b" xlink:href="esta-20210331.xsd#esta_NumberOfManufacturingFacilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_806be5be-7459-4454-b6be-c7e082e0486a" xlink:to="loc_esta_NumberOfManufacturingFacilities_5c98383d-5304-4c55-964c-df58d6403c4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPolicies"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_cd2b03d4-cfb6-4504-873b-495e23280d56" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9bcf14bd-b925-49aa-b5c1-6b037da29f6f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SignificantAccountingPoliciesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_cd2b03d4-cfb6-4504-873b-495e23280d56" xlink:to="loc_us-gaap_SignificantAccountingPoliciesTextBlock_9bcf14bd-b925-49aa-b5c1-6b037da29f6f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesPolicies"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5a7e652e-924d-417a-bad3-d580c89c8340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BasisOfAccountingPolicyPolicyTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_BasisOfAccountingPolicyPolicyTextBlock_5a7e652e-924d-417a-bad3-d580c89c8340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConsolidationPolicyTextBlock_70191d33-872a-47c5-b27e-219c53de52a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConsolidationPolicyTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ConsolidationPolicyTextBlock_70191d33-872a-47c5-b27e-219c53de52a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_960d00e5-2f5c-4e0c-8ed6-54f93e79f86c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SegmentReportingPolicyPolicyTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_SegmentReportingPolicyPolicyTextBlock_960d00e5-2f5c-4e0c-8ed6-54f93e79f86c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_GeographicConcentrationsPolicyPolicyTextBlock_3a47fb3e-1475-4809-8a36-e34e95dbd976" xlink:href="esta-20210331.xsd#esta_GeographicConcentrationsPolicyPolicyTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_esta_GeographicConcentrationsPolicyPolicyTextBlock_3a47fb3e-1475-4809-8a36-e34e95dbd976" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_UseOfEstimates_5b07bb6c-ed55-4a7b-9845-1c1535b8f742" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_UseOfEstimates"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_UseOfEstimates_5b07bb6c-ed55-4a7b-9845-1c1535b8f742" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskCreditRisk_4a27ec0a-a105-4a65-b4ea-aa0df17db337" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskCreditRisk"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ConcentrationRiskCreditRisk_4a27ec0a-a105-4a65-b4ea-aa0df17db337" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_c0c578d4-f588-4cd1-8752-8b4991977647" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy_c0c578d4-f588-4cd1-8752-8b4991977647" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_d459f9d0-3900-43e6-979f-560c8ac45a19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy_d459f9d0-3900-43e6-979f-560c8ac45a19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryPolicyTextBlock_22a5fcec-eac9-45ae-998f-53b3e94d89b7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryPolicyTextBlock"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_InventoryPolicyTextBlock_22a5fcec-eac9-45ae-998f-53b3e94d89b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeasesPolicyTextBlock_528cab83-d866-4e20-941b-7f4c0558ec7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeasesPolicyTextBlock"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_LesseeLeasesPolicyTextBlock_528cab83-d866-4e20-941b-7f4c0558ec7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_fc48cd23-66cc-4a5b-a47f-41c5a82c51c1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerPolicyTextBlock"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock_fc48cd23-66cc-4a5b-a47f-41c5a82c51c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_8e8e38d0-367d-4799-bab2-8bffb676c5cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpensePolicy"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpensePolicy_8e8e38d0-367d-4799-bab2-8bffb676c5cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f3f28d5a-fa9b-42a1-b785-6937c6ad55b3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock_f3f28d5a-fa9b-42a1-b785-6937c6ad55b3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_63b5f728-92e6-4050-955d-d3a08340d5be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentPolicyTextBlock"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock_63b5f728-92e6-4050-955d-d3a08340d5be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3b81ead6-8013-411a-97c8-ac6aaa9aa26d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock_3b81ead6-8013-411a-97c8-ac6aaa9aa26d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_db762fae-21fc-4366-9189-f9bce8f0ea36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_db762fae-21fc-4366-9189-f9bce8f0ea36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativesEmbeddedDerivatives_eac6edf1-e6c3-4e7a-b19c-725a27dfe911" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativesEmbeddedDerivatives"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_DerivativesEmbeddedDerivatives_eac6edf1-e6c3-4e7a-b19c-725a27dfe911" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtPolicyTextBlock_8c4cdcdd-318a-4bb6-af25-8a4115258956" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtPolicyTextBlock"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_DebtPolicyTextBlock_8c4cdcdd-318a-4bb6-af25-8a4115258956" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeTaxPolicyTextBlock_d43c660b-b9a0-467c-923b-3cc8042d472a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeTaxPolicyTextBlock"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_IncomeTaxPolicyTextBlock_d43c660b-b9a0-467c-923b-3cc8042d472a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e92d4510-d8be-48cd-a777-593ed7777e2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock_e92d4510-d8be-48cd-a777-593ed7777e2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_785d53fc-0a4c-453e-831d-8717a1564329" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ComprehensiveIncomePolicyPolicyTextBlock"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock_785d53fc-0a4c-453e-831d-8717a1564329" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_64c78721-f3bd-4592-b758-045df54cc8b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy_64c78721-f3bd-4592-b758-045df54cc8b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerSharePolicyTextBlock_09d341ae-5ddc-4958-82d4-da9281a20031" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerSharePolicyTextBlock"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_EarningsPerSharePolicyTextBlock_09d341ae-5ddc-4958-82d4-da9281a20031" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_895f84be-3162-44d2-83c3-38d126bb9dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PriorPeriodReclassificationAdjustmentDescription"/>
    <link:presentationArc order="24" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_PriorPeriodReclassificationAdjustmentDescription_895f84be-3162-44d2-83c3-38d126bb9dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3f069282-2089-45ab-b67c-4bed802aba0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock"/>
    <link:presentationArc order="25" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_bf11fbde-c8cd-49f4-aefd-e7dc7f17b5c2" xlink:to="loc_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock_3f069282-2089-45ab-b67c-4bed802aba0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_56e18f64-11cf-4aa4-96c6-f6976f315e8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ScheduleOfConsolidatedEntitiesTableTextBlock_246c1d42-e9cf-4663-b4c2-1eccf6c640e1" xlink:href="esta-20210331.xsd#esta_ScheduleOfConsolidatedEntitiesTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56e18f64-11cf-4aa4-96c6-f6976f315e8f" xlink:to="loc_esta_ScheduleOfConsolidatedEntitiesTableTextBlock_246c1d42-e9cf-4663-b4c2-1eccf6c640e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1df1eeb3-e005-433b-99b5-4b1400a704ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_56e18f64-11cf-4aa4-96c6-f6976f315e8f" xlink:to="loc_us-gaap_DisaggregationOfRevenueTableTextBlock_1df1eeb3-e005-433b-99b5-4b1400a704ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_518ce400-1405-4b4d-9a55-cd09889ec2a0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_518ce400-1405-4b4d-9a55-cd09889ec2a0" xlink:to="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MajorCustomersAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_NameOfMajorCustomerDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_MajorCustomersAxis_47c0ce5e-1fe3-4caf-a713-3f91d5b72cba" xlink:to="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CustomerOneMember_bbab3334-f195-46eb-8183-7c3716b75497" xlink:href="esta-20210331.xsd#esta_CustomerOneMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_NameOfMajorCustomerDomain_b1192b9b-c59c-47c5-9b2e-873735bfa550" xlink:to="loc_esta_CustomerOneMember_bbab3334-f195-46eb-8183-7c3716b75497" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByBenchmarkAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskBenchmarkDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByBenchmarkAxis_934ec598-05f8-40c1-9f2a-636a229610cf" xlink:to="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SalesRevenueNetMember_4a171c16-dad6-46c9-bdc0-fb081f5ce634" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SalesRevenueNetMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_us-gaap_SalesRevenueNetMember_4a171c16-dad6-46c9-bdc0-fb081f5ce634" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_InventoryRawMaterialsPurchasesMember_44f3daf3-a036-4e6b-9cb4-f750912777fd" xlink:href="esta-20210331.xsd#esta_InventoryRawMaterialsPurchasesMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_esta_InventoryRawMaterialsPurchasesMember_44f3daf3-a036-4e6b-9cb4-f750912777fd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LongLivedAssetsMember_3786fea7-5fb7-42be-b459-d147ffacfb0a" xlink:href="esta-20210331.xsd#esta_LongLivedAssetsMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskBenchmarkDomain_397892ef-017c-40a6-b3b3-2e19aa37f7ab" xlink:to="loc_esta_LongLivedAssetsMember_3786fea7-5fb7-42be-b459-d147ffacfb0a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskByTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskByTypeAxis_05d7b6b4-41ad-4bd3-a2ba-ee79cdebe8d1" xlink:to="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GeographicConcentrationRiskMember_d487afd3-debf-45e2-b92d-b972d4460a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GeographicConcentrationRiskMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_GeographicConcentrationRiskMember_d487afd3-debf-45e2-b92d-b972d4460a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerConcentrationRiskMember_8e93038d-f76b-4e09-a318-1cd77e1a04d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerConcentrationRiskMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_CustomerConcentrationRiskMember_8e93038d-f76b-4e09-a318-1cd77e1a04d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplierConcentrationRiskMember_b0a15d48-164f-4741-910d-68d53707ae99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplierConcentrationRiskMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ConcentrationRiskTypeDomain_f78ed0bd-df49-4717-9c0c-72b67f308506" xlink:to="loc_us-gaap_SupplierConcentrationRiskMember_b0a15d48-164f-4741-910d-68d53707ae99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_c122aff6-d615-4e4c-933f-0e37e9c9efbb" xlink:to="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_BR_9f58aa59-1898-4416-9f11-8bec9829bbf7" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_BR"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:to="loc_country_BR_9f58aa59-1898-4416-9f11-8bec9829bbf7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_country_CR_f9023d53-d46a-46fe-a654-7ea8705695f2" xlink:href="https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd#country_CR"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_366e0f00-27f0-4bf8-9835-e7b4fa2915f3" xlink:to="loc_country_CR_f9023d53-d46a-46fe-a654-7ea8705695f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_8de86c12-ec40-4623-ad20-e2e4f90c8c81" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NuSilTechnologyLLCMember_c80562ed-2ef1-4670-bddc-c897d7fad3b1" xlink:href="esta-20210331.xsd#esta_NuSilTechnologyLLCMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_664e9d65-dd2f-4fab-8dc1-ddec133cc363" xlink:to="loc_esta_NuSilTechnologyLLCMember_c80562ed-2ef1-4670-bddc-c897d7fad3b1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductOrServiceAxis"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_ProductsAndServicesDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductOrServiceAxis_323c1f02-c319-4b86-8572-c2f5a66734db" xlink:to="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShippingAndHandlingMember_7618ddcf-23b5-4a4b-84bc-e92d4a3bd4cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShippingAndHandlingMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_ProductsAndServicesDomain_b9a72499-9031-4604-82fb-490647d8c84b" xlink:to="loc_us-gaap_ShippingAndHandlingMember_7618ddcf-23b5-4a4b-84bc-e92d4a3bd4cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_1050c85b-0529-4f92-b826-7f0690611a35" xlink:to="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1699d788-ffb8-4a27-9aa7-633a46b701dd" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:to="loc_srt_MinimumMember_1699d788-ffb8-4a27-9aa7-633a46b701dd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_03c055a4-c241-4cf4-8f7c-07af43816950" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_c8d04897-3474-4481-9d14-3e93bef4cc33" xlink:to="loc_srt_MaximumMember_03c055a4-c241-4cf4-8f7c-07af43816950" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:href="esta-20210331.xsd#esta_SummaryOfSignificantAccountingPoliciesLineItems"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesTable_a7b44b8f-607a-4aea-b514-dcaf3110b938" xlink:to="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfOperatingSegments_68383ebe-a435-454f-a35e-1c80c4b0e940" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfOperatingSegments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfOperatingSegments_68383ebe-a435-454f-a35e-1c80c4b0e940" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConcentrationRiskPercentage1_fafd517e-664c-4399-94b0-d616d4740f0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConcentrationRiskPercentage1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ConcentrationRiskPercentage1_fafd517e-664c-4399-94b0-d616d4740f0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PaymentsToSuppliers_0253a633-f823-4cb3-8a6e-ba556806cbeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PaymentsToSuppliers"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_PaymentsToSuppliers_0253a633-f823-4cb3-8a6e-ba556806cbeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsPayableTradeCurrent_6e45b9dc-23bb-4947-997b-84816d8a57b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsPayableTradeCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_AccountsPayableTradeCurrent_6e45b9dc-23bb-4947-997b-84816d8a57b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CashEquivalentsAtCarryingValue_79f05af8-7293-4686-b81d-89df8ad8f207" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CashEquivalentsAtCarryingValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_CashEquivalentsAtCarryingValue_79f05af8-7293-4686-b81d-89df8ad8f207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryValuationReserves_a19aaf06-d762-47f6-9bc1-cd14f2cf7105" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryValuationReserves"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_InventoryValuationReserves_a19aaf06-d762-47f6-9bc1-cd14f2cf7105" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efcb51f9-fae8-4a4a-94d5-fa764c6a95f9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpense"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpense_efcb51f9-fae8-4a4a-94d5-fa764c6a95f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod_48d0ba9e-5902-4bc8-b61e-dfaf7df11cc4" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductReturnPeriod"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_esta_RevenueFromContractWithCustomerProductReturnPeriod_48d0ba9e-5902-4bc8-b61e-dfaf7df11cc4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_8274ec60-2fdb-4daf-ad1b-036a8787f9b5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss_8274ec60-2fdb-4daf-ad1b-036a8787f9b5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RevenueFromContractWithCustomerProductShelfLife_c9c17f44-734c-4d5c-aa71-0e3b4c6c16b6" xlink:href="esta-20210331.xsd#esta_RevenueFromContractWithCustomerProductShelfLife"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_esta_RevenueFromContractWithCustomerProductShelfLife_c9c17f44-734c-4d5c-aa71-0e3b4c6c16b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8b33a81-0165-4ddb-a423-1b1d6682ed58" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentUsefulLife"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentUsefulLife_e8b33a81-0165-4ddb-a423-1b1d6682ed58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportableSegments_8b2eb2b9-a3fd-4272-82b8-e2546f7494e0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportableSegments"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfReportableSegments_8b2eb2b9-a3fd-4272-82b8-e2546f7494e0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NumberOfReportingUnits_076a329f-3226-4a65-b0e4-426d9b9faf50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NumberOfReportingUnits"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_NumberOfReportingUnits_076a329f-3226-4a65-b0e4-426d9b9faf50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_08e259a1-ed11-42e0-93c5-9aaab97104ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_08e259a1-ed11-42e0-93c5-9aaab97104ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1bb512ff-2380-401d-ba26-95bc1a541fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetImpairment"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetImpairment_1bb512ff-2380-401d-ba26-95bc1a541fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AssetImpairmentCharges_92e1cdc7-e2db-431d-b0bc-e8c7c1010974" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AssetImpairmentCharges"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_AssetImpairmentCharges_92e1cdc7-e2db-431d-b0bc-e8c7c1010974" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_edbae19a-1047-4ba0-ae96-e3b299ce69b6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ForeignCurrencyTransactionGainLossBeforeTax"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax_edbae19a-1047-4ba0-ae96-e3b299ce69b6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6046f02-40c6-4d9a-a973-6b8f43b7924c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_a6046f02-40c6-4d9a-a973-6b8f43b7924c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_21f4461b-5cd6-4dcb-b51e-fb6e6aea1048" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_SummaryOfSignificantAccountingPoliciesLineItems_5961f869-66cf-4770-a262-4a0254bbe532" xlink:to="loc_us-gaap_OperatingLeaseLiability_21f4461b-5cd6-4dcb-b51e-fb6e6aea1048" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountingPoliciesAbstract_8db4e906-e9ce-4deb-995c-dc3c325e385b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountingPoliciesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AccountingPoliciesAbstract_8db4e906-e9ce-4deb-995c-dc3c325e385b" xlink:to="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_StatementGeographicalAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:to="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_SegmentGeographicalDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_StatementGeographicalAxis_11e1394f-6ac3-45a0-ad49-a5f15938c712" xlink:to="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_EuropeMember_3ec0c2dc-1fd2-4101-9a62-d9c3e77fc90d" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_EuropeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_srt_EuropeMember_3ec0c2dc-1fd2-4101-9a62-d9c3e77fc90d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_LatinAmericaMember_c7394501-c004-4dde-ad0a-c0828c6437c7" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_LatinAmericaMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_srt_LatinAmericaMember_c7394501-c004-4dde-ad0a-c0828c6437c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AsiaPacificAndMiddleEastMember_81cee04a-449d-4033-8617-ecf3bd3d2e57" xlink:href="esta-20210331.xsd#esta_AsiaPacificAndMiddleEastMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_esta_AsiaPacificAndMiddleEastMember_81cee04a-449d-4033-8617-ecf3bd3d2e57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_OtherGeographicalAreasMember_46d41451-4553-4831-b1a8-3d7eea89b9cd" xlink:href="esta-20210331.xsd#esta_OtherGeographicalAreasMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_SegmentGeographicalDomain_7653f1b3-a233-4df6-8952-27f1983c9cad" xlink:to="loc_esta_OtherGeographicalAreasMember_46d41451-4553-4831-b1a8-3d7eea89b9cd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisaggregationOfRevenueLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueTable_d828a3f6-8cae-41e0-9878-079911b504ef" xlink:to="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c94bee4-6514-44b5-947b-bdf645ba83e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisaggregationOfRevenueLineItems_e82ea1e2-8171-45bb-adb9-5a67a87728e4" xlink:to="loc_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax_9c94bee4-6514-44b5-947b-bdf645ba83e1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccounts"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccounts" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c342a4ab-7437-4dd1-b8b4-9dbe61f1ebbe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a50bb709-4196-416f-8493-da7168051b91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SupplementalBalanceSheetDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c342a4ab-7437-4dd1-b8b4-9dbe61f1ebbe" xlink:to="loc_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock_a50bb709-4196-416f-8493-da7168051b91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5a52bcdf-09d0-43b1-bdf0-72b979ef3406" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfInventoryCurrentTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:to="loc_us-gaap_ScheduleOfInventoryCurrentTableTextBlock_5a52bcdf-09d0-43b1-bdf0-72b979ef3406" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7f094490-1f9d-4741-aaa2-a083e46d8788" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTextBlock_7f094490-1f9d-4741-aaa2-a083e46d8788" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_93aa5346-1956-4c5a-a87e-bd54d36f7382" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:to="loc_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock_93aa5346-1956-4c5a-a87e-bd54d36f7382" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9997baf6-7780-4099-a4ce-a2f533d894c7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherCurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:to="loc_us-gaap_OtherCurrentLiabilitiesTableTextBlock_9997baf6-7780-4099-a4ce-a2f533d894c7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_66dd1ea7-4466-499e-98f3-3ec95f314d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherNoncurrentLiabilitiesTableTextBlock"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_955a420e-c61f-43c1-8f17-41691ff6a6bf" xlink:to="loc_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock_66dd1ea7-4466-499e-98f3-3ec95f314d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsInventoryDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c04efce-22cf-4115-87fa-682ea35dec83" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryRawMaterialsNetOfReserves_540c7381-eba7-4728-9327-85646c126e22" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryRawMaterialsNetOfReserves"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c04efce-22cf-4115-87fa-682ea35dec83" xlink:to="loc_us-gaap_InventoryRawMaterialsNetOfReserves_540c7381-eba7-4728-9327-85646c126e22" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryWorkInProcessNetOfReserves_816047b3-50b3-42d8-baf9-f2a3a39fb2ba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryWorkInProcessNetOfReserves"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c04efce-22cf-4115-87fa-682ea35dec83" xlink:to="loc_us-gaap_InventoryWorkInProcessNetOfReserves_816047b3-50b3-42d8-baf9-f2a3a39fb2ba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_90490c42-85ec-4ade-a762-2dff743caca6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryFinishedGoodsNetOfReserves"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c04efce-22cf-4115-87fa-682ea35dec83" xlink:to="loc_us-gaap_InventoryFinishedGoodsNetOfReserves_90490c42-85ec-4ade-a762-2dff743caca6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InventoryNet_76c564f8-a335-47e9-93a4-7f30869799d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InventoryNet"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_4c04efce-22cf-4115-87fa-682ea35dec83" xlink:to="loc_us-gaap_InventoryNet_76c564f8-a335-47e9-93a4-7f30869799d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsPropertyandEquipmentDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e6189c6b-c21d-42f1-a1e1-38816587467e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfPropertyPlantAndEquipmentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_e6189c6b-c21d-42f1-a1e1-38816587467e" xlink:to="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentByTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentByTypeAxis_ef6b6769-44ca-41e9-8584-d7e8f23e723b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MachineryAndEquipmentMember_fd981a43-f3d6-411b-9fbe-8aa6743ca5eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MachineryAndEquipmentMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_MachineryAndEquipmentMember_fd981a43-f3d6-411b-9fbe-8aa6743ca5eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingImprovementsMember_6535a8e2-2b88-42cd-82c8-1e223a8e7a46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingImprovementsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_BuildingImprovementsMember_6535a8e2-2b88-42cd-82c8-1e223a8e7a46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FurnitureAndFixturesMember_d1fd04ab-d227-4e0a-83a6-00a86fbe4674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FurnitureAndFixturesMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_FurnitureAndFixturesMember_d1fd04ab-d227-4e0a-83a6-00a86fbe4674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_BuildingMember_0cb00056-d1db-4b67-ae62-6869a2bc6d55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_BuildingMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_BuildingMember_0cb00056-d1db-4b67-ae62-6869a2bc6d55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseholdImprovementsMember_b57853d6-3553-49d2-81f2-240fb8742c8d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseholdImprovementsMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_LeaseholdImprovementsMember_b57853d6-3553-49d2-81f2-240fb8742c8d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LandMember_c78df011-7557-48a7-a962-0bd82a9b4991" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LandMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_LandMember_c78df011-7557-48a7-a962-0bd82a9b4991" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VehiclesMember_8b464e49-639b-4e50-b347-1e46d8a48d63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VehiclesMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_VehiclesMember_8b464e49-639b-4e50-b347-1e46d8a48d63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ConstructionInProgressMember_0d7b22bc-0145-44be-9682-51c8e7b63a5b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ConstructionInProgressMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentTypeDomain_7f20e05d-8051-43fc-a46a-7c8db796651d" xlink:to="loc_us-gaap_ConstructionInProgressMember_0d7b22bc-0145-44be-9682-51c8e7b63a5b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfPropertyPlantAndEquipmentTable_edbbdc28-4934-44ab-9e85-60cbcc05445b" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentGross_0394b123-88a9-4b4b-acca-6f508ccb9f01" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentGross_0394b123-88a9-4b4b-acca-6f508ccb9f01" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d791710c-0f6e-4cfe-962d-ef14e29eb793" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_d791710c-0f6e-4cfe-962d-ef14e29eb793" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PropertyPlantAndEquipmentNet_d8bed431-be46-4e28-9274-89f7404d4b61" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PropertyPlantAndEquipmentNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PropertyPlantAndEquipmentLineItems_d9dca435-e4c9-44b4-b4a2-6c93e38d9f7e" xlink:to="loc_us-gaap_PropertyPlantAndEquipmentNet_d8bed431-be46-4e28-9274-89f7404d4b61" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27a5b59f-261e-480b-abca-2f166b56d88c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_a6017f0f-cb16-4163-a949-aa51c06ed20a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27a5b59f-261e-480b-abca-2f166b56d88c" xlink:to="loc_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment_a6017f0f-cb16-4163-a949-aa51c06ed20a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DepreciationAndAmortizationPropertyPlantAndEquipment_e25f93d2-4589-4684-8693-eb8e0aee1635" xlink:href="esta-20210331.xsd#esta_DepreciationAndAmortizationPropertyPlantAndEquipment"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27a5b59f-261e-480b-abca-2f166b56d88c" xlink:to="loc_esta_DepreciationAndAmortizationPropertyPlantAndEquipment_e25f93d2-4589-4684-8693-eb8e0aee1635" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_7cc9d1e1-d26a-490c-84d1-24a60b7ec6e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27a5b59f-261e-480b-abca-2f166b56d88c" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization_7cc9d1e1-d26a-490c-84d1-24a60b7ec6e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Depreciation_e89b7821-ae58-45ca-9d3a-c7f755fb885f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Depreciation"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_27a5b59f-261e-480b-abca-2f166b56d88c" xlink:to="loc_us-gaap_Depreciation_e89b7821-ae58-45ca-9d3a-c7f755fb885f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsAccruedLiabilitiesDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedBonusesCurrent_40058fee-6644-4242-b0a9-65fb35d495d1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedBonusesCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_AccruedBonusesCurrent_40058fee-6644-4242-b0a9-65fb35d495d1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalariesCurrent_fa5b5066-e5a9-40b6-bd9c-dfe029a143d8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalariesCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_AccruedSalariesCurrent_fa5b5066-e5a9-40b6-bd9c-dfe029a143d8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AccruedStockOptionGrantBonusCurrent_8581b938-1f74-42d6-9d49-4b593c53eacc" xlink:href="esta-20210331.xsd#esta_AccruedStockOptionGrantBonusCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_esta_AccruedStockOptionGrantBonusCurrent_8581b938-1f74-42d6-9d49-4b593c53eacc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_a258a680-13df-4163-abe5-30ae1d4a2632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_a258a680-13df-4163-abe5-30ae1d4a2632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedSalesCommissionCurrent_f4b7cfed-9dc4-446a-a19b-4f9eb219a2af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedSalesCommissionCurrent"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_AccruedSalesCommissionCurrent_f4b7cfed-9dc4-446a-a19b-4f9eb219a2af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedProfessionalFeesCurrent_52a6de58-ca2d-41b2-b0ea-4f6be47860bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedProfessionalFeesCurrent"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_AccruedProfessionalFeesCurrent_52a6de58-ca2d-41b2-b0ea-4f6be47860bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_bb049e48-7ceb-46c1-b7e2-64749aa66cbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_bb049e48-7ceb-46c1-b7e2-64749aa66cbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_f2a33e6d-9a79-4fb2-9a31-c2df9b3b281c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProductWarrantyAccrualClassifiedCurrent"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_ProductWarrantyAccrualClassifiedCurrent_f2a33e6d-9a79-4fb2-9a31-c2df9b3b281c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_7934d372-d69c-465e-baf4-22eddd45a387" xlink:href="esta-20210331.xsd#esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent_7934d372-d69c-465e-baf4-22eddd45a387" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8435e070-7e0e-43ab-8df6-7075a3f68ab8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherAccruedLiabilitiesCurrent"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_OtherAccruedLiabilitiesCurrent_8435e070-7e0e-43ab-8df6-7075a3f68ab8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccruedLiabilitiesCurrent_9265f5a1-a630-48fe-8cbb-0129071b5765" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccruedLiabilitiesCurrent"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_AccruedLiabilitiesCurrent_9265f5a1-a630-48fe-8cbb-0129071b5765" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3df24f26-ce81-41fc-a1ac-9796806d52aa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_c0c23899-bc13-46cb-811b-4eb9e36c7ede" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList_3df24f26-ce81-41fc-a1ac-9796806d52aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesShortTermDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_245db185-8daa-4fea-b78c-6c7a7627e4ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityCurrent_618e028e-7b50-4671-86f5-a0ba06ab49c3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityCurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_245db185-8daa-4fea-b78c-6c7a7627e4ce" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityCurrent_618e028e-7b50-4671-86f5-a0ba06ab49c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionCurrent_68d4c67d-4db6-4997-83ba-92e6f56ef461" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_245db185-8daa-4fea-b78c-6c7a7627e4ce" xlink:to="loc_esta_CashPayableForAssetAcquisitionCurrent_68d4c67d-4db6-4997-83ba-92e6f56ef461" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesCurrent_18d9dffd-a193-487d-bc0d-41ee50d7f059" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesCurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_245db185-8daa-4fea-b78c-6c7a7627e4ce" xlink:to="loc_us-gaap_OtherLiabilitiesCurrent_18d9dffd-a193-487d-bc0d-41ee50d7f059" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#BalanceSheetAccountsOtherLiabilitiesLongTermDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9f7fcc-912f-4d1d-a582-342b9f2aa9a5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6cd6d6ea-a754-410a-8124-72da324bd009" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ContractWithCustomerLiabilityNoncurrent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9f7fcc-912f-4d1d-a582-342b9f2aa9a5" xlink:to="loc_us-gaap_ContractWithCustomerLiabilityNoncurrent_6cd6d6ea-a754-410a-8124-72da324bd009" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashPayableForAssetAcquisitionNoncurrent_e0b8065b-5ae9-4f1e-9ed4-1f1b91d3ebfa" xlink:href="esta-20210331.xsd#esta_CashPayableForAssetAcquisitionNoncurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9f7fcc-912f-4d1d-a582-342b9f2aa9a5" xlink:to="loc_esta_CashPayableForAssetAcquisitionNoncurrent_e0b8065b-5ae9-4f1e-9ed4-1f1b91d3ebfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_16a05f1e-7168-4637-8734-0a840dc6410c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherSundryLiabilitiesNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9f7fcc-912f-4d1d-a582-342b9f2aa9a5" xlink:to="loc_us-gaap_OtherSundryLiabilitiesNoncurrent_16a05f1e-7168-4637-8734-0a840dc6410c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherLiabilitiesNoncurrent_b01d4aa3-fc2d-4dea-86bd-f795593f95cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherLiabilitiesNoncurrent"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract_ad9f7fcc-912f-4d1d-a582-342b9f2aa9a5" xlink:to="loc_us-gaap_OtherLiabilitiesNoncurrent_b01d4aa3-fc2d-4dea-86bd-f795593f95cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssets"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e5df4a71-df25-4eef-8f8e-dd37734f6ac0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_60757904-9fb0-40dd-9310-dc0d0dd555bc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_e5df4a71-df25-4eef-8f8e-dd37734f6ac0" xlink:to="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock_60757904-9fb0-40dd-9310-dc0d0dd555bc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24df2fbc-a55c-4332-a582-cec6f9941c89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfGoodwillTextBlock_738f5798-a062-4975-b14b-bf59e71f7fa1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfGoodwillTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24df2fbc-a55c-4332-a582-cec6f9941c89" xlink:to="loc_us-gaap_ScheduleOfGoodwillTextBlock_738f5798-a062-4975-b14b-bf59e71f7fa1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0b7ab8a5-b944-453d-83c4-21510f9e3c2f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24df2fbc-a55c-4332-a582-cec6f9941c89" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_0b7ab8a5-b944-453d-83c4-21510f9e3c2f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_03b35aa9-6a41-4178-a0cb-58a29a77d349" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24df2fbc-a55c-4332-a582-cec6f9941c89" xlink:to="loc_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock_03b35aa9-6a41-4178-a0cb-58a29a77d349" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3c297f19-98d0-447a-9936-c8454518cc9b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_24df2fbc-a55c-4332-a582-cec6f9941c89" xlink:to="loc_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_3c297f19-98d0-447a-9936-c8454518cc9b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsGoodwillDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8607b265-1499-4e33-ae0b-b4aa6daebbdb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_8607b265-1499-4e33-ae0b-b4aa6daebbdb" xlink:to="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_6cfaf27d-e4d3-41fc-9539-28155e0a490f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:to="loc_us-gaap_Goodwill_6cfaf27d-e4d3-41fc-9539-28155e0a490f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAcquiredDuringPeriod_1b82765b-b9bd-4c58-87d8-6ef234891e75" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAcquiredDuringPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:to="loc_us-gaap_GoodwillAcquiredDuringPeriod_1b82765b-b9bd-4c58-87d8-6ef234891e75" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillImpairmentLoss_b8b25a21-6614-4a86-94f7-dbdcf57f08c4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillImpairmentLoss"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:to="loc_us-gaap_GoodwillImpairmentLoss_b8b25a21-6614-4a86-94f7-dbdcf57f08c4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_Goodwill_bfe32422-30a1-4442-94cb-89b4f41d0a84" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_Goodwill"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillRollForward_e138be72-745d-4814-8c7a-ae8f94b05396" xlink:to="loc_us-gaap_Goodwill_bfe32422-30a1-4442-94cb-89b4f41d0a84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe978866-c2cd-4a1c-86f4-732db59f2fb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_fe978866-c2cd-4a1c-86f4-732db59f2fb1" xlink:to="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis_879ae3d4-25e6-47e5-8270-9905704dd0f0" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_PatentsAndLicensingAgreementsMember_a43387f6-036e-4632-af7f-d988fd966565" xlink:href="esta-20210331.xsd#esta_PatentsAndLicensingAgreementsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_esta_PatentsAndLicensingAgreementsMember_a43387f6-036e-4632-af7f-d988fd966565" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CustomerRelationshipsMember_04ee4b6e-4c8f-4023-8603-7bd49b2d97d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CustomerRelationshipsMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_CustomerRelationshipsMember_04ee4b6e-4c8f-4023-8603-7bd49b2d97d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_A510kAuthorizationMember_7065612d-27bd-419e-a71c-0ee561216c58" xlink:href="esta-20210331.xsd#esta_A510kAuthorizationMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_esta_A510kAuthorizationMember_7065612d-27bd-419e-a71c-0ee561216c58" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DevelopedTechnologyRightsMember_d56a1b0b-4467-4e85-ac77-55b123214fe1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DevelopedTechnologyRightsMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_DevelopedTechnologyRightsMember_d56a1b0b-4467-4e85-ac77-55b123214fe1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SoftwareDevelopmentMember_1c4131c6-cae1-4075-b2c3-578818a8ce24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SoftwareDevelopmentMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_SoftwareDevelopmentMember_1c4131c6-cae1-4075-b2c3-578818a8ce24" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OtherIntangibleAssetsMember_746504db-9f06-4936-8e92-c7d30da08c0c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OtherIntangibleAssetsMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain_112c627e-e2bf-415f-a4bd-fe3db16e3dc9" xlink:to="loc_us-gaap_OtherIntangibleAssetsMember_746504db-9f06-4936-8e92-c7d30da08c0c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:to="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_9bf83ede-c3dd-4c1e-a36e-fd680cd9ef0e" xlink:to="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_1b5bca8c-20ba-4397-b14b-9185f5232f72" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:to="loc_srt_MinimumMember_1b5bca8c-20ba-4397-b14b-9185f5232f72" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_f4787b29-6814-4418-9d4a-06694460948f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_dfe12e29-e427-4dcd-88d7-1b3c777f5290" xlink:to="loc_srt_MaximumMember_f4787b29-6814-4418-9d4a-06694460948f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable_042a147b-9052-4692-8bb8-06009bc68b9a" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNetAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0c754ce8-ed24-4ee0-aba2-2cd41a810288" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsGross"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsGross_0c754ce8-ed24-4ee0-aba2-2cd41a810288" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a5d59704-3526-4fd8-b5d8-18caf240074a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization_a5d59704-3526-4fd8-b5d8-18caf240074a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d595d177-91ed-49bc-adf4-cb2842e022e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_d595d177-91ed-49bc-adf4-cb2842e022e9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_06686d51-cfa1-4ffa-80f4-8de75e2bae31" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetUsefulLife"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsNetAbstract_e1058ba7-ffe5-492a-9e24-98d61c08646d" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetUsefulLife_06686d51-cfa1-4ffa-80f4-8de75e2bae31" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_17fa9261-f5d5-429a-8d7e-1ff97cc82bec" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract_937b7fe9-d066-49c4-bd06-64b205e0b451" xlink:to="loc_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill_17fa9261-f5d5-429a-8d7e-1ff97cc82bec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FiniteLivedIntangibleAssetsLineItems_3e381e0b-063a-4ef9-aefd-70ac4b4632de" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f0f94bdf-6fe6-40c2-9020-fcb8111c7cb1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsGrossExcludingGoodwill"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:to="loc_us-gaap_IntangibleAssetsGrossExcludingGoodwill_f0f94bdf-6fe6-40c2-9020-fcb8111c7cb1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cb14cc25-90af-4c25-8cdc-b3ffdd08acbc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IntangibleAssetsNetExcludingGoodwill"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract_a974fe08-d442-4c0c-9528-a8762e45c32b" xlink:to="loc_us-gaap_IntangibleAssetsNetExcludingGoodwill_cb14cc25-90af-4c25-8cdc-b3ffdd08acbc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46c9c4a0-c653-4caf-aae9-aac0d635db24" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AmortizationOfIntangibleAssets_30288494-50e9-4c3e-a549-8d2bbac15f2b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AmortizationOfIntangibleAssets"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_46c9c4a0-c653-4caf-aae9-aac0d635db24" xlink:to="loc_us-gaap_AmortizationOfIntangibleAssets_30288494-50e9-4c3e-a549-8d2bbac15f2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b387d4a7-81f5-413e-8340-4e66936b0cf1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear_b387d4a7-81f5-413e-8340-4e66936b0cf1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fe0e6748-67be-4113-ac37-829ec0e3658f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_fe0e6748-67be-4113-ac37-829ec0e3658f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dd9d271e-222f-4570-82a3-93b6a5066f40" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_dd9d271e-222f-4570-82a3-93b6a5066f40" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7bdebe21-612b-4736-8039-13c399bd4926" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_7bdebe21-612b-4736-8039-13c399bd4926" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ce1609f7-10b9-4a08-aa85-cdcf0300c63c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour_ce1609f7-10b9-4a08-aa85-cdcf0300c63c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_fe6599e2-ccba-4454-bdf5-c1d8c029e805" xlink:href="esta-20210331.xsd#esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour_fe6599e2-ccba-4454-bdf5-c1d8c029e805" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19476636-1297-4c44-8033-3e4d90f2e2ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FiniteLivedIntangibleAssetsNet"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract_860e1498-894b-4971-b26f-2a3ea9ae4935" xlink:to="loc_us-gaap_FiniteLivedIntangibleAssetsNet_19476636-1297-4c44-8033-3e4d90f2e2ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurements"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurements" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bc4b7971-5a72-4311-8316-5c40749d6a4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresTextBlock_addc6e6a-fb9e-4f0f-8d64-5d119506ac87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bc4b7971-5a72-4311-8316-5c40749d6a4b" xlink:to="loc_us-gaap_FairValueDisclosuresTextBlock_addc6e6a-fb9e-4f0f-8d64-5d119506ac87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_b67b3d53-c7c1-4c5f-ad61-314b3bc4e870" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_61e5ce33-62b4-4429-8290-351e3f3361f6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b67b3d53-c7c1-4c5f-ad61-314b3bc4e870" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_61e5ce33-62b4-4429-8290-351e3f3361f6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5b5e0a16-7186-43ce-916f-6da39dad4c79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b67b3d53-c7c1-4c5f-ad61-314b3bc4e870" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock_5b5e0a16-7186-43ce-916f-6da39dad4c79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_901316aa-da52-44e2-aa35-c22eaaa82ed3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_b67b3d53-c7c1-4c5f-ad61-314b3bc4e870" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_901316aa-da52-44e2-aa35-c22eaaa82ed3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsFVonaRecurringBasisDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_bd8cd1a0-40db-4c86-aff5-cecca6a111e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_bd8cd1a0-40db-4c86-aff5-cecca6a111e1" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByMeasurementFrequencyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:to="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementFrequencyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByMeasurementFrequencyAxis_d7351adb-a276-4080-a516-5c3d00177f94" xlink:to="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsRecurringMember_4f7b24fc-d7db-4d98-958a-a6da7f6d88d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsRecurringMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementFrequencyDomain_08860558-b7d5-4df1-a496-c611187d08d5" xlink:to="loc_us-gaap_FairValueMeasurementsRecurringMember_4f7b24fc-d7db-4d98-958a-a6da7f6d88d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByFairValueHierarchyLevelAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:to="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementsFairValueHierarchyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByFairValueHierarchyLevelAxis_17dba4ee-1566-4704-b343-5b54624d077e" xlink:to="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel1Member_d40464b1-8d77-4c36-9dfc-d11d768f96f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel1Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel1Member_d40464b1-8d77-4c36-9dfc-d11d768f96f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel2Member_eebadc0b-f4cf-4974-901f-fc52e4a9b94b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel2Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel2Member_eebadc0b-f4cf-4974-901f-fc52e4a9b94b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueInputsLevel3Member_522c1c4f-1b77-448d-8d5f-c6af72463ec8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueInputsLevel3Member"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueMeasurementsFairValueHierarchyDomain_2931fdd5-0b47-4c61-9698-71bd2666b74f" xlink:to="loc_us-gaap_FairValueInputsLevel3Member_522c1c4f-1b77-448d-8d5f-c6af72463ec8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_97668ec3-3594-4e55-9633-00c78f4539bf" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilities_3bd03b76-0736-4ca2-940d-d363dd944736" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilities"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_76df5025-772d-471d-bdda-f39f92fe06c2" xlink:to="loc_us-gaap_DerivativeLiabilities_3bd03b76-0736-4ca2-940d-d363dd944736" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_e56a385e-f729-4172-9a4f-d7a84ef5a1ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_e56a385e-f729-4172-9a4f-d7a84ef5a1ef" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_44749bdb-a9a0-47c9-835c-ec461ca31fa3" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_577a2c89-5654-41da-90f0-ef7d0a6cad8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_79e501e1-18d0-4964-91b3-34b165dc4a1e" xlink:to="loc_us-gaap_LineOfCreditMember_577a2c89-5654-41da-90f0-ef7d0a6cad8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_a8cf5f6e-b928-4d21-af9a-ffdd5045ce60" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_dd36e7e9-7a04-494d-af03-029ed033560a" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_7e018fd2-0e7d-43d4-8690-4e12e64be46b" xlink:to="loc_esta_MadrynCreditAgreementMember_dd36e7e9-7a04-494d-af03-029ed033560a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_51a408d0-4ce1-43f6-9715-33c86fa9f410" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputProbabilityOfChangeInControlMember_c910f7d4-d161-4b90-9af0-2b5f454b409d" xlink:href="esta-20210331.xsd#esta_MeasurementInputProbabilityOfChangeInControlMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_2dbde3fc-e56f-4f43-bca6-599263275484" xlink:to="loc_esta_MeasurementInputProbabilityOfChangeInControlMember_c910f7d4-d161-4b90-9af0-2b5f454b409d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable_36413261-ad61-44fc-8995-d550d90adb7b" xlink:to="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_3f3b8aca-70f3-4937-b868-8acf0d896edd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_3f3b8aca-70f3-4937-b868-8acf0d896edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_532350d6-8a42-4c36-b3df-2bafeae12061" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_532350d6-8a42-4c36-b3df-2bafeae12061" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromIssuanceOfDebt_aa537b42-7e2b-4e0a-9778-55a92056afa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromIssuanceOfDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_ProceedsFromIssuanceOfDebt_aa537b42-7e2b-4e0a-9778-55a92056afa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_c34e19c9-7cc0-4d87-93bc-5e53aaf41c74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems_09c164ce-ddfb-495b-8292-082906c53679" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_c34e19c9-7cc0-4d87-93bc-5e53aaf41c74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsDerivativesDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_50d1ee6c-d534-4296-a3a0-d770f4f88f36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_50d1ee6c-d534-4296-a3a0-d770f4f88f36" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:to="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeAxis_fee608c5-c353-4b31-b4f5-4b5f1c0977f2" xlink:to="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputInterestRateVolatilityMember_92b56e24-3e05-4b7d-b82b-8762e698bda6" xlink:href="esta-20210331.xsd#esta_MeasurementInputInterestRateVolatilityMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_esta_MeasurementInputInterestRateVolatilityMember_92b56e24-3e05-4b7d-b82b-8762e698bda6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MeasurementInputMarketYieldRateMember_1b413eb2-05d1-49f4-9cae-418f939babd9" xlink:href="esta-20210331.xsd#esta_MeasurementInputMarketYieldRateMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_esta_MeasurementInputMarketYieldRateMember_1b413eb2-05d1-49f4-9cae-418f939babd9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedTermMember_acac7859-0ef1-4dc9-8c77-471308d7003b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedTermMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_us-gaap_MeasurementInputExpectedTermMember_acac7859-0ef1-4dc9-8c77-471308d7003b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_MeasurementInputExpectedDividendRateMember_95c2a526-25be-43a9-9ca6-5831d923ac9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_MeasurementInputExpectedDividendRateMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_MeasurementInputTypeDomain_c9fc29be-df37-46a9-b25a-4e72b9852100" xlink:to="loc_us-gaap_MeasurementInputExpectedDividendRateMember_95c2a526-25be-43a9-9ca6-5831d923ac9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinancialInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:to="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinancialInstrumentAxis_43204dd8-ebf2-4a78-845f-6d4da542c803" xlink:to="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_1bdf600c-ffde-42ac-8022-b2569ef85270" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PutOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain_ba5ba992-3282-4972-8315-7b67efe890eb" xlink:to="loc_us-gaap_PutOptionMember_1bdf600c-ffde-42ac-8022-b2569ef85270" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable_36a3e3c9-5bc6-46ae-ac80-eb5747769c2a" xlink:to="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DerivativeLiabilityMeasurementInput_1c3e8821-bc0e-4e53-9ca4-86365f5ac787" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DerivativeLiabilityMeasurementInput"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems_6cbd5484-c02a-4649-9d7e-50a3bf60e7f7" xlink:to="loc_us-gaap_DerivativeLiabilityMeasurementInput_1c3e8821-bc0e-4e53-9ca4-86365f5ac787" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#FairValueMeasurementsLevel3FinancialInstrumentsDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueDisclosuresAbstract_29d2031b-2683-4834-87be-2432899904ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueDisclosuresAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueDisclosuresAbstract_29d2031b-2683-4834-87be-2432899904ef" xlink:to="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueByLiabilityClassAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:to="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueByLiabilityClassAxis_b4b6e6d2-763d-41fb-a041-4cabad48a689" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PutOptionMember_696bec61-6511-44c3-81ca-f194888543fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PutOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain_af36c8d6-a741-470a-8f66-b89bdd15aa6c" xlink:to="loc_us-gaap_PutOptionMember_696bec61-6511-44c3-81ca-f194888543fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable_239a7d80-8d32-4bce-9c98-7598a9606b27" xlink:to="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems_64dce7b6-126d-4a52-8e50-c52afdc04096" xlink:to="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0ad608c6-b10f-48e5-9c37-05e4dda94bb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_0ad608c6-b10f-48e5-9c37-05e4dda94bb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6d6cec8-7505-48a1-aac9-bb09ece95c50" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings_f6d6cec8-7505-48a1-aac9-bb09ece95c50" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2f7a05b5-0a5f-48e8-819d-c147ddc6b89a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward_087d5778-9948-48a4-8876-b1dc57457be7" xlink:to="loc_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue_2f7a05b5-0a5f-48e8-819d-c147ddc6b89a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Debt" xlink:type="simple" xlink:href="esta-20210331.xsd#Debt"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/Debt" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_d4420f52-207b-465f-8888-4d1b74dd7864" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureTextBlock_900a2304-9327-4f17-a866-e43901a7b1e7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_d4420f52-207b-465f-8888-4d1b74dd7864" xlink:to="loc_us-gaap_DebtDisclosureTextBlock_900a2304-9327-4f17-a866-e43901a7b1e7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtTables" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/DebtTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_ee200b91-c4af-4d1b-a137-ac446531205f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_39305c5a-1d46-4a98-98b0-d30b5ca8c405" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfDebtInstrumentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_ee200b91-c4af-4d1b-a137-ac446531205f" xlink:to="loc_us-gaap_ScheduleOfDebtInstrumentsTextBlock_39305c5a-1d46-4a98-98b0-d30b5ca8c405" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/DebtNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_585b5ad8-f298-4bb4-be26-b5971f7b63a9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_585b5ad8-f298-4bb4-be26-b5971f7b63a9" xlink:to="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_144578bf-4731-4e68-96e4-f1dffb9f3e09" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_29730f7e-bfcf-41d4-a92e-5a93d574a0ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_88a3305c-4b58-4699-add5-77d5838a51ef" xlink:to="loc_us-gaap_LineOfCreditMember_29730f7e-bfcf-41d4-a92e-5a93d574a0ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_ecae9158-69b0-4ca7-9d28-b279fd2227a3" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_5d1bbee3-dbfb-42b3-8994-49ac6a2c1edd" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementMember_5d1bbee3-dbfb-42b3-8994-49ac6a2c1edd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AmendedMadrynCreditAgreementMember_4a396280-5226-4d14-b71e-8ea8ad2c498a" xlink:href="esta-20210331.xsd#esta_AmendedMadrynCreditAgreementMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_AmendedMadrynCreditAgreementMember_4a396280-5226-4d14-b71e-8ea8ad2c498a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermAMember_56a7d394-a6bd-4aa5-ab2c-a9630e199927" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermAMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermAMember_56a7d394-a6bd-4aa5-ab2c-a9630e199927" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB1Member_49d9b11f-cb78-4387-ab90-689a6167ce3c" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB1Member"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB1Member_49d9b11f-cb78-4387-ab90-689a6167ce3c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB2Member_483832ab-6a13-4cd4-9d54-0c688ca4e3c2" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB2Member"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB2Member_483832ab-6a13-4cd4-9d54-0c688ca4e3c2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3AndB4Member"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_58fcb882-ba2a-4d03-b796-ab15ab0d1639" xlink:to="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB3Member_f0f74f71-f6bd-4990-a28a-a6d0fae187c9" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB3Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:to="loc_esta_MadrynCreditAgreementTermB3Member_f0f74f71-f6bd-4990-a28a-a6d0fae187c9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementTermB4Member_ac8b3fd8-6b6a-4867-8f60-9793f49543ef" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementTermB4Member"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_MadrynCreditAgreementTermB3AndB4Member_0d3c8737-cce8-4f50-a75c-88be79c5e95f" xlink:to="loc_esta_MadrynCreditAgreementTermB4Member_ac8b3fd8-6b6a-4867-8f60-9793f49543ef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_VariableRateDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateAxis_1e4c3e06-98b8-4b1e-a983-4379f99f5316" xlink:to="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_52ef3ad1-1a70-442a-b2c3-ae935b307556" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LondonInterbankOfferedRateLIBORMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_VariableRateDomain_4a846874-ea0a-4d45-90ef-a174a72bd063" xlink:to="loc_us-gaap_LondonInterbankOfferedRateLIBORMember_52ef3ad1-1a70-442a-b2c3-ae935b307556" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentTable_954d1c73-c6ca-4ae5-a8bc-9a46218a4f39" xlink:to="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a9e52c60-2a38-43f5-9d15-2b022be8b953" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity_a9e52c60-2a38-43f5-9d15-2b022be8b953" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ProceedsFromLinesOfCredit_78911a84-ecf4-441a-af31-264360112adb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ProceedsFromLinesOfCredit"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_ProceedsFromLinesOfCredit_78911a84-ecf4-441a-af31-264360112adb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_4f5f52e9-758e-40d6-bf2c-51e91178fa9c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_4f5f52e9-758e-40d6-bf2c-51e91178fa9c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_3a3c8c18-78ae-4c2c-baf3-e7e63cd31380" xlink:href="esta-20210331.xsd#esta_LineOfCreditFacilityAdditionalBorrowingCapacity"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_esta_LineOfCreditFacilityAdditionalBorrowingCapacity_3a3c8c18-78ae-4c2c-baf3-e7e63cd31380" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3461541e-95b1-487f-837c-1c6335206674" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentBasisSpreadOnVariableRate1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1_3461541e-95b1-487f-837c-1c6335206674" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_DebtInstrumentDefaultInterestRateIncrease_fb87b65e-a9c7-4b01-b8d8-ca38d073f754" xlink:href="esta-20210331.xsd#esta_DebtInstrumentDefaultInterestRateIncrease"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_esta_DebtInstrumentDefaultInterestRateIncrease_fb87b65e-a9c7-4b01-b8d8-ca38d073f754" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f93d2e40-efbb-4d99-bfa6-e336a38422af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentInterestRateEffectivePercentage"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentInterestRateEffectivePercentage_f93d2e40-efbb-4d99-bfa6-e336a38422af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtWeightedAverageInterestRate_47741217-5bf2-4b53-8db6-f4d21901f2fa" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtWeightedAverageInterestRate"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtWeightedAverageInterestRate_47741217-5bf2-4b53-8db6-f4d21901f2fa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_InterestExpenseDebt_cda14f3a-0ebe-491d-871c-a8ebc2f9e63a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_InterestExpenseDebt"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_InterestExpenseDebt_cda14f3a-0ebe-491d-871c-a8ebc2f9e63a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_853ad253-9ba0-4ff8-ad3c-f0d8b5cbb90e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability_853ad253-9ba0-4ff8-ad3c-f0d8b5cbb90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6159b85b-5394-442a-9be3-2220a3200e12" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscount"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscount_6159b85b-5394-442a-9be3-2220a3200e12" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DeferredFinanceCostsNet_e5c1c9d4-7358-446b-9ae3-39fda145ea76" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DeferredFinanceCostsNet"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentLineItems_845daf0f-adf8-4c30-8b0c-79d568dd0091" xlink:to="loc_us-gaap_DeferredFinanceCostsNet_e5c1c9d4-7358-446b-9ae3-39fda145ea76" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#DebtScheduleofMadrynDebtDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtDisclosureAbstract_078c8c1a-d44c-44fb-895d-3c5c636d4421" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtDisclosureAbstract_078c8c1a-d44c-44fb-895d-3c5c636d4421" xlink:to="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:to="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentAxis_3d14f244-0fd6-4b15-b9ab-0f150660fa6c" xlink:to="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_MadrynCreditAgreementMember_fca8f93c-f52f-463c-9067-84fa2a204015" xlink:href="esta-20210331.xsd#esta_MadrynCreditAgreementMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DebtInstrumentNameDomain_1ef1a971-1fc4-4b6c-85c6-1b33bc5d288d" xlink:to="loc_esta_MadrynCreditAgreementMember_fca8f93c-f52f-463c-9067-84fa2a204015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:to="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongtermDebtTypeDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeAxis_2db0aed1-f802-45bd-a9bc-ff300480aa27" xlink:to="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditMember_90baed68-dfde-489d-9e93-dfc776d74bdc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LongtermDebtTypeDomain_8b0dd717-894c-4909-b664-8c5cddb6b492" xlink:to="loc_us-gaap_LineOfCreditMember_90baed68-dfde-489d-9e93-dfc776d74bdc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LineOfCreditFacilityLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityTable_cd2a75ee-e52d-433e-a05b-ffa18b43acb7" xlink:to="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentCarryingAmount_087038f9-8c88-44d1-9b0d-a479512d5e26" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentCarryingAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_DebtInstrumentCarryingAmount_087038f9-8c88-44d1-9b0d-a479512d5e26" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_75920964-01d2-47ce-b8a4-15b0b37ffa73" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet_75920964-01d2-47ce-b8a4-15b0b37ffa73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LongTermDebt_1a039e4b-2c6d-41ab-8d16-3747067a9668" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LongTermDebt"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LineOfCreditFacilityLineItems_960f527e-3da9-4d8a-bc03-6909d3d4eefc" xlink:to="loc_us-gaap_LongTermDebt_1a039e4b-2c6d-41ab-8d16-3747067a9668" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Leases" xlink:type="simple" xlink:href="esta-20210331.xsd#Leases"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/Leases" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_cc03df6e-70eb-4390-b326-1a99ea331c15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeasesTextBlock_b101a442-4151-4215-be5e-5c10302d4d36" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeasesTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cc03df6e-70eb-4390-b326-1a99ea331c15" xlink:to="loc_us-gaap_LesseeOperatingLeasesTextBlock_b101a442-4151-4215-be5e-5c10302d4d36" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeasesTextBlock_48ff2668-f98b-44f1-89ed-f359582cc649" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeasesTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_cc03df6e-70eb-4390-b326-1a99ea331c15" xlink:to="loc_us-gaap_LesseeFinanceLeasesTextBlock_48ff2668-f98b-44f1-89ed-f359582cc649" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesTables" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_d7ae22af-983c-43c4-a2dc-9908c89a03e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCostTableTextBlock_e2b50e7d-7e66-48a7-a7d6-86e86fdf4b06" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCostTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7ae22af-983c-43c4-a2dc-9908c89a03e9" xlink:to="loc_us-gaap_LeaseCostTableTextBlock_e2b50e7d-7e66-48a7-a7d6-86e86fdf4b06" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_AssetsAndLiabilitiesLesseeTableTextBlock_9bc6615b-c20a-4c9b-8132-0a3f81590a73" xlink:href="esta-20210331.xsd#esta_AssetsAndLiabilitiesLesseeTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7ae22af-983c-43c4-a2dc-9908c89a03e9" xlink:to="loc_esta_AssetsAndLiabilitiesLesseeTableTextBlock_9bc6615b-c20a-4c9b-8132-0a3f81590a73" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a33d3957-48b9-4f2f-8fe0-9e500a2b343c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7ae22af-983c-43c4-a2dc-9908c89a03e9" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock_a33d3957-48b9-4f2f-8fe0-9e500a2b343c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_c62c93c2-49a2-4bba-9795-e8843b80de69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_d7ae22af-983c-43c4-a2dc-9908c89a03e9" xlink:to="loc_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock_c62c93c2-49a2-4bba-9795-e8843b80de69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_c06b7486-9cfd-4edc-ba5b-22b59f8a5a81" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_c06b7486-9cfd-4edc-ba5b-22b59f8a5a81" xlink:to="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:to="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_18bcbb77-3a08-4e38-8d18-93a3b25b1194" xlink:to="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_ac41f7bd-2b0e-4bcb-ba72-1c075faeb867" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_de952aac-e8ca-43a1-bcdb-4244ab6faa1f" xlink:to="loc_srt_MaximumMember_ac41f7bd-2b0e-4bcb-ba72-1c075faeb867" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeLeaseDescriptionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionTable_deeaeee3-bc63-40b0-bdbe-d2b25f71b925" xlink:to="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dcd2b5d9-8fbb-4326-8782-0406587bfacb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseTermOfContract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:to="loc_us-gaap_LesseeOperatingLeaseTermOfContract_dcd2b5d9-8fbb-4326-8782-0406587bfacb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_133b8396-6037-4385-9688-97fe8abccc91" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeFinanceLeaseTermOfContract1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LesseeLeaseDescriptionLineItems_d856575c-a3c2-4008-a44a-df589553c472" xlink:to="loc_us-gaap_LesseeFinanceLeaseTermOfContract1_133b8396-6037-4385-9688-97fe8abccc91" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseCostDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseCostDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_e4410f60-0cd2-47d8-a083-5cd5e899289a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseCost_02e01204-f590-47cb-8adb-46deac57da48" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseCost"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4410f60-0cd2-47d8-a083-5cd5e899289a" xlink:to="loc_us-gaap_OperatingLeaseCost_02e01204-f590-47cb-8adb-46deac57da48" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestExpense_3c33cc77-ea85-42b1-a8c0-3db56f0c9762" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestExpense"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4410f60-0cd2-47d8-a083-5cd5e899289a" xlink:to="loc_us-gaap_FinanceLeaseInterestExpense_3c33cc77-ea85-42b1-a8c0-3db56f0c9762" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0d6ea2d0-a286-415c-bfa4-1334ecdce254" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAssetAmortization"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4410f60-0cd2-47d8-a083-5cd5e899289a" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAssetAmortization_0d6ea2d0-a286-415c-bfa4-1334ecdce254" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeaseCost_fd536860-0894-47c9-b869-47180852323d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeaseCost"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_e4410f60-0cd2-47d8-a083-5cd5e899289a" xlink:to="loc_us-gaap_LeaseCost_fd536860-0894-47c9-b869-47180852323d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalBalanceSheetInformationDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_0842c2d2-ad9c-4fc9-90ff-4124f2754b77" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:href="esta-20210331.xsd#esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0842c2d2-ad9c-4fc9-90ff-4124f2754b77" xlink:to="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseRightOfUseAsset_73008199-28cc-4313-86c6-3c71286e3506" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:to="loc_us-gaap_OperatingLeaseRightOfUseAsset_73008199-28cc-4313-86c6-3c71286e3506" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a59193f-9598-41d9-9615-218450c90901" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:to="loc_us-gaap_OperatingLeaseLiabilityCurrent_3a59193f-9598-41d9-9615-218450c90901" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c9cdb792-09db-4d2b-9fdb-4f75ddf84c86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:to="loc_us-gaap_OperatingLeaseLiabilityNoncurrent_c9cdb792-09db-4d2b-9fdb-4f75ddf84c86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_cc8962b2-dcd2-4f4c-ac71-aea8309ebf5e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract_ed790b2c-4d58-46f0-a383-2383ad827e44" xlink:to="loc_us-gaap_OperatingLeaseLiability_cc8962b2-dcd2-4f4c-ac71-aea8309ebf5e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:href="esta-20210331.xsd#esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0842c2d2-ad9c-4fc9-90ff-4124f2754b77" xlink:to="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseRightOfUseAsset_82fcc169-8706-4fac-9e23-89b2ff580960" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseRightOfUseAsset"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:to="loc_us-gaap_FinanceLeaseRightOfUseAsset_82fcc169-8706-4fac-9e23-89b2ff580960" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityCurrent_e449b7b5-11b9-467d-a5fe-4e7192b939ce" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityCurrent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:to="loc_us-gaap_FinanceLeaseLiabilityCurrent_e449b7b5-11b9-467d-a5fe-4e7192b939ce" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_62b9cca4-ac05-4981-892e-4d3f91b735f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityNoncurrent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:to="loc_us-gaap_FinanceLeaseLiabilityNoncurrent_62b9cca4-ac05-4981-892e-4d3f91b735f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_a6a487a8-baf8-4bc0-a3f1-08d915a23846" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract_0e4cdf65-6f6f-4d01-b6ce-0d7c20a6e919" xlink:to="loc_us-gaap_FinanceLeaseLiability_a6a487a8-baf8-4bc0-a3f1-08d915a23846" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_WeightedAverageRemainingLeaseTermAbstract_39652dee-caa7-480f-8097-eae41d30c624" xlink:href="esta-20210331.xsd#esta_WeightedAverageRemainingLeaseTermAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0842c2d2-ad9c-4fc9-90ff-4124f2754b77" xlink:to="loc_esta_WeightedAverageRemainingLeaseTermAbstract_39652dee-caa7-480f-8097-eae41d30c624" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_dc95bb28-b35b-4d86-bdee-72031d1da83c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_WeightedAverageRemainingLeaseTermAbstract_39652dee-caa7-480f-8097-eae41d30c624" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1_dc95bb28-b35b-4d86-bdee-72031d1da83c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5347dd0f-69e0-4e5c-b141-cfc542be2029" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_WeightedAverageRemainingLeaseTermAbstract_39652dee-caa7-480f-8097-eae41d30c624" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1_5347dd0f-69e0-4e5c-b141-cfc542be2029" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_LeasesWeightedAverageDiscountRateAbstract_a252f85d-14b3-44c0-8784-05421946bdfe" xlink:href="esta-20210331.xsd#esta_LeasesWeightedAverageDiscountRateAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_0842c2d2-ad9c-4fc9-90ff-4124f2754b77" xlink:to="loc_esta_LeasesWeightedAverageDiscountRateAbstract_a252f85d-14b3-44c0-8784-05421946bdfe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1b269b58-a08e-48c8-b318-b3a0fa8e9a13" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_LeasesWeightedAverageDiscountRateAbstract_a252f85d-14b3-44c0-8784-05421946bdfe" xlink:to="loc_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent_1b269b58-a08e-48c8-b318-b3a0fa8e9a13" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_474068db-4001-411d-a8c8-7579d9456186" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_LeasesWeightedAverageDiscountRateAbstract_a252f85d-14b3-44c0-8784-05421946bdfe" xlink:to="loc_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent_474068db-4001-411d-a8c8-7579d9456186" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesSupplementalCashFlowsDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6b0bbf46-befb-456f-8683-51385169e737" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CashFlowLesseeAbstract_bd8c7806-5f6f-4b0b-a2df-3d44014dd5c6" xlink:href="esta-20210331.xsd#esta_CashFlowLesseeAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b0bbf46-befb-456f-8683-51385169e737" xlink:to="loc_esta_CashFlowLesseeAbstract_bd8c7806-5f6f-4b0b-a2df-3d44014dd5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeasePayments_e0782344-6975-4e01-9e2d-ab1b60bd48e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeasePayments"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_CashFlowLesseeAbstract_bd8c7806-5f6f-4b0b-a2df-3d44014dd5c6" xlink:to="loc_us-gaap_OperatingLeasePayments_e0782344-6975-4e01-9e2d-ab1b60bd48e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_bd64d6a7-f99c-44c0-ab88-e4c04f938a69" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseInterestPaymentOnLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_CashFlowLesseeAbstract_bd8c7806-5f6f-4b0b-a2df-3d44014dd5c6" xlink:to="loc_us-gaap_FinanceLeaseInterestPaymentOnLiability_bd64d6a7-f99c-44c0-ab88-e4c04f938a69" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeasePrincipalPayments_4b75e42a-e9a8-491d-b369-d752ad42ab79" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeasePrincipalPayments"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_CashFlowLesseeAbstract_bd8c7806-5f6f-4b0b-a2df-3d44014dd5c6" xlink:to="loc_us-gaap_FinanceLeasePrincipalPayments_4b75e42a-e9a8-491d-b369-d752ad42ab79" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_5952d29f-0f15-4ed5-8e91-220418b8fdf9" xlink:href="esta-20210331.xsd#esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6b0bbf46-befb-456f-8683-51385169e737" xlink:to="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_5952d29f-0f15-4ed5-8e91-220418b8fdf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a6bf3632-5568-4c27-aa54-bc82c86e7f99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_5952d29f-0f15-4ed5-8e91-220418b8fdf9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_a6bf3632-5568-4c27-aa54-bc82c86e7f99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ed2fa45c-2315-451b-b497-43f0f1afd8d3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract_5952d29f-0f15-4ed5-8e91-220418b8fdf9" xlink:to="loc_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability_ed2fa45c-2315-451b-b497-43f0f1afd8d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseMaturityDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LeasesAbstract_6c6bc2f5-c6a1-438c-bd8b-7a04ce33e3db" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LeasesAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c6bc2f5-c6a1-438c-bd8b-7a04ce33e3db" xlink:to="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_258b29ec-2125-4816-87ad-68f4be039af4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_258b29ec-2125-4816-87ad-68f4be039af4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_19567f65-f7a6-4de4-93e8-43570beefbcf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_19567f65-f7a6-4de4-93e8-43570beefbcf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_72ce8b4e-2e17-4807-b81e-623b040e1957" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree_72ce8b4e-2e17-4807-b81e-623b040e1957" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_20e837eb-2358-4d8a-8b3f-256bcb79701e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour_20e837eb-2358-4d8a-8b3f-256bcb79701e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_75b3de15-489a-48da-a81e-8140d8eac3e2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive_75b3de15-489a-48da-a81e-8140d8eac3e2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4bf3b813-8df8-4db7-956a-8cf49e237e68" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_4bf3b813-8df8-4db7-956a-8cf49e237e68" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c81358a3-3e5e-4fff-a6af-8351b74cde86" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue_c81358a3-3e5e-4fff-a6af-8351b74cde86" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_36f697e7-55fd-497d-aca6-d683ea5a6251" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_36f697e7-55fd-497d-aca6-d683ea5a6251" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_OperatingLeaseLiability_851365d0-830b-40e5-87af-14acd9eca1be" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_OperatingLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract_57cd7c66-c484-431f-a82a-edcf7ef2106d" xlink:to="loc_us-gaap_OperatingLeaseLiability_851365d0-830b-40e5-87af-14acd9eca1be" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_LeasesAbstract_6c6bc2f5-c6a1-438c-bd8b-7a04ce33e3db" xlink:to="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f5b5c6ca-65f0-442e-9811-c6a7d06a2f80" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths_f5b5c6ca-65f0-442e-9811-c6a7d06a2f80" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4adf24b6-0cbe-4021-90fc-95f19c0f644d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo_4adf24b6-0cbe-4021-90fc-95f19c0f644d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ce17fdcc-34f9-49c7-aca4-3b69ac69c082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree_ce17fdcc-34f9-49c7-aca4-3b69ac69c082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_cc5984e5-1b6f-4381-8a02-5d0cd60a9ca7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour_cc5984e5-1b6f-4381-8a02-5d0cd60a9ca7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9fdff0b1-2d82-41fa-8737-0b678e65b142" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive_9fdff0b1-2d82-41fa-8737-0b678e65b142" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_176a8f35-da6f-4219-b77a-e34da0cb91fc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive_176a8f35-da6f-4219-b77a-e34da0cb91fc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d539c614-c047-4a3b-a493-c11878e62237" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityPaymentsDue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityPaymentsDue_d539c614-c047-4a3b-a493-c11878e62237" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/totalLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_eb177e4a-16b6-488e-bd8b-b2702da8978b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount_eb177e4a-16b6-488e-bd8b-b2702da8978b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_FinanceLeaseLiability_33c5dc8d-01dc-477c-bf60-5b877e5b645c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_FinanceLeaseLiability"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract_b24f801f-b0bf-49ff-ae08-1a0ace8f5ffe" xlink:to="loc_us-gaap_FinanceLeaseLiability_33c5dc8d-01dc-477c-bf60-5b877e5b645c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1" xlink:type="simple" xlink:href="esta-20210331.xsd#LeasesLeaseMaturityDetails_1"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1" xlink:type="extended"/>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquity"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquity" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_1846c2a2-2e56-4249-8f2c-0bcf54de4fde" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c2ae96ac-67bd-4fe6-8dda-de5d1c96e639" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_1846c2a2-2e56-4249-8f2c-0bcf54de4fde" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_c2ae96ac-67bd-4fe6-8dda-de5d1c96e639" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_8ef9d474-6572-40a8-9588-59039ab73dc1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTextBlock_f33b0f0a-25fd-4884-8062-b149aa7f7e35" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_8ef9d474-6572-40a8-9588-59039ab73dc1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTextBlock_f33b0f0a-25fd-4884-8062-b149aa7f7e35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_10042ed8-3d16-4578-adf5-5085ec940e09" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesIssued_01918a28-3347-4fe0-a084-a5a0893f117c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesIssued"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10042ed8-3d16-4578-adf5-5085ec940e09" xlink:to="loc_us-gaap_CommonStockSharesIssued_01918a28-3347-4fe0-a084-a5a0893f117c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesOutstanding_6f0c6953-c86f-4a4b-9f76-32f102074f63" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesOutstanding"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_10042ed8-3d16-4578-adf5-5085ec940e09" xlink:to="loc_us-gaap_CommonStockSharesOutstanding_6f0c6953-c86f-4a4b-9f76-32f102074f63" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#ShareholdersEquityReservedOrdinarySharesDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_d89ad019-7862-4dba-a0ee-47ca0f29e8e9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_d89ad019-7862-4dba-a0ee-47ca0f29e8e9" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_e9e3fa28-ec22-4dba-b345-85781a913593" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_20e23298-34af-4c89-a09e-18925dd0b741" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_5610bed7-293d-4b78-adfe-9991788b890c" xlink:to="loc_esta_RockportWarrantsMember_20e23298-34af-4c89-a09e-18925dd0b741" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_6520d4d3-ebdd-4462-8592-c32716d3bde4" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_08a7a861-0493-4528-b4b9-54b0438a1721" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_EmployeeStockOptionMember_08a7a861-0493-4528-b4b9-54b0438a1721" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_40aa1122-4e4f-4972-9a9a-ccab028c616c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_RestrictedStockMember_40aa1122-4e4f-4972-9a9a-ccab028c616c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockMember_a14894c8-9af9-411b-bab7-491a85ab8e8c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_1c789503-f803-4f38-ae3d-5dce2ef31c55" xlink:to="loc_us-gaap_EmployeeStockMember_a14894c8-9af9-411b-bab7-491a85ab8e8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_a3b5e3dd-c5c3-4ea5-82ee-31e80e703c07" xlink:to="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EquityIncentivePlan2018Member_79b88cd8-6509-4c56-ae10-fa292cc303cc" xlink:href="esta-20210331.xsd#esta_EquityIncentivePlan2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_26b17273-5d42-4c49-9a0b-9abde80ccbe7" xlink:to="loc_esta_EquityIncentivePlan2018Member_79b88cd8-6509-4c56-ae10-fa292cc303cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_8df691ba-afe2-486c-b3f6-4a9288451c87" xlink:to="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e3f85c68-c448-482a-b0d7-1de7d5fb8632" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_791e5188-45db-4ee0-b0ba-444bb5f2e3cb" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_e3f85c68-c448-482a-b0d7-1de7d5fb8632" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/Warrants" xlink:type="simple" xlink:href="esta-20210331.xsd#Warrants"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/Warrants" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_620e0fa2-de62-413a-b7cb-2381f6a5ca17" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3dc915ee-0482-4c4e-9ab7-b9d1c201b26b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockholdersEquityNoteDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_620e0fa2-de62-413a-b7cb-2381f6a5ca17" xlink:to="loc_us-gaap_StockholdersEquityNoteDisclosureTextBlock_3dc915ee-0482-4c4e-9ab7-b9d1c201b26b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsTables" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/WarrantsTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_3b941a3f-76c0-4b07-a1f3-9cda69eda6af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_b64b7274-ee57-434b-be5c-19fd85b7edf9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_3b941a3f-76c0-4b07-a1f3-9cda69eda6af" xlink:to="loc_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_b64b7274-ee57-434b-be5c-19fd85b7edf9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/WarrantsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_cec9868f-62cc-4c2a-914a-2250106162bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_cec9868f-62cc-4c2a-914a-2250106162bb" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_0cbc8883-8b1a-44ab-ade8-64dbf1418dd1" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_b62991eb-3f44-486a-bc0c-4f5372a0e5c1" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_645bd439-960f-4642-863d-42a55c954024" xlink:to="loc_esta_RockportWarrantsMember_b62991eb-3f44-486a-bc0c-4f5372a0e5c1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StatementClassOfStockAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:to="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_StatementClassOfStockAxis_1c18dcaa-4e57-4a7a-a09c-4b63c7a38542" xlink:to="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonClassBMember_3481a071-4b6b-42b8-97c7-272769e1ae74" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonClassBMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockDomain_c382b1e3-5e9a-4ce4-a174-0099716dae1b" xlink:to="loc_us-gaap_CommonClassBMember_3481a071-4b6b-42b8-97c7-272769e1ae74" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_a82a93ea-ccdd-4f27-aa8d-7803c27e63ee" xlink:to="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ddcc43be-5744-4f0f-91d6-768b0d7f4738" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_ddcc43be-5744-4f0f-91d6-768b0d7f4738" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_72fa8c60-9692-4213-aadf-7f0eb5853e0e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_72fa8c60-9692-4213-aadf-7f0eb5853e0e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a8c3d1e2-640c-4ff4-ab0c-0e51857fbddb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_40aab9f3-b79a-424b-afbd-53386f01fc37" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_a8c3d1e2-640c-4ff4-ab0c-0e51857fbddb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#WarrantsWarrantDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/WarrantsWarrantDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EquityAbstract_21a48f4d-d341-4533-9544-d121a2c705e1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EquityAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfStockByClassTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EquityAbstract_21a48f4d-d341-4533-9544-d121a2c705e1" xlink:to="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:to="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightAxis_f09f8bd4-1a14-43e2-89a1-e7cccecd5c46" xlink:to="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RockportWarrantsMember_c542c7f0-26e0-4ddd-b98f-16a0d5e24f15" xlink:href="esta-20210331.xsd#esta_RockportWarrantsMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfWarrantOrRightDomain_7762bd2c-ba57-4828-b6eb-41a3fb430be3" xlink:to="loc_esta_RockportWarrantsMember_c542c7f0-26e0-4ddd-b98f-16a0d5e24f15" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfStockLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfStockByClassTable_20fac5bc-f122-407e-b3ba-39c15f83fa15" xlink:to="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3a87ea3-916d-4931-ad5a-35673354b79a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightOutstanding"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightOutstanding_c3a87ea3-916d-4931-ad5a-35673354b79a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70572702-31d8-4940-8980-42f246335158" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ClassOfStockLineItems_0e76f1e4-c717-4491-80d1-c6b7c3f9b66a" xlink:to="loc_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_70572702-31d8-4940-8980-42f246335158" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensation"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensation" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b86c1abe-41f4-4963-96d3-67697303e9b4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a9f49278-24cc-47f9-92d7-d76ca5007557" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b86c1abe-41f4-4963-96d3-67697303e9b4" xlink:to="loc_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_a9f49278-24cc-47f9-92d7-d76ca5007557" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e513e552-0246-4ee0-8a8a-623f92fb1c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b6eaf655-1cc6-4b7a-a234-237de6b3c340" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e513e552-0246-4ee0-8a8a-623f92fb1c33" xlink:to="loc_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock_b6eaf655-1cc6-4b7a-a234-237de6b3c340" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_459cecd2-a4df-47aa-9479-389928b1ca5f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e513e552-0246-4ee0-8a8a-623f92fb1c33" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_459cecd2-a4df-47aa-9479-389928b1ca5f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_34d6105b-b372-4927-ba69-611fa469678e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e513e552-0246-4ee0-8a8a-623f92fb1c33" xlink:to="loc_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock_34d6105b-b372-4927-ba69-611fa469678e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_7c8d5489-6a45-4cf0-bc83-2406e7ba8ff4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_e513e552-0246-4ee0-8a8a-623f92fb1c33" xlink:to="loc_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock_7c8d5489-6a45-4cf0-bc83-2406e7ba8ff4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0acfbb1-da51-4d5d-b67d-e6571b7a8cb7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_a0acfbb1-da51-4d5d-b67d-e6571b7a8cb7" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_PlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameAxis_27dfbf13-3132-432b-b8c8-f8b43b58108c" xlink:to="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EquityIncentivePlan2018Member_f29b8f3e-986e-4008-96fe-3dda46a3ae84" xlink:href="esta-20210331.xsd#esta_EquityIncentivePlan2018Member"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_PlanNameDomain_52e75abf-2cd7-4393-9a2b-44535fd7791a" xlink:to="loc_esta_EquityIncentivePlan2018Member_f29b8f3e-986e-4008-96fe-3dda46a3ae84" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_9eee54e2-a658-403e-904f-9779a673f2e8" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ConsultantMember_4aeddd5d-cbfc-4fa1-8aef-c44458b2eca5" xlink:href="esta-20210331.xsd#esta_ConsultantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_8914dad3-1790-4e37-ad28-5b8e1aa3f64a" xlink:to="loc_esta_ConsultantMember_4aeddd5d-cbfc-4fa1-8aef-c44458b2eca5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_RangeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeAxis_76ed17b4-44a1-49df-94f6-6b69353a49cf" xlink:to="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MinimumMember_e0ad611c-b363-480c-af3d-1c7d7d591a57" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MinimumMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:to="loc_srt_MinimumMember_e0ad611c-b363-480c-af3d-1c7d7d591a57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_srt_MaximumMember_605e6eb0-cee7-4ba8-95c4-8ec2a6f08af2" xlink:href="http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd#srt_MaximumMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_srt_RangeMember_61a53bad-9a36-4d34-8fd6-1fd035e59301" xlink:to="loc_srt_MaximumMember_605e6eb0-cee7-4ba8-95c4-8ec2a6f08af2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_147b16e9-d020-4878-8bc8-8ccd07819aef" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_2bc62ac7-4c70-4648-a775-8d359b99f184" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:to="loc_us-gaap_EmployeeStockOptionMember_2bc62ac7-4c70-4648-a775-8d359b99f184" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_0525f350-5cab-4b7d-82c4-07e6a7a36306" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_2c49d06a-42be-4f70-9908-54b85bacf204" xlink:to="loc_us-gaap_RestrictedStockMember_0525f350-5cab-4b7d-82c4-07e6a7a36306" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_33569f69-74e0-42db-93c4-0646c95099ad" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ddbd865e-c091-4439-b342-bb7c2ce23cd3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockCapitalSharesReservedForFutureIssuance"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance_ddbd865e-c091-4439-b342-bb7c2ce23cd3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_IncreaseInCommonStockSharesAuthorized_6cd2d524-1098-485a-90f8-ff611dc15c7d" xlink:href="esta-20210331.xsd#esta_IncreaseInCommonStockSharesAuthorized"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_IncreaseInCommonStockSharesAuthorized_6cd2d524-1098-485a-90f8-ff611dc15c7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_d97f488b-696c-49ed-869d-adc1431e8851" xlink:href="esta-20210331.xsd#esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent_d97f488b-696c-49ed-869d-adc1431e8851" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommonStockSharesAuthorized_5a445f2f-03bc-452c-918f-67dd4187c0f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommonStockSharesAuthorized"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_CommonStockSharesAuthorized_5a445f2f-03bc-452c-918f-67dd4187c0f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_763e1191-39a0-4fcd-9a79-411c8f098b67" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber_763e1191-39a0-4fcd-9a79-411c8f098b67" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ea789ae-bcbd-4bf2-92a3-57b0bb8dc89b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice_2ea789ae-bcbd-4bf2-92a3-57b0bb8dc89b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_05b3c24b-350b-4967-96e6-ca7832e7366e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_05b3c24b-350b-4967-96e6-ca7832e7366e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_920e1faf-4663-4f3c-a73f-7fb4051c4c9f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_920e1faf-4663-4f3c-a73f-7fb4051c4c9f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_86e691f2-4fc3-40c4-8b47-e0cd7baeae19" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_86e691f2-4fc3-40c4-8b47-e0cd7baeae19" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_66f334b4-e007-450c-836d-4aa0146094f4" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_66f334b4-e007-450c-836d-4aa0146094f4" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f9725e38-ac47-4d5b-8dd9-160afac4fd0d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions_f9725e38-ac47-4d5b-8dd9-160afac4fd0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_632d6934-cd70-4924-ac67-7804becf654a" xlink:href="esta-20210331.xsd#esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions_632d6934-cd70-4924-ac67-7804becf654a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_81937270-7907-4db8-9b07-687e89ac78ad" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition_81937270-7907-4db8-9b07-687e89ac78ad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bb1d62dc-3400-4c15-a805-0c0da6e9ffa3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_bb1d62dc-3400-4c15-a805-0c0da6e9ffa3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_daad070e-9e73-49f2-83b7-0234ff5bb38c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_daad070e-9e73-49f2-83b7-0234ff5bb38c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_acb44f87-90db-496a-b65e-89b2fbdd3655" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims_acb44f87-90db-496a-b65e-89b2fbdd3655" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7ae9768b-450b-4ae7-9d2e-36a989ff298f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue_7ae9768b-450b-4ae7-9d2e-36a989ff298f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_87e30720-9ec9-4b3e-ba81-cadda8425388" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_87e30720-9ec9-4b3e-ba81-cadda8425388" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2d90f8e4-1516-4cf3-bc3f-a42c3fad7e6c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fb61cd7c-ae5b-4248-8f34-165b2df2d19a" xlink:to="loc_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1_2d90f8e4-1516-4cf3-bc3f-a42c3fad7e6c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsandRestrictedStockDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87ab3ad6-1a99-46ce-83d3-8c205b5caf10" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_87ab3ad6-1a99-46ce-83d3-8c205b5caf10" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:to="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_IncomeStatementLocationDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationAxis_184175b7-0a44-4b4e-bca7-0df51b13459d" xlink:to="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e74c1f62-fd37-43d8-98a3-93f95ec267f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SellingGeneralAndAdministrativeExpensesMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:to="loc_us-gaap_SellingGeneralAndAdministrativeExpensesMember_e74c1f62-fd37-43d8-98a3-93f95ec267f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a7defe0c-1a3c-4f71-8385-e9ef5e51edbd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ResearchAndDevelopmentExpenseMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_IncomeStatementLocationDomain_56432c8e-8f71-4812-ae75-6e2ee5549190" xlink:to="loc_us-gaap_ResearchAndDevelopmentExpenseMember_a7defe0c-1a3c-4f71-8385-e9ef5e51edbd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_5e680dbf-0592-4e10-a067-639fd0c4a4af" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AllocatedShareBasedCompensationExpense_901b2a74-3687-4256-9274-35547b3edeba" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AllocatedShareBasedCompensationExpense"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_13fc25b7-683b-416e-af85-9649f2129abe" xlink:to="loc_us-gaap_AllocatedShareBasedCompensationExpense_901b2a74-3687-4256-9274-35547b3edeba" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_031ff51e-db20-4da5-a7b2-0082d5341058" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_031ff51e-db20-4da5-a7b2-0082d5341058" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eef50102-d345-448d-b27d-41419e63235e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_eef50102-d345-448d-b27d-41419e63235e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_da706a9c-3220-43f4-b89f-d7af4aed9951" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_da706a9c-3220-43f4-b89f-d7af4aed9951" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bbc0f032-5ec8-46bc-8502-b1abed67deab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:to="loc_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised_bbc0f032-5ec8-46bc-8502-b1abed67deab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ddb9e06-e3c6-41ef-8b02-46dadc1f8d7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_3ddb9e06-e3c6-41ef-8b02-46dadc1f8d7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3eb8ec51-531e-45ee-807f-f8c57ed5f2ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward_d345456b-0579-4633-af88-036129bda24c" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_3eb8ec51-531e-45ee-807f-f8c57ed5f2ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1fdd3fa4-c94d-4eab-8419-65e4644943f5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_031ff51e-db20-4da5-a7b2-0082d5341058" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1fdd3fa4-c94d-4eab-8419-65e4644943f5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_031ff51e-db20-4da5-a7b2-0082d5341058" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee51341e-97b7-48dd-af5c-6c9144c2ee88" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_ee51341e-97b7-48dd-af5c-6c9144c2ee88" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c50c08f1-a63c-4e67-bfb5-77357b61adb5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c50c08f1-a63c-4e67-bfb5-77357b61adb5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f7f490a9-d9bc-4f0b-b464-20ed4aa2c6cc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_f7f490a9-d9bc-4f0b-b464-20ed4aa2c6cc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_e6b33cdb-2070-4c7a-ba12-a37b2e3b30a8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice_e6b33cdb-2070-4c7a-ba12-a37b2e3b30a8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_280e150b-f2ce-40ac-a36c-5f8e30865199" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward_fb5151f0-b6e0-499d-89f6-35fb50e83b05" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_280e150b-f2ce-40ac-a36c-5f8e30865199" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e89ec6d4-9198-4017-ae29-0418eb8c73c8" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_031ff51e-db20-4da5-a7b2-0082d5341058" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e89ec6d4-9198-4017-ae29-0418eb8c73c8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_355eec3b-8b3f-47d4-a487-200d990a9748" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e89ec6d4-9198-4017-ae29-0418eb8c73c8" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_355eec3b-8b3f-47d4-a487-200d990a9748" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cb3b1bd9-f67a-4341-be05-37de0d30f128" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract_e89ec6d4-9198-4017-ae29-0418eb8c73c8" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_cb3b1bd9-f67a-4341-be05-37de0d30f128" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionGrantedtoEmployeesDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_94902217-87af-469d-924d-64e8f2739688" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_94902217-87af-469d-924d-64e8f2739688" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:to="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_bb3a0ee5-84af-4e25-ad18-58e120930c33" xlink:to="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_22a028ea-3dc5-4d19-b705-9b291cfa7982" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementEmployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_c25f4d01-bbec-43d4-8bed-cab2552cdf05" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementEmployeeMember_22a028ea-3dc5-4d19-b705-9b291cfa7982" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:to="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_fa45322e-350c-483d-af3a-f5c6c37e7e7e" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_cebfd483-f109-48d3-8702-593f0ea0ad7a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_425e90e1-5f51-4ac5-b40e-7ffb2965b6f7" xlink:to="loc_us-gaap_EmployeeStockOptionMember_cebfd483-f109-48d3-8702-593f0ea0ad7a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_a82186f1-e8a1-4708-b78d-262b2456eba5" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3922f128-55ba-48e9-bfec-e6b3f3901ea5" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_3922f128-55ba-48e9-bfec-e6b3f3901ea5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c50fea69-d538-4917-907f-b93633a4b59e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_c50fea69-d538-4917-907f-b93633a4b59e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_42fe6030-195a-457c-bd5d-a08f90d6d6ab" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_42fe6030-195a-457c-bd5d-a08f90d6d6ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dabb47a8-5515-4bd2-aed2-5d56d432b4bb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_dabb47a8-5515-4bd2-aed2-5d56d432b4bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ba163c93-b2af-41fa-8276-093a0ec78f2c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_ba163c93-b2af-41fa-8276-093a0ec78f2c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_25f61cb4-578b-4a5f-9c6e-d1ad5fa665f0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_fc680a1b-464f-4c4a-b959-0fe4f982567d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_25f61cb4-578b-4a5f-9c6e-d1ad5fa665f0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96b9c061-2300-4f86-badf-b012732fe458" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_96b9c061-2300-4f86-badf-b012732fe458" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_GranteeStatusDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusAxis_01a8ed16-6a61-4b74-9538-a01926b662bf" xlink:to="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_641f129b-4ac8-4828-9eae-d17bbd906fdd" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedPaymentArrangementNonemployeeMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_GranteeStatusDomain_d254de2e-5087-4219-a7bb-ef6a7544cfeb" xlink:to="loc_us-gaap_ShareBasedPaymentArrangementNonemployeeMember_641f129b-4ac8-4828-9eae-d17bbd906fdd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_f8a46589-3d01-4a6a-ab84-0d6f469389a7" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EmployeeStockOptionMember_460ed450-735a-4e07-8367-ad5119927ed7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EmployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_004426eb-702f-4f1d-b29a-0d8a9a62c139" xlink:to="loc_us-gaap_EmployeeStockOptionMember_460ed450-735a-4e07-8367-ad5119927ed7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis_1139f385-ede4-42d9-87f5-00ddc14c88d9" xlink:to="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_ConsultantMember_ec5d33c1-e580-4040-8933-6cf429694fd0" xlink:href="esta-20210331.xsd#esta_ConsultantMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain_269c7184-3b0d-4c4c-a11c-7e6fd0b7858c" xlink:to="loc_esta_ConsultantMember_ec5d33c1-e580-4040-8933-6cf429694fd0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_72602739-03e6-4c93-80ca-cdfa5c45c4b9" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c950aa1c-8ec3-47da-b6b1-086ba8f2fbe3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_c950aa1c-8ec3-47da-b6b1-086ba8f2fbe3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_132a0fcd-e48e-4e52-b53f-09a3a11248ee" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_132a0fcd-e48e-4e52-b53f-09a3a11248ee" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_eba982f7-0120-40e0-94d0-89d9ab798fa9" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_eba982f7-0120-40e0-94d0-89d9ab798fa9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8a21d987-eb48-48bc-8555-25896c5cdf44" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_a346663f-936a-437c-b3a3-ecb138ebdd11" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_8a21d987-eb48-48bc-8555-25896c5cdf44" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#SharebasedCompensationRestrictedStockActivityDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b6719864-7a67-4436-ad6e-ae5bf5d59a94" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract_b6719864-7a67-4436-ad6e-ae5bf5d59a94" xlink:to="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AwardTypeAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:to="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AwardTypeAxis_69ca708e-d15e-4e80-9a1f-f7bce7bf604d" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockMember_628d3f27-0451-45c5-ba0c-4507e119f358" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain_712d1dbc-0ccf-464c-857a-f0be6b1f480f" xlink:to="loc_us-gaap_RestrictedStockMember_628d3f27-0451-45c5-ba0c-4507e119f358" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable_4bacb19a-aecc-4fc6-9921-7737054cf2b0" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e416bf6-df48-440a-823f-5264c242e139" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_6e416bf6-df48-440a-823f-5264c242e139" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c9e4c78-3f06-4db0-af9a-c78352c00fdf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod_6c9e4c78-3f06-4db0-af9a-c78352c00fdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e5ddcf4-b6b5-4945-83db-36a05cf3b321" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod_2e5ddcf4-b6b5-4945-83db-36a05cf3b321" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_845dabbb-b616-4ca9-b28a-c497eae545f1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod_845dabbb-b616-4ca9-b28a-c497eae545f1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2009/role/negatedTerseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f066ece6-dc2f-4f1d-9fcd-70e7222b837b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward_c70ae079-6323-444a-8e19-5e71c219d445" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber_f066ece6-dc2f-4f1d-9fcd-70e7222b837b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems_2dc31d4e-909a-47e0-97c0-23994562af34" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3b971a6-e480-4600-b50a-06c70a579ec6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_e3b971a6-e480-4600-b50a-06c70a579ec6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodStartLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_860b524e-cc7b-4929-ba4b-922b774f79ea" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_860b524e-cc7b-4929-ba4b-922b774f79ea" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2482065e-184d-4492-ba8f-c0de5513b287" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue_2482065e-184d-4492-ba8f-c0de5513b287" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eaa56693-2078-4ecb-a97a-d0b484cba026" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue_eaa56693-2078-4ecb-a97a-d0b484cba026" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7b41a56d-3825-4c94-a45c-b610e5c75082" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward_286cc019-8d1a-409b-8208-e34eee2f84a6" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue_7b41a56d-3825-4c94-a45c-b610e5c75082" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/periodEndLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShare"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShare" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_78c1d310-2a8c-4afc-99bc-5fe542b44566" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareTextBlock_c15aae3a-71bb-4f93-8289-1ac03bc14ebc" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_78c1d310-2a8c-4afc-99bc-5fe542b44566" xlink:to="loc_us-gaap_EarningsPerShareTextBlock_c15aae3a-71bb-4f93-8289-1ac03bc14ebc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareTables"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareTables" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_e6f96b4e-5bae-4af3-be7a-bc8e6e636f4b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a0181da0-1920-418b-bd7d-45d1894de6d6" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e6f96b4e-5bae-4af3-be7a-bc8e6e636f4b" xlink:to="loc_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock_a0181da0-1920-418b-bd7d-45d1894de6d6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_de325625-deb8-4350-af35-dd6f31cd6747" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_e6f96b4e-5bae-4af3-be7a-bc8e6e636f4b" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock_de325625-deb8-4350-af35-dd6f31cd6747" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareBasicandDilutedDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_77c5ee0a-c9c7-4674-a1c8-773335512626" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b87a9848-a0da-4fdb-a888-fe19031050cf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedAbstract"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77c5ee0a-c9c7-4674-a1c8-773335512626" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b87a9848-a0da-4fdb-a888-fe19031050cf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_NetIncomeLoss_de5c7a38-c95f-4e3b-b84e-ead52cba6449" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_NetIncomeLoss"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedAbstract_b87a9848-a0da-4fdb-a888-fe19031050cf" xlink:to="loc_us-gaap_NetIncomeLoss_de5c7a38-c95f-4e3b-b84e-ead52cba6449" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_f991539a-f10e-4ebd-988c-e9ec7d061462" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77c5ee0a-c9c7-4674-a1c8-773335512626" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_f991539a-f10e-4ebd-988c-e9ec7d061462" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_88371204-e2c9-4411-926d-1da657f12823" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract_f991539a-f10e-4ebd-988c-e9ec7d061462" xlink:to="loc_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted_88371204-e2c9-4411-926d-1da657f12823" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAbstract_64a4bfef-b49f-4433-b4a5-94bdd7219dbf" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAbstract"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_77c5ee0a-c9c7-4674-a1c8-773335512626" xlink:to="loc_us-gaap_EarningsPerShareBasicAbstract_64a4bfef-b49f-4433-b4a5-94bdd7219dbf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareBasicAndDiluted_e5181b70-4cd3-4a36-bfc7-29d36c3e3b60" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareBasicAndDiluted"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareBasicAbstract_64a4bfef-b49f-4433-b4a5-94bdd7219dbf" xlink:to="loc_us-gaap_EarningsPerShareBasicAndDiluted_e5181b70-4cd3-4a36-bfc7-29d36c3e3b60" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_EarningsPerShareAbstract_65cb0f0c-85e2-4196-a634-5a8258035ec7" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_EarningsPerShareAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_EarningsPerShareAbstract_65cb0f0c-85e2-4196-a634-5a8258035ec7" xlink:to="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesNameDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis_7e3a28fd-bd04-44fd-8566-811f008a8399" xlink:to="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_EmployeeAndNonemployeeStockOptionMember_af15b9a2-5d54-42a3-b319-8cf2ecc31525" xlink:href="esta-20210331.xsd#esta_EmployeeAndNonemployeeStockOptionMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_esta_EmployeeAndNonemployeeStockOptionMember_af15b9a2-5d54-42a3-b319-8cf2ecc31525" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RestrictedStockUnitsRSUMember_7bf90861-25d6-41c3-a789-3ff8b0838d4a" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RestrictedStockUnitsRSUMember"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_us-gaap_RestrictedStockUnitsRSUMember_7bf90861-25d6-41c3-a789-3ff8b0838d4a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_WarrantMember_89e46528-b50c-4f3e-a66e-9635b66589d2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_WarrantMember"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesNameDomain_b9b5799f-ae50-4cce-bb44-fe08256bcf99" xlink:to="loc_us-gaap_WarrantMember_89e46528-b50c-4f3e-a66e-9635b66589d2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable_5480bb11-7623-4492-aa75-5c25b59d88ca" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc478710-57fd-440c-9055-2ea6c9f2cfeb" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems_c474ef81-49b9-4828-b0b1-e53d17587317" xlink:to="loc_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_cc478710-57fd-440c-9055-2ea6c9f2cfeb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactions"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactions" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_8b33905e-9791-4b32-badb-18f4890ef7af" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_55429533-9546-437f-a1c2-d8af15d7cae2" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_8b33905e-9791-4b32-badb-18f4890ef7af" xlink:to="loc_us-gaap_RelatedPartyTransactionsDisclosureTextBlock_55429533-9546-437f-a1c2-d8af15d7cae2" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="simple" xlink:href="esta-20210331.xsd#RelatedPartyTransactionsNarrativeDetails"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsAbstract_00f9f1ef-63cf-4527-97a5-bf1543fec392" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsAbstract_00f9f1ef-63cf-4527-97a5-bf1543fec392" xlink:to="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionsByRelatedPartyAxis"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:to="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyDomain"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis_c6a8f35a-23a3-4606-bc19-69b4cd21cf49" xlink:to="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_ddd64cc9-3cb4-4ab2-80c8-497d74069d8f" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyDomain_e786e7ce-4104-4bf3-b9d0-cb7ff40ec5c0" xlink:to="loc_us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember_ddd64cc9-3cb4-4ab2-80c8-497d74069d8f" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionLineItems"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable_43ba75d1-f099-4e1a-bd99-55b12194fc57" xlink:to="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RevenueFromRelatedParties_a1ff34f4-ec84-4d05-a645-e7192dc90d89" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RevenueFromRelatedParties"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_RevenueFromRelatedParties_a1ff34f4-ec84-4d05-a645-e7192dc90d89" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_AccountsReceivableRelatedParties_b5e8cdb1-31b5-4017-9cab-11cbca6b34a1" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_AccountsReceivableRelatedParties"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_AccountsReceivableRelatedParties_b5e8cdb1-31b5-4017-9cab-11cbca6b34a1" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ce80882-d866-4ceb-96e0-88dbb1eb8dad" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_8ce80882-d866-4ceb-96e0-88dbb1eb8dad" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/verboseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e9bb613-d31b-4a4c-bd5e-1aba95658dc0" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_1e9bb613-d31b-4a4c-bd5e-1aba95658dc0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_5c4add36-e533-4b9d-8831-d674c2b59d3b" xlink:href="esta-20210331.xsd#esta_RelatedPartyTransactionCashReimbursementPerDayForServices"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_esta_RelatedPartyTransactionCashReimbursementPerDayForServices_5c4add36-e533-4b9d-8831-d674c2b59d3b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8495c8df-be16-44f4-bd8b-a56c613c0710" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_RelatedPartyTransactionLineItems_b44384da-0157-42ef-bd5d-f3ed04e288f3" xlink:to="loc_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty_8495c8df-be16-44f4-bd8b-a56c613c0710" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
  <link:roleRef roleURI="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="simple" xlink:href="esta-20210331.xsd#CommitmentsandContingencies"/>
  <link:presentationLink xlink:role="http://establishmentlabs.com/role/CommitmentsandContingencies" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c10e146-dcff-4a5e-8d83-e59e5b2ee04e" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_29d44205-1d2e-4f60-ab2b-1f80462ff02b" xlink:href="http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd#us-gaap_CommitmentsAndContingenciesDisclosureTextBlock"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaap_CommitmentsAndContingenciesDisclosureAbstract_1c10e146-dcff-4a5e-8d83-e59e5b2ee04e" xlink:to="loc_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock_29d44205-1d2e-4f60-ab2b-1f80462ff02b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>esta-20210331_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:country="http://xbrl.sec.gov/country/2020-01-31"
  xmlns:dei="http://xbrl.sec.gov/dei/2020-01-31"
  xmlns:esta="http://establishmentlabs.com/20210331"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:srt="http://fasb.org/srt/2020-01-31"
  xmlns:us-gaap="http://fasb.org/us-gaap/2020-01-31"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <link:schemaRef xlink:href="esta-20210331.xsd" xlink:type="simple"/>
    <context id="i9d8ea79494ab42e4843111748f602625_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i518b1d7c980a42fcbaee9300b5097f76_I20210505">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <instant>2021-05-05</instant>
        </period>
    </context>
    <context id="i220c6103ff954277ae7622703799d5e7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib16374b323b64d7eb6f72c7a60281d29_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i99d366567ea04542ae012abac0572301_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i27dba17eccf84c9498625bbb25746d84_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id69290453e57482aa28d8af7f2da3e28_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="icfc0d371d9dd4ebab9502457b3b27e7a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i5553b0e30a6b47359efbe2db3fd9d04d_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i13e571bed5bb4c89b0b49d66d7bcbf02_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic6f7657c1342467f9d573a50f47b9d88_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9a6b7f3567044b68b1e616d124468d00_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3a0ab61152174dbdaa572644ecc6b59b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ia3ba1914f323451f89eb5903cdba7731_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7d4a80508a874fea812a9bf34453045f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i9b7a1e0a518244cc92beac16b86bacf4_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ie486adfced4149c7b72ce4eb4e0c316c_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i362d2bbbd4e448569b56bbaee1759caa_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i51349f298359423dbbd0501a71ab38ef_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i7788fd91dc6d471fa4673c7a9251123e_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="iadc48570b61b405a97585b09fb39f436_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i176f5f3fed6946c0a3f5a48340d39eb9_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1541abdbaa374948b1b9a005046d4619_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4f1c51ee57d844558ea1135f49bae5c0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:CommonStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="icbae770df24748ea9b96a10664c50302_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:TreasuryStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i572345c645984642a2707a36a0be8636_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AdditionalPaidInCapitalMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i592974b4edd4462d8c0a59600b23a746_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:RetainedEarningsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i1dd6b5f4c6e54f6da671c43da519f1b0_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementEquityComponentsAxis">us-gaap:AccumulatedOtherComprehensiveIncomeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="ifd5a00be8cba48418ad7288e78d73ae7_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i8bd19aab21a94b07b796f48b84ac115a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic9ea8ba03f124881b6cb4934a8317cf3_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:BR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">us-gaap:SalesRevenueNetMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i2d40f566ba694c62a29ae89f751ed9ee_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:LongLivedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i081fde0d54924d748cd0047a247aca91_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">country:CR</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:LongLivedAssetsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:GeographicConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ib1162e78c15d49bb9ac650a48748dcd6_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:MajorCustomersAxis">esta:CustomerOneMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:CustomerConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i73eb050084884d97aabea10fa887eb00_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9c4421ada28146c7bd79ce446cfd0743_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:InventoryRawMaterialsPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i68ae26916d1344978f6c5489277d557b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1425d844a2054eb1874c578463f2cd02_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByBenchmarkAxis">esta:InventoryRawMaterialsPurchasesMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i05b2ab81a8424def8cac4bbd46817c34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7eb8031bfbf744fd8a075ed851059c67_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ConcentrationRiskByTypeAxis">us-gaap:SupplierConcentrationRiskMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:NuSilTechnologyLLCMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i004b7705a98e4c32b860182a8c4f08b3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i3b07bb856af64942a2e4ba6539ed0b99_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:ProductOrServiceAxis">us-gaap:ShippingAndHandlingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ib3ef82464d324a3a9122d68d6f8222d4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i4beb3e97e88a46229246ffae5ae38b10_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:EuropeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8d50b891602a40ae8475374170cd88a9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0f90130bb6ee4c95851406f50fa32310_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">srt:LatinAmericaMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i60a99d33ac56428badf4fa77635987cc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:AsiaPacificAndMiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="id8f4d7ebd44a431298ec2a860ec67dc5_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:AsiaPacificAndMiddleEastMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ic1895da228434d8c86601eebd0eb076b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i01fdfa1c7b87456c91b44f087364d012_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:StatementGeographicalAxis">esta:OtherGeographicalAreasMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id3996f92cc944a339de5caa40d1800d5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i29eb930880f043a89583c6fc57efa900_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:MachineryAndEquipmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ife4026763f654a77bc94bbe390a2fc4a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i9f0ae59c23484eb780355e39397ef553_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i160d575ddcb0470f83ed19730eb5fb61_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="iab56151cd6614657ab84386f1061d9c5_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:FurnitureAndFixturesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ieb8e6e4dd99449fb88bbbca0acc2862b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i43b3f0124f284ee699ac3fd4d34805b2_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:BuildingMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i2121ef462b904bc38a4a252ab9b29bcd_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i98c64154fe544ca7bd6cee9aadcc28ef_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LeaseholdImprovementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="if284ebc70ba8430c827c84cea2ebd7c0_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id5bc7817e64f42009391e541e0bed5b9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:LandMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i4df511fe868145bb8de184fd4579130b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ic63ccb3e5f68497baa493ee0a27489ff_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:VehiclesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1811e0f3590c40d0b8b5264bef9323fa_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ib89a316782de4b9aa036ee79cbb8a6a8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PropertyPlantAndEquipmentByTypeAxis">us-gaap:ConstructionInProgressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia40ff3845c404ee89df2259094867ea7_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i873ca24dbc894b9e8daab00025293c33_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="if0cce1c6c85749738e3b59dc105867e4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifd06ef7b1af0422c93f821f4a2f4cdce_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i6dc8ae01d3fd43de87978f967915da5f_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic96c2ad8891740878a37a78c477c68e5_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i3162e9ed932d412fb094be4a89be74cb_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0c230954c47a42a2a8f3f7a01264f32a_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i689c07f08f64464b9f3b1686974bd26c_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i9dca6d717b2a43bcb02a10e44f07718f_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7d0ffc41700c443db6b4f0218c08c5f9_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia584179cdecd4217be8aa815f6592f34_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8d86c11463554b5dae342b3e252588bc_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i14be8b6604984469ba137e25363566e7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ifcfcfc5c853545cfb75ef591c4c89c42_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i49c86d6704eb428f9ade6dcef7f7c2ba_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i01b3a59d508e48d9b117f28aeb5c7264_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:PatentsAndLicensingAgreementsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3edec611128b4e3ab3d4aa78897c8d21_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i89fb77590e764015b6a150b0c8ffe09d_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:CustomerRelationshipsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i9fa0089fc31649e58eec8035eada66ac_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i6997f7df2347466ab6eff3ece39e0830_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">esta:A510kAuthorizationMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i78118302909b42fe814d72c9776a9be6_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i3c454b81cfb24c619a23bb42c3d8fd20_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:DevelopedTechnologyRightsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i6494d630a4134e7bab16b46694c01385_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i059a7469f92d475985e17381b3f435bf_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i089cb2848143463d8c43064f3bebf723_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:SoftwareDevelopmentMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id15204a07aef47d79b3d1359d3d2298a_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ic2100b1681d141eb80d0946f6fecde49_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="id757366e4d8c40e7a89ea6fdd3bf8800_D20200101-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FiniteLivedIntangibleAssetsByMajorClassAxis">us-gaap:OtherIntangibleAssetsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="i95331fe2443f47f2a92a6d7d257f21c3_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="ifa130603b0d34bcaba896c6b2fbc06e8_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4e9b5f5e5662468497f5df0724ed1d00_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id0a4ea3cfc9b4f2d86192db4068663ca_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i71bb3412c07447beaadc22f1358a2b26_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i790092f6c06c4e31b55aa091e6e08ed8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="idaea600f2d8040ed846ffa50db817b73_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1ddf079de41d4d389e34c1fe33bd8373_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByFairValueHierarchyLevelAxis">us-gaap:FairValueInputsLevel3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByMeasurementFrequencyAxis">us-gaap:FairValueMeasurementsRecurringMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie0f77adbac95434d9b0d6d9480e92d51_I20170831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-31</instant>
        </period>
    </context>
    <context id="i9330e02904744171946200efc674cd7f_I20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-12-31</instant>
        </period>
    </context>
    <context id="i830e948888774878a6aef7ca1259e422_I20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-08-31</instant>
        </period>
    </context>
    <context id="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-01</startDate>
            <endDate>2017-12-31</endDate>
        </period>
    </context>
    <context id="ia6941f5711ff453faf70724a85877a15_D20190801-20190831">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-01</startDate>
            <endDate>2019-08-31</endDate>
        </period>
    </context>
    <context id="i059114baa58f4872bbfdcb04e021af01_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputProbabilityOfChangeInControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i14303ccbd1cf4882a177c1af2b917801_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputProbabilityOfChangeInControlMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i27da2686b48242f7a22212016aa9bccb_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputInterestRateVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i31a7c4a5a5f04c84a1769a691fe0f9e8_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputInterestRateVolatilityMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i86193100685843efbbbb39fedddbac34_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputMarketYieldRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if774d5d7adbc4aac92f6d23ce833114e_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">esta:MeasurementInputMarketYieldRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia29fed8a4345411c9e198ad402e4bf12_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i7ca4bc90ca3d4e5a87867faec60ebc94_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedTermMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i210e77df9d574a529b2c2f319b1dee8b_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i6d2f8614a7724e108142603cacaa1bb9_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FinancialInstrumentAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:MeasurementInputTypeAxis">us-gaap:MeasurementInputExpectedDividendRateMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i35ee0f70fefa4c82929e447a5cec9bb3_I20191231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-12-31</instant>
        </period>
    </context>
    <context id="ibe39498f97ab4942a773e100eed6a382_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i90151a15234f4bf594dddc4ccebc3bac_I20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-03-31</instant>
        </period>
    </context>
    <context id="i366040d3254b4edebd0cb69800364ef1_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ibc537e3dcd364e198a3715d83f0505b5_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:FairValueByLiabilityClassAxis">us-gaap:PutOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i5aed9212cd444c949bd6daaee2b29e84_I20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-17</instant>
        </period>
    </context>
    <context id="i6b2546ff36954e819bb93630aa88e260_I20170824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:AmendedMadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-24</instant>
        </period>
    </context>
    <context id="ia833a43aacd04fb58829b20141aedaf6_I20170824">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermAMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-08-24</instant>
        </period>
    </context>
    <context id="ied61c55aaefd4fa6ab4618839ed979f0_D20171031-20171031">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB1Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-10-31</startDate>
            <endDate>2017-10-31</endDate>
        </period>
    </context>
    <context id="ia1f9be83f245489ba3f93a2a2970a743_D20171215-20171215">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB2Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2017-12-15</startDate>
            <endDate>2017-12-15</endDate>
        </period>
    </context>
    <context id="icb1b1b6522f146e2a92e6845b3354b0e_I20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB3Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-17</instant>
        </period>
    </context>
    <context id="iefa578fa70ce4695a1914cbd8fad0ccd_I20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-06-17</instant>
        </period>
    </context>
    <context id="i56705c8ada8c45b8893dfc488df6e515_D20190812-20190812">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementTermB3AndB4Member</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-08-12</startDate>
            <endDate>2019-08-12</endDate>
        </period>
    </context>
    <context id="i15ac743227854d2c9afe9117722a0e53_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="if0313e61c81e4ee8a20a20c25abd823f_D20190101-20190616">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-06-16</endDate>
        </period>
    </context>
    <context id="idd8ee19aeac5495bb1e420bf7d180a2b_D20190617-20190617">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:VariableRateAxis">us-gaap:LondonInterbankOfferedRateLIBORMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-06-17</startDate>
            <endDate>2019-06-17</endDate>
        </period>
    </context>
    <context id="i709a73d169864a389bd4608c3299e861_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i0007a8ee0a3a4436b52008e19adf5975_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:DebtInstrumentAxis">esta:MadrynCreditAgreementMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:LongtermDebtTypeAxis">us-gaap:LineOfCreditMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i759011d78d1d4884b0ec06f0e36e3637_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i0f4c0806d8b045fd8478b54e30beab7e_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="id90136f7b3494c6a9628a63b0d9d7b06_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i1bd2c2bf38844a08b1d34482f0bd0b6d_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5f2199649ba74639a58014d05b0e0980_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i4983eb1dc3b54e3da8367f9521c63168_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i84d60646549649c5b45c4a188e368335_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i13079f6ba18c4ea6bd64156a196823ad_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="ia2caa5751cee42809a8237b7da9369d9_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i2fa6b9cdd0424fd2946a54b840e1d4fb_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="i247e8da1272d441ea7089934a2671ae9_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">us-gaap:CommonClassBMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="idc6ad514225b434ea180652c54cb7361_I20170331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ClassOfWarrantOrRightAxis">esta:RockportWarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2017-03-31</instant>
        </period>
    </context>
    <context id="ieda0ffc7bc7d4fa4861317378b2356ed_I20181231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2018-12-31</instant>
        </period>
    </context>
    <context id="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2019-01-01</instant>
        </period>
    </context>
    <context id="i87fb0387087841b6b020b35c3bc5ad74_D20190101-20190101">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:PlanNameAxis">esta:EquityIncentivePlan2018Member</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2019-01-01</startDate>
            <endDate>2019-01-01</endDate>
        </period>
    </context>
    <context id="ia1ec09e636ce49e4903a5f3d5ac3e7c7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i986acae19ce84fab8f8d01f4ded6532e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:SellingGeneralAndAdministrativeExpensesMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1f351807ee89478e92c86e857311533d_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ie71a900e3d434bcab7ea26baa565deb4_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:IncomeStatementLocationAxis">us-gaap:ResearchAndDevelopmentExpenseMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ie0fdf8bc2e1e409db1472911b124d683_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i15b02aa6633a436480804341634e94d3_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i478c73ce4642455cba1f5dffb0d3782a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic68469141fd244179893ceb45866a4a1_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementEmployeeMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia2edc59bec53490994496014ae3b59a2_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic6df5fcf8c8343ea957122278a45e96b_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:EmployeeStockOptionMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:GranteeStatusAxis">us-gaap:ShareBasedPaymentArrangementNonemployeeMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis">esta:ConsultantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="ia91fb86dcab548bc9e44e800b0fe1b3a_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MinimumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="ic880ec3a676b4f12a08eb325a02676fa_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="srt:RangeAxis">srt:MaximumMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i2bfc12cdfee24225bc3c5d74083ada83_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AwardTypeAxis">us-gaap:RestrictedStockMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i695c26f28c134a87811302e003a58006_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">esta:EmployeeAndNonemployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i07c8793eb73f4c988ba24cd20e54c766_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">esta:EmployeeAndNonemployeeStockOptionMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i99e5a665c04f40eca5f9a0b3a98ca5a4_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="icbb360d504184d689fa5022115013737_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:RestrictedStockUnitsRSUMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4915579cae994b35a1b781ee5e5104d7_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i52d7890a8568427a9a9331d06f4f7f6e_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis">us-gaap:WarrantMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-03-31</endDate>
        </period>
    </context>
    <context id="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-03-31</endDate>
        </period>
    </context>
    <context id="i8874a1e19376447fbb0ebf1b8cb9d361_I20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2020-12-31</instant>
        </period>
    </context>
    <context id="id7adeaf0b41a4c8289f265e3a67c7204_I20210331">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2021-03-31</instant>
        </period>
    </context>
    <context id="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2016-01-01</startDate>
            <endDate>2016-12-31</endDate>
        </period>
    </context>
    <context id="if841a633a7064c10a7ea55273d751563_I20161231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <instant>2016-12-31</instant>
        </period>
    </context>
    <context id="i29f43ea253394bd380b244709b366727_D20201201-20201231">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001688757</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:RelatedPartyTransactionsByRelatedPartyAxis">us-gaap:ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2020-12-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <unit id="shares">
        <measure>shares</measure>
    </unit>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="usdPerShare">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <unit id="facility">
        <measure>esta:facility</measure>
    </unit>
    <unit id="number">
        <measure>pure</measure>
    </unit>
    <unit id="segment">
        <measure>esta:segment</measure>
    </unit>
    <unit id="reportingunit">
        <measure>esta:reportingunit</measure>
    </unit>
    <dei:CountryRegion
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMS0xLTEtMS0w_72a1cb71-aced-4595-9e3a-c90782b25fa1">506</dei:CountryRegion>
    <dei:CityAreaCode
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMi0xLTEtMS0w_f5abdbca-6127-4183-b97c-8308361db706">24</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8xMy0xLTEtMS0w_640e0397-b2f0-4ed9-a8ce-dc67e122a933">34 2400</dei:LocalPhoneNumber>
    <dei:CurrentFiscalYearEndDate
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yMi0xLTEtMS0w_7cc26fc9-5c1b-416a-b6da-d3c0172acafd">--12-31</dei:CurrentFiscalYearEndDate>
    <dei:AmendmentFlag
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yMy0xLTEtMS0w_33dfd91e-69a3-4d69-a3c1-ee74f7697f53">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8yNC0xLTEtMS0w_a6719743-96d5-4e6f-b4da-1b41ca093044">0001688757</dei:EntityCentralIndexKey>
    <dei:DocumentFiscalYearFocus
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8zMi0xLTEtMS0w_f8c12ece-fdbb-4903-87d3-72b59358f05f">2021</dei:DocumentFiscalYearFocus>
    <dei:DocumentFiscalPeriodFocus
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80L2ZyYWc6ZjYxNzI2N2I3NzNiNGI4M2EyNzU4NWJmOWM3ZWEwN2IvdGFibGU6N2YwNjJmMjNmODY4NDA0Njg4NzI4MWM3OTNhOTY4YTkvdGFibGVyYW5nZTo3ZjA2MmYyM2Y4Njg0MDQ2ODg3MjgxYzc5M2E5NjhhOV8zMy0xLTEtMS0w_fe401401-e50c-4cee-9dd8-c974a824219b">Q1</dei:DocumentFiscalPeriodFocus>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b">P5Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7c74e65418b84778929bacb6ec905edc_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzIzL2ZyYWc6OGY1YjViYjA0OWFjNGY1NjkyNWFkNDNjZjRmZWZkOWIvdGV4dHJlZ2lvbjo4ZjViNWJiMDQ5YWM0ZjU2OTI1YWQ0M2NmNGZlZmQ5Yl80OTQ3ODAyMzI1MTU2_22e54002-68f8-49aa-a3a8-1b94cfd75ce3"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfOperatingSegments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzIzL2ZyYWc6OGY1YjViYjA0OWFjNGY1NjkyNWFkNDNjZjRmZWZkOWIvdGV4dHJlZ2lvbjo4ZjViNWJiMDQ5YWM0ZjU2OTI1YWQ0M2NmNGZlZmQ5Yl80OTQ3ODAyMzI1MTU2_78018be4-7f3a-443d-ab4c-4d364c999fc2"
      unitRef="segment">1</us-gaap:NumberOfOperatingSegments>
    <us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzE1L2ZyYWc6MTgxZGYxMzhjYzIwNDgyNGI0ODc4ZjIzZjk5NTYxNjkvdGFibGU6MWY5MDY5MGFlY2UwNDk2MWE3OWQ0Y2EzNjVlNTg0YWIvdGFibGVyYW5nZToxZjkwNjkwYWVjZTA0OTYxYTc5ZDRjYTM2NWU1ODRhYl8xLTAtMS0xLTE1MDI_bae51b41-1f29-44f1-97ca-43f30d817cc7">us-gaap:AccruedLiabilitiesCurrent</us-gaap:OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ia91fb86dcab548bc9e44e800b0fe1b3a_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzU1OA_84b51ed7-33dc-4765-9c9e-ef71511b6db7">P1Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <dei:DocumentType
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDUw_c69bf5f3-8dd6-4a7f-b565-66b1c96865ca">10-Q</dei:DocumentType>
    <dei:DocumentQuarterlyReport
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDUy_a1f6df08-f49b-4ee9-8de8-900a2d71c821">true</dei:DocumentQuarterlyReport>
    <dei:DocumentPeriodEndDate
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMjI_6706ef66-8207-4726-8a37-abfb3932696a">2021-03-31</dei:DocumentPeriodEndDate>
    <dei:DocumentTransitionReport
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ2_2da1a388-edae-4848-bc5c-bb2bec27bf5f">false</dei:DocumentTransitionReport>
    <dei:EntityFileNumber
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ3_c27a18dc-f624-480f-bf03-620f891562fd">001-38593</dei:EntityFileNumber>
    <dei:EntityRegistrantName
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ4_7eb6f545-6b09-4b6f-aa64-64e23809bf7e">Establishment Labs Holdings Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8wLTAtMS0xLTA_f5fa9a07-a149-4a68-9c70-c1b97b2f3a4d">D8</dei:EntityIncorporationStateCountryCode>
    <dei:EntityAddressAddressLine1
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF80_217a8512-fa59-4f42-90d0-ceb97416729b">Building B15 and 25</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF83_66d44191-08dc-4733-a4c6-f59f037885d4">Coyol Free Zone</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF8xMA_71377024-5328-4d1c-beaa-a31e7bf83bd5">Alajuela</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6MDEyNTJlNWYwZGFmNGJmOWExZDdhNGJiNjQ1NDFiOGEvdGFibGVyYW5nZTowMTI1MmU1ZjBkYWY0YmY5YTFkN2E0YmI2NDU0MWI4YV8zLTAtMS0xLTAvdGV4dHJlZ2lvbjo5YTliNzVhZDIzYzA0ZmFlYTNmN2M5YWE5NDkxODQyZF8xMw_498ccf5d-29e3-4315-ade6-bda71b2e094f">CR</dei:EntityAddressCountry>
    <dei:EntityCurrentReportingStatus
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ5_a54a2c86-0d0f-4d06-b96d-e3f1f954bd98">Yes</dei:EntityCurrentReportingStatus>
    <dei:EntityInteractiveDataCurrent
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQz_04449dc7-74df-480a-9e51-e87ada32cdec">Yes</dei:EntityInteractiveDataCurrent>
    <dei:EntityFilerCategory
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18xLTAtMS0xLTQzNjYvdGV4dHJlZ2lvbjo5MzRmNmQ4MzM4Njk0NzVmODA1ZTRhMTgwZmRhN2UyNF80OTQ3ODAyMzI1MDQw_e9a99c9b-00a1-4c5a-b13a-1824793efc31">Non-accelerated Filer</dei:EntityFilerCategory>
    <dei:EntitySmallBusiness
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18xLTItMS0xLTAvdGV4dHJlZ2lvbjpjM2ExOTM3ZDM0OTk0YmFlYTJjNTZjYTZmYzk2MDM2ZV8zMA_cca1e270-8a8a-4eac-bd97-fda6aab8b830">true</dei:EntitySmallBusiness>
    <dei:EntityEmergingGrowthCompany
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZWFkZTQxZWIyNDVhNDdmODkzOGM5MzdjOGFmZDNlMTMvdGFibGVyYW5nZTplYWRlNDFlYjI0NWE0N2Y4OTM4YzkzN2M4YWZkM2UxM18yLTAtMS0xLTAvdGV4dHJlZ2lvbjphZjFmMDFkMWM4YjA0MjAwOWFiMDUxNDgyMDJhM2M2MV8yOA_450c2f70-07a9-44eb-abb3-112f6ece7f8a">true</dei:EntityEmergingGrowthCompany>
    <dei:EntityExTransitionPeriod
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDU0_864b29e3-b524-404b-aba0-34954ce0a449">false</dei:EntityExTransitionPeriod>
    <dei:EntityShellCompany
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQ0_1a22a992-f84c-455c-b397-54ec41e8205f">false</dei:EntityShellCompany>
    <dei:Security12bTitle
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTAtMS0xLTA_b2350373-d4a0-450e-83b9-37e7a3a2f97d">Common Shares, No Par Value</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTEtMS0xLTA_613a571d-87a5-46cc-9865-99495ff14ad8">ESTA</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGFibGU6ZjliMzJjZDkxODI3NGNlNjg2MjdkZGExZDQ5Zjc3ZTYvdGFibGVyYW5nZTpmOWIzMmNkOTE4Mjc0Y2U2ODYyN2RkYTFkNDlmNzdlNl8xLTItMS0xLTAvdGV4dHJlZ2lvbjozOTdjMTc2MjA1NzY0ZDZlYTJhNTllNmU2OWRlODE0ZV84_d330aaec-173a-41bf-abde-20161ca53787">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityCommonStockSharesOutstanding
      contextRef="i518b1d7c980a42fcbaee9300b5097f76_I20210505"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xL2ZyYWc6NDIxNWVhZGZiOGRmNDA4OGI2MzVlNjM4ZWFmOTA5NzcvdGV4dHJlZ2lvbjo0MjE1ZWFkZmI4ZGY0MDg4YjYzNWU2MzhlYWY5MDk3N18yMDQx_5d267636-135c-46f4-874d-d7ac6c2667ad"
      unitRef="shares">23687808</dei:EntityCommonStockSharesOutstanding>
    <us-gaap:Cash
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNS0xLTEtMS0w_9cca0165-5370-4b77-9970-9580eaa273ad"
      unitRef="usd">77950000</us-gaap:Cash>
    <us-gaap:Cash
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNS0zLTEtMS0w_24ad9f79-a981-4ec2-91a6-34b304c02980"
      unitRef="usd">84523000</us-gaap:Cash>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0wLTEtMS0wL3RleHRyZWdpb246MmExNjU4ZDdiOTJmNGUwNTg4NTQyMTk4M2I2ZDFlOWZfNjc_ae1c299d-3d10-4c73-a6bc-bcb878e72311"
      unitRef="usd">1121000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0wLTEtMS0wL3RleHRyZWdpb246MmExNjU4ZDdiOTJmNGUwNTg4NTQyMTk4M2I2ZDFlOWZfNzQ_9bc7aa9c-63c9-4077-8e29-b0439604fbfd"
      unitRef="usd">1143000</us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0xLTEtMS0w_d7808043-6784-4b0a-b89f-8553a1ba8a9b"
      unitRef="usd">23777000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:AccountsReceivableNetCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNi0zLTEtMS0w_4e8c9160-f233-456f-a644-84fbb5fee6a6"
      unitRef="usd">19127000</us-gaap:AccountsReceivableNetCurrent>
    <us-gaap:InventoryNet
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNy0xLTEtMS0w_c51ba677-c8d3-463b-a1f7-08837e5f0f1b"
      unitRef="usd">22377000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfNy0zLTEtMS0w_60de96c7-f43a-4526-b275-5eb5821f664d"
      unitRef="usd">23210000</us-gaap:InventoryNet>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOC0xLTEtMS0w_2bbefca3-540c-46cd-a01a-62d84c26f221"
      unitRef="usd">4194000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:PrepaidExpenseAndOtherAssetsCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOC0zLTEtMS0w_e51151c0-0b7b-4d75-bdde-2be80a05bfd4"
      unitRef="usd">5439000</us-gaap:PrepaidExpenseAndOtherAssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOS0xLTEtMS0w_14c693e6-cb90-464a-92f0-a1fe33a6727a"
      unitRef="usd">128298000</us-gaap:AssetsCurrent>
    <us-gaap:AssetsCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfOS0zLTEtMS0w_a853cae5-32ee-495d-8be8-69cf87a30b27"
      unitRef="usd">132299000</us-gaap:AssetsCurrent>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTEtMS0xLTEtMA_8b234edb-7bdf-4ec7-9fd7-e0d6f7875cde"
      unitRef="usd">16321000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTEtMy0xLTEtMA_014cc911-1c33-47d8-8ef5-28b4270807d3"
      unitRef="usd">16202000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:Goodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTItMS0xLTEtMA_b11b9cdf-18f5-472a-b5ec-08deff9b90ab"
      unitRef="usd">465000</us-gaap:Goodwill>
    <us-gaap:Goodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTItMy0xLTEtMA_b60b0951-f27c-46e5-b9f4-1994d9d831fb"
      unitRef="usd">465000</us-gaap:Goodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTMtMS0xLTEtMA_89e76878-b487-452a-8f2c-6770c7e5a8e5"
      unitRef="usd">4126000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTMtMy0xLTEtMA_239330c7-3bb1-472e-8e94-7fa4ec84dd8f"
      unitRef="usd">4148000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMS0xLTEtNDA_9bfdd304-0cd1-45e8-b7ae-90e3b2a420f2"
      unitRef="usd">2511000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMy0xLTEtNTg_106bea3b-9dad-464a-80d0-e99871abcfbb"
      unitRef="usd">2610000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMS0xLTEtMA_70dd55f0-b9fd-424f-bdfe-af84a34c7e5d"
      unitRef="usd">628000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:OtherAssetsNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTUtMy0xLTEtMA_09a46261-758a-4434-8865-2a663782329f"
      unitRef="usd">664000</us-gaap:OtherAssetsNoncurrent>
    <us-gaap:Assets
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTYtMS0xLTEtMA_d10eea5e-a4f3-4278-aff6-6238ec16778d"
      unitRef="usd">152349000</us-gaap:Assets>
    <us-gaap:Assets
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTYtMy0xLTEtMA_420723a3-b884-44cc-af64-249a9ee64a4c"
      unitRef="usd">156388000</us-gaap:Assets>
    <us-gaap:AccountsPayableCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTktMS0xLTEtMA_f3ac84af-6f21-4c6c-839b-974e1381ee44"
      unitRef="usd">8994000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccountsPayableCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMTktMy0xLTEtMA_08b6bf68-e7c6-4188-9dce-0df44cebf171"
      unitRef="usd">9722000</us-gaap:AccountsPayableCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjAtMS0xLTEtMA_7f240c9a-1881-440b-9f4c-4f9c8a053920"
      unitRef="usd">14408000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjAtMy0xLTEtMA_d88aed1d-0350-4f80-8083-929730b3cb27"
      unitRef="usd">14532000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjEtMS0xLTEtMA_8aea8ff2-1ca6-4a43-8e72-a25ea164450a"
      unitRef="usd">1431000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjEtMy0xLTEtMA_5b6e4ce7-bc68-489e-b2d4-850d05e163d6"
      unitRef="usd">1646000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjItMS0xLTEtMA_24e891d4-291b-4d01-9cd4-8ce414c5ab9b"
      unitRef="usd">24833000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjItMy0xLTEtMA_2693e081-8726-4062-9282-1f8c670194ce"
      unitRef="usd">25900000</us-gaap:LiabilitiesCurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjQtMS0xLTEtMA_662c6692-e696-47f5-90e7-c310e293c4d2"
      unitRef="usd">50305000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:LongTermDebtNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjQtMy0xLTEtMA_23e3d664-d4ed-4de0-ab96-df5f3a8081e1"
      unitRef="usd">49832000</us-gaap:LongTermDebtNoncurrent>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i99d366567ea04542ae012abac0572301_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMS0xLTEtMA_7d73786f-66b0-4e39-99d0-2e5389d5fe8e"
      unitRef="usd">1210000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMS0xLTEtMA_e4f1ffd1-4aae-46e1-8d1e-80d9343ee31c"
      unitRef="usd">1210000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:DerivativeLiabilitiesNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjUtMy0xLTEtMA_f903eb47-e665-4331-abe7-01d28e4cecc0"
      unitRef="usd">1440000</us-gaap:DerivativeLiabilitiesNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMS0xLTEtNjg_76045df7-35a2-4a8e-99aa-7484c0d17f2b"
      unitRef="usd">1630000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMy0xLTEtNjQ_e2f556db-6f4f-4473-bb8c-34773dd78044"
      unitRef="usd">1923000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjYtMS0xLTEtMA_c500af28-e7c7-43c1-97ed-d091f3b3c78c"
      unitRef="usd">1820000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjYtMy0xLTEtMA_b26bdda8-eeb4-402b-b500-93c0b0a27300"
      unitRef="usd">2332000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:Liabilities
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMS0xLTEtMA_ae2a192c-0daf-403c-b038-f1e4ffc94b7a"
      unitRef="usd">79798000</us-gaap:Liabilities>
    <us-gaap:Liabilities
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjctMy0xLTEtMA_adcde8c1-a6a2-4a1a-bdbe-5285c5953c85"
      unitRef="usd">81427000</us-gaap:Liabilities>
    <us-gaap:CommitmentsAndContingencies
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjgtMS0xLTEtMA_7e9c190b-b860-429f-b31b-266f2cec3613"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommitmentsAndContingencies
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMjgtMy0xLTEtMA_a23b3c4f-62c4-4a8b-aa5a-d7efb9783c9b"
      unitRef="usd"
      xsi:nil="true"/>
    <us-gaap:CommonStockSharesIssued
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzY1_fea9dc35-31c0-420d-b26d-83f20fb4cf63"
      unitRef="shares">24094051</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzcy_d674b4c5-db63-4510-97b0-6bb9c9ce1cb7"
      unitRef="shares">23925789</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzE0OA_76b2ff02-b315-4bdc-aaaf-28f6d228c438"
      unitRef="shares">23685981</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMC0xLTEtMC90ZXh0cmVnaW9uOmI2NWUyYTAzMjRjYTQxNGNiMWZkZmM1NTAwNmY5ZGFlXzE1NQ_4ffcc7e8-e0b2-4404-a934-4e2371c27e73"
      unitRef="shares">23517719</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockValue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMS0xLTEtMA_45b5560b-da56-45df-bac4-53d522d43575"
      unitRef="usd">215358000</us-gaap:CommonStockValue>
    <us-gaap:CommonStockValue
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzAtMy0xLTEtMA_3c4117ac-919e-4d88-9ffd-92621a4cf62f"
      unitRef="usd">213471000</us-gaap:CommonStockValue>
    <us-gaap:AdditionalPaidInCapital
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzEtMS0xLTEtMA_f21aa9e5-b038-4568-b0f3-d77b4eb492ab"
      unitRef="usd">28427000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:AdditionalPaidInCapital
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzEtMy0xLTEtMA_7715ef92-a9d1-458e-b3ee-efe451e08e01"
      unitRef="usd">26717000</us-gaap:AdditionalPaidInCapital>
    <us-gaap:TreasuryStockShares
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjFiZWRkN2U5NTk5ZDRlY2NhYTE3OTliYmY3MWYzZmU2XzMw_2b1d5f8c-4bfb-4f79-9f62-b4bee099322f"
      unitRef="shares">408070</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockShares
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMC0xLTEtMC90ZXh0cmVnaW9uOjFiZWRkN2U5NTk5ZDRlY2NhYTE3OTliYmY3MWYzZmU2XzMw_2b929161-97d5-4b24-a1ff-c1f07d5aba41"
      unitRef="shares">408070</us-gaap:TreasuryStockShares>
    <us-gaap:TreasuryStockValue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMS0xLTEtMA_22e16da7-a64f-4cdc-a791-7fa5092e9482"
      unitRef="usd">2854000</us-gaap:TreasuryStockValue>
    <us-gaap:TreasuryStockValue
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzItMy0xLTEtMA_d283ac66-c25f-48f0-897a-f3daec9f0d01"
      unitRef="usd">2854000</us-gaap:TreasuryStockValue>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzMtMS0xLTEtMA_183da65b-f33d-43d7-b4b2-3cf62302a93c"
      unitRef="usd">-172194000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:RetainedEarningsAccumulatedDeficit
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzMtMy0xLTEtMA_4c9fa4aa-9f97-4169-bcae-3b49b0c0f65d"
      unitRef="usd">-165246000</us-gaap:RetainedEarningsAccumulatedDeficit>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzQtMS0xLTEtMA_d70930a2-5eda-449c-a3ac-16ad9c3caba6"
      unitRef="usd">3814000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzQtMy0xLTEtMA_c5e6949e-6cf9-42a3-814c-43c0a83c60b3"
      unitRef="usd">2873000</us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax>
    <us-gaap:StockholdersEquity
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzUtMS0xLTEtMA_f28b2724-6df4-4ba3-bf2c-31d3bc442836"
      unitRef="usd">72551000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzUtMy0xLTEtMA_7ace3179-38e4-462b-8071-78000c8a692d"
      unitRef="usd">74961000</us-gaap:StockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzYtMS0xLTEtMA_16184dac-de3a-4d82-b71f-3f03280c47ec"
      unitRef="usd">152349000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:LiabilitiesAndStockholdersEquity
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xNi9mcmFnOmEyMzc1OGUwNmIzNjQ5ZmY4NWVhODdmYjQ3ZWYwYTczL3RhYmxlOjAzY2Q3YzZhZTJiMDRiNDA5NGMwNGMwMDIyZWJiY2ZlL3RhYmxlcmFuZ2U6MDNjZDdjNmFlMmIwNGI0MDk0YzA0YzAwMjJlYmJjZmVfMzYtMy0xLTEtMA_1fcee1d8-8c80-4436-9ae4-4a7420dbfe84"
      unitRef="usd">156388000</us-gaap:LiabilitiesAndStockholdersEquity>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMy02LTEtMS0w_f8b8885f-cc18-4a2e-84ce-a607396bd805"
      unitRef="usd">30336000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMy04LTEtMS0w_4c7a90bb-b732-4c34-86be-f6ca32dff340"
      unitRef="usd">24481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:CostOfRevenue
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNC02LTEtMS0w_919b523e-fc5b-4596-b79e-186604c32089"
      unitRef="usd">10246000</us-gaap:CostOfRevenue>
    <us-gaap:CostOfRevenue
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNC04LTEtMS0w_1bd3867d-e9fa-43f5-b20f-33e24deab0a5"
      unitRef="usd">9003000</us-gaap:CostOfRevenue>
    <us-gaap:GrossProfit
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNS02LTEtMS0w_d6648089-2e20-4c2a-ad06-238d082a69c7"
      unitRef="usd">20090000</us-gaap:GrossProfit>
    <us-gaap:GrossProfit
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNS04LTEtMS0w_677771f3-4218-4965-80e0-00310f81768f"
      unitRef="usd">15478000</us-gaap:GrossProfit>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNy02LTEtMS0w_b8673451-c3c2-4a31-97b5-96cde059aa41"
      unitRef="usd">18138000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfNy04LTEtMS0w_97abf68e-b7f2-4fcc-b1ba-f02e52469a27"
      unitRef="usd">18984000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOC02LTEtMS0w_cedb8f6a-0a70-41bc-8dc1-683648f4d6b2"
      unitRef="usd">4048000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:ResearchAndDevelopmentExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOC04LTEtMS0w_71419a1f-6ed0-4e1f-8670-4d74b3991281"
      unitRef="usd">4199000</us-gaap:ResearchAndDevelopmentExpense>
    <us-gaap:OperatingExpenses
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOS02LTEtMS0w_2c81a7b9-d2fa-4c4a-a9fc-70a1ac1c5e15"
      unitRef="usd">22186000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingExpenses
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfOS04LTEtMS0w_46b58cbd-9572-471f-ad06-c6edd6e77eff"
      unitRef="usd">23183000</us-gaap:OperatingExpenses>
    <us-gaap:OperatingIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTAtNi0xLTEtMA_a836e76b-a826-4950-a9e9-486babd46d0c"
      unitRef="usd">-2096000</us-gaap:OperatingIncomeLoss>
    <us-gaap:OperatingIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTAtOC0xLTEtMA_bcc380f3-eeb3-46ec-92b5-2b3c1e43f8a1"
      unitRef="usd">-7705000</us-gaap:OperatingIncomeLoss>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTEtNi0xLTEtMA_5d357525-0681-427f-8077-b723175c23b4"
      unitRef="usd">4000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InvestmentIncomeInterest
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTEtOC0xLTEtMA_a74756c1-5d63-4da0-822c-25e95e5a5fa1"
      unitRef="usd">8000</us-gaap:InvestmentIncomeInterest>
    <us-gaap:InterestExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTItNi0xLTEtMA_4c1f532f-33e5-431f-bf22-efce1856134a"
      unitRef="usd">2195000</us-gaap:InterestExpense>
    <us-gaap:InterestExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTItOC0xLTEtMA_0c8a14c5-5f90-4533-9bdd-611b94e8d431"
      unitRef="usd">2146000</us-gaap:InterestExpense>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTMtNi0xLTEtMA_3875b5a6-3d9d-475c-b540-04816a6585fb"
      unitRef="usd">230000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:GainLossOnDerivativeInstrumentsNetPretax
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTMtOC0xLTEtMA_4daeb9b9-872d-4c01-8a3c-994225d8ebdc"
      unitRef="usd">-1929000</us-gaap:GainLossOnDerivativeInstrumentsNetPretax>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTQtNi0xLTEtMA_f820fa4d-5397-4ea9-9b90-c1835c7fe31a"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTQtOC0xLTEtMA_4ade64c4-826b-4b2e-8051-b6f5e74871c1"
      unitRef="usd">-440000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTYtNi0xLTEtMA_34cafbce-c035-4f20-b15c-bb7c6183c066"
      unitRef="usd">-2726000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:OtherNonoperatingIncomeExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTYtOC0xLTEtMA_20aabfd8-ed54-4e8f-a56a-a30bff9a8404"
      unitRef="usd">-6190000</us-gaap:OtherNonoperatingIncomeExpense>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTctNi0xLTEtMA_58f03211-1c77-4411-ac71-9b24821c2952"
      unitRef="usd">-6783000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTctOC0xLTEtMA_f778499b-a93f-4646-a306-03e503665782"
      unitRef="usd">-17522000</us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTgtNi0xLTEtMA_dc03a3f7-e89a-4b16-9440-88c8f7444202"
      unitRef="usd">165000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:IncomeTaxExpenseBenefit
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTgtOC0xLTEtMA_3e117403-47e3-4dfa-9a60-61c8a34168e2"
      unitRef="usd">231000</us-gaap:IncomeTaxExpenseBenefit>
    <us-gaap:NetIncomeLoss
      contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktNi0xLTEtMA_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktNi0xLTEtMA_e52cb721-7370-454d-94fa-56383aa1257a"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMTktOC0xLTEtMA_ef1bacbe-ecde-4483-9a94-2223bfbb2136"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjEtNi0xLTEtMA_94b15bb6-65a4-4361-bd75-95873be68845"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjEtOC0xLTEtMA_8d61c6f8-d664-480a-943f-67808af75935"
      unitRef="usdPerShare">-0.79</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjMtNi0xLTEtMA_3b8f333e-0fdf-492c-a099-5e0bce6ef8ee"
      unitRef="shares">23827137</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xOS9mcmFnOmQ2ZGViMjk5ZjJjNDQzZWE4MmZmNDMyNGRhYWEzN2NiL3RhYmxlOmU2YjNjNTM2MmEyOTQ4YjhhNzdiNTZjYjczYzJiMjQ0L3RhYmxlcmFuZ2U6ZTZiM2M1MzYyYTI5NDhiOGE3N2I1NmNiNzNjMmIyNDRfMjMtOC0xLTEtMA_f667509d-60dd-48cb-a123-b1786cf8d5a7"
      unitRef="shares">22456365</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:NetIncomeLoss
      contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy01LTEtMS0w_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy01LTEtMS0w_e52cb721-7370-454d-94fa-56383aa1257a"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfMy03LTEtMS0w_ef1bacbe-ecde-4483-9a94-2223bfbb2136"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNS01LTEtMS0w_e25006af-ab58-43ff-905f-f9b78539959e"
      unitRef="usd">941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNS03LTEtMS0w_f34fd8c0-dfc3-4c0d-a132-b0c8f8fd5347"
      unitRef="usd">2821000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNi01LTEtMS0w_44743d93-6b51-4536-839c-30d96688c0d5"
      unitRef="usd">941000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNi03LTEtMS0w_4bbc407b-ac7c-4d30-891e-0607630b9dee"
      unitRef="usd">2821000</us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNy01LTEtMS0w_78f9d283-1342-4ddd-8ae1-305786817bac"
      unitRef="usd">-6007000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:ComprehensiveIncomeNetOfTax
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yMi9mcmFnOjQzMzhjYTlmNzBkNDQ1NmU5YjQ0NDc5ZGIzMDk1ZTA2L3RhYmxlOmEyMWY3ZDhkMDQzNDQ3MzNhNjRiNDk3Y2M4YTE3MDlkL3RhYmxlcmFuZ2U6YTIxZjdkOGQwNDM0NDczM2E2NGI0OTdjYzhhMTcwOWRfNy03LTEtMS0w_47d882eb-191d-4f3c-a8f9-7dc9352fa0f4"
      unitRef="usd">-14932000</us-gaap:ComprehensiveIncomeNetOfTax>
    <us-gaap:SharesIssued
      contextRef="i27dba17eccf84c9498625bbb25746d84_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMi0xLTEtMA_dcbda8be-5b45-4ae7-9510-dfee6ae6d1c5"
      unitRef="shares">23925789</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i27dba17eccf84c9498625bbb25746d84_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtNC0xLTEtMA_82518856-da83-4715-b78f-0e38a45d2a21"
      unitRef="usd">213471000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTAtMS0xLTA_24018275-e642-435f-b31f-c7c112a4ce95"
      unitRef="shares">408070</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i67dbf4c9f0c347d9b22a02e58a51517b_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTItMS0xLTA_83f5fc1c-e836-4491-8710-deaa1c56c030"
      unitRef="usd">-2854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="id69290453e57482aa28d8af7f2da3e28_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTQtMS0xLTA_da9df87d-d27e-4ab8-b9d0-44b782d29c81"
      unitRef="usd">26717000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="icfc0d371d9dd4ebab9502457b3b27e7a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTYtMS0xLTA_ceafce51-a349-428d-b062-fe31d96a280c"
      unitRef="usd">-165246000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i5553b0e30a6b47359efbe2db3fd9d04d_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMTgtMS0xLTA_833a3605-ee9c-40f1-bb28-bc4d3541cec8"
      unitRef="usd">2873000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTUtMjAtMS0xLTA_6afe24e0-b850-457f-8125-e23c6055afce"
      unitRef="usd">74961000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtMi0xLTEtMA_26d16370-6845-48ff-b835-edee23e1a9ec"
      unitRef="shares">163034</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtNC0xLTEtMA_6bd30098-3a17-4fb0-98b4-c2678f1c4a89"
      unitRef="usd">1882000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMTgtMjAtMS0xLTA_cf6bf953-a8e4-48fd-8f1e-6c495e4d1bcd"
      unitRef="usd">1882000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMi0xLTEtMA_7bd5adc7-d50e-4819-b158-7741f13fec1b"
      unitRef="shares">5939</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtNC0xLTEtMA_7f30bcc8-a45d-4558-aeb1-a36448edd713"
      unitRef="usd">6000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMTQtMS0xLTA_26524b8e-d5ce-461d-8807-04d4b0c49b08"
      unitRef="usd">1750000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjAtMjAtMS0xLTA_63a04672-0729-4f06-99eb-91347da11c69"
      unitRef="usd">1756000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMi0xLTEtMA_702d0bb1-9745-4cea-880b-be10a9671e67"
      unitRef="shares">711</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ia8f0ccb013054eb680a901debccff0e2_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtNC0xLTEtMA_b5097b36-8386-4d02-bb46-a6848d8fd2db"
      unitRef="usd">1000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="ib419295799fc4ae8bc826fb85aed00d3_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMTQtMS0xLTA_21874a20-7b3b-4b80-96e1-7096119f834c"
      unitRef="usd">40000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjEtMjAtMS0xLTA_20a12df1-12ec-4ead-bd55-e94b78d98f5b"
      unitRef="usd">41000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i13e571bed5bb4c89b0b49d66d7bcbf02_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjMtMTgtMS0xLTA_daf3a213-ecd1-4755-bd52-2adfaca7627f"
      unitRef="usd">941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjMtMjAtMS0xLTA_c658ece6-c9dd-4c04-b519-25fe989356c5"
      unitRef="usd">941000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMTYtMS0xLTA_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMTYtMS0xLTA_e52cb721-7370-454d-94fa-56383aa1257a"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjQtMjAtMS0xLTA_6d5f90a8-c1ed-48b4-b8bc-64751471be74"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="ic6f7657c1342467f9d573a50f47b9d88_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMi0xLTEtMA_194ab096-4b5b-4bcd-8fcc-a0da57ecc097"
      unitRef="shares">24094051</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="ic6f7657c1342467f9d573a50f47b9d88_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtNC0xLTEtMA_b8ecb4b9-3cc0-406b-9a96-dbc4a592402b"
      unitRef="usd">215358000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i9a6b7f3567044b68b1e616d124468d00_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTAtMS0xLTA_a6cd1da4-ed83-46a7-8bc8-9d671b5c35ef"
      unitRef="shares">408070</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9a6b7f3567044b68b1e616d124468d00_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTItMS0xLTA_be594475-f1da-4cae-99c6-ac6131f609de"
      unitRef="usd">-2854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i3a0ab61152174dbdaa572644ecc6b59b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTQtMS0xLTA_27383593-c1f6-436e-9d9d-7be45a82682d"
      unitRef="usd">28427000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ia3ba1914f323451f89eb5903cdba7731_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTYtMS0xLTA_0bff2281-135b-4bac-9ece-ec8893ee4492"
      unitRef="usd">-172194000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7d4a80508a874fea812a9bf34453045f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMTgtMS0xLTA_65b1644b-fd3d-426a-bdaa-9df45f28bd54"
      unitRef="usd">3814000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjExY2IxOWY2NmE3NDRiYjY4YWVlMTU4NjkyMGY4YmZhL3RhYmxlcmFuZ2U6MTFjYjE5ZjY2YTc0NGJiNjhhZWUxNTg2OTIwZjhiZmFfMjUtMjAtMS0xLTA_e04bc652-d7f2-44f9-ab90-2f7550e6ab40"
      unitRef="usd">72551000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMi0xLTEtMA_3802998b-032f-41c6-9ae7-6d77c0b1c4ef"
      unitRef="shares">21057040</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtNC0xLTEtMA_df92a522-1ec5-4c6a-beef-2081d9a83c1a"
      unitRef="usd">147688000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="i9b7a1e0a518244cc92beac16b86bacf4_I20191231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTAtMS0xLTA_a68a59ef-5c53-46d9-ac18-525818ee8bfe"
      unitRef="shares">408070</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i9b7a1e0a518244cc92beac16b86bacf4_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTItMS0xLTA_3eb3fa22-1551-4795-a13e-4e23da017bdf"
      unitRef="usd">-2854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ie486adfced4149c7b72ce4eb4e0c316c_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTQtMS0xLTA_b4e40bfe-854c-44e5-8666-104026ceb46f"
      unitRef="usd">21214000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i362d2bbbd4e448569b56bbaee1759caa_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTYtMS0xLTA_8dbadfc4-191f-42c9-b2b3-a086f7603424"
      unitRef="usd">-127125000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i51349f298359423dbbd0501a71ab38ef_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMTgtMS0xLTA_02571e2a-555d-44b9-a122-867ef0dc242d"
      unitRef="usd">691000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i7788fd91dc6d471fa4673c7a9251123e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTUtMjAtMS0xLTA_01aa80ca-6e87-4372-96ff-f8425f936236"
      unitRef="usd">39614000</us-gaap:StockholdersEquity>
    <us-gaap:StockIssuedDuringPeriodSharesNewIssues
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtMi0xLTEtMA_7ed43b93-7e48-4614-a245-0bdac7529a68"
      unitRef="shares">2628571</us-gaap:StockIssuedDuringPeriodSharesNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtNC0xLTEtMA_43aea9c5-d910-47d8-b5cc-5ced75197595"
      unitRef="usd">63855000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodValueNewIssues
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTYtMjAtMS0xLTA_910cfb6a-6b9d-407c-acf1-1e3ba63b231d"
      unitRef="usd">63855000</us-gaap:StockIssuedDuringPeriodValueNewIssues>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctMi0xLTEtMA_6ee3622c-79e3-439b-ab27-09defc5c83dc"
      unitRef="shares">39723</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctNC0xLTEtMA_beea7853-fd5b-4914-8c4c-d608c711248c"
      unitRef="usd">181000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTctMjAtMS0xLTA_ba1d2762-8c08-4a7a-82bb-31add82e78cf"
      unitRef="usd">181000</us-gaap:StockIssuedDuringPeriodValueStockOptionsExercised>
    <us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMi0xLTEtMA_1e8dedb7-9fe3-4b59-9cd1-252b3d6dc103"
      unitRef="shares">11062</us-gaap:StockIssuedDuringPeriodSharesShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktNC0xLTEtMA_049798ef-8408-4427-a5ac-128155125e72"
      unitRef="usd">11000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="iadc48570b61b405a97585b09fb39f436_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMTQtMS0xLTA_241260b9-d8af-439d-af56-752b81aa8dc8"
      unitRef="usd">1618000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMTktMjAtMS0xLTA_c9c6f0d8-23a1-4a01-a754-a221db1541ab"
      unitRef="usd">1629000</us-gaap:StockIssuedDuringPeriodValueShareBasedCompensation>
    <us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMi0xLTEtMA_a7bf8690-15b4-4076-9338-221472666c9c"
      unitRef="shares">1383</us-gaap:SharesPaidForTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i59b37bd444e14a3d9ef7875d9341a1a4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtNC0xLTEtMA_cc6499d6-2630-4bc6-bb3b-0ee3c87e5763"
      unitRef="usd">1000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="iadc48570b61b405a97585b09fb39f436_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMTQtMS0xLTA_20cde836-a252-4688-b0df-5c9996e7237b"
      unitRef="usd">33000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjAtMjAtMS0xLTA_40624edb-53fa-4e8b-9408-065f03d514d7"
      unitRef="usd">34000</us-gaap:AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i176f5f3fed6946c0a3f5a48340d39eb9_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjEtMTgtMS0xLTA_b92e4bfe-aacb-4f05-8981-f7a7e517880c"
      unitRef="usd">2821000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjEtMjAtMS0xLTA_713997ff-a464-44d4-9cc6-2664f79e23aa"
      unitRef="usd">2821000</us-gaap:OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent>
    <us-gaap:NetIncomeLoss
      contextRef="i1541abdbaa374948b1b9a005046d4619_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjItMTYtMS0xLTA_b10dd5d8-09c2-456c-b588-e3e076f2feb7"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjItMjAtMS0xLTA_225661ce-6f62-4393-8c09-3cc88b3676a4"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <us-gaap:SharesIssued
      contextRef="i4f1c51ee57d844558ea1135f49bae5c0_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMi0xLTEtMA_2b77b2f3-0d6c-4f54-aa8f-a6c86d25fd23"
      unitRef="shares">23735013</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="i4f1c51ee57d844558ea1135f49bae5c0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtNC0xLTEtMA_68260f4c-2a9a-4f7d-aa79-5569095f400a"
      unitRef="usd">211734000</us-gaap:StockholdersEquity>
    <us-gaap:SharesIssued
      contextRef="icbae770df24748ea9b96a10664c50302_I20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTAtMS0xLTA_d2ef4dd7-5e53-4cbd-a58c-383553577d6d"
      unitRef="shares">408070</us-gaap:SharesIssued>
    <us-gaap:StockholdersEquity
      contextRef="icbae770df24748ea9b96a10664c50302_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTItMS0xLTA_47a94026-1583-48c4-bd50-86d65b68da37"
      unitRef="usd">-2854000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i572345c645984642a2707a36a0be8636_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTQtMS0xLTA_98049d12-6dcd-4d24-acd5-0634fda4fd53"
      unitRef="usd">22799000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i592974b4edd4462d8c0a59600b23a746_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTYtMS0xLTA_6f254417-707c-4726-873f-4f42d2edcf9c"
      unitRef="usd">-144878000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="i1dd6b5f4c6e54f6da671c43da519f1b0_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMTgtMS0xLTA_8f1230bb-8ce6-4749-aa6f-e428987514d0"
      unitRef="usd">3512000</us-gaap:StockholdersEquity>
    <us-gaap:StockholdersEquity
      contextRef="ifd5a00be8cba48418ad7288e78d73ae7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yNS9mcmFnOjg3ODUyZTc3ZDA4MzQyZjk4NWIyNWVmZWQ3YmEwZDg4L3RhYmxlOjZjMDQxZGZiYzIxNTQ0ODU4ZTEwYzZiODhiMTViZmRiL3RhYmxlcmFuZ2U6NmMwNDFkZmJjMjE1NDQ4NThlMTBjNmI4OGIxNWJmZGJfMjMtMjAtMS0xLTA_32dfa984-99cc-45e5-869a-859c168b6efc"
      unitRef="usd">90313000</us-gaap:StockholdersEquity>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNC0yLTEtMS0w_25818941-a9ca-4993-ac53-b9c0e5408b50"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNC00LTEtMS0w_777258f6-e5ec-41ad-92b1-577905794c11"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <esta:DepreciationandAmortizationExcludingDebtDiscountPremium
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNi0yLTEtMS0w_082000ef-a154-464a-a759-1f343987e9c7"
      unitRef="usd">908000</esta:DepreciationandAmortizationExcludingDebtDiscountPremium>
    <esta:DepreciationandAmortizationExcludingDebtDiscountPremium
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNi00LTEtMS0w_eb7e3ba1-aaf4-48a6-80f4-9f1d0c6dba44"
      unitRef="usd">833000</esta:DepreciationandAmortizationExcludingDebtDiscountPremium>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNy0yLTEtMS0w_81e1fc28-a391-418e-96c2-70d7d7d5af55"
      unitRef="usd">6000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:ProvisionForDoubtfulAccounts
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNy00LTEtMS0w_2e2850d8-b03e-4173-99d0-ecfa99cbcd07"
      unitRef="usd">599000</us-gaap:ProvisionForDoubtfulAccounts>
    <us-gaap:InventoryWriteDown
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOC0yLTEtMS0w_7088837a-faba-442e-a4c0-54e33f6c149c"
      unitRef="usd">93000</us-gaap:InventoryWriteDown>
    <us-gaap:InventoryWriteDown
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOC00LTEtMS0w_68f207ba-d88d-46d2-a021-bd7662d6787b"
      unitRef="usd">137000</us-gaap:InventoryWriteDown>
    <us-gaap:ShareBasedCompensation
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOS0yLTEtMS0w_e3126c8c-0e31-4394-b967-06f04ed1bed6"
      unitRef="usd">1756000</us-gaap:ShareBasedCompensation>
    <us-gaap:ShareBasedCompensation
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfOS00LTEtMS0w_e785db8a-8e15-4625-b5e1-d26eb26916b9"
      unitRef="usd">1629000</us-gaap:ShareBasedCompensation>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTAtMi0xLTEtMA_91e14270-9627-474d-af12-25a0ce485e76"
      unitRef="usd">-20000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:GainLossOnSaleOfPropertyPlantEquipment
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTAtNC0xLTEtMA_45c07d7d-6f8f-4f45-a442-9647d2154453"
      unitRef="usd">-5000</us-gaap:GainLossOnSaleOfPropertyPlantEquipment>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTItMi0xLTEtMA_012fed3c-fb81-44f9-bb73-4cc088a8c2ea"
      unitRef="usd">-3030000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:ForeignCurrencyTransactionGainLossUnrealized
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTItNC0xLTEtMA_fe7b367c-8530-4d6b-a528-6e35995012ca"
      unitRef="usd">-5845000</us-gaap:ForeignCurrencyTransactionGainLossUnrealized>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtMi0xLTEtMTUz_0774db73-306d-4077-87e8-2108bed774f8"
      unitRef="usd">101000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtNC0xLTEtMTQ5_779e6c36-5259-42e7-bd82-8271d383dc27"
      unitRef="usd">79000</us-gaap:OperatingLeaseRightOfUseAssetAmortizationExpense>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtMi0xLTEtMA_1d157645-0a69-417a-8b1e-6ffdf1984942"
      unitRef="usd">230000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:UnrealizedGainLossOnDerivatives
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTMtNC0xLTEtMA_3840ea84-b89f-400b-a785-598dae57aee2"
      unitRef="usd">-1929000</us-gaap:UnrealizedGainLossOnDerivatives>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTQtMi0xLTEtMA_7f7663e4-c555-4f61-9886-970cefc9087f"
      unitRef="usd">0</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTQtNC0xLTEtMA_cb9355c3-98e2-4672-bc51-5d7ed8c19512"
      unitRef="usd">-440000</us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTUtMi0xLTEtMA_21e30d6a-0a38-43a9-9ee0-94df8fd0fd77"
      unitRef="usd">474000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:AmortizationOfFinancingCostsAndDiscounts
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTUtNC0xLTEtMA_dd6c2150-0b80-4f3d-8c1c-ae74b97c717b"
      unitRef="usd">388000</us-gaap:AmortizationOfFinancingCostsAndDiscounts>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTctMi0xLTEtMA_fc1d1951-1fed-4c38-acd5-ea90255ce638"
      unitRef="usd">5218000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInAccountsReceivable
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTctNC0xLTEtMA_2f51a331-22b2-41b5-ae48-c543e3a9ffb1"
      unitRef="usd">171000</us-gaap:IncreaseDecreaseInAccountsReceivable>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTgtMi0xLTEtMA_3fde4dad-1267-4c90-9162-35ab8aece067"
      unitRef="usd">698000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInInventories
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTgtNC0xLTEtMA_ffa20f9a-5af6-432e-a19d-bdc864697961"
      unitRef="usd">-438000</us-gaap:IncreaseDecreaseInInventories>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTktMi0xLTEtMA_9d6144f9-f2c1-4732-b159-719d56d7b092"
      unitRef="usd">-1217000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMTktNC0xLTEtMA_7e25ddd8-1f04-483e-916f-f7a064d88b1f"
      unitRef="usd">660000</us-gaap:IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjAtMi0xLTEtMA_ff0de94c-8436-48b8-acba-b44cf05595b7"
      unitRef="usd">-26000</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInOtherNoncurrentAssets
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjAtNC0xLTEtMA_0d905490-7295-40ba-804e-10ad908e4e2c"
      unitRef="usd">0</us-gaap:IncreaseDecreaseInOtherNoncurrentAssets>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjEtMi0xLTEtMA_4e6edb18-71fa-4576-9fb3-0fee132856fa"
      unitRef="usd">-617000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccountsPayable
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjEtNC0xLTEtMA_2cc573b4-6ce3-4fba-b017-fa513a0c3421"
      unitRef="usd">366000</us-gaap:IncreaseDecreaseInAccountsPayable>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjItMi0xLTEtMA_7b9dcc6c-d512-48a0-87aa-538b44d192c6"
      unitRef="usd">-158000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <us-gaap:IncreaseDecreaseInAccruedLiabilities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjItNC0xLTEtMA_d57a302d-afdf-4139-85c5-62176157b21b"
      unitRef="usd">40000</us-gaap:IncreaseDecreaseInAccruedLiabilities>
    <esta:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtMi0xLTEtMTYx_9c060bf8-61b4-48cf-b37a-b5ed1e4eddc8"
      unitRef="usd">-95000</esta:IncreaseDecreaseInOperatingLeaseLiabilities>
    <esta:IncreaseDecreaseInOperatingLeaseLiabilities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtNC0xLTEtMTU3_441686db-ebce-4806-90eb-818a3a6ae553"
      unitRef="usd">-70000</esta:IncreaseDecreaseInOperatingLeaseLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjMtMi0xLTEtMA_41c01b48-01b9-48b6-a4b1-875efc3390eb"
      unitRef="usd">-221000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:IncreaseDecreaseInOtherOperatingLiabilities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjMtNC0xLTEtMA_318484f7-f793-4116-bcb2-6cc9e044ae13"
      unitRef="usd">4000</us-gaap:IncreaseDecreaseInOtherOperatingLiabilities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtMi0xLTEtMA_64519fe8-8894-4c09-b1be-51ce9b58a452"
      unitRef="usd">-6554000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:NetCashProvidedByUsedInOperatingActivities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjQtNC0xLTEtMA_d0f5f2fe-e47f-456a-87a5-4f1500fcb986"
      unitRef="usd">-6802000</us-gaap:NetCashProvidedByUsedInOperatingActivities>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjYtMi0xLTEtMA_b9c51d84-ec55-4f7a-a2af-f05c7ec06a3e"
      unitRef="usd">804000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjYtNC0xLTEtMA_4666d558-6b10-4860-9e55-eac0b13cdf91"
      unitRef="usd">687000</us-gaap:PaymentsToAcquirePropertyPlantAndEquipment>
    <esta:PaymentstoAcquireAssetsIncludingReceivablesHeld
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjctMi0xLTEtMA_d5e8153b-0a36-4715-a327-c37442784859"
      unitRef="usd">434000</esta:PaymentstoAcquireAssetsIncludingReceivablesHeld>
    <esta:PaymentstoAcquireAssetsIncludingReceivablesHeld
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjctNC0xLTEtMA_8e7bdb36-0acc-4f2f-9099-75450b540019"
      unitRef="usd">0</esta:PaymentstoAcquireAssetsIncludingReceivablesHeld>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjgtMi0xLTEtMA_d5e8baee-7b95-4ebb-b94f-98ad937a8452"
      unitRef="usd">294000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:PaymentsToAcquireIntangibleAssets
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMjgtNC0xLTEtMA_f98217ad-a003-45bf-8132-b688cddc4fb3"
      unitRef="usd">262000</us-gaap:PaymentsToAcquireIntangibleAssets>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzAtMi0xLTEtMA_04a6f99b-dfb1-4d5d-96b9-98b931a1fbad"
      unitRef="usd">-1532000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:NetCashProvidedByUsedInInvestingActivities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzAtNC0xLTEtMA_fcebc8c6-ecbe-4c4a-815f-ff88d1dcb414"
      unitRef="usd">-949000</us-gaap:NetCashProvidedByUsedInInvestingActivities>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzgtMi0xLTEtMA_67f3af5b-1e53-4210-999f-2eb4aeaacf18"
      unitRef="usd">55000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfMzgtNC0xLTEtMA_92ffa02e-d00c-4ab1-accf-af62078b3b5e"
      unitRef="usd">76000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDAtMi0xLTEtMA_cfba3eb2-1d73-42ee-8aad-d8a60f2af7c7"
      unitRef="usd">0</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromIssuanceOfCommonStock
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDAtNC0xLTEtMA_97921494-9c14-4258-9544-783d276f5166"
      unitRef="usd">63855000</us-gaap:ProceedsFromIssuanceOfCommonStock>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDMtMi0xLTEtMA_b3ec5d0e-f70b-4dc8-b73e-df525e265241"
      unitRef="usd">1882000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:ProceedsFromStockOptionsExercised
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDMtNC0xLTEtMA_b21fd8d1-295e-45d1-9609-a97ac7e3f583"
      unitRef="usd">181000</us-gaap:ProceedsFromStockOptionsExercised>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDUtMi0xLTEtMA_3cb87e0d-0ca6-4e97-98d8-29b02a0bdf3e"
      unitRef="usd">41000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDUtNC0xLTEtMA_63b5ad01-9511-42b7-b456-cbf44762ede7"
      unitRef="usd">34000</us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDYtMi0xLTEtMA_c1fc2adc-2c88-43f9-bc1c-905db00c8f01"
      unitRef="usd">1786000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:NetCashProvidedByUsedInFinancingActivities
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDYtNC0xLTEtMA_5cbd592a-9219-4577-9f64-c0d23174d13c"
      unitRef="usd">63926000</us-gaap:NetCashProvidedByUsedInFinancingActivities>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDctMi0xLTEtMA_d056f35d-0951-4f01-a81f-2715dec611c1"
      unitRef="usd">-273000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDctNC0xLTEtMA_ea3dff9b-7824-44ad-9ac3-3e3f6f9400ee"
      unitRef="usd">-234000</us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDgtMi0xLTEtMA_99699d7e-1010-427a-8f7e-8346aa6398f4"
      unitRef="usd">-6573000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDgtNC0xLTEtMA_f24b2a05-7137-47ba-9669-4d4e69e2891c"
      unitRef="usd">55941000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDktMi0xLTEtMA_607634bf-d8c8-42b9-9bef-064368ef579f"
      unitRef="usd">84523000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i7788fd91dc6d471fa4673c7a9251123e_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNDktNC0xLTEtMA_d293f4c9-0833-4741-a7f1-541d860a9e96"
      unitRef="usd">37655000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTAtMi0xLTEtMA_0c039126-1dd6-4210-8571-9bb15017b8e6"
      unitRef="usd">77950000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
      contextRef="ifd5a00be8cba48418ad7288e78d73ae7_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTAtNC0xLTEtMA_94302f37-1858-4740-8514-62e1e4ef2d8d"
      unitRef="usd">93596000</us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents>
    <us-gaap:InterestPaidNet
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTQtMi0xLTEtMA_7f4f6561-2b27-40af-aeb5-aacc54f27cc4"
      unitRef="usd">1710000</us-gaap:InterestPaidNet>
    <us-gaap:InterestPaidNet
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTQtNC0xLTEtMA_e5a582c3-1ea4-49a5-a654-bf05e36dfcb6"
      unitRef="usd">1734000</us-gaap:InterestPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTUtMi0xLTEtMA_7add73d6-2e4a-4841-a678-7120227e8e1b"
      unitRef="usd">10000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:IncomeTaxesPaidNet
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTUtNC0xLTEtMA_1370e330-7e65-46b4-a7bd-d9c967a66f6c"
      unitRef="usd">1000</us-gaap:IncomeTaxesPaidNet>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTgtMi0xLTEtMA_e1d1f1f4-cd3c-479b-9933-d0925b70065c"
      unitRef="usd">143000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <us-gaap:CapitalExpendituresIncurredButNotYetPaid
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNTgtNC0xLTEtMA_c05bdcda-09b3-4abb-865e-5769595d1fef"
      unitRef="usd">395000</us-gaap:CapitalExpendituresIncurredButNotYetPaid>
    <esta:NoncashConsiderationPayableRelatedtoAssetAcquisition
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNjQtMi0xLTEtMA_c7d4b5a6-0311-4a68-bd7d-160721e41818"
      unitRef="usd">407000</esta:NoncashConsiderationPayableRelatedtoAssetAcquisition>
    <esta:NoncashConsiderationPayableRelatedtoAssetAcquisition
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8yOC9mcmFnOjllZWRjY2UyZGNlZTQ0Mjk4NGU0ZDhiNTY3NWViMTE2L3RhYmxlOmM4MmJiNWExY2JhODQ5ZjFhYWVmODBiZGQ4MWZlNjE1L3RhYmxlcmFuZ2U6YzgyYmI1YTFjYmE4NDlmMWFhZWY4MGJkZDgxZmU2MTVfNjQtNC0xLTEtMA_91d7515d-b0b2-4b6e-a6f5-94402092cc00"
      unitRef="usd">1257000</esta:NoncashConsiderationPayableRelatedtoAssetAcquisition>
    <us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNC9mcmFnOmIyMWE2MDhhNTA5ZDRkOTI4MWQ2NjNhYjlkNTc4YzdjL3RleHRyZWdpb246YjIxYTYwOGE1MDlkNGQ5MjgxZDY2M2FiOWQ1NzhjN2NfMzUzOQ_c3fe1ba1-4f3d-4a84-a2a2-a73b6b7f41db">Formation and Business of the Company&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Formation and Business of the Company&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Establishment Labs Holdings Inc. and its wholly owned subsidiaries (collectively &#x201c;the Company&#x201d;, &#x201c;we&#x201d;, &#x201c;us&#x201d;, or &#x201c;our&#x201d;) is a global company that manufactures and markets innovative medical devices for aesthetic and reconstructive plastic surgery. The Company was established in the British Virgin Islands on October 9, 2013, at which time Establishment Labs, S.A., the Costa Rican manufacturing company, was reincorporated as a wholly-owned subsidiary. As of March&#160;31, 2021, the Company also has wholly-owned subsidiaries in the United States (JAMM Technologies, Inc. and Motiva USA LLC), Brazil (Establishment Labs Produtos para Saude Ltda), Belgium (European Distribution Center Motiva BVBA), France (Motiva Implants France SAS), Sweden (Motiva Nordica AB), Switzerland (JEN-Vault AG), the United Kingdom (Motiva Implants UK Limited), Italy (Motiva Italy S.R.L), Spain (Motiva Implants Spain, S.L.), Austria (Motiva Austria GmbH), Germany (Motiva Germany GmbH) and Argentina (Motiva Argentina S.R.L). Substantially all of the Company&#x2019;s revenues are derived from the sale of silicone gel-filled breast implants, branded as Motiva Implants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The main manufacturing activities are conducted at two manufacturing facilities in Costa Rica. In 2010, the Company began operating under the Costa Rica free zone regime (R&#xe9;gimen de Zona Franca), which provides for reduced income tax and other tax obligations pursuant to an agreement with the Costa Rican authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s products are approved for sale in Europe, the Middle East, Latin America, and Asia. The Company sells its products internationally through a combination of distributors and direct sales to customers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company is pursuing regulatory approval to commercialize its products in the United States. The Company received approval for an investigational device exemption, or IDE, from the FDA in March 2018 to initiate a clinical trial in the United States for its Motiva Implants. In August 2019, we completed all patient surgeries for the IDE aesthetic cohorts, which include primary augmentation and revision. As of March&#160;31, 2021, we are continuing to enroll subjects in the remaining reconstruction cohorts. &lt;/span&gt;&lt;/div&gt;The Company has been expanding its global operations through a series of acquisitions and establishing wholly-owned subsidiaries. In November 2015, the Company purchased certain assets from Magna Equities I, LLC and established its wholly-owned subsidiary, JAMM Technologies, Inc., in the United States. In January 2016, the Company purchased a distribution company in Brazil to support the application to sell its products in Brazil. In March 2016, the Company purchased a storage and distribution company in Belgium to support its continued growth in Europe. In September 2016, the Company purchased a distribution company in France, and it also established a wholly-owned subsidiary in Switzerland. In November 2017, the Company acquired certain assets from Femiline AB and established its wholly-owned subsidiary in Sweden, Motiva Nordica AB. During 2018, the Company established wholly-owned subsidiaries in the United Kingdom and Italy and purchased certain assets from Menke Med GmbH, Motiva Matrix Spain, S.L. and Belle Health Ltd. In 2019, the Company purchased certain assets from AFS Medical GMBH and established wholly-owned subsidiaries in Austria, Spain and Germany. In 2020, the Company established a wholly-owned subsidiary in Argentina and purchased certain assets from Orion Trading SRL for the Italian operations.</us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock>
    <esta:NumberOfManufacturingFacilities
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNC9mcmFnOmIyMWE2MDhhNTA5ZDRkOTI4MWQ2NjNhYjlkNTc4YzdjL3RleHRyZWdpb246YjIxYTYwOGE1MDlkNGQ5MjgxZDY2M2FiOWQ1NzhjN2NfMTIyNw_102708b5-2a50-48f0-a59e-9bf14ebc45d2"
      unitRef="facility">2</esta:NumberOfManufacturingFacilities>
    <us-gaap:SignificantAccountingPoliciesTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDI_de341e2c-cb49-465d-a10f-00d95cbecf17">Summary of Significant Accounting Policies&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There have been no material changes to the Company&#x2019;s significant accounting policies during the&#160;three months ended March&#160;31, 2021 as compared to the significant accounting policies described in Note 2 of the &#x201c;Notes to Consolidated Financial Statements&#x201d; in the Company&#x2019;s audited consolidated financial statements as of December&#160;31, 2020 and 2019 and for the years then ended. Below are those policies with current period updates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements and related financial information should be read &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#x2019;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the Company&#x2019;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Incorporation/Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs, S.A. (Costa Rica)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 18, 2004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva USA, LLC (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 20, 2014&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JAMM Technologies, Inc. (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 27, 2015&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs Produtos par Saude Ltda (Brazil)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;European Distribution Center Motiva BVBA (Belgium)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants France SAS (France)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 12, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JEN-Vault AG (Switzerland)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 22, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Nordica AB (Sweden)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants UK Limited (the United Kingdom)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Italy S.R.L (Italy)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants Spain, S.L. (Spain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 3, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Austria GmbH (Austria)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 14, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Germany GmbH (Germany)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Argentina S.R.L (Argentina)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 7, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All intercompany accounts and transactions have been eliminated in consolidation. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Unaudited Interim Condensed Consolidated Financial Information&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying interim condensed consolidated financial statements as of March&#160;31, 2021 and for the three months ended March&#160;31, 2021 and 2020, and the related interim information contained within the notes to the condensed consolidated financial statements, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments which are necessary to state fairly the Company&#x2019;s financial position as of March&#160;31, 2021, and the results of its operations and cash flows for the three months ended March&#160;31, 2021 and 2020. Such adjustments are of a normal and recurring nature. The results for the three months ended March&#160;31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year 2021, or for any future period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic regions in which the Company operates.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Geographic Concentrations &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company derives all its revenues from sales to customers in Europe, the Middle East, Latin America, and Asia, and has not yet received approval to sell its products in the United States. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For the three months ended March&#160;31, 2021 and 2020 Brazil accounted for 10.6% and 10.0% of consolidated revenue, respectively, and no other individual country exceeded 10% of consolidated revenue, on a ship-to destination basis. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The majority of the Company&#x2019;s consolidated total assets, including cash and tangible assets, is held in the United States. The Company&#x2019;s long-lived assets, which primarily consist of property and equipment and intangible assets located in Costa Rica represented &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;78% and 80% &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;of the total long-lived assets as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimates and management judgments reflected in the condensed &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets&#x2019; useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company&#x2019;s cash is held at two financial institutions in the United States. Balances in the Company&#x2019;s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of the Company&#x2019;s revenues were derived from the sale of Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, no customer accounted for more than 10% of the Company&#x2019;s revenue. No customer accounted for more than 10% of the Company&#x2019;s trade accounts receivable balance as of March&#160;31, 2021 or &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, the Company had purchases of $4.3 million, or 55.8% of total purchases, and $5.0&#160;million, or 64.9% of total purchases, respectively, from NuSil. As of March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company had an outstanding balance owed to this vendor of $1.6 million and $1.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company&#x2019;s current and potential future products, uncertainty of market acceptance of the Company&#x2019;s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2020, the World Health Organization declared the outbreak of a novel coronavirus, or COVID-19, as a pandemic which has spread globally, including locations where the Company does business. This outbreak caused a material disruption of the operations of the Company and its suppliers and customers in fiscal 2020 and resulted in delayed clinical trial enrollment within the reconstruction cohorts of its IDE clinical trial in the United States. However, the impact from the COVID-19 outbreak has not had a material effect on the Company&#x2019;s liquidity or financial position. The full extent of any future impact of the continuing outbreak, related business and travel restrictions and changes to behavior intended to reduce its spread are uncertain and continues to evolve globally. Management continues to monitor the impact that the COVID-19 pandemic is having on the Company, the breast aesthetics and reconstruction market and the economies in which the Company operates. The Company anticipates that its future results of operations, including the results for 2021 could be materially impacted by the COVID-19 outbreak. However, given the speed and frequency of continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the potential impact to the results of its operations. To the extent that the Company&#x2019;s customers continue to be materially and adversely impacted by the COVID-19 outbreak, this could materially interrupt the Company&#x2019;s business operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Cash &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s cash consists of cash maintained in checking and interest-bearing accounts. The majority of the Company&#x2019;s cash is held at two financial institutions in the United States. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held no cash equivalents as of March&#160;31, 2021 or &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accounts Receivable and Allowance for Doubtful Accounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accounts receivable is stated at invoice value less estimated allowances for returns and doubtful accounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from customers&#x2019; inability to make required payments. In evaluating the Company&#x2019;s ability to collect outstanding receivable balances, the Company considers various factors including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#x2019;s current financial condition. In cases where there are circumstances that may impair a specific customer&#x2019;s ability to meet its financial obligations, an allowance is recorded against amounts due, which reduces the net recognized receivable to the amount reasonably believed to be collectible. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory and Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost to purchase or manufacture the inventory or the net realizable value of such inventory. Cost is determined using the standard cost method which approximates actual costs using the first-in, first-out basis. The Company regularly reviews inventory quantities considering actual losses, projected future demand, and remaining shelf life to record a provision for excess and slow-moving inventory. An inventory reserve of $1.7 million and $1.6 million has been recorded as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the cost of inventory transferred to the customer in cost of revenue when revenue is recognized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is, or contains, a lease at the inception date of the contract. The Company has elected an expedient to account for each separate lease component and its associated non-lease components as a single lease component for the majority of its asset classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. The Company recognizes lease liabilities and right-of-use, or ROU, assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Shipping and Handling Costs&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Shipping and handling costs are expensed as incurred and are included in selling, general and administrative, or SG&amp;amp;A, expenses. For the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and 2020, shipping and handling costs were &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$1.2&#160;million and $0.8&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue related to sales of products to distributors or directly to customers in markets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;where it has regulatory approval, net of discounts and allowances. The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, Revenue from Contracts with Customers. ASC 606 requires the Company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue related to the sales of products to distributors at the time of shipment of the product, which represents the point in time when the distributor has taken ownership and assumed the risk of loss and the required revenue recognition criteria are satisfied. The Company&#x2019;s distributors are obligated to pay within specified terms regardless of when, or if, they sell the products. The Company&#x2019;s contracts with distributors typically do not contain right of return or price protection and have no post-delivery obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when title to the product and risk of loss transfer to customers, provided there are no remaining performance obligations required of the Company or any written matters requiring customer acceptance. The Company allows for the return of product from direct customers in certain regions in limited instances within fifteen days after the original sale and records estimated sales returns as a reduction of sales in the same period revenue is recognized. Appropriate reserves are established for anticipated sales returns based on historical experience, recent gross sales and any notification of pending returns. Actual sales returns in any future period are inherently uncertain and thus may differ from the estimates. If actual sales returns differ significantly from the estimates, an adjustment to revenue in the current or subsequent period is recorded. As of March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an allowance of zero and $54,000 was recorded for product returns, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s revenue is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For these products, revenue is recognized at the time the Company is notified by the consignee that the product has been implanted, not when the consigned products are delivered to the consignee&#x2019;s warehouse. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue was generated in these primary geographic markets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific/Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a limited warranty for the shelf life of the product, which is five years from the time of manufacture. Estimated warranty obligations are recorded at the time of sale. The Company also offers a warranty to patients in the event of rupture and a replacement program for capsular contracture events, provided certain registration requirements are met. Revenue for extended warranties is recognized ratably over the term of the agreement. To date, these warranty and program costs have been de minimis. The Company will continue to evaluate the warranty reserve policies for adequacy considering claims history.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Deferred revenue primarily consists of payments received in advance of meeting revenue recognition criteria. The Company has received payments from distributors to provide distribution exclusivity within a geographic area and recognizes deferred revenue on a ratable basis over the term of such contractual distribution relationship. Additionally, the Company has received payments from customers in direct markets prior to surgical implantation and recognizes deferred revenue at the time the Company is notified by the customer that the product has been implanted. For all arrangements, any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue and included in &#x201c;Other liabilities, long-term&#x201d; on the condensed consolidated balance sheets (see Note 3).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs related to research and development, or R&amp;amp;D, activities are expensed as incurred. R&amp;amp;D costs primarily include personnel costs, materials, clinical expenses, regulatory expenses, product development, consulting services, and outside research activities, all of which are directly related to research and development activities. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company estimates IDE clinical trial expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations that conduct and manage clinical trials on its behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Selling, General and Administrative Expenses&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;SG&amp;amp;A expenses include sales and marketing costs, payroll and related benefit costs, insurance expenses, shipping and handling costs, legal and professional fees and administrative overhead. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.05pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:0.1pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Following the exercise of its option to purchase its manufacturing facility in June 2019, the Company depreciates the owned building on a straight-line basis over 50 years of useful life. Depreciation of property and equipment is computed using the straight-line method over the assets&#x2019; estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b"&gt;five&lt;/span&gt; to ten years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the remaining lease term after factoring expected renewal periods. Upon retirement or disposal of assets, the costs and related accumulated depreciation are eliminated from the accounts and any gain or loss is recognized in operations. Maintenance and repairs are expensed as incurred. Substantially all of the Company&#x2019;s manufacturing operations and related property and equipment is located in Costa Rica. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records the excess of the acquisition purchase price over the net fair value of the tangible and identifiable intangible assets acquired and liabilities assumed as goodwill. In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company tests goodwill for impairment annually during the fourth quarter of each year and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with the annual impairment test for goodwill, the Company elected the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it was more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test is performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the Company's assessment that it has only one reporting segment, the Company has determined that it has only one reporting unit and tests goodwill for impairment at the entity level using the two-step process required by ASC 350. In the first step, the Company compares the carrying amount of the reporting unit to the fair value of the enterprise. If the fair value of the enterprise exceeds the carrying value, goodwill is not considered impaired and no further testing is required. If the carrying value of the enterprise exceeds the fair value, goodwill is potentially impaired, and the second step of the impairment test must be performed. In the second step, the Company compares the implied fair value of the goodwill, as defined by ASC 350, to its carrying amount to determine the impairment loss, if any.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company capitalizes certain costs related to intangible assets, such as patents, trademarks and software &lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;development costs. The Company follows the provisions of ASC 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Internal Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for determining whether computer software is internal-use software and on accounting for the proceeds of computer software originally developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of software development and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company records purchased intangible assets at their respective estimated fair values at the date of acquisition. Purchased finite-lived intangible assets are being amortized using the straight-line method over their remaining estimated useful lives, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94"&gt;two&lt;/span&gt; to fifteen years. The Company evaluates the remaining useful lives of intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining estimated amortization period. The Company tests indefinite-lived intangible assets for impairment on at least an annual basis and whenever circumstances suggest the assets may be impaired. If indicators of impairment are present, the Company evaluates the carrying value of the intangible assets in relation to estimates of future undiscounted cash flows. The Company also evaluates the remaining useful life of an indefinite-lived intangible asset to determine whether events and circumstances continue to support an indefinite useful life. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the year ended December&#160;31, 2020, there was no impairment of goodwill or intangible assets based on the qualitative assessments performed by the Company. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.4pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#x2019;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives recorded d&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;uring the year ended December&#160;31, 2020. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;long-lived&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; asset values may not be recoverable.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Embedded Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note&#160;5).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in connection with the issuance of new debt are capitalized. Capitalizable debt issuance costs paid to third parties and debt discounts, net of amortization, are recorded as a reduction to the long-term debt balance on the condensed consolidated balance sheets. Amortization expense on capitalized debt issuance costs and debt discounts related to loans are calculated using the effective interest method over the term of the loan commitment and is recorded as interest expense in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#x2019;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events, enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.09pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.34pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.34pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no material uncertain tax positions in fiscal 2020 and for the three months ended March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Foreign Currency &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The financial statements of the Company&#x2019;s foreign subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, stockholders&#x2019; equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries&#x2019; accounts are included in &#x201c;Accumulated other comprehensive income&#x201d; as equity in the condensed consolidated balance sheet. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within &#x201c;Other expense, net&#x201d; in the condensed consolidated statement of operations. For the three months ended March&#160;31, 2021 and March&#160;31, 2020, foreign currency transaction loss amounted to $2.7 million and $6.2&#160;million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Comprehensive Loss&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s comprehensive loss consists of net loss and foreign currency translation adjustments arising from the consolidation of the Company&#x2019;s foreign subsidiaries. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all share-based awards in accordance with the provisions of ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Share-based awards granted include stock options, restricted stock units, or RSUs, and restricted stock awards, or RSAs. Share-based compensation expense for stock options and RSAs granted to employees is measured at the grant date based on the fair value of the awards and is recognized as an expense ratably on a straight-line basis over the requisite service period. The fair value of options to purchase shares granted to employees is estimated on the grant date using the Black-Scholes option valuation model. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The calculation of share-based compensation expense requires the Company to make assumptions and judgments about the variables used in the Black-Scholes model, including the expected term, expected volatility of the underlying common shares, risk-free interest rate and dividends. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted-average number of shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted-average number of shares and potentially &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dilutive &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities outstanding for the period. For purposes of the diluted net loss per share calculation, any shares issuable upon exercise of warrants, stock options and non-vested restricted stock outstanding under the Company&#x2019;s equity plan are potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for periods where the Company reported a net loss because including the dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effective January 1, 2020, using the modified retrospective &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the three months ended March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, the Company meets the definition of an emerging growth company, and has elected the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. The Company will remain an emerging growth company until the earliest of (1)&#160;the last day of its first fiscal year (a)&#160;following the fifth anniversary of the completion of our initial public offering, (b)&#160;in which we have total annual gross revenue of at least $1.07 billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and (2)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following recent accounting pronouncements issued by the FASB, could have a material effect on our financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU modifies the disclosure requirements for fair value measurements. The modifications removed the following disclosure requirements: (i) the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy; (ii) the policy for timing of transfers between levels; and (iii) the valuation processes for Level 3 fair value measurements. This ASU added the following disclosure requirements: (i) the changes in unrealized gains and losses for the period included in other comprehensive income, or OCI, for recurring Level 3 fair value measurements held at the end of the reporting period; and (ii) the range and weighted average of significant observable inputs used to develop Level 3 fair value measurements. This update is effective for non-public entities for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-13 on January 1, 2021. As the requirements of this literature are disclosure only, ASU 2018-13 did not impact our financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect the updated standard will have on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for nonpublic business entities and emerging growth companies for fiscal years after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently assessing the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:SignificantAccountingPoliciesTextBlock>
    <us-gaap:BasisOfAccountingPolicyPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTY_6e550028-9c72-4ecd-b945-ad25e83c12b7">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Basis of Presentation and Consolidation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The accompanying condensed consolidated financial statements and related financial information should be read &lt;/span&gt;&lt;/div&gt;in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#x2019;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.Unaudited Interim Condensed Consolidated Financial InformationThe accompanying interim condensed consolidated financial statements as of March&#160;31, 2021 and for the three months ended March&#160;31, 2021 and 2020, and the related interim information contained within the notes to the condensed consolidated financial statements, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments which are necessary to state fairly the Company&#x2019;s financial position as of March&#160;31, 2021, and the results of its operations and cash flows for the three months ended March&#160;31, 2021 and 2020. Such adjustments are of a normal and recurring nature. The results for the three months ended March&#160;31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year 2021, or for any future period.</us-gaap:BasisOfAccountingPolicyPolicyTextBlock>
    <us-gaap:ConsolidationPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODQ_7e3016bf-9405-4b15-aa01-bdf93ca14ed6">The accompanying condensed consolidated financial statements and related financial information should be read &lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#x2019;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the Company&#x2019;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Incorporation/Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs, S.A. (Costa Rica)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 18, 2004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva USA, LLC (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 20, 2014&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JAMM Technologies, Inc. (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 27, 2015&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs Produtos par Saude Ltda (Brazil)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;European Distribution Center Motiva BVBA (Belgium)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants France SAS (France)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 12, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JEN-Vault AG (Switzerland)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 22, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Nordica AB (Sweden)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants UK Limited (the United Kingdom)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Italy S.R.L (Italy)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants Spain, S.L. (Spain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 3, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Austria GmbH (Austria)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 14, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Germany GmbH (Germany)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Argentina S.R.L (Argentina)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 7, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;All intercompany accounts and transactions have been eliminated in consolidation.</us-gaap:ConsolidationPolicyTextBlock>
    <esta:ScheduleOfConsolidatedEntitiesTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTE_4c14027c-e59b-46fa-889c-4ddf690d7e29">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The condensed consolidated financial statements include the Company&#x2019;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.394%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:29.406%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Subsidiary&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Incorporation/Acquisition Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs, S.A. (Costa Rica)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 18, 2004&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva USA, LLC (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 20, 2014&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JAMM Technologies, Inc. (USA)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;October 27, 2015&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Establishment Labs Produtos par Saude Ltda (Brazil)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;European Distribution Center Motiva BVBA (Belgium)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;March 4, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants France SAS (France)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;September 12, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;JEN-Vault AG (Switzerland)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 22, 2016&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Nordica AB (Sweden)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;November 2, 2017&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants UK Limited (the United Kingdom)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Italy S.R.L (Italy)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;July 31, 2018&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Implants Spain, S.L. (Spain)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 3, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Austria GmbH (Austria)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;January 14, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Germany GmbH (Germany)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;August 1, 2019&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Motiva Argentina S.R.L (Argentina)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;February 7, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</esta:ScheduleOfConsolidatedEntitiesTableTextBlock>
    <us-gaap:SegmentReportingPolicyPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjc_235dc418-70da-40a1-802e-d8636d795bef">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Segments&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic regions in which the Company operates.&lt;/span&gt;&lt;/div&gt;</us-gaap:SegmentReportingPolicyPolicyTextBlock>
    <esta:GeographicConcentrationsPolicyPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTc_a73b96d4-d9bc-47cb-b591-c5896615fc79">Geographic Concentrations The Company derives all its revenues from sales to customers in Europe, the Middle East, Latin America, and Asia, and has not yet received approval to sell its products in the United States.</esta:GeographicConcentrationsPolicyPolicyTextBlock>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i8bd19aab21a94b07b796f48b84ac115a_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzU0MQ_472d3b6d-46e5-4386-b77a-79908c844a6d"
      unitRef="number">0.106</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ic9ea8ba03f124881b6cb4934a8317cf3_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEyMTc3Mg_9670a174-26d6-4a51-b839-67d18d0dfa6e"
      unitRef="number">0.100</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i2d40f566ba694c62a29ae89f751ed9ee_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEwMzkwNQ_58fd6a70-4296-4cd4-9e2d-cd2f3ee58e65"
      unitRef="number">0.78</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i081fde0d54924d748cd0047a247aca91_D20200101-20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTEwMzkxOA_767e9794-7941-402d-8b02-7014ca8ca4e4"
      unitRef="number">0.80</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:UseOfEstimates
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDA_54d1b758-1014-48bd-9c14-2582e7dbc379">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Use of Estimates&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;estimates and management judgments reflected in the condensed &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;consolidated&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets&#x2019; useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.&lt;/span&gt;&lt;/div&gt;</us-gaap:UseOfEstimates>
    <us-gaap:ConcentrationRiskCreditRisk
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTI_42e70db4-3c62-494d-a3ce-f00c725c65a0">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Concentration of Credit Risk and Other Risks and Uncertainties&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company&#x2019;s cash is held at two financial institutions in the United States. Balances in the Company&#x2019;s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;All of the Company&#x2019;s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Substantially all of the Company&#x2019;s revenues were derived from the sale of Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, no customer accounted for more than 10% of the Company&#x2019;s revenue. No customer accounted for more than 10% of the Company&#x2019;s trade accounts receivable balance as of March&#160;31, 2021 or &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company relies on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, the Company had purchases of $4.3 million, or 55.8% of total purchases, and $5.0&#160;million, or 64.9% of total purchases, respectively, from NuSil. As of March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, the Company had an outstanding balance owed to this vendor of $1.6 million and $1.3 million, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#x2019;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company&#x2019;s current and potential future products, uncertainty of market acceptance of the Company&#x2019;s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. &lt;/span&gt;&lt;/div&gt;Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.</us-gaap:ConcentrationRiskCreditRisk>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="ib1162e78c15d49bb9ac650a48748dcd6_D20200101-20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM3NzAxNw_1a3e128b-24b2-43b6-a7fb-f8184a68fdac"
      unitRef="number">0</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PaymentsToSuppliers
      contextRef="i73eb050084884d97aabea10fa887eb00_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI1NQ_f88bf559-aba9-4931-b077-4b33823c7405"
      unitRef="usd">4300000</us-gaap:PaymentsToSuppliers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i9c4421ada28146c7bd79ce446cfd0743_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI2Mg_5652849d-093e-4c74-abc3-2f000fa03a48"
      unitRef="number">0.558</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:PaymentsToSuppliers
      contextRef="i68ae26916d1344978f6c5489277d557b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI4OQ_3890c3e3-ea52-4ebc-a3eb-54e877a4e58d"
      unitRef="usd">5000000.0</us-gaap:PaymentsToSuppliers>
    <us-gaap:ConcentrationRiskPercentage1
      contextRef="i1425d844a2054eb1874c578463f2cd02_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjI5Ng_48af9be9-2396-4d42-b5ab-79be16a4fb49"
      unitRef="number">0.649</us-gaap:ConcentrationRiskPercentage1>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i05b2ab81a8424def8cac4bbd46817c34_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjQyNA_140dd637-76bd-4a43-843b-c8f3d6fa9b71"
      unitRef="usd">1600000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:AccountsPayableTradeCurrent
      contextRef="i7eb8031bfbf744fd8a075ed851059c67_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNjQzMQ_3f2a5132-c768-4e3a-a1e6-de555356b9ae"
      unitRef="usd">1300000</us-gaap:AccountsPayableTradeCurrent>
    <us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzE_9c440d36-a2a9-4b1c-80a4-682bfdd3c138">Cash The Company&#x2019;s cash consists of cash maintained in checking and interest-bearing accounts. The majority of the Company&#x2019;s cash is held at two financial institutions in the United States. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents.</us-gaap:CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfOTI0NA_0f6391ce-b425-4b1c-9efa-dbddeec2bc11"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:CashEquivalentsAtCarryingValue
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfOTI0NA_84627d40-95ec-4229-8a90-f50393270f40"
      unitRef="usd">0</us-gaap:CashEquivalentsAtCarryingValue>
    <us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTM_41e4963a-f83a-4414-891f-0bc3d5f365c3">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable is stated at invoice value less estimated allowances for returns and doubtful accounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from customers&#x2019; inability to make required payments. In evaluating the Company&#x2019;s ability to collect outstanding receivable balances, the Company considers various factors including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#x2019;s current financial condition. In cases where there are circumstances that may impair a specific customer&#x2019;s ability to meet its financial obligations, an allowance is recorded against amounts due, which reduces the net recognized receivable to the amount reasonably believed to be collectible.</us-gaap:ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy>
    <us-gaap:InventoryPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTQ_dc321365-c944-4136-bfe8-ff2698a1ac52">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory and Cost of Revenue&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Inventory is stated at the lower of cost to purchase or manufacture the inventory or the net realizable value of such inventory. Cost is determined using the standard cost method which approximates actual costs using the first-in, first-out basis. The Company regularly reviews inventory quantities considering actual losses, projected future demand, and remaining shelf life to record a provision for excess and slow-moving inventory. An inventory reserve of $1.7 million and $1.6 million has been recorded as of &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes the cost of inventory transferred to the customer in cost of revenue when revenue is recognized.&lt;/span&gt;&lt;/div&gt;</us-gaap:InventoryPolicyTextBlock>
    <us-gaap:InventoryValuationReserves
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTA2NzQ_86759702-7960-47ca-b1b5-d7d3b30b600b"
      unitRef="usd">1700000</us-gaap:InventoryValuationReserves>
    <us-gaap:InventoryValuationReserves
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTA2ODE_d392099a-ad0c-44b6-a73b-34ac4832649b"
      unitRef="usd">1600000</us-gaap:InventoryValuationReserves>
    <us-gaap:LesseeLeasesPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM3NzAxMg_f0f93d1b-276d-4ad2-aec3-16f296ec9500">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Leases&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company determines if an arrangement is, or contains, a lease at the inception date of the contract. The Company has elected an expedient to account for each separate lease component and its associated non-lease components as a single lease component for the majority of its asset classes.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. The Company recognizes lease liabilities and right-of-use, or ROU, assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;</us-gaap:LesseeLeasesPolicyTextBlock>
    <us-gaap:RevenueFromContractWithCustomerPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjU_9a35e2c5-e2c8-4c98-8ea2-6d11867721dd">Shipping and Handling CostsShipping and handling costs are expensed as incurred and are included in selling, general and administrative, or SG&amp;amp;A, expenses.&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Revenue Recognition&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue related to sales of products to distributors or directly to customers in markets &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;where it has regulatory approval, net of discounts and allowances. The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, Revenue from Contracts with Customers. ASC 606 requires the Company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue related to the sales of products to distributors at the time of shipment of the product, which represents the point in time when the distributor has taken ownership and assumed the risk of loss and the required revenue recognition criteria are satisfied. The Company&#x2019;s distributors are obligated to pay within specified terms regardless of when, or if, they sell the products. The Company&#x2019;s contracts with distributors typically do not contain right of return or price protection and have no post-delivery obligations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes revenue when title to the product and risk of loss transfer to customers, provided there are no remaining performance obligations required of the Company or any written matters requiring customer acceptance. The Company allows for the return of product from direct customers in certain regions in limited instances within fifteen days after the original sale and records estimated sales returns as a reduction of sales in the same period revenue is recognized. Appropriate reserves are established for anticipated sales returns based on historical experience, recent gross sales and any notification of pending returns. Actual sales returns in any future period are inherently uncertain and thus may differ from the estimates. If actual sales returns differ significantly from the estimates, an adjustment to revenue in the current or subsequent period is recorded. As of March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, an allowance of zero and $54,000 was recorded for product returns, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;A portion of the Company&#x2019;s revenue is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For these products, revenue is recognized at the time the Company is notified by the consignee that the product has been implanted, not when the consigned products are delivered to the consignee&#x2019;s warehouse. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue was generated in these primary geographic markets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific/Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has a limited warranty for the shelf life of the product, which is five years from the time of manufacture. Estimated warranty obligations are recorded at the time of sale. The Company also offers a warranty to patients in the event of rupture and a replacement program for capsular contracture events, provided certain registration requirements are met. Revenue for extended warranties is recognized ratably over the term of the agreement. To date, these warranty and program costs have been de minimis. The Company will continue to evaluate the warranty reserve policies for adequacy considering claims history.&lt;/span&gt;&lt;/div&gt;Deferred revenue primarily consists of payments received in advance of meeting revenue recognition criteria. The Company has received payments from distributors to provide distribution exclusivity within a geographic area and recognizes deferred revenue on a ratable basis over the term of such contractual distribution relationship. Additionally, the Company has received payments from customers in direct markets prior to surgical implantation and recognizes deferred revenue at the time the Company is notified by the customer that the product has been implanted. For all arrangements, any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue and included in &#x201c;Other liabilities, long-term&#x201d; on the condensed consolidated balance sheets (see Note 3).</us-gaap:RevenueFromContractWithCustomerPolicyTextBlock>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i004b7705a98e4c32b860182a8c4f08b3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTExNzQ_301596e8-72ee-4105-859a-7f73e272efa0"
      unitRef="usd">1200000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <us-gaap:SellingGeneralAndAdministrativeExpense
      contextRef="i3b07bb856af64942a2e4ba6539ed0b99_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTExODE_0e351792-175b-48a6-80d0-5649e6077793"
      unitRef="usd">800000</us-gaap:SellingGeneralAndAdministrativeExpense>
    <esta:RevenueFromContractWithCustomerProductReturnPeriod
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTI3ODQ_fb6e594f-7e59-4415-8de1-d9687c01c2c4">P15D</esta:RevenueFromContractWithCustomerProductReturnPeriod>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTMyODU_37384c52-66d5-4ce4-bfe2-3580b2d27751"
      unitRef="usd">0</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTMyOTI_f1de219e-9c11-4331-8c79-395cf547f6e7"
      unitRef="usd">54000</us-gaap:ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss>
    <us-gaap:DisaggregationOfRevenueTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNDk_25581737-0705-4b52-ac02-d499e7189b9f">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Revenue was generated in these primary geographic markets:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.096%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.395%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Europe&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;12,693&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,779&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Latin America&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,141&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Asia-Pacific/Middle East&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,495&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,471&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;147&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;90&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;30,336&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;24,481&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:DisaggregationOfRevenueTableTextBlock>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ib3ef82464d324a3a9122d68d6f8222d4_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNC02LTEtMS0w_8698a40c-7017-462c-90e6-f6226b473b56"
      unitRef="usd">12693000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i4beb3e97e88a46229246ffae5ae38b10_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNC04LTEtMS0w_43e9d18b-1c76-4502-929e-4a6373ea8236"
      unitRef="usd">9779000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i8d50b891602a40ae8475374170cd88a9_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNS02LTEtMS0w_33f86e18-bea9-4f06-9ba0-98d7ca828c8d"
      unitRef="usd">8001000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i0f90130bb6ee4c95851406f50fa32310_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNS04LTEtMS0w_24c9a323-2529-4d2d-960c-32fd432c56c7"
      unitRef="usd">7141000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i60a99d33ac56428badf4fa77635987cc_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNi02LTEtMS0w_aa969814-b5c9-4e66-8a07-58c7b7b96d40"
      unitRef="usd">9495000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="id8f4d7ebd44a431298ec2a860ec67dc5_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNi04LTEtMS0w_b746a314-95b0-4ed0-977a-c429d9d79cbb"
      unitRef="usd">7471000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="ic1895da228434d8c86601eebd0eb076b_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNy02LTEtMS0w_8c1fa2bf-7aaa-46fa-bb5a-a6e15ef839f7"
      unitRef="usd">147000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i01fdfa1c7b87456c91b44f087364d012_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfNy04LTEtMS0w_35355a74-b65b-47e3-833f-33b665ed37f0"
      unitRef="usd">90000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfOC02LTEtMS0w_b844f77d-45c1-4787-a296-b5b457ab5432"
      unitRef="usd">30336000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RhYmxlOjRhMGIwNmI1ZGQ2OTRkMjNiMjQ0NmExYjkzYTAxOWMzL3RhYmxlcmFuZ2U6NGEwYjA2YjVkZDY5NGQyM2IyNDQ2YTFiOTNhMDE5YzNfOC04LTEtMS0w_9a49da3f-99e2-4dc8-b709-1645bffa64ea"
      unitRef="usd">24481000</us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax>
    <esta:RevenueFromContractWithCustomerProductShelfLife
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTM4MzQ_6ee8643d-8e7f-4247-a689-9c453cce0353">P5Y</esta:RevenueFromContractWithCustomerProductShelfLife>
    <us-gaap:ResearchAndDevelopmentExpensePolicy
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODA_dac01270-0633-4119-b36e-aa84f5f7bb5a">&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Research and Development&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:5pt;margin-top:5pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs related to research and development, or R&amp;amp;D, activities are expensed as incurred. R&amp;amp;D costs primarily include personnel costs, materials, clinical expenses, regulatory expenses, product development, consulting services, and outside research activities, all of which are directly related to research and development activities. &lt;/span&gt;&lt;/div&gt;The Company estimates IDE clinical trial expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations that conduct and manage clinical trials on its behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly.</us-gaap:ResearchAndDevelopmentExpensePolicy>
    <us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjg_bc904f42-625e-4745-9999-dd53604c1652">Selling, General and Administrative ExpensesSG&amp;amp;A expenses include sales and marketing costs, payroll and related benefit costs, insurance expenses, shipping and handling costs, legal and professional fees and administrative overhead.</us-gaap:SellingGeneralAndAdministrativeExpensesPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjE_d62d9a0d-6abe-46c1-b2f3-c247a056bf55">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.05pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Property and equipment are stated at cost less accumulated depreciation and amortization.&lt;/span&gt;&lt;/div&gt;Following the exercise of its option to purchase its manufacturing facility in June 2019, the Company depreciates the owned building on a straight-line basis over 50 years of useful life. Depreciation of property and equipment is computed using the straight-line method over the assets&#x2019; estimated useful lives of &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b"&gt;five&lt;/span&gt; to ten years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the remaining lease term after factoring expected renewal periods. Upon retirement or disposal of assets, the costs and related accumulated depreciation are eliminated from the accounts and any gain or loss is recognized in operations. Maintenance and repairs are expensed as incurred. Substantially all of the Company&#x2019;s manufacturing operations and related property and equipment is located in Costa Rica.</us-gaap:PropertyPlantAndEquipmentPolicyTextBlock>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY2MTg_23e1d17f-c9d5-42f1-ad7c-d4f68a70eda1">P50Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:PropertyPlantAndEquipmentUsefulLife
      contextRef="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3NzQ_12fd4b86-4ac0-4386-9b6b-bfa85d2d90d4">P10Y</us-gaap:PropertyPlantAndEquipmentUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjY_e305f131-4b4b-4833-9746-ecf27d0f95b8">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Goodwill and Intangible Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records the excess of the acquisition purchase price over the net fair value of the tangible and identifiable intangible assets acquired and liabilities assumed as goodwill. In accordance with ASC 350, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Intangibles - Goodwill and Other, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the Company tests goodwill for impairment annually during the fourth quarter of each year and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with the annual impairment test for goodwill, the Company elected the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it was more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test is performed. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Consistent with the Company's assessment that it has only one reporting segment, the Company has determined that it has only one reporting unit and tests goodwill for impairment at the entity level using the two-step process required by ASC 350. In the first step, the Company compares the carrying amount of the reporting unit to the fair value of the enterprise. If the fair value of the enterprise exceeds the carrying value, goodwill is not considered impaired and no further testing is required. If the carrying value of the enterprise exceeds the fair value, goodwill is potentially impaired, and the second step of the impairment test must be performed. In the second step, the Company compares the implied fair value of the goodwill, as defined by ASC 350, to its carrying amount to determine the impairment loss, if any.&lt;/span&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;The Company capitalizes certain costs related to intangible assets, such as patents, trademarks and software &lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;development costs. The Company follows the provisions of ASC 350-40, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%"&gt;Internal Use Software &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%"&gt;for determining whether computer software is internal-use software and on accounting for the proceeds of computer software originally developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of software development and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.&lt;/span&gt;The Company records purchased intangible assets at their respective estimated fair values at the date of acquisition. Purchased finite-lived intangible assets are being amortized using the straight-line method over their remaining estimated useful lives, which range from &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94"&gt;two&lt;/span&gt; to fifteen years. The Company evaluates the remaining useful lives of intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining estimated amortization period. The Company tests indefinite-lived intangible assets for impairment on at least an annual basis and whenever circumstances suggest the assets may be impaired. If indicators of impairment are present, the Company evaluates the carrying value of the intangible assets in relation to estimates of future undiscounted cash flows. The Company also evaluates the remaining useful life of an indefinite-lived intangible asset to determine whether events and circumstances continue to support an indefinite useful life.</us-gaap:GoodwillAndIntangibleAssetsPolicyTextBlock>
    <us-gaap:NumberOfReportableSegments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTgyODE_cd7275cc-decc-4611-a607-d7c831ac45c8"
      unitRef="segment">1</us-gaap:NumberOfReportableSegments>
    <us-gaap:NumberOfReportingUnits
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTgzNDc_912b51ab-6f96-49aa-8187-ba8559f3649a"
      unitRef="reportingunit">1</us-gaap:NumberOfReportingUnits>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i166e9915a9854e5bae47d848296baa6c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxODA_be2f7bdb-43a4-4cee-906c-b67281c38570">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:GoodwillAndIntangibleAssetImpairment
      contextRef="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjA5MzU_e2c0e650-6e23-49c3-b24f-2b377248be5e"
      unitRef="usd">0</us-gaap:GoodwillAndIntangibleAssetImpairment>
    <us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTU_b62fb2de-7a5c-4918-aa32-69c32c858618">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Long-Lived Assets&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.4pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#x2019;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives recorded d&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;uring the year ended December&#160;31, 2020. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;long-lived&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; asset values may not be recoverable.&lt;/span&gt;&lt;/div&gt;</us-gaap:ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9f04d8b8f5fe45278f167806865cef1f_D20200101-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjE5OTI_41a35aec-3cb1-4608-aa6f-b5114d3626b2"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:AssetImpairmentCharges
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjE5OTI_bfcbc271-9dbb-4758-a798-550e92712e6f"
      unitRef="usd">0</us-gaap:AssetImpairmentCharges>
    <us-gaap:DerivativesEmbeddedDerivatives
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxOTg_9186de92-b63b-4ada-83ff-d83db2eec0a2">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt and Embedded Derivatives&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and Other Options&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; (see Note 6).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note&#160;5).&lt;/span&gt;&lt;/div&gt;</us-gaap:DerivativesEmbeddedDerivatives>
    <us-gaap:DebtPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzU_89773d43-fdb4-4595-819f-50ab28dabb38">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Debt Issuance Costs and Debt Discounts&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Costs incurred in connection with the issuance of new debt are capitalized. Capitalizable debt issuance costs paid to third parties and debt discounts, net of amortization, are recorded as a reduction to the long-term debt balance on the condensed consolidated balance sheets. Amortization expense on capitalized debt issuance costs and debt discounts related to loans are calculated using the effective interest method over the term of the loan commitment and is recorded as interest expense in the condensed consolidated statements of operations.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtPolicyTextBlock>
    <us-gaap:IncomeTaxPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNzY_3a4965fc-a5fc-4898-a02b-6116ca8f10a0">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Income Taxes&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#x2019;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events, enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.09pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:4.34pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.&lt;/span&gt;&lt;/div&gt;</us-gaap:IncomeTaxPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDE_03efaf11-7119-46ca-a47d-7873b02fa5a5">Foreign Currency The financial statements of the Company&#x2019;s foreign subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, stockholders&#x2019; equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries&#x2019; accounts are included in &#x201c;Accumulated other comprehensive income&#x201d; as equity in the condensed consolidated balance sheet. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within &#x201c;Other expense, net&#x201d; in the condensed consolidated statement of operations.</us-gaap:ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjYxNzM_5f1a0dfe-5ff8-4e5d-8871-9070ceeafe12"
      unitRef="usd">-2700000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ForeignCurrencyTransactionGainLossBeforeTax
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjc0ODc3OTExODI0MA_76e446cb-d13b-4fad-baaa-d020eba71bc3"
      unitRef="usd">-6200000</us-gaap:ForeignCurrencyTransactionGainLossBeforeTax>
    <us-gaap:ComprehensiveIncomePolicyPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxODk_1e06b92e-5a7f-42fc-b6c4-b9978e9c7546">Comprehensive LossThe Company&#x2019;s comprehensive loss consists of net loss and foreign currency translation adjustments arising from the consolidation of the Company&#x2019;s foreign subsidiaries.</us-gaap:ComprehensiveIncomePolicyPolicyTextBlock>
    <us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNjM_3457dab9-f5ff-4ca6-9602-8347a72a3c37">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Share-Based Compensation &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company measures and recognizes compensation expense for all share-based awards in accordance with the provisions of ASC 718, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Stock Compensation&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Share-based awards granted include stock options, restricted stock units, or RSUs, and restricted stock awards, or RSAs. Share-based compensation expense for stock options and RSAs granted to employees is measured at the grant date based on the fair value of the awards and is recognized as an expense ratably on a straight-line basis over the requisite service period. The fair value of options to purchase shares granted to employees is estimated on the grant date using the Black-Scholes option valuation model. &lt;/span&gt;&lt;/div&gt;The calculation of share-based compensation expense requires the Company to make assumptions and judgments about the variables used in the Black-Scholes model, including the expected term, expected volatility of the underlying common shares, risk-free interest rate and dividends.</us-gaap:ShareBasedCompensationOptionAndIncentivePlansPolicy>
    <us-gaap:EarningsPerSharePolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQyMDQ_7ef40cb6-f478-4741-a485-492f29b0b897">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Net Income (Loss) Per Share &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6.25pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted-average number of shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted-average number of shares and potentially &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;dilutive &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;securities outstanding for the period. For purposes of the diluted net loss per share calculation, any shares issuable upon exercise of warrants, stock options and non-vested restricted stock outstanding under the Company&#x2019;s equity plan are potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for periods where the Company reported a net loss because including the dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;</us-gaap:EarningsPerSharePolicyTextBlock>
    <us-gaap:PriorPeriodReclassificationAdjustmentDescription
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfNDk0NzgwMjM5Mzc2MQ_bf27b55b-04dd-4983-9a5a-e07388a7d045">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Reclassifications&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of ASU No. 2016-02, &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Leases (Topic 842)&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; effective January 1, 2020, using the modified retrospective &lt;/span&gt;&lt;/div&gt;approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the three months ended March 31, 2020.</us-gaap:PriorPeriodReclassificationAdjustmentDescription>
    <us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMzQxNTI_5ffe565b-e662-4229-a7c8-7198f64728cd">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Recent Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#x2019;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, the Company meets the definition of an emerging growth company, and has elected the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. The Company will remain an emerging growth company until the earliest of (1)&#160;the last day of its first fiscal year (a)&#160;following the fifth anniversary of the completion of our initial public offering, (b)&#160;in which we have total annual gross revenue of at least $1.07 billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline"&gt;th&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and (2)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following recent accounting pronouncements issued by the FASB, could have a material effect on our financial statements:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Adopted Accounting Standards&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2018, the FASB issued ASU 2018-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU modifies the disclosure requirements for fair value measurements. The modifications removed the following disclosure requirements: (i) the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy; (ii) the policy for timing of transfers between levels; and (iii) the valuation processes for Level 3 fair value measurements. This ASU added the following disclosure requirements: (i) the changes in unrealized gains and losses for the period included in other comprehensive income, or OCI, for recurring Level 3 fair value measurements held at the end of the reporting period; and (ii) the range and weighted average of significant observable inputs used to develop Level 3 fair value measurements. This update is effective for non-public entities for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-13 on January 1, 2021. As the requirements of this literature are disclosure only, ASU 2018-13 did not impact our financial condition or results of operations.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Recently Issued Accounting Standards &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2020, the FASB issued ASU No. 2020-06, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#x2019;s Own Equity (Subtopic 815-40)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#x2019;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect the updated standard will have on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2019, the FASB issued ASU No. 2019-12, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for nonpublic business entities and emerging growth companies for fiscal years after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company is &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In June 2016, the FASB issued ASU 2016-13, &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently assessing the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and footnote disclosures.&lt;/span&gt;&lt;/div&gt;</us-gaap:NewAccountingPronouncementsPolicyPolicyTextBlock>
    <us-gaap:SupplementalBalanceSheetDisclosuresTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTEwNQ_90de81c5-af6f-419a-8c3f-8a21d72b166d">Balance Sheet Accounts&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Inventory, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;December&#160;31, 2020, $2.3&#160;million and $2.0&#160;million of inventory was on consignment, respectively.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Property and Equipment, Net&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For each of the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended March&#160;31, 2021 and 2020, depreciation and amortization expense related to property and equipment was $0.6&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company entered into finance leases relating to equipment and vehicles and recorded the fair value of the lease payments on the initial contract date and is amortizing the assets over the term of the leases. As of each of March&#160;31, 2021 and December&#160;31, 2020, the gross asset value for capital lease assets was $1.4 million. Depreciation expense for assets under finance leases was $43,000 and $20,000 for the three months ended March&#160;31, 2021 and &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;2020, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Accrued Liabilities&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus feature of stock option grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional and legal services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term minimum lease payments under finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advisory board and board of director related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Liabilities, Short-Term&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, short-term consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payable for asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:24pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Other Liabilities, Long-Term&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, long-term consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payable for asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:SupplementalBalanceSheetDisclosuresTextBlock>
    <us-gaap:ScheduleOfInventoryCurrentTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTEwNw_3893673a-165b-455f-8821-a20e7c5fa571">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Raw materials&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,450&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Work in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,625&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,121&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finished goods&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,647&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,639&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,377&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfInventoryCurrentTableTextBlock>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNC0yLTEtMS0w_0c041c22-6e15-4dd4-9ecb-47a72ce13fcf"
      unitRef="usd">6105000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryRawMaterialsNetOfReserves
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNC00LTEtMS0w_22f93afe-1f12-4e62-9156-df28cd6adf3d"
      unitRef="usd">5450000</us-gaap:InventoryRawMaterialsNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNS0yLTEtMS0w_0abe736d-4c5d-4371-84c0-9e067aca0a68"
      unitRef="usd">1625000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryWorkInProcessNetOfReserves
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNS00LTEtMS0w_feaa918e-8196-484b-9b6e-e1a40e115f66"
      unitRef="usd">1121000</us-gaap:InventoryWorkInProcessNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNi0yLTEtMS0w_9338a288-6e8f-4048-996b-094c85908d36"
      unitRef="usd">14647000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryFinishedGoodsNetOfReserves
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNi00LTEtMS0w_e1fac797-f335-4944-8060-23f8880cccb7"
      unitRef="usd">16639000</us-gaap:InventoryFinishedGoodsNetOfReserves>
    <us-gaap:InventoryNet
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNy0yLTEtMS0w_ad728bc9-92ef-4863-96bb-618f5c75765b"
      unitRef="usd">22377000</us-gaap:InventoryNet>
    <us-gaap:InventoryNet
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmIxNDVlZDUwMzEwOTQ2NTk5OTQwODJiOTY3YWJhMTIzL3RhYmxlcmFuZ2U6YjE0NWVkNTAzMTA5NDY1OTk5NDA4MmI5NjdhYmExMjNfNy00LTEtMS0w_cdd0e95f-ad46-42c6-8ab1-5e44538e7f83"
      unitRef="usd">23210000</us-gaap:InventoryNet>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMjc0ODc3OTA3MDgyOA_3d288022-4966-4506-b604-bca09f9b90c2"
      unitRef="usd">2300000</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMjc0ODc3OTA3MDc5Mw_da44fb49-9609-474a-9613-4a5d2f732275"
      unitRef="usd">2000000.0</us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment>
    <us-gaap:PropertyPlantAndEquipmentTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExMg_fc21191a-97a0-43e0-9b6f-917bc4601a69">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Machinery and equipment&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9,232&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Furniture and fixtures&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,268&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,092&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Building&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Leasehold improvements&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,025&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Land&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;802&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vehicles&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;395&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;399&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Construction in process&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;579&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;317&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26,491&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Accumulated depreciation and amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(10,170)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(9,633)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,321&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16,202&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:PropertyPlantAndEquipmentTextBlock>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id3996f92cc944a339de5caa40d1800d5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNC0yLTEtMS0w_b30c7e7b-9621-4b27-8c23-cc415a154c27"
      unitRef="usd">9494000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i29eb930880f043a89583c6fc57efa900_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNC00LTEtMS0w_eeb3a37c-67cf-49e7-8a82-e25c7a6c79af"
      unitRef="usd">9232000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ife4026763f654a77bc94bbe390a2fc4a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNS0yLTEtMS0w_ed92bcb7-8652-4491-b1bd-c0cf08d378ec"
      unitRef="usd">6456000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i9f0ae59c23484eb780355e39397ef553_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNS00LTEtMS0w_28fe6c0e-5024-415b-ae69-eeed2a6af713"
      unitRef="usd">6456000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i160d575ddcb0470f83ed19730eb5fb61_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNi0yLTEtMS0w_5dcaad98-ba62-4bd5-bb60-bc9b85b300e1"
      unitRef="usd">4268000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="iab56151cd6614657ab84386f1061d9c5_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNi00LTEtMS0w_f522635e-637a-41eb-b09d-b8d54ef7095a"
      unitRef="usd">4092000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ieb8e6e4dd99449fb88bbbca0acc2862b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNy0yLTEtMS0w_991867dc-993a-4ca3-a92c-927d4f3c14e8"
      unitRef="usd">2472000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i43b3f0124f284ee699ac3fd4d34805b2_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfNy00LTEtMS0w_8d06e913-5ea3-4a67-adbe-ce5953a1b451"
      unitRef="usd">2472000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i2121ef462b904bc38a4a252ab9b29bcd_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOC0yLTEtMS0w_d8d72e00-90be-4f63-b9e5-2f399b7faf5c"
      unitRef="usd">2025000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i98c64154fe544ca7bd6cee9aadcc28ef_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOC00LTEtMS0w_d77fa928-bcad-486e-8925-a9ddaaa34642"
      unitRef="usd">2065000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="if284ebc70ba8430c827c84cea2ebd7c0_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOS0yLTEtMS0w_0bd0d017-e96b-4910-938e-3cd2f4f207aa"
      unitRef="usd">802000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="id5bc7817e64f42009391e541e0bed5b9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfOS00LTEtMS0w_85a82f9b-7ed7-4511-ac37-92b438c77733"
      unitRef="usd">802000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i4df511fe868145bb8de184fd4579130b_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTAtMi0xLTEtMA_d8d02ade-526f-41fb-a35d-e0d1b751855c"
      unitRef="usd">395000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ic63ccb3e5f68497baa493ee0a27489ff_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTAtNC0xLTEtMA_a2561ca0-f043-4425-bc16-45f459a40907"
      unitRef="usd">399000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i1811e0f3590c40d0b8b5264bef9323fa_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTEtMi0xLTEtMA_f0076fff-09ee-47a8-9450-f5f83bb9efe1"
      unitRef="usd">579000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib89a316782de4b9aa036ee79cbb8a6a8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTEtNC0xLTEtMA_1d5b2937-593e-4cdb-9a03-dafa5b39ea41"
      unitRef="usd">317000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTItMi0xLTEtMA_262227f6-9608-464e-9866-6ffcf7ca91d5"
      unitRef="usd">26491000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:PropertyPlantAndEquipmentGross
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTItNC0xLTEtMA_4a2c5386-d89f-4fe8-b979-494f82f9b5a2"
      unitRef="usd">25835000</us-gaap:PropertyPlantAndEquipmentGross>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTMtMi0xLTEtMA_bff810b9-fdeb-4362-9c39-9ac1c5b9ab1f"
      unitRef="usd">10170000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTMtNC0xLTEtMA_36ce76b8-e0bb-432c-a3e9-d61be06120f9"
      unitRef="usd">9633000</us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTQtMi0xLTEtMA_bc507ac7-246a-4a52-a9d0-d8501ac8e955"
      unitRef="usd">16321000</us-gaap:PropertyPlantAndEquipmentNet>
    <us-gaap:PropertyPlantAndEquipmentNet
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjMyMGM0MGM0ZTg5NDRjMTA4MTkxNjMwZGYxOTIwOWI1L3RhYmxlcmFuZ2U6MzIwYzQwYzRlODk0NGMxMDgxOTE2MzBkZjE5MjA5YjVfMTQtNC0xLTEtMA_7c05d967-3dc6-4455-83c7-8611c6acc019"
      unitRef="usd">16202000</us-gaap:PropertyPlantAndEquipmentNet>
    <esta:DepreciationAndAmortizationPropertyPlantAndEquipment
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMzAz_9ad83a7a-99de-4e94-9435-b934689f3dc0"
      unitRef="usd">600000</esta:DepreciationAndAmortizationPropertyPlantAndEquipment>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNjE2_e16b3507-95d3-45c5-ad88-5337a95bd84c"
      unitRef="usd">1400000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNjE2_ec41aa9c-67ff-4e23-8cd8-5dfef04cbcca"
      unitRef="usd">1400000</us-gaap:FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization>
    <us-gaap:Depreciation
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfNzk2_57d957df-ee22-423b-811e-12b5780225be"
      unitRef="usd">43000</us-gaap:Depreciation>
    <us-gaap:Depreciation
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfODAz_3347c9ef-779f-4820-88e4-b98caf8313c2"
      unitRef="usd">20000</us-gaap:Depreciation>
    <us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExMw_efb15e47-d4c4-421c-882e-9d6dc873ec36">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Accrued liabilities consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Performance bonus&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;971&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,406&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Payroll and related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,619&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,781&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Bonus feature of stock option grants&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,605&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,992&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - current&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Commissions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;648&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;628&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Professional and legal services&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;469&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;439&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Short-term minimum lease payments under finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warranty reserve&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;236&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;237&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Advisory board and board of director related expenses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;70&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;699&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,021&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,408&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock>
    <us-gaap:AccruedBonusesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNS0yLTEtMS0w_04339c1c-a9fe-44b8-825a-707fc1dcf5bc"
      unitRef="usd">971000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedBonusesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNS00LTEtMS0w_83ac1939-24a6-4e19-8e4f-8458a030fa06"
      unitRef="usd">2406000</us-gaap:AccruedBonusesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNi0yLTEtMS0w_971ce965-c16b-48e9-8285-efa0c546da99"
      unitRef="usd">3619000</us-gaap:AccruedSalariesCurrent>
    <us-gaap:AccruedSalariesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNi00LTEtMS0w_2597996e-a369-4acb-a1c8-570ea07887bd"
      unitRef="usd">2781000</us-gaap:AccruedSalariesCurrent>
    <esta:AccruedStockOptionGrantBonusCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNy0yLTEtMS0w_850ead52-d35b-4536-b83a-b0c21abfee51"
      unitRef="usd">6605000</esta:AccruedStockOptionGrantBonusCurrent>
    <esta:AccruedStockOptionGrantBonusCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfNy00LTEtMS0w_84d0374b-5f8e-4382-8c9d-875e5409736b"
      unitRef="usd">5992000</esta:AccruedStockOptionGrantBonusCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS0yLTEtMS0xNDAz_35757bd0-2415-45c0-b35b-274ebc918217"
      unitRef="usd">986000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS00LTEtMS0xNDAx_ebd7b0ff-7451-4b06-89a5-c969b31e8515"
      unitRef="usd">788000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS0yLTEtMS0w_3afc7730-6d9f-4d26-9507-67504ae2a2ef"
      unitRef="usd">648000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedSalesCommissionCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfOS00LTEtMS0w_fe39050d-a2b0-41f1-ac48-6f9811ba3916"
      unitRef="usd">628000</us-gaap:AccruedSalesCommissionCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTAtMi0xLTEtMA_4218a4da-7207-4bd2-b822-f292407db915"
      unitRef="usd">469000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:AccruedProfessionalFeesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTAtNC0xLTEtMA_363340ab-1c8f-4a0c-95bd-06730184a426"
      unitRef="usd">439000</us-gaap:AccruedProfessionalFeesCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTEtMi0xLTEtMA_6777688e-d866-425b-abff-349432e57966"
      unitRef="usd">105000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTEtNC0xLTEtMA_43d5e7d2-1c14-42c9-97e8-c0ce1c90bf2a"
      unitRef="usd">160000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTItMi0xLTEtMA_a030ad39-d672-48dd-a828-c498fbfa95ef"
      unitRef="usd">236000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <us-gaap:ProductWarrantyAccrualClassifiedCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTItNC0xLTEtMA_ec0b91e3-1975-408e-9fa4-8a2a7295de93"
      unitRef="usd">237000</us-gaap:ProductWarrantyAccrualClassifiedCurrent>
    <esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTMtMi0xLTEtMA_20988a82-0a7e-4b83-be5f-aacbbab47ecb"
      unitRef="usd">70000</esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent>
    <esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTMtNC0xLTEtMA_90e05065-869c-40cb-9d98-67921a504387"
      unitRef="usd">80000</esta:AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTQtMi0xLTEtMA_8a7f3285-5114-47d4-ace6-5f51277542f2"
      unitRef="usd">699000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:OtherAccruedLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTQtNC0xLTEtMA_7f6e4b73-8b2c-4326-ae46-b3b70fd83971"
      unitRef="usd">1021000</us-gaap:OtherAccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTUtMi0xLTEtMA_25323d03-b3c4-4ea8-ae9e-5e85cf259bd4"
      unitRef="usd">14408000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:AccruedLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjM1YTM1YTQ4NWM2ZTQ4MTBhZjc0MTBiODcxYmM5ZDJiL3RhYmxlcmFuZ2U6MzVhMzVhNDg1YzZlNDgxMGFmNzQxMGI4NzFiYzlkMmJfMTUtNC0xLTEtMA_51b1ced3-3301-498f-a63f-72ae306c3bf2"
      unitRef="usd">14532000</us-gaap:AccruedLiabilitiesCurrent>
    <us-gaap:OtherCurrentLiabilitiesTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExNA_4b6f9a1d-cfed-49d8-9ae6-8c9625dee6e5">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, short-term consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,024&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,214&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payable for asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;407&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;432&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,431&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,646&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherCurrentLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNi0yLTEtMS0w_f634d675-d6ea-4b6c-8493-be1d583281a5"
      unitRef="usd">1024000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <us-gaap:ContractWithCustomerLiabilityCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNi00LTEtMS0w_cd0f2f0f-ba69-442b-acb5-b5e9b18e709f"
      unitRef="usd">1214000</us-gaap:ContractWithCustomerLiabilityCurrent>
    <esta:CashPayableForAssetAcquisitionCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNy0yLTEtMS0w_a883d4ab-e4a4-47e3-b7f9-ab98e146628b"
      unitRef="usd">407000</esta:CashPayableForAssetAcquisitionCurrent>
    <esta:CashPayableForAssetAcquisitionCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfNy00LTEtMS0w_5cb65e73-1b7f-4e7e-badb-64701188807d"
      unitRef="usd">432000</esta:CashPayableForAssetAcquisitionCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfOC0yLTEtMS0w_519c8f86-3b6f-4e65-958b-37534b7cc216"
      unitRef="usd">1431000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherLiabilitiesCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOmM5ZGFmNmU3NjY5YTQxMGFhYWY5OGRjNDk4N2RkYzgyL3RhYmxlcmFuZ2U6YzlkYWY2ZTc2NjlhNDEwYWFhZjk4ZGM0OTg3ZGRjODJfOC00LTEtMS0w_c435d496-56d1-4737-ad42-a0507ee6ba72"
      unitRef="usd">1646000</us-gaap:OtherLiabilitiesCurrent>
    <us-gaap:OtherNoncurrentLiabilitiesTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RleHRyZWdpb246ZjZlYjUwYzFhZTk5NDIwMGE5YjNiZTM1ODg4NDBlN2NfMTExNg_05b16856-88f5-437c-8a91-2098a28b9709">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Other liabilities, long-term consisted of the following:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.947%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.632%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.633%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%"&gt;(in thousands)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Deferred revenue&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,778&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,860&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Cash payable for asset acquisitions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;425&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,820&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,332&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:OtherNoncurrentLiabilitiesTableTextBlock>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNS0yLTEtMS0w_c7868bbb-6bc7-4e88-ac43-00e9a21f7fd7"
      unitRef="usd">1778000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <us-gaap:ContractWithCustomerLiabilityNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNS00LTEtMS0w_78866aca-ef39-412c-b5a1-241de74d6527"
      unitRef="usd">1860000</us-gaap:ContractWithCustomerLiabilityNoncurrent>
    <esta:CashPayableForAssetAcquisitionNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNi0yLTEtMS0w_31286f04-25f1-49b7-9f52-5365f6e69166"
      unitRef="usd">0</esta:CashPayableForAssetAcquisitionNoncurrent>
    <esta:CashPayableForAssetAcquisitionNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNi00LTEtMS0w_24c54d64-1e12-44cb-9056-51ecce824d85"
      unitRef="usd">425000</esta:CashPayableForAssetAcquisitionNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNy0yLTEtMS0w_0a5c2dd2-8422-4499-a32a-61c31765b0d0"
      unitRef="usd">42000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherSundryLiabilitiesNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfNy00LTEtMS0w_b4b2eae9-473d-4bf7-8a33-50ea2eb88a10"
      unitRef="usd">47000</us-gaap:OtherSundryLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfOC0yLTEtMS0w_a2579d76-0feb-4e91-8aa2-d1dae9a0864d"
      unitRef="usd">1820000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:OtherLiabilitiesNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80MC9mcmFnOmY2ZWI1MGMxYWU5OTQyMDBhOWIzYmUzNTg4ODQwZTdjL3RhYmxlOjY4MDk2YTUyZWFmNzRjNWNhMDNmMGU5OGU3NzNjOGQ0L3RhYmxlcmFuZ2U6NjgwOTZhNTJlYWY3NGM1Y2EwM2YwZTk4ZTc3M2M4ZDRfOC00LTEtMS0w_30bda811-999a-4147-8c3d-3ebdeb879246"
      unitRef="usd">2332000</us-gaap:OtherLiabilitiesNoncurrent>
    <us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMA_bbb636da-980a-4791-986b-7ae80de24837">Goodwill and Other Intangible Assets&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. Intangible assets resulting from the acquisitions of entities accounted for using the acquisition method of accounting are recorded at the estimated fair value of the assets acquired. Purchased intangibles include certain patents and license rights, 510(k) authorization by the FDA to sell a medical device and other intangible assets.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s goodwill and most intangibles at March&#160;31, 2021 are the result of acquisitions of certain assets formerly owned by VeriTeQ Corporation in November 2015, Femiline AB in November 2017 and Orion Trading S.r.l in August 2020 and business acquisitions of Establishment Labs Brasil Productos para Saude Ltda. in January 2016, European Distribution Center Motiva BVBA in March 2016 and Motiva Implants France in September 2016. Finite-lived intangibles are amortized over their estimated useful lives based on expected future benefit.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the intangibles acquired, the Company capitalized certain patent and license rights as identified intangibles based on patent and license rights agreements entered into over the past several years. Additionally, the Company capitalized certain software development costs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes in the carrying amount of goodwill during the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Impairment Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:30pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The amortization expense associated with intangible assets was $0.3&#160;million and $0.2&#160;million for the &lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;three&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; months ended March&#160;31, 2021 and 2020, respectively&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. Non-product related amortization is recorded in SG&amp;amp;A while product related amortization is recorded in cost of revenue.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the amortization expense related to identifiable intangible assets, with definite useful lives, in future periods is expected to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;The Company evaluates the recoverability of goodwill and indefinite-lived intangible assets annually and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.</us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock>
    <us-gaap:ScheduleOfGoodwillTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMw_ba088167-6128-47da-b01f-85157634d54a">&lt;div style="margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;There were no changes in the carrying amount of goodwill during the three months ended March&#160;31, 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:48.450%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.876%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.025%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.548%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.880%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of January 1, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Additions&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Impairment Losses&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Balance as of March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Goodwill&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;465&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfGoodwillTextBlock>
    <us-gaap:Goodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC0xLTEtMS0w_39747bba-4a8b-4070-9edf-42203a23f626"
      unitRef="usd">465000</us-gaap:Goodwill>
    <us-gaap:GoodwillAcquiredDuringPeriod
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC0zLTEtMS0w_fc405c74-b9a3-46b2-968e-703812707736"
      unitRef="usd">0</us-gaap:GoodwillAcquiredDuringPeriod>
    <us-gaap:GoodwillImpairmentLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC01LTEtMS0w_e1fdbb89-5837-4be8-b20a-66b4d4e0e498"
      unitRef="usd">0</us-gaap:GoodwillImpairmentLoss>
    <us-gaap:Goodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOmI0ZTk1ZTFiMjJmMDRiYTJiYTZlMzE3MWUxMmY0OWMyL3RhYmxlcmFuZ2U6YjRlOTVlMWIyMmYwNGJhMmJhNmUzMTcxZTEyZjQ5YzJfNC03LTEtMS0w_c952b508-59db-47c6-984d-092450db94d1"
      unitRef="usd">465000</us-gaap:Goodwill>
    <us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQxNg_a5aff0fa-8c1f-4019-843e-002242596f5c">&lt;div style="margin-top:30pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQyMQ_a97e303d-3cb5-450e-bd59-93fedb9975a4">&lt;div style="margin-top:30pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(994)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;742&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,452)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;581&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(203)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;364&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(47)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,497&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(411)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,086&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(28)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7,261&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(3,135)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:50.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.885%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Gross Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Accumulated Amortization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Carrying Amount&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Estimated Useful Lives&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in years)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Patents and license rights&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(951)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;785&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7-12&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Customer relationships&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,033&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(1,297)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;736&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4-10&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;510(k) authorization&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;567&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(194)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;373&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;15&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Developed technology&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;62&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(46)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized software development costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,203&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(302)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,901&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Other&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;75&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;46&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2-5&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Capitalized patents and license rights not yet amortized&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;291&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6,967&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(2,819)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,148&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC0xLTEtMS0w_9ac3cd78-352d-42a5-b3c3-26770a9db528"
      unitRef="usd">1736000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC0zLTEtMS0w_c52828e5-f07f-4800-aa89-057bcf987c48"
      unitRef="usd">994000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ia40ff3845c404ee89df2259094867ea7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC01LTEtMS0w_9119be9c-1ec7-47de-a2e0-438d25c49d44"
      unitRef="usd">742000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i873ca24dbc894b9e8daab00025293c33_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC03LTEtMS0wL3RleHRyZWdpb246ZTU3NmYxNTYzOGJkNGE4N2IwMThlOGU2Mjk1Y2U2OTFfNA_5a1fa7d1-0aa5-4b07-81fb-c9f41bc5101e">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="if0cce1c6c85749738e3b59dc105867e4_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNC03LTEtMS0wL3RleHRyZWdpb246ZTU3NmYxNTYzOGJkNGE4N2IwMThlOGU2Mjk1Y2U2OTFfNw_871b2136-f99b-446e-89b7-bdc125c38dd4">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS0xLTEtMS0w_1c5ceb2d-7055-498b-bbbe-f21cc67efe7a"
      unitRef="usd">2033000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS0zLTEtMS0w_cadcc137-4049-4e71-b726-0dcf6cad1091"
      unitRef="usd">1452000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i2c8d5f4e4aa44e30b4a9ba4222e81219_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS01LTEtMS0w_128a0841-a923-4efe-a7e1-72a0e037c22b"
      unitRef="usd">581000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifd06ef7b1af0422c93f821f4a2f4cdce_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS03LTEtMS0wL3RleHRyZWdpb246YmEyOTAyMzUxOTJjNDVmNzk5NjhmMTIzZjk5MjQxMGJfNA_c7915113-8220-4ad9-803f-72318a867449">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6dc8ae01d3fd43de87978f967915da5f_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNS03LTEtMS0wL3RleHRyZWdpb246YmEyOTAyMzUxOTJjNDVmNzk5NjhmMTIzZjk5MjQxMGJfNw_f0ede5ba-bf87-4669-9763-01f7cbe7b8b6">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi0xLTEtMS0w_211457c0-9829-47ac-a9a3-60d03cd08f11"
      unitRef="usd">567000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi0zLTEtMS0w_c63af029-b77f-4298-9209-e5adf88176cc"
      unitRef="usd">203000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ic96c2ad8891740878a37a78c477c68e5_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi01LTEtMS0w_c3886ff2-2171-4c23-911a-4b4c82bce036"
      unitRef="usd">364000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3162e9ed932d412fb094be4a89be74cb_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNi03LTEtMS0w_79b48356-9495-4299-8e70-9e512e4baad8">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy0xLTEtMS0w_640b7637-8c2d-43bc-b334-87d8b4b1e13b"
      unitRef="usd">62000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy0zLTEtMS0w_1446e55a-6023-4807-9e8a-cfc8ffb95cd6"
      unitRef="usd">47000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0c230954c47a42a2a8f3f7a01264f32a_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy01LTEtMS0w_a577f480-7a84-4f2c-bce1-7eda2a790aef"
      unitRef="usd">15000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i689c07f08f64464b9f3b1686974bd26c_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfNy03LTEtMS0w_545518e8-94f6-4a05-8034-bce568e32c7e">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC0xLTEtMS0w_fb42e4cf-1b6a-4a76-b734-850fa18bbb58"
      unitRef="usd">2497000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC0zLTEtMS0w_5f8a1e44-7032-4d36-abd8-7531b0140c57"
      unitRef="usd">411000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9dca6d717b2a43bcb02a10e44f07718f_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC01LTEtMS0w_b553f08b-bcb9-4c69-83f0-38c86eeee486"
      unitRef="usd">2086000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i7d0ffc41700c443db6b4f0218c08c5f9_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC03LTEtMS0wL3RleHRyZWdpb246NjY5MDU0MWNiNzk0NGFkNGFiMTJhY2QxYmU2ZTAxNDNfNA_1987ef7d-9682-4e39-9709-0922a0cfb239">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ia584179cdecd4217be8aa815f6592f34_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOC03LTEtMS0wL3RleHRyZWdpb246NjY5MDU0MWNiNzk0NGFkNGFiMTJhY2QxYmU2ZTAxNDNfNw_f67149e9-3bb5-4542-b496-12c168c48171">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS0xLTEtMS0w_c3df0494-7a64-4d0c-aa30-59ca3329077e"
      unitRef="usd">75000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS0zLTEtMS0w_cdd23276-2418-4d25-a768-742b230e49ab"
      unitRef="usd">28000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i8d86c11463554b5dae342b3e252588bc_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS01LTEtMS0w_50949f68-90d9-4709-9909-1e567cea53a8"
      unitRef="usd">47000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i14be8b6604984469ba137e25363566e7_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS03LTEtMS0wL3RleHRyZWdpb246NTRiMzE1ZTNjM2I1NDA1M2EwNTg3MTVkMGE0YmI1NzlfNA_a15dd763-fba3-46a4-afdc-3fb968df9198">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ifcfcfc5c853545cfb75ef591c4c89c42_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfOS03LTEtMS0wL3RleHRyZWdpb246NTRiMzE1ZTNjM2I1NDA1M2EwNTg3MTVkMGE0YmI1NzlfNw_04394aaa-a368-4862-a51a-ad67b9ff51d3">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTAtMS0xLTEtMA_6dd55665-f762-4e83-9acf-254e9ec5319f"
      unitRef="usd">291000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTAtNS0xLTEtMA_1e25b6cd-f0bd-446f-ade7-b2af5e45d9d3"
      unitRef="usd">291000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtMS0xLTEtMA_6553f6e6-ca66-4b56-a650-2b2fc3e61175"
      unitRef="usd">7261000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtMy0xLTEtMA_e63af0b0-b2a5-484e-a281-f93c46cfe81f"
      unitRef="usd">3135000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZhNTZmMDIwOGM3NTRhODU5OGMyODBlOTM0ODRmYjM5L3RhYmxlcmFuZ2U6NmE1NmYwMjA4Yzc1NGE4NTk4YzI4MGU5MzQ4NGZiMzlfMTEtNS0xLTEtMA_89e76878-b487-452a-8f2c-6770c7e5a8e5"
      unitRef="usd">4126000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC0xLTEtMS0w_2ea19b55-3d14-4cf7-a30f-ee183656dea2"
      unitRef="usd">1736000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC0zLTEtMS0w_9b7d0163-8e1c-4973-8b2e-37d207cfe5a2"
      unitRef="usd">951000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i0bfcf8fa8577415cbd8f7d0d3cc667d9_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC01LTEtMS0w_adc1a719-2f2a-487e-a604-41fc9a49bbbc"
      unitRef="usd">785000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i49c86d6704eb428f9ade6dcef7f7c2ba_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC03LTEtMS0wL3RleHRyZWdpb246ZDc5NDZhZjM1NWMwNGFjNDg1Mzc4MGU3MjIxNTMyZjFfNA_c76a2852-1baf-44e4-88ed-c31370ba732b">P7Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i01b3a59d508e48d9b117f28aeb5c7264_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNC03LTEtMS0wL3RleHRyZWdpb246ZDc5NDZhZjM1NWMwNGFjNDg1Mzc4MGU3MjIxNTMyZjFfNw_37acd7e5-061b-40c7-a07d-ef331c777fb5">P12Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS0xLTEtMS0w_bf9dfa5e-e793-4471-a75d-6c4ee473f17c"
      unitRef="usd">2033000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS0zLTEtMS0w_2045fb1d-ba91-4a48-9f03-d054417a924d"
      unitRef="usd">1297000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="ibf3157d64e1c4973b17293fbef1cd4a4_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS01LTEtMS0w_30f94ad0-124a-4895-bf0d-66725cb47a07"
      unitRef="usd">736000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3edec611128b4e3ab3d4aa78897c8d21_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS03LTEtMS0wL3RleHRyZWdpb246YzEyYmZhNjRmNzI1NDRkZThiMjgxOGE0MGUyOTk3ZDdfNA_1bc13ef9-b726-44b1-82a8-916b92da46fd">P4Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i89fb77590e764015b6a150b0c8ffe09d_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNS03LTEtMS0wL3RleHRyZWdpb246YzEyYmZhNjRmNzI1NDRkZThiMjgxOGE0MGUyOTk3ZDdfNw_56e1bd78-6efc-4ff3-b560-2dd714a77b26">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi0xLTEtMS0w_a3683243-8a35-4f54-8793-b5783f0f4fbf"
      unitRef="usd">567000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi0zLTEtMS0w_73e8095d-726a-46b5-93a1-61a6e7bbb712"
      unitRef="usd">194000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i9fa0089fc31649e58eec8035eada66ac_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi01LTEtMS0w_2b91a785-651e-45a3-9889-690e4f146eec"
      unitRef="usd">373000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i6997f7df2347466ab6eff3ece39e0830_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNi03LTEtMS0w_5e9e8de3-889f-4a8f-9bda-6464f9219112">P15Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i78118302909b42fe814d72c9776a9be6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy0xLTEtMS0w_2114c47b-78e9-41e1-ae05-14b538ea1cbc"
      unitRef="usd">62000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i78118302909b42fe814d72c9776a9be6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy0zLTEtMS0w_800771b0-f8db-4e72-a824-5afd66584cda"
      unitRef="usd">46000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i78118302909b42fe814d72c9776a9be6_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy01LTEtMS0w_0d82d358-6d67-4abc-a1b4-8ba857ca50b7"
      unitRef="usd">16000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i3c454b81cfb24c619a23bb42c3d8fd20_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfNy03LTEtMS0w_6184952a-e40b-48b8-82b6-0864388fe3d3">P10Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="i6494d630a4134e7bab16b46694c01385_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC0xLTEtMS0w_f996fb44-ffb5-44fa-8e63-eda0dc933376"
      unitRef="usd">2203000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="i6494d630a4134e7bab16b46694c01385_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC0zLTEtMS0w_2cd07d2c-6bdf-4042-96db-a9d199f154ae"
      unitRef="usd">302000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i6494d630a4134e7bab16b46694c01385_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC01LTEtMS0w_7180d6a1-9048-4d11-bf04-fcbad854e022"
      unitRef="usd">1901000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i059a7469f92d475985e17381b3f435bf_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC03LTEtMS0wL3RleHRyZWdpb246ODQ5ZmFhNWI1ZjIwNDRkZjk0NWVlZTAyM2EwY2RkNmVfNA_c8fe93da-e47f-4b69-ba6a-c8ccf9bf7cf7">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="i089cb2848143463d8c43064f3bebf723_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOC03LTEtMS0wL3RleHRyZWdpb246ODQ5ZmFhNWI1ZjIwNDRkZjk0NWVlZTAyM2EwY2RkNmVfNw_40bedc60-e19c-49c2-98b9-30334876b18d">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetsGross
      contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS0xLTEtMS0w_7d701462-797a-40c5-8936-172d3e062713"
      unitRef="usd">75000</us-gaap:FiniteLivedIntangibleAssetsGross>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS0zLTEtMS0w_be0f5be6-38d9-46bc-ac54-5b15a55a1954"
      unitRef="usd">29000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="id15204a07aef47d79b3d1359d3d2298a_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS01LTEtMS0w_1f41c879-1f4f-4e30-92e3-34f2aa38df2b"
      unitRef="usd">46000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="ic2100b1681d141eb80d0946f6fecde49_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS03LTEtMS0wL3RleHRyZWdpb246OGJjNjM4NzUyODZkNGU5NDg2NmY0OTQ4NGFhYzQyNmZfNA_44a26e9e-8d9a-4631-adb7-187fe770b721">P2Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:FiniteLivedIntangibleAssetUsefulLife
      contextRef="id757366e4d8c40e7a89ea6fdd3bf8800_D20200101-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfOS03LTEtMS0wL3RleHRyZWdpb246OGJjNjM4NzUyODZkNGU5NDg2NmY0OTQ4NGFhYzQyNmZfNw_f051e0d3-b079-41f4-aac9-a42abbc40efc">P5Y</us-gaap:FiniteLivedIntangibleAssetUsefulLife>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTAtMS0xLTEtMA_4f1791df-87a6-4a9f-8912-2d1ee537692c"
      unitRef="usd">291000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTAtNS0xLTEtMA_0eb22213-621a-4a2c-9f81-78d883e16a6e"
      unitRef="usd">291000</us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill>
    <us-gaap:IntangibleAssetsGrossExcludingGoodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtMS0xLTEtMA_4278f520-dce7-4fa4-8f6a-0308cecf462a"
      unitRef="usd">6967000</us-gaap:IntangibleAssetsGrossExcludingGoodwill>
    <us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtMy0xLTEtMA_1a27bd5c-565d-4801-80e0-d067c928b846"
      unitRef="usd">2819000</us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization>
    <us-gaap:IntangibleAssetsNetExcludingGoodwill
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjExNzJjZmMzN2Y5YjQ3NTA5Mzc1OWQxOTdiNmQ5N2Y0L3RhYmxlcmFuZ2U6MTE3MmNmYzM3ZjliNDc1MDkzNzU5ZDE5N2I2ZDk3ZjRfMTEtNS0xLTEtMA_0b79c88b-c20f-483e-b439-586a2c8a0f9e"
      unitRef="usd">4148000</us-gaap:IntangibleAssetsNetExcludingGoodwill>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMTc3NA_880ed0c2-19bb-42ae-846d-99d2009c9d92"
      unitRef="usd">300000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:AmortizationOfIntangibleAssets
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMTc4MQ_bf670809-fdff-43c6-b824-77c47b2ddff7"
      unitRef="usd">200000</us-gaap:AmortizationOfIntangibleAssets>
    <us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RleHRyZWdpb246MmI3MTRmMGFlZjIxNDkyMDk1YmRjMDU2YzdhMjAwMWZfMjQxOA_840a6b6b-6f77-46c2-b52e-1e66cd655aec">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the amortization expense related to identifiable intangible assets, with definite useful lives, in future periods is expected to be as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:85.209%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline"&gt;Year Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021 (remaining)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;868&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;617&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;592&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;393&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;490&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,835&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfMi0yLTEtMS0w_2f27bf3e-0622-4c5d-861f-bcc3bbe8105c"
      unitRef="usd">868000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfMy0yLTEtMS0w_f91c1f66-b878-4ba4-a026-143af9c38c27"
      unitRef="usd">875000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNC0yLTEtMS0w_87a7108c-29bf-438f-ab1c-83dfe00e0a3d"
      unitRef="usd">617000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNS0yLTEtMS0w_b7d9a709-003a-44b6-9d4f-5ca210446d63"
      unitRef="usd">592000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree>
    <us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNi0yLTEtMS0w_0e78bb37-8f65-4efe-b426-a28d2c92c4ae"
      unitRef="usd">393000</us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour>
    <esta:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfNy0yLTEtMS0w_49ae9ade-7c97-4393-90df-5c046794aa2c"
      unitRef="usd">490000</esta:FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour>
    <us-gaap:FiniteLivedIntangibleAssetsNet
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80My9mcmFnOjJiNzE0ZjBhZWYyMTQ5MjA5NWJkYzA1NmM3YTIwMDFmL3RhYmxlOjZiMDI3YmFhZWE1NjQ0YTJhNmI0Y2VlMTkyODE3NGU0L3RhYmxlcmFuZ2U6NmIwMjdiYWFlYTU2NDRhMmE2YjRjZWUxOTI4MTc0ZTRfOC0yLTEtMS0w_e0adcef3-92f7-4c29-9a30-6cbfb78215aa"
      unitRef="usd">3835000</us-gaap:FiniteLivedIntangibleAssetsNet>
    <us-gaap:FairValueDisclosuresTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4NA_ec8b9e16-bfad-4bc5-a9d5-0b969e6ad4ae">Fair Value Measurements&lt;div style="margin-bottom:6pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The carrying value of the Company&#x2019;s cash, accounts receivable and accounts payable approximate fair value due to the short-term nature of these items. Contingent equity consideration and embedded derivatives that qualify for liability treatment are carried at fair value and re-measured at each reporting period. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the use of observable inputs and minimize the use of unobservable inputs. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level I&#160;&#160;&#160;&#160;Unadjusted quoted prices in active markets for identical assets or liabilities;&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level II&#160;&#160;&#160;&#160;Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Level III Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy at period end: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madryn put option liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madryn put option liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value measurement of derivatives is based on significant inputs not observed in the market and thus represents a Level 3 measurement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In August 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders (see Note 6). The Company determined that the Madryn Credit Agreement contained put options related to early redemption mandatory prepayment terms in case of change in control or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $15.1 million for these identified embedded derivatives as a debt discount on the original commitment date. An additional $5.0 million and $1.6 million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $10.0 million in the fourth quarter of fiscal 2017 and $25.0 million in August 2019 (see Note 6). The Company revalued the options as of each reporting period and recorded the change in the fair value in the consolidated statement of operations as other income or expense.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Valuation of the embedded derivatives is complex and requires interest rate simulation, capturing optimal decision making process as interest rate fluctuates and estimating the resultant bond valuation and the resultant pay-off to the option holder. The Company estimated the fair value of the embedded redemption options based on a &#x201c;with&#x201d; and &#x201c;without&#x201d; approach using the Black-Derman-Toy model, a form of the Binomial Lattice Model that captures interest rate variability and the prepayment optionality. The Binomial Lattice Model allows for the possibility of exercise before the end of the option&#x2019;s life and considers future interest rates, volatility and other data with &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;regards to the Company&#x2019;s credit rating and credit spread. The value of the embedded derivatives was based on the difference between the &#x201c;with&#x201d; and &#x201c;without&#x201d; analysis. The probability of a change in control occurring was determined to be 50% (cumulative probability through the maturity date) at March&#160;31, 2021 and December&#160;31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used the following assumptions to value Madryn derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Put Option Liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market yield rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The estimates are based, in part, on subjective assumptions and could differ materially in the future.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the three months ended March&#160;31, 2021 or during the year ended December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of the debt redemption feature liability includes the estimated market rate (credit spread and risk-free rate) and volatility.&#160;The higher/lower the estimated volatility, the higher/lower the value of the debt redemption feature liability. The higher/lower the estimated market rate, the higher/lower the value of the debt redemption feature liability.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Put Option Liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueDisclosuresTextBlock>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4Nw_d1f73543-c67e-4892-a744-3a7857a65fb8">&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth the Company&#x2019;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy at period end: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madryn put option liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:53.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.798%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Fair Value Measurements at December&#160;31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;2&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Level&#160;3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Madryn put option liability&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock>
    <us-gaap:DerivativeLiabilities
      contextRef="i95331fe2443f47f2a92a6d7d257f21c3_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi0xLTEtMS0w_fe1f4fb9-306f-4e3e-9e9d-076b15f6be00"
      unitRef="usd">1210000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="ifa130603b0d34bcaba896c6b2fbc06e8_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi0zLTEtMS0w_2d6295f8-2617-4b53-ab0e-04e411dd6bad"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i4e9b5f5e5662468497f5df0724ed1d00_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi01LTEtMS0w_1f0fbd2d-7d6c-4742-8cd9-1554c3081985"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="id0a4ea3cfc9b4f2d86192db4068663ca_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjQ5NGNmMzkzYjYwMTQzYmNiYWI2ZjU0MGU0OGVjY2QzL3RhYmxlcmFuZ2U6NDk0Y2YzOTNiNjAxNDNiY2JhYjZmNTQwZTQ4ZWNjZDNfNi03LTEtMS0w_c67eafec-b47b-4eeb-b66e-199a03c9c811"
      unitRef="usd">1210000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i71bb3412c07447beaadc22f1358a2b26_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi0xLTEtMS0w_09c9a2f8-0635-401a-835a-5690f9a043c3"
      unitRef="usd">1440000</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i790092f6c06c4e31b55aa091e6e08ed8_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi0zLTEtMS0w_c494c94b-fa9b-4e62-95ff-91b41596a3aa"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="idaea600f2d8040ed846ffa50db817b73_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi01LTEtMS0w_3f5ade11-516a-4b2b-95d0-4352a755e2b6"
      unitRef="usd">0</us-gaap:DerivativeLiabilities>
    <us-gaap:DerivativeLiabilities
      contextRef="i1ddf079de41d4d389e34c1fe33bd8373_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjUxMDMwY2I0YjMxMzQ1NDc4YmZkMThhYzE0YTg5YzIzL3RhYmxlcmFuZ2U6NTEwMzBjYjRiMzEzNDU0NzhiZmQxOGFjMTRhODljMjNfNi03LTEtMS0w_f64cbbf6-87ea-4a59-a071-25f3f8a2995b"
      unitRef="usd">1440000</us-gaap:DerivativeLiabilities>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="ie0f77adbac95434d9b0d6d9480e92d51_I20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjQzOQ_56b18e3d-53c3-4b13-b886-87e7b72daab4"
      unitRef="usd">15100000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9330e02904744171946200efc674cd7f_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjU1MA_3a005fc6-df5e-4ad2-8cc1-1835e951569f"
      unitRef="usd">5000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i830e948888774878a6aef7ca1259e422_I20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjU1Nw_1182e89f-3702-4fe4-9528-529e990c9891"
      unitRef="usd">1600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjY4OQ_532518ef-d23e-4c28-9f50-abe4c68cae8c"
      unitRef="usd">10000000.0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:ProceedsFromIssuanceOfDebt
      contextRef="ia6941f5711ff453faf70724a85877a15_D20190801-20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMjczMw_a58a72a2-9197-4149-a932-bc2ae8f22b34"
      unitRef="usd">25000000.0</us-gaap:ProceedsFromIssuanceOfDebt>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i059114baa58f4872bbfdcb04e021af01_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMzc4Mw_260cf02c-7444-4887-b880-48e5e384c053"
      unitRef="number">0.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i14303ccbd1cf4882a177c1af2b917801_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfMzc4Mw_5419c860-9bb4-4673-807b-3f145191fdb9"
      unitRef="number">0.50</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4OQ_d24f103f-b92d-437c-afa5-2856beee4e5a">&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company used the following assumptions to value Madryn derivatives:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Put Option Liability &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:74.011%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.971%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.973%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest rate volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20.9%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;19.7%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Market yield rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.3%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.9%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.57&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4.82&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i27da2686b48242f7a22212016aa9bccb_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMi0zLTEtMS0w_9fc55ca0-298c-4944-a376-0fd55856935b"
      unitRef="number">0.209</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i31a7c4a5a5f04c84a1769a691fe0f9e8_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMi01LTEtMS0w_5aca937e-4a3b-4ff5-a0ab-58691c52e3c3"
      unitRef="number">0.197</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i86193100685843efbbbb39fedddbac34_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMy0zLTEtMS0w_d16da57d-9873-419f-ad12-09555b9953af"
      unitRef="number">0.073</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="if774d5d7adbc4aac92f6d23ce833114e_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfMy01LTEtMS0w_a791022d-6e10-4d9a-92d3-4487d8bc1422"
      unitRef="number">0.079</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="ia29fed8a4345411c9e198ad402e4bf12_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNC0zLTEtMS0w_983b6ec2-3b1c-4b7a-9c5b-8549ddc340c5"
      unitRef="number">4.57</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i7ca4bc90ca3d4e5a87867faec60ebc94_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNC01LTEtMS0w_645903dd-744c-4c21-a3b1-f3d244c20363"
      unitRef="number">4.82</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i210e77df9d574a529b2c2f319b1dee8b_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNS0zLTEtMS0w_bf73a870-3476-4c4c-939d-ef19e66019d2"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:DerivativeLiabilityMeasurementInput
      contextRef="i6d2f8614a7724e108142603cacaa1bb9_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjk0ZTNhYmU2OWVmNDQ1ODE4ZDUzMGU0NzQwMTdkNDE0L3RhYmxlcmFuZ2U6OTRlM2FiZTY5ZWY0NDU4MThkNTMwZTQ3NDAxN2Q0MTRfNS01LTEtMS0w_4d73e9f0-d9da-4318-ac86-238998084950"
      unitRef="number">0</us-gaap:DerivativeLiabilityMeasurementInput>
    <us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RleHRyZWdpb246YTJjNmQ0NTE3M2M4NDM3MGE4ODg0NTZkYjBkYjliYTlfNTg4Mw_bef55998-7950-4b11-958b-7e7b8ac6984e">&lt;div style="margin-bottom:9pt;margin-top:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table sets forth a summary of the changes in the fair value of the Company&#x2019;s Level 3 financial instruments as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:12pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:80.447%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.609%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Put Option Liability &lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2019&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,072&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,929&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,001&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,440&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Change in fair value&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(230)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balance at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,210&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i35ee0f70fefa4c82929e447a5cec9bb3_I20191231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMi0xMC0xLTEtMA_7d3b40f4-c44b-4c73-9764-71f718bcb1e4"
      unitRef="usd">3072000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ibe39498f97ab4942a773e100eed6a382_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfNC0xMC0xLTEtMA_24fd3032-1b98-4f53-aebb-52072c2bbc9e"
      unitRef="usd">1929000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i90151a15234f4bf594dddc4ccebc3bac_I20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfNy0xMC0xLTEtMA_3d00bdea-b95f-4b41-b3ac-97bc5d23a708"
      unitRef="usd">5001000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i366040d3254b4edebd0cb69800364ef1_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfOS0xMC0xLTEtMA_7188a5c2-0e48-4a53-a4e1-e51fb2510517"
      unitRef="usd">1440000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings
      contextRef="ibc537e3dcd364e198a3715d83f0505b5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMTEtMTAtMS0xLTA_981d07c7-93bd-41c7-a93f-22d93ab42dd4"
      unitRef="usd">-230000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings>
    <us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue
      contextRef="i99d366567ea04542ae012abac0572301_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80Ni9mcmFnOmEyYzZkNDUxNzNjODQzNzBhODg4NDU2ZGIwZGI5YmE5L3RhYmxlOjgxOTA1M2QyODM4NDQyMjZhZDg2YWNlYWJmMTU2ZjhhL3RhYmxlcmFuZ2U6ODE5MDUzZDI4Mzg0NDIyNmFkODZhY2VhYmYxNTZmOGFfMTMtMTAtMS0xLTA_592d1543-973f-4695-8da6-8951feef36eb"
      unitRef="usd">1210000</us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue>
    <us-gaap:DebtDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDkyNw_c2892bf6-58f2-4628-88ec-9acbc76e4360">Debt&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Madryn Debt&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;On August 24, 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders. On June 17, 2019, the Madryn Credit Agreement was amended to lower the interest rate on the outstanding debt facilities, provide for &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;$25.0 million of new term loan commitments, decrease the amount of the prepayment penalties, remove all principal payments and extend the maturity date and repayment from September 30, 2023 to September 30, 2025. On August 5, 2020, the Company amended the Madryn Credit Agreement to adjust the minimum product revenue milestone previously applicable to December 31, 2020 to September 31, 2021 and to add Motiva Implants UK Limited, Motiva Implants France SAS, Motiva Implants Spain, S.L. and Motiva Germany GmbH, wholly-owned subsidiaries of the Company, as guarantors to the Madryn Credit Agreement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Madryn Credit Agreement, as amended, provides for a term loan in a maximum principal amount of $65.0 million, $30.0 million (Term A) of which became available upon signing and was subsequently borrowed by the Company.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to amending the Madryn Credit Agreement on June 17, 2019, the Company&#x2019;s ability to borrow the remaining term loans under the Madryn Credit Agreement was subject to the Company achieving certain revenue milestones. The Company met milestones sufficient to borrow and borrowed an additional $5.0 million (Term B-1) on October 31, 2017 and $5.0 million (Term B-2) on December 15, 2017, increasing the total outstanding principal balance to $40.0 million as of December 31, 2017.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the June 2019 amendment, the Company became eligible to borrow an additional $10.0 million (Term B-3) and $15.0 million (Term B-4) on or before September 30, 2019 and December 31, 2019, respectively. The Company borrowed the available funds under both tranches equal to $25.0 million on August 12, 2019, bringing up the total outstanding principal balance to $65.0 million as of March&#160;31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In connection with the Madryn Credit Agreement, the Company and certain of its subsidiaries granted a security interest in substantially all of their respective assets, including, without limitation, intellectual property, and pledges of certain shares of the Company&#x2019;s subsidiaries, subject to certain excluded collateral exceptions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Madryn Credit Agreement contains customary affirmative and negative covenants, including, but not limited to, restrictions on the ability of the Company and its subsidiaries to incur additional indebtedness, create liens, make certain investments, make restricted payments, enter into or undertake certain liquidations, mergers, consolidations or acquisitions and dispose of assets or subsidiaries. In addition, the Madryn Credit Agreement requires the Company to maintain minimum revenues and liquidity.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Prior to the effectiveness of the June 17, 2019 amendment, borrowings under the Madryn Credit Agreement bore interest at a rate equal to 3-month LIBOR plus 11.0% per annum. As of the amendment on June 17, 2019, borrowings under the Madryn Credit Agreement bear interest at a rate equal to 3-month LIBOR plus 8.0% per annum provided that no default has occurred. In an event of a default, the interest would increase by an additional 4.0% per annum. The effective interest rate under the amended Madryn Credit Agreement is 18.4%, and the weighted average interest rate was approximately 10.6% at March&#160;31, 2021. The Company incurred $1.7 million in interest expense in connection with Madryn Credit Agreement during each of the three months ended March&#160;31, 2021 and 2020. No principal payments are due on the term loans until the final maturity date on September 30, 2025. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company also determined that the Madryn Credit Agreement contained put options which are mandatory repayment provisions related to liquidity events or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $15.1 million for these embedded derivatives as a debt discount on the original commitment date in August 2017. An additional $5.0 million and $1.6 million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $10.0 million in the fourth quarter of fiscal 2017 and $25.0&#160;million in August 2019. The Company revalues the embedded derivatives as of each reporting period and records the change in the fair value in the consolidated statement of operations as other income or expense (see Note 5). The Company also incurred legal expenses of $1.3 million in 2017 and $0.3 million in August 2019, which were recorded as a debt discount and are being amortized over the term of the Madryn Credit Agreement. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded Madryn debt on the balance sheet as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unamortized debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of Madryn debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, the Company is in compliance with all financial debt covenants.&lt;/span&gt;&lt;/div&gt;</us-gaap:DebtDisclosureTextBlock>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i5aed9212cd444c949bd6daaee2b29e84_I20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzUw_a6fda9a4-4504-4013-bc3b-7ec831e24ff5"
      unitRef="usd">25000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="i6b2546ff36954e819bb93630aa88e260_I20170824"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTAzOQ_1faf2068-13a7-4caf-a3a0-df8f9c48b28a"
      unitRef="usd">65000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity
      contextRef="ia833a43aacd04fb58829b20141aedaf6_I20170824"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTA0Mw_427d2200-e12b-46ca-a2a2-a46eb70ce885"
      unitRef="usd">30000000.0</us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ied61c55aaefd4fa6ab4618839ed979f0_D20171031-20171031"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTQzNQ_65706fec-d10e-4787-93b0-4a2ae53bae71"
      unitRef="usd">5000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia1f9be83f245489ba3f93a2a2970a743_D20171215-20171215"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTQ3Mw_ad5b8105-c373-4973-8422-f57cd009b2c2"
      unitRef="usd">5000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i9330e02904744171946200efc674cd7f_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTU2Mw_618a5d6b-9684-457e-942d-7babd155adb4"
      unitRef="usd">40000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <esta:LineOfCreditFacilityAdditionalBorrowingCapacity
      contextRef="icb1b1b6522f146e2a92e6845b3354b0e_I20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTY4MA_4aa1a5c0-65cb-4b43-87b4-37922916ebdc"
      unitRef="usd">10000000.0</esta:LineOfCreditFacilityAdditionalBorrowingCapacity>
    <esta:LineOfCreditFacilityAdditionalBorrowingCapacity
      contextRef="iefa578fa70ce4695a1914cbd8fad0ccd_I20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTY5OA_0e2d343d-83a5-49ad-9eb6-4f02bb73765e"
      unitRef="usd">15000000.0</esta:LineOfCreditFacilityAdditionalBorrowingCapacity>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="i56705c8ada8c45b8893dfc488df6e515_D20190812-20190812"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTg1MQ_308675c4-dffb-44fb-9fc6-770781358444"
      unitRef="usd">25000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMTkyOQ_aff31062-d5b6-4307-ad9c-e014a693909d"
      unitRef="usd">65000000.0</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="if0313e61c81e4ee8a20a20c25abd823f_D20190101-20190616"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMjk0Mg_dc3d30a0-884a-4ec7-ac6b-3bb7d2bc7fb2"
      unitRef="number">0.110</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <us-gaap:DebtInstrumentBasisSpreadOnVariableRate1
      contextRef="idd8ee19aeac5495bb1e420bf7d180a2b_D20190617-20190617"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzA5MQ_d17dcb52-3a49-4d52-8de7-9069d23f4b3e"
      unitRef="number">0.080</us-gaap:DebtInstrumentBasisSpreadOnVariableRate1>
    <esta:DebtInstrumentDefaultInterestRateIncrease
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzIxNA_e6720460-7c0e-4ef6-a032-18d467605e7f"
      unitRef="number">0.040</esta:DebtInstrumentDefaultInterestRateIncrease>
    <us-gaap:DebtInstrumentInterestRateEffectivePercentage
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzMwMQ_3e52ed20-2e40-4e17-905b-c7454555ae78"
      unitRef="number">0.184</us-gaap:DebtInstrumentInterestRateEffectivePercentage>
    <us-gaap:DebtWeightedAverageInterestRate
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzM2Mg_095e8081-1f87-4a82-9e4d-cf8292b25869"
      unitRef="number">0.106</us-gaap:DebtWeightedAverageInterestRate>
    <us-gaap:InterestExpenseDebt
      contextRef="i709a73d169864a389bd4608c3299e861_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzQwMA_16de6a90-5665-4d21-b947-b8e747facb80"
      unitRef="usd">1700000</us-gaap:InterestExpenseDebt>
    <us-gaap:InterestExpenseDebt
      contextRef="i0007a8ee0a3a4436b52008e19adf5975_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfMzQwMA_a221c6e5-e292-4e43-bc88-ea486d39820b"
      unitRef="usd">1700000</us-gaap:InterestExpenseDebt>
    <us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability
      contextRef="ie0f77adbac95434d9b0d6d9480e92d51_I20170831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDA1MQ_33920679-7e4e-443a-a029-cf2016be9726"
      unitRef="usd">15100000</us-gaap:EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i9330e02904744171946200efc674cd7f_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDE2Ng_ece01014-3c53-4bbf-89b5-d740f5d39e71"
      unitRef="usd">5000000.0</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:DebtInstrumentUnamortizedDiscount
      contextRef="i830e948888774878a6aef7ca1259e422_I20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDE3Mw_1ec79ffc-14ef-4383-a143-48c2340954a7"
      unitRef="usd">1600000</us-gaap:DebtInstrumentUnamortizedDiscount>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ib0e5c77ab6f446018f6dd5b9e1d1ed3b_D20171001-20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDMwNQ_bc6756f0-1571-4f9e-9a43-23732eed20c9"
      unitRef="usd">10000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:ProceedsFromLinesOfCredit
      contextRef="ia6941f5711ff453faf70724a85877a15_D20190801-20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDM0OQ_ecf93593-21c7-45b6-9695-cacfff7afab1"
      unitRef="usd">25000000.0</us-gaap:ProceedsFromLinesOfCredit>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i9330e02904744171946200efc674cd7f_I20171231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDYxMg_f2407641-94b2-419c-89d7-b2b92f48bd62"
      unitRef="usd">1300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:DeferredFinanceCostsNet
      contextRef="i830e948888774878a6aef7ca1259e422_I20190831"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDY1NQ_1ab876ff-8264-4eab-92ef-6b33a0cac678"
      unitRef="usd">300000</us-gaap:DeferredFinanceCostsNet>
    <us-gaap:ScheduleOfDebtInstrumentsTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RleHRyZWdpb246MzA3Y2FlZjc4OGM0NGRiMjk4YzE4NjhlZjBkYjEzYTlfNDkyNQ_2ef84c5f-133e-45e7-8702-e7884b82d224">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recorded Madryn debt on the balance sheet as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.304%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Principal&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;65,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net unamortized debt discount and issuance costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(14,695)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(15,168)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net carrying value of Madryn debt&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;50,305&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;49,832&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfDebtInstrumentsTextBlock>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNC0xLTEtMS0w_e7f689bd-0e07-414b-a199-c488596aeb86"
      unitRef="usd">65000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentCarryingAmount
      contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNC0zLTEtMS0w_9ba0c0a5-b3f9-4e3b-94e5-f40e1ecd44f7"
      unitRef="usd">65000000</us-gaap:DebtInstrumentCarryingAmount>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNy0xLTEtMS0w_527b1381-f50f-4b01-a86b-1310b897e2e6"
      unitRef="usd">14695000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet
      contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfNy0zLTEtMS0w_00e8aca8-cf96-46f7-ac7b-bffaa805a1fa"
      unitRef="usd">15168000</us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet>
    <us-gaap:LongTermDebt
      contextRef="i15ac743227854d2c9afe9117722a0e53_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfOC0xLTEtMS0w_35b594bc-38b1-435a-b69f-20b780b30554"
      unitRef="usd">50305000</us-gaap:LongTermDebt>
    <us-gaap:LongTermDebt
      contextRef="i536f3d3e23d34b9993ea9b67dc3a01b7_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF80OS9mcmFnOjMwN2NhZWY3ODhjNDRkYjI5OGMxODY4ZWYwZGIxM2E5L3RhYmxlOjIxZDM5YmZjZjIxOTQzZThiNTA4NDkxOTJjZmE2NzAwL3RhYmxlcmFuZ2U6MjFkMzliZmNmMjE5NDNlOGI1MDg0OTE5MmNmYTY3MDBfOC0zLTEtMS0w_1e41bbff-59fb-436e-aae2-74fefa8656eb"
      unitRef="usd">49832000</us-gaap:LongTermDebt>
    <us-gaap:LesseeFinanceLeasesTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Ng_052620b3-b62c-4810-80bc-69a7ed620fb2">Leases&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes lease liabilities and ROU assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When the rate implicit to the lease cannot be readily determined, the Company utilizes its incremental borrowing rate in determining the present value of the future lease payments. Lease liabilities are accreted each period and reduced for payments. The ROU asset also includes other adjustments, such as for the effects of escalating rents, rent abatements or initial lease costs. The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. For finance leases, the ROU asset depreciates on a straight-line basis over the shorter of the lease term or useful life of the ROU asset and the lease liability accretes interest based on the interest method using the discount rate determined at lease commencement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for facilities and office space as well as finance leases for equipment and vehicles. Operating lease assets and the related lease liabilities are included within the ROU assets&#x2014;operating leases. The determination of whether an arrangement is, or contains, a lease is performed at the inception of the arrangement. The Company has operating and finance leases for certain facilities, office space, equipment, and vehicles to be used in its operations, with remaining lease terms ranging from monthly to 8 years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for additional years. These optional periods have not been considered in the determination of the ROU or lease liabilities associated with these leases as management did not consider it reasonably certain it would exercise the options. Short-term leases, which have an initial term of 12 months or less, are not recorded in the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements do not contain any termination options, material residual value guarantees, material bargain purchase options or material restrictive covenants. The Company does not have any lease transactions with related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%"&gt;Supplemental balance sheet information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate (%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeFinanceLeasesTextBlock>
    <us-gaap:LesseeOperatingLeasesTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Ng_deaf924d-ce0d-43f3-b0a8-fd16e2d47675">Leases&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company recognizes lease liabilities and ROU assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;ROU assets represent the Company&#x2019;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#x2019;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When the rate implicit to the lease cannot be readily determined, the Company utilizes its incremental borrowing rate in determining the present value of the future lease payments. Lease liabilities are accreted each period and reduced for payments. The ROU asset also includes other adjustments, such as for the effects of escalating rents, rent abatements or initial lease costs. The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. For finance leases, the ROU asset depreciates on a straight-line basis over the shorter of the lease term or useful life of the ROU asset and the lease liability accretes interest based on the interest method using the discount rate determined at lease commencement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has operating leases for facilities and office space as well as finance leases for equipment and vehicles. Operating lease assets and the related lease liabilities are included within the ROU assets&#x2014;operating leases. The determination of whether an arrangement is, or contains, a lease is performed at the inception of the arrangement. The Company has operating and finance leases for certain facilities, office space, equipment, and vehicles to be used in its operations, with remaining lease terms ranging from monthly to 8 years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for additional years. These optional periods have not been considered in the determination of the ROU or lease liabilities associated with these leases as management did not consider it reasonably certain it would exercise the options. Short-term leases, which have an initial term of 12 months or less, are not recorded in the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company&#x2019;s lease agreements do not contain any termination options, material residual value guarantees, material bargain purchase options or material restrictive covenants. The Company does not have any lease transactions with related parties.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%"&gt;Supplemental balance sheet information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate (%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeasesTextBlock>
    <us-gaap:LesseeFinanceLeaseTermOfContract1
      contextRef="i759011d78d1d4884b0ec06f0e36e3637_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfMzI5ODUzNDg4OTc1Mw_18e4ea17-64a2-4fa2-801f-8e1178199fce">P8Y</us-gaap:LesseeFinanceLeaseTermOfContract1>
    <us-gaap:LesseeOperatingLeaseTermOfContract
      contextRef="i759011d78d1d4884b0ec06f0e36e3637_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfMzI5ODUzNDg4OTc1Mw_f5975e0b-69b8-4831-9e6f-6f50b5005c71">P8Y</us-gaap:LesseeOperatingLeaseTermOfContract>
    <us-gaap:LeaseCostTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2Nw_92ad5841-7d33-4c0e-baa8-82499990fb53">Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:9pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease expense cost&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;150&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance Lease Costs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Interest expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Amortization expense&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;35&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;20&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease costs&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;38&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;26&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Cash paid for amounts included in the measurement of lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Financing cash outflows from finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;76&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;ROU assets obtained in exchange for new lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:LeaseCostTableTextBlock>
    <us-gaap:OperatingLeaseCost
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfMi0yLTEtMS0xNDMx_7bfe1778-391e-4584-83b1-a1d17fd4dfef"
      unitRef="usd">167000</us-gaap:OperatingLeaseCost>
    <us-gaap:OperatingLeaseCost
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfMi00LTEtMS0xNDMz_28c18821-3eaa-460a-b5ab-359d76860f8c"
      unitRef="usd">150000</us-gaap:OperatingLeaseCost>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNS0yLTEtMS0xNDM1_5c17577c-752d-466f-a38f-954e27948a46"
      unitRef="usd">3000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseInterestExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNS00LTEtMS0xNDM3_6e85b043-f5fc-4d1c-804d-626d76a9b49e"
      unitRef="usd">6000</us-gaap:FinanceLeaseInterestExpense>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNi0yLTEtMS0xNDM1_59f1da80-429c-4d3a-8b30-37f5bf72d380"
      unitRef="usd">35000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:FinanceLeaseRightOfUseAssetAmortization
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNi00LTEtMS0xNDM3_866d3d08-3e06-48a9-8011-b585bc1e0fcd"
      unitRef="usd">20000</us-gaap:FinanceLeaseRightOfUseAssetAmortization>
    <us-gaap:LeaseCost
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNy0yLTEtMS0xNDM1_4b457aa3-3ca8-4603-a113-a116e9f02e6d"
      unitRef="usd">38000</us-gaap:LeaseCost>
    <us-gaap:LeaseCost
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjdkMDlmODgzNTk3NjQ3MmNiM2YzMzlhZWQ1YzM3Mjg1L3RhYmxlcmFuZ2U6N2QwOWY4ODM1OTc2NDcyY2IzZjMzOWFlZDVjMzcyODVfNy00LTEtMS0xNDM3_22854254-19d2-450d-b6c9-bdc6d8d27571"
      unitRef="usd">26000</us-gaap:LeaseCost>
    <esta:AssetsAndLiabilitiesLesseeTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA2OA_f6e81251-1a00-4578-9735-6afbd9c5debd">&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%"&gt;Supplemental balance sheet information&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,511&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,610&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;986&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;788&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,630&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,923&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total operating lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,711&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease right-of-use assets&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;278&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;313&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - short-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;105&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;160&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance lease liabilities - long-term&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;28&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total finance lease liabilities&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;188&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average remaining lease term (years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5.9&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.2&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.8&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted-average discount rate (%)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Operating leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10.5&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Finance leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;9.1&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;</esta:AssetsAndLiabilitiesLesseeTableTextBlock>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNC0yLTEtMS0xNDI5_505d4eda-4a1e-4a91-baaa-36723e926aba"
      unitRef="usd">2511000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseRightOfUseAsset
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNC00LTEtMS0xNDI5_9e23d688-dcbe-4dbf-8dba-882ac8cbb441"
      unitRef="usd">2610000</us-gaap:OperatingLeaseRightOfUseAsset>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNS0yLTEtMS0xNDI5_a563f92f-be61-4f03-8ed5-cc8e61aee0b7"
      unitRef="usd">986000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNS00LTEtMS0xNDI5_7fe4c4fb-edf9-47b2-91b6-f98ac45cc218"
      unitRef="usd">788000</us-gaap:OperatingLeaseLiabilityCurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNi0yLTEtMS0xNDI5_b7491f87-e5a3-4e05-b4b3-e5cf867ea488"
      unitRef="usd">1630000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiabilityNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNi00LTEtMS0xNDI5_4e9876a2-1d6b-44aa-b4a8-6fd60f84568b"
      unitRef="usd">1923000</us-gaap:OperatingLeaseLiabilityNoncurrent>
    <us-gaap:OperatingLeaseLiability
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNy0yLTEtMS0xNDI5_253337d6-cd46-4ee8-a000-34d2ebba8990"
      unitRef="usd">2616000</us-gaap:OperatingLeaseLiability>
    <us-gaap:OperatingLeaseLiability
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfNy00LTEtMS0xNDI5_9a8e1e6f-fdbd-43ae-a771-f9e54e3e7533"
      unitRef="usd">2711000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTAtMi0xLTEtMTQyOQ_3294c7ef-6905-4203-b0af-5666069c4d62"
      unitRef="usd">278000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseRightOfUseAsset
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTAtNC0xLTEtMTQyOQ_c82f99b1-796b-45c4-a8be-c734fc61f6f0"
      unitRef="usd">313000</us-gaap:FinanceLeaseRightOfUseAsset>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTEtMi0xLTEtMTQyOQ_aa495aca-7098-4061-9695-a34da3f91b76"
      unitRef="usd">105000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityCurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTEtNC0xLTEtMTQyOQ_ee5bf5e9-ad29-4aaa-8f60-11995d422793"
      unitRef="usd">160000</us-gaap:FinanceLeaseLiabilityCurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTItMi0xLTEtMTQyOQ_ab96d305-d451-4e4b-99a3-314b332028f5"
      unitRef="usd">28000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiabilityNoncurrent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTItNC0xLTEtMTQyOQ_86012b10-f11f-4920-b813-93b1e9b2b341"
      unitRef="usd">28000</us-gaap:FinanceLeaseLiabilityNoncurrent>
    <us-gaap:FinanceLeaseLiability
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTMtMi0xLTEtMTQyOQ_90f4a327-3dbe-4e2b-9d32-9fcf8612f364"
      unitRef="usd">133000</us-gaap:FinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTMtNC0xLTEtMTQyOQ_c9b4b3fb-f805-48d6-9e04-1e3b279d1631"
      unitRef="usd">188000</us-gaap:FinanceLeaseLiability>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTYtMi0xLTEtMzUxNA_22557f85-3d33-4012-a323-140e1112ee64">P5Y10M24D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTYtNC0xLTEtMTQyOQ_a718b2e9-320e-4411-8080-5aeecc7ba678">P6Y2M12D</us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTctMi0xLTEtNDA5MA_077243fa-6c22-47eb-aa15-f4e05b881d09">P0Y9M18D</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMTctNC0xLTEtMTQyOQ_9895201d-f12d-44a3-827b-f16b88f5be17">P1Y</us-gaap:FinanceLeaseWeightedAverageRemainingLeaseTerm1>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjAtMi0xLTEtNDA5MA_3c85f093-d21a-4641-9db2-6dfcd929a87c"
      unitRef="number">0.105</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjAtNC0xLTEtMTQyOQ_450eb337-d9b4-4499-b079-7333f71942b2"
      unitRef="number">0.105</us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjEtMi0xLTEtNDA5MA_8dc934bd-bd01-4a6a-8976-74882335dd07"
      unitRef="number">0.091</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmY2ZWYzMzgxMzM0NzQ4ZjU4ODNmZTMzNmQ5NGZjNzc2L3RhYmxlcmFuZ2U6ZjZlZjMzODEzMzQ3NDhmNTg4M2ZlMzM2ZDk0ZmM3NzZfMjEtNC0xLTEtMTQyOQ_38cc1c2b-8826-4437-9e62-38d36d174cab"
      unitRef="number">0.091</us-gaap:FinanceLeaseWeightedAverageDiscountRatePercent>
    <us-gaap:OperatingLeasePayments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfMy0yLTEtMS0xNDI3_64fba255-7ef2-492e-ba50-a5fcbbba77da"
      unitRef="usd">160000</us-gaap:OperatingLeasePayments>
    <us-gaap:OperatingLeasePayments
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfMy00LTEtMS0xNDI3_f0edd5a8-79e0-4a8e-92dc-f642c4303283"
      unitRef="usd">137000</us-gaap:OperatingLeasePayments>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNC0yLTEtMS0xNDI3_cca27c29-bc3a-4dba-938c-b2cab877797a"
      unitRef="usd">3000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeaseInterestPaymentOnLiability
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNC00LTEtMS0xNDI3_774054c3-5cee-4caa-87ab-75ccba79e2f8"
      unitRef="usd">6000</us-gaap:FinanceLeaseInterestPaymentOnLiability>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNS0yLTEtMS0xNDI3_0ba51772-18df-4825-90be-6db65167a6ba"
      unitRef="usd">55000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:FinanceLeasePrincipalPayments
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfNS00LTEtMS0xNDI3_e7f3056a-c67b-482a-8e17-77fef3669d00"
      unitRef="usd">76000</us-gaap:FinanceLeasePrincipalPayments>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOC0yLTEtMS0xNDI3_b0def68f-5382-46aa-b807-e6106bfa1e8d"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOC00LTEtMS0xNDI3_d637d611-904e-4da7-994c-66bd7924dbe2"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOS0yLTEtMS0xNDI3_0da3d640-bbd5-4f72-89f9-2c7ad086b431"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOmNlODczN2E1YThhMTRjODBiYjI5MWU5NTQ4OWQzYTI5L3RhYmxlcmFuZ2U6Y2U4NzM3YTVhOGExNGM4MGJiMjkxZTk1NDg5ZDNhMjlfOS00LTEtMS0xNDI3_6980fcdb-4313-4af9-8934-184e6a865e2e"
      unitRef="usd">0</us-gaap:RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability>
    <us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA3MA_08795870-2c3a-4026-b998-1d7ccb816bb2">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RleHRyZWdpb246ZWQ3NjFjMmQ4Yjg3NDczOTgwNTA2ODY0MTFhZTVjMGFfNDk0NzgwMjMzODA3MA_6080baeb-f3ed-46f8-854e-bc6529cde8e8">&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Maturities of lease liabilities as of March&#160;31, 2021 were as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.654%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.396%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.655%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Years Ending December 31,&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Operating Leases&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Finance Leases&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;494&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;109&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;594&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;29&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;565&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;532&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2025&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;449&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Thereafter&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;878&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,512&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;138&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Less: Amount of lease payments representing interest&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(896)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5)&lt;/span&gt;&lt;/td&gt;&lt;td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Present value of future minimum lease payments&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,616&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;133&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMy0yLTEtMS0xNDIz_c3bf8caf-e234-4b48-a135-4b53d477bdb8"
      unitRef="usd">494000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMy00LTEtMS0xNDI1_9b03d44d-1b93-408f-987b-d0c09a5e2056"
      unitRef="usd">109000</us-gaap:FinanceLeaseLiabilityPaymentsDueNextTwelveMonths>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNC0yLTEtMS0xNDIz_4768b75c-859b-4b21-a18c-1650cd79f4b8"
      unitRef="usd">594000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNC00LTEtMS0xNDI1_2db1d23d-de09-4e73-9dac-15c2f3dcef06"
      unitRef="usd">29000</us-gaap:FinanceLeaseLiabilityPaymentsDueYearTwo>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNS0yLTEtMS0xNDIz_8239c462-de3f-44cc-8572-929b0afd2142"
      unitRef="usd">565000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNS00LTEtMS0xNDI1_2eadcbcc-1717-46ca-9f6e-c6bb807bf7f8"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearThree>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNi0yLTEtMS0xNDIz_2bbc627e-e225-439e-89cd-57e2cfbb2908"
      unitRef="usd">532000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNi00LTEtMS0xNDI1_6e26d171-c286-48ce-af9d-a04787ba7549"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFour>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNy0yLTEtMS0xNDIz_585ee086-03b4-400e-8301-76ff1f5513c3"
      unitRef="usd">449000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfNy00LTEtMS0xNDI1_4e5b7516-cd64-4dfd-b84a-6f76cccbdfde"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOC0yLTEtMS0xNDIz_076f79e7-1bc0-41d1-b94f-5ff76ec16158"
      unitRef="usd">878000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOC00LTEtMS0xNDI1_ab2818b0-9558-4765-abc7-f908b051f760"
      unitRef="usd">0</us-gaap:FinanceLeaseLiabilityPaymentsDueAfterYearFive>
    <us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOS0yLTEtMS0xNDIz_d1134fb2-af4f-4312-b5a6-7321b8a06287"
      unitRef="usd">3512000</us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue>
    <us-gaap:FinanceLeaseLiabilityPaymentsDue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfOS00LTEtMS0xNDI1_f6d33330-670a-4c25-953a-65433fc04962"
      unitRef="usd">138000</us-gaap:FinanceLeaseLiabilityPaymentsDue>
    <us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTAtMi0xLTEtMTQyMw_822c82af-9aed-4dfa-a17f-443183a0d687"
      unitRef="usd">896000</us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTAtNC0xLTEtMTQyNQ_f228a73d-3427-4bd2-ba94-7aae761e8e82"
      unitRef="usd">5000</us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount>
    <us-gaap:OperatingLeaseLiability
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTEtMi0xLTEtMTQyMw_22e41746-63de-4c0f-9fcf-ce0b0e6c6dcf"
      unitRef="usd">2616000</us-gaap:OperatingLeaseLiability>
    <us-gaap:FinanceLeaseLiability
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81Mi9mcmFnOmVkNzYxYzJkOGI4NzQ3Mzk4MDUwNjg2NDExYWU1YzBhL3RhYmxlOjViZmY2ZmU0NWE4MTQwMTFiZTQ5YzkyNmM5ZDY1YjBmL3RhYmxlcmFuZ2U6NWJmZjZmZTQ1YTgxNDAxMWJlNDljOTI2YzlkNjViMGZfMTEtNC0xLTEtMTQyNQ_9eb8ca86-df46-4617-b9d6-d21a5c046214"
      unitRef="usd">133000</us-gaap:FinanceLeaseLiability>
    <us-gaap:StockholdersEquityNoteDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfNTEw_7e31536b-0c16-4124-895b-c1af963c17aa">Shareholders&#x2019; Equity&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Under the Memorandum of Association and Articles of Association, or Articles, in effect as of &lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;March&#160;31, 2021&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; and December&#160;31, 2020, the Company had authorized an unlimited number of common shares with no par value.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021 and December&#160;31, 2020, 24,094,051 and 23,925,789 common shares, respectively, were issued and 23,685,981 and 23,517,719 common shares, respectively, were outstanding.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, the Company granted stock options to employees and contractors (see Note 10).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had reserved common shares for future issuances as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available under the 2018 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable on vesting of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available under the 2018 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,950,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;Warrants &lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In March 2017, the Company issued warrants for the purchase of 145,000 Class B ordinary shares to parties related to Rockport Ventures, with a fixed exercise price of $3.80 per share.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, no warrants were exercised. As of each of March&#160;31, 2021 and December&#160;31, 2020, 5,500 warrants to purchase the Company&#x2019;s common shares were outstanding and exercisable: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant Holder&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In Connection With&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant&#160;to Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rockport&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/3/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/28/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:StockholdersEquityNoteDisclosureTextBlock>
    <us-gaap:CommonStockSharesIssued
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjE2_5736161f-6ea9-4703-848c-8efc77e31d75"
      unitRef="shares">24094051</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesIssued
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjIz_707611d2-e463-4b33-83da-92bc3efdf638"
      unitRef="shares">23925789</us-gaap:CommonStockSharesIssued>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjcx_6208fb15-876f-40dc-8ee0-4e5e171441da"
      unitRef="shares">23685981</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:CommonStockSharesOutstanding
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfMjc4_7ddc69ff-3010-4961-9215-47c28561e260"
      unitRef="shares">23517719</us-gaap:CommonStockSharesOutstanding>
    <us-gaap:ScheduleOfStockByClassTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RleHRyZWdpb246ODk0MzY0NzRkMzhiNGM0MTg0NjIzZWQ0Nzg4M2VmYWNfNTE0_5996e527-42f0-440c-84fd-22767f716b6b">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company had reserved common shares for future issuances as follows:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:72.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;March 31,&lt;br/&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;December 31,&lt;br/&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available under the 2018 Equity Incentive Plan&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,079,873&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,641,112&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable on vesting of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Remaining shares available under the 2018 ESPP&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;661,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;474,000&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,950,223&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,182,196&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfStockByClassTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNC0xLTEtMS0w_39ddd3c2-df0a-4703-bc2a-69659174aa21"
      unitRef="shares">5500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="id90136f7b3494c6a9628a63b0d9d7b06_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNC0zLTEtMS0w_c6dea6ad-9cca-4d29-b2be-0fc9e4cd43a9"
      unitRef="shares">5500</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i1bd2c2bf38844a08b1d34482f0bd0b6d_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNS0xLTEtMS0w_b931cbd2-1e4a-4e48-81b4-394c49322aa7"
      unitRef="shares">2161165</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i5f2199649ba74639a58014d05b0e0980_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNS0zLTEtMS0w_35a69292-7753-41a3-807a-5f8763f8b9fa"
      unitRef="shares">2012960</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNi0xLTEtMS0w_2ccfa72b-4b7c-437a-b6de-0d9949400723"
      unitRef="shares">2079873</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i4983eb1dc3b54e3da8367f9521c63168_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNi0zLTEtMS0w_42342afb-5628-4e60-a145-379421fe8691"
      unitRef="shares">1641112</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i84d60646549649c5b45c4a188e368335_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNy0xLTEtMS0w_3da25a5f-6283-4077-94ee-5d7c3bfb1825"
      unitRef="shares">42685</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfNy0zLTEtMS0w_e626be60-285d-4cf1-8cf9-e70c8105ef89"
      unitRef="shares">48624</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ia2caa5751cee42809a8237b7da9369d9_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOC0xLTEtMS0w_5e3cc439-5ce9-4811-956c-3eeca76fcb73"
      unitRef="shares">661000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i2fa6b9cdd0424fd2946a54b840e1d4fb_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOC0zLTEtMS0w_7f561cb3-682e-4345-be20-cb83ca845633"
      unitRef="shares">474000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOS0xLTEtMS0w_d41b12db-e921-44cb-9b7b-37b5fdd42a4d"
      unitRef="shares">4950223</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81NS9mcmFnOjg5NDM2NDc0ZDM4YjRjNDE4NDYyM2VkNDc4ODNlZmFjL3RhYmxlOjZlM2Y0ZjVhMTFkMzRlMDJiNDExZTFkMDQ2MTU0NzM1L3RhYmxlcmFuZ2U6NmUzZjRmNWExMWQzNGUwMmI0MTFlMWQwNDYxNTQ3MzVfOS0zLTEtMS0w_2be476b4-2290-451e-9f89-61c1f79bbcf0"
      unitRef="shares">4182196</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
      contextRef="i247e8da1272d441ea7089934a2671ae9_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfNzU_2d6edb75-597e-4d8b-917d-5e302a2c8f70"
      unitRef="shares">145000</us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="idc6ad514225b434ea180652c54cb7361_I20170331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMTc0_9346ddcc-baf3-48ee-8af9-6c22db6bdbd4"
      unitRef="usdPerShare">3.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMzYz_f4515b80-1f48-418a-a39c-3ffbd0e1a80c">As of each of March&#160;31, 2021 and December&#160;31, 2020, 5,500 warrants to purchase the Company&#x2019;s common shares were outstanding and exercisable: &lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.079%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.795%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:17.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:16.362%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:7.258%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.989%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.546%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.083%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant Holder&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Issue Date&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;In Connection With&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Warrant&#160;to Purchase&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Expiration Date&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Rockport&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3/3/2017&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Loan agreement&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Common&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3.80&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;8/28/2022&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;/table&gt;</us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMjcy_df9629a1-2af0-4a99-861c-6b9cf15d2628"
      unitRef="shares">5500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="id90136f7b3494c6a9628a63b0d9d7b06_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RleHRyZWdpb246MjFmYjNiZmNjZTBhNGQ3NDhkZWUzYTY2N2QwNGNhZDlfMjcy_e084e9bd-7e80-44bc-aff8-b21befed2c38"
      unitRef="shares">5500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightOutstanding
      contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RhYmxlOjE3MWRlYWZlMjhhMTRkMjJhZTUwNGJjZmRiM2ViZjFkL3RhYmxlcmFuZ2U6MTcxZGVhZmUyOGExNGQyMmFlNTA0YmNmZGIzZWJmMWRfMi04LTEtMS0w_daa34a81-a979-4408-8ce6-b79508676e19"
      unitRef="shares">5500</us-gaap:ClassOfWarrantOrRightOutstanding>
    <us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
      contextRef="i0f4c0806d8b045fd8478b54e30beab7e_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF81OC9mcmFnOjIxZmIzYmZjY2UwYTRkNzQ4ZGVlM2E2NjdkMDRjYWQ5L3RhYmxlOjE3MWRlYWZlMjhhMTRkMjJhZTUwNGJjZmRiM2ViZjFkL3RhYmxlcmFuZ2U6MTcxZGVhZmUyOGExNGQyMmFlNTA0YmNmZGIzZWJmMWRfMi0xMC0xLTEtMA_7dd4e55e-3f8f-4ba6-82db-b513448e48c4"
      unitRef="usdPerShare">3.80</us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1>
    <us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0MQ_82601962-d0de-4791-82a8-e84101074565">Share-Based Compensation&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In December 2015, the Board of Directors approved and adopted the 2015 Equity Incentive Plan, or 2015 Plan. Pursuant to the 2015 Plan, the Company has granted RSAs and stock options to Board of Directors, employees and consultants.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2018, the Board of Directors terminated the 2015 Plan and approved the 2018 Equity Incentive Plan, or the 2018 Plan, with an initial reserve of 1,500,000 common shares. Under the 2018 Plan, the Company may grant stock options, equity appreciation rights, and restricted shares and restricted share units. If an award granted under the 2018 Plan expires, terminates, is unexercised, or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares become available for further awards under the 2018 Plan. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Pursuant to the &#x201c;evergreen&#x201d; provision contained in the 2018 Plan, the number of common shares reserved for issuance under the 2018 Plan automatically increases on first day of each fiscal year, commencing on January 1, 2019, in an amount equal to the least of (1) 750,000 shares, (2) 4% of the total number of the Company&#x2019;s common shares outstanding on the last day of the preceding fiscal year, or (3) a number of common shares as may be determined by the Company&#x2019;s Board of Directors prior to any such increase date. On each of January 1, 2019, 2020 and 2021 the number of common shares authorized for issuance increased automatically by 750,000 shares in accordance with the evergreen provision, increasing the number of common shares reserved under the 2018 Plan to 3,750,000 as of March 31, 2021.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the periods presented, the Company recorded the following share-based compensation expense for stock &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;options and restricted stock awards: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales, general and administrative &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted (weighted-average fair value of $38.55 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;As of March&#160;31, 2021, 857,094 options were vested and exercisable with weighted-average exercise price of $12.22&#160;per share and a total aggregate intrinsic value of $43.1&#160;million.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During the three months ended March&#160;31, 2021, 163,034 options were exercised at a weighted-average price of $11.54 per share. The intrinsic value of the options exercised during the three months ended March&#160;31, 2021 and 2020 was $7.3 million and $0.4&#160;million, respectively. Upon the exercise of stock options, the Company issued new shares from its authorized shares.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;At March&#160;31, 2021, unrecognized compensation expense was $19.0 million related to stock options granted to employees and Board of Directors and $2.5 million related to stock options granted to consultants. The weighted-average period over which such compensation expense will be recognized is 2.5 years. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options Granted to Employees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense for employees is based on the grant date fair value. The Company recognizes compensation expense for all share-based awards ratably on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years. During the three months ended March&#160;31, 2021 and 2020, the Company recognized $1.1 million and $0.6 million, respectively, of share-based compensation expense for stock options granted to employees.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company uses the Black-Scholes option valuation model to value options granted to employees and consultants, which requires the use of highly subjective assumptions to determine the fair value of share-based awards. The assumptions used in the Company&#x2019;s option-pricing model represent management&#x2019;s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management&#x2019;s judgment. If factors change and different assumptions are used, the Company&#x2019;s share-based compensation expense could be materially different in the future. The assumptions and estimates that the Company uses in the Black-Scholes model are as follows: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Fair Value of Common Shares.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; Following the Company&#x2019;s IPO in 2018, the closing price of the Company&#x2019;s publicly-traded common shares on the date of grant is used as the fair value of the shares. Prior to the &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;IPO, the fair value of ordinary shares was estimated on a periodic basis by the Company&#x2019;s Board of Directors, with the assistance of an independent third-party valuation firm.&#160;The Board of Directors intended all options granted to be exercisable at a price per share not less than the estimated per share fair value of the shares underlying those options on the date of grant.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Risk-Free Interest Rate.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company bases the risk-free interest rate used in the Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with a term equivalent to that of the term of the options for each option group on the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Term.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; For employee stock options, the expected term represents the period that the Company&#x2019;s share-based awards are expected to be outstanding. Because of the limitations on the sale or transfer of the Company&#x2019;s shares during the period the Company was a privately held company, the Company does not believe its historical exercise pattern is indicative of the pattern it will experience as a publicly traded company. The Company consequently uses the Staff Accounting Bulletin 110, or SAB 110, simplified method to calculate the expected term of employee stock options, which is the average of the contractual term and vesting period. The Company plans to continue to use the SAB 110 simplified method until it has sufficient trading history as a publicly traded company. For consultant stock options, the term used is equal to the remaining contractual term on the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Volatility.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The Company determines the price volatility based on the historical volatilities of industry peers as it does not have sufficient trading history for its shares. Industry peers consist of several public companies in the medical device industry with comparable characteristics, including revenue growth, operating model and working capital requirements. The Company intends to continue to consistently apply this process using the same or a similar peer group of public companies until a sufficient amount of historical information regarding the volatility of its own shares becomes available, or unless circumstances change such that the identified peer companies are no longer similar, in which case other suitable peer companies whose common share prices are publicly available would be utilized in the calculation. The volatility is calculated based on the term on the measurement date.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x25aa;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt"&gt;Dividend Yield.&lt;/span&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; The expected dividend assumption is based on the Company&#x2019;s current expectations about its anticipated dividend policy. The Company has no expectation that it will declare dividends on its common shares, and therefore has used an expected dividend yield of zero.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options granted to employees was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options Granted to Non-Employees &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Share-based compensation expense related to stock options granted to non-employees is recognized as the stock options are earned using an accelerated attribution method. The Company believes that the estimated fair value of the stock options is more readily measurable than the fair value of the services rendered. For the three months ended March&#160;31, 2021 and 2020, the Company recognized expense of $0.5 million and $0.8 million, respectively, for stock options granted to consultants. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Restricted Stock&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Each vested RSA entitles the holder to be issued one common share. These awards vest according to a vesting schedule determined by the Compensation Committee of the Company&#x2019;s Board of Directors, generally over a &lt;span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzU1OA_84b51ed7-33dc-4765-9c9e-ef71511b6db7"&gt;one&lt;/span&gt; to four year period.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents RSA activity for fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:24pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of restricted stock is the grant date market value of common shares. The Company recognizes share-based compensation expense related to restricted stock using a straight-line method over the vesting term of the awards. The share-based compensation expense for RSAs that vested during the three months ended March&#160;31, 2021 and 2020, was $0.2 million and $0.1 million, respectively, which was calculated based on the market value of the Company&#x2019;s common shares on the applicable date of vesting.&lt;/span&gt;&lt;/div&gt;As of March&#160;31, 2021, the Company had unrecognized share-based compensation cost of approximately $0.3 million associated with unvested restricted stock awards. This cost is expected to be recognized over a weighted-average period of approximately 0.5 years.</us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock>
    <us-gaap:CommonStockCapitalSharesReservedForFutureIssuance
      contextRef="ieda0ffc7bc7d4fa4861317378b2356ed_I20181231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMzkx_63e68f82-4ced-4c7a-b131-860ca355b2d1"
      unitRef="shares">1500000</us-gaap:CommonStockCapitalSharesReservedForFutureIssuance>
    <esta:IncreaseInCommonStockSharesAuthorized
      contextRef="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTE1MA_7d159225-d28f-4d39-90f2-4fd38060018e"
      unitRef="shares">750000</esta:IncreaseInCommonStockSharesAuthorized>
    <esta:CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent
      contextRef="i87fb0387087841b6b020b35c3bc5ad74_D20190101-20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTE2NQ_2970d93a-57ad-4eef-9664-f0c41729ce50"
      unitRef="number">0.04</esta:CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent>
    <esta:IncreaseInCommonStockSharesAuthorized
      contextRef="ic710cf1653d54d7ca3b69d821a4b86a5_I20190101"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTQ5OQ_2f5ae2a3-c8cd-492b-85ba-ca0e8159567a"
      unitRef="shares">750000</esta:IncreaseInCommonStockSharesAuthorized>
    <us-gaap:CommonStockSharesAuthorized
      contextRef="ie9268fd798a04e50bbfd63aafa1e5b19_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTY0MQ_67314a2b-da59-4953-9eec-e0548d5dd11f"
      unitRef="shares">3750000</us-gaap:CommonStockSharesAuthorized>
    <us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Ng_99e543e8-37a1-4f5f-9d0f-73f0295b931c">During the periods presented, the Company recorded the following share-based compensation expense for stock &lt;div style="margin-bottom:9pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;options and restricted stock awards: &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:73.602%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.804%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:10.806%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:3pt"&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Sales, general and administrative &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,146&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,307&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Research and development&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;611&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;322&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total &lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,757&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,629&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ia1ec09e636ce49e4903a5f3d5ac3e7c7_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNS02LTEtMS0w_8735b2e1-d5ea-48f8-b099-b8cf18c6fbc7"
      unitRef="usd">1146000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i986acae19ce84fab8f8d01f4ded6532e_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNS04LTEtMS0w_e222368d-71e5-4e45-8422-3fa46434efee"
      unitRef="usd">1307000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i1f351807ee89478e92c86e857311533d_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNi02LTEtMS0w_1f089a39-967b-4896-a4de-d22875b4daba"
      unitRef="usd">611000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="ie71a900e3d434bcab7ea26baa565deb4_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNi04LTEtMS0w_58d0b743-fe62-493d-9336-917053f2e172"
      unitRef="usd">322000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNy02LTEtMS0w_942700d8-f476-468a-881a-1252ec98a99b"
      unitRef="usd">1757000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmNlZWRkYWZlOGE1ZjQ0Yzc4Mzg2NTBiMTlkMTVhMmM1L3RhYmxlcmFuZ2U6Y2VlZGRhZmU4YTVmNDRjNzgzODY1MGIxOWQxNWEyYzVfNy04LTEtMS0w_bdcecfa1-39d7-4318-ba14-726045651374"
      unitRef="usd">1629000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Mw_573980d3-a1b6-431e-ac49-0ffa0dc6925f">&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Stock Options&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.553%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:52.263%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.811%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.547%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:9.816%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Number of Options Outstanding&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Exercise Price&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-Average Remaining Contractual Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Aggregate Intrinsic Value (in thousands)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,012,960&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;16.71&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.75&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,126&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted (weighted-average fair value of $38.55 per share)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;347,239&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;68.97&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Exercised&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(163,034)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.54&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(36,000)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;18.51&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Balances at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;2,161,165&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;25.47&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;7.94&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;82,375&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItNC0xLTEtMA_7a9cc3d7-0986-46e0-a8a2-bb9955ccdfcb"
      unitRef="shares">2012960</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItNi0xLTEtMA_cd40a378-d2d4-4c46-b97f-96ed0fe0582e"
      unitRef="usdPerShare">16.71</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItOC0xLTEtMA_bcae6f8f-90ab-422a-8730-a15574ad30aa">P7Y9M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="ib16374b323b64d7eb6f72c7a60281d29_I20201231"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTItMTAtMS0xLTA_f10bfe0c-164a-420d-8a56-3095fc3626bd"
      unitRef="usd">42126000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtMC0xLTEtMC90ZXh0cmVnaW9uOjk5ODY0NjU0NWRlNTQzNzViOTE4N2NlY2E5NWZmNTk0XzQ0_8f348e3f-72fe-4c78-9b56-b984ebf1c49d"
      unitRef="usdPerShare">38.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtNC0xLTEtMA_edfe4a7b-16b5-4b59-9a02-b6887af27a06"
      unitRef="shares">347239</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTMtNi0xLTEtMA_57b88594-78a4-42df-b6a5-795aad7a4540"
      unitRef="usdPerShare">68.97</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTQtNC0xLTEtMA_b93f5081-f28e-4c18-bc11-d50646e1095e"
      unitRef="shares">163034</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTQtNi0xLTEtMA_0b5e9c16-24b3-4652-bdc5-494adcb0d0e6"
      unitRef="usdPerShare">11.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTUtNC0xLTEtMA_2ba11e5c-8934-4b95-a3fd-43854340d6a6"
      unitRef="shares">36000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTUtNi0xLTEtMA_291ae026-95fb-4096-834f-a5911fe21313"
      unitRef="usdPerShare">18.51</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtNC0xLTEtMA_859fcbb4-90e3-4375-8933-e66a6e8123e4"
      unitRef="shares">2161165</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtNi0xLTEtMA_1b7ee25d-5f00-4c9c-99d7-28496fa14191"
      unitRef="usdPerShare">25.47</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtOC0xLTEtMA_8429a3ec-9935-4177-b002-f92374c14a03">P7Y11M8D</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjZhZGZmNDE3NTIwNzRhZjA5MzUwZGYzZTUzMmVkNzVmL3RhYmxlcmFuZ2U6NmFkZmY0MTc1MjA3NGFmMDkzNTBkZjNlNTMyZWQ3NWZfMTYtMTAtMS0xLTA_201e319c-0ca7-412c-b69e-b553266b20e9"
      unitRef="usd">82375000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTgxOQ_22e842a6-7d7e-4505-bb7c-57767f6ea38c"
      unitRef="shares">857094</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTg5OA_3c88a04d-161c-4bfb-9b95-ab23c8964129"
      unitRef="usdPerShare">12.22</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTk1Mg_8121a6c6-d356-484d-8fe8-d3f5424174fd"
      unitRef="usd">43100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue>
    <us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMTk4Nw_2e76a316-c0d2-4cd9-bc1b-c86186052574"
      unitRef="shares">163034</us-gaap:StockIssuedDuringPeriodSharesStockOptionsExercised>
    <us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjA0NA_ecec9830-6229-4f52-8504-ecb68ae4feb9"
      unitRef="usdPerShare">11.54</us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjEzNw_d6ad1c90-e898-4f40-b32a-5e8c06f42aa1"
      unitRef="usd">7300000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMzI5ODUzNDg5MTgxOQ_bf3ac2e0-1e4b-44e2-87a7-2bfb1c351fe1"
      unitRef="usd">400000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
      contextRef="i220c6103ff954277ae7622703799d5e7_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjI4MA_7a007f78-d7f2-4e29-bd38-1b49ba67a7af"
      unitRef="usd">19000000.0</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions>
    <esta:NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions
      contextRef="ie0fdf8bc2e1e409db1472911b124d683_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjM1Ng_177a4da6-1100-4db6-a05c-14e40cff1372"
      unitRef="usd">2500000</esta:NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions>
    <esta:EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjQ5NQ_7afe58f2-3878-40bc-8f4e-6b868a9ba33a">P2Y6M</esta:EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i15b02aa6633a436480804341634e94d3_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjgxNA_a531427d-2cb5-415f-b43b-026bb37eef2f">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i15b02aa6633a436480804341634e94d3_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjg3OQ_55a6d348-1e4b-4ba0-8855-7733c334925b"
      unitRef="usd">1100000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:AllocatedShareBasedCompensationExpense
      contextRef="i478c73ce4642455cba1f5dffb0d3782a_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfMjg4Ng_579343de-a8af-498a-8d1e-82a7ec9ea6a9"
      unitRef="usd">600000</us-gaap:AllocatedShareBasedCompensationExpense>
    <us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0Nw_930d983c-44cb-4443-9fc0-4942936f56e8">&lt;div style="margin-bottom:12pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options granted to employees was estimated using the following assumptions:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.050%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.399%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:12.761%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;55%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;0.7% - 1.1%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.5%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;6.25&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:68.497%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.356%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.545%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.357%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Volatility&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;60%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;56%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Risk-free interest rate&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1.6%&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Term (in years)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Dividend yield&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfMy0yLTEtMS0wL3RleHRyZWdpb246MjBiY2RlMDUzNzUxNGQ1YmIxZDE4OWYyOWQwMGE1ZmJfOQ_5b658956-7779-4fd2-80b2-134779161526"
      unitRef="number">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfMy00LTEtMS0wL3RleHRyZWdpb246NDg2MjFkNjU4ZWRhNDBkYmI3MzNlOTA4Nzc3ODlhOTdfNA_fd6987f5-2db4-4a75-8a39-648474597ac2"
      unitRef="number">0.55</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
      contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQxMTExMDQ2N2M0NDkxNmEwYzI2N2EzOGE2YmIxNjNfNA_380c5721-80ed-47cb-b581-b3dfccc8ab81"
      unitRef="number">0.007</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
      contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQxMTExMDQ2N2M0NDkxNmEwYzI2N2EzOGE2YmIxNjNfOQ_261c2346-5ff9-4eb9-8d1a-1ecd0370588b"
      unitRef="number">0.011</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNC00LTEtMS0wL3RleHRyZWdpb246ZjhhYjVhNGM4Njc1NDM1M2E2NmFiOTI0NWNhMDZhYThfNA_42f0697d-0209-4c25-8a0f-5fa2fca8e4ab"
      unitRef="number">0.015</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNS0yLTEtMS0w_bdfd26cc-22d1-4c85-957c-490b01f04528">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNS00LTEtMS0w_399bb030-2c4a-4331-be80-a342320dbdd9">P6Y3M</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i6da5c159d78d49d8b73902bb14537731_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNi0yLTEtMS0w_94350bc5-258a-4d46-85d6-0f152aff1c28"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ic68469141fd244179893ceb45866a4a1_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOmFkOTYxNzM4NGIyZDQxN2NiZGVlYmE3MzVkZjdjY2QzL3RhYmxlcmFuZ2U6YWQ5NjE3Mzg0YjJkNDE3Y2JkZWViYTczNWRmN2NjZDNfNi00LTEtMS0w_f4a780a2-0d26-46c1-ae46-35e9e907c032"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="ia2edc59bec53490994496014ae3b59a2_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzExOA_4b9af80c-79d0-4080-b0aa-064911d22bf6"
      unitRef="usd">500000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims
      contextRef="ic6df5fcf8c8343ea957122278a45e96b_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzEyNQ_58663800-7adf-4831-a3e1-d1b4f9bb89f8"
      unitRef="usd">800000</us-gaap:IssuanceOfStockAndWarrantsForServicesOrClaims>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfMy0yLTEtMS0wL3RleHRyZWdpb246MTcxNDNjZDA0MDBiNDI3ZGE4ZWJkYTlhYmNjNjFmMmJfOQ_af9bca82-ae3a-4798-b526-44c9038b0051"
      unitRef="number">0.60</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
      contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfMy00LTEtMS0w_abb8aa70-26b4-4e9d-8c5f-cd6260427a98"
      unitRef="number">0.56</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNC0yLTEtMS0wL3RleHRyZWdpb246MGQ0ZTNiYjEzMGNkNGIwM2E0NTQzZDU1YTkzNzgwMDlfOQ_af9b6725-f955-4cad-89f0-d78c76e5a2dc"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
      contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331"
      decimals="3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNC00LTEtMS0w_2f27ff71-ac8c-4ea0-a3bc-70d8068ad806"
      unitRef="number">0.016</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNS0yLTEtMS0w_932ae5bb-4cf6-445f-8e49-b678221f124a">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
      contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNS00LTEtMS0w_8904b399-188f-42b3-b236-e2d48b028c2c">P10Y</us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNi0yLTEtMS0w_72f1e511-ff31-4b97-9df0-8d2fdc29dd7e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
      contextRef="ia83652eb9bcb44d9b91b9226519e077a_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjI2N2M4ODVlZjYxNTRjNmE5MThjOTgxYzEzOTY5NzBjL3RhYmxlcmFuZ2U6MjY3Yzg4NWVmNjE1NGM2YTkxOGM5ODFjMTM5Njk3MGNfNi00LTEtMS0w_48e3ccc4-fe63-4578-b686-b83a67b1756e"
      unitRef="number">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="ic880ec3a676b4f12a08eb325a02676fa_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0NQ_a82cf4cf-bc61-47b6-9941-b26ec49e35e7">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODM0MA_ba424f3d-c5b2-4057-8740-61f274889596">&lt;div style="margin-bottom:9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table represents RSA activity for fiscal 2021:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:71.519%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.846%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:11.847%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:14pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Restricted Stock Awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Weighted-&lt;br/&gt;Average&lt;br/&gt;Grant Date&lt;br/&gt;Fair Value&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding unvested at December 31, 2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;48,624&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.32&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Granted&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Vested&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(5,939)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;13.31&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Forfeited/canceled&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Outstanding unvested at March 31, 2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;11.04&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTAtMi0xLTEtMA_a7e12373-c27f-4ef7-8e81-16a1f106f6d9"
      unitRef="shares">48624</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i13079f6ba18c4ea6bd64156a196823ad_I20201231"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTAtNC0xLTEtMA_bf55b0bf-5222-4136-b34d-df1b18dbadd4"
      unitRef="usdPerShare">11.32</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTEtMi0xLTEtMA_1e5cc610-4f1e-4f04-86fb-428352636b20"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTEtNC0xLTEtMA_9a56ae78-8530-4fac-be2c-9373abf5d2bd"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTItMi0xLTEtMA_0e8e143e-8128-4f75-b425-b9fb8be402a8"
      unitRef="shares">5939</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTItNC0xLTEtMA_b08cb203-9b95-4524-b202-582d219c763e"
      unitRef="usdPerShare">13.31</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTMtMi0xLTEtMA_47c1124d-07b3-44f0-a412-d66fb5200f51"
      unitRef="shares">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTMtNC0xLTEtMA_ee684605-9368-4bea-aadc-d14715d7be56"
      unitRef="usdPerShare">0</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
      contextRef="i84d60646549649c5b45c4a188e368335_I20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTQtMi0xLTEtMA_56c56fe5-7c04-4384-80be-d3aa1b6266d1"
      unitRef="shares">42685</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
      contextRef="i84d60646549649c5b45c4a188e368335_I20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RhYmxlOjhjMGI1MTI0ZGZmNjRiZWNhMjI1ODRhMGNjOGMwYThkL3RhYmxlcmFuZ2U6OGMwYjUxMjRkZmY2NGJlY2EyMjU4NGEwY2M4YzBhOGRfMTQtNC0xLTEtMA_13a95c2c-4b9d-4fa1-8423-224b1e3d58ab"
      unitRef="usdPerShare">11.04</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzk3Nw_8d4032e8-990f-480e-a8ac-16885b443f56"
      unitRef="usd">200000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue
      contextRef="i2bfc12cdfee24225bc3c5d74083ada83_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzk4NA_eb471c99-3353-4947-ada0-b763f9a7dec3"
      unitRef="usd">100000</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions
      contextRef="i84d60646549649c5b45c4a188e368335_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODE5Mg_7c7c34b3-4d2a-4802-8488-6d5d2d54d086"
      unitRef="usd">300000</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions>
    <us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
      contextRef="i2d8c6fe88898417ea52ebf55f16e4552_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfODMzMg_47fe8328-1c35-4f70-9e7e-b2c49ea2335f">P0Y6M</us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1>
    <us-gaap:EarningsPerShareTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTAy_e5a72520-1386-4e89-9b0d-f175d8c16fcf">Net Loss Per Share&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the computation of basic and diluted net loss per share for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares used for basic and diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,827,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,456,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and dilutive share equivalents outstanding for the period, determined using the treasury-share method and the as-if converted method, for convertible securities, if inclusion of these is dilutive&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6.25pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;If the Company reports a net loss&lt;/span&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, diluted net loss per share is the same as basic net loss per share for those periods because including the dilutive securities would be anti-dilutive.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:9pt;margin-top:8.3pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable on vesting of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,949,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:EarningsPerShareTextBlock>
    <us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTAz_60b0834a-df31-4e19-88c0-faff227b2904">&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table summarizes the computation of basic and diluted net loss per share for the periods presented:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:69.138%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.036%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:13.038%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;(in thousands, except share and per share data)&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Numerator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Net loss&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(6,948)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(17,753)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Denominator:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Weighted average common shares used for basic and diluted earnings per share&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;23,827,137&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;22,456,365&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;Loss per share:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="padding-left:20.25pt;text-indent:-9pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Basic and diluted&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.29)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;$&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;(0.79)&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr style="height:18pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock>
    <us-gaap:NetIncomeLoss
      contextRef="i35ea6c6335504fcab590f0465e6d62c5_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi01LTEtMS0w_aaf5c59e-a7d0-4b99-bd42-4eb4a8458caa"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi01LTEtMS0w_e52cb721-7370-454d-94fa-56383aa1257a"
      unitRef="usd">-6948000</us-gaap:NetIncomeLoss>
    <us-gaap:NetIncomeLoss
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="-3"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfNi03LTEtMS0w_ef1bacbe-ecde-4483-9a94-2223bfbb2136"
      unitRef="usd">-17753000</us-gaap:NetIncomeLoss>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfOC01LTEtMS0w_3b8f333e-0fdf-492c-a099-5e0bce6ef8ee"
      unitRef="shares">23827137</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfOC03LTEtMS0w_f667509d-60dd-48cb-a123-b1786cf8d5a7"
      unitRef="shares">22456365</us-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfMTItNS0xLTEtMA_d5c0fd0d-3446-4868-803a-7b5afacd668a"
      unitRef="usdPerShare">-0.29</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:EarningsPerShareBasicAndDiluted
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="2"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOjZhZTRhZTc2NjhiOTRjZWQ4Mzc4NWI5ZGM0NTc3ZWI2L3RhYmxlcmFuZ2U6NmFlNGFlNzY2OGI5NGNlZDgzNzg1YjlkYzQ1NzdlYjZfMTItNy0xLTEtMA_cc7a9a60-7e42-4301-afdc-4a2222f2e66a"
      unitRef="usdPerShare">-0.79</us-gaap:EarningsPerShareBasicAndDiluted>
    <us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RleHRyZWdpb246ZmRkYTVkYjYwMjNhNDhiNzk1Yjc1MzFiOGU1MjBlNDdfOTA2_7049fff6-7c3e-440d-bcd1-7ad0ac532d26">&lt;div style="margin-bottom:9pt;margin-top:8.3pt"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares:&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:67.203%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.376%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:0.544%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;td style="width:1.0%"/&gt;&lt;td style="width:14.377%"/&gt;&lt;td style="width:0.1%"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Three Months Ended March 31,&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;td colspan="3" style="display:none"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Options to purchase common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,900,825&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,632,871&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Shares issuable on vesting of restricted stock awards&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;42,685&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;108,472&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Warrants to purchase common shares&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;5,500&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;Total&lt;/span&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,949,010&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"/&gt;&lt;td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;1,746,843&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/&gt;&lt;td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i695c26f28c134a87811302e003a58006_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNC0xLTEtMS0w_4154eda3-24b7-40a0-9226-37398045162d"
      unitRef="shares">1900825</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i07c8793eb73f4c988ba24cd20e54c766_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNC0zLTEtMS0w_a16b9bfc-e5e7-4535-a5d7-bd7df2b42978"
      unitRef="shares">1632871</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i99e5a665c04f40eca5f9a0b3a98ca5a4_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNS0xLTEtMS0w_fb737923-92dc-463c-a855-b1fa670eaf64"
      unitRef="shares">42685</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="icbb360d504184d689fa5022115013737_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNS0zLTEtMS0w_641fdab5-f634-4094-9be4-5b1ad2649708"
      unitRef="shares">108472</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i4915579cae994b35a1b781ee5e5104d7_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNi0xLTEtMS0w_877227bf-e7a8-43b7-9f84-7c88697b927f"
      unitRef="shares">5500</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i52d7890a8568427a9a9331d06f4f7f6e_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNi0zLTEtMS0w_561fec8f-5f31-41ab-bd09-184377931c07"
      unitRef="shares">5500</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNy0xLTEtMS0w_957a5b51-adfb-4561-8d4d-356461cbe4fd"
      unitRef="shares">1949010</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
      contextRef="i46791cd043814a93a5a8b1a653b25836_D20200101-20200331"
      decimals="0"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82Ny9mcmFnOmZkZGE1ZGI2MDIzYTQ4Yjc5NWI3NTMxYjhlNTIwZTQ3L3RhYmxlOmEzYzUzMGM2NzA1MTQyZTViYzYyOTY5NjNkZTY2MGViL3RhYmxlcmFuZ2U6YTNjNTMwYzY3MDUxNDJlNWJjNjI5Njk2M2RlNjYwZWJfNy0zLTEtMS0w_4697708f-f838-4d51-b64a-20f605627afa"
      unitRef="shares">1746843</us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount>
    <us-gaap:RelatedPartyTransactionsDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTU1OA_1c710b80-7298-4691-aa63-314f12bc10bf">Related Party Transactions&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;During each of the three months ended March&#160;31, 2021 and 2020, the Company recorded revenue of $0.2 million for product sales to Herramientas Medicas, S.A., a distribution company owned by a family member of the Chief Executive Officer of the Company. Accounts receivable owed to the Company from this distribution company amounted to approximately $0.2 million for each of March&#160;31, 2021 and December&#160;31, 2020. &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In 2016, the Company entered into a scientific board advisory agreement with Dr. Manuel Enrique Chac&#xf3;n Quir&#xf3;s, the brother of our Chief Executive Officer, Juan Jos&#xe9; Chac&#xf3;n Quir&#xf3;s, pursuant to which Dr. Chac&#xf3;n Quir&#xf3;s joined the Company&#x2019;s Scientific Advisory Board, provided general scientific advice, and served as a clinical investigator, among other services. In exchange for these services, Dr. Chac&#xf3;n Quir&#xf3;s was granted options to purchase &lt;/span&gt;&lt;/div&gt;20,580 shares. The grant vested over four years in equal annual installments. Dr. Chac&#xf3;n Quir&#xf3;s resigned from the Company&#x2019;s Scientific Advisory Board in November 2019.In 2016, the Company also entered into a separate agreement with Dr.&#160;Chac&#xf3;n Quir&#xf3;s to maintain his clinic in Costa Rica as a MotivaImagine Excellence Center and to host and train physicians in the use of the Company products in relevant procedures, among other services, in exchange for cash reimbursement of up to $4,500 per day that such services are rendered. In December 2020, Dr. Chac&#xf3;n Quir&#xf3;s was granted options to purchase 22,068 shares vesting over four years in equal annual installments, provided that he continues to provide these services at such times. During the three months ended March&#160;31, 2021 and 2020, the Company paid Dr. Chac&#xf3;n Quir&#xf3;s approximately $93,000 and $20,000, respectively, for services rendered.</us-gaap:RelatedPartyTransactionsDisclosureTextBlock>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfOTA_8a26a421-2ce2-4849-b4bf-2dac6a105c6d"
      unitRef="usd">200000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:RevenueFromRelatedParties
      contextRef="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfOTA_90e94c7d-a301-4d2e-bfcf-70a2276e9142"
      unitRef="usd">200000</us-gaap:RevenueFromRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="i8874a1e19376447fbb0ebf1b8cb9d361_I20201231"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzQx_7c62fdbf-8e2e-4477-9acd-1219cf636ad6"
      unitRef="usd">200000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:AccountsReceivableRelatedParties
      contextRef="id7adeaf0b41a4c8289f265e3a67c7204_I20210331"
      decimals="-5"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzQx_88966b81-1c4a-4ffa-afb8-b6b741629db6"
      unitRef="usd">200000</us-gaap:AccountsReceivableRelatedParties>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfNzUz_4d1f5fce-b995-4fb5-be82-bc90dd237025"
      unitRef="shares">20580</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i5d669e2fca0843b0bd72b82094f9185b_D20160101-20161231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfNzc3_58e73340-68b0-41cd-bb66-99093bce7e70">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <esta:RelatedPartyTransactionCashReimbursementPerDayForServices
      contextRef="if841a633a7064c10a7ea55273d751563_I20161231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTE5OA_fbc4fd85-791c-4986-afc2-4e5d347acec6"
      unitRef="usd">4500</esta:RelatedPartyTransactionCashReimbursementPerDayForServices>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
      contextRef="i29f43ea253394bd380b244709b366727_D20201201-20201231"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzI5ODUzNDg4NTU0NA_6aae8238-392f-4299-8e22-cb752ab9e369"
      unitRef="shares">22068</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross>
    <us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1
      contextRef="i29f43ea253394bd380b244709b366727_D20201201-20201231"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMzI5ODUzNDg4NTU1MQ_1a14f182-6e13-4f29-a2e8-2101ee26fcb2">P4Y</us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTUwOQ_a482b48b-1e4c-4520-8949-679bbafaaa50"
      unitRef="usd">93000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
      contextRef="i4c277f7db95b46428d3624fc96650a72_D20200101-20200331"
      decimals="INF"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF83MC9mcmFnOjE4NWM3MmRmZTA1MjRlMDhiNzQ4MWRiNzc4NDRhMzIxL3RleHRyZWdpb246MTg1YzcyZGZlMDUyNGUwOGI3NDgxZGI3Nzg0NGEzMjFfMTUxNg_72900c13-0b42-4d77-813f-3a5ffa4f7de3"
      unitRef="usd">20000</us-gaap:RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty>
    <us-gaap:CommitmentsAndContingenciesDisclosureTextBlock
      contextRef="i9d8ea79494ab42e4843111748f602625_D20210101-20210331"
      id="id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8xMzMzL2ZyYWc6ZTA0YjhiYmY0MDQ2NDU1YjliYzY4N2IwNTg4OWMwNzcvdGV4dHJlZ2lvbjplMDRiOGJiZjQwNDY0NTViOWJjNjg3YjA1ODg5YzA3N180OTQ3ODAyMzI4NzU3_ff9dd3ca-8ae7-4475-a3e0-7fa2e3e96074">Commitments and Contingencies&lt;div style="margin-bottom:3pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"&gt;Contingencies&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;Periodically, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual or disclosure at March&#160;31, 2021 and 2020 except for contingent equity consideration related to past asset acquisitions as of March 31, 2020.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt;margin-top:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%"&gt;Indemnification&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#x2019;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-bottom:6pt"&gt;&lt;span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.&lt;/span&gt;&lt;/div&gt;</us-gaap:CommitmentsAndContingenciesDisclosureTextBlock>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799467032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover - shares<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>May 05, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">10-Q<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentQuarterlyReport', window );">Document Quarterly Report</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 31,  2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentTransitionReport', window );">Document Transition Report</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38593<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Establishment Labs Holdings Inc.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">D8<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">Building B15 and 25<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Coyol Free Zone<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alajuela<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CountryRegion', window );">Country Region</a></td>
<td class="text">506<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">24<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">34 2400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCurrentReportingStatus', window );">Entity Current Reporting Status</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityInteractiveDataCurrent', window );">Entity Interactive Data Current</a></td>
<td class="text">Yes<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFilerCategory', window );">Entity Filer Category</a></td>
<td class="text">Non-accelerated Filer<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntitySmallBusiness', window );">Entity Small Business</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">true<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityExTransitionPeriod', window );">Entity Ex Transition Period</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityShellCompany', window );">Entity Shell Company</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Shares, No Par Value<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">ESTA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCommonStockSharesOutstanding', window );">Entity Common Stock, Shares Outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,687,808<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CurrentFiscalYearEndDate', window );">Current Fiscal Year End Date</a></td>
<td class="text">--12-31<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001688757<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalYearFocus', window );">Document Fiscal Year Focus</a></td>
<td class="text">2021<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentFiscalPeriodFocus', window );">Document Fiscal Period Focus</a></td>
<td class="text">Q1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CountryRegion">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Region code of country</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CountryRegion</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CurrentFiscalYearEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>End date of current fiscal year in the format --MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CurrentFiscalYearEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gMonthDayItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalPeriodFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalPeriodFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fiscalPeriodItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentFiscalYearFocus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentFiscalYearFocus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:gYearItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentQuarterlyReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as an quarterly report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 10-Q<br> -Number 240<br> -Section 308<br> -Subsection a<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentQuarterlyReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentTransitionReport">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true only for a form used as a transition report.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Forms 10-K, 10-Q, 20-F<br> -Number 240<br> -Section 13<br> -Subsection a-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentTransitionReport</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCurrentReportingStatus">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCurrentReportingStatus</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityExTransitionPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 7A<br> -Section B<br> -Subsection 2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityExTransitionPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFilerCategory">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFilerCategory</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:filerCategoryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInteractiveDataCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-T<br> -Number 232<br> -Section 405<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInteractiveDataCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:yesNoItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityShellCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityShellCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntitySmallBusiness">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates that the company is a Smaller Reporting Company (SRC).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntitySmallBusiness</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875559864">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Balance Sheets - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrentAbstract', window );"><strong>Current assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Cash', window );">Cash</a></td>
<td class="nump">$ 77,950<span></span>
</td>
<td class="nump">$ 84,523<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableNetCurrent', window );">Accounts receivable, net of allowance for doubtful accounts of $1,121 and $1,143</a></td>
<td class="nump">23,777<span></span>
</td>
<td class="nump">19,127<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">22,377<span></span>
</td>
<td class="nump">23,210<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">4,194<span></span>
</td>
<td class="nump">5,439<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsCurrent', window );">Total current assets</a></td>
<td class="nump">128,298<span></span>
</td>
<td class="nump">132,299<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetsNoncurrentAbstract', window );"><strong>Long-term assets:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property and equipment, net of accumulated depreciation</a></td>
<td class="nump">16,321<span></span>
</td>
<td class="nump">16,202<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Goodwill</a></td>
<td class="nump">465<span></span>
</td>
<td class="nump">465<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Intangible assets, net of accumulated amortization</a></td>
<td class="nump">4,126<span></span>
</td>
<td class="nump">4,148<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets, net</a></td>
<td class="nump">2,511<span></span>
</td>
<td class="nump">2,610<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAssetsNoncurrent', window );">Other non-current assets</a></td>
<td class="nump">628<span></span>
</td>
<td class="nump">664<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Assets', window );">Total assets</a></td>
<td class="nump">152,349<span></span>
</td>
<td class="nump">156,388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrentAbstract', window );"><strong>Current liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableCurrent', window );">Accounts payable</a></td>
<td class="nump">8,994<span></span>
</td>
<td class="nump">9,722<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">14,408<span></span>
</td>
<td class="nump">14,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities, short-term</a></td>
<td class="nump">1,431<span></span>
</td>
<td class="nump">1,646<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesCurrent', window );">Total current liabilities</a></td>
<td class="nump">24,833<span></span>
</td>
<td class="nump">25,900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesNoncurrentAbstract', window );"><strong>Long-term liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebtNoncurrent', window );">Note payable, Madryn, net of debt discount and issuance costs</a></td>
<td class="nump">50,305<span></span>
</td>
<td class="nump">49,832<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilitiesNoncurrent', window );">Madryn put option</a></td>
<td class="nump">1,210<span></span>
</td>
<td class="nump">1,440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">1,630<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, long-term</a></td>
<td class="nump">1,820<span></span>
</td>
<td class="nump">2,332<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Liabilities', window );">Total liabilities</a></td>
<td class="nump">79,798<span></span>
</td>
<td class="nump">81,427<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingencies', window );">Commitments and contingencies (Note 13)</a></td>
<td class="text"> <span></span>
</td>
<td class="text"> <span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityAbstract', window );"><strong>Shareholders&#8217; equity:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockValue', window );">Common shares - zero par value, unlimited amount authorized; 24,094,051 and 23,925,789 shares issued at March 31, 2021 and December 31, 2020, respectively; 23,685,981 and 23,517,719 shares outstanding at March 31, 2021 and December 31, 2020, respectively</a></td>
<td class="nump">215,358<span></span>
</td>
<td class="nump">213,471<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdditionalPaidInCapital', window );">Additional paid-in-capital</a></td>
<td class="nump">28,427<span></span>
</td>
<td class="nump">26,717<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockValue', window );">Treasury shares, at cost, 408,070 shares held at March 31, 2021 and December 31, 2020</a></td>
<td class="num">(2,854)<span></span>
</td>
<td class="num">(2,854)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RetainedEarningsAccumulatedDeficit', window );">Accumulated deficit</a></td>
<td class="num">(172,194)<span></span>
</td>
<td class="num">(165,246)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax', window );">Accumulated other comprehensive income</a></td>
<td class="nump">3,814<span></span>
</td>
<td class="nump">2,873<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Total shareholders&#8217; equity</a></td>
<td class="nump">72,551<span></span>
</td>
<td class="nump">74,961<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LiabilitiesAndStockholdersEquity', window );">Total liabilities and shareholders&#8217; equity</a></td>
<td class="nump">$ 152,349<span></span>
</td>
<td class="nump">$ 156,388<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableNetCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4428-111522<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121593590&amp;loc=d3e4531-111522<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableNetCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e637-108580<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14A<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669686-108580<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e681-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdditionalPaidInCapital">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdditionalPaidInCapital</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Assets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(12))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Assets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6801-107765<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetsNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetsNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Cash">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631418-115840<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 210<br> -Section 45<br> -Paragraph 21<br> -URI http://asc.fasb.org/extlink&amp;oid=118262064&amp;loc=SL116631419-115840<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Cash</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingencies">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.25)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03.(a),19)<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121557415&amp;loc=d3e14326-108349<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingencies</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Liabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19-26)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Liabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesAndStockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(23))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(25))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(32))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesAndStockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (bb)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=116870748&amp;loc=SL6758485-165988<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.21)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559654&amp;loc=d3e5710-111685<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesCurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesCurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LiabilitiesNoncurrentAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LiabilitiesNoncurrentAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebtNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebtNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAssetsNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAssetsNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PrepaidExpenseAndOtherAssetsCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(7))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PrepaidExpenseAndOtherAssetsCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RetainedEarningsAccumulatedDeficit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cumulative amount of the reporting entity's undistributed earnings or deficit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 65<br> -Paragraph 15<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121322162&amp;loc=SL121327923-165333<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(23)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (h)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 40<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=121370832&amp;loc=SL117420844-207641<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RetainedEarningsAccumulatedDeficit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=6405834&amp;loc=d3e23315-112656<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794739384">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Consolidated Balance Sheets (Parenthetical) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfFinancialPositionAbstract', window );"><strong>Statement of Financial Position [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent', window );">Allowance for doubtful accounts</a></td>
<td class="nump">$ 1,121<span></span>
</td>
<td class="nump">$ 1,143<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">24,094,051<span></span>
</td>
<td class="nump">23,925,789<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">23,685,981<span></span>
</td>
<td class="nump">23,517,719<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_TreasuryStockShares', window );">Treasury stock, shares held (in shares)</a></td>
<td class="nump">408,070<span></span>
</td>
<td class="nump">408,070<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss on accounts receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5074-111524<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfFinancialPositionAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfFinancialPositionAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_TreasuryStockShares">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29,30)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6405813&amp;loc=d3e23239-112655<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_TreasuryStockShares</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210877917720">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Operations - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementAbstract', window );"><strong>Income Statement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 30,336<span></span>
</td>
<td class="nump">$ 24,481<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CostOfRevenue', window );">Cost of revenue</a></td>
<td class="nump">10,246<span></span>
</td>
<td class="nump">9,003<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GrossProfit', window );">Gross profit</a></td>
<td class="nump">20,090<span></span>
</td>
<td class="nump">15,478<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpensesAbstract', window );"><strong>Operating expenses:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Sales, general and administrative</a></td>
<td class="nump">18,138<span></span>
</td>
<td class="nump">18,984<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpense', window );">Research and development</a></td>
<td class="nump">4,048<span></span>
</td>
<td class="nump">4,199<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingExpenses', window );">Total operating expenses</a></td>
<td class="nump">22,186<span></span>
</td>
<td class="nump">23,183<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingIncomeLoss', window );">Loss from operations</a></td>
<td class="num">(2,096)<span></span>
</td>
<td class="num">(7,705)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InvestmentIncomeInterest', window );">Interest income</a></td>
<td class="nump">4<span></span>
</td>
<td class="nump">8<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpense', window );">Interest expense</a></td>
<td class="num">(2,195)<span></span>
</td>
<td class="num">(2,146)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax', window );">Change in fair value of derivative instruments</a></td>
<td class="nump">230<span></span>
</td>
<td class="num">(1,929)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNonoperatingIncomeExpense', window );">Other expense, net</a></td>
<td class="num">(2,726)<span></span>
</td>
<td class="num">(6,190)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest', window );">Loss before income taxes</a></td>
<td class="num">(6,783)<span></span>
</td>
<td class="num">(17,522)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxExpenseBenefit', window );">Provision for income taxes</a></td>
<td class="num">(165)<span></span>
</td>
<td class="num">(231)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (6,948)<span></span>
</td>
<td class="num">$ (17,753)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted net loss per share (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted average outstanding shares used for basic and diluted net loss per share (in shares)</a></td>
<td class="nump">23,827,137<span></span>
</td>
<td class="nump">22,456,365<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CostOfRevenue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate cost of goods produced and sold and services rendered during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CostOfRevenue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnDerivativeInstrumentsNetPretax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5618551-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnDerivativeInstrumentsNetPretax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GrossProfit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1,2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GrossProfit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 940<br> -SubTopic 20<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=68072869&amp;loc=d3e41242-110953<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(10))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 235<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-05(b)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399901&amp;loc=d3e537907-122884<br><br>Reference 9: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxExpenseBenefit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB TOPIC 6.I.7)<br> -URI http://asc.fasb.org/extlink&amp;oid=116825942&amp;loc=d3e330036-122817<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32672-109319<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (h)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(h))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120385591&amp;loc=d3e38679-109324<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(9))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxExpenseBenefit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6450988&amp;loc=d3e26243-108391<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (210.5-03(11))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InvestmentIncomeInterest">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.7(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InvestmentIncomeInterest</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpenses">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpenses</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingExpensesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingExpensesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net result for the period of deducting operating expenses from operating revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNonoperatingIncomeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of income (expense) related to nonoperating activities, classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.9)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNonoperatingIncomeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 985<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6501960&amp;loc=d3e128462-111756<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>R5.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800005384">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Comprehensive Income (Loss) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract', window );"><strong>Statement of Comprehensive Income [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (6,948)<span></span>
</td>
<td class="num">$ (17,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract', window );"><strong>Other comprehensive income:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent', window );">Other comprehensive gain</a></td>
<td class="nump">941<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomeNetOfTax', window );">Comprehensive loss</a></td>
<td class="num">$ (6,007)<span></span>
</td>
<td class="num">$ (14,932)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomeNetOfTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=d3e557-108580<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(26))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomeNetOfTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax of other comprehensive income (loss) attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>R6.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210801049544">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Condensed Consolidated Statement of Shareholders&#8217; Equity - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Total</div></th>
<th class="th"><div>Common Shares</div></th>
<th class="th"><div>Treasury Shares</div></th>
<th class="th"><div>Additional Paid-In Capital</div></th>
<th class="th"><div>Accumulated Deficit</div></th>
<th class="th"><div>Accumulated Other Comprehensive Income</div></th>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2019</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">21,057,040<span></span>
</td>
<td class="nump">408,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2019</a></td>
<td class="nump">$ 39,614<span></span>
</td>
<td class="nump">$ 147,688<span></span>
</td>
<td class="num">$ (2,854)<span></span>
</td>
<td class="nump">$ 21,214<span></span>
</td>
<td class="num">$ (127,125)<span></span>
</td>
<td class="nump">$ 691<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues', window );">Issuance of common stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,628,571<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueNewIssues', window );">Issuance of common stock</a></td>
<td class="nump">63,855<span></span>
</td>
<td class="nump">$ 63,855<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">39,723<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">181<span></span>
</td>
<td class="nump">$ 181<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11,062<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,629<span></span>
</td>
<td class="nump">$ 11<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,618<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(1,383)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover income tax obligation upon vesting of restricted stock</a></td>
<td class="num">(34)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(33)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain</a></td>
<td class="nump">2,821<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,821<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(17,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(17,753)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Mar. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,735,013<span></span>
</td>
<td class="nump">408,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2020</a></td>
<td class="nump">90,313<span></span>
</td>
<td class="nump">$ 211,734<span></span>
</td>
<td class="num">$ (2,854)<span></span>
</td>
<td class="nump">22,799<span></span>
</td>
<td class="num">(144,878)<span></span>
</td>
<td class="nump">3,512<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Beginning balance (in shares) at Dec. 31, 2020</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">23,925,789<span></span>
</td>
<td class="nump">408,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Beginning balance at Dec. 31, 2020</a></td>
<td class="nump">$ 74,961<span></span>
</td>
<td class="nump">$ 213,471<span></span>
</td>
<td class="num">$ (2,854)<span></span>
</td>
<td class="nump">26,717<span></span>
</td>
<td class="num">(165,246)<span></span>
</td>
<td class="nump">2,873<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward', window );"><strong>Increase (Decrease) in Stockholders' Equity [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Stock option exercises (in shares)</a></td>
<td class="nump">163,034<span></span>
</td>
<td class="nump">163,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised', window );">Stock option exercises</a></td>
<td class="nump">$ 1,882<span></span>
</td>
<td class="nump">$ 1,882<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation', window );">Share-based compensation (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,939<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">$ 6<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,750<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(711)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Shares withheld to cover income tax obligation upon vesting of restricted stock</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">$ (1)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(40)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent', window );">Foreign currency translation gain</a></td>
<td class="nump">941<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">941<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">(6,948)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(6,948)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharesIssued', window );">Ending balance (in shares) at Mar. 31, 2021</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">24,094,051<span></span>
</td>
<td class="nump">408,070<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rc">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquity', window );">Ending balance at Mar. 31, 2021</a></td>
<td class="nump">$ 72,551<span></span>
</td>
<td class="nump">$ 215,358<span></span>
</td>
<td class="num">$ (2,854)<span></span>
</td>
<td class="nump">$ 28,427<span></span>
</td>
<td class="num">$ (172,194)<span></span>
</td>
<td class="nump">$ 3,814<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInStockholdersEquityRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInStockholdersEquityRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569643-111683<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1A<br> -Subparagraph (c)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=SL4573702-111684<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 45<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=108774443&amp;loc=SL4569616-111683<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of new stock issued during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueNewIssues">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueNewIssues</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of stock issued as a result of the exercise of stock options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29-31)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 4.E)<br> -URI http://asc.fasb.org/extlink&amp;oid=27010918&amp;loc=d3e74512-122707<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(31))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(30))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 6: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 7: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>R7.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875299896">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Condensed Consolidated Statements of Cash Flows - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Cash flows from operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (6,948)<span></span>
</td>
<td class="num">$ (17,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract', window );"><strong>Adjustments to reconcile net loss to net cash used in operating activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_DepreciationandAmortizationExcludingDebtDiscountPremium', window );">Depreciation and amortization</a></td>
<td class="nump">908<span></span>
</td>
<td class="nump">833<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProvisionForDoubtfulAccounts', window );">Provision for doubtful accounts</a></td>
<td class="nump">6<span></span>
</td>
<td class="nump">599<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWriteDown', window );">Provision for inventory obsolescence</a></td>
<td class="nump">93<span></span>
</td>
<td class="nump">137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensation', window );">Share-based compensation</a></td>
<td class="nump">1,756<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment', window );">Loss from disposal of property and equipment</a></td>
<td class="nump">20<span></span>
</td>
<td class="nump">5<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized', window );">Unrealized foreign currency loss, net</a></td>
<td class="nump">3,030<span></span>
</td>
<td class="nump">5,845<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense', window );">Amortization of right-to-use asset</a></td>
<td class="nump">101<span></span>
</td>
<td class="nump">79<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UnrealizedGainLossOnDerivatives', window );">Change in fair value of derivative instruments</a></td>
<td class="num">(230)<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1', window );">Change in fair value of contingent consideration</a></td>
<td class="nump">0<span></span>
</td>
<td class="num">(440)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts', window );">Amortization of debt discount</a></td>
<td class="nump">474<span></span>
</td>
<td class="nump">388<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract', window );"><strong>Changes in operating assets and liabilities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsReceivable', window );">Accounts receivable</a></td>
<td class="num">(5,218)<span></span>
</td>
<td class="num">(171)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInInventories', window );">Inventory</a></td>
<td class="num">(698)<span></span>
</td>
<td class="nump">438<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets', window );">Prepaid expenses and other current assets</a></td>
<td class="nump">1,217<span></span>
</td>
<td class="num">(660)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets', window );">Other assets</a></td>
<td class="nump">26<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccountsPayable', window );">Accounts payable</a></td>
<td class="num">(617)<span></span>
</td>
<td class="nump">366<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInAccruedLiabilities', window );">Accrued liabilities</a></td>
<td class="num">(158)<span></span>
</td>
<td class="nump">40<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_IncreaseDecreaseInOperatingLeaseLiabilities', window );">Operating lease liabilities</a></td>
<td class="num">(95)<span></span>
</td>
<td class="num">(70)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities', window );">Other liabilities</a></td>
<td class="num">(221)<span></span>
</td>
<td class="nump">4<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInOperatingActivities', window );">Net cash used in operating activities</a></td>
<td class="num">(6,554)<span></span>
</td>
<td class="num">(6,802)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract', window );"><strong>Cash flows from investing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment', window );">Purchases of property and equipment</a></td>
<td class="num">(804)<span></span>
</td>
<td class="num">(687)<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld', window );">Cash used in asset acquisitions</a></td>
<td class="num">(434)<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToAcquireIntangibleAssets', window );">Cost incurred for intangible assets</a></td>
<td class="num">(294)<span></span>
</td>
<td class="num">(262)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInInvestingActivities', window );">Net cash used in investing activities</a></td>
<td class="num">(1,532)<span></span>
</td>
<td class="num">(949)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract', window );"><strong>Cash flows from financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Repayments on finance leases</a></td>
<td class="num">(55)<span></span>
</td>
<td class="num">(76)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfCommonStock', window );">Proceeds from issuance of ordinary shares, net of issuance costs</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">63,855<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromStockOptionsExercised', window );">Proceeds from stock option exercises</a></td>
<td class="nump">1,882<span></span>
</td>
<td class="nump">181<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation', window );">Tax&#160;payments&#160;related&#160;to&#160;shares&#160;withheld&#160;upon&#160;vesting of&#160;restricted&#160;stock</a></td>
<td class="num">(41)<span></span>
</td>
<td class="num">(34)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetCashProvidedByUsedInFinancingActivities', window );">Net cash provided by financing activities</a></td>
<td class="nump">1,786<span></span>
</td>
<td class="nump">63,926<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Effect of exchange rate changes on cash</a></td>
<td class="num">(273)<span></span>
</td>
<td class="num">(234)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect', window );">Net (decrease)/increase in cash</a></td>
<td class="num">(6,573)<span></span>
</td>
<td class="nump">55,941<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at beginning of period</a></td>
<td class="nump">84,523<span></span>
</td>
<td class="nump">37,655<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents', window );">Cash at end of period</a></td>
<td class="nump">77,950<span></span>
</td>
<td class="nump">93,596<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalCashFlowInformationAbstract', window );"><strong>Supplemental disclosures:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestPaidNet', window );">Cash paid for interest</a></td>
<td class="nump">1,710<span></span>
</td>
<td class="nump">1,734<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxesPaidNet', window );">Cash paid for income taxes</a></td>
<td class="nump">10<span></span>
</td>
<td class="nump">1<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract', window );"><strong>Supplemental disclosures of non-cash investing and financing activities:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid', window );">Unpaid balance for property and equipment</a></td>
<td class="nump">143<span></span>
</td>
<td class="nump">395<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition', window );">Consideration payable related to asset acquisition</a></td>
<td class="nump">$ 407<span></span>
</td>
<td class="nump">$ 1,257<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_DepreciationandAmortizationExcludingDebtDiscountPremium">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Depreciation and Amortization, Excluding Debt Discount (Premium)</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_DepreciationandAmortizationExcludingDebtDiscountPremium</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_IncreaseDecreaseInOperatingLeaseLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase (Decrease) In Operating Lease Liabilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_IncreaseDecreaseInOperatingLeaseLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_NoncashConsiderationPayableRelatedtoAssetAcquisition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Noncash Consideration Payable Related to Asset Acquisition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_NoncashConsiderationPayableRelatedtoAssetAcquisition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_PaymentstoAcquireAssetsIncludingReceivablesHeld">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments to Acquire Assets Including Receivables Held</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_PaymentstoAcquireAssetsIncludingReceivablesHeld</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfFinancingCostsAndDiscounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfFinancingCostsAndDiscounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 805<br> -SubTopic 30<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120321790&amp;loc=d3e7008-128479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CapitalExpendituresIncurredButNotYetPaid">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Future cash outflow to pay for purchases of fixed assets that have occurred.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4332-108586<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4313-108586<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4304-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CapitalExpendituresIncurredButNotYetPaid</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3044-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=SL98516268-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 230<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=98513438&amp;loc=d3e33268-110906<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossUnrealized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossUnrealized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GainLossOnSaleOfPropertyPlantEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GainLossOnSaleOfPropertyPlantEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxesPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxesPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsPayable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsPayable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccountsReceivable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccountsReceivable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInAccruedLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInAccruedLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInInventories">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInInventories</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherNoncurrentAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in noncurrent assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherNoncurrentAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInOtherOperatingLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in operating liabilities classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInOtherOperatingLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase (decrease) in prepaid expenses, and assets classified as other.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestPaidNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4297-108586<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestPaidNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWriteDown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4542-108314<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWriteDown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3536-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 24<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3521-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense for right-of-use asset from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 15<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3291-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquireIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquireIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToAcquirePropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 13<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3213-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToAcquirePropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfCommonStock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow from the additional capital contribution to the entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfCommonStock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from exercise of option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=SL79508275-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProvisionForDoubtfulAccounts">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense (reversal of expense) for expected credit loss on accounts receivable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(5))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProvisionForDoubtfulAccounts</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of noncash expense for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalCashFlowInformationAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalCashFlowInformationAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UnrealizedGainLossOnDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UnrealizedGainLossOnDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>R8.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210792984536">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Formation and Business of the Company<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock', window );">Formation and Business of the Company</a></td>
<td class="text">Formation and Business of the Company<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Formation and Business of the Company</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Establishment Labs Holdings Inc. and its wholly owned subsidiaries (collectively &#8220;the Company&#8221;, &#8220;we&#8221;, &#8220;us&#8221;, or &#8220;our&#8221;) is a global company that manufactures and markets innovative medical devices for aesthetic and reconstructive plastic surgery. The Company was established in the British Virgin Islands on October 9, 2013, at which time Establishment Labs, S.A., the Costa Rican manufacturing company, was reincorporated as a wholly-owned subsidiary. As of March&#160;31, 2021, the Company also has wholly-owned subsidiaries in the United States (JAMM Technologies, Inc. and Motiva USA LLC), Brazil (Establishment Labs Produtos para Saude Ltda), Belgium (European Distribution Center Motiva BVBA), France (Motiva Implants France SAS), Sweden (Motiva Nordica AB), Switzerland (JEN-Vault AG), the United Kingdom (Motiva Implants UK Limited), Italy (Motiva Italy S.R.L), Spain (Motiva Implants Spain, S.L.), Austria (Motiva Austria GmbH), Germany (Motiva Germany GmbH) and Argentina (Motiva Argentina S.R.L). Substantially all of the Company&#8217;s revenues are derived from the sale of silicone gel-filled breast implants, branded as Motiva Implants.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The main manufacturing activities are conducted at two manufacturing facilities in Costa Rica. In 2010, the Company began operating under the Costa Rica free zone regime (R&#233;gimen de Zona Franca), which provides for reduced income tax and other tax obligations pursuant to an agreement with the Costa Rican authorities.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s products are approved for sale in Europe, the Middle East, Latin America, and Asia. The Company sells its products internationally through a combination of distributors and direct sales to customers. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is pursuing regulatory approval to commercialize its products in the United States. The Company received approval for an investigational device exemption, or IDE, from the FDA in March 2018 to initiate a clinical trial in the United States for its Motiva Implants. In August 2019, we completed all patient surgeries for the IDE aesthetic cohorts, which include primary augmentation and revision. As of March&#160;31, 2021, we are continuing to enroll subjects in the remaining reconstruction cohorts. </span></div>The Company has been expanding its global operations through a series of acquisitions and establishing wholly-owned subsidiaries. In November 2015, the Company purchased certain assets from Magna Equities I, LLC and established its wholly-owned subsidiary, JAMM Technologies, Inc., in the United States. In January 2016, the Company purchased a distribution company in Brazil to support the application to sell its products in Brazil. In March 2016, the Company purchased a storage and distribution company in Belgium to support its continued growth in Europe. In September 2016, the Company purchased a distribution company in France, and it also established a wholly-owned subsidiary in Switzerland. In November 2017, the Company acquired certain assets from Femiline AB and established its wholly-owned subsidiary in Sweden, Motiva Nordica AB. During 2018, the Company established wholly-owned subsidiaries in the United Kingdom and Italy and purchased certain assets from Menke Med GmbH, Motiva Matrix Spain, S.L. and Belle Health Ltd. In 2019, the Company purchased certain assets from AFS Medical GMBH and established wholly-owned subsidiaries in Austria, Spain and Germany. In 2020, the Company established a wholly-owned subsidiary in Argentina and purchased certain assets from Orion Trading SRL for the Italian operations.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -URI http://asc.fasb.org/topic&amp;trid=2122149<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -URI http://asc.fasb.org/topic&amp;trid=2197479<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R9.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793208616">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SignificantAccountingPoliciesTextBlock', window );">Summary of Significant Accounting Policies</a></td>
<td class="text">Summary of Significant Accounting Policies<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There have been no material changes to the Company&#8217;s significant accounting policies during the&#160;three months ended March&#160;31, 2021 as compared to the significant accounting policies described in Note 2 of the &#8220;Notes to Consolidated Financial Statements&#8221; in the Company&#8217;s audited consolidated financial statements as of December&#160;31, 2020 and 2019 and for the years then ended. Below are those policies with current period updates.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements and related financial information should be read </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#8217;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the Company&#8217;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.406%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporation/Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs, S.A. (Costa Rica)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2004</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva USA, LLC (USA)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JAMM Technologies, Inc. (USA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs Produtos par Saude Ltda (Brazil)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Distribution Center Motiva BVBA (Belgium)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants France SAS (France)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 12, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JEN-Vault AG (Switzerland)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Nordica AB (Sweden)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants UK Limited (the United Kingdom)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Italy S.R.L (Italy)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants Spain, S.L. (Spain)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 3, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Austria GmbH (Austria)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 14, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Germany GmbH (Germany)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Argentina S.R.L (Argentina)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All intercompany accounts and transactions have been eliminated in consolidation. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Unaudited Interim Condensed Consolidated Financial Information</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying interim condensed consolidated financial statements as of March&#160;31, 2021 and for the three months ended March&#160;31, 2021 and 2020, and the related interim information contained within the notes to the condensed consolidated financial statements, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments which are necessary to state fairly the Company&#8217;s financial position as of March&#160;31, 2021, and the results of its operations and cash flows for the three months ended March&#160;31, 2021 and 2020. Such adjustments are of a normal and recurring nature. The results for the three months ended March&#160;31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year 2021, or for any future period. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic regions in which the Company operates.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Geographic Concentrations </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company derives all its revenues from sales to customers in Europe, the Middle East, Latin America, and Asia, and has not yet received approval to sell its products in the United States. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For the three months ended March&#160;31, 2021 and 2020 Brazil accounted for 10.6% and 10.0% of consolidated revenue, respectively, and no other individual country exceeded 10% of consolidated revenue, on a ship-to destination basis. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The majority of the Company&#8217;s consolidated total assets, including cash and tangible assets, is held in the United States. The Company&#8217;s long-lived assets, which primarily consist of property and equipment and intangible assets located in Costa Rica represented </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">78% and 80% </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of the total long-lived assets as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the condensed </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets&#8217; useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. Balances in the Company&#8217;s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s revenues were derived from the sale of Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, no customer accounted for more than 10% of the Company&#8217;s revenue. No customer accounted for more than 10% of the Company&#8217;s trade accounts receivable balance as of March&#160;31, 2021 or </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, the Company had purchases of $4.3 million, or 55.8% of total purchases, and $5.0&#160;million, or 64.9% of total purchases, respectively, from NuSil. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had an outstanding balance owed to this vendor of $1.6 million and $1.3 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company&#8217;s current and potential future products, uncertainty of market acceptance of the Company&#8217;s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2020, the World Health Organization declared the outbreak of a novel coronavirus, or COVID-19, as a pandemic which has spread globally, including locations where the Company does business. This outbreak caused a material disruption of the operations of the Company and its suppliers and customers in fiscal 2020 and resulted in delayed clinical trial enrollment within the reconstruction cohorts of its IDE clinical trial in the United States. However, the impact from the COVID-19 outbreak has not had a material effect on the Company&#8217;s liquidity or financial position. The full extent of any future impact of the continuing outbreak, related business and travel restrictions and changes to behavior intended to reduce its spread are uncertain and continues to evolve globally. Management continues to monitor the impact that the COVID-19 pandemic is having on the Company, the breast aesthetics and reconstruction market and the economies in which the Company operates. The Company anticipates that its future results of operations, including the results for 2021 could be materially impacted by the COVID-19 outbreak. However, given the speed and frequency of continuously evolving developments with respect to this pandemic, the Company cannot reasonably estimate the magnitude of the potential impact to the results of its operations. To the extent that the Company&#8217;s customers continue to be materially and adversely impacted by the COVID-19 outbreak, this could materially interrupt the Company&#8217;s business operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Cash </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s cash consists of cash maintained in checking and interest-bearing accounts. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents. The Company held no cash equivalents as of March&#160;31, 2021 or </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accounts Receivable and Allowance for Doubtful Accounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable is stated at invoice value less estimated allowances for returns and doubtful accounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from customers&#8217; inability to make required payments. In evaluating the Company&#8217;s ability to collect outstanding receivable balances, the Company considers various factors including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition. In cases where there are circumstances that may impair a specific customer&#8217;s ability to meet its financial obligations, an allowance is recorded against amounts due, which reduces the net recognized receivable to the amount reasonably believed to be collectible. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory and Cost of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost to purchase or manufacture the inventory or the net realizable value of such inventory. Cost is determined using the standard cost method which approximates actual costs using the first-in, first-out basis. The Company regularly reviews inventory quantities considering actual losses, projected future demand, and remaining shelf life to record a provision for excess and slow-moving inventory. An inventory reserve of $1.7 million and $1.6 million has been recorded as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of inventory transferred to the customer in cost of revenue when revenue is recognized.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at the inception date of the contract. The Company has elected an expedient to account for each separate lease component and its associated non-lease components as a single lease component for the majority of its asset classes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. The Company recognizes lease liabilities and right-of-use, or ROU, assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Shipping and Handling Costs</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Shipping and handling costs are expensed as incurred and are included in selling, general and administrative, or SG&amp;A, expenses. For the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 2020, shipping and handling costs were </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$1.2&#160;million and $0.8&#160;million, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to sales of products to distributors or directly to customers in markets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where it has regulatory approval, net of discounts and allowances. The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, Revenue from Contracts with Customers. ASC 606 requires the Company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to the sales of products to distributors at the time of shipment of the product, which represents the point in time when the distributor has taken ownership and assumed the risk of loss and the required revenue recognition criteria are satisfied. The Company&#8217;s distributors are obligated to pay within specified terms regardless of when, or if, they sell the products. The Company&#8217;s contracts with distributors typically do not contain right of return or price protection and have no post-delivery obligations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when title to the product and risk of loss transfer to customers, provided there are no remaining performance obligations required of the Company or any written matters requiring customer acceptance. The Company allows for the return of product from direct customers in certain regions in limited instances within fifteen days after the original sale and records estimated sales returns as a reduction of sales in the same period revenue is recognized. Appropriate reserves are established for anticipated sales returns based on historical experience, recent gross sales and any notification of pending returns. Actual sales returns in any future period are inherently uncertain and thus may differ from the estimates. If actual sales returns differ significantly from the estimates, an adjustment to revenue in the current or subsequent period is recorded. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an allowance of zero and $54,000 was recorded for product returns, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s revenue is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For these products, revenue is recognized at the time the Company is notified by the consignee that the product has been implanted, not when the consigned products are delivered to the consignee&#8217;s warehouse. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was generated in these primary geographic markets:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific/Middle East</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a limited warranty for the shelf life of the product, which is five years from the time of manufacture. Estimated warranty obligations are recorded at the time of sale. The Company also offers a warranty to patients in the event of rupture and a replacement program for capsular contracture events, provided certain registration requirements are met. Revenue for extended warranties is recognized ratably over the term of the agreement. To date, these warranty and program costs have been de minimis. The Company will continue to evaluate the warranty reserve policies for adequacy considering claims history.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deferred revenue primarily consists of payments received in advance of meeting revenue recognition criteria. The Company has received payments from distributors to provide distribution exclusivity within a geographic area and recognizes deferred revenue on a ratable basis over the term of such contractual distribution relationship. Additionally, the Company has received payments from customers in direct markets prior to surgical implantation and recognizes deferred revenue at the time the Company is notified by the customer that the product has been implanted. For all arrangements, any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue and included in &#8220;Other liabilities, long-term&#8221; on the condensed consolidated balance sheets (see Note 3).</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to research and development, or R&amp;D, activities are expensed as incurred. R&amp;D costs primarily include personnel costs, materials, clinical expenses, regulatory expenses, product development, consulting services, and outside research activities, all of which are directly related to research and development activities. </span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company estimates IDE clinical trial expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations that conduct and manage clinical trials on its behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Selling, General and Administrative Expenses</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SG&amp;A expenses include sales and marketing costs, payroll and related benefit costs, insurance expenses, shipping and handling costs, legal and professional fees and administrative overhead. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;margin-top:4.05pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization.</span></div><div style="margin-bottom:6pt;margin-top:0.1pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Following the exercise of its option to purchase its manufacturing facility in June 2019, the Company depreciates the owned building on a straight-line basis over 50 years of useful life. Depreciation of property and equipment is computed using the straight-line method over the assets&#8217; estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b">five</span> to ten years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the remaining lease term after factoring expected renewal periods. Upon retirement or disposal of assets, the costs and related accumulated depreciation are eliminated from the accounts and any gain or loss is recognized in operations. Maintenance and repairs are expensed as incurred. Substantially all of the Company&#8217;s manufacturing operations and related property and equipment is located in Costa Rica. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the excess of the acquisition purchase price over the net fair value of the tangible and identifiable intangible assets acquired and liabilities assumed as goodwill. In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company tests goodwill for impairment annually during the fourth quarter of each year and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with the annual impairment test for goodwill, the Company elected the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it was more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test is performed. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the Company's assessment that it has only one reporting segment, the Company has determined that it has only one reporting unit and tests goodwill for impairment at the entity level using the two-step process required by ASC 350. In the first step, the Company compares the carrying amount of the reporting unit to the fair value of the enterprise. If the fair value of the enterprise exceeds the carrying value, goodwill is not considered impaired and no further testing is required. If the carrying value of the enterprise exceeds the fair value, goodwill is potentially impaired, and the second step of the impairment test must be performed. In the second step, the Company compares the implied fair value of the goodwill, as defined by ASC 350, to its carrying amount to determine the impairment loss, if any.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes certain costs related to intangible assets, such as patents, trademarks and software </span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">development costs. The Company follows the provisions of ASC 350-40, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Use Software </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for determining whether computer software is internal-use software and on accounting for the proceeds of computer software originally developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of software development and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company records purchased intangible assets at their respective estimated fair values at the date of acquisition. Purchased finite-lived intangible assets are being amortized using the straight-line method over their remaining estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94">two</span> to fifteen years. The Company evaluates the remaining useful lives of intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining estimated amortization period. The Company tests indefinite-lived intangible assets for impairment on at least an annual basis and whenever circumstances suggest the assets may be impaired. If indicators of impairment are present, the Company evaluates the carrying value of the intangible assets in relation to estimates of future undiscounted cash flows. The Company also evaluates the remaining useful life of an indefinite-lived intangible asset to determine whether events and circumstances continue to support an indefinite useful life. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the year ended December&#160;31, 2020, there was no impairment of goodwill or intangible assets based on the qualitative assessments performed by the Company. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:6pt;margin-top:4.4pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives recorded d</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the year ended December&#160;31, 2020. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-lived</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset values may not be recoverable.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Embedded Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 6).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note&#160;5).</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs and Debt Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in connection with the issuance of new debt are capitalized. Capitalizable debt issuance costs paid to third parties and debt discounts, net of amortization, are recorded as a reduction to the long-term debt balance on the condensed consolidated balance sheets. Amortization expense on capitalized debt issuance costs and debt discounts related to loans are calculated using the effective interest method over the term of the loan commitment and is recorded as interest expense in the condensed consolidated statements of operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:4.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events, enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:6pt;margin-top:4.09pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.</span></div><div style="margin-bottom:6pt;margin-top:4.34pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.</span></div><div style="margin-bottom:6pt;margin-top:4.34pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no material uncertain tax positions in fiscal 2020 and for the three months ended March&#160;31, 2021.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Foreign Currency </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The financial statements of the Company&#8217;s foreign subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, stockholders&#8217; equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries&#8217; accounts are included in &#8220;Accumulated other comprehensive income&#8221; as equity in the condensed consolidated balance sheet. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within &#8220;Other expense, net&#8221; in the condensed consolidated statement of operations. For the three months ended March&#160;31, 2021 and March&#160;31, 2020, foreign currency transaction loss amounted to $2.7 million and $6.2&#160;million, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Comprehensive Loss</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s comprehensive loss consists of net loss and foreign currency translation adjustments arising from the consolidation of the Company&#8217;s foreign subsidiaries. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all share-based awards in accordance with the provisions of ASC 718, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Share-based awards granted include stock options, restricted stock units, or RSUs, and restricted stock awards, or RSAs. Share-based compensation expense for stock options and RSAs granted to employees is measured at the grant date based on the fair value of the awards and is recognized as an expense ratably on a straight-line basis over the requisite service period. The fair value of options to purchase shares granted to employees is estimated on the grant date using the Black-Scholes option valuation model. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The calculation of share-based compensation expense requires the Company to make assumptions and judgments about the variables used in the Black-Scholes model, including the expected term, expected volatility of the underlying common shares, risk-free interest rate and dividends. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share </span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted-average number of shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted-average number of shares and potentially </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilutive </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities outstanding for the period. For purposes of the diluted net loss per share calculation, any shares issuable upon exercise of warrants, stock options and non-vested restricted stock outstanding under the Company&#8217;s equity plan are potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for periods where the Company reported a net loss because including the dilutive securities would be anti-dilutive.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of ASU No. 2016-02, </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effective January 1, 2020, using the modified retrospective </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the three months ended March 31, 2020.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, the Company meets the definition of an emerging growth company, and has elected the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. The Company will remain an emerging growth company until the earliest of (1)&#160;the last day of its first fiscal year (a)&#160;following the fifth anniversary of the completion of our initial public offering, (b)&#160;in which we have total annual gross revenue of at least $1.07 billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (2)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following recent accounting pronouncements issued by the FASB, could have a material effect on our financial statements:</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements. The modifications removed the following disclosure requirements: (i) the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy; (ii) the policy for timing of transfers between levels; and (iii) the valuation processes for Level 3 fair value measurements. This ASU added the following disclosure requirements: (i) the changes in unrealized gains and losses for the period included in other comprehensive income, or OCI, for recurring Level 3 fair value measurements held at the end of the reporting period; and (ii) the range and weighted average of significant observable inputs used to develop Level 3 fair value measurements. This update is effective for non-public entities for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-13 on January 1, 2021. As the requirements of this literature are disclosure only, ASU 2018-13 did not impact our financial condition or results of operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect the updated standard will have on its consolidated financial statements and footnote disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for nonpublic business entities and emerging growth companies for fiscal years after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company is </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently assessing the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and footnote disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SignificantAccountingPoliciesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for all significant accounting policies of the reporting entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -URI http://asc.fasb.org/topic&amp;trid=2122369<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SignificantAccountingPoliciesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R10.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794628568">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock', window );">Balance Sheet Accounts</a></td>
<td class="text">Balance Sheet Accounts<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory, Net</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, $2.3&#160;million and $2.0&#160;million of inventory was on consignment, respectively.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment, Net</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,170)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,633)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each of the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2021 and 2020, depreciation and amortization expense related to property and equipment was $0.6&#160;million.</span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company entered into finance leases relating to equipment and vehicles and recorded the fair value of the lease payments on the initial contract date and is amortizing the assets over the term of the leases. As of each of March&#160;31, 2021 and December&#160;31, 2020, the gross asset value for capital lease assets was $1.4 million. Depreciation expense for assets under finance leases was $43,000 and $20,000 for the three months ended March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2020, respectively</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Accrued Liabilities</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus feature of stock option grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and legal services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term minimum lease payments under finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advisory board and board of director related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Short-Term</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, short-term consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:24pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Other Liabilities, Long-Term</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, long-term consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SupplementalBalanceSheetDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -URI http://asc.fasb.org/topic&amp;trid=2122208<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SupplementalBalanceSheetDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R11.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793291656">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock', window );">Goodwill and Other Intangible Assets</a></td>
<td class="text">Goodwill and Other Intangible Assets<div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Goodwill represents the excess of the purchase price over the fair value of the net tangible and identifiable intangible assets acquired in a business combination. Intangible assets resulting from the acquisitions of entities accounted for using the acquisition method of accounting are recorded at the estimated fair value of the assets acquired. Purchased intangibles include certain patents and license rights, 510(k) authorization by the FDA to sell a medical device and other intangible assets.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s goodwill and most intangibles at March&#160;31, 2021 are the result of acquisitions of certain assets formerly owned by VeriTeQ Corporation in November 2015, Femiline AB in November 2017 and Orion Trading S.r.l in August 2020 and business acquisitions of Establishment Labs Brasil Productos para Saude Ltda. in January 2016, European Distribution Center Motiva BVBA in March 2016 and Motiva Implants France in September 2016. Finite-lived intangibles are amortized over their estimated useful lives based on expected future benefit.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the intangibles acquired, the Company capitalized certain patent and license rights as identified intangibles based on patent and license rights agreements entered into over the past several years. Additionally, the Company capitalized certain software development costs.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the carrying amount of goodwill during the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:48.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.880%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Impairment Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,819)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The amortization expense associated with intangible assets was $0.3&#160;million and $0.2&#160;million for the </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">three</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> months ended March&#160;31, 2021 and 2020, respectively</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Non-product related amortization is recorded in SG&amp;A while product related amortization is recorded in cost of revenue.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the amortization expense related to identifiable intangible assets, with definite useful lives, in future periods is expected to be as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>The Company evaluates the recoverability of goodwill and indefinite-lived intangible assets annually and whenever events or changes in circumstances indicate that the carrying amount may not be recoverable. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired intangible asset values may not be recoverable.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -URI http://asc.fasb.org/topic&amp;trid=2144416<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R12.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799621624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresTextBlock', window );">Fair Value Measurements</a></td>
<td class="text">Fair Value Measurements<div style="margin-bottom:6pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying value of the Company&#8217;s cash, accounts receivable and accounts payable approximate fair value due to the short-term nature of these items. Contingent equity consideration and embedded derivatives that qualify for liability treatment are carried at fair value and re-measured at each reporting period. </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Fair value is defined as the exchange price that would be received for an asset or an exit price paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value must maximize </span></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the use of observable inputs and minimize the use of unobservable inputs. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value hierarchy defines a three-level valuation hierarchy for disclosure of fair value measurements as follows: </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level I&#160;&#160;&#160;&#160;Unadjusted quoted prices in active markets for identical assets or liabilities;</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level II&#160;&#160;&#160;&#160;Inputs other than quoted prices included within Level I that are observable, unadjusted quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or liabilities; and</span></div><div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Level III Unobservable inputs that are supported by little or no market activity for the related assets or liabilities.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The categorization of a financial instrument within the valuation hierarchy is based upon the lowest level of input that is significant to the fair value measurement. </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy at period end: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:53.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:53.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value measurement of derivatives is based on significant inputs not observed in the market and thus represents a Level 3 measurement. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders (see Note 6). The Company determined that the Madryn Credit Agreement contained put options related to early redemption mandatory prepayment terms in case of change in control or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $15.1 million for these identified embedded derivatives as a debt discount on the original commitment date. An additional $5.0 million and $1.6 million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $10.0 million in the fourth quarter of fiscal 2017 and $25.0 million in August 2019 (see Note 6). The Company revalued the options as of each reporting period and recorded the change in the fair value in the consolidated statement of operations as other income or expense.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Valuation of the embedded derivatives is complex and requires interest rate simulation, capturing optimal decision making process as interest rate fluctuates and estimating the resultant bond valuation and the resultant pay-off to the option holder. The Company estimated the fair value of the embedded redemption options based on a &#8220;with&#8221; and &#8220;without&#8221; approach using the Black-Derman-Toy model, a form of the Binomial Lattice Model that captures interest rate variability and the prepayment optionality. The Binomial Lattice Model allows for the possibility of exercise before the end of the option&#8217;s life and considers future interest rates, volatility and other data with </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">regards to the Company&#8217;s credit rating and credit spread. The value of the embedded derivatives was based on the difference between the &#8220;with&#8221; and &#8220;without&#8221; analysis. The probability of a change in control occurring was determined to be 50% (cumulative probability through the maturity date) at March&#160;31, 2021 and December&#160;31, 2020.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used the following assumptions to value Madryn derivatives:</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put Option Liability </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:74.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market yield rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The estimates are based, in part, on subjective assumptions and could differ materially in the future.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods presented, the Company has not changed the manner in which it values liabilities that are measured at fair value using Level 3 inputs. The Company recognizes transfers between levels of the fair value hierarchy as of the end of the reporting period. There were no transfers within the hierarchy during the three months ended March&#160;31, 2021 or during the year ended December&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of the debt redemption feature liability includes the estimated market rate (credit spread and risk-free rate) and volatility.&#160;The higher/lower the estimated volatility, the higher/lower the value of the debt redemption feature liability. The higher/lower the estimated market rate, the higher/lower the value of the debt redemption feature liability.</span></div><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.447%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.609%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Put Option Liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>R13.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793307000">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureTextBlock', window );">Debt</a></td>
<td class="text">Debt<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Madryn Debt</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 24, 2017, the Company entered into a credit agreement, or the Madryn Credit Agreement, with Madryn Health Partners, LP, or Madryn, as administrative agent, and a syndicate of lenders. On June 17, 2019, the Madryn Credit Agreement was amended to lower the interest rate on the outstanding debt facilities, provide for </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">$25.0 million of new term loan commitments, decrease the amount of the prepayment penalties, remove all principal payments and extend the maturity date and repayment from September 30, 2023 to September 30, 2025. On August 5, 2020, the Company amended the Madryn Credit Agreement to adjust the minimum product revenue milestone previously applicable to December 31, 2020 to September 31, 2021 and to add Motiva Implants UK Limited, Motiva Implants France SAS, Motiva Implants Spain, S.L. and Motiva Germany GmbH, wholly-owned subsidiaries of the Company, as guarantors to the Madryn Credit Agreement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement, as amended, provides for a term loan in a maximum principal amount of $65.0 million, $30.0 million (Term A) of which became available upon signing and was subsequently borrowed by the Company.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to amending the Madryn Credit Agreement on June 17, 2019, the Company&#8217;s ability to borrow the remaining term loans under the Madryn Credit Agreement was subject to the Company achieving certain revenue milestones. The Company met milestones sufficient to borrow and borrowed an additional $5.0 million (Term B-1) on October 31, 2017 and $5.0 million (Term B-2) on December 15, 2017, increasing the total outstanding principal balance to $40.0 million as of December 31, 2017.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the June 2019 amendment, the Company became eligible to borrow an additional $10.0 million (Term B-3) and $15.0 million (Term B-4) on or before September 30, 2019 and December 31, 2019, respectively. The Company borrowed the available funds under both tranches equal to $25.0 million on August 12, 2019, bringing up the total outstanding principal balance to $65.0 million as of March&#160;31, 2021.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with the Madryn Credit Agreement, the Company and certain of its subsidiaries granted a security interest in substantially all of their respective assets, including, without limitation, intellectual property, and pledges of certain shares of the Company&#8217;s subsidiaries, subject to certain excluded collateral exceptions.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Madryn Credit Agreement contains customary affirmative and negative covenants, including, but not limited to, restrictions on the ability of the Company and its subsidiaries to incur additional indebtedness, create liens, make certain investments, make restricted payments, enter into or undertake certain liquidations, mergers, consolidations or acquisitions and dispose of assets or subsidiaries. In addition, the Madryn Credit Agreement requires the Company to maintain minimum revenues and liquidity.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Prior to the effectiveness of the June 17, 2019 amendment, borrowings under the Madryn Credit Agreement bore interest at a rate equal to 3-month LIBOR plus 11.0% per annum. As of the amendment on June 17, 2019, borrowings under the Madryn Credit Agreement bear interest at a rate equal to 3-month LIBOR plus 8.0% per annum provided that no default has occurred. In an event of a default, the interest would increase by an additional 4.0% per annum. The effective interest rate under the amended Madryn Credit Agreement is 18.4%, and the weighted average interest rate was approximately 10.6% at March&#160;31, 2021. The Company incurred $1.7 million in interest expense in connection with Madryn Credit Agreement during each of the three months ended March&#160;31, 2021 and 2020. No principal payments are due on the term loans until the final maturity date on September 30, 2025. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also determined that the Madryn Credit Agreement contained put options which are mandatory repayment provisions related to liquidity events or an event of default and a call option related to voluntary repayment option. The Company allocated a fair value of $15.1 million for these embedded derivatives as a debt discount on the original commitment date in August 2017. An additional $5.0 million and $1.6 million debt discount was recorded on respective borrowing dates when the Company met the required milestones and borrowed an additional $10.0 million in the fourth quarter of fiscal 2017 and $25.0&#160;million in August 2019. The Company revalues the embedded derivatives as of each reporting period and records the change in the fair value in the consolidated statement of operations as other income or expense (see Note 5). The Company also incurred legal expenses of $1.3 million in 2017 and $0.3 million in August 2019, which were recorded as a debt discount and are being amortized over the term of the Madryn Credit Agreement. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded Madryn debt on the balance sheet as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.806%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of Madryn debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the Company is in compliance with all financial debt covenants.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -URI http://asc.fasb.org/topic&amp;trid=2208564<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>R14.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793302072">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease liabilities and ROU assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When the rate implicit to the lease cannot be readily determined, the Company utilizes its incremental borrowing rate in determining the present value of the future lease payments. Lease liabilities are accreted each period and reduced for payments. The ROU asset also includes other adjustments, such as for the effects of escalating rents, rent abatements or initial lease costs. The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. For finance leases, the ROU asset depreciates on a straight-line basis over the shorter of the lease term or useful life of the ROU asset and the lease liability accretes interest based on the interest method using the discount rate determined at lease commencement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for facilities and office space as well as finance leases for equipment and vehicles. Operating lease assets and the related lease liabilities are included within the ROU assets&#8212;operating leases. The determination of whether an arrangement is, or contains, a lease is performed at the inception of the arrangement. The Company has operating and finance leases for certain facilities, office space, equipment, and vehicles to be used in its operations, with remaining lease terms ranging from monthly to 8 years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for additional years. These optional periods have not been considered in the determination of the ROU or lease liabilities associated with these leases as management did not consider it reasonably certain it would exercise the options. Short-term leases, which have an initial term of 12 months or less, are not recorded in the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements do not contain any termination options, material residual value guarantees, material bargain purchase options or material restrictive covenants. The Company does not have any lease transactions with related parties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Supplemental balance sheet information</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate (%)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amount of lease payments representing interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeasesTextBlock', window );">Leases</a></td>
<td class="text">Leases<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes lease liabilities and ROU assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at commencement date of the lease based on the present value of lease payments over the lease term. When the rate implicit to the lease cannot be readily determined, the Company utilizes its incremental borrowing rate in determining the present value of the future lease payments. Lease liabilities are accreted each period and reduced for payments. The ROU asset also includes other adjustments, such as for the effects of escalating rents, rent abatements or initial lease costs. The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. For operating leases, lease expense for minimum lease payments is recognized on a straight-line basis over the expected lease term. For finance leases, the ROU asset depreciates on a straight-line basis over the shorter of the lease term or useful life of the ROU asset and the lease liability accretes interest based on the interest method using the discount rate determined at lease commencement.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has operating leases for facilities and office space as well as finance leases for equipment and vehicles. Operating lease assets and the related lease liabilities are included within the ROU assets&#8212;operating leases. The determination of whether an arrangement is, or contains, a lease is performed at the inception of the arrangement. The Company has operating and finance leases for certain facilities, office space, equipment, and vehicles to be used in its operations, with remaining lease terms ranging from monthly to 8 years. These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain of these leases also include renewal options at the election of the Company to renew or extend the lease for additional years. These optional periods have not been considered in the determination of the ROU or lease liabilities associated with these leases as management did not consider it reasonably certain it would exercise the options. Short-term leases, which have an initial term of 12 months or less, are not recorded in the balance sheet and expense for these leases is recognized on a straight-line basis over the lease term. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s lease agreements do not contain any termination options, material residual value guarantees, material bargain purchase options or material restrictive covenants. The Company does not have any lease transactions with related parties.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Supplemental balance sheet information</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate (%)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amount of lease payments representing interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeasesTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -URI http://asc.fasb.org/subtopic&amp;trid=77888251<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeasesTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>25
<FILENAME>R15.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793203192">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Shareholders' Equity</a></td>
<td class="text">Shareholders&#8217; Equity<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Memorandum of Association and Articles of Association, or Articles, in effect as of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and December&#160;31, 2020, the Company had authorized an unlimited number of common shares with no par value.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, 24,094,051 and 23,925,789 common shares, respectively, were issued and 23,685,981 and 23,517,719 common shares, respectively, were outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company granted stock options to employees and contractors (see Note 10).</span></div><div style="margin-bottom:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had reserved common shares for future issuances as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,950,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182,196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>Warrants <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued warrants for the purchase of 145,000 Class B ordinary shares to parties related to Rockport Ventures, with a fixed exercise price of $3.80 per share.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, no warrants were exercised. As of each of March&#160;31, 2021 and December&#160;31, 2020, 5,500 warrants to purchase the Company&#8217;s common shares were outstanding and exercisable: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:13.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Holder</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In Connection With</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant&#160;to Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockport</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/28/2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>R16.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799621624">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock', window );">Warrants</a></td>
<td class="text">Shareholders&#8217; Equity<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under the Memorandum of Association and Articles of Association, or Articles, in effect as of </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and December&#160;31, 2020, the Company had authorized an unlimited number of common shares with no par value.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021 and December&#160;31, 2020, 24,094,051 and 23,925,789 common shares, respectively, were issued and 23,685,981 and 23,517,719 common shares, respectively, were outstanding.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, the Company granted stock options to employees and contractors (see Note 10).</span></div><div style="margin-bottom:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had reserved common shares for future issuances as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,950,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182,196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div>Warrants <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In March 2017, the Company issued warrants for the purchase of 145,000 Class B ordinary shares to parties related to Rockport Ventures, with a fixed exercise price of $3.80 per share.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, no warrants were exercised. As of each of March&#160;31, 2021 and December&#160;31, 2020, 5,500 warrants to purchase the Company&#8217;s common shares were outstanding and exercisable: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:13.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Holder</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In Connection With</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant&#160;to Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockport</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/28/2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockholdersEquityNoteDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(e)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -URI http://asc.fasb.org/topic&amp;trid=2208762<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockholdersEquityNoteDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>27
<FILENAME>R17.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794627448">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock', window );">Share-based Compensation</a></td>
<td class="text">Share-Based Compensation<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2015, the Board of Directors approved and adopted the 2015 Equity Incentive Plan, or 2015 Plan. Pursuant to the 2015 Plan, the Company has granted RSAs and stock options to Board of Directors, employees and consultants.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2018, the Board of Directors terminated the 2015 Plan and approved the 2018 Equity Incentive Plan, or the 2018 Plan, with an initial reserve of 1,500,000 common shares. Under the 2018 Plan, the Company may grant stock options, equity appreciation rights, and restricted shares and restricted share units. If an award granted under the 2018 Plan expires, terminates, is unexercised, or is forfeited, or if any shares are surrendered in connection with an incentive award, the shares subject to such award and the surrendered shares become available for further awards under the 2018 Plan. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the &#8220;evergreen&#8221; provision contained in the 2018 Plan, the number of common shares reserved for issuance under the 2018 Plan automatically increases on first day of each fiscal year, commencing on January 1, 2019, in an amount equal to the least of (1) 750,000 shares, (2) 4% of the total number of the Company&#8217;s common shares outstanding on the last day of the preceding fiscal year, or (3) a number of common shares as may be determined by the Company&#8217;s Board of Directors prior to any such increase date. On each of January 1, 2019, 2020 and 2021 the number of common shares authorized for issuance increased automatically by 750,000 shares in accordance with the evergreen provision, increasing the number of common shares reserved under the 2018 Plan to 3,750,000 as of March 31, 2021.</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the periods presented, the Company recorded the following share-based compensation expense for stock </span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options and restricted stock awards: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.806%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.553%"><tr><td style="width:1.0%"/><td style="width:52.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.816%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (weighted-average fair value of $38.55 per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, 857,094 options were vested and exercisable with weighted-average exercise price of $12.22&#160;per share and a total aggregate intrinsic value of $43.1&#160;million.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During the three months ended March&#160;31, 2021, 163,034 options were exercised at a weighted-average price of $11.54 per share. The intrinsic value of the options exercised during the three months ended March&#160;31, 2021 and 2020 was $7.3 million and $0.4&#160;million, respectively. Upon the exercise of stock options, the Company issued new shares from its authorized shares.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At March&#160;31, 2021, unrecognized compensation expense was $19.0 million related to stock options granted to employees and Board of Directors and $2.5 million related to stock options granted to consultants. The weighted-average period over which such compensation expense will be recognized is 2.5 years. </span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options Granted to Employees </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense for employees is based on the grant date fair value. The Company recognizes compensation expense for all share-based awards ratably on a straight-line basis over the requisite service period of the awards, which is generally the vesting term of four years. During the three months ended March&#160;31, 2021 and 2020, the Company recognized $1.1 million and $0.6 million, respectively, of share-based compensation expense for stock options granted to employees.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses the Black-Scholes option valuation model to value options granted to employees and consultants, which requires the use of highly subjective assumptions to determine the fair value of share-based awards. The assumptions used in the Company&#8217;s option-pricing model represent management&#8217;s best estimates. These estimates are complex, involve a number of variables, uncertainties and assumptions and the application of management&#8217;s judgment. If factors change and different assumptions are used, the Company&#8217;s share-based compensation expense could be materially different in the future. The assumptions and estimates that the Company uses in the Black-Scholes model are as follows: </span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Fair Value of Common Shares.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Following the Company&#8217;s IPO in 2018, the closing price of the Company&#8217;s publicly-traded common shares on the date of grant is used as the fair value of the shares. Prior to the </span></div><div style="margin-bottom:2pt;padding-left:36pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IPO, the fair value of ordinary shares was estimated on a periodic basis by the Company&#8217;s Board of Directors, with the assistance of an independent third-party valuation firm.&#160;The Board of Directors intended all options granted to be exercisable at a price per share not less than the estimated per share fair value of the shares underlying those options on the date of grant.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Risk-Free Interest Rate.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company bases the risk-free interest rate used in the Black-Scholes valuation model on the implied yield available on U.S. Treasury zero-coupon issues with a term equivalent to that of the term of the options for each option group on the measurement date.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Term.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> For employee stock options, the expected term represents the period that the Company&#8217;s share-based awards are expected to be outstanding. Because of the limitations on the sale or transfer of the Company&#8217;s shares during the period the Company was a privately held company, the Company does not believe its historical exercise pattern is indicative of the pattern it will experience as a publicly traded company. The Company consequently uses the Staff Accounting Bulletin 110, or SAB 110, simplified method to calculate the expected term of employee stock options, which is the average of the contractual term and vesting period. The Company plans to continue to use the SAB 110 simplified method until it has sufficient trading history as a publicly traded company. For consultant stock options, the term used is equal to the remaining contractual term on the measurement date.</span></div><div style="margin-bottom:2pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Volatility.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Company determines the price volatility based on the historical volatilities of industry peers as it does not have sufficient trading history for its shares. Industry peers consist of several public companies in the medical device industry with comparable characteristics, including revenue growth, operating model and working capital requirements. The Company intends to continue to consistently apply this process using the same or a similar peer group of public companies until a sufficient amount of historical information regarding the volatility of its own shares becomes available, or unless circumstances change such that the identified peer companies are no longer similar, in which case other suitable peer companies whose common share prices are publicly available would be utilized in the calculation. The volatility is calculated based on the term on the measurement date.</span></div><div style="margin-bottom:9.5pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9642;</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.46pt">Dividend Yield.</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The expected dividend assumption is based on the Company&#8217;s current expectations about its anticipated dividend policy. The Company has no expectation that it will declare dividends on its common shares, and therefore has used an expected dividend yield of zero.</span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to employees was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.761%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options Granted to Non-Employees </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Share-based compensation expense related to stock options granted to non-employees is recognized as the stock options are earned using an accelerated attribution method. The Company believes that the estimated fair value of the stock options is more readily measurable than the fair value of the services rendered. For the three months ended March&#160;31, 2021 and 2020, the Company recognized expense of $0.5 million and $0.8 million, respectively, for stock options granted to consultants. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.497%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.357%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Restricted Stock</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Each vested RSA entitles the holder to be issued one common share. These awards vest according to a vesting schedule determined by the Compensation Committee of the Company&#8217;s Board of Directors, generally over a <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF82MS9mcmFnOmNkNTA3NmQ2YWU2ZTQ5NDliY2UzNzgxODQ0ZmI3YjQ1L3RleHRyZWdpb246Y2Q1MDc2ZDZhZTZlNDk0OWJjZTM3ODE4NDRmYjdiNDVfNzU1OA_84b51ed7-33dc-4765-9c9e-ef71511b6db7">one</span> to four year period.</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents RSA activity for fiscal 2021:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:24pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of restricted stock is the grant date market value of common shares. The Company recognizes share-based compensation expense related to restricted stock using a straight-line method over the vesting term of the awards. The share-based compensation expense for RSAs that vested during the three months ended March&#160;31, 2021 and 2020, was $0.2 million and $0.1 million, respectively, which was calculated based on the market value of the Company&#8217;s common shares on the applicable date of vesting.</span></div>As of March&#160;31, 2021, the Company had unrecognized share-based compensation cost of approximately $0.3 million associated with unvested restricted stock awards. This cost is expected to be recognized over a weighted-average period of approximately 0.5 years.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -URI http://asc.fasb.org/topic&amp;trid=2228938<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>28
<FILENAME>R18.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793261912">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareTextBlock', window );">Net Loss Per Share</a></td>
<td class="text">Net Loss Per Share<div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share for the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used for basic and diluted earnings per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,827,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,456,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net loss per share is computed by dividing the net loss by the weighted-average number of shares outstanding for the period. Diluted net loss per share is computed by dividing the net loss by the weighted-average number of shares and dilutive share equivalents outstanding for the period, determined using the treasury-share method and the as-if converted method, for convertible securities, if inclusion of these is dilutive</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </span></div><div style="margin-top:6.25pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company reports a net loss</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, diluted net loss per share is the same as basic net loss per share for those periods because including the dilutive securities would be anti-dilutive.</span></div><div style="margin-bottom:9pt;margin-top:8.3pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.376%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.377%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,949,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746,843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for earnings per share.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109243012&amp;loc=SL65017193-207537<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -URI http://asc.fasb.org/topic&amp;trid=2144383<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>29
<FILENAME>R19.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874856648">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsAbstract', window );"><strong>Related Party Transactions [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock', window );">Related Party Transactions</a></td>
<td class="text">Related Party Transactions<div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During each of the three months ended March&#160;31, 2021 and 2020, the Company recorded revenue of $0.2 million for product sales to Herramientas Medicas, S.A., a distribution company owned by a family member of the Chief Executive Officer of the Company. Accounts receivable owed to the Company from this distribution company amounted to approximately $0.2 million for each of March&#160;31, 2021 and December&#160;31, 2020. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2016, the Company entered into a scientific board advisory agreement with Dr. Manuel Enrique Chac&#243;n Quir&#243;s, the brother of our Chief Executive Officer, Juan Jos&#233; Chac&#243;n Quir&#243;s, pursuant to which Dr. Chac&#243;n Quir&#243;s joined the Company&#8217;s Scientific Advisory Board, provided general scientific advice, and served as a clinical investigator, among other services. In exchange for these services, Dr. Chac&#243;n Quir&#243;s was granted options to purchase </span></div>20,580 shares. The grant vested over four years in equal annual installments. Dr. Chac&#243;n Quir&#243;s resigned from the Company&#8217;s Scientific Advisory Board in November 2019.In 2016, the Company also entered into a separate agreement with Dr.&#160;Chac&#243;n Quir&#243;s to maintain his clinic in Costa Rica as a MotivaImagine Excellence Center and to host and train physicians in the use of the Company products in relevant procedures, among other services, in exchange for cash reimbursement of up to $4,500 per day that such services are rendered. In December 2020, Dr. Chac&#243;n Quir&#243;s was granted options to purchase 22,068 shares vesting over four years in equal annual installments, provided that he continues to provide these services at such times. During the three months ended March&#160;31, 2021 and 2020, the Company paid Dr. Chac&#243;n Quir&#243;s approximately $93,000 and $20,000, respectively, for services rendered.<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -URI http://asc.fasb.org/topic&amp;trid=2122745<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39691-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>R20.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794625320">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Commitments and Contingencies<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract', window );"><strong>Commitments and Contingencies Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock', window );">Commitments and Contingencies</a></td>
<td class="text">Commitments and Contingencies<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Contingencies</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, the Company may have certain contingent liabilities that arise in the ordinary course of business activities. The Company accrues a liability for such matters when it is probable that future expenditures will be made, and such expenditures can be reasonably estimated. There have been no contingent liabilities requiring accrual or disclosure at March&#160;31, 2021 and 2020 except for contingent equity consideration related to past asset acquisitions as of March 31, 2020.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:107%">Indemnification</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company enters into standard indemnification arrangements in the ordinary course of business. Pursuant to these arrangements, the Company indemnifies, holds harmless, and agrees to reimburse the indemnified parties for losses suffered or incurred by the indemnified party, in connection with any trade secret, copyright, patent or other intellectual property infringement claim by any third-party with respect to the Company&#8217;s technology. The term of these indemnification agreements is generally perpetual. The maximum potential amount of future payments the Company could be required to make under these agreements is not determinable because it involves claims that may be made against the Company in the future, but have not yet been made.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has entered into indemnification agreements with its directors and officers that may require the Company to indemnify its directors and officers against liabilities that may arise by reason of their status or service as directors or officers, other than liabilities arising from willful misconduct of the individual.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has not incurred costs to defend lawsuits or settle claims related to these indemnification agreements. No liability associated with such indemnifications has been recorded to date.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommitmentsAndContingenciesDisclosureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The entire disclosure for commitments and contingencies.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 450<br> -URI http://asc.fasb.org/topic&amp;trid=2127136<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -URI http://asc.fasb.org/topic&amp;trid=2144648<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 440<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121559207&amp;loc=d3e25336-109308<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommitmentsAndContingenciesDisclosureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>31
<FILENAME>R21.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875420664">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Policies)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock', window );">Basis of Presentation and Consolidation/Unaudited Interim Condensed Consolidated Financial Information</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Basis of Presentation and Consolidation </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America, or GAAP, and the applicable rules and regulations of the Securities and Exchange Commission, or SEC, for interim financial information. Accordingly, they do not include all of the information and notes required by GAAP for complete financial statements. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying condensed consolidated financial statements and related financial information should be read </span></div>in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#8217;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.Unaudited Interim Condensed Consolidated Financial InformationThe accompanying interim condensed consolidated financial statements as of March&#160;31, 2021 and for the three months ended March&#160;31, 2021 and 2020, and the related interim information contained within the notes to the condensed consolidated financial statements, are unaudited. The unaudited interim condensed consolidated financial statements have been prepared in accordance with GAAP and on the same basis as the audited consolidated financial statements. In the opinion of management, the accompanying unaudited interim condensed consolidated financial statements contain all adjustments which are necessary to state fairly the Company&#8217;s financial position as of March&#160;31, 2021, and the results of its operations and cash flows for the three months ended March&#160;31, 2021 and 2020. Such adjustments are of a normal and recurring nature. The results for the three months ended March&#160;31, 2021 are not necessarily indicative of the results to be expected for the full fiscal year 2021, or for any future period.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConsolidationPolicyTextBlock', window );">Consolidation</a></td>
<td class="text">The accompanying condensed consolidated financial statements and related financial information should be read <div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">in conjunction with the audited consolidated financial statements and the related notes thereto for the years ended December&#160;31, 2020 and 2019 presented in the Company&#8217;s Form 10-K filed on March&#160;15, 2021, with the U.S. Securities and Exchange Commission.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the Company&#8217;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.406%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporation/Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs, S.A. (Costa Rica)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2004</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva USA, LLC (USA)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JAMM Technologies, Inc. (USA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs Produtos par Saude Ltda (Brazil)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Distribution Center Motiva BVBA (Belgium)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants France SAS (France)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 12, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JEN-Vault AG (Switzerland)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Nordica AB (Sweden)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants UK Limited (the United Kingdom)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Italy S.R.L (Italy)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants Spain, S.L. (Spain)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 3, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Austria GmbH (Austria)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 14, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Germany GmbH (Germany)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Argentina S.R.L (Argentina)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div>All intercompany accounts and transactions have been eliminated in consolidation.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SegmentReportingPolicyPolicyTextBlock', window );">Segments</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Segments</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The chief operating decision maker for the Company is the Chief Executive Officer. The Chief Executive Officer reviews financial information presented on a consolidated basis, accompanied by information about revenue by geographic region, for purposes of allocating resources and evaluating financial performance. The Company has one business activity and there are no segment managers who are held accountable for operations, operating results or plans for levels or components below the consolidated unit level. Accordingly, the Company has determined that it has a single reportable and operating segment structure. The Company and its Chief Executive Officer evaluate performance based primarily on revenue in the geographic regions in which the Company operates.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_GeographicConcentrationsPolicyPolicyTextBlock', window );">Geographic Concentrations</a></td>
<td class="text">Geographic Concentrations The Company derives all its revenues from sales to customers in Europe, the Middle East, Latin America, and Asia, and has not yet received approval to sell its products in the United States.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_UseOfEstimates', window );">Use of Estimates</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the amounts reported in the condensed consolidated financial statements and accompanying notes. Significant accounting </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">estimates and management judgments reflected in the condensed </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">consolidated</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> financial statements include items such as accounts receivable valuation and allowances, inventory valuation and allowances, valuation of acquired intangible assets, valuation of derivatives, estimation of assets&#8217; useful lives and valuation of deferred income tax assets, including tax valuation allowances. Estimates are based</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on historical experience, where applicable, and other assumptions believed to be reasonable by management. Actual results may differ from those estimates under different assumptions or conditions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskCreditRisk', window );">Concentration of Credit Risk and Other Risks and Uncertainties</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Financial instruments that potentially subject the Company to a concentration of credit risk consist principally of cash and accounts receivable. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. Balances in the Company&#8217;s cash accounts exceed the Federal Deposit Insurance Corporation, or FDIC, limit of $250,000. The Company has not experienced any losses to its deposits of cash.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All of the Company&#8217;s revenue has been derived from sales of its products in international markets, principally Europe, the Middle East, Latin America, and Asia. In the international markets in which the Company participates, the Company uses a combination of distributors and makes direct sales to customers. The Company performs ongoing credit evaluations of its distributors and customers, does not require collateral, and maintains allowances for potential credit losses on customer accounts when deemed necessary.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Substantially all of the Company&#8217;s revenues were derived from the sale of Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, no customer accounted for more than 10% of the Company&#8217;s revenue. No customer accounted for more than 10% of the Company&#8217;s trade accounts receivable balance as of March&#160;31, 2021 or </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on Avantor, Inc., formerly known as NuSil Technology, LLC, or NuSil, as the sole supplier of medical-grade silicone used in Motiva Implants. During the three months ended March&#160;31, 2021 and 2020, the Company had purchases of $4.3 million, or 55.8% of total purchases, and $5.0&#160;million, or 64.9% of total purchases, respectively, from NuSil. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, the Company had an outstanding balance owed to this vendor of $1.6 million and $1.3 million, respectively.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s future results of operations involve a number of risks and uncertainties. Factors that could affect the Company&#8217;s future operating results and cause actual results to vary materially from expectations include, but are not limited to, uncertainty of regulatory approval of the Company&#8217;s current and potential future products, uncertainty of market acceptance of the Company&#8217;s products, competition from substitute products and larger companies, securing and protecting proprietary technology, strategic relationships and dependence on key individuals and sole source suppliers. </span></div>Products developed by the Company require clearances from the FDA or other international regulatory agencies prior to commercial sales. There can be no assurance that the products will receive the necessary clearances. If the Company was denied clearance, clearance was delayed, or the Company was unable to maintain its existing clearances, these developments could have a material adverse impact on the Company.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy', window );">Cash</a></td>
<td class="text">Cash The Company&#8217;s cash consists of cash maintained in checking and interest-bearing accounts. The majority of the Company&#8217;s cash is held at two financial institutions in the United States. The Company accounts for financial instruments with original maturities of three months or less at the date of purchase as cash equivalents.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy', window );">Accounts Receivable and Allowance for Doubtful Accounts</a></td>
<td class="text">Accounts Receivable and Allowance for Doubtful AccountsAccounts receivable is stated at invoice value less estimated allowances for returns and doubtful accounts. The Company continually monitors customer payments and maintains an allowance for estimated losses resulting from customers&#8217; inability to make required payments. In evaluating the Company&#8217;s ability to collect outstanding receivable balances, the Company considers various factors including the age of the balance, the creditworthiness of the customer, which is assessed based on ongoing credit evaluations and payment history, and the customer&#8217;s current financial condition. In cases where there are circumstances that may impair a specific customer&#8217;s ability to meet its financial obligations, an allowance is recorded against amounts due, which reduces the net recognized receivable to the amount reasonably believed to be collectible.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryPolicyTextBlock', window );">Inventory and Cost of Revenue</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Inventory and Cost of Revenue</span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Inventory is stated at the lower of cost to purchase or manufacture the inventory or the net realizable value of such inventory. Cost is determined using the standard cost method which approximates actual costs using the first-in, first-out basis. The Company regularly reviews inventory quantities considering actual losses, projected future demand, and remaining shelf life to record a provision for excess and slow-moving inventory. An inventory reserve of $1.7 million and $1.6 million has been recorded as of </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes the cost of inventory transferred to the customer in cost of revenue when revenue is recognized.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeasesPolicyTextBlock', window );">Leases</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Leases</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company determines if an arrangement is, or contains, a lease at the inception date of the contract. The Company has elected an expedient to account for each separate lease component and its associated non-lease components as a single lease component for the majority of its asset classes.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The lease term may include periods covered by options to extend or terminate the lease when it is reasonably certain that the Company will exercise a renewal option, or reasonably certain it will not exercise an early termination option. The Company recognizes lease liabilities and right-of-use, or ROU, assets upon commencement for all leases with a term greater than 12 months. The Company has elected an expedient not to recognize leases with a lease term of 12 months or less on the balance sheet. These short-term leases are expensed on a straight-line basis over the lease term.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock', window );">Shipping and Handling Costs/Revenue Recognition</a></td>
<td class="text">Shipping and Handling CostsShipping and handling costs are expensed as incurred and are included in selling, general and administrative, or SG&amp;A, expenses.<div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Revenue Recognition</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to sales of products to distributors or directly to customers in markets </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">where it has regulatory approval, net of discounts and allowances. The Company recognizes revenue in accordance with Accounting Standards Codification, or ASC, 606, Revenue from Contracts with Customers. ASC 606 requires the Company to recognize revenue to depict the transfer of goods or services to a customer at an amount that reflects the consideration it expects to receive in exchange for those goods or services.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue related to the sales of products to distributors at the time of shipment of the product, which represents the point in time when the distributor has taken ownership and assumed the risk of loss and the required revenue recognition criteria are satisfied. The Company&#8217;s distributors are obligated to pay within specified terms regardless of when, or if, they sell the products. The Company&#8217;s contracts with distributors typically do not contain right of return or price protection and have no post-delivery obligations.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recognizes revenue when title to the product and risk of loss transfer to customers, provided there are no remaining performance obligations required of the Company or any written matters requiring customer acceptance. The Company allows for the return of product from direct customers in certain regions in limited instances within fifteen days after the original sale and records estimated sales returns as a reduction of sales in the same period revenue is recognized. Appropriate reserves are established for anticipated sales returns based on historical experience, recent gross sales and any notification of pending returns. Actual sales returns in any future period are inherently uncertain and thus may differ from the estimates. If actual sales returns differ significantly from the estimates, an adjustment to revenue in the current or subsequent period is recorded. As of March&#160;31, 2021 and </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">December&#160;31, 2020</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, an allowance of zero and $54,000 was recorded for product returns, respectively.</span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A portion of the Company&#8217;s revenue is generated from the sale of consigned inventory maintained at physician, hospital, and clinic locations. For these products, revenue is recognized at the time the Company is notified by the consignee that the product has been implanted, not when the consigned products are delivered to the consignee&#8217;s warehouse. </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was generated in these primary geographic markets:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific/Middle East</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company has a limited warranty for the shelf life of the product, which is five years from the time of manufacture. Estimated warranty obligations are recorded at the time of sale. The Company also offers a warranty to patients in the event of rupture and a replacement program for capsular contracture events, provided certain registration requirements are met. Revenue for extended warranties is recognized ratably over the term of the agreement. To date, these warranty and program costs have been de minimis. The Company will continue to evaluate the warranty reserve policies for adequacy considering claims history.</span></div>Deferred revenue primarily consists of payments received in advance of meeting revenue recognition criteria. The Company has received payments from distributors to provide distribution exclusivity within a geographic area and recognizes deferred revenue on a ratable basis over the term of such contractual distribution relationship. Additionally, the Company has received payments from customers in direct markets prior to surgical implantation and recognizes deferred revenue at the time the Company is notified by the customer that the product has been implanted. For all arrangements, any revenue that has been deferred and is expected to be recognized beyond one year is classified as long-term deferred revenue and included in &#8220;Other liabilities, long-term&#8221; on the condensed consolidated balance sheets (see Note 3).<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ResearchAndDevelopmentExpensePolicy', window );">Research and Development</a></td>
<td class="text"><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Research and Development</span></div><div style="margin-bottom:5pt;margin-top:5pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs related to research and development, or R&amp;D, activities are expensed as incurred. R&amp;D costs primarily include personnel costs, materials, clinical expenses, regulatory expenses, product development, consulting services, and outside research activities, all of which are directly related to research and development activities. </span></div>The Company estimates IDE clinical trial expenses based on the services performed, pursuant to contracts with research institutions and clinical research organizations that conduct and manage clinical trials on its behalf. In accruing service fees, the Company estimates the time period over which services will be performed and the level of patient enrollment and activity expended in each period. If the actual timing of the performance of services or the level of effort varies from the estimate, the Company will adjust the accrual accordingly.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock', window );">Selling, General and Administrative Expenses</a></td>
<td class="text">Selling, General and Administrative ExpensesSG&amp;A expenses include sales and marketing costs, payroll and related benefit costs, insurance expenses, shipping and handling costs, legal and professional fees and administrative overhead.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock', window );">Property and Equipment</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Property and Equipment</span></div><div style="margin-bottom:6pt;margin-top:4.05pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Property and equipment are stated at cost less accumulated depreciation and amortization.</span></div>Following the exercise of its option to purchase its manufacturing facility in June 2019, the Company depreciates the owned building on a straight-line basis over 50 years of useful life. Depreciation of property and equipment is computed using the straight-line method over the assets&#8217; estimated useful lives of <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMTY3Njg_e9d6adec-b325-4f94-86a8-60f2b1fbcb2b">five</span> to ten years. Leasehold improvements are amortized on a straight-line basis over the shorter of the estimated useful life of the asset or the remaining lease term after factoring expected renewal periods. Upon retirement or disposal of assets, the costs and related accumulated depreciation are eliminated from the accounts and any gain or loss is recognized in operations. Maintenance and repairs are expensed as incurred. Substantially all of the Company&#8217;s manufacturing operations and related property and equipment is located in Costa Rica.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock', window );">Goodwill and Intangible Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Goodwill and Intangible Assets</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records the excess of the acquisition purchase price over the net fair value of the tangible and identifiable intangible assets acquired and liabilities assumed as goodwill. In accordance with ASC 350, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Intangibles - Goodwill and Other, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the Company tests goodwill for impairment annually during the fourth quarter of each year and whenever events or changes in circumstances indicate that the carrying value of the asset may not be recoverable. In connection with the annual impairment test for goodwill, the Company elected the option to perform a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying amount. If the Company determines that it was more likely than not that the fair value of the reporting unit is less than its carrying amount, then the impairment test is performed. </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Consistent with the Company's assessment that it has only one reporting segment, the Company has determined that it has only one reporting unit and tests goodwill for impairment at the entity level using the two-step process required by ASC 350. In the first step, the Company compares the carrying amount of the reporting unit to the fair value of the enterprise. If the fair value of the enterprise exceeds the carrying value, goodwill is not considered impaired and no further testing is required. If the carrying value of the enterprise exceeds the fair value, goodwill is potentially impaired, and the second step of the impairment test must be performed. In the second step, the Company compares the implied fair value of the goodwill, as defined by ASC 350, to its carrying amount to determine the impairment loss, if any.</span></div><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">The Company capitalizes certain costs related to intangible assets, such as patents, trademarks and software </span></div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">development costs. The Company follows the provisions of ASC 350-40, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:115%">Internal Use Software </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:115%">for determining whether computer software is internal-use software and on accounting for the proceeds of computer software originally developed or obtained for internal use. The Company expenses all costs incurred during the preliminary project stage of software development and capitalizes the costs incurred during the application development stage. Costs incurred relating to upgrades and enhancements to the software are capitalized if it is determined that these upgrades or enhancements add additional functionality to the software. Costs incurred to improve and support products after they become available are charged to expense as incurred.</span>The Company records purchased intangible assets at their respective estimated fair values at the date of acquisition. Purchased finite-lived intangible assets are being amortized using the straight-line method over their remaining estimated useful lives, which range from <span style="-sec-ix-hidden:id3VybDovL2RvY3MudjEvZG9jOjFmZmQzODRiMjk5ZDQ4N2ZhNWIxNGYxMzAwM2M1NmQ0L3NlYzoxZmZkMzg0YjI5OWQ0ODdmYTViMTRmMTMwMDNjNTZkNF8zNy9mcmFnOmQwN2ZhZWYyOTNlMjQzZTdhYzI5MmIyMWEyNzYwMWZmL3RleHRyZWdpb246ZDA3ZmFlZjI5M2UyNDNlN2FjMjkyYjIxYTI3NjAxZmZfMjAxNzQ_8859136f-e50b-424a-a955-35295d59bd94">two</span> to fifteen years. The Company evaluates the remaining useful lives of intangible assets on a periodic basis to determine whether events or circumstances warrant a revision to the remaining estimated amortization period. The Company tests indefinite-lived intangible assets for impairment on at least an annual basis and whenever circumstances suggest the assets may be impaired. If indicators of impairment are present, the Company evaluates the carrying value of the intangible assets in relation to estimates of future undiscounted cash flows. The Company also evaluates the remaining useful life of an indefinite-lived intangible asset to determine whether events and circumstances continue to support an indefinite useful life.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock', window );">Long-Lived Assets</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Long-Lived Assets</span></div><div style="margin-bottom:6pt;margin-top:4.4pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company reviews long-lived assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset might not be recoverable. When such an event occurs, management determines whether there has been impairment by comparing the anticipated undiscounted future net cash flows to the related asset group&#8217;s carrying value. If an asset is considered impaired, the asset is written down to fair value, which is determined based either on discounted cash flows or appraised value, depending on the nature of the asset. There were no impairment charges, or changes in estimated useful lives recorded d</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">uring the year ended December&#160;31, 2020. As of March&#160;31, 2021, no triggering events have occurred which would indicate that the acquired </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">long-lived</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> asset values may not be recoverable.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativesEmbeddedDerivatives', window );">Debt and Embedded Derivatives</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt and Embedded Derivatives</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company applies the accounting standards for derivatives and hedging and for distinguishing liabilities from equity when accounting for hybrid contracts. The Company accounts for convertible debt instruments when the Company has determined that the embedded conversion options should not be bifurcated from their host instruments in accordance with ASC 470-20 </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and Other Options</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (see Note 6).</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company uses option pricing valuation models to determine the fair value of embedded derivatives and records any change in fair value as a component of other income or expense in the condensed consolidated statements of operations (see Note&#160;5).</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtPolicyTextBlock', window );">Debt Issuance Costs and Debt Discounts</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Debt Issuance Costs and Debt Discounts</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Costs incurred in connection with the issuance of new debt are capitalized. Capitalizable debt issuance costs paid to third parties and debt discounts, net of amortization, are recorded as a reduction to the long-term debt balance on the condensed consolidated balance sheets. Amortization expense on capitalized debt issuance costs and debt discounts related to loans are calculated using the effective interest method over the term of the loan commitment and is recorded as interest expense in the condensed consolidated statements of operations.</span></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeTaxPolicyTextBlock', window );">Income Taxes</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Income Taxes</span></div><div style="margin-bottom:6pt;margin-top:4.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records income taxes using the asset and liability method, which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been recognized in the Company&#8217;s consolidated financial statements or income tax returns. In estimating future tax consequences, expected future events, enactments or changes in the tax law or rates are considered. Valuation allowances are provided when necessary to reduce deferred tax assets to the amount expected to be realized.</span></div><div style="margin-bottom:6pt;margin-top:4.09pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in various tax jurisdictions and is subject to audit by various tax authorities.</span></div><div style="margin-bottom:6pt;margin-top:4.34pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company records uncertain tax positions based on a two-step process whereby (1) a determination is made as to whether it is more likely than not that the tax positions will be sustained based on the technical merits of the position and (2) for those tax positions that meet the more-likely-than-not recognition threshold the Company recognizes the largest amount of tax benefit that is greater than 50% likely to be realized upon ultimate settlement with the related tax authority. </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s policy is to recognize interest and penalties accrued on any unrecognized tax benefits as a component of income tax expense. Significant judgment is required in the identification of uncertain tax positions and in the estimation of penalties and interest on uncertain tax positions.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock', window );">Foreign Currency</a></td>
<td class="text">Foreign Currency The financial statements of the Company&#8217;s foreign subsidiaries whose functional currencies are the local currencies are translated into U.S. dollars for consolidation as follows: assets and liabilities at the exchange rate as of the balance sheet date, stockholders&#8217; equity at the historical rates of exchange, and income and expense amounts at the average exchange rate for the period. Translation adjustments resulting from the translation of the subsidiaries&#8217; accounts are included in &#8220;Accumulated other comprehensive income&#8221; as equity in the condensed consolidated balance sheet. Transactions denominated in currencies other than the applicable functional currency are converted to the functional currency at the exchange rate on the transaction date. At period end, monetary assets and liabilities are remeasured to the functional currency using exchange rates in effect at the balance sheet date. Non-monetary assets and liabilities are remeasured at historical exchange rates. Gains and losses resulting from foreign currency transactions are included within &#8220;Other expense, net&#8221; in the condensed consolidated statement of operations.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock', window );">Comprehensive Income (Loss)</a></td>
<td class="text">Comprehensive LossThe Company&#8217;s comprehensive loss consists of net loss and foreign currency translation adjustments arising from the consolidation of the Company&#8217;s foreign subsidiaries.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy', window );">Share-based Compensation</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Share-Based Compensation </span></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company measures and recognizes compensation expense for all share-based awards in accordance with the provisions of ASC 718, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Compensation</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Share-based awards granted include stock options, restricted stock units, or RSUs, and restricted stock awards, or RSAs. Share-based compensation expense for stock options and RSAs granted to employees is measured at the grant date based on the fair value of the awards and is recognized as an expense ratably on a straight-line basis over the requisite service period. The fair value of options to purchase shares granted to employees is estimated on the grant date using the Black-Scholes option valuation model. </span></div>The calculation of share-based compensation expense requires the Company to make assumptions and judgments about the variables used in the Black-Scholes model, including the expected term, expected volatility of the underlying common shares, risk-free interest rate and dividends.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerSharePolicyTextBlock', window );">Net Income (Loss) Per Share</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Net Income (Loss) Per Share </span></div><div style="margin-bottom:6pt;margin-top:6.25pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Basic net income (loss) per share is calculated by dividing the net income (loss) attributable to shareholders by the weighted-average number of shares outstanding during the period, without consideration for potentially dilutive securities. Diluted net income (loss) per share is computed by dividing the net income (loss) by the weighted-average number of shares and potentially </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">dilutive </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">securities outstanding for the period. For purposes of the diluted net loss per share calculation, any shares issuable upon exercise of warrants, stock options and non-vested restricted stock outstanding under the Company&#8217;s equity plan are potentially dilutive securities. Diluted net loss per share is the same as basic net loss per share for periods where the Company reported a net loss because including the dilutive securities would be anti-dilutive.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription', window );">Reclassifications</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassifications</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior year amounts to conform to the current year presentation due to the adoption of ASU No. 2016-02, </span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Leases (Topic 842)</span><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> effective January 1, 2020, using the modified retrospective </span></div>approach. These reclassifications had no material impact on the results of operations or the cash flows of the Company for the three months ended March 31, 2020.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock', window );">Recent Accounting Standards</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Recent Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Periodically, new accounting pronouncements are issued by the Financial Accounting Standards Board, or FASB, or other standard setting bodies and adopted by the Company as of the specified effective date. Unless otherwise discussed, the impact of recently issued standards that are not yet effective will not have a material impact on the Company&#8217;s consolidated financial statements upon adoption. Under the Jumpstart Our Business Startups Act of 2012, or JOBS Act, the Company meets the definition of an emerging growth company, and has elected the extended transition period for complying with new or revised accounting standards pursuant to Section&#160;107(b) of the JOBS Act. The Company will remain an emerging growth company until the earliest of (1)&#160;the last day of its first fiscal year (a)&#160;following the fifth anniversary of the completion of our initial public offering, (b)&#160;in which we have total annual gross revenue of at least $1.07 billion, or (c)&#160;in which we are deemed to be a large accelerated filer, which means the market value of our common stock that is held by non-affiliates exceeds $700.0 million as of the prior June 30</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and (2)&#160;the date on which we have issued more than $1.0 billion in non-convertible debt securities during the prior three-year period.</span></div><div style="margin-bottom:6pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following recent accounting pronouncements issued by the FASB, could have a material effect on our financial statements:</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Adopted Accounting Standards</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2018, the FASB issued ASU 2018-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Fair Value Measurement: Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU modifies the disclosure requirements for fair value measurements. The modifications removed the following disclosure requirements: (i) the amount of, and reasons for, transfers between Level 1 and Level 2 of the fair value hierarchy; (ii) the policy for timing of transfers between levels; and (iii) the valuation processes for Level 3 fair value measurements. This ASU added the following disclosure requirements: (i) the changes in unrealized gains and losses for the period included in other comprehensive income, or OCI, for recurring Level 3 fair value measurements held at the end of the reporting period; and (ii) the range and weighted average of significant observable inputs used to develop Level 3 fair value measurements. This update is effective for non-public entities for annual and interim periods beginning after December 15, 2020, with early adoption permitted. The Company adopted ASU 2018-13 on January 1, 2021. As the requirements of this literature are disclosure only, ASU 2018-13 did not impact our financial condition or results of operations.</span></div><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Recently Issued Accounting Standards </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In August 2020, the FASB issued ASU No. 2020-06, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Debt with Conversion and other Options (Subtopic 470-20) and Derivatives and Hedging - Contracts in Entity&#8217;s Own Equity (Subtopic 815-40)</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The new guidance eliminates the beneficial conversion and cash conversion accounting models for convertible instruments. It also amends the accounting for certain contracts in an entity&#8217;s own equity that are currently accounted for as derivatives because of specific settlement provisions. In addition, the new guidance modifies how particular convertible instruments and certain contracts that may be settled in cash or shares impact the diluted EPS computation. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The Company is currently evaluating the effect the updated standard will have on its consolidated financial statements and footnote disclosures.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In December 2019, the FASB issued ASU No. 2019-12, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as part of its initiative to reduce complexity in the accounting standards. The standard eliminates certain exceptions related to the approach for intra-period tax allocation, the methodology for calculating income taxes in an interim period and the recognition of deferred tax liabilities for outside basis differences. The standard also clarifies and simplifies other aspects of the accounting for income taxes. The standard is effective for nonpublic business entities and emerging growth companies for fiscal years after December 15, 2021, and interim periods within fiscal years beginning after December 15, 2022. Early adoption is permitted. The Company is </span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">currently evaluating the impact that this guidance will have upon its financial position and results of operations, if any.</span></div><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In June 2016, the FASB issued ASU 2016-13, </span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Financial Instruments - Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments</span><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. This ASU replaces the impairment methodology in current GAAP, which delays recognition of credit losses until it is probable a loss has been incurred, with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. For non-public business entities and emerging growth companies the standard is effective for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The Company is currently assessing the impact the adoption of ASU 2016-13 will have on its consolidated financial statements and footnote disclosures.</span></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_GeographicConcentrationsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Geographic Concentrations, Policy [Policy Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_GeographicConcentrationsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_BasisOfAccountingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_BasisOfAccountingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121583591&amp;loc=d3e4273-108586<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ComprehensiveIncomePolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for comprehensive income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ComprehensiveIncomePolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskCreditRisk">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for credit risk.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 825<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=108315417&amp;loc=d3e61044-112788<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskCreditRisk</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConsolidationPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 810<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109239629&amp;loc=d3e5614-111684<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConsolidationPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6802200&amp;loc=d3e1835-112601<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativesEmbeddedDerivatives">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5B<br> -URI http://asc.fasb.org/extlink&amp;oid=107671284&amp;loc=SL5844817-113951<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=77984636&amp;loc=d3e40733-113955<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=56949186&amp;loc=d3e50579-113967<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 15<br> -Section 25<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121596415&amp;loc=d3e48542-113965<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativesEmbeddedDerivatives</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerSharePolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3630-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerSharePolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -URI http://asc.fasb.org/topic&amp;trid=2175825<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 05<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226317&amp;loc=d3e202-110218<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.CC)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011434&amp;loc=d3e125687-122742<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeTaxPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 25<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32247-109318<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32847-109319<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 954<br> -SubTopic 740<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6491622&amp;loc=d3e9504-115650<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32840-109319<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116657188&amp;loc=SL116659661-227067<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32639-109319<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=120406818&amp;loc=d3e32280-109318<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 740<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=84230637&amp;loc=d3e32809-109319<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeTaxPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4556-108314<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=116847112&amp;loc=d3e4492-108314<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 270<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=116846552&amp;loc=d3e543-108305<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -URI http://asc.fasb.org/topic&amp;trid=2126998<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeasesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for leasing arrangement entered into by lessee.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918666-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeasesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PriorPeriodReclassificationAdjustmentDescription">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6359566&amp;loc=d3e326-107755<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PriorPeriodReclassificationAdjustmentDescription</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99779-112916<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 958<br> -SubTopic 360<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=120429125&amp;loc=d3e99893-112916<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 310<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121611835&amp;loc=d3e5144-111524<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ResearchAndDevelopmentExpensePolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 730<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6420194&amp;loc=d3e21568-108373<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ResearchAndDevelopmentExpensePolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for revenue from contract with customer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130561-203045<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -URI http://asc.fasb.org/topic&amp;trid=49130388<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130563-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18823-107790<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 19<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130564-203045<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130566-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SegmentReportingPolicyPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for segment reporting.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 29<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8864-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SegmentReportingPolicyPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 720<br> -SubTopic 35<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6420018&amp;loc=d3e36677-107848<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=84158767&amp;loc=d3e18780-107790<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b),(f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_UseOfEstimates">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 12<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6191-108592<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6161-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6143-108592<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6061-108592<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6132-108592<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e5967-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_UseOfEstimates</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>32
<FILENAME>R22.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793346984">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountingPoliciesAbstract', window );"><strong>Accounting Policies [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_ScheduleOfConsolidatedEntitiesTableTextBlock', window );">Schedule of Consolidated Entities</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The condensed consolidated financial statements include the Company&#8217;s accounts and those of its wholly owned subsidiaries as of March&#160;31, 2021 as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.394%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.406%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Subsidiary</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Incorporation/Acquisition Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs, S.A. (Costa Rica)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 18, 2004</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva USA, LLC (USA)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 20, 2014</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JAMM Technologies, Inc. (USA)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">October 27, 2015</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Establishment Labs Produtos par Saude Ltda (Brazil)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">European Distribution Center Motiva BVBA (Belgium)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 4, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants France SAS (France)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">September 12, 2016</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JEN-Vault AG (Switzerland)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 22, 2016</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Nordica AB (Sweden)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">November 2, 2017</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants UK Limited (the United Kingdom)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Italy S.R.L (Italy)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">July 31, 2018</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Implants Spain, S.L. (Spain)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 3, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Austria GmbH (Austria)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">January 14, 2019</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Germany GmbH (Germany)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">August 1, 2019</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Motiva Argentina S.R.L (Argentina)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">February 7, 2020</span></td></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueTableTextBlock', window );">Disaggregation of Revenue</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Revenue was generated in these primary geographic markets:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:68.096%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.395%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Europe</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,693&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,779&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Latin America</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,001&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,141&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Asia-Pacific/Middle East</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,495&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,471&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">147&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,336&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,481&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_ScheduleOfConsolidatedEntitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Schedule Of Consolidated Entities [Table Text Block]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_ScheduleOfConsolidatedEntitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountingPoliciesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountingPoliciesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>33
<FILENAME>R23.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210881307432">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock', window );">Schedule of inventory, current</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Raw materials</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,450&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Work in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,121&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finished goods</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,647&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,639&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,377&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,210&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentTextBlock', window );">Property, Plant and Equipment</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Machinery and equipment</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,232&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building improvements</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Furniture and fixtures</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,268&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,092&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Building</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Leasehold improvements</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,065&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Land</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">802&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vehicles</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">395&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">399&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Construction in process</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">317&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26,491&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Accumulated depreciation and amortization</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(10,170)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(9,633)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,321&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16,202&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock', window );">Schedule of Accrued Liabilities</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accrued liabilities consisted of the following:</span></div><div style="margin-bottom:3pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Performance bonus</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">971&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,406&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payroll and related expenses</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,619&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,781&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bonus feature of stock option grants</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,605&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,992&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - current</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Commissions</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">648&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">628&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Professional and legal services</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">469&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">439&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Short-term minimum lease payments under finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warranty reserve</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">236&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">237&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Advisory board and board of director related expenses</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">699&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,021&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,408&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,532&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock', window );">Other Current Liabilities</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, short-term consisted of the following:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,024&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,214&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">407&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">432&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,431&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,646&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock', window );">Other Noncurrent Liabilities</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Other liabilities, long-term consisted of the following:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.947%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.632%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.633%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(in thousands)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Deferred revenue</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,778&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,860&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cash payable for asset acquisitions</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">425&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,820&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,332&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherCurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other current liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherCurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherNoncurrentLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of other noncurrent liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherNoncurrentLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the components of accrued liabilities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfInventoryCurrentTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6361739&amp;loc=d3e7789-107766<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfInventoryCurrentTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>34
<FILENAME>R24.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874834600">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfGoodwillTextBlock', window );">Schedule of Goodwill</a></td>
<td class="text"><div style="margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There were no changes in the carrying amount of goodwill during the three months ended March&#160;31, 2021:</span></div><div style="margin-bottom:6pt;margin-top:6pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.404%"><tr><td style="width:1.0%"/><td style="width:48.450%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.876%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.025%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.548%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.880%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of January 1, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Additions</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Impairment Losses</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Balance as of March 31, 2021</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Goodwill</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,819)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock', window );">Schedule of Indefinite-Lived Intangible Assets</a></td>
<td class="text"><div style="margin-top:30pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of these intangible assets other than goodwill as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(994)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">742&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,452)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">581&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(203)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">364&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(47)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,497&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(411)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,086&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(28)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">47&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,261&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(3,135)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,126&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The carrying amounts of intangible assets other than goodwill as of December&#160;31, 2020 were as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:50.989%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.885%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Gross Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Accumulated Amortization</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Carrying Amount</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Estimated Useful Lives</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in years)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Patents and license rights</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,736&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(951)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7-12</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Customer relationships</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,033&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(1,297)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">736&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4-10</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510(k) authorization</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">567&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(194)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">373&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Developed technology</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">62&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(46)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized software development costs</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,203&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(302)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,901&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Other</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(29)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">46&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2-5</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Capitalized patents and license rights not yet amortized</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">291&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,967&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(2,819)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,148&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock', window );">Schedule of Finite-Lived Intangible Assets, Future Amortization Expense</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As of March&#160;31, 2021, the amortization expense related to identifiable intangible assets, with definite useful lives, in future periods is expected to be as follows:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:85.209%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%;text-decoration:underline">Year Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021 (remaining)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">875&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">617&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">592&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">393&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">490&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,835&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16265-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfGoodwillTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfGoodwillTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (b),(d)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16373-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>35
<FILENAME>R25.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210897364376">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueDisclosuresAbstract', window );"><strong>Fair Value Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the Company&#8217;s financial instruments that were measured at fair value on a recurring basis by level within the fair value hierarchy at period end: </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:53.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at March 31, 2021</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:53.079%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.798%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fair Value Measurements at December&#160;31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;1</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;2</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Level&#160;3</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="21" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Madryn put option liability</span></td><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock', window );">Fair Value Measurement Inputs and Valuation Techniques</a></td>
<td class="text"><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company used the following assumptions to value Madryn derivatives:</span></div><div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Put Option Liability </span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:74.011%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.971%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.973%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31, 2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest rate volatility</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20.9%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">19.7%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Market yield rate</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.3%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.9%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.57</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.82</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock', window );">Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth a summary of the changes in the fair value of the Company&#8217;s Level 3 financial instruments as follows:</span></div><div style="margin-bottom:6pt;margin-top:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:80.447%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.609%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Put Option Liability </span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2019</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,072&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,001&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at December 31, 2020</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,440&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Change in fair value</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(230)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balance at March 31, 2021</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,210&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19279-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>36
<FILENAME>R26.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794453880">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtDisclosureAbstract', window );"><strong>Debt Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock', window );">Schedule of Long-term Debt</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company recorded Madryn debt on the balance sheet as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.304%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.806%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Principal</span></td><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">65,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net unamortized debt discount and issuance costs</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(14,695)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(15,168)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net carrying value of Madryn debt</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50,305&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">49,832&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfDebtInstrumentsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(e),(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 470<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=75038535&amp;loc=d3e64711-112823<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfDebtInstrumentsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>37
<FILENAME>R27.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874825256">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCostTableTextBlock', window );">Lease, Cost</a></td>
<td class="text">Total lease cost includes the following components for the three months ended March&#160;31, 2021 and 2020, as well as for the year ended December&#160;31, 2020:<table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:9pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease expense cost</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance Lease Costs</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Interest expense</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Amortization expense</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">20&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease costs</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">38&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">26&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Cash paid for amounts included in the measurement of lease liabilities</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from operating leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating cash outflows from finance leases</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Financing cash outflows from finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">76&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt 0 13pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:100%">ROU assets obtained in exchange for new lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td style="padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_AssetsAndLiabilitiesLesseeTableTextBlock', window );">Assets And Liabilities, Lessee</a></td>
<td class="text"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31, 2020</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:9pt;font-weight:700;line-height:107%">Supplemental balance sheet information</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,511&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,610&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">986&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">788&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating lease liabilities - long-term</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,630&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total operating lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,711&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease right-of-use assets</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">313&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - short-term</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">105&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:3pt double #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">160&#160;</span></td><td style="background-color:#cceeff;border-top:3pt double #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance lease liabilities - long-term</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total finance lease liabilities</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">188&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:3pt double #000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average remaining lease term (years)</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.9</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.2</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.8</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.0</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted-average discount rate (%)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Operating leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.5&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance leases</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9.1&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">%</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000;padding:0 1pt"/></tr></table><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock', window );">Lessee, Operating Lease, Liability, Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amount of lease payments representing interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock', window );">Finance Lease, Liability, Fiscal Year Maturity</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:9pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Maturities of lease liabilities as of March&#160;31, 2021 were as follows:</span></div><div style="margin-bottom:6pt;margin-top:9pt"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.654%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.655%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Years Ending December 31,</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Operating Leases</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Finance Leases</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">494&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">109&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">594&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">565&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">532&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2025</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">449&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Thereafter</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">878&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,512&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">138&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 13pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Less: Amount of lease payments representing interest</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(896)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5)</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 19pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Present value of future minimum lease payments</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,616&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">133&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000;border-top:3pt double #000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_AssetsAndLiabilitiesLesseeTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_AssetsAndLiabilitiesLesseeTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCostTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCostTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>38
<FILENAME>R28.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210792131976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Shareholders' Equity (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockByClassTextBlock', window );">Schedule of Reserved Ordinary Shares for Future Issuances</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company had reserved common shares for future issuances as follows:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:72.263%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">March 31,<br/>2021</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">December 31,<br/>2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #231f20;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase shares</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161,165&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 Equity Incentive Plan</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,079,873&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,641,112&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Remaining shares available under the 2018 ESPP</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">661,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">474,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,950,223&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,182,196&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:middle"/></tr><tr style="height:14pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockByClassTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=65888546&amp;loc=d3e21300-112643<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21553-112644<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 480<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=65877616&amp;loc=d3e177068-122764<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21538-112644<br><br>Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21521-112644<br><br>Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21488-112644<br><br>Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21506-112644<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(27))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21484-112644<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockByClassTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>39
<FILENAME>R29.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795029640">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Warrants (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock', window );">Schedule of Stockholders' Equity Note, Warrants or Rights</a></td>
<td class="text">As of each of March&#160;31, 2021 and December&#160;31, 2020, 5,500 warrants to purchase the Company&#8217;s common shares were outstanding and exercisable: <table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.702%"><tr><td style="width:1.0%"/><td style="width:13.079%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.795%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.362%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.258%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.989%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.546%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.083%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant Holder</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Issue Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">In Connection With</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Warrant&#160;to Purchase</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Shares</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Expiration Date</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Rockport</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3/3/2017</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Loan agreement</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Common</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.80&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8/28/2022</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 50<br> -Section S99<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6784392&amp;loc=d3e188667-122775<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>40
<FILENAME>R30.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874855176">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract', window );"><strong>Share-based Payment Arrangement [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock', window );">Schedule of Share-based Compensation Expense</a></td>
<td class="text">During the periods presented, the Company recorded the following share-based compensation expense for stock <div style="margin-bottom:9pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">options and restricted stock awards: </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:73.602%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:10.804%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.806%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="9" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sales, general and administrative </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,146</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,307</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Research and development</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">611</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 5.5pt 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">322</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,757</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 5.5pt 2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,629</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock', window );">Schedule of Stock Options</a></td>
<td class="text"><div style="margin-bottom:3pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.553%"><tr><td style="width:1.0%"/><td style="width:52.263%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.811%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.547%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.816%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Options Outstanding</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Exercise Price</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-Average Remaining Contractual Term (in years)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Intrinsic Value (in thousands)</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,012,960&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">16.71&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.75</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,126&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted (weighted-average fair value of $38.55 per share)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">347,239&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">68.97&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Exercised</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(163,034)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.54&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(36,000)</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18.51&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Balances at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,161,165&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25.47&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7.94</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">82,375&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock', window );">Schedule of Employee Stock Options Valuation Assumptions</a></td>
<td class="text"><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to employees was estimated using the following assumptions:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.050%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.399%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.761%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55%</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">0.7% - 1.1%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.5%</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6.25</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-bottom:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The fair value of stock options granted to consultants was estimated using the following assumptions during the following periods presented:</span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:99.851%"><tr><td style="width:1.0%"/><td style="width:68.497%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.356%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.545%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.357%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Volatility</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">56%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1.6%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Term (in years)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr style="height:14pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock', window );">Schedule of Restricted Stock</a></td>
<td class="text"><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table represents RSA activity for fiscal 2021:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:71.519%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.846%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.847%"/><td style="width:0.1%"/></tr><tr style="height:14pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Restricted Stock Awards</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Weighted-<br/>Average<br/>Grant Date<br/>Fair Value</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at December 31, 2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">48,624&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.32&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Granted</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vested</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(5,939)</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13.31&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Forfeited/canceled</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Outstanding unvested at March 31, 2021</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11.04&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the changes in outstanding nonvested restricted stock shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>41
<FILENAME>R31.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793347816">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share (Tables)<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th"><div>Mar. 31, 2021</div></th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareAbstract', window );"><strong>Earnings Per Share [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock', window );">Schedule of Basic and Diluted Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:6pt;margin-top:6pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table summarizes the computation of basic and diluted net loss per share for the periods presented:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:69.138%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.036%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.038%"/><td style="width:0.1%"/></tr><tr style="height:18pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(in thousands, except share and per share data)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Numerator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Net loss</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(6,948)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(17,753)</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Denominator:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Weighted average common shares used for basic and diluted earnings per share</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23,827,137&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">22,456,365&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-top:3pt double #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Loss per share:</span></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:20.25pt;text-indent:-9pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Basic and diluted</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.29)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(0.79)</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:18pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock', window );">Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share</a></td>
<td class="text"><div style="margin-bottom:9pt;margin-top:8.3pt"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following potentially dilutive securities outstanding at the end of the periods presented have been excluded from the computation of diluted shares:</span></div><div style="margin-bottom:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;vertical-align:top;width:100.000%"><tr><td style="width:1.0%"/><td style="width:67.203%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.376%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.544%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.377%"/><td style="width:0.1%"/></tr><tr style="height:15pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Three Months Ended March 31,</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2021</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2020</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Options to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,900,825&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,632,871&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Shares issuable on vesting of restricted stock awards</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,685&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">108,472&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Warrants to purchase common shares</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#231f20;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,949,010&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,746,843&#160;</span></td><td style="background-color:#ffffff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-bottom:1pt solid #000000;border-top:3pt double #000000;padding:0 1pt"/></tr></table></div><span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>nonnum:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>42
<FILENAME>R32.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794521288">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Formation and Business of the Company (Details)<br></strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>facility</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_NumberOfManufacturingFacilities', window );">Number of manufacturing facilities</a></td>
<td class="nump">2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_NumberOfManufacturingFacilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number Of Manufacturing Facilities</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_NumberOfManufacturingFacilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>43
<FILENAME>R33.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874933496">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Narrative (Details)<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($) </div>
<div>segment </div>
<div>reportingunit</div>
</th>
<th class="th">
<div>Mar. 31, 2020 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2020 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfOperatingSegments', window );">Number of operating segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CashEquivalentsAtCarryingValue', window );">Cash equivalents</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryValuationReserves', window );">Inventory valuation reserves</a></td>
<td class="nump">1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Sales, general and administrative</a></td>
<td class="nump">$ 18,138,000<span></span>
</td>
<td class="nump">$ 18,984,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_RevenueFromContractWithCustomerProductReturnPeriod', window );">Product return period</a></td>
<td class="text">15 days<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss', window );">Valuation allowances and reserves, amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">54,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_RevenueFromContractWithCustomerProductShelfLife', window );">Product shelf life</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">50 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportableSegments', window );">Number of reportable segments | segment</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NumberOfReportingUnits', window );">Number of reporting units | reportingunit</a></td>
<td class="nump">1<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetImpairment', window );">Goodwill and intangible asset impairment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AssetImpairmentCharges', window );">Asset impairment charges</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax', window );">Foreign currency transaction gain (loss)</a></td>
<td class="nump">2,700,000<span></span>
</td>
<td class="nump">6,200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets, net</a></td>
<td class="nump">2,511,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,610,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease, liability</a></td>
<td class="nump">$ 2,616,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,711,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated useful lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember', window );">Shipping and Handling</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SellingGeneralAndAdministrativeExpense', window );">Sales, general and administrative</a></td>
<td class="nump">$ 1,200,000<span></span>
</td>
<td class="nump">800,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember', window );">Product Concentration Risk | NuSil Technology LLC</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PaymentsToSuppliers', window );">Purchases from suppliers</a></td>
<td class="nump">4,300,000<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsPayableTradeCurrent', window );">Outstanding balance owed</a></td>
<td class="nump">$ 1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember', window );">Revenue | Geographic Concentration Risk | Brazil</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">10.60%<span></span>
</td>
<td class="nump">10.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=esta_InventoryRawMaterialsPurchasesMember', window );">Purchases | Product Concentration Risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">55.80%<span></span>
</td>
<td class="nump">64.90%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskByBenchmarkAxis=esta_LongLivedAssetsMember', window );">Long-lived Assets | Geographic Concentration Risk | COSTA RICA</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="nump">78.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">80.00%<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_MajorCustomersAxis=esta_CustomerOneMember', window );">Customer One | Customer concentration risk</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_SummaryOfSignificantAccountingPoliciesLineItems', window );"><strong>Summary Of Significant Accounting Policies [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ConcentrationRiskPercentage1', window );">Concentration risk (as a percent)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_RevenueFromContractWithCustomerProductReturnPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Product Return Period</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_RevenueFromContractWithCustomerProductReturnPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_RevenueFromContractWithCustomerProductShelfLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Revenue From Contract With Customer, Product Shelf Life</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_RevenueFromContractWithCustomerProductShelfLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_SummaryOfSignificantAccountingPoliciesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>[Line Items] for Summary Of Significant Accounting Policies [Table]</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_SummaryOfSignificantAccountingPoliciesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsPayableTradeCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsPayableTradeCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AssetImpairmentCharges">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 45<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109226348&amp;loc=d3e2420-110228<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AssetImpairmentCharges</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CashEquivalentsAtCarryingValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CashEquivalentsAtCarryingValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskPercentage1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6351-108592<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13531-108611<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 21<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13537-108611<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 275<br> -SubTopic 10<br> -Section 50<br> -Paragraph 20<br> -URI http://asc.fasb.org/extlink&amp;oid=99393423&amp;loc=d3e6404-108592<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskPercentage1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130533-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121599878&amp;loc=SL82895884-210446<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 326<br> -SubTopic 20<br> -Section 50<br> -Paragraph 13<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121599337&amp;loc=SL82919249-210447<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ForeignCurrencyTransactionGainLossBeforeTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=109240200&amp;loc=d3e30690-110894<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 35<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121605123&amp;loc=d3e30226-110892<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -URI http://asc.fasb.org/extlink&amp;oid=120253306&amp;loc=d3e28228-110885<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 830<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6450222&amp;loc=d3e30840-110895<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ForeignCurrencyTransactionGainLossBeforeTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetImpairment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetImpairment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryValuationReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of valuation reserve for inventory.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB TOPIC 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 4<br> -Subparagraph (SX 210.12-09)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e24092-122690<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryValuationReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfOperatingSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfOperatingSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportableSegments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 18<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8672-108599<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportableSegments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NumberOfReportingUnits">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NumberOfReportingUnits</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:integerItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PaymentsToSuppliers">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Payments of cash to suppliers for goods and services during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br><br>Reference 2: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 17<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3367-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PaymentsToSuppliers</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SellingGeneralAndAdministrativeExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SellingGeneralAndAdministrativeExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_ProductOrServiceAxis=us-gaap_ShippingAndHandlingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_SupplierConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_NuSilTechnologyLLCMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_NuSilTechnologyLLCMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=us-gaap_SalesRevenueNetMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_GeographicConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_BR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_BR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=esta_InventoryRawMaterialsPurchasesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=esta_InventoryRawMaterialsPurchasesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByBenchmarkAxis=esta_LongLivedAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByBenchmarkAxis=esta_LongLivedAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=country_CR">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=country_CR</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_MajorCustomersAxis=esta_CustomerOneMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_MajorCustomersAxis=esta_CustomerOneMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ConcentrationRiskByTypeAxis=us-gaap_CustomerConcentrationRiskMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>44
<FILENAME>R34.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875706312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Summary of Significant Accounting Policies - Disaggregation of Revenue (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 30,336<span></span>
</td>
<td class="nump">$ 24,481<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_EuropeMember', window );">Europe</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">12,693<span></span>
</td>
<td class="nump">9,779<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember', window );">Latin America</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">8,001<span></span>
</td>
<td class="nump">7,141<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=esta_AsiaPacificAndMiddleEastMember', window );">Asia-Pacific/Middle East</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">9,495<span></span>
</td>
<td class="nump">7,471<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_StatementGeographicalAxis=esta_OtherGeographicalAreasMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DisaggregationOfRevenueLineItems', window );"><strong>Disaggregation of Revenue [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax', window );">Revenue</a></td>
<td class="nump">$ 147<span></span>
</td>
<td class="nump">$ 90<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DisaggregationOfRevenueLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DisaggregationOfRevenueLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 40<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9031-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 41<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9038-108599<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130543-203045<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 42<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e9054-108599<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130545-203045<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 924<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 11.L)<br> -URI http://asc.fasb.org/extlink&amp;oid=6472922&amp;loc=d3e499488-122856<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_EuropeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_EuropeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=srt_LatinAmericaMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=srt_LatinAmericaMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=esta_AsiaPacificAndMiddleEastMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=esta_AsiaPacificAndMiddleEastMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_StatementGeographicalAxis=esta_OtherGeographicalAreasMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_StatementGeographicalAxis=esta_OtherGeographicalAreasMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>45
<FILENAME>R35.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795809144">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts - Inventory (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryRawMaterialsNetOfReserves', window );">Raw materials</a></td>
<td class="nump">$ 6,105<span></span>
</td>
<td class="nump">$ 5,450<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryWorkInProcessNetOfReserves', window );">Work in process</a></td>
<td class="nump">1,625<span></span>
</td>
<td class="nump">1,121<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryFinishedGoodsNetOfReserves', window );">Finished goods</a></td>
<td class="nump">14,647<span></span>
</td>
<td class="nump">16,639<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InventoryNet', window );">Inventory, net</a></td>
<td class="nump">$ 22,377<span></span>
</td>
<td class="nump">$ 23,210<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryFinishedGoodsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryFinishedGoodsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6676-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.6(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryRawMaterialsNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(4))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryRawMaterialsNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InventoryWorkInProcessNetOfReserves">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 330<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SAB Topic 5.BB)<br> -URI http://asc.fasb.org/extlink&amp;oid=27011343&amp;loc=d3e100047-122729<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InventoryWorkInProcessNetOfReserves</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>46
<FILENAME>R36.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210801041512">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts - Property and Equipment (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 26,491<span></span>
</td>
<td class="nump">$ 25,835<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment', window );">Less: Accumulated depreciation and amortization</a></td>
<td class="num">(10,170)<span></span>
</td>
<td class="num">(9,633)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentNet', window );">Property, plant and equipment, net</a></td>
<td class="nump">16,321<span></span>
</td>
<td class="nump">16,202<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember', window );">Machinery and equipment</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">9,494<span></span>
</td>
<td class="nump">9,232<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember', window );">Building improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">6,456<span></span>
</td>
<td class="nump">6,456<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember', window );">Furniture and fixtures</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">4,268<span></span>
</td>
<td class="nump">4,092<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember', window );">Building</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,472<span></span>
</td>
<td class="nump">2,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember', window );">Leasehold improvements</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">2,025<span></span>
</td>
<td class="nump">2,065<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember', window );">Land</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">802<span></span>
</td>
<td class="nump">802<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember', window );">Vehicles</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">395<span></span>
</td>
<td class="nump">399<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember', window );">Construction in process</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentLineItems', window );"><strong>Property, Plant and Equipment [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PropertyPlantAndEquipmentGross', window );">Property, plant and equipment, gross</a></td>
<td class="nump">$ 579<span></span>
</td>
<td class="nump">$ 317<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.14)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.13)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(14))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(8))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(13))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_MachineryAndEquipmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_FurnitureAndFixturesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_BuildingMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LeaseholdImprovementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_LandMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_VehiclesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PropertyPlantAndEquipmentByTypeAxis=us-gaap_ConstructionInProgressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>47
<FILENAME>R37.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799655480">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Balance Sheet Accounts - Narrative (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment', window );">Inventory on consignment</a></td>
<td class="nump">$ 2,300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_DepreciationAndAmortizationPropertyPlantAndEquipment', window );">Depreciation and amortization expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization', window );">Finance Lease, ROU asset, before accumulated amortization</a></td>
<td class="nump">1,400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,400<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Depreciation', window );">Depreciation</a></td>
<td class="nump">$ 43<span></span>
</td>
<td class="nump">$ 20<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_DepreciationAndAmortizationPropertyPlantAndEquipment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Depreciation And Amortization, Property, Plant And Equipment</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_DepreciationAndAmortizationPropertyPlantAndEquipment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Depreciation">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 360<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=6391035&amp;loc=d3e2868-110229<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Depreciation</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(6)(a))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>48
<FILENAME>R38.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875386584">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts - Accrued Liabilities (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedBonusesCurrent', window );">Performance bonus</a></td>
<td class="nump">$ 971<span></span>
</td>
<td class="nump">$ 2,406<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalariesCurrent', window );">Payroll and related expenses</a></td>
<td class="nump">3,619<span></span>
</td>
<td class="nump">2,781<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_AccruedStockOptionGrantBonusCurrent', window );">Bonus feature of stock option grants</a></td>
<td class="nump">6,605<span></span>
</td>
<td class="nump">5,992<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedSalesCommissionCurrent', window );">Commissions</a></td>
<td class="nump">648<span></span>
</td>
<td class="nump">628<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedProfessionalFeesCurrent', window );">Professional and legal services</a></td>
<td class="nump">469<span></span>
</td>
<td class="nump">439<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Short-term minimum lease payments under finance leases</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent', window );">Warranty reserve</a></td>
<td class="nump">236<span></span>
</td>
<td class="nump">237<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent', window );">Advisory board and board of director related expenses</a></td>
<td class="nump">70<span></span>
</td>
<td class="nump">80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherAccruedLiabilitiesCurrent', window );">Other</a></td>
<td class="nump">699<span></span>
</td>
<td class="nump">1,021<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccruedLiabilitiesCurrent', window );">Accrued liabilities</a></td>
<td class="nump">$ 14,408<span></span>
</td>
<td class="nump">$ 14,532<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList', window );">Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]</a></td>
<td class="text">Accrued liabilities<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_AccruedStockOptionGrantBonusCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accrued Stock Option Grant Bonus, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_AccruedStockOptionGrantBonusCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Advisory Board And Board Of Director Liabilities, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedBonusesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedBonusesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedProfessionalFeesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedProfessionalFeesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalariesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalariesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccruedSalesCommissionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccruedSalesCommissionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicates line item in statement of financial position that includes current operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918631-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>srt-types:extensibleListItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherAccruedLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e7018-107765<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6935-107765<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherAccruedLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProductWarrantyAccrualClassifiedCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=68068213&amp;loc=d3e12524-110249<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 460<br> -SubTopic 10<br> -Section 25<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=68070138&amp;loc=d3e11281-110244<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProductWarrantyAccrualClassifiedCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>49
<FILENAME>R39.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800188136">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts - Other Liabilities, Short-Term (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityCurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 1,024<span></span>
</td>
<td class="nump">$ 1,214<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_CashPayableForAssetAcquisitionCurrent', window );">Cash payable for asset acquisitions</a></td>
<td class="nump">407<span></span>
</td>
<td class="nump">432<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesCurrent', window );">Other liabilities, short term</a></td>
<td class="nump">$ 1,431<span></span>
</td>
<td class="nump">$ 1,646<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_CashPayableForAssetAcquisitionCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Payable For Asset Acquisition, Current</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_CashPayableForAssetAcquisitionCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6904-107765<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section 45<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121566466&amp;loc=d3e6911-107765<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.20)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>50
<FILENAME>R40.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793038536">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Balance Sheet Accounts - Other Liabilities, Long-Term (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract', window );"><strong>Organization, Consolidation and Presentation of Financial Statements [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ContractWithCustomerLiabilityNoncurrent', window );">Deferred revenue</a></td>
<td class="nump">$ 1,778<span></span>
</td>
<td class="nump">$ 1,860<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_CashPayableForAssetAcquisitionNoncurrent', window );">Cash payable for asset acquisitions</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">425<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherSundryLiabilitiesNoncurrent', window );">Other</a></td>
<td class="nump">42<span></span>
</td>
<td class="nump">47<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OtherLiabilitiesNoncurrent', window );">Other liabilities, long term</a></td>
<td class="nump">$ 1,820<span></span>
</td>
<td class="nump">$ 2,332<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_CashPayableForAssetAcquisitionNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Payable For Asset Acquisition, Noncurrent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_CashPayableForAssetAcquisitionNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ContractWithCustomerLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130532-203044<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=121556615&amp;loc=SL49130531-203044<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 606<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121604090&amp;loc=SL49130549-203045<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ContractWithCustomerLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.24)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OtherSundryLiabilitiesNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(15))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(24))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OtherSundryLiabilitiesNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>51
<FILENAME>R41.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795814408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Goodwill (Details)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillRollForward', window );"><strong>Goodwill [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Beginning Balance</a></td>
<td class="nump">$ 465<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAcquiredDuringPeriod', window );">Additions</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillImpairmentLoss', window );">Accumulated Impairment Losses</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_Goodwill', window );">Ending Balance</a></td>
<td class="nump">$ 465<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_Goodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(10)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120320667&amp;loc=SL49117168-202975<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13770-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_Goodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAcquiredDuringPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAcquiredDuringPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillImpairmentLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13854-109267<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (e)<br> -URI http://asc.fasb.org/extlink&amp;oid=121556970&amp;loc=d3e13816-109267<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 20<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=99380562&amp;loc=d3e13777-109266<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillImpairmentLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>52
<FILENAME>R42.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795621976">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Intangible Assets (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">$ (3,135)<span></span>
</td>
<td class="num">$ (2,819)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">3,835<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract', window );"><strong>Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill', window );">Capitalized patents and license rights not yet amortized</a></td>
<td class="nump">291<span></span>
</td>
<td class="nump">291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract', window );"><strong>Intangible Assets, Net (Excluding Goodwill) [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill', window );">Gross Carrying Amount</a></td>
<td class="nump">7,261<span></span>
</td>
<td class="nump">6,967<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IntangibleAssetsNetExcludingGoodwill', window );">Net Carrying Amount</a></td>
<td class="nump">$ 4,126<span></span>
</td>
<td class="nump">4,148<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_PatentsAndLicensingAgreementsMember', window );">Patents and license rights</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 1,736<span></span>
</td>
<td class="nump">1,736<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(994)<span></span>
</td>
<td class="num">(951)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 742<span></span>
</td>
<td class="nump">$ 785<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_PatentsAndLicensingAgreementsMember', window );">Patents and license rights | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">7 years<span></span>
</td>
<td class="text">7 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_PatentsAndLicensingAgreementsMember', window );">Patents and license rights | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">12 years<span></span>
</td>
<td class="text">12 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,033<span></span>
</td>
<td class="nump">$ 2,033<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(1,452)<span></span>
</td>
<td class="num">(1,297)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 581<span></span>
</td>
<td class="nump">$ 736<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember', window );">Customer relationships | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_A510kAuthorizationMember', window );">510(k) authorization</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 567<span></span>
</td>
<td class="nump">$ 567<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(203)<span></span>
</td>
<td class="num">(194)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 364<span></span>
</td>
<td class="nump">$ 373<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">15 years<span></span>
</td>
<td class="text">15 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember', window );">Developed technology</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 62<span></span>
</td>
<td class="nump">$ 62<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(47)<span></span>
</td>
<td class="num">(46)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 15<span></span>
</td>
<td class="nump">$ 16<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Capitalized software development costs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 2,497<span></span>
</td>
<td class="nump">$ 2,203<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(411)<span></span>
</td>
<td class="num">(302)<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 2,086<span></span>
</td>
<td class="nump">$ 1,901<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Capitalized software development costs | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember', window );">Capitalized software development costs | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsGross', window );">Gross Carrying Amount</a></td>
<td class="nump">$ 75<span></span>
</td>
<td class="nump">$ 75<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization', window );">Accumulated Amortization</a></td>
<td class="num">(28)<span></span>
</td>
<td class="num">(29)<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 47<span></span>
</td>
<td class="nump">$ 46<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other | Minimum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">2 years<span></span>
</td>
<td class="text">2 years<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember', window );">Other | Maximum</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract', window );"><strong>Finite-Lived Intangible Assets, Net [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife', window );">Estimated Useful Lives</a></td>
<td class="text">5 years<span></span>
</td>
<td class="text">5 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetUsefulLife">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetUsefulLife</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 928<br> -SubTopic 340<br> -Section 50<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6473545&amp;loc=d3e61844-108004<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNetAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNetAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsGrossExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount before accumulated amortization of intangible assets, excluding goodwill.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsGrossExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwill">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph ((a)(1),(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16212-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwill</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_PatentsAndLicensingAgreementsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_PatentsAndLicensingAgreementsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_CustomerRelationshipsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_A510kAuthorizationMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=esta_A510kAuthorizationMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_DevelopedTechnologyRightsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_SoftwareDevelopmentMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis=us-gaap_OtherIntangibleAssetsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>53
<FILENAME>R43.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794586936">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Narrative (Details) - USD ($)<br> $ in Millions</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AmortizationOfIntangibleAssets', window );">Amortization of intangible assets</a></td>
<td class="nump">$ 0.3<span></span>
</td>
<td class="nump">$ 0.2<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AmortizationOfIntangibleAssets">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=6388964&amp;loc=d3e16225-109274<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AmortizationOfIntangibleAssets</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>54
<FILENAME>R44.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800200680">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Goodwill and Other Intangible Assets - Amortization Expense (Details)<br> $ in Thousands</strong></div></th>
<th class="th">
<div>Mar. 31, 2021 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract', window );"><strong>Goodwill and Intangible Assets Disclosure [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear', window );">2021 (remaining)</a></td>
<td class="nump">$ 868<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths', window );">2022</a></td>
<td class="nump">875<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo', window );">2023</a></td>
<td class="nump">617<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree', window );">2024</a></td>
<td class="nump">592<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour', window );">2025</a></td>
<td class="nump">393<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour', window );">Thereafter</a></td>
<td class="nump">490<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FiniteLivedIntangibleAssetsNet', window );">Net Carrying Amount</a></td>
<td class="nump">$ 3,835<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finite Lived Intangible Assets, Amortization Expense, After Year Four</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FiniteLivedIntangibleAssetsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 926<br> -SubTopic 20<br> -Section 50<br> -Paragraph 5<br> -URI http://asc.fasb.org/extlink&amp;oid=120154696&amp;loc=d3e54445-107959<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 350<br> -SubTopic 30<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=66006027&amp;loc=d3e16323-109275<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FiniteLivedIntangibleAssetsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>55
<FILENAME>R45.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210791296024">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - FV on a Recurring Basis (Details) - Fair Value, Measurements, Recurring - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Madryn put option liability</a></td>
<td class="nump">$ 1,210<span></span>
</td>
<td class="nump">$ 1,440<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Madryn put option liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Madryn put option liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember', window );">Level&#160;3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilities', window );">Madryn put option liability</a></td>
<td class="nump">$ 1,210<span></span>
</td>
<td class="nump">$ 1,440<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilities">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=51824906&amp;loc=SL20225862-175312<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=121572278&amp;loc=d3e13433-108611<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 20<br> -Section 55<br> -Paragraph 10<br> -URI http://asc.fasb.org/extlink&amp;oid=99393222&amp;loc=SL20226008-175313<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilities</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByMeasurementFrequencyAxis=us-gaap_FairValueMeasurementsRecurringMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByFairValueHierarchyLevelAxis=us-gaap_FairValueInputsLevel3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>56
<FILENAME>R46.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875673592">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Narrative (Details)<br> $ in Millions</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="1">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th">
<div>Aug. 31, 2019 </div>
<div>USD ($)</div>
</th>
<th class="th">
<div>Dec. 31, 2017 </div>
<div>USD ($)</div>
</th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th">
<div>Aug. 31, 2017 </div>
<div>USD ($)</div>
</th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputProbabilityOfChangeInControlMember', window );">Measurement Input, Probability of Change in Control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Change in control</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="nump">0.50<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Line of Credit | Madryn Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems', window );"><strong>Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15.1<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="nump">$ 1.6<span></span>
</td>
<td class="nump">$ 5.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromIssuanceOfDebt', window );">Additional amount borrowed</a></td>
<td class="nump">$ 25.0<span></span>
</td>
<td class="nump">$ 10.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromIssuanceOfDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromIssuanceOfDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputProbabilityOfChangeInControlMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputProbabilityOfChangeInControlMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>57
<FILENAME>R47.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875526408">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Fair Value Measurements - Derivatives (Details) - Put Option Liability<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputInterestRateVolatilityMember', window );">Interest rate volatility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability</a></td>
<td class="nump">0.209<span></span>
</td>
<td class="nump">0.197<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputMarketYieldRateMember', window );">Market yield rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability</a></td>
<td class="nump">0.073<span></span>
</td>
<td class="nump">0.079<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember', window );">Term (in years)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability</a></td>
<td class="nump">4.57<span></span>
</td>
<td class="nump">4.82<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember', window );">Dividend yield</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems', window );"><strong>Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DerivativeLiabilityMeasurementInput', window );">Derivative liability</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DerivativeLiabilityMeasurementInput">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Value of input used to measure derivative liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (bbb)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DerivativeLiabilityMeasurementInput</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputInterestRateVolatilityMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputInterestRateVolatilityMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinancialInstrumentAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinancialInstrumentAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputMarketYieldRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=esta_MeasurementInputMarketYieldRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedTermMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_MeasurementInputTypeAxis=us-gaap_MeasurementInputExpectedDividendRateMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>58
<FILENAME>R48.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210877107848">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Fair Value Measurements - Level 3 Financial Instruments (Details) - Put Option Liability - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward', window );"><strong>Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Beginning Balance</a></td>
<td class="nump">$ 1,440<span></span>
</td>
<td class="nump">$ 3,072<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings', window );">Change in fair value</a></td>
<td class="num">(230)<span></span>
</td>
<td class="nump">1,929<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue', window );">Ending Balance</a></td>
<td class="nump">$ 1,210<span></span>
</td>
<td class="nump">$ 5,001<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 820<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=117815213&amp;loc=d3e19207-110258<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FairValueByLiabilityClassAxis=us-gaap_PutOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FairValueByLiabilityClassAxis=us-gaap_PutOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>59
<FILENAME>R49.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210796589288">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Debt - Narrative (Details) - Line of Credit - USD ($)<br></strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="3">3 Months Ended</th>
<th class="th" colspan="1">6 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Aug. 12, 2019</div></th>
<th class="th"><div>Jun. 17, 2019</div></th>
<th class="th"><div>Dec. 15, 2017</div></th>
<th class="th"><div>Oct. 31, 2017</div></th>
<th class="th"><div>Aug. 31, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
<th class="th"><div>Jun. 16, 2019</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Aug. 31, 2017</div></th>
<th class="th"><div>Aug. 24, 2017</div></th>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Outstanding principal balance</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">40,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_DebtInstrumentDefaultInterestRateIncrease', window );">Default interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage', window );">Effective interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.40%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtWeightedAverageInterestRate', window );">Weighted average interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">10.60%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_InterestExpenseDebt', window );">Interest expense</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="nump">$ 1,700,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability', window );">Fair value of options</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,100,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscount', window );">Debt discount</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,600,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DeferredFinanceCostsNet', window );">Legal expenses</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,300,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement | London Interbank Offered Rate (LIBOR)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1', window );">Credit agreement interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">8.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Amended Madryn Credit Agreement</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 65,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term A</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity', window );">Maximum borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 30,000,000.0<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term B-1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term B-2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on credit facility</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 5,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term B-3 And B-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ProceedsFromLinesOfCredit', window );">Borrowings on credit facility</a></td>
<td class="nump">$ 25,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term B-3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_LineOfCreditFacilityAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 10,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember', window );">Madryn Credit Agreement - Term B-4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentLineItems', window );"><strong>Debt Instrument [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_LineOfCreditFacilityAdditionalBorrowingCapacity', window );">Additional borrowing capacity</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 15,000,000.0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_DebtInstrumentDefaultInterestRateIncrease">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Debt Instrument, Default Interest Rate Increase</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_DebtInstrumentDefaultInterestRateIncrease</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_LineOfCreditFacilityAdditionalBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line Of Credit Facility, Additional Borrowing Capacity</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_LineOfCreditFacilityAdditionalBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentBasisSpreadOnVariableRate1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Percentage points added to the reference rate to compute the variable rate on the debt instrument.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentBasisSpreadOnVariableRate1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentInterestRateEffectivePercentage">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28551-108399<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.22(a)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentInterestRateEffectivePercentage</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt discount.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 1A<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28541-108399<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 55<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=114775985&amp;loc=d3e28878-108400<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtWeightedAverageInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average interest rate of debt outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtWeightedAverageInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DeferredFinanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.17)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DeferredFinanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 815<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4B<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121590274&amp;loc=SL5624163-113959<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_InterestExpenseDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of the cost of borrowed funds accounted for as interest expense for debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6036836-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.8)<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_InterestExpenseDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.19(b),22(b))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ProceedsFromLinesOfCredit">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 14<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3255-108585<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08.(f))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ProceedsFromLinesOfCredit</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_VariableRateAxis=us-gaap_LondonInterbankOfferedRateLIBORMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_AmendedMadrynCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_AmendedMadrynCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermAMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermAMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB1Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB1Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB2Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB2Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB3AndB4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB3AndB4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB3Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB3Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB4Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementTermB4Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>60
<FILENAME>R50.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799667080">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Debt - Schedule of Madryn Debt (Details) - Madryn Credit Agreement - Line of Credit - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LineOfCreditFacilityLineItems', window );"><strong>Line of Credit Facility [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentCarryingAmount', window );">Principal</a></td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 65,000<span></span>
</td>
<td class="nump">$ 40,000<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet', window );">Net unamortized debt discount and issuance costs</a></td>
<td class="num">(14,695)<span></span>
</td>
<td class="num">(15,168)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LongTermDebt', window );">Net carrying value of Madryn debt</a></td>
<td class="nump">$ 50,305<span></span>
</td>
<td class="nump">$ 49,832<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentCarryingAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentCarryingAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of unamortized debt discount (premium) and debt issuance costs.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 835<br> -SubTopic 30<br> -Section 45<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=119993939&amp;loc=d3e28555-108399<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LineOfCreditFacilityLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LineOfCreditFacilityLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongTermDebt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 470<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120520924&amp;loc=SL6031897-161870<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-03(16))<br> -URI http://asc.fasb.org/extlink&amp;oid=120398452&amp;loc=d3e534808-122878<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongTermDebt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_DebtInstrumentAxis=esta_MadrynCreditAgreementMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LongtermDebtTypeAxis=us-gaap_LineOfCreditMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>61
<FILENAME>R51.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794371368">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Narrative (Details) - Maximum<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeLeaseDescriptionLineItems', window );"><strong>Lessee, Lease, Description [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseTermOfContract', window );">Operating lease, term of contract</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeFinanceLeaseTermOfContract1', window );">Finance lease, term of contract</a></td>
<td class="text">8 years<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeFinanceLeaseTermOfContract1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeFinanceLeaseTermOfContract1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeLeaseDescriptionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeLeaseDescriptionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseTermOfContract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (a)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918673-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseTermOfContract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>62
<FILENAME>R52.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800140408">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Lease Cost (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeasesAbstract', window );"><strong>Leases [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseCost', window );">Operating lease expense cost</a></td>
<td class="nump">$ 167<span></span>
</td>
<td class="nump">$ 150<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestExpense', window );">Interest expense</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization', window );">Amortization expense</a></td>
<td class="nump">35<span></span>
</td>
<td class="nump">20<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LeaseCost', window );">Total finance lease costs</a></td>
<td class="nump">$ 38<span></span>
</td>
<td class="nump">$ 26<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest expense on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAssetAmortization">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of amortization expense attributable to right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 4<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918638-209977<br><br>Reference 3: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAssetAmortization</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lease cost recognized by lessee for lease contract.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LeasesAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LeasesAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseCost">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseCost</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>63
<FILENAME>R53.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210877883160">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Supplemental Balance Sheet Information (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Operating leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseRightOfUseAsset', window );">Right-of-use operating lease assets, net</a></td>
<td class="nump">$ 2,511<span></span>
</td>
<td class="nump">$ 2,610<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityCurrent', window );">Operating lease liabilities - current</a></td>
<td class="nump">986<span></span>
</td>
<td class="nump">788<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilityNoncurrent', window );">Operating lease liabilities, non-current</a></td>
<td class="nump">1,630<span></span>
</td>
<td class="nump">1,923<span></span>
</td>
</tr>
<tr class="reu">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Operating lease liabilities</a></td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">2,711<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract', window );"><strong>Finance leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseRightOfUseAsset', window );">Finance lease right-of-use assets</a></td>
<td class="nump">278<span></span>
</td>
<td class="nump">313<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityCurrent', window );">Finance lease liabilities - short-term</a></td>
<td class="nump">105<span></span>
</td>
<td class="nump">160<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityNoncurrent', window );">Finance lease liabilities - long-term</a></td>
<td class="nump">28<span></span>
</td>
<td class="nump">28<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Total finance lease liabilities</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_WeightedAverageRemainingLeaseTermAbstract', window );"><strong>Weighted-average remaining lease term (years)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1', window );">Operating leases</a></td>
<td class="text">5 years 10 months 24 days<span></span>
</td>
<td class="text">6 years 2 months 12 days<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1', window );">Finance leases</a></td>
<td class="text">9 months 18 days<span></span>
</td>
<td class="text">1 year<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_LeasesWeightedAverageDiscountRateAbstract', window );"><strong>Weighted-average discount rate (%)</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent', window );">Operating leases</a></td>
<td class="nump">10.50%<span></span>
</td>
<td class="nump">10.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent', window );">Finance leases</a></td>
<td class="nump">9.10%<span></span>
</td>
<td class="nump">9.10%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Finance Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_LeasesWeightedAverageDiscountRateAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Leases, Weighted Average Discount Rate</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_LeasesWeightedAverageDiscountRateAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Operating Lease, Assets And Liabilities, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_WeightedAverageRemainingLeaseTermAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted Average Remaining Lease Term</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_WeightedAverageRemainingLeaseTermAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount, after accumulated amortization, of right-of-use asset from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for finance lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityCurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityCurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilityNoncurrent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilityNoncurrent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseRightOfUseAsset">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's right to use underlying asset under operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseRightOfUseAsset</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average discount rate for operating lease calculated at point in time.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>64
<FILENAME>R54.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793114120">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Leases - Supplemental Cash Flows (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_CashFlowLesseeAbstract', window );"><strong>Cash paid for amounts included in the measurement of lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeasePayments', window );">Operating cash outflows from operating leases</a></td>
<td class="nump">$ 160<span></span>
</td>
<td class="nump">$ 137<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseInterestPaymentOnLiability', window );">Operating cash outflows from finance leases</a></td>
<td class="nump">3<span></span>
</td>
<td class="nump">6<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeasePrincipalPayments', window );">Financing cash outflows from finance leases</a></td>
<td class="nump">55<span></span>
</td>
<td class="nump">76<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract', window );"><strong>ROU assets obtained in exchange for new lease liabilities</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability', window );">Operating leases</a></td>
<td class="nump">0<span></span>
</td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability', window );">Finance leases</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="nump">$ 0<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_CashFlowLesseeAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Cash Flow, Lessee</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_CashFlowLesseeAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Right-Of-Use Asset Obtained In Exchange For Lease Liability</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseInterestPaymentOnLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of interest paid on finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseInterestPaymentOnLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeasePrincipalPayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow for principal payment on finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeasePrincipalPayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeasePayments">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 5<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918643-209977<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeasePayments</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for finance lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of increase in right-of-use asset obtained in exchange for operating lease liability.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 55<br> -Paragraph 53<br> -URI http://asc.fasb.org/extlink&amp;oid=121568110&amp;loc=SL77918982-209971<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 4<br> -Subparagraph (g)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918686-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>65
<FILENAME>R55.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210801067896">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Leases - Lease Maturity (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Operating Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">$ 494<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">594<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">565<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">532<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">449<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">878<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">3,512<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amount of lease payments representing interest</a></td>
<td class="num">(896)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_OperatingLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">2,616<span></span>
</td>
<td class="nump">$ 2,711<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract', window );"><strong>Finance Leases</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths', window );">2021</a></td>
<td class="nump">109<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo', window );">2022</a></td>
<td class="nump">29<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree', window );">2023</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour', window );">2024</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive', window );">2025</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive', window );">Thereafter</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rou">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityPaymentsDue', window );">Total future minimum lease payments</a></td>
<td class="nump">138<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount', window );">Less: Amount of lease payments representing interest</a></td>
<td class="num">(5)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_FinanceLeaseLiability', window );">Present value of future minimum lease payments</a></td>
<td class="nump">$ 133<span></span>
</td>
<td class="nump">$ 188<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 50<br> -Paragraph 6<br> -URI http://asc.fasb.org/extlink&amp;oid=121609121&amp;loc=SL77918701-209980<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_OperatingLeaseLiability">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Present value of lessee's discounted obligation for lease payments from operating lease.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 842<br> -SubTopic 20<br> -Section 45<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121603541&amp;loc=SL77918627-209977<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_OperatingLeaseLiability</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>66
<FILENAME>R56.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210794703112">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Narrative (Details) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EquityAbstract', window );"><strong>Equity [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesIssued', window );">Common stock, shares issued (in shares)</a></td>
<td class="nump">24,094,051<span></span>
</td>
<td class="nump">23,925,789<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesOutstanding', window );">Common stock, shares outstanding (in shares)</a></td>
<td class="nump">23,685,981<span></span>
</td>
<td class="nump">23,517,719<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesIssued">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesIssued</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EquityAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EquityAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>67
<FILENAME>R57.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795743352">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Shareholders' Equity - Reserved Ordinary Shares (Details) - shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">4,950,223<span></span>
</td>
<td class="nump">4,182,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member', window );">Equity Incentive Plan, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,079,873<span></span>
</td>
<td class="nump">1,641,112<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Options to purchase shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">2,161,165<span></span>
</td>
<td class="nump">2,012,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">42,685<span></span>
</td>
<td class="nump">48,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember', window );">ESPP</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">661,000<span></span>
</td>
<td class="nump">474,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember', window );">Rockport Warrants</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>68
<FILENAME>R58.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795045976">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Narrative (Details) - Rockport Warrants - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise price of warrants (in dollars per share)</a></td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Warrants outstanding (in shares)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember', window );">Common Class B</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights', window );">Number of shares called by warrants (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">145,000<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=us-gaap_CommonClassBMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>69
<FILENAME>R59.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210874789016">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Warrants - Warrant (Details) - Rockport Warrants - $ / shares<br></strong></div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2017</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfStockLineItems', window );"><strong>Class of Stock [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightOutstanding', window );">Shares (in shares)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1', window );">Exercise Price (in dollars per share)</a></td>
<td class="nump">$ 3.80<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 3.80<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfStockLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfStockLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Exercise price per share or per unit of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21475-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightOutstanding">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of warrants or rights outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightOutstanding</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ClassOfWarrantOrRightAxis=esta_RockportWarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>70
<FILENAME>R60.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210796508488">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Narrative (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1"></th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1"></th>
<th class="th" colspan="1"></th>
</tr>
<tr>
<th class="th"><div>Jan. 01, 2019</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2018</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,950,223<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">4,182,196<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber', window );">Number of options vested and exercisable (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">857,094<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice', window );">Weighted average exercise price vested and exercisable (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 12.22<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue', window );">Aggregate intrinsic value of options vested and exercisable</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 43,100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Number of options exercised in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">163,034<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Weighted average exercise price of options exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 11.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue', window );">Intrinsic value of options exercised in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 7,300<span></span>
</td>
<td class="nump">$ 400<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions', window );">Unrecognized compensation expense of stock options granted</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 19,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition', window );">Unrecognized compensation expense period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">2 years 6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Unrecognized share-based compensation cost of unvested RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,757<span></span>
</td>
<td class="nump">1,629<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember', window );">Employee Stock Option</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,161,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,012,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Unrecognized share-based compensation cost of unvested RSAs</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 1,100<span></span>
</td>
<td class="nump">600<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember', window );">Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">42,685<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">48,624<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue', window );">RSAs vested in period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200<span></span>
</td>
<td class="nump">100<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions', window );">Unrecognized share-based compensation cost</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 300<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1', window );">Employee unrecognized compensation expense, period for recognition</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">6 months<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MinimumMember', window );">Minimum | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">1 year<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_srt_RangeAxis=srt_MaximumMember', window );">Maximum | Restricted Stock</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_ConsultantMember', window );">Consultant</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions', window );">Unrecognized compensation expense of stock options to non-employees</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 2,500<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims', window );">Issuance of stock and warrants for services or claims</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 500<span></span>
</td>
<td class="nump">$ 800<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member', window );">Equity Incentive Plan, 2018</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance', window );">Shares reserved for future issuance (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,079,873<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1,641,112<span></span>
</td>
<td class="nump">1,500,000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_IncreaseInCommonStockSharesAuthorized', window );">Increase in common stock, shares authorized (in shares)</a></td>
<td class="nump">750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent', window );">Common stock, capital shares reserved for future issuance, increase (decrease), percent</a></td>
<td class="nump">4.00%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_CommonStockSharesAuthorized', window );">Common Stock, Shares Authorized</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">3,750,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Common Stock, Capital Shares Reserved for Future Issuance, Increase (Decrease), Percent</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Employee And Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_IncreaseInCommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Increase In Common Stock, Shares Authorized</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_IncreaseInCommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Stock Options</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockCapitalSharesReservedForFutureIssuance">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Aggregate number of common shares reserved for future issuance.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02.29)<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockCapitalSharesReservedForFutureIssuance</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_CommonStockSharesAuthorized">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum number of common shares permitted to be issued by an entity's charter and bylaws.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_CommonStockSharesAuthorized</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of cost to be recognized for option under share-based payment arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MinimumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MinimumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_srt_RangeAxis=srt_MaximumMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">srt_RangeAxis=srt_MaximumMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_PlanNameAxis=esta_EquityIncentivePlan2018Member</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>71
<FILENAME>R61.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210793011768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Stock Options and Restricted Stock (Details) - USD ($)<br> $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 1,757<span></span>
</td>
<td class="nump">$ 1,629<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember', window );">Sales, general and administrative</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">1,146<span></span>
</td>
<td class="nump">1,307<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember', window );">Research and development</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AllocatedShareBasedCompensationExpense', window );">Share-based compensation expense</a></td>
<td class="nump">$ 611<span></span>
</td>
<td class="nump">$ 322<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AllocatedShareBasedCompensationExpense">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5047-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.F)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (h)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AllocatedShareBasedCompensationExpense</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_SellingGeneralAndAdministrativeExpensesMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_IncomeStatementLocationAxis=us-gaap_ResearchAndDevelopmentExpenseMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>72
<FILENAME>R62.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875638312">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Stock Options (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward', window );"><strong>Number of Options Outstanding</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance outstanding (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">2,012,960<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Granted (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised', window );">Exercised (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(163,034)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod', window );">Forfeited/canceled (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="num">(36,000)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber', window );">Balance outstanding (in shares)</a></td>
<td class="nump">2,012,960<span></span>
</td>
<td class="nump">2,161,165<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Weighted average fair value (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 38.55<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward', window );"><strong>Weighted-Average Exercise Price</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">16.71<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice', window );">Granted (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">68.97<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice', window );">Exercised (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">11.54<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice', window );">Forfeited/canceled (in dollars per share)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">18.51<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice', window );">Options outstanding (in dollars per share)</a></td>
<td class="nump">$ 16.71<span></span>
</td>
<td class="nump">$ 25.47<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2', window );">Weighted-average remaining contractual term</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">7 years 11 months 8 days<span></span>
</td>
<td class="text">7 years 9 months<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue', window );">Aggregate intrinsic value</a></td>
<td class="nump">$ 42,126<span></span>
</td>
<td class="nump">$ 82,375<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price of options that were either forfeited or expired.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)-(4)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (d)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of options outstanding, including both vested and non-vested options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average price at which option holders acquired shares when converting their stock options into shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (e)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Number of share options (or share units) exercised during the current period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.3-04)<br> -URI http://asc.fasb.org/extlink&amp;oid=120397183&amp;loc=d3e187085-122770<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(28))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(29))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 505<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -URI http://asc.fasb.org/extlink&amp;oid=109259400&amp;loc=d3e21463-112644<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>73
<FILENAME>R63.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210797635560">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Stock Option Granted to Employees (Details) - Employee - Employee Stock Option<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">55.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">1.50%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum', window );">Risk free interest rate, minimum</a></td>
<td class="nump">0.70%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum', window );">Risk-free interest rate, maximum</a></td>
<td class="nump">1.10%<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (in years)</a></td>
<td class="text">6 years 3 months<span></span>
</td>
<td class="text">6 years 3 months<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementEmployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>74
<FILENAME>R64.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210799667080">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Stock Options Granted to Non-employees (Details) - Non-employee - Employee Stock Option - Consultant<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems', window );"><strong>Share-based Compensation Arrangement by Share-based Payment Award [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate', window );">Volatility</a></td>
<td class="nump">60.00%<span></span>
</td>
<td class="nump">56.00%<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate', window );">Risk-free interest rate</a></td>
<td class="nump">1.60%<span></span>
</td>
<td class="nump">1.60%<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1', window );">Term (in years)</a></td>
<td class="text">10 years<span></span>
</td>
<td class="text">10 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate', window );">Dividend yield</a></td>
<td class="nump">0.00%<span></span>
</td>
<td class="nump">0.00%<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The risk-free interest rate assumption that is used in valuing an option on its own shares.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(iv)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:percentItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (f)(2)(i)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SAB Topic 14.D.2)<br> -URI http://asc.fasb.org/extlink&amp;oid=115993241&amp;loc=d3e301413-122809<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_GranteeStatusAxis=us-gaap_ShareBasedPaymentArrangementNonemployeeMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_EmployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_ConsultantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis=esta_ConsultantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>75
<FILENAME>R65.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210795955032">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Share-based Compensation - Restricted Stock Activity (Details) - Restricted Stock<br></strong></div></th>
<th class="th" colspan="1">3 Months Ended</th>
</tr>
<tr><th class="th">
<div>Mar. 31, 2021 </div>
<div>$ / shares </div>
<div>shares</div>
</th></tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward', window );"><strong>Restricted Stock Awards</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding balance (in shares) | shares</a></td>
<td class="nump">48,624<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod', window );">Granted (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod', window );">Vested (in shares) | shares</a></td>
<td class="num">(5,939)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod', window );">Forfeited/canceled (in shares) | shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber', window );">Outstanding balance (in shares) | shares</a></td>
<td class="nump">42,685<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward', window );"><strong>Weighted- Average Grant Date Fair Value</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance outstanding (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.32<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue', window );">Granted (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue', window );">Vested (in dollars per share) | $ / shares</a></td>
<td class="nump">13.31<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue', window );">Forfeited/canceled (in dollars per share) | $ / shares</a></td>
<td class="nump">0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue', window );">Balance outstanding (in dollars per share) | $ / shares</a></td>
<td class="nump">$ 11.04<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(1)(iv)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(3)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(i)-(ii)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (c)(2)(iii)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AwardTypeAxis=us-gaap_RestrictedStockMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>76
<FILENAME>R66.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800303960">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Basic and Diluted (Details) - USD ($)<br> $ / shares in Units, $ in Thousands</strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract', window );"><strong>Numerator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net loss</a></td>
<td class="num">$ (6,948)<span></span>
</td>
<td class="num">$ (17,753)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract', window );"><strong>Denominator:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted', window );">Weighted averave common shares used for basic and diluted earnings per share (in shares)</a></td>
<td class="nump">23,827,137<span></span>
</td>
<td class="nump">22,456,365<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAbstract', window );"><strong>Loss per share:</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_EarningsPerShareBasicAndDiluted', window );">Basic and diluted (in dollars per share)</a></td>
<td class="num">$ (0.29)<span></span>
</td>
<td class="num">$ (0.79)<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=d3e1337-109256<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>num:perShareItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- References</a><div><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669619-108580<br><br>Reference 2: http://www.xbrl.org/2003/role/exampleRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 31<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8924-108599<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 942<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -URI http://asc.fasb.org/extlink&amp;oid=120399700&amp;loc=SL114874048-224260<br><br>Reference 5: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22694-107794<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 205<br> -SubTopic 20<br> -Section 50<br> -Paragraph 7<br> -URI http://asc.fasb.org/extlink&amp;oid=109222650&amp;loc=SL51721683-107760<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 4<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22595-107794<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121641772&amp;loc=SL7669625-108580<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 22<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8736-108599<br><br>Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400993&amp;loc=SL114874131-224263<br><br>Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br><br>Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 230<br> -SubTopic 10<br> -Section 45<br> -Paragraph 28<br> -URI http://asc.fasb.org/extlink&amp;oid=121586364&amp;loc=d3e3602-108585<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22499-107794<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 9<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22663-107794<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 825<br> -SubTopic 10<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -URI http://asc.fasb.org/extlink&amp;oid=75031198&amp;loc=d3e14064-108612<br><br>Reference 17: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 30<br> -Subparagraph (b)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8906-108599<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22583-107794<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -URI http://asc.fasb.org/extlink&amp;oid=121326447&amp;loc=SL5780133-109256<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 323<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=114001798&amp;loc=d3e33918-111571<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 280<br> -SubTopic 10<br> -Section 50<br> -Paragraph 32<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=120311839&amp;loc=d3e8933-108599<br><br>Reference 23: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 250<br> -SubTopic 10<br> -Section 50<br> -Paragraph 8<br> -URI http://asc.fasb.org/extlink&amp;oid=109234566&amp;loc=d3e22658-107794<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>77
<FILENAME>R67.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210800323768">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares<br></strong></div></th>
<th class="th" colspan="2">3 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,949,010<span></span>
</td>
<td class="nump">1,746,843<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=esta_EmployeeAndNonemployeeStockOptionMember', window );">Options to purchase common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">1,900,825<span></span>
</td>
<td class="nump">1,632,871<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember', window );">Shares issuable on vesting of restricted stock awards</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">42,685<span></span>
</td>
<td class="nump">108,472<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember', window );">Warrants to purchase common shares</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems', window );"><strong>Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount', window );">Antidilutive securities excluded from computation of earnings per share (in shares)</a></td>
<td class="nump">5,500<span></span>
</td>
<td class="nump">5,500<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 260<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6371337&amp;loc=d3e3550-109257<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=esta_EmployeeAndNonemployeeStockOptionMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=esta_EmployeeAndNonemployeeStockOptionMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_RestrictedStockUnitsRSUMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis=us-gaap_WarrantMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>78
<FILENAME>R68.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.21.1</span><table class="report" border="0" cellspacing="2" id="idm140210875108008">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Related Party Transactions - Narrative (Details) - USD ($)<br></strong></div></th>
<th class="th" colspan="1">1 Months Ended</th>
<th class="th" colspan="2">3 Months Ended</th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2020</div></th>
<th class="th"><div>Mar. 31, 2021</div></th>
<th class="th"><div>Mar. 31, 2020</div></th>
<th class="th"><div>Dec. 31, 2016</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Grants in period (in shares)</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">347,239<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember', window );">Immediate Family Member of Management or Principal Owner</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionLineItems', window );"><strong>Related Party Transaction [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RevenueFromRelatedParties', window );">Revenue from related parties</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_AccountsReceivableRelatedParties', window );">Accounts receivable</a></td>
<td class="nump">$ 200,000<span></span>
</td>
<td class="nump">200,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross', window );">Grants in period (in shares)</a></td>
<td class="nump">22,068<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">20,580<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1', window );">Vesting period</a></td>
<td class="text">4 years<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">4 years<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_esta_RelatedPartyTransactionCashReimbursementPerDayForServices', window );">Cash reimbursement per day for services</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 4,500<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty', window );">Purchases from related party</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="nump">$ 93,000<span></span>
</td>
<td class="nump">$ 20,000<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_esta_RelatedPartyTransactionCashReimbursementPerDayForServices">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Related Party Transaction, Cash Reimbursement Per Day For Services</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">esta_RelatedPartyTransactionCashReimbursementPerDayForServices</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>esta_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_AccountsReceivableRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For an unclassified balance sheet, amount of receivables arising from transactions with related parties.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (d)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 944<br> -SubTopic 210<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-03(a)(3))<br> -URI http://asc.fasb.org/extlink&amp;oid=120400017&amp;loc=d3e572229-122910<br><br>Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 3<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39603-107864<br><br>Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 210<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.5-02(3)(a)(2))<br> -URI http://asc.fasb.org/extlink&amp;oid=120391452&amp;loc=d3e13212-122682<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 235<br> -SubTopic 10<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(k)(1))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395691&amp;loc=d3e23780-122690<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_AccountsReceivableRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>instant</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 850<br> -SubTopic 10<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (c)<br> -URI http://asc.fasb.org/extlink&amp;oid=6457730&amp;loc=d3e39549-107864<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>debit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RevenueFromRelatedParties">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 946<br> -SubTopic 220<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07.1(c))<br> -URI http://asc.fasb.org/extlink&amp;oid=120401555&amp;loc=SL114874292-224272<br><br>Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 220<br> -SubTopic 10<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03.1(e))<br> -URI http://asc.fasb.org/extlink&amp;oid=120395209&amp;loc=SL114868664-224227<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RevenueFromRelatedParties</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Publisher FASB<br> -Name Accounting Standards Codification<br> -Topic 718<br> -SubTopic 10<br> -Section 50<br> -Paragraph 2<br> -Subparagraph (a)(1)<br> -URI http://asc.fasb.org/extlink&amp;oid=120381028&amp;loc=d3e5070-113901<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:durationItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Gross number of share options (or share units) granted during the period.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:sharesItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>79
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M9%9$7&Z4L+]RGC",K2X+'F[L_V(KQZ 5"U>:/&% =87P<%_?3P(SHX4]/;A
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MX>0!2U1C;+50_&@FP2U7,%>:RP1&?R:T #S?<ZXN"[U!\\^$]?]02P,$%
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MT%"";;.$1Y)($P#S2R'TOF,6:)_=[!]02P,$%     @ A("F4AWZ_W !!@
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M.U(=7MX<;@3;UN\.'I@0K*@O4TJDIE &\O<U8^+E1KV..+Y"6_P'4$L#!!0
M   ( (2 IE)2/H;HRP<  -4@   8    >&PO=V]R:W-H965T<R]S:&5E=#<N
M>&ULG9IM<]LV$L>_"D;7N6EGJD@$^"#E;,\X2CO7F4OKB9OK:XB$+%PH0@5
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MR0\5GBD_HKW=(4UV)KL_T+?7Q[V7].U]1]\G7RBKKU/H0\1I@S,ZO\G$N>?
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M5MG'NG2YL^WS1QVLAT\]RF7NESSWV8&YS[-?ZJI;M]GKJK!%^OPC@-,#>Z;
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M#D;E95\ 7&6I2T</TMH5$6!C_]4[Q-?BAK9$J^(IE!:(=@S9TW_OJ!@QY6!
M#%R[KOL2  )4@KC&PX!9_^@KEH=TDH3RN].]')(NRSOOD+O _4L)GAG +7=D
MRV0<J&1X'U'J9J>SDW\ ,"4, YB9GYP^9GXR"7OX/+V:WH$F&.7WP;*>_RC#
MX&N@>,&K#"3BX(O=NL9[4.\JF+?M%ZTKG&D(,*+@?;ZXA ?J7?M]=J6C;[)W
M%1#EMF[H-!_-<R"PUM'9@:BWV6L <U&Z=HV09N_-HIUD5]/Y-#NZK.&G[!/<
MH^/L9U/U.-GI,UQL=@$R&?0@DWV^FD^R]^\OLR/X=)R]L8N&QIW-<-SI1?;S
M_)=?LM]LOJ[JLEX![!,$:"KC/^1=C>=Z]I2&/QZ!!AA57?1=W6; 2+(K@VA\
MWQ4F.WK9F#]=&6"[H#F>9*_[!K1- _MS((/=HJ?-7B*5- KWR]]?SF$&6ZY<
MOSD63.H$,N8=W#J#!_.F(:9U-;_*COCS,5 )L":BR=,S>>SGU[^>_(YZ7#9_
MFQU= 57]:1N8H3@&D7/-@\_.TC5^17Z1FVS^$I^P0%#Q8!K[= ^>S__(WKL-
MW;:CB#'^ ^Y^4<-N?NZ!:I@L3I_YISL#WUY-/TW?9T?TQZ&!NLS5%K1Q)(;W
M<%ST1\#U^82OGSPS[Q'3)GN[6?R4'<E?$=5<I,/?6F NU8T,E[^.8985/)F=
M#N9N0"2 E# *O/\BHK>GPA?F9<E,6MCAX';!X;4F9Q$0A)0M 9N5$2:2QW)P
M"LA5SO9.F/^EO_@'=(5W$??<8\XJ0N[%I$>O>Z0=W$%I(H:)UW+(?A6@F.<#
M2!V<-_R*O%$X:Z4J4G<_[C<A):57/#+W]'_^)83<3<$@ 8K;K7D#K=E8-+X<
M8?1>0FL*ATI/U%M7(8;@/(!HP>#$GR<\67S,_][^!/^D+YCB#[@5_/UN[>!0
M$9T5B,2V1=*' Z$GLZ5Q#=SG,1D3%MG6POS':"HFCA886:N2"/AI(YH3CLA-
MN\Z6*&G^ @6"A.UQ$]&V<$.PD@$2 PHL12E!%191"3>S;RR3C<)UCV4;HER/
M, <H<A4R733D51O3>0&9H.C8KULP]VVX7\L>#F+IVAR 0\5$L 6_X@CD,\L>
M@11U&Y6(%6^--(6ULTO%(6RHL+DC=\3&?+&-7T0.+7-,FY?TU.NO@ >"],,2
M#!S;,!X._ C[N$:/PP%5+BA+2  I'=*]F'@B=JR#)EKJHNX[7,%6O<4?5[9>
M-68+-(FZ-2G+N)=M#^I&RRHZ$'"=\ZYA[;IO<E&K[+4I>_XA(D[;T')P@V6;
M@I(U4FL%B_8M<*6V93>,ZVZ48 'U?-!9RYB7V]F0%D6_K2UHL2(.R#) 6 -A
M3Z(#\M0/FP%9R.16PL9+^@XQ!-#@\2[("!.&&)#9@T3F!_:-@F13!:CUS88X
M;;<V8"AT]+4!BQ8>0+H$S8W!)4;F0=1M@J3M\W _=&X<C!?W$)T(^FV,<O)+
M%6B+;?B:D,.,3UM$P-Z)HVHK7"G>&L.)]N;;\ 1(RQQ 5D82@UO M;E&RD#Q
MW;6Z+""^J3? MTL6/.S)PD.%55G-8Y3^XHH"4/3:M,"+WR.&@G&(J)BW3CXA
M=I$=W%@DY=S"L@6:BTT-&"%>:@6&+>J=.2GO^^;G%.V*>S*^C!56I4%A+Z>S
MZ9._T1CX-/L;7IJ$E 05$R1*Y$H ,!(2FXQ9C;1/_.S:%3TZ8G!JD KV:VXM
M G-ZVYS$!MJUVY[ S@O;HE9%=YVX 9/4QOQ1-WC5A%4.94LR<U=WR+_;UJ+<
M9[.'3%*4&'17P99R1,XZIN6;.8[EWT86+.MJ=5+RP<DD3(&!<A$F4/X1Y"U2
M22.< JWK+=T;NB#5 )J,F!4K$\'ZP4OH&>?39WQ8SQBM1 &TYSVH#FMM>^9L
M>KB@<[(-",:0VY"S ]' F@X?#_QXP,X<5X+$K=!&.@O2.LJ?S/I5$#: O=]L
M^8821S++)0#&"LZ&56EF2L'DOJ^_(5&42*N<)L['R#&4 A=!_T=?B(1M[+)D
M:?T7P%'#'(ANTX*-C8I)9)(SAR#V*_)*O#4HUW:(9*)RN$U=#9?N\)CP"PK%
M7)P\>P0X&$ALD?04^$50H7/0>+D36=]:4%&RDIDHK#V89FD;7@\0#P1KOHY<
M4?PVVH '?AK1(<I1EA(P9 TWK$8>6Y+"U#@+P_$NDC3V'CCF5<RH8NH"T>GL
M-?MPV;G4UA6A&E2+<-(H0#OD;"J4-P;DA0.J;%@ZL,LD$$H/I]_("+KIT9HD
MO(%9TE_35"(AIBX!2R""/[GV"T']@:#&/QFMGV%\@YHYN8?>1$H6RF$F*;HU
M6Z!J&$1^S+9?_*%72 4>[)GTKW3YG)=O<'EE8>(:I9EPB#+2$1J]([_&&93K
M JC=KD[414!DUW<JVT=X\DM3$F$<\K@QB H>"R(:^ 8$4@-KO+)DA8!)U?;L
M6KD,'BK2JM^\>G<YR= L)Q[^\.SQ;#*;S?:50A3E@?@*4L7+NFU97T Q7O!B
MK2)O2CZ" [A1=0>G)O.2%9,BUD/$)(K5 S+Q6'+"]D &?:&[%1_=?;45;W".
MSCVN=8%XZ!PNV"&_B'_I$2%(<)N%2GCD"^H?JQOEKU\P6 *\"<AU7^M*T2^:
M(RKFJYID/%.O]4S$XVIO(3_E)"MJR\<H,@J +-$Q 80R$: <&<-MQ)/8SM [
MIBO+P:/_0N8/9+A;TVD"2RF"[3PE/RGP8+FIYIN4 1,A=TO(@ET+)8GL@0]M
MFKVZ5V3+.VFJ>F\/HB]N:HKXF$HUNUN@G6:__GOS &\J[*@X7# 3&%=R8/I]
MEWU*/0UR?SJK^;5!Z<E^8;(@ 5@XC"]5O2,WQ:_]%6C-WH=\0PYG8A/TRT2=
M.2#JX9\>!0^LBPX:BV9^>;*B7;0.!!(:D7W+NL)_ZJQ2FZY ^S<'!L*LXN'%
M]#S;N+)4UO;X\?09XYO41C^8B?WAX^DL&?[D8OK=^/#4'B!*)'P @[NSXIGM
M0P\$ 68^7@K2"O2<ZYU&6T%T '$5-:'XX>GTB<++&SB-]YNJM6/*O/A-(G]3
MY&L"S:HNP6HU6=43W/!SXX5Q'PMC,,A,3OR%Y&].,:M(=SVP[K[-S_XMH!'T
M,<1Z!VS^&OUM&O,&$B6DL[/(0TSZY"0#9N==3Z4XZ[MZ$@%- EIBDJ@\>B/T
MD-R6B"X"&%B?^IU$&NTMP )#8JE\DN/3AQE0.;<=>PE9[B&31*4@K$-0E*99
M67:'H,,('FTI=@;8)" ;@#*7^&X-PM!VY*^,+C+F2'1V1>X$"<V",<JS@^#&
MBT<@5]D7>Q.9N3R"+SPYE?R]!T+XJ# 6Z("!$R9/5I<P'Q$UI36-"!3EY&]>
MS?'>J6$="]_XL%8 &#(PV!8Z FK$ O MMB]0<DXE7P(L&E1O@:&C(LKJ#I%H
MMX[0N8,;H_X(=K9[_VX $G2"Y.RR'7F0R%?G1TW"1_F]-#>V(&8R?+9G?9LL
M01:R)*[M5]?2L86EB4^T5E&J7FJ\9.2+-R$5Q!37< R@N, Z</GJ1$DDM88Y
M4V">_ZP;F.<G:TJP5S\T*R"F/UE)*6Q><IX'NM[[;@%6PA=U%0,D $(#1W/M
MFKZE'5Y^^/W=JY/3[T@H&-"(@((V0%ZL+*%:QUEGV:JL%WB'8PN(795XC=F&
MB=%%:HJZ'_%L,8M" 2)^4<1( (VGZ;>J:''@P+.U] 9Z7YTGX51%0E$EKF<?
M^F:>Q&),#A@.RU5DC'4$@:T:4*3(5HYB.$!B=<4^0X[SK,&2]WK:NU>OA].,
MFP _@3B 4^;CDX/V-TC/(.!'-762+P%)EMES/6Y&E XN:4&&3#,2P&!Q0HYY
M^Q6Y(9%%\,0K^2W5)P 4W>,I*U03'P$+7F6.$2)A 88! 7D4\P@93@L+-.\D
M'81T _@2J+3/+1\DDQA'O80;\QP,!<]B6;8I(4[A6GCO1C(0M!#7R>V577D&
MXG'M*=U1=(PVFN"5SPIW#D:E@=VM@<?GF@"24(7*#(D%X8_UQMEO^GI3![0W
M1=2S?;NP3UP1@T@/*3"YIJ%$ IC1$3'X(>E%I+H"UBIQP*TE4Q'U=Y $P,EO
MQ$6*2*_[%F:FT^%@3<3QR*,F2HW7AA3UJ2X%?)^M&G%KW'@7!0W;F!6<*KJ>
MA$*#2-<SKF^/Q &^>820?Z")/<5!.8F2E;A<(D221X$9]UW0.N&=\Y'$YX'R
M$AG?*"#^GL6;N$1OP9AF2&X$\8)XZ]T+*HG5KVW^1?4-6AR0?+( J45?BMWR
MO^072<A?3:9EPKQB/Q'1$D"T<FS8=YIU1/!%Y@?%GI [,5;1FTF.;3$%*!\2
M84>E!O3'D!3FU7K<$5J4@U'W,M[FNJ-/P0@D9X4:Y;355W6_Z- 5Z8?/1XQ'
MP#+Y8 G/J.2[G!VLEG>J-Z48FOR-!2P)0RYTJ?28_?UC6B>R% X:K@+<V9O@
MCXX\#)'CDQ8,D(AS@:\CA2U1WOF[I9Y8.,P%&)K=C?>O^Y0^79-TH"C^.9H4
M%B9!?PB)R<@JVS?$!PX?NC<%WGFP61RPM&PIYE'*94'@Z'V0B7@>]JCL0#E8
MRY45.2K[U9 +I5( 7EJ.(+-C^!:'$-D%C ?Q']^$I .=?,_D"1?(>V\)B3E9
MV5Y9DR!P[IJ\W[0=DPVQ1?09(U-S#<:[@'MCJ&%_O?CHL)2!9)9?NUZ4;J7"
M*J$41]1=-Z@*F!524N>#)45O%5FL(K2BWU/\L08I\"=%Y/R!"M_GYV/Y,7"8
M"UTX<OR^\S$(3N7EV-<G<6>&7Y.;A\O %MBNSO$9F-FS%?01F:I'NNE%&0Z1
M#E%'>!>F!'U=8R1$3Q1(\:.G#)!+PMTH"Y@&B:I-4S (&]NMZT(S7= F_JK!
M![;'<50;/;YT#?!\S%3C3YBD$(4O@\V'QALZEC1'(NSF7SVJ*\1\]>*P_* %
M^>:C.[?^0])"6(\!J0^03T2%0BY"D7E@MTO07I>6U4*D"S1%P+CGK _B*U]S
M53A;.(*337W-R6$>9?,J A##CPUGJSP\G3X=>ER""\8[K@,]_N4H9(H](=56
MU&DFL  AI=9)F$E3Q)394E(=/Z .=G+'^N2"-KH*T^R]I6N=Y@<(W<"I+>GN
M-0VJX\1'')M^DC.%=Q.D" G&3J@6?1]D3HKH5(L "S3V8PI6PHFP#/IV"B?1
M4I$S?'X&T-ER0-;*<CXMQ%MTP!IK8!V<Y%R=#(:U69SI,9Q#LX)BM47FA$L'
M9C$2)0//CR*&F-%)3)-SD9"D0:]C9:[6R&[-6F-!%YE0JXHI3T;GXSH^&L^!
MU)89JIKLOK!?T?^!>(=G*KM#EKGU(9V1:5S'#W(01Q\&K-,U5;#(AMX&DV^$
M)!GFTC'_ULSM!DNI3NKE"1CG!,*G#Y\G&ISOMV3^;C;H8-HHPC$ 4#+Y<8D"
M8W4%P&/R,+O+ST0QNR/EX.Z$$1"X@P6BPX,3]I-[K4^L./7#4HT6K=SB'R"@
M3^A9F13E'RY=M9KDA2XV0@16_DCV(Q)$=-@XP32[6KOM5G7IG^"?$O^X)&Z;
M_+;6WY@3)TL:4C!Z8@-D4S16Z9$4=LRN@4<G6N8AA@<<M"-?(+ >KKAX^W>S
MV?XPG^C4?RGC9D*Y+8< IT@.<,^SE)W.IL\..;!5GG[BL_0)OB,DJ;Q-?0R8
M6:3A0^_UPZ2;.#16-Q)\*V_VTITT\L?:CN2)C;B/)R24.;H7I3['\?QO@#R2
M1!*5@UV)M&YABH(R-OP5GU]=3K(GLR<3CRC2D2^%TPK)7X9P(CR XT-ZRB!$
M'NZ,PD9I2ELG3GT5.KC=58V\#J! 2>ER=IV8*/K5D=Q@K8H8F"2.J$1CN<_\
MQG7BUF\%#/++.KS64@W"[!DS#_86_B:"(YK0V.'M="'<%DP1UJ[6DL2DK@-^
M+JB9DJ[4BF/!H9"L^'%B[&1&A@6(E#JP52JJ-6EP_I ,)-Y72DJ !5$;BM*$
MQ;8)6PLW(P>QA8X!8@(M(+9=.DW_'MH[Z78Q,,/*-F,)+ 9U8HKRCM];##[#
M#0!B+,5$P=T1*;JE%&!1.E_L:A]?/T]I- &GN]FB0[3TU5R:G4T"AK4:-$LI
M7;1!4U8C'\)2R$,.]O<6V,Y)83%+!U7H8$Y\DV+XU%P7S /9C@BZZ&C\G8@9
MR(35S\(.DF6#UAKG@4:0A1,>.*TE[7D'9PQZ!+HO.F14/)QX;!1VEM#3P$52
M)@GDBD-_#9AY2#)"P@I5?XA24#7$AJ87VWU"+TNW["B1P]P 82T[$7S>[T*!
M>_6!(E<+%C_?2^]R:$FO*<1'BM>0?G=1;8$46Q[0:^=;#H.AIB4*O4A/+7J2
MT'SPG0Z!^%;N%7(JN.RK!BF!'Z5[#.@&PO7<FK!LU95 4_LTJW1!<EP/LMM%
MJ*\IO0IN1>KC[M;]6(Y6E*%%82PSMIH\$E7S:I UF8"M;U\_P"PZR5-6QP%R
MY7[1DI/7U\)&UOH]8^6)T0^/_6F;6L+V%YB?1$$U;WE1CHK0LNQPJ%#,,\RD
MC*)$AQ*2G!;&=F-9)R2\5NP358,L<I1B/MKZI@6:,L =06AM7:?9-1SN":$O
MKV:U<5!YE*(3L13S!M<*M04/LD*X'_L,)JOC1 R,52*7]9(J["Y$G\GZ)D8:
MV9NZAL?>#L:M:U#_@^J&)Q0PR>1"6W54!A\EN(O"]3TP+=0WXR8$0WHA\CBB
MR6 U0&M[+ E?V4.L#WSRW3E\^&[R].EW:;Y7]@S(YC1[.CF].*6TKY./AGQ3
MCZ(<,7CPXKO',.CBZ:ED))Y>/,V^F\&<Y[/)^?D3^'!V,;EX=KIGD1C/&7=D
M,H,=J0PW\E.,ZQ$.G5_76HGKB4ZUD,@Y%%)$HW5B*6(:&WDD!MJ,*?<D0UO#
M+TL*A88)21'HG"8Z$TNX%C4(8P[(H8C;H094&C'K8%-PHALNI#;;%IU 7MSC
M(S1'+"%C\=)J=J;(P5"OM$$SS.NYY-*18*  3 &SY+[ 5&3_>O-+K3[VQ#96
M$EY_J\E3H3%WCP!)JJ#ML D3ZN# WD<C:C-T>Y&!'<=]?.4'+NJG5@>3;R)
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MBXK_X/C>UG7!Q%Q1<PHM)9MSA&/H4D+G!B,[CP+Z)NH'XY'-7BP/%3J4L;E
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MV^^5ZN0,<:Y\J*1M,>0P4@A3X%,V=\&MDTP9O=8U [0 ]3"9/$S6ZQ>SXP3
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MC4@5-4,:Z' ZYF&R]H#/ZMIJO3[LN7S8>G78<RMA O"YI$3AVFR$&3*!%W6
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MEJX7?EC2?0ZU,Z#UK:*SJ'MQ 88;XNH_4$L#!!0    ( (2 IE(R@&(<,@X
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MS5/^ND&U4H86X/XJSVWU@PZHW^Y\]7]02P,$%     @ A("F4A"$.Y$C!
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M)^-W;Q*@X0T:)MZV\=[/K>=7) YK?K:1@@'OE];ZXR0$./T06/T#4$L#!!0
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MG_!VR\L&CV4*+(#SVJ,5QPT;F)[?NW\ 4$L#!!0    ( (2 IE),COM?,B<
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M87PNRGV!\__2+$P>8C:W%. A,4&_C' ,G4$)<-D&]2>L"U#!6:.2':]I%]:
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M5=9(7!CEJ_-$[X&>:*;A[&[HJ9C=U1HA;OJ;R$V_;+GIZI7@H9=,_KKI)1)
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M&2.3V4"*?0(QA&Q,JP_4QQ+A>X]^LNZ/7/_2'^BG+IX:Y.V:8UM"CQ15(^I
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M?0#;E%YZORSKNMS2GWA'A*YP /R.0+L/N  &"0B\'_X/4$L#!!0    ( (2
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MHPG=A&H? >W&R-H-WK4T-,;=LJ!W$RHK0-\W4IK=QAK8O\3F_P%02P,$%
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MZN&*/'2LVOEKZ5I97')]L\:_"J'=!'S?*&4/';?!\7_*Y3]02P,$%     @
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MXO[SSOH['SO%LF &;Y7XBV<VGP17 62X9)6PSVKS'IMX!LY>JH3QO[!I9*,
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M5^,;,=:*26T<_TOI0]Z")JIK1;E4 =S:.J3/M746+GN#[NAFV"%CV.V-QIU
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M$XUSX/.]YA)I#9>@'\3+OU!+ P04    " "$@*92-!(+5M($  "!#   &0
M 'AL+W=O<FMS:&5E=',O<VAE970S,"YX;6R=5]MNXS80_96!NRD20)%UL20[
M30PXE[;[L-W 2;,/11\8:2P3D40O2=GQWW=(V?)E;2-;P)!$<N;,[7!(7R^$
M?%-31 WO95&IF\Y4Z]E5MZO2*99,N6*&%:U,A"R9IJ',NVHFD656J2RZ@>?%
MW9+QJC.\MG./<G@M:EWP"A\EJ+HLF5S>8B$6-QV_LYX8\WRJS41W>#UC.3ZA
M_GOV*&G4;5$R7F*EN*A XN2F,_*O;A,C;P5>."[4UC>82%Z%>#.#S]E-QS,.
M88&I-@B,7G.\PZ(P0.3&]Q5FIS5I%+>_U^B_V]@IEE>F\$X4WWBFIS>=?@<R
MG+"ZT&.Q^!-7\40&+Q6%LD]8-+)1TH&T5EJ4*V7RH.15\V;OJSQL*?2](PK!
M2B&P?C>&K)?W3+/AM10+D$::T,R'#=5JDW.\,D5YTI)6.>GIX=.42;PT<65P
M)TJJM6(V7>?/[+5 =7'=U63&"'?3%>1M QD<@0SABZCT5,%#E6&VJ]\E]UH?
M@[6/M\%)P"],NA#Z#@1>X)_ "]N80XL7?B#F1[8DBFD82<FJ'.WW/Z-7I27Q
MY=\3QGJML9XUUCMFC+915A<(8@)'D_WP;K[Q4*Y/H]_7DE<YZ"G"#"47F0+:
MFXJBP,RQT\8.JY:T@5(AJ1YV<B(*VHU&4VVYE&Z[A(U+)$I;6(OT#<3,+"A@
M549HE"&>DI75(ELPF:DK>)Y*Q!T" )4OG;;U,P\/SGE%CHA:$9BZ@"=&5',@
MQPHE*ZP%EA';N:F#V;;P"7S'[\7V'7H)C"E(BVMD,YQ3=YG9XL6^#V$0P+/0
MA&3$DRBQ[S@8G*AGU-8S^G@];>A?F[P<*MY)*--OK]2,I7C3L463<^P,=S#A
MK[I\16ELK6>^UEII"MH4[YOM.9A=CN:4MQR)1RA33E5[I.+@C^MC-'W:J-Y1
MA0S%:TK2,\K25F1)*:5JC/)<8LXTPF<2XM2 4WAA18W[9;ME!:M2)$IHN,<4
MK:^K0GL0.)X?.(/8,]F/W<2'Q$TB&O0"QP]B^(-VG"'0^6+M)ENY.6%<PMQ:
MI,@_A7TWB@R_&[9>0-A+G" <0-QW!TD;-"'Y<>AX8>\"?-^->D!]>X*<D+NI
M\;,P(F'L>)Y'$@3J[T2PSU/'CXESL?$XB-Q>0NX/>C3H!TY(<9S@4MQR*?XP
MEQ[*62&6M'=V"6#RWFS(D:*#\SC53EMZGNYG=7=/YZM:: &X<D3!@BF@?<[I
M[*.E6JT[S:9[L(U/'][Z+Z*@@ JNEQ![9Q!%9S#FZNUR8K0Y>6%Z"TA#/\]-
MSN 2?-<_HP<)[C,U=H.H>=SS.<^0>L&28Y'!K[_T S_XK7W_1/PIC>E(I_%/
M9@"R33/>"/S0EO]WHN+CB?+=^*QY[&?(]\SO='9.,#EIF9Q\F,GCS=E@N7R(
MK2?1#C?&YYVT:G,[H6-HE58%XZ=1<\4S^3*'UH2KE)J;R>?5#S[!R)Y7FPZY
MTU?K:D[R)'NPK_7Z=)281D!-)@S:-K9/N9<&XCQR!N& "A&ZH7^H(^WK'7-D
MCR+41.-^U'CA]0YVH^[6M;!$F=O+KR*"UY5N;HCM;'N_'C77RHUX<SDGXSD=
M!%#@A%1I7]+))IL+;S/08F8OF:]"TY75?D[I/P)*(T#K$R'T>F ,M/\ZAO\!
M4$L#!!0    ( (2 IE)4C5R:E@,  %\(   9    >&PO=V]R:W-H965T<R]S
M:&5E=#,Q+GAM;(U6VV[C-A#]E8'0AQ@0(EF2K[ -Q$F*%NBFP3IM'HH^T-+8
M(D*1*DG%V?WZ#BE9<783(R\R+S-GSLP<DEX<E'XR):*%ETI(LPQ*:^MY%)F\
MQ(J92U6CI)V=TA6S--7[R-0:6>&=*A$E<3R.*L9EL%KXM7N]6JC&"B[Q7H-I
MJHKI;VL4ZK ,AL%QX2O?E]8M1*M%S?:X0?M7?:]I%O4H!:]0&JXD:-PM@ZOA
M?#UR]M[@;XX'<S(&E\E6J2<W^;U8!K$CA )SZQ 8_3SC-0KA@(C&?QUFT(=T
MCJ?C(_JO/G?*9<L,7BOQR M;+H-I  7N6"/L5W7X#;M\/,%<">._<.ALXP#R
MQEA5=<[$H.*R_64O71T^XY!T#HGGW0;R+&^89:N%5@?0SIK0W,"GZKV)')>N
M*1NK:9>3GUW=4=__4,; /6K8E$PC7#RPK4 S6$26 CBS*._ UBU8\@%8"E^4
MM*6!6UE@\=8_(F(]N^3(;IV<!?S"]"6DPQ"2.!F>P4O[;%./EWZ =\NTY')_
MFNT_5UMC-8GCWS/X68^?>?SL _P-G9FB$0AJ!VMF> Y,%G##16.Q@)^COU?B
M\Q$>2H2=$G26" FLZU1WH/AW-&!I.U=5W5CF14\\MCV/HN,AJ>?"];PF'L97
M@4ZW]Z45K@K:T6A0DO$<'DJ-^*:Q0&W)R[XO[A/#!9>$H!I#D4P(^))C;3MT
M%_PU5D$Z'<!=4Z%F5NDYW!WY_ (7XW"630=N-)R$DU$Z@!N4BH3?FC[Z4T84
MV#-Y[WVR%>7ID0TTAK9<+C\GC<?BOQ))TG":3,)A.H$D";/1.$S'H_8T]$;S
MDSX>H8A<?)G,!NU@,AN<4<ZH5\[HT\JYDI;[6'1?P0;S1G/+*;O;EUPTKOX[
MK2JX?MOFSXGK+ GW ,Q-S7)<!EX ^AF#'Q17*TNZX$R(;]!S-*\<Z=XWEHKE
M;)GUFD(J'1%\5UY04B-ABRB=8DZR>T?(Q_*WO?ZT,/^L'0 =#05U0]MTA?^@
MFF$XBV.2PHA&XS0)IY-A6T$#W)C&GS&R?D9C75I$A;:LYKEG8U7^!.S -.65
M)>%X2C#Q-,PF"3PRK9FTYV*/PE$<=]\'99EP;+)9& ]C&DVR<3C-4GA/8-')
MI4]':>^?-D/PC;3M_=^O]J_G5?MHO)JW3R^5;<^I1 )WY$J2)IGH]CEK)U;5
M_@G9*DL/DA^6] \ M3.@_9TB6703%Z#_3['Z'U!+ P04    " "$@*92YVX
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M5W"A@/9K:_$4A!F:_P&*%U!+ P04    " "$@*92[T(:KS8&  "&'0  &0
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M'>:Z/01A O3[&>=J/3$;- WG\!]02P,$%     @ A("F4J%QR:^2 @  = 8
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M2592#K=E<NAUE(ZN][@-:*5I_&687-J32T^2ZV_4)1%@ALBE!^6*HOAZG]R
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M)&2%RTQ^8=N/I)F0K^O%+!/5+]@VL8X%XE)(EC?)2D%.B_H?/S8@>@G0.Y*
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M6_GJ,"4X(5P'J/LKQN3N1._GV^\W\_\!4$L#!!0    ( (2 IE*YJ0<)X@(
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MW++$>0W*)N!Y(:5Y"^Q(Z+X Z1]02P,$%     @ A("F4@=:;>^D @  EP8
M !D   !X;"]W;W)K<VAE971S+W-H965T-# N>&ULC95M3]LP$,>_RBGB!4B,
MI$D?$&HK02NT24Q4%+87TUZXR;6Q<.QB.RWLT^_LA*B4M-N;Q _W/__N<KX,
MMTH_FQS1PFLAI!D%N;7KJS T:8X%,Q=JC9)VEDH7S-)4KT*SUL@R+RI$&$=1
M/RP8E\%XZ-=F>CQ4I15<XDR#*8N"Z;<;%&H["CK!^\(#7^76+83CX9JM<([V
M:3W3- L;+QDO4!JN)&A<CH+KSM6D[^R]P0^.6[,S!A?)0JEG-_F6C8+( :'
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MR])-7#3>P9VOM::=X07Z&9[]!5!+ P04    " "$@*92MW0C3-X&  #H*@
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M 6$6Z/D-Y^JE8XK:\$LJ_@!02P,$%     @ A("F4N&]Z<6R @  K0D  !D
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M0?@8AH^YI^"='-XUP&]@^*,GVXCB@_#;!K&7<)/X7V'X Q-;.,$&^%USN&V
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M3H -";A?&^-/0>C=\>4I_P!02P,$%     @ A("F4J=#KXB- @  V 8  !D
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M-,W,ITNU$M)0/DNB'%R,J62ZF:/- 57M1M%"(0TVMRWHUP/:.M#[I5*X/=@
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M%VKZ>?.]T PDJ\V1^XE)=8 WMX7ZQL)<&ZCW>\;DZT"?XKNOMLU_4$L#!!0
M   ( (2 IE*H.)%.WP(  &,(   9    >&PO=V]R:W-H965T<R]S:&5E=#4T
M+GAM;)V6;6_:,!#'OXH5]44K;0TD$* "I$)7;=*J5F7=7IOD0JPZ=F8[I?OV
M.SO@41ZBKF\@MN_^_MV=X\MX+=6S+@ ,>2VYT).@,*:Z"D.=%E!2?2DK$+B2
M2U52@T.U"G6E@&;.J>1AU.DD84F9"*9C-_>@IF-9&\X$/"BBZ[*DZL\,N%Q/
M@FZPG7ADJ\+8B7 ZKN@*%F">J@>%H]"K9*P$H9D41$$^":Z[5_.1M7<&/QFL
M]<XSL9$LI7RV@V_9).A8(."0&JM \>\%YL"Y%4*,WQO-P&]I'7>?M^JW+G:,
M94DUS"7_Q3)33()A0#+(:<W-HUQ_A4T\?:N72J[=+UDWM@/<,:VUD>7&&<<E
M$\T_?=WD8<<!=8X[1!N':-^A=\(AWCC$+M"&S(5U0PV=CI5<$V6M4<T^N-PX
M;XR&"5O%A5&XRM#/3+\#YD"3SV115Q4'K(^AG,RI+L@M5EB3\QLPE'%]@39/
MBQMR?G9!S@@3Y$<A:TU%IL>A01 K%Z:;36?-IM&)36-R)X4I-/DB,LC>^H<8
M@(\BVD8QBUH%[ZBZ)''W$XDZ4?<(S_S][IT6G-@G-79Z\0D]E[Z*LHS@:T9H
M*6MA-.8LY37&:Y-G"B EIKY6+N5$YH3;2A#.Z))Q9ACH%I">!^DYD-X)D/L*
M%#5,K$AJD? MSEU1<R5+(OVBV_IH'1OYQ,G;"^%EVDTP0R^[N3UB$P^\S1ON
MON?N?YP[9X**%%JH&_'^#E&\QWQHD1PG3CQQTDI\ZZ ^3)P<\/3[>\B')H,3
MS ///&@]IH_W3X1J#7@VY1)?<M&<37A-"RI6X ZOP(OX?T[FT.\]?&>%3R=E
M>!#Q_M%KLWB#-?)8HW>4L:U2HX/3O@_59M% A3OW=0EJY=J8)JF])YI+S\_Z
M3GGM&L3>_ P[:-/P_LDT[1>OM!43&@/)4;)S.< DJ::E-0,C*]<5EM)@CW&/
M!7X%@+(&N)Y+:;8#NX'_KIC^!5!+ P04    " "$@*92?9;T-$ #  #W#
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M),)%(N_8[@NI&@IUOA5+A/D+=N6SX=@!JT)(EE;!JH*49N4O?JD6HA4  TL
MJ@+0GP;X58!O&BTK,VTML,2S"6<[P/73*IL>F+4QT:H;FNE_X[WDZBY5<7)V
M0]0:"/ 9F &XQ;+@5+Z"TP61F";B3-UZO%^ TY,S< )H!AYB5@B<K<7$E8JO
ML[BKBG55LI"%=8OY.?#A)X \!'O"Y_O#%V15AWN_A[NJZ[IU5+>.3#[?DN];
M3CB6--N4O8L]*?TZI6]2!I:4EL:NRJB!B=(;:SL+QL'$W?:@@AH5'$*A/E09
M%;90H0T5UJCP$,KO0X5=U"#L1PUJU. 0*NA##;HH'_6CAC5J> @5]J&&'500
MC/M1HQHUVHMZB(E2;"0)[P...L#1<-0/'-? \7X@DS@!4:$V,]'6H&F1@L3L
M\!R_*@O+WNT[[E3BA]"RS-!K#./M+>:&"'$!+E-69!*PZ%T=ZEV@WC]"#?5.
MI)E:)")DKUR\3GF?1^.!I;R6 .'>\I8E'6QQ4A!=WU\O6P5H%X8&L"FLDAOL
M2  -(;24WT@,[K?8-<UPMB*''08;B<'C+%:%M?N$GF5KP,9C\#B1P:[)D W6
MF P>IS+8=9EG834J@\>Y#'9E9F,U+H/'R0QV;69C-3*#_V(SV-69C=C8#'Z(
MSF#79]"WF!4U.D/_1V>H1V>6MR=J9(8^6F:HJRGH^^]<UO?0Z/W*NJU3J?XD
M4,>_#<V$JB%24=[Y4+7.RU-V.9$L-P?5)R;5L=<,8_5E0KA^0-V/&)-O$WWV
MK;]U9K\ 4$L#!!0    ( (2 IE+G#M?++P(  #$%   9    >&PO=V]R:W-H
M965T<R]S:&5E=#4V+GAM;)5436_;, S]*X(O:X$N_FZ2PC'0)ANV0X>@P;;#
ML(-B,[$0R7(EN6G__2C9,=(BZ;:+)5)\CWPTI6POU4Y7 (8\"U[KF5<9T]SX
MOBXJ$%2/9 ,UGFRD$M2@J;:^;A30TH$$]Z,@N/8%9;679\ZW5'DF6\-9#4M%
M="L$52]WP.5^YH7>P?' MI6Q#C_/&KJ%%9COS5*AY0\L)1-0:R9KHF S\V[#
MFWEBXUW #P9[?;0G5LE:RITUOI8S+[ % 8?"6 :*RQ/,@7-+A&4\]IS>D-("
MC_<']L]..VI94PUSR7^RTE0S;^*1$C:TY>9![K] KR>U?(7DVGW)OHM-(X\4
MK392]&"L0+"Z6^ESWX<C0)B< 40](/I70-P#8B>TJ\S)6E!#\TS)/5$V&MGL
MQO7&H5$-J^U?7!F%IPQQ)E]55$$E>0E*?R"?'EMF7LA'\HTJ16V#R<4"#&5<
M7Z)7VV"=^0836[A?]$GNNB31F23W5(U('%Z1*(C"$_#Y^_ %% ,\> WW4>Z@
M.1HT1XXO/L/7J_QUN]9&X1S]?H<S'CACQYF<X9Q+(7 J\7\5NZN^481IW4))
M+EC=>RY/]:XC3AVQO71/>90$TR1(L55/QUTZ$1A/HW0\F0Z!KVI/AMJ3_Z\=
M;[PVM"Y9O?V;@.1$7=>3=#IY*^!48!J.Q^%; ?[10-O'! =HRVI-.&P0&HS&
MR*&Z"]H91C9NQM?2X(UQVPK?-% V ,\W4IJ#8:_-\$KF?P!02P,$%     @
MA("F4K[.(XHO P  ?0P  !D   !X;"]W;W)K<VAE971S+W-H965T-3<N>&UL
MM5==;YLP%/TK%B]KI:U@AZ]42:0UZ;1*FQHEVOHP[<$%)U@%S&R3M/]^MJ&0
M-(3VA3P$?]QS['LN/C*3/>-/(B%$@N<LS<742J0LKFU;1 G)L+AB!<G5S(;Q
M#$O5Y5M;%)S@V("RU$:.X]L9IKDUFYBQ)9]-6"E3FI,E!Z+,,LQ?;DC*]E,+
M6J\#*[I-I!ZP9Y,";\F:R%_%DJN>W;#$-".YH"P'G&RFUE=XO8"A!IB(WY3L
MQ4$;Z%0>&7O2G;MX:CEZ1R0ED=046#UV9$[25#.I??RK2:UF30T\;+^R?S/)
MJV0>L2!SEC[06"93*[1 3#:X3.6*[;^3.B%/\T4L%>8?[*M8/[! 5 K)LAJL
M=I#1O'KBYUJ( P!TSP!0#4 ?!8QJP.BC +<&N$:9*A6CPP)+/)MPM@=<1RLV
MW3!B&K1*G^:Z[FO)U2Q5.#E;)YB3A*4QX>(3N/U74OD"OH 5$83O2 SN>4QS
M]4( $RC Q8)(3%-QJ8*$&9K84NU#L]E1O>9-M28ZL^9/S*_ "'X&R$&P S[O
MAR](U,"=#OCBPW 8'L-M)5ZC(&H41(9O=(9OGF(A -N M631$_CS0\V#.TDR
M\;>'?=2PCPR[VU<?H4Y870]UTL&FE"4G@ I1XCPBX(+F=2TNNXI1+>"9!;0-
M[&;NV',0&DWLW:'J'7$P1'#L-W%'&;A-!FYO!O4[=:=VFNLS#I8ISM]5WVO8
MO0'4]QMV?VCU_1-5D1.,P^"M^J=QT'<AA.@X;M$1YSGZUUVEH,DTZ,WTOM V
M+(!DH"AYE"@K[3S?1^1A0QX.4*1QPSX>NDCCTR)!'T+?>U.DCC@'HK%_1GSH
MM"[L].:@_%9R&DFU?:-1CRSPP-KA ++#UO@@&EKX>H4CTT%^^%;WKK#01^X9
MV5MSA?WN>KM>+OND:#T.ND-(W;H<] :7VCO1T/?AH7'46I_&N8%[UF!@ZZ6P
MWTQ72IF"<0D>,.<XEWW. EO?@L$0RK?6!</!E0]/%/6\4]W?B:KV;Q]<]?3%
M7-VEME3Y=DHV"N9<!0K/J[MNU9&L,+>_1R;57=(T$_5]0+@.4/,;QN1K1U\H
MFR^.V7]02P,$%     @ A("F4H79.02$ @  ZP8  !D   !X;"]W;W)K<VAE
M971S+W-H965T-3@N>&ULM57+;MLP$/P50N@A 5KK:2L(9 &-W:(!FB!(T.90
M]$!+:XL(*:HD'2=_WR4E"W)KJ[GT8O&Q,SN<I9?93JHG70$8\B)XK>=>94QS
MZ?NZJ$!0/9$-U+BSEDI0@U.U\76C@)8.)+@?!<',%Y357IZYM3N59W)K.*OA
M3A&]%8*JURO@<C?W0F^_<,\VE;$+?IXU= ,/8+XU=PIG?L]2,@&U9K(F"M9S
M[V-XN4QMO OXSF"G!V-B3[*2\LE.KLNY%UA!P*$PEH'BYQD6P+DE0AF_.DZO
M3VF!P_&>_;,[.YYE134L)']DI:GFWH5'2EC3+3?W<O<%NO-,+5\AN7:_9-?&
MSA*/%%MMI.C J$"PNOW2E\Z' 2 \!8@Z0/160-P!XK<"D@Z0.&?:HS@?EM30
M/%-R1Y2-1C8[<&8Z-!Z?U;;L#T;A+D.<R1^I4K0VFGP@MW9HJT#.EF HX_H<
M5^]E\=1(9<@@\AWQB:ZH IWY!D58*K_H$EZU":,3"6^HFI X?$^B( J/P!?C
M\"44/3PX E^^.7N8'L)]=*ZW+^KMBQQ??()OP:G61*[)@T&?R(^ON$^N#0C]
M<X0][MECQYZ<8/_T JI@&DBC6 $VS6Y?A#-6DU)R3I4F#:BV'.?'RM&F2%T*
MVP2>\WARD?G/0]/&8PZT)[WV9%1[?UVPUVA#ZY+5&Z>ZO3A'I;:,TX&,Z30(
M#K4N_A%T(';:BYV.BEU((; )M=6\&JG<K"><_8=[D?;LZ:C<VZU88<V1OC63
M%)1S*,GJ]?""G+9ZF?[E8IB@C7_ZZ \ZBWT&\/^S8;4F'-8(#"8I,JBVM;83
M(QO7;%;28.MRPPI?(U V /?74IK]Q/:O_GW+?P-02P,$%     @ A("F4E]"
M;%$T @  AP4  !D   !X;"]W;W)K<VAE971S+W-H965T-3DN>&ULC51=C]HP
M$/PKJZ@/=U*+\P''Z10B]4BKGM1*"-3>0]4'DVR(A1.GMH&[?U_;"5&0@/*2
M>.V=V=E)UO%!R*TJ$36\5;Q6,Z_4NGDB1&4E5E2-1(.U.2F$K*@VH=P0U4BD
MN0-5G(2^_T JRFHOB=W>0B:QV&G.:EQ(4+NJHO+]&;DXS+S .VXLV:;4=H,D
M<4,WN$+]LUE($Y&>)6<5UHJ)&B06,^]S\)2.;;Y+^,7PH 9KL)VLA=C:X"6?
M>;X5A!PS;1FH>>UQCIQ;(B/C;\?I]24M<+@^LG]UO9M>UE3A7/!7ENMRYCUZ
MD&-!=UPOQ>$;=OU,+%\FN')/.+2Y#Z$'V4YI475@HZ!B=?NF;YT/ T PO@ (
M.T!X*R#J -&M@'$'<%:3MA7G0THU36(I#B!MMF&S"V>F0YOV66T_^TI+<\H,
M3B>O5$I::P6?H%O"78J:,J[NS=Y29-M&2 V#O ] 0)54HHJ)-A(L$<FZ<L]M
MN?!"N1]4CB */D+HA\$9^/PZ/,6LA_MGX.G-U8/I*9P8WWKSPMZ\T/%%%_CF
MG"H%HH"5-C[![^_F'%XT5NK/%?:H9X\<^_@"^\IY#'>L[NR^/^=WRS%Q'';&
M]\EDXAMO]D-7_Y-T(F_<RQM?E??E#67&%,)"L@R=S%QP3J6"!F4K^:SBEG8Z
M$!.-'D\%I]=S6KUD\-?;*\I\W0VK%7 L#,H?34V_LAW[-M"B<8.P%MJ,E5N6
MYJ9$:1/,>2&$/@9VMOJ[-_D'4$L#!!0    ( (2 IE)!*.$M]@4  $<<   9
M    >&PO=V]R:W-H965T<R]S:&5E=#8P+GAM;,U976_;-A3]*X31 0V0VB*I
M#ZMP#*1)@V58NB!>VH=A#XQ,VT(ET24I.QGVXT=*LB1'%.VL><A+0LGWDN=^
M\!Q*FFP9_RY6E$KPF":9.!NLI%Q_'(U$M*(I$4.VIIGZ9<%X2J2ZY,N16'-*
MYH53FHR0X_BCE,398#HI[MWRZ83E,HDS>LN!R-.4\*=/-&';LP$<[&[<Q<N5
MU#=&T\F:+.F,ROOU+5=7HWJ6>9S23,0L YPNS@;G\.,5#K5#8?$UIEO1&@,=
MR@-CW_7%]?QLX&A$-*&1U%,0]6]#+VB2Z)D4CA_5I(-Z3>W8'N]FORJ"5\$\
M$$$O6/(MGLO5V6 \ '.Z('DB[]CV5UH%Y.GY(I:(XB_85K;. $2YD"RMG!6"
M-,[*_^2Q2D3+ ;H]#JAR0,\=@AX'7#G@8U=P*P?W6 >O<O".=? K![_(?9FL
M(M.71)+IA+,MX-I:S:8'1;D*;Y7@.-.=-9-<_1HK/SF=K0BG'W1MYN""I:IA
M!2E*_@%\(9P377?P_I)*$B?B1-V]GUV"]^].P#LP D(["Q!GX#Z+I3A5-]7X
MSQ7+!<GF8C*2"J%>9Q15:#Z5:% /FM](-@0./ 7(@:'!_<+N?D/X$.#"'4&#
M^^7Q[H[!_;/=_9)&5O>KH]WA>-]]I(I:5Q;5E47%?/BEE3U79<V65-&#! ]/
MH&UW2YZ*V^=;PN?@K]_5E.!:TE3\;0&$:T"X .3:  E%1X+RC5I,T2)8Y#+G
M%,1"Y"2+5*>I_BF[ZL14_G(!KUA <^9FZH:>@Q">C#;M0AGLX!C!T*_M]B)P
MZPA<:P1?\O2!<L 6@*UU*@784"%5**K; 7VD/(H%>4@.AN%VX(V]P E=,SJO
M1N=9T7TK6%2CV5"N5&&'B((UCU5N+5CG+$D(%V"MHBMP&V&7RP<MV! -$3*C
M]FO4OA7U^7+)Z9)(U029Y+&2K AL2)+3PVDV82P7\]N5Q]!QS!B#&F/PPKKO
M4CO7A*>R%K/YH:('G:)#'SNXI^CC&MKXIXINQ'Q\R<?=DL.AUX,YK#&'5LS7
M_84VY-4$*^Q4.<"M(I=DWS5R^QH!.HU<.E;L]QFG$5MF\3\*8]2F5?JHQT4T
M2K6C[W5,2T6WJD)&.7,Z&&'H]*)LB3K\2915SVH.KDSUST:,]J40>**ZCWR0
MLDRNA$4H8"-=$!V/7[0$:B^6B FITYUG%3_<S<Y-AXZ+:K6]- =>\*Q?*JO]
M'8K"GEHTJ@?MLO<Y72?LB5(P*[KBCW4WT?LS-VH$W;>A\+"1(&C7H%?0^&J%
M=AD0]"'TO6<B;S)T( K]ONW32!*T:])7U4YQMK00T($)W')3V%+:: ^TB\]K
M[X6@NQ=@ASMA5ZW\7EIJM K:Q>I.05.JI.$5F\&6GT9,8/@V=@%J1 +91>(5
M=D&UPMX1%OGCYWO 9#;V48] HT9 D)W5=??L3EU6):[F\?<VX?-NJHSVF+6O
MFU#K^>:U1,((O*L)N!=30_;H2++/#RGPZ0LD^,"B1T@O:D0%V9]Q;N(L3O,4
M_ M>L%M1(Q#(>R.[M6%[]+-L?V "6+"]#4M#]LA.]C?D\7]DOR%@-'XCV6_H
M&]D?!H[(OGV"PUJ+&^+&=N*^4.?U/)'JO&Z;KF%1#-]&NG%#FO@%I'G<\XMD
M(&/9!UI1F_%4@;MLBKP^.L6M-T9V9KO>J64-2K\"V.H7DYD4!75JB54/N@*H
M<920.#7CPQU\7D>F#$;CWA@:0L5V0OW\(X_E$[A6863%V]3;A&0'W_+AAE'Q
M&V%4W# JMA/B:[SI\PV'^R <!YU7?5U#Z+L00K1O>&4R5#W0^[2-&]+&=M)6
MI>54Y56?E-264F)<-NOI[@4YR>6*\6++V</^A+OG[L"S8&R8']N/WA=[N"*R
MCB5)=OALA3I5457AO9_3<G12'%YT/QMCL"-QAX[SBZW-&NG =N:O8IJ5,55-
M=U[GVMA682>_V)C@4>N3BO[$=D/X,E9DF-"%\G2&@9J"EU^MR@O)UL57E@<F
M)4N+X8J2.>7:0/V^8$SN+O2'F_K;X?0_4$L#!!0    ( (2 IE*K3U0XSP(
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M6??&>J)%9=O+7&AL5G:8X_\$2&. ^PLA]'9B#FC_4))_4$L#!!0    ( (2
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M< O//RKT!OB^X5R=)EI!\Z"<_@-02P,$%     @ A("F4IVR8UW1 @  X@@
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M.( 4-ZP0]D$=/F.5S]#QK94P_A<.56PO@'5AK,HK,"G(N2S_V6OE0P- /.V
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MT:7H$FQ]\S9TF(6TY7VN5^OWX=:WQ9/U.;T;99O_0U,^.G1;MUP:$+@A2M)
MYZ/+1EY.K-KY7OBL+'56/\SH[4/M FA_HY0]3MP'ZM=T]AM02P,$%     @
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MQJ;+OJ;8%X,T ;B^%$)O!Z9 TVF/?P-02P,$%     @ A("F4GC1ARMG P
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M?*HY>!6TY&+MS'TPS)10.C"VLC9<!);ZT<&1FT'16YZ22Z6;V"Z"^SMMEQ\
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M=OP5MA<EW2N6C<5ESE8LG[13/9\VP\ .;-3V H=#Y+JY_ CFXS _ A@6!U.
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M4')O<',O87!P+GAM;%!+ 0(4 Q0    ( (2 IE(7)L-&[@   "L"   1
M          "  :\   !D;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( (2
MIE*97)PC$ 8  )PG   3              "  <P!  !X;"]T:&5M92]T:&5M
M93$N>&UL4$L! A0#%     @ A("F4G' ;O,R!0  XQ4  !@
M ("!#0@  'AL+W=O<FMS:&5E=',O<VAE970Q+GAM;%!+ 0(4 Q0    ( (2
MIE(&:PK/CP8  ,T9   8              " @74-  !X;"]W;W)K<VAE971S
M+W-H965T,BYX;6Q02P$"% ,4    " "$@*92/]E=CZ "  "_!@  &
M        @($Z%   >&PO=V]R:W-H965T<R]S:&5E=#,N>&UL4$L! A0#%
M  @ A("F4E60\\2F!   6!   !@              ("!$!<  'AL+W=O<FMS
M:&5E=',O<VAE970T+GAM;%!+ 0(4 Q0    ( (2 IE)?3"87N (  (('   8
M              " @>P;  !X;"]W;W)K<VAE971S+W-H965T-2YX;6Q02P$"
M% ,4    " "$@*92'?K_< $&  !.&P  &               @(':'@  >&PO
M=V]R:W-H965T<R]S:&5E=#8N>&UL4$L! A0#%     @ A("F4E(^ANC+!P
MU2   !@              ("!$24  'AL+W=O<FMS:&5E=',O<VAE970W+GAM
M;%!+ 0(4 Q0    ( (2 IE+#A73(&@8  , -   8              " @1(M
M  !X;"]W;W)K<VAE971S+W-H965T."YX;6Q02P$"% ,4    " "$@*92Q#5K
M)'\J  "TA0  &               @(%B,P  >&PO=V]R:W-H965T<R]S:&5E
M=#DN>&UL4$L! A0#%     @ A("F4F:1B,+!!0  @@T  !D
M ("!%UX  'AL+W=O<FMS:&5E=',O<VAE970Q,"YX;6Q02P$"% ,4    " "$
M@*92T-OA(N(&  "O$0  &0              @($/9   >&PO=V]R:W-H965T
M<R]S:&5E=#$Q+GAM;%!+ 0(4 Q0    ( (2 IE*KHY2:"PH  !T;   9
M          " @2AK  !X;"]W;W)K<VAE971S+W-H965T,3(N>&UL4$L! A0#
M%     @ A("F4E< PB%/"0  4A@  !D              ("!:G4  'AL+W=O
M<FMS:&5E=',O<VAE970Q,RYX;6Q02P$"% ,4    " "$@*92D/'FF]@(  #1
M*P  &0              @('P?@  >&PO=V]R:W-H965T<R]S:&5E=#$T+GAM
M;%!+ 0(4 Q0    ( (2 IE*U4<$";P0  $4*   9              " @?^'
M  !X;"]W;W)K<VAE971S+W-H965T,34N>&UL4$L! A0#%     @ A("F4HKO
MT8QN!   +0H  !D              ("!I8P  'AL+W=O<FMS:&5E=',O<VAE
M970Q-BYX;6Q02P$"% ,4    " "$@*92,H!B'#(.  #I*0  &0
M    @(%*D0  >&PO=V]R:W-H965T<R]S:&5E=#$W+GAM;%!+ 0(4 Q0    (
M (2 IE(0A#N1(P0  /$)   9              " @;.?  !X;"]W;W)K<VAE
M971S+W-H965T,3@N>&UL4$L! A0#%     @ A("F4L'H'(J5 P  % @  !D
M             ("!#:0  'AL+W=O<FMS:&5E=',O<VAE970Q.2YX;6Q02P$"
M% ,4    " "$@*92M)M1L=,$  "*"P  &0              @('9IP  >&PO
M=V]R:W-H965T<R]S:&5E=#(P+GAM;%!+ 0(4 Q0    ( (2 IE),COM?,B<
M !*!   9              " @>.L  !X;"]W;W)K<VAE971S+W-H965T,C$N
M>&UL4$L! A0#%     @ A("F4D6C00*-!   E0D  !D              ("!
M3-0  'AL+W=O<FMS:&5E=',O<VAE970R,BYX;6Q02P$"% ,4    " "$@*92
M/X@SY@P%  "S#   &0              @($0V0  >&PO=V]R:W-H965T<R]S
M:&5E=#(S+GAM;%!+ 0(4 Q0    ( (2 IE(N2&VIZ00  .H1   9
M      " @5/>  !X;"]W;W)K<VAE971S+W-H965T,C0N>&UL4$L! A0#%
M  @ A("F4MP49CWE P  < H  !D              ("!<^,  'AL+W=O<FMS
M:&5E=',O<VAE970R-2YX;6Q02P$"% ,4    " "$@*92%?FOW)8"  !2!0
M&0              @(&/YP  >&PO=V]R:W-H965T<R]S:&5E=#(V+GAM;%!+
M 0(4 Q0    ( (2 IE*K>^O,W 0   H/   9              " @5SJ  !X
M;"]W;W)K<VAE971S+W-H965T,C<N>&UL4$L! A0#%     @ A("F4BHRZB'L
M @  ) 8  !D              ("!;^\  'AL+W=O<FMS:&5E=',O<VAE970R
M."YX;6Q02P$"% ,4    " "$@*92] E(L:L"  "4!0  &0
M@(&2\@  >&PO=V]R:W-H965T<R]S:&5E=#(Y+GAM;%!+ 0(4 Q0    ( (2
MIE(T$@M6T@0  ($,   9              " @73U  !X;"]W;W)K<VAE971S
M+W-H965T,S N>&UL4$L! A0#%     @ A("F4E2-7)J6 P  7P@  !D
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M=#,U+GAM;%!+ 0(4 Q0    ( (2 IE*:T+^XWP,  ,L1   9
M  " @?\, 0!X;"]W;W)K<VAE971S+W-H965T,S8N>&UL4$L! A0#%     @
MA("F4KFI!PGB @  I <  !D              ("!%1$! 'AL+W=O<FMS:&5E
M=',O<VAE970S-RYX;6Q02P$"% ,4    " "$@*921JWSH>P#   T#   &0
M            @($N% $ >&PO=V]R:W-H965T<R]S:&5E=#,X+GAM;%!+ 0(4
M Q0    ( (2 IE)ES$.3C@(   T&   9              " @5$8 0!X;"]W
M;W)K<VAE971S+W-H965T,SDN>&UL4$L! A0#%     @ A("F4@=:;>^D @
MEP8  !D              ("!%AL! 'AL+W=O<FMS:&5E=',O<VAE970T,"YX
M;6Q02P$"% ,4    " "$@*92/51R;& "  #/!0  &0              @('Q
M'0$ >&PO=V]R:W-H965T<R]S:&5E=#0Q+GAM;%!+ 0(4 Q0    ( (2 IE*W
M="-,W@8  .@J   9              " @8@@ 0!X;"]W;W)K<VAE971S+W-H
M965T-#(N>&UL4$L! A0#%     @ A("F4D3R_Z]+ @  1@4  !D
M     ("!G2<! 'AL+W=O<FMS:&5E=',O<VAE970T,RYX;6Q02P$"% ,4
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M+GAM;%!+ 0(4 Q0    ( (2 IE)8!*RAR0(  -$&   9              "
M@4$V 0!X;"]W;W)K<VAE971S+W-H965T-#@N>&UL4$L! A0#%     @ A("F
M4CJA5?41!0  Q!D  !D              ("!03D! 'AL+W=O<FMS:&5E=',O
M<VAE970T.2YX;6Q02P$"% ,4    " "$@*92QJ9>]Y("  "?!@  &0
M        @(&)/@$ >&PO=V]R:W-H965T<R]S:&5E=#4P+GAM;%!+ 0(4 Q0
M   ( (2 IE*C<N?O^ $  (4$   9              " @5)! 0!X;"]W;W)K
M<VAE971S+W-H965T-3$N>&UL4$L! A0#%     @ A("F4J=#KXB- @  V 8
M !D              ("!@4,! 'AL+W=O<FMS:&5E=',O<VAE970U,BYX;6Q0
M2P$"% ,4    " "$@*92E75ZQ9P#  #!#0  &0              @(%%1@$
M>&PO=V]R:W-H965T<R]S:&5E=#4S+GAM;%!+ 0(4 Q0    ( (2 IE*H.)%.
MWP(  &,(   9              " @1A* 0!X;"]W;W)K<VAE971S+W-H965T
M-30N>&UL4$L! A0#%     @ A("F4GV6]#1  P  ]PP  !D
M ("!+DT! 'AL+W=O<FMS:&5E=',O<VAE970U-2YX;6Q02P$"% ,4    " "$
M@*92YP[7RR\"   Q!0  &0              @(&E4 $ >&PO=V]R:W-H965T
M<R]S:&5E=#4V+GAM;%!+ 0(4 Q0    ( (2 IE*^SB.*+P,  'T,   9
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M970V,2YX;6Q02P$"% ,4    " "$@*92.[\_Q"$$  !<#@  &0
M    @('*9 $ >&PO=V]R:W-H965T<R]S:&5E=#8R+GAM;%!+ 0(4 Q0    (
M (2 IE*=LF-=T0(  .((   9              " @2)I 0!X;"]W;W)K<VAE
M971S+W-H965T-C,N>&UL4$L! A0#%     @ A("F4DO,D#"T @  ZP<  !D
M             ("!*FP! 'AL+W=O<FMS:&5E=',O<VAE970V-"YX;6Q02P$"
M% ,4    " "$@*92*RW*Y@,#   O"@  &0              @($5;P$ >&PO
M=V]R:W-H965T<R]S:&5E=#8U+GAM;%!+ 0(4 Q0    ( (2 IE+PA*;KS (
M %D'   9              " @4]R 0!X;"]W;W)K<VAE971S+W-H965T-C8N
M>&UL4$L! A0#%     @ A("F4G)R]$$4 P  =0L  !D              ("!
M4G4! 'AL+W=O<FMS:&5E=',O<VAE970V-RYX;6Q02P$"% ,4    " "$@*92
M>-&'*V<#  !$"P  &0              @(&=> $ >&PO=V]R:W-H965T<R]S
M:&5E=#8X+GAM;%!+ 0(4 Q0    ( (2 IE*S,59X'P,   X2   -
M      "  3M\ 0!X;"]S='EL97,N>&UL4$L! A0#%     @ A("F4I>*NQS
M    $P(   L              ( !A7\! %]R96QS+RYR96QS4$L! A0#%
M  @ A("F4L+FUX\E!0   2T   \              ( !;H ! 'AL+W=O<FMB
M;V]K+GAM;%!+ 0(4 Q0    ( (2 IE(6W6L4)@(  &,H   :
M  "  <"% 0!X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0    (
M (2 IE+A[%X1] $  *(G   3              "  1Z( 0!;0V]N=&5N=%]4
?>7!E<UTN>&UL4$L%!@    !, $P RQ0  $.* 0    $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>80
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>81
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>82
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.21.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>196</ContextCount>
  <ElementCount>415</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>72</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>7</UnitCount>
  <MyReports>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0001001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>1001002 - Statement - Condensed Consolidated Balance Sheets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets</Role>
      <ShortName>Condensed Consolidated Balance Sheets</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>1002003 - Statement - Consolidated Balance Sheets (Parenthetical)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical</Role>
      <ShortName>Consolidated Balance Sheets (Parenthetical)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>1003004 - Statement - Condensed Consolidated Statements of Operations</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations</Role>
      <ShortName>Condensed Consolidated Statements of Operations</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R5.htm</HtmlFileName>
      <LongName>1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss</Role>
      <ShortName>Condensed Consolidated Statements of Comprehensive Income (Loss)</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>5</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R6.htm</HtmlFileName>
      <LongName>1005006 - Statement - Condensed Consolidated Statement of Shareholders??? Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity</Role>
      <ShortName>Condensed Consolidated Statement of Shareholders??? Equity</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>6</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R7.htm</HtmlFileName>
      <LongName>1006007 - Statement - Condensed Consolidated Statements of Cash Flows</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows</Role>
      <ShortName>Condensed Consolidated Statements of Cash Flows</ShortName>
      <MenuCategory>Statements</MenuCategory>
      <Position>7</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R8.htm</HtmlFileName>
      <LongName>2101101 - Disclosure - Formation and Business of the Company</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FormationandBusinessoftheCompany</Role>
      <ShortName>Formation and Business of the Company</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>8</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R9.htm</HtmlFileName>
      <LongName>2103102 - Disclosure - Summary of Significant Accounting Policies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>9</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R10.htm</HtmlFileName>
      <LongName>2108103 - Disclosure - Balance Sheet Accounts</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccounts</Role>
      <ShortName>Balance Sheet Accounts</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>10</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R11.htm</HtmlFileName>
      <LongName>2116104 - Disclosure - Goodwill and Other Intangible Assets</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets</Role>
      <ShortName>Goodwill and Other Intangible Assets</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>11</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R12.htm</HtmlFileName>
      <LongName>2122105 - Disclosure - Fair Value Measurements</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurements</Role>
      <ShortName>Fair Value Measurements</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>12</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R13.htm</HtmlFileName>
      <LongName>2128106 - Disclosure - Debt</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/Debt</Role>
      <ShortName>Debt</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>13</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R14.htm</HtmlFileName>
      <LongName>2132107 - Disclosure - Leases</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/Leases</Role>
      <ShortName>Leases</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>14</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R15.htm</HtmlFileName>
      <LongName>2139108 - Disclosure - Shareholders' Equity</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/ShareholdersEquity</Role>
      <ShortName>Shareholders' Equity</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>15</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R16.htm</HtmlFileName>
      <LongName>2143109 - Disclosure - Warrants</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/Warrants</Role>
      <ShortName>Warrants</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>16</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R17.htm</HtmlFileName>
      <LongName>2147110 - Disclosure - Share-based Compensation</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensation</Role>
      <ShortName>Share-based Compensation</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>17</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R18.htm</HtmlFileName>
      <LongName>2155111 - Disclosure - Net Loss Per Share</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/NetLossPerShare</Role>
      <ShortName>Net Loss Per Share</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>18</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R19.htm</HtmlFileName>
      <LongName>2159112 - Disclosure - Related Party Transactions</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/RelatedPartyTransactions</Role>
      <ShortName>Related Party Transactions</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>19</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R20.htm</HtmlFileName>
      <LongName>2161113 - Disclosure - Commitments and Contingencies</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/CommitmentsandContingencies</Role>
      <ShortName>Commitments and Contingencies</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>20</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R21.htm</HtmlFileName>
      <LongName>2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies</Role>
      <ShortName>Summary of Significant Accounting Policies (Policies)</ShortName>
      <MenuCategory>Policies</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>21</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R22.htm</HtmlFileName>
      <LongName>2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables</Role>
      <ShortName>Summary of Significant Accounting Policies (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies</ParentRole>
      <Position>22</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R23.htm</HtmlFileName>
      <LongName>2309302 - Disclosure - Balance Sheet Accounts (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsTables</Role>
      <ShortName>Balance Sheet Accounts (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/BalanceSheetAccounts</ParentRole>
      <Position>23</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R24.htm</HtmlFileName>
      <LongName>2317303 - Disclosure - Goodwill and Other Intangible Assets (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables</Role>
      <ShortName>Goodwill and Other Intangible Assets (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets</ParentRole>
      <Position>24</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R25.htm</HtmlFileName>
      <LongName>2323304 - Disclosure - Fair Value Measurements (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurementsTables</Role>
      <ShortName>Fair Value Measurements (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/FairValueMeasurements</ParentRole>
      <Position>25</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R26.htm</HtmlFileName>
      <LongName>2329305 - Disclosure - Debt (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/DebtTables</Role>
      <ShortName>Debt (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/Debt</ParentRole>
      <Position>26</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R27.htm</HtmlFileName>
      <LongName>2333306 - Disclosure - Leases (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesTables</Role>
      <ShortName>Leases (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/Leases</ParentRole>
      <Position>27</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R28.htm</HtmlFileName>
      <LongName>2340307 - Disclosure - Shareholders' Equity (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/ShareholdersEquityTables</Role>
      <ShortName>Shareholders' Equity (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/ShareholdersEquity</ParentRole>
      <Position>28</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R29.htm</HtmlFileName>
      <LongName>2344308 - Disclosure - Warrants (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/WarrantsTables</Role>
      <ShortName>Warrants (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/Warrants</ParentRole>
      <Position>29</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R30.htm</HtmlFileName>
      <LongName>2348309 - Disclosure - Share-based Compensation (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationTables</Role>
      <ShortName>Share-based Compensation (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/SharebasedCompensation</ParentRole>
      <Position>30</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R31.htm</HtmlFileName>
      <LongName>2356310 - Disclosure - Net Loss Per Share (Tables)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/NetLossPerShareTables</Role>
      <ShortName>Net Loss Per Share (Tables)</ShortName>
      <MenuCategory>Tables</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/NetLossPerShare</ParentRole>
      <Position>31</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R32.htm</HtmlFileName>
      <LongName>2402401 - Disclosure - Formation and Business of the Company (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails</Role>
      <ShortName>Formation and Business of the Company (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <ParentRole>http://establishmentlabs.com/role/FormationandBusinessoftheCompany</ParentRole>
      <Position>32</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R33.htm</HtmlFileName>
      <LongName>2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>33</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R34.htm</HtmlFileName>
      <LongName>2407403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails</Role>
      <ShortName>Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>34</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R35.htm</HtmlFileName>
      <LongName>2410404 - Disclosure - Balance Sheet Accounts - Inventory (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails</Role>
      <ShortName>Balance Sheet Accounts - Inventory (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>35</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R36.htm</HtmlFileName>
      <LongName>2411405 - Disclosure - Balance Sheet Accounts - Property and Equipment (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails</Role>
      <ShortName>Balance Sheet Accounts - Property and Equipment (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>36</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R37.htm</HtmlFileName>
      <LongName>2412406 - Disclosure - Balance Sheet Accounts - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails</Role>
      <ShortName>Balance Sheet Accounts - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>37</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R38.htm</HtmlFileName>
      <LongName>2413407 - Disclosure - Balance Sheet Accounts - Accrued Liabilities (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails</Role>
      <ShortName>Balance Sheet Accounts - Accrued Liabilities (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>38</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R39.htm</HtmlFileName>
      <LongName>2414408 - Disclosure - Balance Sheet Accounts - Other Liabilities, Short-Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails</Role>
      <ShortName>Balance Sheet Accounts - Other Liabilities, Short-Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>39</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R40.htm</HtmlFileName>
      <LongName>2415409 - Disclosure - Balance Sheet Accounts - Other Liabilities, Long-Term (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails</Role>
      <ShortName>Balance Sheet Accounts - Other Liabilities, Long-Term (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>40</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R41.htm</HtmlFileName>
      <LongName>2418410 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Goodwill (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>41</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R42.htm</HtmlFileName>
      <LongName>2419411 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Intangible Assets (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>42</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R43.htm</HtmlFileName>
      <LongName>2420412 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>43</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R44.htm</HtmlFileName>
      <LongName>2421413 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails</Role>
      <ShortName>Goodwill and Other Intangible Assets - Amortization Expense (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>44</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R45.htm</HtmlFileName>
      <LongName>2424414 - Disclosure - Fair Value Measurements - FV on a Recurring Basis (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails</Role>
      <ShortName>Fair Value Measurements - FV on a Recurring Basis (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>45</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R46.htm</HtmlFileName>
      <LongName>2425415 - Disclosure - Fair Value Measurements - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails</Role>
      <ShortName>Fair Value Measurements - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>46</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R47.htm</HtmlFileName>
      <LongName>2426416 - Disclosure - Fair Value Measurements - Derivatives (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails</Role>
      <ShortName>Fair Value Measurements - Derivatives (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>47</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R48.htm</HtmlFileName>
      <LongName>2427417 - Disclosure - Fair Value Measurements - Level 3 Financial Instruments (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails</Role>
      <ShortName>Fair Value Measurements - Level 3 Financial Instruments (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>48</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R49.htm</HtmlFileName>
      <LongName>2430418 - Disclosure - Debt - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/DebtNarrativeDetails</Role>
      <ShortName>Debt - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>49</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R50.htm</HtmlFileName>
      <LongName>2431419 - Disclosure - Debt - Schedule of Madryn Debt (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails</Role>
      <ShortName>Debt - Schedule of Madryn Debt (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>50</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R51.htm</HtmlFileName>
      <LongName>2434420 - Disclosure - Leases - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesNarrativeDetails</Role>
      <ShortName>Leases - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>51</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R52.htm</HtmlFileName>
      <LongName>2435421 - Disclosure - Leases - Lease Cost (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesLeaseCostDetails</Role>
      <ShortName>Leases - Lease Cost (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>52</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R53.htm</HtmlFileName>
      <LongName>2436422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails</Role>
      <ShortName>Leases - Supplemental Balance Sheet Information (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>53</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R54.htm</HtmlFileName>
      <LongName>2437423 - Disclosure - Leases - Supplemental Cash Flows (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails</Role>
      <ShortName>Leases - Supplemental Cash Flows (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>54</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R55.htm</HtmlFileName>
      <LongName>2438424 - Disclosure - Leases - Lease Maturity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/LeasesLeaseMaturityDetails</Role>
      <ShortName>Leases - Lease Maturity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>55</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R56.htm</HtmlFileName>
      <LongName>2441425 - Disclosure - Shareholders' Equity - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails</Role>
      <ShortName>Shareholders' Equity - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>56</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R57.htm</HtmlFileName>
      <LongName>2442426 - Disclosure - Shareholders' Equity - Reserved Ordinary Shares (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails</Role>
      <ShortName>Shareholders' Equity - Reserved Ordinary Shares (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>57</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R58.htm</HtmlFileName>
      <LongName>2445427 - Disclosure - Warrants - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/WarrantsNarrativeDetails</Role>
      <ShortName>Warrants - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>58</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R59.htm</HtmlFileName>
      <LongName>2446428 - Disclosure - Warrants - Warrant (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/WarrantsWarrantDetails</Role>
      <ShortName>Warrants - Warrant (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>59</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R60.htm</HtmlFileName>
      <LongName>2449429 - Disclosure - Share-based Compensation - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails</Role>
      <ShortName>Share-based Compensation - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>60</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R61.htm</HtmlFileName>
      <LongName>2450430 - Disclosure - Share-based Compensation - Stock Options and Restricted Stock (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails</Role>
      <ShortName>Share-based Compensation - Stock Options and Restricted Stock (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>61</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R62.htm</HtmlFileName>
      <LongName>2451431 - Disclosure - Share-based Compensation - Stock Options (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails</Role>
      <ShortName>Share-based Compensation - Stock Options (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>62</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R63.htm</HtmlFileName>
      <LongName>2452432 - Disclosure - Share-based Compensation - Stock Option Granted to Employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails</Role>
      <ShortName>Share-based Compensation - Stock Option Granted to Employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>63</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R64.htm</HtmlFileName>
      <LongName>2453433 - Disclosure - Share-based Compensation - Stock Options Granted to Non-employees (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails</Role>
      <ShortName>Share-based Compensation - Stock Options Granted to Non-employees (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>64</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R65.htm</HtmlFileName>
      <LongName>2454434 - Disclosure - Share-based Compensation - Restricted Stock Activity (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails</Role>
      <ShortName>Share-based Compensation - Restricted Stock Activity (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>65</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R66.htm</HtmlFileName>
      <LongName>2457435 - Disclosure - Net Loss Per Share - Basic and Diluted (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails</Role>
      <ShortName>Net Loss Per Share - Basic and Diluted (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>66</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R67.htm</HtmlFileName>
      <LongName>2458436 - Disclosure - Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails</Role>
      <ShortName>Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>67</Position>
    </Report>
    <Report instance="esta-20210331.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R68.htm</HtmlFileName>
      <LongName>2460437 - Disclosure - Related Party Transactions - Narrative (Details)</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails</Role>
      <ShortName>Related Party Transactions - Narrative (Details)</ShortName>
      <MenuCategory>Details</MenuCategory>
      <Position>68</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="10-Q" original="esta-20210331.htm">esta-20210331.htm</File>
    <File>esta-20210331.xsd</File>
    <File>esta-20210331_cal.xml</File>
    <File>esta-20210331_def.xml</File>
    <File>esta-20210331_lab.xml</File>
    <File>esta-20210331_pre.xml</File>
    <File>exhibit311q12021.htm</File>
    <File>exhibit312q12021.htm</File>
    <File>exhibit321q12021.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy>http://xbrl.sec.gov/dei/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://xbrl.sec.gov/country/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/srt/2020-01-31</BaseTaxonomy>
    <BaseTaxonomy>http://fasb.org/us-gaap/2020-01-31</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>85
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "esta-20210331.htm": {
   "axisCustom": 0,
   "axisStandard": 26,
   "contextCount": 196,
   "dts": {
    "calculationLink": {
     "local": [
      "esta-20210331_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "esta-20210331_def.xml"
     ],
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml",
      "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml"
     ]
    },
    "inline": {
     "local": [
      "esta-20210331.htm"
     ]
    },
    "labelLink": {
     "local": [
      "esta-20210331_lab.xml"
     ],
     "remote": [
      "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-doc-2020-01-31.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "esta-20210331_pre.xml"
     ]
    },
    "referenceLink": {
     "remote": [
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-ref-2020-01-31.xml",
      "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml"
     ]
    },
    "schema": {
     "local": [
      "esta-20210331.xsd"
     ],
     "remote": [
      "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd",
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd",
      "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd",
      "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd",
      "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "http://xbrl.fasb.org/us-gaap/2020/elts/us-parts-codification-2020-01-31.xsd"
     ]
    }
   },
   "elementCount": 556,
   "entityCount": 1,
   "hidden": {
    "http://fasb.org/us-gaap/2020-01-31": 6,
    "http://xbrl.sec.gov/dei/2020-01-31": 8,
    "total": 14
   },
   "keyCustom": 23,
   "keyStandard": 392,
   "memberCustom": 23,
   "memberStandard": 48,
   "nsprefix": "esta",
   "nsuri": "http://establishmentlabs.com/20210331",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0001001 - Document - Cover",
     "role": "http://establishmentlabs.com/role/Cover",
     "shortName": "Cover",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R10": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2108103 - Disclosure - Balance Sheet Accounts",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccounts",
     "shortName": "Balance Sheet Accounts",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SupplementalBalanceSheetDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R11": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2116104 - Disclosure - Goodwill and Other Intangible Assets",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets",
     "shortName": "Goodwill and Other Intangible Assets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:GoodwillAndIntangibleAssetsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R12": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2122105 - Disclosure - Fair Value Measurements",
     "role": "http://establishmentlabs.com/role/FairValueMeasurements",
     "shortName": "Fair Value Measurements",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueDisclosuresTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R13": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2128106 - Disclosure - Debt",
     "role": "http://establishmentlabs.com/role/Debt",
     "shortName": "Debt",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R14": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2132107 - Disclosure - Leases",
     "role": "http://establishmentlabs.com/role/Leases",
     "shortName": "Leases",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeasesTextBlock",
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeasesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R15": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2139108 - Disclosure - Shareholders' Equity",
     "role": "http://establishmentlabs.com/role/ShareholdersEquity",
     "shortName": "Shareholders' Equity",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R16": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock",
      "reportCount": 1,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2143109 - Disclosure - Warrants",
     "role": "http://establishmentlabs.com/role/Warrants",
     "shortName": "Warrants",
     "subGroupType": "",
     "uniqueAnchor": null
    },
    "R17": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2147110 - Disclosure - Share-based Compensation",
     "role": "http://establishmentlabs.com/role/SharebasedCompensation",
     "shortName": "Share-based Compensation",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R18": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2155111 - Disclosure - Net Loss Per Share",
     "role": "http://establishmentlabs.com/role/NetLossPerShare",
     "shortName": "Net Loss Per Share",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:EarningsPerShareTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R19": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2159112 - Disclosure - Related Party Transactions",
     "role": "http://establishmentlabs.com/role/RelatedPartyTransactions",
     "shortName": "Related Party Transactions",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R2": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1001002 - Statement - Condensed Consolidated Balance Sheets",
     "role": "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
     "shortName": "Condensed Consolidated Balance Sheets",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Cash",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R20": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2161113 - Disclosure - Commitments and Contingencies",
     "role": "http://establishmentlabs.com/role/CommitmentsandContingencies",
     "shortName": "Commitments and Contingencies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R21": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2204201 - Disclosure - Summary of Significant Accounting Policies (Policies)",
     "role": "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies",
     "shortName": "Summary of Significant Accounting Policies (Policies)",
     "subGroupType": "policies",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R22": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "esta:ScheduleOfConsolidatedEntitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2305301 - Disclosure - Summary of Significant Accounting Policies (Tables)",
     "role": "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables",
     "shortName": "Summary of Significant Accounting Policies (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "esta:ScheduleOfConsolidatedEntitiesTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R23": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2309302 - Disclosure - Balance Sheet Accounts (Tables)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsTables",
     "shortName": "Balance Sheet Accounts (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R24": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2317303 - Disclosure - Goodwill and Other Intangible Assets (Tables)",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables",
     "shortName": "Goodwill and Other Intangible Assets (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfGoodwillTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R25": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2323304 - Disclosure - Fair Value Measurements (Tables)",
     "role": "http://establishmentlabs.com/role/FairValueMeasurementsTables",
     "shortName": "Fair Value Measurements (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R26": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2329305 - Disclosure - Debt (Tables)",
     "role": "http://establishmentlabs.com/role/DebtTables",
     "shortName": "Debt (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R27": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2333306 - Disclosure - Leases (Tables)",
     "role": "http://establishmentlabs.com/role/LeasesTables",
     "shortName": "Leases (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LeaseCostTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R28": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2340307 - Disclosure - Shareholders' Equity (Tables)",
     "role": "http://establishmentlabs.com/role/ShareholdersEquityTables",
     "shortName": "Shareholders' Equity (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockByClassTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R29": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2344308 - Disclosure - Warrants (Tables)",
     "role": "http://establishmentlabs.com/role/WarrantsTables",
     "shortName": "Warrants (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R3": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1002003 - Statement - Consolidated Balance Sheets (Parenthetical)",
     "role": "http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical",
     "shortName": "Consolidated Balance Sheets (Parenthetical)",
     "subGroupType": "parenthetical",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllowanceForDoubtfulAccountsReceivableCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R30": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2348309 - Disclosure - Share-based Compensation (Tables)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationTables",
     "shortName": "Share-based Compensation (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R31": {
     "firstAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2356310 - Disclosure - Net Loss Per Share (Tables)",
     "role": "http://establishmentlabs.com/role/NetLossPerShareTables",
     "shortName": "Net Loss Per Share (Tables)",
     "subGroupType": "tables",
     "uniqueAnchor": {
      "ancestors": [
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R32": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "esta:NumberOfManufacturingFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2402401 - Disclosure - Formation and Business of the Company (Details)",
     "role": "http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails",
     "shortName": "Formation and Business of the Company (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "esta:NumberOfManufacturingFacilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "facility",
      "xsiNil": "false"
     }
    },
    "R33": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2406402 - Disclosure - Summary of Significant Accounting Policies - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails",
     "shortName": "Summary of Significant Accounting Policies - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CashEquivalentsAtCarryingValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R34": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2407403 - Disclosure - Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "role": "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails",
     "shortName": "Summary of Significant Accounting Policies - Disaggregation of Revenue (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:DisaggregationOfRevenueTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "ib3ef82464d324a3a9122d68d6f8222d4_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R35": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2410404 - Disclosure - Balance Sheet Accounts - Inventory (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails",
     "shortName": "Balance Sheet Accounts - Inventory (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:ScheduleOfInventoryCurrentTableTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:InventoryRawMaterialsNetOfReserves",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R36": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2411405 - Disclosure - Balance Sheet Accounts - Property and Equipment (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails",
     "shortName": "Balance Sheet Accounts - Property and Equipment (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "us-gaap:PropertyPlantAndEquipmentTextBlock",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:PropertyPlantAndEquipmentGross",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R37": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2412406 - Disclosure - Balance Sheet Accounts - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails",
     "shortName": "Balance Sheet Accounts - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R38": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedBonusesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2413407 - Disclosure - Balance Sheet Accounts - Accrued Liabilities (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails",
     "shortName": "Balance Sheet Accounts - Accrued Liabilities (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAccruedLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AccruedBonusesCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R39": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2414408 - Disclosure - Balance Sheet Accounts - Other Liabilities, Short-Term (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails",
     "shortName": "Balance Sheet Accounts - Other Liabilities, Short-Term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherCurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityCurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R4": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1003004 - Statement - Condensed Consolidated Statements of Operations",
     "role": "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
     "shortName": "Condensed Consolidated Statements of Operations",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:CostOfRevenue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R40": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2415409 - Disclosure - Balance Sheet Accounts - Other Liabilities, Long-Term (Details)",
     "role": "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails",
     "shortName": "Balance Sheet Accounts - Other Liabilities, Long-Term (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:OtherNoncurrentLiabilitiesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ContractWithCustomerLiabilityNoncurrent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R41": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "ib16374b323b64d7eb6f72c7a60281d29_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:Goodwill",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2418410 - Disclosure - Goodwill and Other Intangible Assets - Goodwill (Details)",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails",
     "shortName": "Goodwill and Other Intangible Assets - Goodwill (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfGoodwillTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:GoodwillAcquiredDuringPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R42": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2419411 - Disclosure - Goodwill and Other Intangible Assets - Intangible Assets (Details)",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
     "shortName": "Goodwill and Other Intangible Assets - Intangible Assets (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
       "us-gaap:ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAccumulatedAmortization",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R43": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2420412 - Disclosure - Goodwill and Other Intangible Assets - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails",
     "shortName": "Goodwill and Other Intangible Assets - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-5",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AmortizationOfIntangibleAssets",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R44": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2421413 - Disclosure - Goodwill and Other Intangible Assets - Amortization Expense (Details)",
     "role": "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
     "shortName": "Goodwill and Other Intangible Assets - Amortization Expense (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R45": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i95331fe2443f47f2a92a6d7d257f21c3_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2424414 - Disclosure - Fair Value Measurements - FV on a Recurring Basis (Details)",
     "role": "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails",
     "shortName": "Fair Value Measurements - FV on a Recurring Basis (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i95331fe2443f47f2a92a6d7d257f21c3_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilities",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R46": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:DerivativeLiabilityMeasurementInput",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i14303ccbd1cf4882a177c1af2b917801_I20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2425415 - Disclosure - Fair Value Measurements - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails",
     "shortName": "Fair Value Measurements - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:DerivativeLiabilityMeasurementInput",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i14303ccbd1cf4882a177c1af2b917801_I20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R47": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i27da2686b48242f7a22212016aa9bccb_I20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2426416 - Disclosure - Fair Value Measurements - Derivatives (Details)",
     "role": "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails",
     "shortName": "Fair Value Measurements - Derivatives (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i27da2686b48242f7a22212016aa9bccb_I20210331",
      "decimals": "3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DerivativeLiabilityMeasurementInput",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R48": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i366040d3254b4edebd0cb69800364ef1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2427417 - Disclosure - Fair Value Measurements - Level 3 Financial Instruments (Details)",
     "role": "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails",
     "shortName": "Fair Value Measurements - Level 3 Financial Instruments (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i366040d3254b4edebd0cb69800364ef1_I20201231",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R49": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i5aed9212cd444c949bd6daaee2b29e84_I20190617",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2430418 - Disclosure - Debt - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/DebtNarrativeDetails",
     "shortName": "Debt - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i5aed9212cd444c949bd6daaee2b29e84_I20190617",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R5": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1004005 - Statement - Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "role": "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
     "shortName": "Condensed Consolidated Statements of Comprehensive Income (Loss)",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R50": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i15ac743227854d2c9afe9117722a0e53_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentCarryingAmount",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2431419 - Disclosure - Debt - Schedule of Madryn Debt (Details)",
     "role": "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
     "shortName": "Debt - Schedule of Madryn Debt (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfDebtInstrumentsTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i15ac743227854d2c9afe9117722a0e53_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R51": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeaseTermOfContract1",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i759011d78d1d4884b0ec06f0e36e3637_I20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2434420 - Disclosure - Leases - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/LeasesNarrativeDetails",
     "shortName": "Leases - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:LesseeFinanceLeaseTermOfContract1",
       "span",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i759011d78d1d4884b0ec06f0e36e3637_I20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseTermOfContract",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R52": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2435421 - Disclosure - Leases - Lease Cost (Details)",
     "role": "http://establishmentlabs.com/role/LeasesLeaseCostDetails",
     "shortName": "Leases - Lease Cost (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseCost",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R53": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeaseRightOfUseAsset",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2436422 - Disclosure - Leases - Supplemental Balance Sheet Information (Details)",
     "role": "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails",
     "shortName": "Leases - Supplemental Balance Sheet Information (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "esta:AssetsAndLiabilitiesLesseeTableTextBlock",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:FinanceLeaseRightOfUseAsset",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R54": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2437423 - Disclosure - Leases - Supplemental Cash Flows (Details)",
     "role": "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails",
     "shortName": "Leases - Supplemental Cash Flows (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OperatingLeasePayments",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R55": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2438424 - Disclosure - Leases - Lease Maturity (Details)",
     "role": "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails",
     "shortName": "Leases - Lease Maturity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
       "us-gaap:FinanceLeaseLiabilityMaturityTableTextBlock",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R56": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockSharesIssued",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2441425 - Disclosure - Shareholders' Equity - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails",
     "shortName": "Shareholders' Equity - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R57": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2442426 - Disclosure - Shareholders' Equity - Reserved Ordinary Shares (Details)",
     "role": "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
     "shortName": "Shareholders' Equity - Reserved Ordinary Shares (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "ia2caa5751cee42809a8237b7da9369d9_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R58": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "ix:continuation",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i0f4c0806d8b045fd8478b54e30beab7e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
      "reportCount": 1,
      "unitRef": "usdPerShare",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2445427 - Disclosure - Warrants - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
     "shortName": "Warrants - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i247e8da1272d441ea7089934a2671ae9_I20170331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R59": {
     "firstAnchor": {
      "ancestors": [
       "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i0f4c0806d8b045fd8478b54e30beab7e_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ClassOfWarrantOrRightOutstanding",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2446428 - Disclosure - Warrants - Warrant (Details)",
     "role": "http://establishmentlabs.com/role/WarrantsWarrantDetails",
     "shortName": "Warrants - Warrant (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R6": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1005006 - Statement - Condensed Consolidated Statement of Shareholders\u2019 Equity",
     "role": "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity",
     "shortName": "Condensed Consolidated Statement of Shareholders\u2019 Equity",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i5610a0dd1f3e4f9a8ab312df63a13b49_I20191231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SharesIssued",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R60": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfStockByClassTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:CommonStockCapitalSharesReservedForFutureIssuance",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2449429 - Disclosure - Share-based Compensation - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
     "shortName": "Share-based Compensation - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i220c6103ff954277ae7622703799d5e7_I20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R61": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2450430 - Disclosure - Share-based Compensation - Stock Options and Restricted Stock (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails",
     "shortName": "Share-based Compensation - Stock Options and Restricted Stock (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "ia1ec09e636ce49e4903a5f3d5ac3e7c7_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "us-gaap:AllocatedShareBasedCompensationExpense",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R62": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "ib16374b323b64d7eb6f72c7a60281d29_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2451431 - Disclosure - Share-based Compensation - Stock Options (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails",
     "shortName": "Share-based Compensation - Stock Options (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "INF",
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R63": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i6da5c159d78d49d8b73902bb14537731_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2452432 - Disclosure - Share-based Compensation - Stock Option Granted to Employees (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
     "shortName": "Share-based Compensation - Stock Option Granted to Employees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i6da5c159d78d49d8b73902bb14537731_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R64": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2453433 - Disclosure - Share-based Compensation - Stock Options Granted to Non-employees (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
     "shortName": "Share-based Compensation - Stock Options Granted to Non-employees (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "td",
       "tr",
       "table",
       "div",
       "ix:continuation",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i1c660aa4f3f64aef8a138587ad488d6b_D20210101-20210331",
      "decimals": "2",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
      "reportCount": 1,
      "unique": true,
      "unitRef": "number",
      "xsiNil": "false"
     }
    },
    "R65": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i13079f6ba18c4ea6bd64156a196823ad_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2454434 - Disclosure - Share-based Compensation - Restricted Stock Activity (Details)",
     "role": "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
     "shortName": "Share-based Compensation - Restricted Stock Activity (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:NonvestedRestrictedStockSharesActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i13079f6ba18c4ea6bd64156a196823ad_I20201231",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R66": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2457435 - Disclosure - Net Loss Per Share - Basic and Diluted (Details)",
     "role": "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails",
     "shortName": "Net Loss Per Share - Basic and Diluted (Details)",
     "subGroupType": "details",
     "uniqueAnchor": null
    },
    "R67": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2458436 - Disclosure - Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "role": "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails",
     "shortName": "Net Loss Per Share - Dilutive Securities Excluded from Computation of Earnings Per Share (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "0",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
      "reportCount": 1,
      "unique": true,
      "unitRef": "shares",
      "xsiNil": "false"
     }
    },
    "R68": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "INF",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
      "reportCount": 1,
      "unitRef": "shares",
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2460437 - Disclosure - Related Party Transactions - Narrative (Details)",
     "role": "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails",
     "shortName": "Related Party Transactions - Narrative (Details)",
     "subGroupType": "details",
     "uniqueAnchor": {
      "ancestors": [
       "us-gaap:RevenueFromRelatedParties",
       "span",
       "div",
       "ix:continuation",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i8d9dbebf76e14d5287f973e0cf394d40_D20210101-20210331",
      "decimals": "-5",
      "lang": "en-US",
      "name": "us-gaap:RevenueFromRelatedParties",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R7": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:NetIncomeLoss",
      "reportCount": 1,
      "unitRef": "usd",
      "xsiNil": "false"
     },
     "groupType": "statement",
     "isDefault": "false",
     "longName": "1006007 - Statement - Condensed Consolidated Statements of Cash Flows",
     "role": "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows",
     "shortName": "Condensed Consolidated Statements of Cash Flows",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": "-3",
      "lang": "en-US",
      "name": "esta:DepreciationandAmortizationExcludingDebtDiscountPremium",
      "reportCount": 1,
      "unique": true,
      "unitRef": "usd",
      "xsiNil": "false"
     }
    },
    "R8": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2101101 - Disclosure - Formation and Business of the Company",
     "role": "http://establishmentlabs.com/role/FormationandBusinessoftheCompany",
     "shortName": "Formation and Business of the Company",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    },
    "R9": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "disclosure",
     "isDefault": "false",
     "longName": "2103102 - Disclosure - Summary of Significant Accounting Policies",
     "role": "http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies",
     "shortName": "Summary of Significant Accounting Policies",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "esta-20210331.htm",
      "contextRef": "i9d8ea79494ab42e4843111748f602625_D20210101-20210331",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "us-gaap:SignificantAccountingPoliciesTextBlock",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 72,
   "tag": {
    "country_BR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "BRAZIL",
        "terseLabel": "Brazil"
       }
      }
     },
     "localname": "BR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "country_CR": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "COSTA RICA",
        "terseLabel": "COSTA RICA"
       }
      }
     },
     "localname": "CR",
     "nsuri": "http://xbrl.sec.gov/country/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CountryRegion": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Region code of country",
        "label": "Country Region",
        "terseLabel": "Country Region"
       }
      }
     },
     "localname": "CountryRegion",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "dei_CurrentFiscalYearEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "End date of current fiscal year in the format --MM-DD.",
        "label": "Current Fiscal Year End Date",
        "terseLabel": "Current Fiscal Year End Date"
       }
      }
     },
     "localname": "CurrentFiscalYearEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "gMonthDayItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus",
        "terseLabel": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus",
        "terseLabel": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented.  If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentQuarterlyReport": {
     "auth_ref": [
      "r560"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as an quarterly report.",
        "label": "Document Quarterly Report",
        "terseLabel": "Document Quarterly Report"
       }
      }
     },
     "localname": "DocumentQuarterlyReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentTransitionReport": {
     "auth_ref": [
      "r561"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a form used as a transition report.",
        "label": "Document Transition Report",
        "terseLabel": "Document Transition Report"
       }
      }
     },
     "localname": "DocumentTransitionReport",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two",
        "terseLabel": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country",
        "terseLabel": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.",
        "label": "Entity Common Stock, Shares Outstanding",
        "terseLabel": "Entity Common Stock, Shares Outstanding (in shares)"
       }
      }
     },
     "localname": "EntityCommonStockSharesOutstanding",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "sharesItemType"
    },
    "dei_EntityCurrentReportingStatus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Current Reporting Status",
        "terseLabel": "Entity Current Reporting Status"
       }
      }
     },
     "localname": "EntityCurrentReportingStatus",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityExTransitionPeriod": {
     "auth_ref": [
      "r564"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.",
        "label": "Entity Ex Transition Period",
        "terseLabel": "Entity Ex Transition Period"
       }
      }
     },
     "localname": "EntityExTransitionPeriod",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityFilerCategory": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.",
        "label": "Entity Filer Category",
        "terseLabel": "Entity Filer Category"
       }
      }
     },
     "localname": "EntityFilerCategory",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "filerCategoryItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityInteractiveDataCurrent": {
     "auth_ref": [
      "r563"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).",
        "label": "Entity Interactive Data Current",
        "terseLabel": "Entity Interactive Data Current"
       }
      }
     },
     "localname": "EntityInteractiveDataCurrent",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "yesNoItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityShellCompany": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.",
        "label": "Entity Shell Company",
        "terseLabel": "Entity Shell Company"
       }
      }
     },
     "localname": "EntityShellCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntitySmallBusiness": {
     "auth_ref": [
      "r562"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).",
        "label": "Entity Small Business",
        "terseLabel": "Entity Small Business"
       }
      }
     },
     "localname": "EntitySmallBusiness",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r558"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r559"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Cover"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "esta_A510kAuthorizationMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "510(k) Authorization [Member]",
        "label": "510(k) Authorization [Member]",
        "terseLabel": "510(k) authorization"
       }
      }
     },
     "localname": "A510kAuthorizationMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_AccruedStockOptionGrantBonusCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accrued Stock Option Grant Bonus, Current",
        "label": "Accrued Stock Option Grant Bonus, Current",
        "terseLabel": "Bonus feature of stock option grants"
       }
      }
     },
     "localname": "AccruedStockOptionGrantBonusCurrent",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 9.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Advisory Board And Board Of Director Liabilities, Current",
        "label": "Advisory Board And Board Of Director Liabilities, Current",
        "terseLabel": "Advisory board and board of director related expenses"
       }
      }
     },
     "localname": "AdvisoryBoardAndBoardOfDirectorLiabilitiesCurrent",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_AmendedMadrynCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amended Madryn Credit Agreement",
        "label": "Amended Madryn Credit Agreement [Member]",
        "terseLabel": "Amended Madryn Credit Agreement"
       }
      }
     },
     "localname": "AmendedMadrynCreditAgreementMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_AsiaPacificAndMiddleEastMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Asia Pacific and Middle East [Member]",
        "label": "Asia Pacific And Middle East [Member]",
        "terseLabel": "Asia-Pacific/Middle East"
       }
      }
     },
     "localname": "AsiaPacificAndMiddleEastMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_AssetsAndLiabilitiesLesseeTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Assets And Liabilities, Lessee",
        "label": "Assets And Liabilities, Lessee [Table Text Block]",
        "terseLabel": "Assets And Liabilities, Lessee"
       }
      }
     },
     "localname": "AssetsAndLiabilitiesLesseeTableTextBlock",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "esta_CashFlowLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Flow, Lessee",
        "label": "Cash Flow, Lessee [Abstract]",
        "terseLabel": "Cash paid for amounts included in the measurement of lease liabilities"
       }
      }
     },
     "localname": "CashFlowLesseeAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_CashPayableForAssetAcquisitionCurrent": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Payable For Asset Acquisition, Current",
        "label": "Cash Payable For Asset Acquisition, Current",
        "terseLabel": "Cash payable for asset acquisitions"
       }
      }
     },
     "localname": "CashPayableForAssetAcquisitionCurrent",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_CashPayableForAssetAcquisitionNoncurrent": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cash Payable For Asset Acquisition, Noncurrent",
        "label": "Cash Payable For Asset Acquisition, Noncurrent",
        "terseLabel": "Cash payable for asset acquisitions"
       }
      }
     },
     "localname": "CashPayableForAssetAcquisitionNoncurrent",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Common Stock, Capital Shares Reserved for Future Issuance, Increase (Decrease), Percent",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance, Increase (Decrease), Percent",
        "terseLabel": "Common stock, capital shares reserved for future issuance, increase (decrease), percent"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedforFutureIssuanceIncreaseDecreasePercent",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "esta_ConsultantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Consultant [Member]",
        "label": "Consultant [Member]",
        "terseLabel": "Consultant"
       }
      }
     },
     "localname": "ConsultantMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_CustomerOneMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer One [Member]",
        "label": "Customer One [Member]",
        "terseLabel": "Customer One"
       }
      }
     },
     "localname": "CustomerOneMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_DebtInstrumentDefaultInterestRateIncrease": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Debt Instrument, Default Interest Rate Increase",
        "label": "Debt Instrument, Default Interest Rate Increase",
        "terseLabel": "Default interest rate"
       }
      }
     },
     "localname": "DebtInstrumentDefaultInterestRateIncrease",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "esta_DepreciationAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation And Amortization, Property, Plant And Equipment",
        "label": "Depreciation And Amortization, Property, Plant And Equipment",
        "verboseLabel": "Depreciation and amortization expense"
       }
      }
     },
     "localname": "DepreciationAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_DepreciationandAmortizationExcludingDebtDiscountPremium": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Depreciation and Amortization, Excluding Debt Discount (Premium)",
        "label": "Depreciation and Amortization, Excluding Debt Discount (Premium)",
        "terseLabel": "Depreciation and amortization"
       }
      }
     },
     "localname": "DepreciationandAmortizationExcludingDebtDiscountPremium",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee And Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
        "label": "Employee And Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Unrecognized compensation expense period for recognition"
       }
      }
     },
     "localname": "EmployeeAndNonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationCostNotyetRecognizedPeriodforRecognition",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "esta_EmployeeAndNonemployeeStockOptionMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Employee And Non-employee Stock Option [Member]",
        "label": "Employee And Non-employee Stock Option [Member]",
        "terseLabel": "Options to purchase common shares"
       }
      }
     },
     "localname": "EmployeeAndNonemployeeStockOptionMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_EquityIncentivePlan2018Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity Incentive Plan, 2018 [Member]",
        "label": "Equity Incentive Plan, 2018 [Member]",
        "terseLabel": "Equity Incentive Plan, 2018"
       }
      }
     },
     "localname": "EquityIncentivePlan2018Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_FinanceLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finance Lease, Assets And Liabilities, Lessee",
        "label": "Finance Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Finite Lived Intangible Assets, Amortization Expense, After Year Four",
        "label": "Finite Lived Intangible Assets, Amortization Expense, After Year Four",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFour",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_GeographicConcentrationsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Geographic Concentrations, Policy [Policy Text Block]",
        "label": "Geographic Concentrations, Policy [Policy Text Block]",
        "terseLabel": "Geographic Concentrations"
       }
      }
     },
     "localname": "GeographicConcentrationsPolicyPolicyTextBlock",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "esta_IncreaseDecreaseInOperatingLeaseLiabilities": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 18.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase (Decrease) In Operating Lease Liabilities",
        "label": "Increase (Decrease) In Operating Lease Liabilities",
        "terseLabel": "Operating lease liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOperatingLeaseLiabilities",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_IncreaseInCommonStockSharesAuthorized": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Increase In Common Stock, Shares Authorized",
        "label": "Increase In Common Stock, Shares Authorized",
        "terseLabel": "Increase in common stock, shares authorized (in shares)"
       }
      }
     },
     "localname": "IncreaseInCommonStockSharesAuthorized",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "esta_InventoryRawMaterialsPurchasesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inventory, Raw Materials, Purchases [Member]",
        "label": "Inventory, Raw Materials, Purchases [Member]",
        "terseLabel": "Purchases"
       }
      }
     },
     "localname": "InventoryRawMaterialsPurchasesMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_LeasesWeightedAverageDiscountRateAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Leases, Weighted Average Discount Rate",
        "label": "Leases, Weighted Average Discount Rate [Abstract]",
        "terseLabel": "Weighted-average discount rate (%)"
       }
      }
     },
     "localname": "LeasesWeightedAverageDiscountRateAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_LineOfCreditFacilityAdditionalBorrowingCapacity": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line Of Credit Facility, Additional Borrowing Capacity",
        "label": "Line Of Credit Facility, Additional Borrowing Capacity",
        "terseLabel": "Additional borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityAdditionalBorrowingCapacity",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_LongLivedAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Long-lived Assets",
        "label": "Long-lived Assets [Member]",
        "terseLabel": "Long-lived Assets"
       }
      }
     },
     "localname": "LongLivedAssetsMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement [Member]",
        "label": "Madryn Credit Agreement [Member]",
        "terseLabel": "Madryn Credit Agreement"
       }
      }
     },
     "localname": "MadrynCreditAgreementMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermAMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term A [Member]",
        "label": "Madryn Credit Agreement - Term A [Member]",
        "terseLabel": "Madryn Credit Agreement - Term A"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermAMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermB1Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term B-1 [Member]",
        "label": "Madryn Credit Agreement - Term B-1 [Member]",
        "terseLabel": "Madryn Credit Agreement - Term B-1"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermB1Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermB2Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term B-2 [Member]",
        "label": "Madryn Credit Agreement - Term B-2 [Member]",
        "terseLabel": "Madryn Credit Agreement - Term B-2"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermB2Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermB3AndB4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term B-3 And B-4 [Member]",
        "label": "Madryn Credit Agreement - Term B-3 And B-4 [Member]",
        "terseLabel": "Madryn Credit Agreement - Term B-3 And B-4"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermB3AndB4Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermB3Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term B-3 [Member]",
        "label": "Madryn Credit Agreement - Term B-3 [Member]",
        "terseLabel": "Madryn Credit Agreement - Term B-3"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermB3Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MadrynCreditAgreementTermB4Member": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Madryn Credit Agreement - Term B-4 [Member]",
        "label": "Madryn Credit Agreement - Term B-4 [Member]",
        "terseLabel": "Madryn Credit Agreement - Term B-4"
       }
      }
     },
     "localname": "MadrynCreditAgreementTermB4Member",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MeasurementInputInterestRateVolatilityMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Interest Rate Volatility [Member]",
        "label": "Measurement Input, Interest Rate Volatility [Member]",
        "terseLabel": "Interest rate volatility"
       }
      }
     },
     "localname": "MeasurementInputInterestRateVolatilityMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MeasurementInputMarketYieldRateMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Market Yield Rate [Member]",
        "label": "Measurement Input, Market Yield Rate [Member]",
        "terseLabel": "Market yield rate"
       }
      }
     },
     "localname": "MeasurementInputMarketYieldRateMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_MeasurementInputProbabilityOfChangeInControlMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement Input, Probability of Change in Control [Member]",
        "label": "Measurement Input, Probability Of Change In Control [Member]",
        "terseLabel": "Measurement Input, Probability of Change in Control"
       }
      }
     },
     "localname": "MeasurementInputProbabilityOfChangeInControlMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Stock Options",
        "label": "Non-Employee Service Share-based Compensation, Nonvested Awards, Compensation Not Yet Recognized, Stock Options",
        "terseLabel": "Unrecognized compensation expense of stock options to non-employees"
       }
      }
     },
     "localname": "NonEmployeeServiceSharebasedCompensationNonvestedAwardsCompensationNotYetRecognizedStockOptions",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_NoncashConsiderationPayableRelatedtoAssetAcquisition": {
     "auth_ref": [],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Noncash Consideration Payable Related to Asset Acquisition",
        "label": "Noncash Consideration Payable Related to Asset Acquisition",
        "terseLabel": "Consideration payable related to asset acquisition"
       }
      }
     },
     "localname": "NoncashConsiderationPayableRelatedtoAssetAcquisition",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_NuSilTechnologyLLCMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "NuSil Technology LLC [Member]",
        "label": "NuSil Technology LLC [Member]",
        "terseLabel": "NuSil Technology LLC"
       }
      }
     },
     "localname": "NuSilTechnologyLLCMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_NumberOfManufacturingFacilities": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number Of Manufacturing Facilities",
        "label": "Number Of Manufacturing Facilities",
        "terseLabel": "Number of manufacturing facilities"
       }
      }
     },
     "localname": "NumberOfManufacturingFacilities",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/FormationandBusinessoftheCompanyDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "esta_OperatingLeaseAssetsAndLiabilitiesLesseeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Operating Lease, Assets And Liabilities, Lessee",
        "label": "Operating Lease, Assets And Liabilities, Lessee [Abstract]",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseAssetsAndLiabilitiesLesseeAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_OtherGeographicalAreasMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Other Geographical Areas [Member]",
        "label": "Other Geographical Areas [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherGeographicalAreasMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_PatentsAndLicensingAgreementsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Patents And Licensing Agreements [Member]",
        "label": "Patents And Licensing Agreements [Member]",
        "terseLabel": "Patents and license rights"
       }
      }
     },
     "localname": "PatentsAndLicensingAgreementsMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_PaymentstoAcquireAssetsIncludingReceivablesHeld": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments to Acquire Assets Including Receivables Held",
        "label": "Payments to Acquire Assets Including Receivables Held",
        "negatedTerseLabel": "Cash used in asset acquisitions"
       }
      }
     },
     "localname": "PaymentstoAcquireAssetsIncludingReceivablesHeld",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_RelatedPartyTransactionCashReimbursementPerDayForServices": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related Party Transaction, Cash Reimbursement Per Day For Services",
        "label": "Related Party Transaction, Cash Reimbursement Per Day For Services",
        "terseLabel": "Cash reimbursement per day for services"
       }
      }
     },
     "localname": "RelatedPartyTransactionCashReimbursementPerDayForServices",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "esta_RevenueFromContractWithCustomerProductReturnPeriod": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Product Return Period",
        "label": "Revenue From Contract With Customer, Product Return Period",
        "terseLabel": "Product return period"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductReturnPeriod",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "esta_RevenueFromContractWithCustomerProductShelfLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue From Contract With Customer, Product Shelf Life",
        "label": "Revenue From Contract With Customer, Product Shelf Life",
        "terseLabel": "Product shelf life"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerProductShelfLife",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "esta_RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Right-Of-Use Asset Obtained In Exchange For Lease Liability",
        "label": "Right-Of-Use Asset Obtained In Exchange For Lease Liability [Abstract]",
        "terseLabel": "ROU assets obtained in exchange for new lease liabilities"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForLeaseLiabilityAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_RockportWarrantsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rockport Warrants [Member]",
        "label": "Rockport Warrants [Member]",
        "terseLabel": "Rockport Warrants"
       }
      }
     },
     "localname": "RockportWarrantsMember",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "esta_ScheduleOfConsolidatedEntitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule Of Consolidated Entities [Table Text Block]",
        "label": "Schedule Of Consolidated Entities [Table Text Block]",
        "terseLabel": "Schedule of Consolidated Entities"
       }
      }
     },
     "localname": "ScheduleOfConsolidatedEntitiesTableTextBlock",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "esta_SummaryOfSignificantAccountingPoliciesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "[Line Items] for Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Line Items]",
        "terseLabel": "Summary Of Significant Accounting Policies [Line Items]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesLineItems",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_SummaryOfSignificantAccountingPoliciesTable": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Summary Of Significant Accounting Policies [Table]",
        "label": "Summary Of Significant Accounting Policies [Table]",
        "terseLabel": "Summary of Significant Accounting Policies [Table]"
       }
      }
     },
     "localname": "SummaryOfSignificantAccountingPoliciesTable",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "esta_WeightedAverageRemainingLeaseTermAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted Average Remaining Lease Term",
        "label": "Weighted Average Remaining Lease Term [Abstract]",
        "terseLabel": "Weighted-average remaining lease term (years)"
       }
      }
     },
     "localname": "WeightedAverageRemainingLeaseTermAbstract",
     "nsuri": "http://establishmentlabs.com/20210331",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_EuropeMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Europe [Member]",
        "terseLabel": "Europe"
       }
      }
     },
     "localname": "EuropeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_LatinAmericaMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Latin America [Member]",
        "terseLabel": "Latin America"
       }
      }
     },
     "localname": "LatinAmericaMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MajorCustomersAxis": {
     "auth_ref": [
      "r185",
      "r287",
      "r291",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Axis]",
        "terseLabel": "Customer [Axis]"
       }
      }
     },
     "localname": "MajorCustomersAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_MaximumMember": {
     "auth_ref": [
      "r307",
      "r308",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r477",
      "r523",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Maximum [Member]",
        "terseLabel": "Maximum"
       }
      }
     },
     "localname": "MaximumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
      "http://establishmentlabs.com/role/LeasesNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_MinimumMember": {
     "auth_ref": [
      "r307",
      "r308",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r477",
      "r523",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Minimum [Member]",
        "terseLabel": "Minimum"
       }
      }
     },
     "localname": "MinimumMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_NameOfMajorCustomerDomain": {
     "auth_ref": [
      "r185",
      "r287",
      "r291",
      "r526"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Customer [Domain]",
        "terseLabel": "Customer [Domain]"
       }
      }
     },
     "localname": "NameOfMajorCustomerDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_ProductOrServiceAxis": {
     "auth_ref": [
      "r182",
      "r287",
      "r289",
      "r478",
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Axis]",
        "terseLabel": "Product and Service [Axis]"
       }
      }
     },
     "localname": "ProductOrServiceAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_ProductsAndServicesDomain": {
     "auth_ref": [
      "r182",
      "r287",
      "r289",
      "r478",
      "r522",
      "r524"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Product and Service [Domain]",
        "terseLabel": "Product and Service [Domain]"
       }
      }
     },
     "localname": "ProductsAndServicesDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_RangeAxis": {
     "auth_ref": [
      "r297",
      "r307",
      "r308",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r477",
      "r523",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Axis]",
        "terseLabel": "Statistical Measurement [Axis]"
       }
      }
     },
     "localname": "RangeAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
      "http://establishmentlabs.com/role/LeasesNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "srt_RangeMember": {
     "auth_ref": [
      "r297",
      "r307",
      "r308",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r477",
      "r523",
      "r527"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statistical Measurement [Domain]",
        "terseLabel": "Statistical Measurement [Domain]"
       }
      }
     },
     "localname": "RangeMember",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
      "http://establishmentlabs.com/role/LeasesNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_SegmentGeographicalDomain": {
     "auth_ref": [
      "r183",
      "r184",
      "r287",
      "r290",
      "r525",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Domain]",
        "terseLabel": "Geographical [Domain]"
       }
      }
     },
     "localname": "SegmentGeographicalDomain",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "srt_StatementGeographicalAxis": {
     "auth_ref": [
      "r183",
      "r184",
      "r287",
      "r290",
      "r525",
      "r544",
      "r548",
      "r549",
      "r550",
      "r551",
      "r552",
      "r553",
      "r554",
      "r555",
      "r556"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Geographical [Axis]",
        "terseLabel": "Geographical [Axis]"
       }
      }
     },
     "localname": "StatementGeographicalAxis",
     "nsuri": "http://fasb.org/srt/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountingPoliciesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Accounting Policies [Abstract]",
        "terseLabel": "Accounting Policies [Abstract]"
       }
      }
     },
     "localname": "AccountingPoliciesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_AccountsPayableCurrent": {
     "auth_ref": [
      "r44"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Current",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "AccountsPayableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsPayableTradeCurrent": {
     "auth_ref": [
      "r9",
      "r44"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accounts Payable, Trade, Current",
        "terseLabel": "Outstanding balance owed"
       }
      }
     },
     "localname": "AccountsPayableTradeCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableNetCurrent": {
     "auth_ref": [
      "r4",
      "r22",
      "r186",
      "r187"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.",
        "label": "Accounts Receivable, after Allowance for Credit Loss, Current",
        "terseLabel": "Accounts receivable, net of allowance for doubtful accounts of $1,121 and $1,143"
       }
      }
     },
     "localname": "AccountsReceivableNetCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccountsReceivableRelatedParties": {
     "auth_ref": [
      "r21",
      "r113",
      "r442",
      "r444",
      "r515"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.",
        "label": "Accounts Receivable, Related Parties",
        "terseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "AccountsReceivableRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedBonusesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable for incentive compensation awarded to employees and directors or earned by them based on the terms of one or more relevant arrangements. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Bonuses, Current",
        "terseLabel": "Performance bonus"
       }
      }
     },
     "localname": "AccruedBonusesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Liabilities, Current",
        "terseLabel": "Accrued liabilities",
        "totalLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "AccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails",
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedProfessionalFeesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for professional fees, such as for legal and accounting services received. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Professional Fees, Current",
        "terseLabel": "Professional and legal services"
       }
      }
     },
     "localname": "AccruedProfessionalFeesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalariesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of the obligations incurred through that date and payable for employees' services provided. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Salaries, Current",
        "terseLabel": "Payroll and related expenses"
       }
      }
     },
     "localname": "AccruedSalariesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccruedSalesCommissionCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for sales commissions. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Accrued Sales Commission, Current",
        "terseLabel": "Commissions"
       }
      }
     },
     "localname": "AccruedSalesCommissionCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": {
     "auth_ref": [
      "r42",
      "r240"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.",
        "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment",
        "negatedTerseLabel": "Less: Accumulated depreciation and amortization"
       }
      }
     },
     "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeLossNetOfTax": {
     "auth_ref": [
      "r25",
      "r64",
      "r65",
      "r66",
      "r512",
      "r532",
      "r533"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated change in equity from transactions and other events and circumstances from non-owner sources, net of tax effect, at period end. Excludes Net Income (Loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners. Includes foreign currency translation items, certain pension adjustments, unrealized gains and losses on certain investments in debt and equity securities, other than temporary impairment (OTTI) losses related to factors other than credit losses on available-for-sale and held-to-maturity debt securities that an entity does not intend to sell and it is not more likely than not that the entity will be required to sell before recovery of the amortized cost basis, as well as changes in the fair value of derivatives related to the effective portion of a designated cash flow hedge.",
        "label": "Accumulated Other Comprehensive Income (Loss), Net of Tax",
        "terseLabel": "Accumulated other comprehensive income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AccumulatedOtherComprehensiveIncomeMember": {
     "auth_ref": [
      "r63",
      "r66",
      "r67",
      "r119",
      "r120",
      "r121",
      "r375",
      "r528",
      "r529"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated increase (decrease) in equity from transactions and other events and circumstances from non-owner sources, attributable to the parent. Excludes net income (loss), and accumulated changes in equity from transactions resulting from investments by owners and distributions to owners.",
        "label": "AOCI Attributable to Parent [Member]",
        "terseLabel": "Accumulated Other Comprehensive Income"
       }
      }
     },
     "localname": "AccumulatedOtherComprehensiveIncomeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdditionalPaidInCapital": {
     "auth_ref": [
      "r23",
      "r349"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.",
        "label": "Additional Paid in Capital",
        "terseLabel": "Additional paid-in-capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapital",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdditionalPaidInCapitalMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r346",
      "r347",
      "r348"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.",
        "label": "Additional Paid-in Capital [Member]",
        "terseLabel": "Additional Paid-In Capital"
       }
      }
     },
     "localname": "AdditionalPaidInCapitalMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of decrease to equity for grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Decrease for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld to cover income tax obligation upon vesting of restricted stock"
       }
      }
     },
     "localname": "AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Adjustments to reconcile net loss to net cash used in operating activities:"
       }
      }
     },
     "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AllocatedShareBasedCompensationExpense": {
     "auth_ref": [
      "r312",
      "r342",
      "r351"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.",
        "label": "Share-based Payment Arrangement, Expense",
        "terseLabel": "Unrecognized share-based compensation cost of unvested RSAs",
        "verboseLabel": "Share-based compensation expense"
       }
      }
     },
     "localname": "AllocatedShareBasedCompensationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AllowanceForDoubtfulAccountsReceivableCurrent": {
     "auth_ref": [
      "r29",
      "r188",
      "r195"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss on accounts receivable, classified as current.",
        "label": "Accounts Receivable, Allowance for Credit Loss, Current",
        "terseLabel": "Allowance for doubtful accounts"
       }
      }
     },
     "localname": "AllowanceForDoubtfulAccountsReceivableCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfFinancingCostsAndDiscounts": {
     "auth_ref": [
      "r98",
      "r417"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 11.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.",
        "label": "Amortization of Debt Issuance Costs and Discounts",
        "terseLabel": "Amortization of debt discount"
       }
      }
     },
     "localname": "AmortizationOfFinancingCostsAndDiscounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AmortizationOfIntangibleAssets": {
     "auth_ref": [
      "r98",
      "r223",
      "r230"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.",
        "label": "Amortization of Intangible Assets",
        "terseLabel": "Amortization of intangible assets"
       }
      }
     },
     "localname": "AmortizationOfIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount",
        "terseLabel": "Antidilutive securities excluded from computation of earnings per share (in shares)"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of antidilutive security.",
        "label": "Antidilutive Securities [Axis]",
        "terseLabel": "Antidilutive Securities [Axis]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]",
        "terseLabel": "Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AntidilutiveSecuritiesNameDomain": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Incremental common shares attributable to securities that were not included in diluted earnings per share (EPS) because to do so would increase EPS amounts or decrease loss per share amounts for the period presented.",
        "label": "Antidilutive Securities, Name [Domain]",
        "terseLabel": "Antidilutive Securities, Name [Domain]"
       }
      }
     },
     "localname": "AntidilutiveSecuritiesNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_AssetImpairmentCharges": {
     "auth_ref": [
      "r98",
      "r237"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill.",
        "label": "Asset Impairment Charges",
        "terseLabel": "Asset impairment charges"
       }
      }
     },
     "localname": "AssetImpairmentCharges",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Assets": {
     "auth_ref": [
      "r111",
      "r165",
      "r174",
      "r180",
      "r193",
      "r371",
      "r376",
      "r401",
      "r495",
      "r509"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets",
        "totalLabel": "Total assets"
       }
      }
     },
     "localname": "Assets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets [Abstract]",
        "terseLabel": "Assets"
       }
      }
     },
     "localname": "AssetsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsCurrent": {
     "auth_ref": [
      "r5",
      "r6",
      "r59",
      "r111",
      "r193",
      "r371",
      "r376",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.",
        "label": "Assets, Current",
        "totalLabel": "Total current assets"
       }
      }
     },
     "localname": "AssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_AssetsCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Current [Abstract]",
        "terseLabel": "Current assets:"
       }
      }
     },
     "localname": "AssetsCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AssetsNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Assets, Noncurrent [Abstract]",
        "terseLabel": "Long-term assets:"
       }
      }
     },
     "localname": "AssetsNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_AwardTypeAxis": {
     "auth_ref": [
      "r314",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of award under share-based payment arrangement.",
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type [Axis]"
       }
      }
     },
     "localname": "AwardTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).",
        "label": "Basis of Accounting, Policy [Policy Text Block]",
        "terseLabel": "Basis of Presentation and Consolidation/Unaudited Interim Condensed Consolidated Financial Information"
       }
      }
     },
     "localname": "BasisOfAccountingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_BuildingImprovementsMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Addition, improvement, or renovation to a facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building Improvements [Member]",
        "terseLabel": "Building improvements"
       }
      }
     },
     "localname": "BuildingImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BuildingMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Facility held for productive use including, but not limited to, office, production, storage and distribution facilities.",
        "label": "Building [Member]",
        "terseLabel": "Building"
       }
      }
     },
     "localname": "BuildingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1": {
     "auth_ref": [
      "r97",
      "r368"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 10.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 5.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in the value of a contingent consideration liability, including, but not limited to, differences arising upon settlement.",
        "label": "Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability",
        "negatedTerseLabel": "Change in fair value of contingent consideration",
        "terseLabel": "Change in fair value of contingent consideration"
       }
      }
     },
     "localname": "BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CapitalExpendituresIncurredButNotYetPaid": {
     "auth_ref": [
      "r103",
      "r104",
      "r105"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Future cash outflow to pay for purchases of fixed assets that have occurred.",
        "label": "Capital Expenditures Incurred but Not yet Paid",
        "terseLabel": "Unpaid balance for property and equipment"
       }
      }
     },
     "localname": "CapitalExpendituresIncurredButNotYetPaid",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Cash": {
     "auth_ref": [
      "r39",
      "r535",
      "r536"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "Cash",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy": {
     "auth_ref": [
      "r101",
      "r107"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for cash and cash equivalents with respect to unrestricted balances.",
        "label": "Cash and Cash Equivalents, Unrestricted Cash and Cash Equivalents, Policy [Policy Text Block]",
        "terseLabel": "Cash"
       }
      }
     },
     "localname": "CashAndCashEquivalentsUnrestrictedCashAndCashEquivalentsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r94",
      "r100",
      "r106"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "periodEndLabel": "Cash at end of period",
        "periodStartLabel": "Cash at beginning of period"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect": {
     "auth_ref": [
      "r94",
      "r406"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in cash, cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including effect from exchange rate change. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect",
        "totalLabel": "Net (decrease)/increase in cash"
       }
      }
     },
     "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashEquivalentsAtCarryingValue": {
     "auth_ref": [
      "r39"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.",
        "label": "Cash Equivalents, at Carrying Value",
        "terseLabel": "Cash equivalents"
       }
      }
     },
     "localname": "CashEquivalentsAtCarryingValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract]",
        "terseLabel": "Supplemental disclosures of non-cash investing and financing activities:"
       }
      }
     },
     "localname": "CashFlowNoncashInvestingAndFinancingActivitiesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfStockDomain": {
     "auth_ref": [
      "r109",
      "r111",
      "r131",
      "r132",
      "r133",
      "r135",
      "r137",
      "r144",
      "r145",
      "r146",
      "r193",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock.",
        "label": "Class of Stock [Domain]",
        "terseLabel": "Class of Stock [Domain]"
       }
      }
     },
     "localname": "ClassOfStockDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfStockLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Class of Stock [Line Items]",
        "terseLabel": "Class of Stock [Line Items]"
       }
      }
     },
     "localname": "ClassOfStockLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightAxis": {
     "auth_ref": [
      "r273",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of warrant or right issued.",
        "label": "Class of Warrant or Right [Axis]",
        "terseLabel": "Class of Warrant or Right [Axis]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ClassOfWarrantOrRightDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months.",
        "label": "Class of Warrant or Right [Domain]",
        "terseLabel": "Class of Warrant or Right [Domain]"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Exercise price per share or per unit of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Exercise Price of Warrants or Rights",
        "terseLabel": "Exercise price of warrants (in dollars per share)",
        "verboseLabel": "Exercise Price (in dollars per share)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": {
     "auth_ref": [
      "r264"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.",
        "label": "Class of Warrant or Right, Number of Securities Called by Warrants or Rights",
        "terseLabel": "Number of shares called by warrants (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ClassOfWarrantOrRightOutstanding": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of warrants or rights outstanding.",
        "label": "Class of Warrant or Right, Outstanding",
        "terseLabel": "Warrants outstanding (in shares)",
        "verboseLabel": "Shares (in shares)"
       }
      }
     },
     "localname": "ClassOfWarrantOrRightOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommitmentsAndContingencies": {
     "auth_ref": [
      "r52",
      "r247",
      "r500",
      "r517"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.",
        "label": "Commitments and Contingencies",
        "terseLabel": "Commitments and contingencies (Note 13)"
       }
      }
     },
     "localname": "CommitmentsAndContingencies",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Commitments and Contingencies Disclosure [Abstract]",
        "terseLabel": "Commitments and Contingencies Disclosure [Abstract]"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": {
     "auth_ref": [
      "r244",
      "r245",
      "r246",
      "r248"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for commitments and contingencies.",
        "label": "Commitments and Contingencies Disclosure [Text Block]",
        "terseLabel": "Commitments and Contingencies"
       }
      }
     },
     "localname": "CommitmentsAndContingenciesDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CommitmentsandContingencies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_CommonClassBMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Classification of common stock that has different rights than Common Class A, representing ownership interest in a corporation.",
        "label": "Common Class B [Member]",
        "terseLabel": "Common Class B"
       }
      }
     },
     "localname": "CommonClassBMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockCapitalSharesReservedForFutureIssuance": {
     "auth_ref": [
      "r54"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate number of common shares reserved for future issuance.",
        "label": "Common Stock, Capital Shares Reserved for Future Issuance",
        "terseLabel": "Shares reserved for future issuance (in shares)"
       }
      }
     },
     "localname": "CommonStockCapitalSharesReservedForFutureIssuance",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockMember": {
     "auth_ref": [
      "r119",
      "r120"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock that is subordinate to all other stock of the issuer.",
        "label": "Common Stock [Member]",
        "terseLabel": "Common Shares"
       }
      }
     },
     "localname": "CommonStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CommonStockSharesAuthorized": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.",
        "label": "Common Stock, Shares Authorized",
        "terseLabel": "Common Stock, Shares Authorized"
       }
      }
     },
     "localname": "CommonStockSharesAuthorized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesIssued": {
     "auth_ref": [
      "r20"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.",
        "label": "Common Stock, Shares, Issued",
        "terseLabel": "Common stock, shares issued (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockSharesOutstanding": {
     "auth_ref": [
      "r20",
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.",
        "label": "Common Stock, Shares, Outstanding",
        "terseLabel": "Common stock, shares outstanding (in shares)"
       }
      }
     },
     "localname": "CommonStockSharesOutstanding",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical",
      "http://establishmentlabs.com/role/ShareholdersEquityNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_CommonStockValue": {
     "auth_ref": [
      "r20"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.",
        "label": "Common Stock, Value, Issued",
        "terseLabel": "Common shares - zero par value, unlimited amount authorized; 24,094,051 and 23,925,789 shares issued at March 31, 2021 and December 31, 2020, respectively; 23,685,981 and 23,517,719 shares outstanding at March 31, 2021 and December 31, 2020, respectively"
       }
      }
     },
     "localname": "CommonStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomeNetOfTax": {
     "auth_ref": [
      "r70",
      "r72",
      "r73",
      "r78",
      "r503",
      "r519"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of increase (decrease) in equity from transactions and other events and circumstances from net income and other comprehensive income, attributable to parent entity. Excludes changes in equity resulting from investments by owners and distributions to owners.",
        "label": "Comprehensive Income (Loss), Net of Tax, Attributable to Parent",
        "totalLabel": "Comprehensive loss"
       }
      }
     },
     "localname": "ComprehensiveIncomeNetOfTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ComprehensiveIncomePolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for comprehensive income.",
        "label": "Comprehensive Income, Policy [Policy Text Block]",
        "terseLabel": "Comprehensive Income (Loss)"
       }
      }
     },
     "localname": "ComprehensiveIncomePolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskBenchmarkDomain": {
     "auth_ref": [
      "r154",
      "r155",
      "r185",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The denominator in a calculation of a disclosed concentration risk percentage.",
        "label": "Concentration Risk Benchmark [Domain]",
        "terseLabel": "Concentration Risk Benchmark [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskBenchmarkDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConcentrationRiskByBenchmarkAxis": {
     "auth_ref": [
      "r154",
      "r155",
      "r185",
      "r399",
      "r400",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by benchmark of concentration risk.",
        "label": "Concentration Risk Benchmark [Axis]",
        "terseLabel": "Concentration Risk Benchmark [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByBenchmarkAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskByTypeAxis": {
     "auth_ref": [
      "r154",
      "r155",
      "r185",
      "r399",
      "r400",
      "r534"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.",
        "label": "Concentration Risk Type [Axis]",
        "terseLabel": "Concentration Risk Type [Axis]"
       }
      }
     },
     "localname": "ConcentrationRiskByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ConcentrationRiskCreditRisk": {
     "auth_ref": [
      "r149",
      "r507"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for credit risk.",
        "label": "Concentration Risk, Credit Risk, Policy [Policy Text Block]",
        "terseLabel": "Concentration of Credit Risk and Other Risks and Uncertainties"
       }
      }
     },
     "localname": "ConcentrationRiskCreditRisk",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConcentrationRiskPercentage1": {
     "auth_ref": [
      "r154",
      "r155",
      "r185",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.",
        "label": "Concentration Risk, Percentage",
        "terseLabel": "Concentration risk (as a percent)"
       }
      }
     },
     "localname": "ConcentrationRiskPercentage1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ConcentrationRiskTypeDomain": {
     "auth_ref": [
      "r154",
      "r155",
      "r185",
      "r399",
      "r400"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration.",
        "label": "Concentration Risk Type [Domain]",
        "terseLabel": "Concentration Risk Type [Domain]"
       }
      }
     },
     "localname": "ConcentrationRiskTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ConsolidationPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r373"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting.  The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.",
        "label": "Consolidation, Policy [Policy Text Block]",
        "terseLabel": "Consolidation"
       }
      }
     },
     "localname": "ConsolidationPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ConstructionInProgressMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service.",
        "label": "Construction in Progress [Member]",
        "terseLabel": "Construction in process"
       }
      }
     },
     "localname": "ConstructionInProgressMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss": {
     "auth_ref": [
      "r195",
      "r197",
      "r199",
      "r277"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of allowance for credit loss for right to consideration in exchange for good or service transferred to customer when right is conditioned on something other than passage of time.",
        "label": "Contract with Customer, Asset, Allowance for Credit Loss",
        "terseLabel": "Valuation allowances and reserves, amount"
       }
      }
     },
     "localname": "ContractWithCustomerAssetAccumulatedAllowanceForCreditLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityCurrent": {
     "auth_ref": [
      "r275",
      "r276",
      "r288"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as current.",
        "label": "Contract with Customer, Liability, Current",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ContractWithCustomerLiabilityNoncurrent": {
     "auth_ref": [
      "r275",
      "r276",
      "r288"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable, classified as noncurrent.",
        "label": "Contract with Customer, Liability, Noncurrent",
        "terseLabel": "Deferred revenue"
       }
      }
     },
     "localname": "ContractWithCustomerLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CostOfRevenue": {
     "auth_ref": [
      "r82",
      "r111",
      "r193",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.",
        "label": "Cost of Revenue",
        "terseLabel": "Cost of revenue"
       }
      }
     },
     "localname": "CostOfRevenue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_CustomerConcentrationRiskMember": {
     "auth_ref": [
      "r152",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.",
        "label": "Customer Concentration Risk [Member]",
        "terseLabel": "Customer concentration risk"
       }
      }
     },
     "localname": "CustomerConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_CustomerRelationshipsMember": {
     "auth_ref": [
      "r366"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Customer relationship that exists between an entity and its customer, for example, but not limited to, tenant relationships.",
        "label": "Customer Relationships [Member]",
        "terseLabel": "Customer relationships"
       }
      }
     },
     "localname": "CustomerRelationshipsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Debt Disclosure [Abstract]",
        "terseLabel": "Debt Disclosure [Abstract]"
       }
      }
     },
     "localname": "DebtDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtDisclosureTextBlock": {
     "auth_ref": [
      "r258"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.",
        "label": "Debt Disclosure [Text Block]",
        "terseLabel": "Debt"
       }
      }
     },
     "localname": "DebtDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Debt"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtInstrumentAxis": {
     "auth_ref": [
      "r14",
      "r15",
      "r16",
      "r496",
      "r498",
      "r508"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.",
        "label": "Debt Instrument [Axis]",
        "terseLabel": "Debt Instrument [Axis]"
       }
      }
     },
     "localname": "DebtInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentBasisSpreadOnVariableRate1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Percentage points added to the reference rate to compute the variable rate on the debt instrument.",
        "label": "Debt Instrument, Basis Spread on Variable Rate",
        "terseLabel": "Credit agreement interest rate"
       }
      }
     },
     "localname": "DebtInstrumentBasisSpreadOnVariableRate1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentCarryingAmount": {
     "auth_ref": [
      "r16",
      "r253",
      "r498",
      "r508"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but is not limited to, notes payable, bonds payable, commercial loans, mortgage loans, convertible debt, subordinated debt and other types of debt.",
        "label": "Long-term Debt, Gross",
        "terseLabel": "Outstanding principal balance",
        "verboseLabel": "Principal"
       }
      }
     },
     "localname": "DebtInstrumentCarryingAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentInterestRateEffectivePercentage": {
     "auth_ref": [
      "r49",
      "r256",
      "r416"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Effective interest rate for the funds borrowed under the debt agreement considering interest compounding and original issue discount or premium.",
        "label": "Debt Instrument, Interest Rate, Effective Percentage",
        "terseLabel": "Effective interest rate"
       }
      }
     },
     "localname": "DebtInstrumentInterestRateEffectivePercentage",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DebtInstrumentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Debt Instrument [Line Items]",
        "terseLabel": "Debt Instrument [Line Items]"
       }
      }
     },
     "localname": "DebtInstrumentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentNameDomain": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities.",
        "label": "Debt Instrument, Name [Domain]",
        "terseLabel": "Debt Instrument, Name [Domain]"
       }
      }
     },
     "localname": "DebtInstrumentNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DebtInstrumentTable": {
     "auth_ref": [
      "r50",
      "r115",
      "r264",
      "r267",
      "r268",
      "r269",
      "r415",
      "r416",
      "r418",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to long-term debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table]",
        "terseLabel": "Schedule of Long-term Debt Instruments [Table]"
       }
      }
     },
     "localname": "DebtInstrumentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscount": {
     "auth_ref": [
      "r415",
      "r418"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt discount.",
        "label": "Debt Instrument, Unamortized Discount",
        "terseLabel": "Debt discount"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet": {
     "auth_ref": [
      "r254",
      "r417"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LongTermDebt",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of unamortized debt discount (premium) and debt issuance costs.",
        "label": "Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net",
        "negatedTerseLabel": "Net unamortized debt discount and issuance costs"
       }
      }
     },
     "localname": "DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DebtPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r251"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.",
        "label": "Debt, Policy [Policy Text Block]",
        "terseLabel": "Debt Issuance Costs and Debt Discounts"
       }
      }
     },
     "localname": "DebtPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DebtWeightedAverageInterestRate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average interest rate of debt outstanding.",
        "label": "Debt, Weighted Average Interest Rate",
        "terseLabel": "Weighted average interest rate"
       }
      }
     },
     "localname": "DebtWeightedAverageInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_DeferredFinanceCostsNet": {
     "auth_ref": [
      "r43",
      "r417"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.",
        "label": "Debt Issuance Costs, Net",
        "terseLabel": "Legal expenses"
       }
      }
     },
     "localname": "DeferredFinanceCostsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_Depreciation": {
     "auth_ref": [
      "r98",
      "r238"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.",
        "label": "Depreciation",
        "terseLabel": "Depreciation"
       }
      }
     },
     "localname": "Depreciation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilities": {
     "auth_ref": [
      "r60",
      "r61",
      "r397"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset. Includes liabilities not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability",
        "terseLabel": "Madryn put option liability"
       }
      }
     },
     "localname": "DerivativeLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilitiesNoncurrent": {
     "auth_ref": [
      "r60"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value, after the effects of master netting arrangements, of a financial liability or contract with one or more underlyings, notional amount or payment provision or both, and the contract can be net settled by means outside the contract or delivery of an asset, expected to be settled after one year or the normal operating cycle, if longer. Includes assets not subject to a master netting arrangement and not elected to be offset.",
        "label": "Derivative Liability, Noncurrent",
        "terseLabel": "Madryn put option"
       }
      }
     },
     "localname": "DerivativeLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_DerivativeLiabilityMeasurementInput": {
     "auth_ref": [
      "r390"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of input used to measure derivative liability.",
        "label": "Derivative Liability, Measurement Input",
        "terseLabel": "Change in control",
        "verboseLabel": "Derivative liability"
       }
      }
     },
     "localname": "DerivativeLiabilityMeasurementInput",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "decimalItemType"
    },
    "us-gaap_DerivativesEmbeddedDerivatives": {
     "auth_ref": [
      "r107",
      "r379",
      "r380",
      "r383",
      "r384"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for embedded derivatives, including how such derivatives are identified and analyzed for possible separation from their host contracts.",
        "label": "Derivatives, Embedded Derivatives [Policy Text Block]",
        "terseLabel": "Debt and Embedded Derivatives"
       }
      }
     },
     "localname": "DerivativesEmbeddedDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DevelopedTechnologyRightsMember": {
     "auth_ref": [
      "r367"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Rights to developed technology, which can include the right to develop, use, market, sell, or offer for sale products, compounds, or intellectual property.",
        "label": "Developed Technology Rights [Member]",
        "terseLabel": "Developed technology"
       }
      }
     },
     "localname": "DevelopedTechnologyRightsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_DisaggregationOfRevenueLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Disaggregation of Revenue [Line Items]",
        "terseLabel": "Disaggregation of Revenue [Line Items]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTable": {
     "auth_ref": [
      "r287",
      "r289",
      "r290",
      "r291",
      "r292",
      "r293",
      "r294",
      "r295"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table]",
        "terseLabel": "Disaggregation of Revenue [Table]"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_DisaggregationOfRevenueTableTextBlock": {
     "auth_ref": [
      "r287"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.",
        "label": "Disaggregation of Revenue [Table Text Block]",
        "terseLabel": "Disaggregation of Revenue"
       }
      }
     },
     "localname": "DisaggregationOfRevenueTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": {
     "auth_ref": [
      "r352"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement [Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensation"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Payment Arrangement [Abstract]",
        "terseLabel": "Share-based Payment Arrangement [Abstract]"
       }
      }
     },
     "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share [Abstract]",
        "terseLabel": "Earnings Per Share [Abstract]"
       }
      }
     },
     "localname": "EarningsPerShareAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic [Abstract]",
        "terseLabel": "Loss per share:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDiluted": {
     "auth_ref": [
      "r136"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of net income or loss for the period per each share in instances when basic and diluted earnings per share are the same amount and reported as a single line item on the face of the financial statements.  Basic earnings per share is the amount of net income or loss for the period per each share of common stock or unit outstanding during the reporting period.  Diluted earnings per share includes the amount of net income or loss for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.",
        "label": "Earnings Per Share, Basic and Diluted",
        "terseLabel": "Basic and diluted (in dollars per share)",
        "verboseLabel": "Basic and diluted net loss per share (in dollars per share)"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted [Abstract]",
        "terseLabel": "Numerator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Earnings Per Share, Basic and Diluted, Other Disclosures [Abstract]",
        "terseLabel": "Denominator:"
       }
      }
     },
     "localname": "EarningsPerShareBasicAndDilutedOtherDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_EarningsPerSharePolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r138",
      "r139"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.",
        "label": "Earnings Per Share, Policy [Policy Text Block]",
        "terseLabel": "Net Income (Loss) Per Share"
       }
      }
     },
     "localname": "EarningsPerSharePolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EarningsPerShareTextBlock": {
     "auth_ref": [
      "r138",
      "r139",
      "r140",
      "r141"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for earnings per share.",
        "label": "Earnings Per Share [Text Block]",
        "terseLabel": "Net Loss Per Share"
       }
      }
     },
     "localname": "EarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShare"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents": {
     "auth_ref": [
      "r406"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) from effect of exchange rate changes on cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; held in foreign currencies. Excludes amounts for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.",
        "label": "Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents",
        "terseLabel": "Effect of exchange rate changes on cash"
       }
      }
     },
     "localname": "EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability": {
     "auth_ref": [
      "r382"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value as of the balance sheet date of the embedded derivative or group of embedded derivatives classified as a liability.",
        "label": "Embedded Derivative, Fair Value of Embedded Derivative Liability",
        "terseLabel": "Fair value of options"
       }
      }
     },
     "localname": "EmbeddedDerivativeFairValueOfEmbeddedDerivativeLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1": {
     "auth_ref": [
      "r343"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average period over which cost not yet recognized is expected to be recognized for award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition",
        "terseLabel": "Employee unrecognized compensation expense, period for recognition"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized share-based compensation cost"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions": {
     "auth_ref": [
      "r343"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cost to be recognized for option under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount",
        "terseLabel": "Unrecognized compensation expense of stock options granted"
       }
      }
     },
     "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_EmployeeStockMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An Employee Stock Purchase Plan is a tax-efficient means by which employees of a corporation can purchase the corporation's stock.",
        "label": "Employee Stock [Member]",
        "terseLabel": "ESPP"
       }
      }
     },
     "localname": "EmployeeStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EmployeeStockOptionMember": {
     "auth_ref": [
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time.",
        "label": "Share-based Payment Arrangement, Option [Member]",
        "terseLabel": "Employee Stock Option",
        "verboseLabel": "Options to purchase shares"
       }
      }
     },
     "localname": "EmployeeStockOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_EquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity [Abstract]",
        "terseLabel": "Equity [Abstract]"
       }
      }
     },
     "localname": "EquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_EquityComponentDomain": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r123",
      "r128",
      "r130",
      "r143",
      "r194",
      "r263",
      "r270",
      "r346",
      "r347",
      "r348",
      "r362",
      "r363",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc.",
        "label": "Equity Component [Domain]",
        "terseLabel": "Equity Component [Domain]"
       }
      }
     },
     "localname": "EquityComponentDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]",
        "terseLabel": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": {
     "auth_ref": [
      "r385",
      "r386",
      "r387",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.",
        "label": "Fair Value, Recurring and Nonrecurring [Table]",
        "terseLabel": "Fair Value, Recurring and Nonrecurring [Table]"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.",
        "label": "Fair Value Measurement Inputs and Valuation Techniques [Table Text Block]",
        "terseLabel": "Fair Value Measurement Inputs and Valuation Techniques"
       }
      }
     },
     "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueByFairValueHierarchyLevelAxis": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r386",
      "r450",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.",
        "label": "Fair Value Hierarchy and NAV [Axis]",
        "terseLabel": "Fair Value Hierarchy and NAV [Axis]"
       }
      }
     },
     "localname": "FairValueByFairValueHierarchyLevelAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByLiabilityClassAxis": {
     "auth_ref": [
      "r393",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by class of liability.",
        "label": "Liability Class [Axis]",
        "terseLabel": "Liability Class [Axis]"
       }
      }
     },
     "localname": "FairValueByLiabilityClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueByMeasurementFrequencyAxis": {
     "auth_ref": [
      "r385",
      "r386",
      "r389",
      "r390",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by measurement frequency.",
        "label": "Measurement Frequency [Axis]",
        "terseLabel": "Measurement Frequency [Axis]"
       }
      }
     },
     "localname": "FairValueByMeasurementFrequencyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Fair Value Disclosures [Abstract]",
        "terseLabel": "Fair Value Disclosures [Abstract]"
       }
      }
     },
     "localname": "FairValueDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueDisclosuresTextBlock": {
     "auth_ref": [
      "r393"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.",
        "label": "Fair Value Disclosures [Text Block]",
        "terseLabel": "Fair Value Measurements"
       }
      }
     },
     "localname": "FairValueDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurements"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueInputsLevel1Member": {
     "auth_ref": [
      "r298",
      "r299",
      "r304",
      "r306",
      "r386",
      "r450"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.",
        "label": "Fair Value, Inputs, Level 1 [Member]",
        "terseLabel": "Level\u00a01"
       }
      }
     },
     "localname": "FairValueInputsLevel1Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel2Member": {
     "auth_ref": [
      "r298",
      "r299",
      "r304",
      "r306",
      "r386",
      "r451"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.",
        "label": "Fair Value, Inputs, Level 2 [Member]",
        "terseLabel": "Level\u00a02"
       }
      }
     },
     "localname": "FairValueInputsLevel2Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueInputsLevel3Member": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r386",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Inputs, Level 3 [Member]",
        "terseLabel": "Level\u00a03"
       }
      }
     },
     "localname": "FairValueInputsLevel3Member",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": {
     "auth_ref": [
      "r385",
      "r386"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).  Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain": {
     "auth_ref": [
      "r391"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Represents classes of liabilities measured and disclosed at fair value.",
        "label": "Fair Value by Liability Class [Domain]",
        "terseLabel": "Fair Value by Liability Class [Domain]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationByLiabilityClassDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationCalculationRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": {
     "auth_ref": [
      "r391",
      "r395"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the fair value measurement of liabilities using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets), and gains or losses recognized in other comprehensive income (loss) and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs) by class of liability.",
        "label": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block]",
        "terseLabel": "Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation"
       }
      }
     },
     "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FairValueMeasurementFrequencyDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement frequency.",
        "label": "Measurement Frequency [Domain]",
        "terseLabel": "Measurement Frequency [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementFrequencyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings": {
     "auth_ref": [
      "r392"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) recognized in income from liability measured at fair value on recurring basis using unobservable input (level 3).",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Gain (Loss) Included in Earnings",
        "terseLabel": "Change in fair value"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue": {
     "auth_ref": [
      "r391"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of financial instrument classified as a liability measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance"
       }
      }
     },
     "localname": "FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": {
     "auth_ref": [
      "r298",
      "r299",
      "r300",
      "r301",
      "r302",
      "r303",
      "r304",
      "r306",
      "r450",
      "r451",
      "r452"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value.",
        "label": "Fair Value Hierarchy and NAV [Domain]",
        "terseLabel": "Fair Value Hierarchy and NAV [Domain]"
       }
      }
     },
     "localname": "FairValueMeasurementsFairValueHierarchyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueMeasurementsRecurringMember": {
     "auth_ref": [
      "r393",
      "r396"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.",
        "label": "Fair Value, Recurring [Member]",
        "terseLabel": "Fair Value, Measurements, Recurring"
       }
      }
     },
     "localname": "FairValueMeasurementsRecurringMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsFVonaRecurringBasisDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable": {
     "auth_ref": [
      "r391",
      "r394"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about financial instrument classified as a derivative asset (liability) after deduction of derivative liability (asset) using recurring unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.",
        "label": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]",
        "terseLabel": "Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Table]"
       }
      }
     },
     "localname": "FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputReconciliationTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FairValueOffBalanceSheetRisksDisclosureInformationLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]",
        "terseLabel": "Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]"
       }
      }
     },
     "localname": "FairValueOffBalanceSheetRisksDisclosureInformationLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseInterestExpense": {
     "auth_ref": [
      "r422",
      "r429",
      "r437"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest expense on finance lease liability.",
        "label": "Finance Lease, Interest Expense",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "FinanceLeaseInterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseInterestPaymentOnLiability": {
     "auth_ref": [
      "r424",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of interest paid on finance lease liability.",
        "label": "Finance Lease, Interest Payment on Liability",
        "terseLabel": "Operating cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeaseInterestPaymentOnLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finance Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Finance Leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FinanceLeaseLiability": {
     "auth_ref": [
      "r420",
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease.",
        "label": "Finance Lease, Liability",
        "totalLabel": "Total finance lease liabilities",
        "verboseLabel": "Present value of future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityCurrent": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 7.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as current.",
        "label": "Finance Lease, Liability, Current",
        "terseLabel": "Finance lease liabilities - short-term",
        "verboseLabel": "Short-term minimum lease payments under finance leases"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of finance lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to finance lease liability recognized in statement of financial position.",
        "label": "Finance Lease, Liability, Fiscal Year Maturity [Table Text Block]",
        "terseLabel": "Finance Lease, Liability, Fiscal Year Maturity"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FinanceLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from finance lease, classified as noncurrent.",
        "label": "Finance Lease, Liability, Noncurrent",
        "terseLabel": "Finance lease liabilities - long-term"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Payment, Due",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for finance lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finance Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_FinanceLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for finance lease.",
        "label": "Finance Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amount of lease payments representing interest"
       }
      }
     },
     "localname": "FinanceLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeasePrincipalPayments": {
     "auth_ref": [
      "r423",
      "r431"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow for principal payment on finance lease.",
        "label": "Finance Lease, Principal Payments",
        "negatedLabel": "Repayments on finance leases",
        "terseLabel": "Financing cash outflows from finance leases"
       }
      }
     },
     "localname": "FinanceLeasePrincipalPayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAsset": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, after Accumulated Amortization",
        "terseLabel": "Finance lease right-of-use assets"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetAmortization": {
     "auth_ref": [
      "r422",
      "r429",
      "r437"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LeaseCost",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense attributable to right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, Amortization",
        "terseLabel": "Amortization expense"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization": {
     "auth_ref": [
      "r419"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, before accumulated amortization, of right-of-use asset from finance lease.",
        "label": "Finance Lease, Right-of-Use Asset, before Accumulated Amortization",
        "terseLabel": "Finance Lease, ROU asset, before accumulated amortization"
       }
      }
     },
     "localname": "FinanceLeaseRightOfUseAssetBeforeAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r434",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for finance lease calculated at point in time.",
        "label": "Finance Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_FinanceLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r433",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Finance Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "FinanceLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FinancialInstrumentAxis": {
     "auth_ref": [
      "r191",
      "r192",
      "r196",
      "r200",
      "r201",
      "r202",
      "r203",
      "r204",
      "r205",
      "r206",
      "r207",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of financial instrument.",
        "label": "Financial Instrument [Axis]",
        "terseLabel": "Financial Instrument [Axis]"
       }
      }
     },
     "localname": "FinancialInstrumentAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Finite-Lived Intangible Asset, Useful Life",
        "terseLabel": "Estimated Useful Lives",
        "verboseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": {
     "auth_ref": [
      "r229"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Accumulated Amortization",
        "negatedTerseLabel": "Accumulated Amortization"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year One",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in remainder of current fiscal year.",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Remainder of Fiscal Year",
        "terseLabel": "2021 (remaining)"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFour": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Four",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Three",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": {
     "auth_ref": [
      "r231"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Finite-Lived Intangible Asset, Expected Amortization, Year Two",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": {
     "auth_ref": [
      "r224",
      "r225",
      "r229",
      "r233",
      "r479",
      "r480"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by major type or class of finite-lived intangible assets.",
        "label": "Finite-Lived Intangible Assets by Major Class [Axis]",
        "terseLabel": "Finite-Lived Intangible Assets by Major Class [Axis]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsGross": {
     "auth_ref": [
      "r229",
      "r480"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_FiniteLivedIntangibleAssetsNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Gross",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Finite-Lived Intangible Assets [Line Items]",
        "terseLabel": "Finite-Lived Intangible Assets [Line Items]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": {
     "auth_ref": [
      "r224",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company.",
        "label": "Finite-Lived Intangible Assets, Major Class Name [Domain]",
        "terseLabel": "Finite-Lived Intangible Assets, Major Class Name [Domain]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNet": {
     "auth_ref": [
      "r229",
      "r479"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Finite-Lived Intangible Assets, Net",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsAmortizationExpenseDetails",
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_FiniteLivedIntangibleAssetsNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Finite-Lived Intangible Assets, Net [Abstract]",
        "terseLabel": "Finite-Lived Intangible Assets, Net [Abstract]"
       }
      }
     },
     "localname": "FiniteLivedIntangibleAssetsNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossBeforeTax": {
     "auth_ref": [
      "r402",
      "r403",
      "r404",
      "r405"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), before Tax",
        "negatedLabel": "Foreign currency transaction gain (loss)"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossBeforeTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionGainLossUnrealized": {
     "auth_ref": [
      "r99",
      "r404",
      "r405"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 7.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before tax of foreign currency transaction unrealized gain (loss) recognized in the income statement.",
        "label": "Foreign Currency Transaction Gain (Loss), Unrealized",
        "negatedTerseLabel": "Unrealized foreign currency loss, net"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionGainLossUnrealized",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r413"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for (1) transactions denominated in a currency other than the reporting enterprise's functional currency, (2) translating foreign currency financial statements that are incorporated into the financial statements of the reporting enterprise by consolidation, combination, or the equity method of accounting, and (3) remeasurement of the financial statements of a foreign reporting enterprise in a hyperinflationary economy.",
        "label": "Foreign Currency Transactions and Translations Policy [Policy Text Block]",
        "terseLabel": "Foreign Currency"
       }
      }
     },
     "localname": "ForeignCurrencyTransactionsAndTranslationsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_FurnitureAndFixturesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment commonly used in offices and stores that have no permanent connection to the structure of a building or utilities. Examples include, but are not limited to, desks, chairs, tables, and bookcases.",
        "label": "Furniture and Fixtures [Member]",
        "terseLabel": "Furniture and fixtures"
       }
      }
     },
     "localname": "FurnitureAndFixturesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GainLossOnDerivativeInstrumentsNetPretax": {
     "auth_ref": [
      "r381"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 4.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate net gain (loss) on all derivative instruments recognized in earnings during the period, before tax effects.",
        "label": "Gain (Loss) on Derivative Instruments, Net, Pretax",
        "terseLabel": "Change in fair value of derivative instruments"
       }
      }
     },
     "localname": "GainLossOnDerivativeInstrumentsNetPretax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GainLossOnSaleOfPropertyPlantEquipment": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 6.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of gain (loss) on sale or disposal of property, plant and equipment assets, including oil and gas property and timber property.",
        "label": "Gain (Loss) on Disposition of Property Plant Equipment",
        "negatedTerseLabel": "Loss from disposal of property and equipment"
       }
      }
     },
     "localname": "GainLossOnSaleOfPropertyPlantEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GeographicConcentrationRiskMember": {
     "auth_ref": [
      "r153"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that a specified dollar value on the balance sheet or income statement in the period from one or more specified geographic areas is to a corresponding consolidated, segment, or product line amount. Risk is the materially adverse effects of economic decline or antagonistic political actions resulting in loss of assets, sales volume, labor supply, or source of materials and supplies in a US state or a specified country, continent, or region such as EMEA (Europe, Middle East, Africa).",
        "label": "Geographic Concentration Risk [Member]",
        "terseLabel": "Geographic Concentration Risk"
       }
      }
     },
     "localname": "GeographicConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_Goodwill": {
     "auth_ref": [
      "r214",
      "r216",
      "r494"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill",
        "periodEndLabel": "Ending Balance",
        "periodStartLabel": "Beginning Balance",
        "terseLabel": "Goodwill"
       }
      }
     },
     "localname": "Goodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAcquiredDuringPeriod": {
     "auth_ref": [
      "r217"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.",
        "label": "Goodwill, Acquired During Period",
        "terseLabel": "Additions"
       }
      }
     },
     "localname": "GoodwillAcquiredDuringPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetImpairment": {
     "auth_ref": [],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total loss recognized during the period from the impairment of goodwill plus the loss recognized in the period resulting from the impairment of the carrying amount of intangible assets, other than goodwill.",
        "label": "Goodwill and Intangible Asset Impairment",
        "terseLabel": "Goodwill and intangible asset impairment"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetImpairment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Goodwill and Intangible Assets Disclosure [Abstract]",
        "terseLabel": "Goodwill and Intangible Assets Disclosure [Abstract]"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsDisclosureTextBlock": {
     "auth_ref": [
      "r235"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets Disclosure [Text Block]",
        "terseLabel": "Goodwill and Other Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssets"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillAndIntangibleAssetsPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r219",
      "r226"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for goodwill and intangible assets. This accounting policy also may address how an entity assesses and measures impairment of goodwill and intangible assets.",
        "label": "Goodwill and Intangible Assets, Policy [Policy Text Block]",
        "terseLabel": "Goodwill and Intangible Assets"
       }
      }
     },
     "localname": "GoodwillAndIntangibleAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_GoodwillImpairmentLoss": {
     "auth_ref": [
      "r98",
      "r215",
      "r218",
      "r220"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.",
        "label": "Goodwill, Impairment Loss",
        "negatedTerseLabel": "Accumulated Impairment Losses"
       }
      }
     },
     "localname": "GoodwillImpairmentLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_GoodwillRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Goodwill [Roll Forward]",
        "terseLabel": "Goodwill [Roll Forward]"
       }
      }
     },
     "localname": "GoodwillRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsGoodwillDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusAxis": {
     "auth_ref": [
      "r309",
      "r310",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by status of recipient to whom award is granted.",
        "label": "Grantee Status [Axis]",
        "terseLabel": "Grantee Status [Axis]"
       }
      }
     },
     "localname": "GranteeStatusAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_GranteeStatusDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Status of recipient to whom award is granted.",
        "label": "Grantee Status [Domain]",
        "terseLabel": "Grantee Status [Domain]"
       }
      }
     },
     "localname": "GranteeStatusDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_GrossProfit": {
     "auth_ref": [
      "r81",
      "r111",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r193",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Aggregate revenue less cost of goods and services sold or operating expenses directly attributable to the revenue generation activity.",
        "label": "Gross Profit",
        "totalLabel": "Gross profit"
       }
      }
     },
     "localname": "GrossProfit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember": {
     "auth_ref": [
      "r441",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Family member whom a principal owner or a member of management might control or influence, or by whom they might be controlled or influenced, because of the family relationship.",
        "label": "Immediate Family Member of Management or Principal Owner [Member]",
        "terseLabel": "Immediate Family Member of Management or Principal Owner"
       }
      }
     },
     "localname": "ImmediateFamilyMemberOfManagementOrPrincipalOwnerMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r236",
      "r243"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.",
        "label": "Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block]",
        "terseLabel": "Long-Lived Assets"
       }
      }
     },
     "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": {
     "auth_ref": [
      "r76",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r493",
      "r501",
      "r505",
      "r520"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.",
        "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest",
        "totalLabel": "Loss before income taxes"
       }
      }
     },
     "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeStatementAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Income Statement [Abstract]",
        "terseLabel": "Income Statement [Abstract]"
       }
      }
     },
     "localname": "IncomeStatementAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationAxis": {
     "auth_ref": [
      "r242"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by location in the income statement.",
        "label": "Income Statement Location [Axis]",
        "terseLabel": "Income Statement Location [Axis]"
       }
      }
     },
     "localname": "IncomeStatementLocationAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncomeStatementLocationDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Location in the income statement.",
        "label": "Income Statement Location [Domain]",
        "terseLabel": "Income Statement Location [Domain]"
       }
      }
     },
     "localname": "IncomeStatementLocationDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_IncomeTaxExpenseBenefit": {
     "auth_ref": [
      "r112",
      "r129",
      "r130",
      "r164",
      "r357",
      "r364",
      "r365",
      "r521"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_NetIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.",
        "label": "Income Tax Expense (Benefit)",
        "negatedTerseLabel": "Provision for income taxes"
       }
      }
     },
     "localname": "IncomeTaxExpenseBenefit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncomeTaxPolicyTextBlock": {
     "auth_ref": [
      "r74",
      "r107",
      "r355",
      "r356",
      "r358",
      "r359",
      "r360",
      "r361",
      "r545"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.",
        "label": "Income Tax, Policy [Policy Text Block]",
        "terseLabel": "Income Taxes"
       }
      }
     },
     "localname": "IncomeTaxPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_IncomeTaxesPaidNet": {
     "auth_ref": [
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.",
        "label": "Income Taxes Paid, Net",
        "terseLabel": "Cash paid for income taxes"
       }
      }
     },
     "localname": "IncomeTaxesPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsPayable": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 16.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.",
        "label": "Increase (Decrease) in Accounts Payable",
        "terseLabel": "Accounts payable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsPayable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccountsReceivable": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 12.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.",
        "label": "Increase (Decrease) in Accounts Receivable",
        "negatedTerseLabel": "Accounts receivable"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccountsReceivable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInAccruedLiabilities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 17.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate amount of expenses incurred but not yet paid.",
        "label": "Increase (Decrease) in Accrued Liabilities",
        "terseLabel": "Accrued liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInAccruedLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInInventories": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 13.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.",
        "label": "Increase (Decrease) in Inventories",
        "negatedTerseLabel": "Inventory"
       }
      }
     },
     "localname": "IncreaseDecreaseInInventories",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherNoncurrentAssets": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 15.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in noncurrent assets classified as other.",
        "label": "Increase (Decrease) in Other Noncurrent Assets",
        "negatedTerseLabel": "Other assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherNoncurrentAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Increase (Decrease) in Other Operating Assets and Liabilities, Net [Abstract]",
        "terseLabel": "Changes in operating assets and liabilities:"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingAssetsAndLiabilitiesNetAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IncreaseDecreaseInOtherOperatingLiabilities": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 19.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in operating liabilities classified as other.",
        "label": "Increase (Decrease) in Other Operating Liabilities",
        "terseLabel": "Other liabilities"
       }
      }
     },
     "localname": "IncreaseDecreaseInOtherOperatingLiabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 14.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.",
        "label": "Increase (Decrease) in Prepaid Expense and Other Assets",
        "negatedTerseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IncreaseDecreaseInStockholdersEquityRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Increase (Decrease) in Stockholders' Equity [Roll Forward]",
        "terseLabel": "Increase (Decrease) in Stockholders' Equity [Roll Forward]"
       }
      }
     },
     "localname": "IncreaseDecreaseInStockholdersEquityRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwill": {
     "auth_ref": [
      "r232"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.",
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill)",
        "terseLabel": "Capitalized patents and license rights not yet amortized"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]",
        "terseLabel": "Indefinite-lived Intangible Assets (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IndefiniteLivedIntangibleAssetsExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_IntangibleAssetsGrossExcludingGoodwill": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_IntangibleAssetsNetExcludingGoodwill",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated amortization of intangible assets, excluding goodwill.",
        "label": "Intangible Assets, Gross (Excluding Goodwill)",
        "terseLabel": "Gross Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsGrossExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwill": {
     "auth_ref": [
      "r222",
      "r227"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.",
        "label": "Intangible Assets, Net (Excluding Goodwill)",
        "terseLabel": "Intangible assets, net of accumulated amortization",
        "totalLabel": "Net Carrying Amount"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwill",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IntangibleAssetsNetExcludingGoodwillAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Intangible Assets, Net (Excluding Goodwill) [Abstract]",
        "terseLabel": "Intangible Assets, Net (Excluding Goodwill) [Abstract]"
       }
      }
     },
     "localname": "IntangibleAssetsNetExcludingGoodwillAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_InterestExpense": {
     "auth_ref": [
      "r75",
      "r163",
      "r414",
      "r417",
      "r504"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 3.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense.",
        "label": "Interest Expense",
        "negatedTerseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestExpenseDebt": {
     "auth_ref": [
      "r85",
      "r257"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of the cost of borrowed funds accounted for as interest expense for debt.",
        "label": "Interest Expense, Debt",
        "terseLabel": "Interest expense"
       }
      }
     },
     "localname": "InterestExpenseDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InterestPaidNet": {
     "auth_ref": [
      "r93",
      "r95",
      "r102"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.",
        "label": "Interest Paid, Excluding Capitalized Interest, Operating Activities",
        "terseLabel": "Cash paid for interest"
       }
      }
     },
     "localname": "InterestPaidNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryFinishedGoodsNetOfReserves": {
     "auth_ref": [
      "r31",
      "r212"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.",
        "label": "Inventory, Finished Goods, Net of Reserves",
        "terseLabel": "Finished goods"
       }
      }
     },
     "localname": "InventoryFinishedGoodsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryNet": {
     "auth_ref": [
      "r3",
      "r57"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.",
        "label": "Inventory, Net",
        "terseLabel": "Inventory, net",
        "totalLabel": "Inventory, net"
       }
      }
     },
     "localname": "InventoryNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails",
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryPolicyTextBlock": {
     "auth_ref": [
      "r11",
      "r58",
      "r107",
      "r142",
      "r208",
      "r210",
      "r213"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of inventory accounting policy for inventory classes, including, but not limited to, basis for determining inventory amounts, methods by which amounts are added and removed from inventory classes, loss recognition on impairment of inventories, and situations in which inventories are stated above cost.",
        "label": "Inventory, Policy [Policy Text Block]",
        "terseLabel": "Inventory and Cost of Revenue"
       }
      }
     },
     "localname": "InventoryPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_InventoryRawMaterialsNetOfReserves": {
     "auth_ref": [
      "r33",
      "r212"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.",
        "label": "Inventory, Raw Materials, Net of Reserves",
        "terseLabel": "Raw materials"
       }
      }
     },
     "localname": "InventoryRawMaterialsNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryValuationReserves": {
     "auth_ref": [
      "r57",
      "r117",
      "r211"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of valuation reserve for inventory.",
        "label": "Inventory Valuation Reserves",
        "terseLabel": "Inventory valuation reserves"
       }
      }
     },
     "localname": "InventoryValuationReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWorkInProcessNetOfReserves": {
     "auth_ref": [
      "r32",
      "r212"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_InventoryNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.",
        "label": "Inventory, Work in Process, Net of Reserves",
        "terseLabel": "Work in process"
       }
      }
     },
     "localname": "InventoryWorkInProcessNetOfReserves",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsInventoryDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InventoryWriteDown": {
     "auth_ref": [
      "r209"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of loss from reductions in inventory due to subsequent measurement adjustments, including, but not limited to, physical deterioration, obsolescence, or changes in price levels.",
        "label": "Inventory Write-down",
        "verboseLabel": "Provision for inventory obsolescence"
       }
      }
     },
     "localname": "InventoryWriteDown",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_InvestmentIncomeInterest": {
     "auth_ref": [
      "r84",
      "r162"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accretion (amortization) of purchase discount (premium) of interest income on nonoperating securities.",
        "label": "Investment Income, Interest",
        "terseLabel": "Interest income"
       }
      }
     },
     "localname": "InvestmentIncomeInterest",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": {
     "auth_ref": [
      "r98"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.",
        "label": "Issuance of Stock and Warrants for Services or Claims",
        "terseLabel": "Issuance of stock and warrants for services or claims"
       }
      }
     },
     "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LandMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Part of earth's surface not covered by water.",
        "label": "Land [Member]",
        "terseLabel": "Land"
       }
      }
     },
     "localname": "LandMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeaseCost": {
     "auth_ref": [
      "r435",
      "r437"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lease cost recognized by lessee for lease contract.",
        "label": "Lease, Cost",
        "totalLabel": "Total finance lease costs"
       }
      }
     },
     "localname": "LeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LeaseCostTableTextBlock": {
     "auth_ref": [
      "r435"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.",
        "label": "Lease, Cost [Table Text Block]",
        "terseLabel": "Lease, Cost"
       }
      }
     },
     "localname": "LeaseCostTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LeaseholdImprovementsMember": {
     "auth_ref": [
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Additions or improvements to assets held under a lease arrangement.",
        "label": "Leasehold Improvements [Member]",
        "terseLabel": "Leasehold improvements"
       }
      }
     },
     "localname": "LeaseholdImprovementsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LeasesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Leases [Abstract]"
       }
      }
     },
     "localname": "LeasesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeFinanceLeaseTermOfContract1": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's finance lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Finance Lease, Term of Contract",
        "terseLabel": "Finance lease, term of contract"
       }
      }
     },
     "localname": "LesseeFinanceLeaseTermOfContract1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeFinanceLeasesTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for finance leases of lessee. Includes, but is not limited to, description of lessee's finance lease and maturity analysis of finance lease liability.",
        "label": "Lessee, Finance Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeFinanceLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeLeaseDescriptionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Lessee, Lease, Description [Line Items]",
        "terseLabel": "Lessee, Lease, Description [Line Items]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeaseDescriptionTable": {
     "auth_ref": [
      "r428"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about lessee's leases.",
        "label": "Lessee, Lease, Description [Table]",
        "terseLabel": "Lessee, Lease, Description [Table]"
       }
      }
     },
     "localname": "LesseeLeaseDescriptionTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LesseeLeasesPolicyTextBlock": {
     "auth_ref": [
      "r426"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.",
        "label": "Lessee, Leases [Policy Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeLeasesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": {
     "auth_ref": [
      "r436"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.",
        "label": "Lessee, Operating Lease, Liability, Maturity [Table Text Block]",
        "terseLabel": "Lessee, Operating Lease, Liability, Maturity"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.",
        "label": "Lessee, Operating Lease, Liability, to be Paid",
        "totalLabel": "Total future minimum lease payments"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 6.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease due after fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, after Year Five",
        "terseLabel": "Thereafter"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year One",
        "terseLabel": "2021"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFive": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 5.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fifth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Five",
        "terseLabel": "2025"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFive",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearFour": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in fourth fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Four",
        "terseLabel": "2024"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearFour",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearThree": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Three",
        "terseLabel": "2023"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearThree",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).",
        "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two",
        "terseLabel": "2022"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": {
     "auth_ref": [
      "r436"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": 1.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.",
        "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount",
        "negatedTerseLabel": "Less: Amount of lease payments representing interest"
       }
      }
     },
     "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LesseeOperatingLeaseTermOfContract": {
     "auth_ref": [
      "r427"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Lessee, Operating Lease, Term of Contract",
        "terseLabel": "Operating lease, term of contract"
       }
      }
     },
     "localname": "LesseeOperatingLeaseTermOfContract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_LesseeOperatingLeasesTextBlock": {
     "auth_ref": [
      "r438"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for operating leases of lessee. Includes, but is not limited to, description of operating lease and maturity analysis of operating lease liability.",
        "label": "Lessee, Operating Leases [Text Block]",
        "terseLabel": "Leases"
       }
      }
     },
     "localname": "LesseeOperatingLeasesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/Leases"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_Liabilities": {
     "auth_ref": [
      "r46",
      "r111",
      "r175",
      "r193",
      "r372",
      "r376",
      "r377",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.",
        "label": "Liabilities",
        "totalLabel": "Total liabilities"
       }
      }
     },
     "localname": "Liabilities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquity": {
     "auth_ref": [
      "r28",
      "r111",
      "r193",
      "r401",
      "r499",
      "r514"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.",
        "label": "Liabilities and Equity",
        "totalLabel": "Total liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesAndStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities and Equity [Abstract]",
        "terseLabel": "Liabilities and shareholders\u2019 equity"
       }
      }
     },
     "localname": "LiabilitiesAndStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesCurrent": {
     "auth_ref": [
      "r48",
      "r111",
      "r193",
      "r372",
      "r376",
      "r377",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 1.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.",
        "label": "Liabilities, Current",
        "totalLabel": "Total current liabilities"
       }
      }
     },
     "localname": "LiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LiabilitiesCurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Current [Abstract]",
        "terseLabel": "Current liabilities:"
       }
      }
     },
     "localname": "LiabilitiesCurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LiabilitiesNoncurrentAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Liabilities, Noncurrent [Abstract]",
        "terseLabel": "Long-term liabilities:"
       }
      }
     },
     "localname": "LiabilitiesNoncurrentAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Line of Credit Facility [Line Items]",
        "terseLabel": "Line of Credit Facility [Line Items]"
       }
      }
     },
     "localname": "LineOfCreditFacilityLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": {
     "auth_ref": [
      "r45"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.",
        "label": "Line of Credit Facility, Maximum Borrowing Capacity",
        "terseLabel": "Maximum borrowing capacity"
       }
      }
     },
     "localname": "LineOfCreditFacilityMaximumBorrowingCapacity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LineOfCreditFacilityTable": {
     "auth_ref": [
      "r45",
      "r115"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A table or schedule providing information pertaining to short-term or long-term contractual arrangements with lenders, including letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line.",
        "label": "Line of Credit Facility [Table]",
        "terseLabel": "Line of Credit Facility [Table]"
       }
      }
     },
     "localname": "LineOfCreditFacilityTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LineOfCreditMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A contractual arrangement with a lender under which borrowings can be made up to a specific amount at any point in time, and under which borrowings outstanding may be either short-term or long-term, depending upon the particulars.",
        "label": "Line of Credit [Member]",
        "terseLabel": "Line of Credit"
       }
      }
     },
     "localname": "LineOfCreditMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LondonInterbankOfferedRateLIBORMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate at which a bank borrows funds from other banks in the London interbank market.",
        "label": "London Interbank Offered Rate (LIBOR) [Member]",
        "terseLabel": "London Interbank Offered Rate (LIBOR)"
       }
      }
     },
     "localname": "LondonInterbankOfferedRateLIBORMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_LongTermDebt": {
     "auth_ref": [
      "r16",
      "r255",
      "r498",
      "r511"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, after unamortized (discount) premium and debt issuance costs, of long-term debt. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt",
        "totalLabel": "Net carrying value of Madryn debt"
       }
      }
     },
     "localname": "LongTermDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongTermDebtNoncurrent": {
     "auth_ref": [
      "r50"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after unamortized (discount) premium and debt issuance costs of long-term debt classified as noncurrent and excluding amounts to be repaid within one year or the normal operating cycle, if longer. Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.",
        "label": "Long-term Debt, Excluding Current Maturities",
        "terseLabel": "Note payable, Madryn, net of debt discount and issuance costs"
       }
      }
     },
     "localname": "LongTermDebtNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_LongtermDebtTypeAxis": {
     "auth_ref": [
      "r50"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-term debt.",
        "label": "Long-term Debt, Type [Axis]",
        "terseLabel": "Long-term Debt, Type [Axis]"
       }
      }
     },
     "localname": "LongtermDebtTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_LongtermDebtTypeDomain": {
     "auth_ref": [
      "r50",
      "r252"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Type of long-term debt arrangement, such as notes, line of credit, commercial paper, asset-based financing, project financing, letter of credit financing. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the company, if longer.",
        "label": "Long-term Debt, Type [Domain]",
        "terseLabel": "Long-term Debt, Type [Domain]"
       }
      }
     },
     "localname": "LongtermDebtTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails",
      "http://establishmentlabs.com/role/DebtScheduleofMadrynDebtDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MachineryAndEquipmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tangible personal property used to produce goods and services, including, but is not limited to, tools, dies and molds, computer and office equipment.",
        "label": "Machinery and Equipment [Member]",
        "terseLabel": "Machinery and equipment"
       }
      }
     },
     "localname": "MachineryAndEquipmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedDividendRateMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.",
        "label": "Measurement Input, Expected Dividend Rate [Member]",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "MeasurementInputExpectedDividendRateMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputExpectedTermMember": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.",
        "label": "Measurement Input, Expected Term [Member]",
        "terseLabel": "Term (in years)"
       }
      }
     },
     "localname": "MeasurementInputExpectedTermMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_MeasurementInputTypeAxis": {
     "auth_ref": [
      "r388"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Axis]",
        "terseLabel": "Measurement Input Type [Axis]"
       }
      }
     },
     "localname": "MeasurementInputTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_MeasurementInputTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Measurement input used to determine value of asset and liability.",
        "label": "Measurement Input Type [Domain]",
        "terseLabel": "Measurement Input Type [Domain]"
       }
      }
     },
     "localname": "MeasurementInputTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.",
        "label": "Net Cash Provided by (Used in) Financing Activities",
        "totalLabel": "Net cash provided by financing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Financing Activities [Abstract]",
        "terseLabel": "Cash flows from financing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivities": {
     "auth_ref": [
      "r94"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.",
        "label": "Net Cash Provided by (Used in) Investing Activities",
        "totalLabel": "Net cash used in investing activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Investing Activities [Abstract]",
        "terseLabel": "Cash flows from investing activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivities": {
     "auth_ref": [
      "r94",
      "r96",
      "r99"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
       "weight": 1.0
      }
     },
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.",
        "label": "Net Cash Provided by (Used in) Operating Activities",
        "totalLabel": "Net cash used in operating activities"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivities",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Cash Provided by (Used in) Operating Activities [Abstract]",
        "terseLabel": "Cash flows from operating activities:"
       }
      }
     },
     "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_NetIncomeLoss": {
     "auth_ref": [
      "r1",
      "r68",
      "r71",
      "r77",
      "r99",
      "r111",
      "r122",
      "r124",
      "r125",
      "r126",
      "r127",
      "r129",
      "r130",
      "r134",
      "r165",
      "r173",
      "r176",
      "r179",
      "r181",
      "r193",
      "r401",
      "r502",
      "r518"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.",
        "label": "Net Income (Loss) Attributable to Parent",
        "terseLabel": "Net loss",
        "totalLabel": "Net loss",
        "verboseLabel": "Net loss"
       }
      }
     },
     "localname": "NetIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.",
        "label": "New Accounting Pronouncements, Policy [Policy Text Block]",
        "terseLabel": "Recent Accounting Standards"
       }
      }
     },
     "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NonvestedRestrictedStockSharesActivityTableTextBlock": {
     "auth_ref": [
      "r318"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the changes in outstanding nonvested restricted stock shares.",
        "label": "Nonvested Restricted Stock Shares Activity [Table Text Block]",
        "terseLabel": "Schedule of Restricted Stock"
       }
      }
     },
     "localname": "NonvestedRestrictedStockSharesActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_NumberOfOperatingSegments": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of operating segments. An operating segment is a component of an enterprise: (a) that engages in business activities from which it may earn revenues and incur expenses (including revenues and expenses relating to transactions with other components of the same enterprise), (b) whose operating results are regularly reviewed by the enterprise's chief operating decision maker to make decisions about resources to be allocated to the segment and assess its performance, and (c) for which discrete financial information is available. An operating segment may engage in business activities for which it has yet to earn revenues, for example, start-up operations may be operating segments before earning revenues.",
        "label": "Number of Operating Segments",
        "terseLabel": "Number of operating segments"
       }
      }
     },
     "localname": "NumberOfOperatingSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportableSegments": {
     "auth_ref": [
      "r159"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.",
        "label": "Number of Reportable Segments",
        "terseLabel": "Number of reportable segments"
       }
      }
     },
     "localname": "NumberOfReportableSegments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_NumberOfReportingUnits": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of reporting units tested for impairment of goodwill. A reporting unit is an operating segment or one level below an operating segment.",
        "label": "Number of Reporting Units",
        "terseLabel": "Number of reporting units"
       }
      }
     },
     "localname": "NumberOfReportingUnits",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "integerItemType"
    },
    "us-gaap_OperatingExpenses": {
     "auth_ref": [],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingIncomeLoss",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Generally recurring costs associated with normal operations except for the portion of these expenses which can be clearly related to production and included in cost of sales or services. Includes selling, general and administrative expense.",
        "label": "Operating Expenses",
        "totalLabel": "Total operating expenses"
       }
      }
     },
     "localname": "OperatingExpenses",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingExpensesAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Operating Expenses [Abstract]",
        "terseLabel": "Operating expenses:"
       }
      }
     },
     "localname": "OperatingExpensesAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingIncomeLoss": {
     "auth_ref": [
      "r165",
      "r173",
      "r176",
      "r179",
      "r181"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net result for the period of deducting operating expenses from operating revenues.",
        "label": "Operating Income (Loss)",
        "totalLabel": "Loss from operations"
       }
      }
     },
     "localname": "OperatingIncomeLoss",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseCost": {
     "auth_ref": [
      "r430",
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.",
        "label": "Operating Lease, Cost",
        "terseLabel": "Operating lease expense cost"
       }
      }
     },
     "localname": "OperatingLeaseCost",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseCostDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilitiesPaymentsDueAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Lessee, Operating Lease, Liability, Payment, Due [Abstract]",
        "terseLabel": "Operating Leases"
       }
      }
     },
     "localname": "OperatingLeaseLiabilitiesPaymentsDueAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OperatingLeaseLiability": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails_1": {
       "order": 2.0,
       "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.",
        "label": "Operating Lease, Liability",
        "terseLabel": "Operating lease, liability",
        "totalLabel": "Operating lease liabilities",
        "verboseLabel": "Present value of future minimum lease payments"
       }
      }
     },
     "localname": "OperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesLeaseMaturityDetails",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrent": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 4.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.",
        "label": "Operating Lease, Liability, Current",
        "terseLabel": "Operating lease liabilities - current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList": {
     "auth_ref": [
      "r421"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicates line item in statement of financial position that includes current operating lease liability.",
        "label": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]",
        "terseLabel": "Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "extensibleListItemType"
    },
    "us-gaap_OperatingLeaseLiabilityNoncurrent": {
     "auth_ref": [
      "r420"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      },
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingLeaseLiability",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.",
        "label": "Operating Lease, Liability, Noncurrent",
        "terseLabel": "Operating lease liabilities, non-current"
       }
      }
     },
     "localname": "OperatingLeaseLiabilityNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeasePayments": {
     "auth_ref": [
      "r425",
      "r431"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.",
        "label": "Operating Lease, Payments",
        "terseLabel": "Operating cash outflows from operating leases"
       }
      }
     },
     "localname": "OperatingLeasePayments",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAsset": {
     "auth_ref": [
      "r419"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of lessee's right to use underlying asset under operating lease.",
        "label": "Operating Lease, Right-of-Use Asset",
        "terseLabel": "Right-of-use operating lease assets, net"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAsset",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseRightOfUseAssetAmortizationExpense": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 8.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of amortization expense for right-of-use asset from operating lease.",
        "label": "Operating Lease, Right-of-Use Asset, Amortization Expense",
        "terseLabel": "Amortization of right-to-use asset"
       }
      }
     },
     "localname": "OperatingLeaseRightOfUseAssetAmortizationExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": {
     "auth_ref": [
      "r434",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average discount rate for operating lease calculated at point in time.",
        "label": "Operating Lease, Weighted Average Discount Rate, Percent",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageDiscountRatePercent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": {
     "auth_ref": [
      "r433",
      "r437"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Operating Lease, Weighted Average Remaining Lease Term",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalBalanceSheetInformationDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]",
        "terseLabel": "Organization, Consolidation and Presentation of Financial Statements [Abstract]"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock": {
     "auth_ref": [
      "r2",
      "r378"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for organization, consolidation and basis of presentation of financial statements disclosure.",
        "label": "Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block]",
        "terseLabel": "Formation and Business of the Company"
       }
      }
     },
     "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FormationandBusinessoftheCompany"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherAccruedLiabilitiesCurrent": {
     "auth_ref": [
      "r8",
      "r9",
      "r10",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 10.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expenses incurred but not yet paid classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Accrued Liabilities, Current",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherAccruedLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherAssetsNoncurrent": {
     "auth_ref": [
      "r43"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 6.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncurrent assets classified as other.",
        "label": "Other Assets, Noncurrent",
        "terseLabel": "Other non-current assets"
       }
      }
     },
     "localname": "OtherAssetsNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r369",
      "r370",
      "r374"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 1.0,
       "parentTag": "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax and reclassification adjustments of gain (loss) on foreign currency translation adjustments, foreign currency transactions designated and effective as economic hedges of a net investment in a foreign entity and intra-entity foreign currency transactions that are of a long-term-investment nature, attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent",
        "terseLabel": "Foreign currency translation gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Comprehensive Income (Loss), Net of Tax [Abstract]",
        "terseLabel": "Other comprehensive income:"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPeriodIncreaseDecreaseAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent": {
     "auth_ref": [
      "r69",
      "r72",
      "r369",
      "r370",
      "r374"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss": {
       "order": 2.0,
       "parentTag": "us-gaap_ComprehensiveIncomeNetOfTax",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after tax of other comprehensive income (loss) attributable to parent entity.",
        "label": "Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent",
        "totalLabel": "Other comprehensive gain"
       }
      }
     },
     "localname": "OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofComprehensiveIncomeLoss"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherCurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other current liabilities.",
        "label": "Other Current Liabilities [Table Text Block]",
        "terseLabel": "Other Current Liabilities"
       }
      }
     },
     "localname": "OtherCurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherIntangibleAssetsMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Intangible assets classified as other.",
        "label": "Other Intangible Assets [Member]",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherIntangibleAssetsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment": {
     "auth_ref": [
      "r34"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross amount of inventory owned by the entity but in the hands of a customer, typically a reseller.",
        "label": "Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross",
        "terseLabel": "Inventory on consignment"
       }
      }
     },
     "localname": "OtherInventoryMaterialsSuppliesAndMerchandiseUnderConsignment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesCurrent": {
     "auth_ref": [
      "r7",
      "r8",
      "r47"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Current",
        "terseLabel": "Other liabilities, short-term",
        "totalLabel": "Other liabilities, short term"
       }
      }
     },
     "localname": "OtherLiabilitiesCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesShortTermDetails",
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherLiabilitiesNoncurrent": {
     "auth_ref": [
      "r51"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 5.0,
       "parentTag": "us-gaap_Liabilities",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of liabilities classified as other, due after one year or the normal operating cycle, if longer.",
        "label": "Other Liabilities, Noncurrent",
        "terseLabel": "Other liabilities, long-term",
        "totalLabel": "Other liabilities, long term"
       }
      }
     },
     "localname": "OtherLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails",
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherNoncurrentLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of other noncurrent liabilities.",
        "label": "Other Noncurrent Liabilities [Table Text Block]",
        "terseLabel": "Other Noncurrent Liabilities"
       }
      }
     },
     "localname": "OtherNoncurrentLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_OtherNonoperatingIncomeExpense": {
     "auth_ref": [
      "r86"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 6.0,
       "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of income (expense) related to nonoperating activities, classified as other.",
        "label": "Other Nonoperating Income (Expense)",
        "terseLabel": "Other expense, net"
       }
      }
     },
     "localname": "OtherNonoperatingIncomeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_OtherSundryLiabilitiesNoncurrent": {
     "auth_ref": [
      "r17",
      "r497",
      "r510"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails": {
       "order": 3.0,
       "parentTag": "us-gaap_OtherLiabilitiesNoncurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are expected to be paid after one year (or the normal operating cycle, if longer), from the balance sheet date.",
        "label": "Other Sundry Liabilities, Noncurrent",
        "terseLabel": "Other"
       }
      }
     },
     "localname": "OtherSundryLiabilitiesNoncurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsOtherLiabilitiesLongTermDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsRelatedToTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [
      "r90"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 4.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash outflow to satisfy grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Payment, Tax Withholding, Share-based Payment Arrangement",
        "negatedTerseLabel": "Tax\u00a0payments\u00a0related\u00a0to\u00a0shares\u00a0withheld\u00a0upon\u00a0vesting of\u00a0restricted\u00a0stock"
       }
      }
     },
     "localname": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquireIntangibleAssets": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.",
        "label": "Payments to Acquire Intangible Assets",
        "negatedTerseLabel": "Cost incurred for intangible assets"
       }
      }
     },
     "localname": "PaymentsToAcquireIntangibleAssets",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": {
     "auth_ref": [
      "r87"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 1.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.",
        "label": "Payments to Acquire Property, Plant, and Equipment",
        "negatedTerseLabel": "Purchases of property and equipment"
       }
      }
     },
     "localname": "PaymentsToAcquirePropertyPlantAndEquipment",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PaymentsToSuppliers": {
     "auth_ref": [
      "r91",
      "r92"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Payments of cash to suppliers for goods and services during the current period.",
        "label": "Payments to Suppliers",
        "terseLabel": "Purchases from suppliers"
       }
      }
     },
     "localname": "PaymentsToSuppliers",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PlanNameAxis": {
     "auth_ref": [
      "r314",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by plan name for share-based payment arrangement.",
        "label": "Plan Name [Axis]",
        "terseLabel": "Plan Name [Axis]"
       }
      }
     },
     "localname": "PlanNameAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PlanNameDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Plan name for share-based payment arrangement.",
        "label": "Plan Name [Domain]",
        "terseLabel": "Plan Name [Domain]"
       }
      }
     },
     "localname": "PlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": {
     "auth_ref": [
      "r5",
      "r37",
      "r38"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_AssetsCurrent",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.",
        "label": "Prepaid Expense and Other Assets, Current",
        "terseLabel": "Prepaid expenses and other current assets"
       }
      }
     },
     "localname": "PrepaidExpenseAndOtherAssetsCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PriorPeriodReclassificationAdjustmentDescription": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for reclassification affecting comparability of financial statement. Excludes amendment to accounting standards, other change in accounting principle, and correction of error.",
        "label": "Reclassification, Comparability Adjustment [Policy Text Block]",
        "terseLabel": "Reclassifications"
       }
      }
     },
     "localname": "PriorPeriodReclassificationAdjustmentDescription",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfCommonStock": {
     "auth_ref": [
      "r88"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 2.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow from the additional capital contribution to the entity.",
        "label": "Proceeds from Issuance of Common Stock",
        "terseLabel": "Proceeds from issuance of ordinary shares, net of issuance costs"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfCommonStock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromIssuanceOfDebt": {
     "auth_ref": [
      "r89"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.",
        "label": "Proceeds from Issuance of Debt",
        "terseLabel": "Additional amount borrowed"
       }
      }
     },
     "localname": "ProceedsFromIssuanceOfDebt",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromLinesOfCredit": {
     "auth_ref": [
      "r89",
      "r116"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from contractual arrangement with the lender, including but not limited to, letter of credit, standby letter of credit and revolving credit arrangements.",
        "label": "Proceeds from Lines of Credit",
        "terseLabel": "Borrowings on credit facility"
       }
      }
     },
     "localname": "ProceedsFromLinesOfCredit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProceedsFromStockOptionsExercised": {
     "auth_ref": [
      "r88",
      "r345"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of cash inflow from exercise of option under share-based payment arrangement.",
        "label": "Proceeds from Stock Options Exercised",
        "terseLabel": "Proceeds from stock option exercises"
       }
      }
     },
     "localname": "ProceedsFromStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ProductWarrantyAccrualClassifiedCurrent": {
     "auth_ref": [
      "r47",
      "r249",
      "r250"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails": {
       "order": 8.0,
       "parentTag": "us-gaap_AccruedLiabilitiesCurrent",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Carrying value as of the balance sheet date of obligations incurred through that date and payable for estimated claims under standard and extended warranty protection rights granted to customers. For classified balance sheets, represents the current portion of the liabilities (due within one year or within the normal operating cycle if longer).",
        "label": "Product Warranty Accrual, Current",
        "terseLabel": "Warranty reserve"
       }
      }
     },
     "localname": "ProductWarrantyAccrualClassifiedCurrent",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsAccruedLiabilitiesDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentByTypeAxis": {
     "auth_ref": [
      "r42",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.",
        "label": "Long-Lived Tangible Asset [Axis]",
        "terseLabel": "Property, Plant and Equipment, Type [Axis]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentByTypeAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentGross": {
     "auth_ref": [
      "r41",
      "r239"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails": {
       "order": 1.0,
       "parentTag": "us-gaap_PropertyPlantAndEquipmentNet",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Gross",
        "terseLabel": "Property, plant and equipment, gross"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Property, Plant and Equipment [Line Items]",
        "terseLabel": "Property, Plant and Equipment [Line Items]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentNet": {
     "auth_ref": [
      "r12",
      "r13",
      "r241",
      "r516"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails": {
       "order": null,
       "parentTag": null,
       "root": true,
       "weight": null
      },
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 2.0,
       "parentTag": "us-gaap_Assets",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.",
        "label": "Property, Plant and Equipment, Net",
        "terseLabel": "Property and equipment, net of accumulated depreciation",
        "totalLabel": "Property, plant and equipment, net"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentNet",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails",
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": {
     "auth_ref": [
      "r40",
      "r107",
      "r241",
      "r546",
      "r547"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.",
        "label": "Property, Plant and Equipment, Policy [Policy Text Block]",
        "terseLabel": "Property and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTextBlock": {
     "auth_ref": [
      "r12",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table Text Block]",
        "terseLabel": "Property, Plant and Equipment"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentTypeDomain": {
     "auth_ref": [
      "r12",
      "r239"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software.",
        "label": "Long-Lived Tangible Asset [Domain]",
        "terseLabel": "Property, Plant and Equipment, Type [Domain]"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentTypeDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_PropertyPlantAndEquipmentUsefulLife": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Useful life of long lived, physical assets used in the normal conduct of business and not intended for resale, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Examples include, but not limited to, land, buildings, machinery and equipment, office equipment, furniture and fixtures, and computer equipment.",
        "label": "Property, Plant and Equipment, Useful Life",
        "terseLabel": "Estimated useful lives"
       }
      }
     },
     "localname": "PropertyPlantAndEquipmentUsefulLife",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ProvisionForDoubtfulAccounts": {
     "auth_ref": [
      "r79",
      "r198"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 3.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.",
        "label": "Accounts Receivable, Credit Loss Expense (Reversal)",
        "terseLabel": "Provision for doubtful accounts"
       }
      }
     },
     "localname": "ProvisionForDoubtfulAccounts",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_PutOptionMember": {
     "auth_ref": [
      "r538",
      "r539",
      "r540",
      "r541",
      "r542",
      "r543"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A financial contract between two parties, the buyer and the seller (writer) of the option, where the buyer has the right but not the obligation to sell a commodity or financial instrument (the underlying instrument) to the seller (writer) at a certain time for a certain price (the strike price). The seller (writer) has the obligation to purchase the underlying asset at that strike price, if the buyer exercises the option.",
        "label": "Put Option [Member]",
        "terseLabel": "Put Option Liability"
       }
      }
     },
     "localname": "PutOptionMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails",
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy": {
     "auth_ref": [
      "r30",
      "r107",
      "r189"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for determining the allowance for doubtful accounts for trade and other accounts receivable balances, and when impairments, charge-offs or recoveries are recognized.",
        "label": "Receivables, Trade and Other Accounts Receivable, Allowance for Doubtful Accounts, Policy [Policy Text Block]",
        "terseLabel": "Accounts Receivable and Allowance for Doubtful Accounts"
       }
      }
     },
     "localname": "ReceivablesTradeAndOtherAccountsReceivableAllowanceForDoubtfulAccountsPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RelatedPartyDomain": {
     "auth_ref": [
      "r305",
      "r441",
      "r442"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Domain]",
        "terseLabel": "Related Party [Domain]"
       }
      }
     },
     "localname": "RelatedPartyDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty": {
     "auth_ref": [
      "r441"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expenses recognized resulting from transactions (excluding transactions that are eliminated in consolidated or combined financial statements) with related party.",
        "label": "Related Party Transaction, Expenses from Transactions with Related Party",
        "terseLabel": "Purchases from related party"
       }
      }
     },
     "localname": "RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RelatedPartyTransactionLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Related Party Transaction [Line Items]",
        "terseLabel": "Related Party Transaction [Line Items]"
       }
      }
     },
     "localname": "RelatedPartyTransactionLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Related Party Transactions [Abstract]",
        "terseLabel": "Related Party Transactions [Abstract]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": {
     "auth_ref": [
      "r305",
      "r441",
      "r444",
      "r481",
      "r482",
      "r483",
      "r484",
      "r485",
      "r486",
      "r487",
      "r488",
      "r489",
      "r490",
      "r491",
      "r492"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.",
        "label": "Related Party [Axis]",
        "terseLabel": "Related Party [Axis]"
       }
      }
     },
     "localname": "RelatedPartyTransactionsByRelatedPartyAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": {
     "auth_ref": [
      "r439",
      "r440",
      "r442",
      "r445",
      "r446"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Related Party Transactions Disclosure [Text Block]",
        "terseLabel": "Related Party Transactions"
       }
      }
     },
     "localname": "RelatedPartyTransactionsDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactions"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpense": {
     "auth_ref": [
      "r354",
      "r557"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 2.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use.",
        "label": "Research and Development Expense",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpenseMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption in which the reported facts about research and development expense have been included.",
        "label": "Research and Development Expense [Member]",
        "terseLabel": "Research and development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpenseMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ResearchAndDevelopmentExpensePolicy": {
     "auth_ref": [
      "r107",
      "r354"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for costs it has incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process.",
        "label": "Research and Development Expense, Policy [Policy Text Block]",
        "terseLabel": "Research and Development"
       }
      }
     },
     "localname": "ResearchAndDevelopmentExpensePolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RestrictedStockMember": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Stock including a provision that prohibits sale or substantive sale of an equity instrument for a specified period of time or until specified performance conditions are met.",
        "label": "Restricted Stock [Member]",
        "terseLabel": "Restricted Stock"
       }
      }
     },
     "localname": "RestrictedStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RestrictedStockUnitsRSUMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Share instrument which is convertible to stock or an equivalent amount of cash, after a specified period of time or when specified performance conditions are met.",
        "label": "Restricted Stock Units (RSUs) [Member]",
        "terseLabel": "Shares issuable on vesting of restricted stock awards"
       }
      }
     },
     "localname": "RestrictedStockUnitsRSUMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RetainedEarningsAccumulatedDeficit": {
     "auth_ref": [
      "r24",
      "r270",
      "r349",
      "r513",
      "r531",
      "r533"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 4.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings (Accumulated Deficit)",
        "terseLabel": "Accumulated deficit"
       }
      }
     },
     "localname": "RetainedEarningsAccumulatedDeficit",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RetainedEarningsMember": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r123",
      "r128",
      "r130",
      "r194",
      "r346",
      "r347",
      "r348",
      "r362",
      "r363",
      "r528",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.",
        "label": "Retained Earnings [Member]",
        "terseLabel": "Accumulated Deficit"
       }
      }
     },
     "localname": "RetainedEarningsMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": {
     "auth_ref": [
      "r160",
      "r161",
      "r172",
      "r177",
      "r178",
      "r182",
      "r183",
      "r185",
      "r286",
      "r287",
      "r478"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_GrossProfit",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.",
        "label": "Revenue from Contract with Customer, Excluding Assessed Tax",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerExcludingAssessedTax",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesDisaggregationofRevenueDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RevenueFromContractWithCustomerPolicyTextBlock": {
     "auth_ref": [
      "r108",
      "r278",
      "r279",
      "r280",
      "r281",
      "r282",
      "r283",
      "r284",
      "r285",
      "r296"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for revenue from contract with customer.",
        "label": "Revenue from Contract with Customer [Policy Text Block]",
        "terseLabel": "Shipping and Handling Costs/Revenue Recognition"
       }
      }
     },
     "localname": "RevenueFromContractWithCustomerPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_RevenueFromRelatedParties": {
     "auth_ref": [
      "r80",
      "r537"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of revenue, fees and commissions earned from transactions between (a) a parent company and its subsidiaries; (b) subsidiaries of a common parent; (c) an entity and trusts for the benefit of employees, for example, but not limited to, pension and profit-sharing trusts that are managed by or under the trusteeship of the entity's management; (d) an entity and its principal, owners, management, or members of their immediate families; and (e) affiliates.",
        "label": "Revenue from Related Parties",
        "terseLabel": "Revenue from related parties"
       }
      }
     },
     "localname": "RevenueFromRelatedParties",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability": {
     "auth_ref": [
      "r432",
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for finance lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Finance Lease Liability",
        "terseLabel": "Finance leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability": {
     "auth_ref": [
      "r432",
      "r437"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of increase in right-of-use asset obtained in exchange for operating lease liability.",
        "label": "Right-of-Use Asset Obtained in Exchange for Operating Lease Liability",
        "terseLabel": "Operating leases"
       }
      }
     },
     "localname": "RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/LeasesSupplementalCashFlowsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SalesRevenueNetMember": {
     "auth_ref": [
      "r154",
      "r185"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.",
        "label": "Revenue Benchmark [Member]",
        "terseLabel": "Revenue"
       }
      }
     },
     "localname": "SalesRevenueNetMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ScheduleOfAccruedLiabilitiesTableTextBlock": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the components of accrued liabilities.",
        "label": "Schedule of Accrued Liabilities [Table Text Block]",
        "terseLabel": "Schedule of Accrued Liabilities"
       }
      }
     },
     "localname": "ScheduleOfAccruedLiabilitiesTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule for securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by Antidilutive Securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table]"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock": {
     "auth_ref": [
      "r138"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) in the future that were not included in the computation of diluted EPS because to do so would increase EPS amounts or decrease loss per share amounts for the period presented, by antidilutive securities.",
        "label": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table Text Block]",
        "terseLabel": "Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock": {
     "auth_ref": [
      "r341"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of cost recognized for award under share-based payment arrangement by plan. Includes, but is not limited to, related tax benefit.",
        "label": "Share-based Payment Arrangement, Cost by Plan [Table Text Block]",
        "terseLabel": "Schedule of Share-based Compensation Expense"
       }
      }
     },
     "localname": "ScheduleOfCompensationCostForShareBasedPaymentArrangementsAllocationOfShareBasedCompensationCostsByPlanTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfDebtInstrumentsTextBlock": {
     "auth_ref": [
      "r50",
      "r115",
      "r264",
      "r267",
      "r268",
      "r269",
      "r415",
      "r416",
      "r418",
      "r506"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.",
        "label": "Schedule of Long-term Debt Instruments [Table Text Block]",
        "terseLabel": "Schedule of Long-term Debt"
       }
      }
     },
     "localname": "ScheduleOfDebtInstrumentsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock": {
     "auth_ref": [
      "r137"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.",
        "label": "Schedule of Earnings Per Share, Basic and Diluted [Table Text Block]",
        "terseLabel": "Schedule of Basic and Diluted Earnings Per Share"
       }
      }
     },
     "localname": "ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfFairValueOffBalanceSheetRisksTable": {
     "auth_ref": [
      "r397",
      "r398"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing the information required and determined to be disclosed regarding the fair value of financial assets and financial liabilities, which are not recognized in the financial statements (off-balance sheet) because they fail to meet some other criterion for recognition.",
        "label": "Schedule of Fair Value, Off-balance Sheet Risks [Table]",
        "terseLabel": "Schedule of Fair Value, Off-balance Sheet Risks [Table]"
       }
      }
     },
     "localname": "ScheduleOfFairValueOffBalanceSheetRisksTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsLevel3FinancialInstrumentsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": {
     "auth_ref": [
      "r224",
      "r228",
      "r479"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets [Table]"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r224",
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.",
        "label": "Schedule of Finite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfGoodwillTextBlock": {
     "auth_ref": [
      "r219",
      "r221"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of goodwill by reportable segment and in total which includes a rollforward schedule.",
        "label": "Schedule of Goodwill [Table Text Block]",
        "terseLabel": "Schedule of Goodwill"
       }
      }
     },
     "localname": "ScheduleOfGoodwillTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock": {
     "auth_ref": [
      "r232",
      "r234"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance and exist in perpetuity, by either major class or business segment.",
        "label": "Schedule of Indefinite-Lived Intangible Assets [Table Text Block]",
        "terseLabel": "Schedule of Indefinite-Lived Intangible Assets"
       }
      }
     },
     "localname": "ScheduleOfIndefiniteLivedIntangibleAssetsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfInventoryCurrentTableTextBlock": {
     "auth_ref": [
      "r11",
      "r34",
      "r35",
      "r36"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.",
        "label": "Schedule of Inventory, Current [Table Text Block]",
        "terseLabel": "Schedule of inventory, current"
       }
      }
     },
     "localname": "ScheduleOfInventoryCurrentTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": {
     "auth_ref": [
      "r42",
      "r241"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.",
        "label": "Property, Plant and Equipment [Table]",
        "terseLabel": "Property, Plant and Equipment [Table]"
       }
      }
     },
     "localname": "ScheduleOfPropertyPlantAndEquipmentTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfRelatedPartyTransactionsByRelatedPartyTable": {
     "auth_ref": [
      "r114",
      "r443",
      "r444"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule of quantitative and qualitative information pertaining to related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.",
        "label": "Schedule of Related Party Transactions, by Related Party [Table]",
        "terseLabel": "Schedule of Related Party Transactions, by Related Party [Table]"
       }
      }
     },
     "localname": "ScheduleOfRelatedPartyTransactionsByRelatedPartyTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": {
     "auth_ref": [
      "r314",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of information about share-based payment arrangement.",
        "label": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]",
        "terseLabel": "Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table]"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": {
     "auth_ref": [
      "r319",
      "r329",
      "r332"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.",
        "label": "Share-based Payment Arrangement, Option, Activity [Table Text Block]",
        "terseLabel": "Schedule of Stock Options"
       }
      }
     },
     "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock": {
     "auth_ref": [
      "r335"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.",
        "label": "Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]",
        "terseLabel": "Schedule of Employee Stock Options Valuation Assumptions"
       }
      }
     },
     "localname": "ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockByClassTable": {
     "auth_ref": [
      "r53",
      "r109",
      "r144",
      "r145",
      "r259",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.",
        "label": "Schedule of Stock by Class [Table]",
        "terseLabel": "Schedule of Stock by Class [Table]"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails",
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails",
      "http://establishmentlabs.com/role/WarrantsWarrantDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ScheduleOfStockByClassTextBlock": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r260",
      "r261",
      "r262",
      "r264",
      "r265",
      "r266",
      "r267",
      "r268",
      "r269",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of an entity's stock, including par or stated value per share, number and dollar amount of share subscriptions, shares authorized, shares issued, shares outstanding, number and dollar amount of shares held in an employee trust, dividend per share, total dividends, share conversion features, par value plus additional paid in capital, the value of treasury stock and other information necessary to a fair presentation, and EPS information.  Stock by class includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. Includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity. If more than one issue is outstanding, state the title of each issue and the corresponding dollar amount; dollar amount of any shares subscribed but unissued and the deduction of subscriptions receivable there from; number of shares authorized, issued, and outstanding.",
        "label": "Schedule of Stock by Class [Table Text Block]",
        "terseLabel": "Schedule of Reserved Ordinary Shares for Future Issuances"
       }
      }
     },
     "localname": "ScheduleOfStockByClassTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquityTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": {
     "auth_ref": [
      "r273",
      "r311"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.",
        "label": "Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block]",
        "terseLabel": "Schedule of Stockholders' Equity Note, Warrants or Rights"
       }
      }
     },
     "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": {
     "auth_ref": [
      "r228"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.",
        "label": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense [Table Text Block]",
        "terseLabel": "Schedule of Finite-Lived Intangible Assets, Future Amortization Expense"
       }
      }
     },
     "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsTables"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SegmentReportingPolicyPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r166",
      "r167",
      "r168",
      "r169",
      "r170",
      "r171",
      "r183"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for segment reporting.",
        "label": "Segment Reporting, Policy [Policy Text Block]",
        "terseLabel": "Segments"
       }
      }
     },
     "localname": "SegmentReportingPolicyPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpense": {
     "auth_ref": [
      "r83"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations": {
       "order": 1.0,
       "parentTag": "us-gaap_OperatingExpenses",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The aggregate total costs related to selling a firm's product and services, as well as all other general and administrative expenses. Direct selling expenses (for example, credit, warranty, and advertising) are expenses that can be directly linked to the sale of specific products. Indirect selling expenses are expenses that cannot be directly linked to the sale of specific products, for example telephone expenses, Internet, and postal charges. General and administrative expenses include salaries of non-sales personnel, rent, utilities, communication, etc.",
        "label": "Selling, General and Administrative Expense",
        "terseLabel": "Sales, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpense",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Primary financial statement caption encompassing selling, general and administrative expense.",
        "label": "Selling, General and Administrative Expenses [Member]",
        "terseLabel": "Sales, general and administrative"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SellingGeneralAndAdministrativeExpensesPolicyTextBlock": {
     "auth_ref": [
      "r107",
      "r353"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for inclusion of significant items in the selling, general and administrative (or similar) expense report caption.",
        "label": "Selling, General and Administrative Expenses, Policy [Policy Text Block]",
        "terseLabel": "Selling, General and Administrative Expenses"
       }
      }
     },
     "localname": "SellingGeneralAndAdministrativeExpensesPolicyTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedCompensation": {
     "auth_ref": [
      "r97"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 5.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": 1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of noncash expense for share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Noncash Expense",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "ShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": {
     "auth_ref": [
      "r315"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Period",
        "terseLabel": "Vesting period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeited in Period",
        "negatedTerseLabel": "Forfeited/canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r328"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value",
        "terseLabel": "Forfeited/canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period",
        "terseLabel": "Granted (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r326"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number",
        "periodEndLabel": "Outstanding balance (in shares)",
        "periodStartLabel": "Outstanding balance (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number of Shares [Roll Forward]",
        "terseLabel": "Restricted Stock Awards"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r325"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value",
        "periodEndLabel": "Balance outstanding (in dollars per share)",
        "periodStartLabel": "Balance outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of equity-based payment instruments, excluding stock (or unit) options, that vested during the reporting period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period",
        "negatedTerseLabel": "Vested (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fair value of share-based awards for which the grantee gained the right by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value",
        "terseLabel": "RSAs vested in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r327"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average fair value as of grant date pertaining to an equity-based award plan other than a stock (or unit) option plan for which the grantee gained the right during the reporting period, by satisfying service and performance requirements, to receive or retain shares or units, other instruments, or cash in accordance with the terms of the arrangement.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Vested (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate": {
     "auth_ref": [
      "r338"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate",
        "terseLabel": "Dividend yield"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": {
     "auth_ref": [
      "r337"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate",
        "verboseLabel": "Volatility"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": {
     "auth_ref": [
      "r339"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate",
        "terseLabel": "Risk-free interest rate"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The maximum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum",
        "terseLabel": "Risk-free interest rate, maximum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The minimum risk-free interest rate assumption that is used in valuing an option on its own shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum",
        "terseLabel": "Risk free interest rate, minimum"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails"
     ],
     "xbrltype": "percentItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award [Line Items]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsandRestrictedStockDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Outstanding [Roll Forward]",
        "terseLabel": "Weighted- Average Grant Date Fair Value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]",
        "terseLabel": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Additional Disclosures [Abstract]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsAdditionalDisclosuresAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": {
     "auth_ref": [
      "r331"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value",
        "verboseLabel": "Intrinsic value of options exercised in period"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [
      "r324"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price of options that were either forfeited or expired.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price",
        "terseLabel": "Forfeited/canceled (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": {
     "auth_ref": [
      "r323"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period",
        "negatedTerseLabel": "Forfeited/canceled (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Gross number of share options (or share units) granted during the period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross",
        "terseLabel": "Granted (in shares)",
        "verboseLabel": "Grants in period (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/RelatedPartyTransactionsNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": {
     "auth_ref": [
      "r330"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value",
        "terseLabel": "Weighted average fair value (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": {
     "auth_ref": [
      "r344"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": {
     "auth_ref": [
      "r321",
      "r344"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of options outstanding, including both vested and non-vested options.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number",
        "periodEndLabel": "Balance outstanding (in shares)",
        "periodStartLabel": "Balance outstanding (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]",
        "terseLabel": "Number of Options Outstanding"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingRollForward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": {
     "auth_ref": [
      "r320"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price",
        "periodEndLabel": "Options outstanding (in dollars per share)",
        "periodStartLabel": "Options outstanding (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price [Abstract]",
        "terseLabel": "Weighted-Average Exercise Price"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePriceRollforward",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": {
     "auth_ref": [
      "r334"
     ],
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value",
        "terseLabel": "Aggregate intrinsic value of options vested and exercisable"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of fully vested and expected to vest exercisable options that may be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number",
        "terseLabel": "Number of options vested and exercisable (in shares)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableNumber",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice": {
     "auth_ref": [
      "r334"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price",
        "terseLabel": "Weighted average exercise price vested and exercisable (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "auth_ref": [
      "r311",
      "r316"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Award under share-based payment arrangement.",
        "label": "Award Type [Domain]",
        "terseLabel": "Award Type [Domain]"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationRestrictedStockActivityDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/ShareholdersEquityReservedOrdinarySharesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price",
        "terseLabel": "Exercised (in dollars per share)",
        "verboseLabel": "Weighted average exercise price of options exercised (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.",
        "label": "Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price",
        "terseLabel": "Granted (in dollars per share)"
       }
      }
     },
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "perShareItemType"
    },
    "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": {
     "auth_ref": [
      "r107",
      "r314",
      "r317"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.",
        "label": "Share-based Payment Arrangement [Policy Text Block]",
        "terseLabel": "Share-based Compensation"
       }
      }
     },
     "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by supplier.",
        "label": "Supplier [Axis]",
        "terseLabel": "Supplier [Axis]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionBySupplierAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Specific identification or general nature of (for example, a construction contractor, a consulting firm) the party from whom the goods or services were or are to be received.",
        "label": "Supplier [Domain]",
        "terseLabel": "Supplier [Domain]"
       }
      }
     },
     "localname": "ShareBasedGoodsAndNonemployeeServicesTransactionSupplierDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails",
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementEmployeeMember": {
     "auth_ref": [
      "r310",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor exercises or has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Includes, but is not limited to, nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Employee [Member]",
        "terseLabel": "Employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementEmployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_ShareBasedPaymentArrangementNonemployeeMember": {
     "auth_ref": [
      "r309",
      "r340"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Recipient, of award granted under share-based payment arrangement, over whom grantor does not exercise nor has right to exercise sufficient control to establish employer-employee relationship based on law of pertinent jurisdiction. Excludes nonemployee director treated as employee when acting as member of board of directors, if elected by grantor's shareholders or appointed to board position to be filled by shareholder election when existing term expires.",
        "label": "Share-based Payment Arrangement, Nonemployee [Member]",
        "terseLabel": "Non-employee"
       }
      }
     },
     "localname": "ShareBasedPaymentArrangementNonemployeeMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": {
     "auth_ref": [
      "r336",
      "r350"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term",
        "terseLabel": "Term (in years)"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionGrantedtoEmployeesDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsGrantedtoNonemployeesDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": {
     "auth_ref": [
      "r333"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term",
        "terseLabel": "Weighted-average remaining contractual term"
       }
      }
     },
     "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "durationItemType"
    },
    "us-gaap_SharesIssued": {
     "auth_ref": [
      "r263"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.",
        "label": "Shares, Issued",
        "periodEndLabel": "Ending balance (in shares)",
        "periodStartLabel": "Beginning balance (in shares)"
       }
      }
     },
     "localname": "SharesIssued",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_SharesPaidForTaxWithholdingForShareBasedCompensation": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of shares used to settle grantee's tax withholding obligation for award under share-based payment arrangement.",
        "label": "Share-based Payment Arrangement, Shares Withheld for Tax Withholding Obligation",
        "negatedTerseLabel": "Shares withheld to cover income tax obligation upon vesting of restricted stock (in shares)"
       }
      }
     },
     "localname": "SharesPaidForTaxWithholdingForShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_ShippingAndHandlingMember": {
     "auth_ref": [
      "r289"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Packing and transport of product.",
        "label": "Shipping and Handling [Member]",
        "terseLabel": "Shipping and Handling"
       }
      }
     },
     "localname": "ShippingAndHandlingMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_SignificantAccountingPoliciesTextBlock": {
     "auth_ref": [
      "r118"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for all significant accounting policies of the reporting entity.",
        "label": "Significant Accounting Policies [Text Block]",
        "terseLabel": "Summary of Significant Accounting Policies"
       }
      }
     },
     "localname": "SignificantAccountingPoliciesTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SoftwareDevelopmentMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Internally developed software for sale, licensing or long-term internal use.",
        "label": "Software Development [Member]",
        "terseLabel": "Capitalized software development costs"
       }
      }
     },
     "localname": "SoftwareDevelopmentMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/GoodwillandOtherIntangibleAssetsIntangibleAssetsDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_StatementClassOfStockAxis": {
     "auth_ref": [
      "r18",
      "r19",
      "r20",
      "r109",
      "r111",
      "r131",
      "r132",
      "r133",
      "r135",
      "r137",
      "r144",
      "r145",
      "r146",
      "r193",
      "r263",
      "r401"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by the different classes of stock of the entity.",
        "label": "Class of Stock [Axis]",
        "terseLabel": "Class of Stock [Axis]"
       }
      }
     },
     "localname": "StatementClassOfStockAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/WarrantsNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementEquityComponentsAxis": {
     "auth_ref": [
      "r56",
      "r119",
      "r120",
      "r121",
      "r123",
      "r128",
      "r130",
      "r143",
      "r194",
      "r263",
      "r270",
      "r346",
      "r347",
      "r348",
      "r362",
      "r363",
      "r407",
      "r408",
      "r409",
      "r410",
      "r411",
      "r412",
      "r528",
      "r529",
      "r530"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by component of equity.",
        "label": "Equity Components [Axis]",
        "terseLabel": "Equity Components [Axis]"
       }
      }
     },
     "localname": "StatementEquityComponentsAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Statement [Line Items]",
        "terseLabel": "Statement [Line Items]"
       }
      }
     },
     "localname": "StatementLineItems",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfCashFlowsAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Cash Flows [Abstract]",
        "terseLabel": "Statement of Cash Flows [Abstract]"
       }
      }
     },
     "localname": "StatementOfCashFlowsAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfFinancialPositionAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Financial Position [Abstract]",
        "terseLabel": "Statement of Financial Position [Abstract]"
       }
      }
     },
     "localname": "StatementOfFinancialPositionAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfIncomeAndComprehensiveIncomeAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Comprehensive Income [Abstract]",
        "terseLabel": "Statement of Comprehensive Income [Abstract]"
       }
      }
     },
     "localname": "StatementOfIncomeAndComprehensiveIncomeAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementOfStockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Statement of Stockholders' Equity [Abstract]",
        "terseLabel": "Statement of Stockholders' Equity [Abstract]"
       }
      }
     },
     "localname": "StatementOfStockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "xbrltype": "stringItemType"
    },
    "us-gaap_StatementTable": {
     "auth_ref": [
      "r119",
      "r120",
      "r121",
      "r143",
      "r478"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.",
        "label": "Statement [Table]",
        "terseLabel": "Statement [Table]"
       }
      }
     },
     "localname": "StatementTable",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of new stock issued during the period.",
        "label": "Stock Issued During Period, Shares, New Issues",
        "terseLabel": "Issuance of common stock (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r263",
      "r270"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number, after forfeiture, of shares or units issued under share-based payment arrangement. Excludes shares or units issued under employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Shares, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": {
     "auth_ref": [
      "r19",
      "r20",
      "r263",
      "r270",
      "r322"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of share options (or share units) exercised during the current period.",
        "label": "Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period",
        "negatedTerseLabel": "Exercised (in shares)",
        "terseLabel": "Stock option exercises (in shares)",
        "verboseLabel": "Number of options exercised in period (in shares)"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity",
      "http://establishmentlabs.com/role/SharebasedCompensationNarrativeDetails",
      "http://establishmentlabs.com/role/SharebasedCompensationStockOptionsDetails"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueNewIssues": {
     "auth_ref": [
      "r19",
      "r20",
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.",
        "label": "Stock Issued During Period, Value, New Issues",
        "verboseLabel": "Issuance of common stock"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueNewIssues",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueShareBasedCompensation": {
     "auth_ref": [
      "r19",
      "r20",
      "r270",
      "r313",
      "r330"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value, after forfeiture, of shares issued under share-based payment arrangement. Excludes employee stock ownership plan (ESOP).",
        "label": "Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture",
        "terseLabel": "Share-based compensation"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueShareBasedCompensation",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockIssuedDuringPeriodValueStockOptionsExercised": {
     "auth_ref": [
      "r56",
      "r263",
      "r270"
     ],
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Value of stock issued as a result of the exercise of stock options.",
        "label": "Stock Issued During Period, Value, Stock Options Exercised",
        "terseLabel": "Stock option exercises"
       }
      }
     },
     "localname": "StockIssuedDuringPeriodValueStockOptionsExercised",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquity": {
     "auth_ref": [
      "r20",
      "r26",
      "r27",
      "r111",
      "r190",
      "r193",
      "r401"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity",
       "weight": 1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.",
        "label": "Stockholders' Equity Attributable to Parent",
        "periodEndLabel": "Ending balance",
        "periodStartLabel": "Beginning balance",
        "totalLabel": "Total shareholders\u2019 equity"
       }
      }
     },
     "localname": "StockholdersEquity",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets",
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_StockholdersEquityAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stockholders' Equity Attributable to Parent [Abstract]",
        "terseLabel": "Shareholders\u2019 equity:"
       }
      }
     },
     "localname": "StockholdersEquityAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_StockholdersEquityNoteDisclosureTextBlock": {
     "auth_ref": [
      "r110",
      "r270",
      "r274"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.",
        "label": "Stockholders' Equity Note Disclosure [Text Block]",
        "terseLabel": "Shareholders' Equity",
        "verboseLabel": "Warrants"
       }
      }
     },
     "localname": "StockholdersEquityNoteDisclosureTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ShareholdersEquity",
      "http://establishmentlabs.com/role/Warrants"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalBalanceSheetDisclosuresTextBlock": {
     "auth_ref": [
      "r62"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The entire disclosure for supplemental balance sheet disclosures, including descriptions and amounts for assets, liabilities, and equity.",
        "label": "Supplemental Balance Sheet Disclosures [Text Block]",
        "terseLabel": "Balance Sheet Accounts"
       }
      }
     },
     "localname": "SupplementalBalanceSheetDisclosuresTextBlock",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccounts"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_SupplementalCashFlowInformationAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "label": "Supplemental Cash Flow Information [Abstract]",
        "terseLabel": "Supplemental disclosures:"
       }
      }
     },
     "localname": "SupplementalCashFlowInformationAbstract",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_SupplierConcentrationRiskMember": {
     "auth_ref": [
      "r152"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Reflects the percentage that purchases in the period from one or more significant suppliers is to cost of goods or services, as defined by the entity, such as total cost of sales or services, product line cost of sales or services, segment cost of sales or services. Risk is the materially adverse effects of loss of a material supplier or a supplier of critically needed goods or services.",
        "label": "Supplier Concentration Risk [Member]",
        "terseLabel": "Product Concentration Risk"
       }
      }
     },
     "localname": "SupplierConcentrationRiskMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": {
     "auth_ref": [
      "r191",
      "r192",
      "r447",
      "r448",
      "r449",
      "r450",
      "r451",
      "r452",
      "r453",
      "r454",
      "r455",
      "r456",
      "r457",
      "r458",
      "r459",
      "r460",
      "r461",
      "r462",
      "r463",
      "r464",
      "r465",
      "r466",
      "r467",
      "r468",
      "r469",
      "r470",
      "r471",
      "r472",
      "r473",
      "r474",
      "r475",
      "r476"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms.",
        "label": "Financial Instruments [Domain]",
        "terseLabel": "Financial Instruments [Domain]"
       }
      }
     },
     "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/FairValueMeasurementsDerivativesDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockMember": {
     "auth_ref": [
      "r55",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Shares of an entity that have been repurchased by the entity. This stock has no voting rights and receives no dividends. Note that treasury stock may be recorded at its total cost or separately as par (or stated) value and additional paid in capital. Classified within stockholders' equity if nonredeemable or redeemable solely at the option of the issuer. Classified within temporary equity if redemption is outside the control of the issuer.",
        "label": "Treasury Stock [Member]",
        "terseLabel": "Treasury Shares"
       }
      }
     },
     "localname": "TreasuryStockMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementofShareholdersEquity"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_TreasuryStockShares": {
     "auth_ref": [
      "r55",
      "r271"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Number of common and preferred shares that were previously issued and that were repurchased by the issuing entity and held in treasury on the financial statement date. This stock has no voting rights and receives no dividends.",
        "label": "Treasury Stock, Shares",
        "verboseLabel": "Treasury stock, shares held (in shares)"
       }
      }
     },
     "localname": "TreasuryStockShares",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/ConsolidatedBalanceSheetsParenthetical"
     ],
     "xbrltype": "sharesItemType"
    },
    "us-gaap_TreasuryStockValue": {
     "auth_ref": [
      "r55",
      "r271",
      "r272"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets": {
       "order": 3.0,
       "parentTag": "us-gaap_StockholdersEquity",
       "weight": -1.0
      }
     },
     "crdr": "debit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The amount allocated to treasury stock. Treasury stock is common and preferred shares of an entity that were issued, repurchased by the entity, and are held in its treasury.",
        "label": "Treasury Stock, Value",
        "negatedTerseLabel": "Treasury shares, at cost, 408,070 shares held at March 31, 2021 and December 31, 2020"
       }
      }
     },
     "localname": "TreasuryStockValue",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedBalanceSheets"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UnrealizedGainLossOnDerivatives": {
     "auth_ref": [
      "r98"
     ],
     "calculation": {
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows": {
       "order": 9.0,
       "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities",
       "weight": -1.0
      }
     },
     "crdr": "credit",
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The net change in the difference between the fair value and the carrying value, or in the comparative fair values, of derivative instruments, including options, swaps, futures, and forward contracts, held at each balance sheet date, that was included in earnings for the period.",
        "label": "Unrealized Gain (Loss) on Derivatives",
        "negatedTerseLabel": "Change in fair value of derivative instruments"
       }
      }
     },
     "localname": "UnrealizedGainLossOnDerivatives",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofCashFlows"
     ],
     "xbrltype": "monetaryItemType"
    },
    "us-gaap_UseOfEstimates": {
     "auth_ref": [
      "r147",
      "r148",
      "r150",
      "r151",
      "r156",
      "r157",
      "r158"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.",
        "label": "Use of Estimates, Policy [Policy Text Block]",
        "terseLabel": "Use of Estimates"
       }
      }
     },
     "localname": "UseOfEstimates",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/SummaryofSignificantAccountingPoliciesPolicies"
     ],
     "xbrltype": "textBlockItemType"
    },
    "us-gaap_VariableRateAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Information by type of variable rate.",
        "label": "Variable Rate [Axis]",
        "terseLabel": "Variable Rate [Axis]"
       }
      }
     },
     "localname": "VariableRateAxis",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "stringItemType"
    },
    "us-gaap_VariableRateDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Interest rate that fluctuates over time as a result of an underlying benchmark interest rate or index.",
        "label": "Variable Rate [Domain]",
        "terseLabel": "Variable Rate [Domain]"
       }
      }
     },
     "localname": "VariableRateDomain",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/DebtNarrativeDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_VehiclesMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Equipment used primarily for road transportation.",
        "label": "Vehicles [Member]",
        "terseLabel": "Vehicles"
       }
      }
     },
     "localname": "VehiclesMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/BalanceSheetAccountsPropertyandEquipmentDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WarrantMember": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.",
        "label": "Warrant [Member]",
        "terseLabel": "Warrants to purchase common shares"
       }
      }
     },
     "localname": "WarrantMember",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/NetLossPerShareDilutiveSecuritiesExcludedfromComputationofEarningsPerShareDetails"
     ],
     "xbrltype": "domainItemType"
    },
    "us-gaap_WeightedAverageNumberOfShareOutstandingBasicAndDiluted": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Average number of shares or units issued and outstanding that are used in calculating basic and diluted earnings per share (EPS).",
        "label": "Weighted Average Number of Shares Outstanding, Basic and Diluted",
        "terseLabel": "Weighted average outstanding shares used for basic and diluted net loss per share (in shares)",
        "verboseLabel": "Weighted averave common shares used for basic and diluted earnings per share (in shares)"
       }
      }
     },
     "localname": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
     "nsuri": "http://fasb.org/us-gaap/2020-01-31",
     "presentation": [
      "http://establishmentlabs.com/role/CondensedConsolidatedStatementsofOperations",
      "http://establishmentlabs.com/role/NetLossPerShareBasicandDilutedDetails"
     ],
     "xbrltype": "sharesItemType"
    }
   },
   "unitCount": 7
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=6359566&loc=d3e326-107755"
  },
  "r1": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "205",
   "URI": "http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760"
  },
  "r10": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e7018-107765"
  },
  "r100": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3044-108585"
  },
  "r101": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4273-108586"
  },
  "r102": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4297-108586"
  },
  "r103": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4304-108586"
  },
  "r104": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4313-108586"
  },
  "r105": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=d3e4332-108586"
  },
  "r106": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121583591&loc=SL98516268-108586"
  },
  "r107": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18780-107790"
  },
  "r108": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=84158767&loc=d3e18823-107790"
  },
  "r109": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(d))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r11": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766"
  },
  "r110": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(e)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r111": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r112": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(h))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r113": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k)(1))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r114": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08(k))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r115": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(e),(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r116": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.4-08.(f))",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690"
  },
  "r117": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.12-09)",
   "Topic": "235",
   "URI": "http://asc.fasb.org/extlink&oid=120395691&loc=d3e24092-122690"
  },
  "r118": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "235",
   "URI": "http://asc.fasb.org/topic&trid=2122369"
  },
  "r119": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "23",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21914-107793"
  },
  "r12": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(13))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r120": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21930-107793"
  },
  "r121": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=115929471&loc=d3e21711-107793"
  },
  "r122": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(2)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r123": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)(3)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794"
  },
  "r124": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r125": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794"
  },
  "r126": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794"
  },
  "r127": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794"
  },
  "r128": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22644-107794"
  },
  "r129": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794"
  },
  "r13": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(14))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r130": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "250",
   "URI": "http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794"
  },
  "r131": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1252-109256"
  },
  "r132": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1278-109256"
  },
  "r133": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "55",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e2626-109256"
  },
  "r134": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r135": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "60B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256"
  },
  "r136": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=121326447&loc=d3e1337-109256"
  },
  "r137": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r138": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257"
  },
  "r139": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=6371337&loc=d3e3630-109257"
  },
  "r14": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(19))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r140": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "260",
   "URI": "http://asc.fasb.org/extlink&oid=109243012&loc=SL65017193-207537"
  },
  "r141": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "260",
   "URI": "http://asc.fasb.org/topic&trid=2144383"
  },
  "r142": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "270",
   "URI": "http://asc.fasb.org/extlink&oid=116846552&loc=d3e543-108305"
  },
  "r143": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70191-108054"
  },
  "r144": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6828210&loc=d3e70229-108054"
  },
  "r145": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055"
  },
  "r146": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "272",
   "URI": "http://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055"
  },
  "r147": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r148": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r149": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592"
  },
  "r15": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(20))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r150": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592"
  },
  "r151": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "12",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592"
  },
  "r152": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r153": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r154": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592"
  },
  "r155": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592"
  },
  "r156": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592"
  },
  "r157": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592"
  },
  "r158": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "275",
   "URI": "http://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592"
  },
  "r159": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8672-108599"
  },
  "r16": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(22))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r160": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r161": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r162": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r163": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r164": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r165": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "22",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599"
  },
  "r166": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r167": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r168": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r169": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r17": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(24))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r170": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r171": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8864-108599"
  },
  "r172": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r173": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r174": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r175": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "30",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599"
  },
  "r176": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "31",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599"
  },
  "r177": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r178": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r179": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r18": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(27))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r180": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r181": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "32",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599"
  },
  "r182": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "40",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9031-108599"
  },
  "r183": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r184": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "41",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9038-108599"
  },
  "r185": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "42",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "280",
   "URI": "http://asc.fasb.org/extlink&oid=120311839&loc=d3e9054-108599"
  },
  "r186": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4428-111522"
  },
  "r187": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121593590&loc=d3e4531-111522"
  },
  "r188": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5074-111524"
  },
  "r189": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=121611835&loc=d3e5144-111524"
  },
  "r19": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(28))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r190": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 4.E)",
   "Topic": "310",
   "URI": "http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707"
  },
  "r191": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=d3e27232-111563"
  },
  "r192": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "320",
   "URI": "http://asc.fasb.org/extlink&oid=121645371&loc=SL120269820-111563"
  },
  "r193": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "323",
   "URI": "http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571"
  },
  "r194": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121646688&loc=SL121648383-210437"
  },
  "r195": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599878&loc=SL82895884-210446"
  },
  "r196": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919244-210447"
  },
  "r197": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r198": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r199": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(f)",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r2": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "205",
   "URI": "http://asc.fasb.org/topic&trid=2122149"
  },
  "r20": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(29))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r200": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919249-210447"
  },
  "r201": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919253-210447"
  },
  "r202": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "16",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919258-210447"
  },
  "r203": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121599337&loc=SL82919230-210447"
  },
  "r204": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922888-210455"
  },
  "r205": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922895-210455"
  },
  "r206": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121582814&loc=SL82922900-210455"
  },
  "r207": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "326",
   "URI": "http://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456"
  },
  "r208": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4492-108314"
  },
  "r209": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4542-108314"
  },
  "r21": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3)(a)(2))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r210": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=116847112&loc=d3e4556-108314"
  },
  "r211": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r212": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.BB)",
   "Topic": "330",
   "URI": "http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729"
  },
  "r213": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "330",
   "URI": "http://asc.fasb.org/topic&trid=2126998"
  },
  "r214": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266"
  },
  "r215": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266"
  },
  "r216": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=120320667&loc=SL49117168-202975"
  },
  "r217": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r218": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(e)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r219": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267"
  },
  "r22": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r220": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r221": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267"
  },
  "r222": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274"
  },
  "r223": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274"
  },
  "r224": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r225": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r226": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275"
  },
  "r227": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "((a)(1),(b))",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r228": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r229": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r23": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r230": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(2)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r231": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(3)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r232": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r233": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275"
  },
  "r234": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(b),(d)",
   "Topic": "350",
   "URI": "http://asc.fasb.org/extlink&oid=66006027&loc=d3e16373-109275"
  },
  "r235": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "350",
   "URI": "http://asc.fasb.org/topic&trid=2144416"
  },
  "r236": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "05",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218"
  },
  "r237": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226348&loc=d3e2420-110228"
  },
  "r238": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r239": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r24": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r240": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r241": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229"
  },
  "r242": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230"
  },
  "r243": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 5.CC)",
   "Topic": "360",
   "URI": "http://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742"
  },
  "r244": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r245": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "440",
   "URI": "http://asc.fasb.org/extlink&oid=121559207&loc=d3e25336-109308"
  },
  "r246": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "440",
   "URI": "http://asc.fasb.org/topic&trid=2144648"
  },
  "r247": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "450",
   "URI": "http://asc.fasb.org/extlink&oid=121557415&loc=d3e14326-108349"
  },
  "r248": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "450",
   "URI": "http://asc.fasb.org/topic&trid=2127136"
  },
  "r249": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68070138&loc=d3e11281-110244"
  },
  "r25": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r250": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "460",
   "URI": "http://asc.fasb.org/extlink&oid=68068213&loc=d3e12524-110249"
  },
  "r251": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=d3e1835-112601"
  },
  "r252": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=6802200&loc=SL6230698-112601"
  },
  "r253": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r254": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r255": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6031897-161870"
  },
  "r256": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r257": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "470",
   "URI": "http://asc.fasb.org/extlink&oid=120520924&loc=SL6036836-161870"
  },
  "r258": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "470",
   "URI": "http://asc.fasb.org/topic&trid=2208564"
  },
  "r259": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(CFRR 211.02)",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r26": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(30))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r260": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Topic": "480",
   "URI": "http://asc.fasb.org/extlink&oid=65877616&loc=d3e177068-122764"
  },
  "r261": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643"
  },
  "r262": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21553-112644"
  },
  "r263": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21463-112644"
  },
  "r264": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644"
  },
  "r265": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21484-112644"
  },
  "r266": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21488-112644"
  },
  "r267": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644"
  },
  "r268": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644"
  },
  "r269": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644"
  },
  "r27": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(31))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r270": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.3-04)",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770"
  },
  "r271": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405813&loc=d3e23239-112655"
  },
  "r272": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6405834&loc=d3e23315-112656"
  },
  "r273": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "50",
   "Topic": "505",
   "URI": "http://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775"
  },
  "r274": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "505",
   "URI": "http://asc.fasb.org/topic&trid=2208762"
  },
  "r275": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130531-203044"
  },
  "r276": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130532-203044"
  },
  "r277": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121556615&loc=SL49130533-203044"
  },
  "r278": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130561-203045"
  },
  "r279": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r28": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(32))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r280": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "18",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130563-203045"
  },
  "r281": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130564-203045"
  },
  "r282": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r283": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r284": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r285": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130566-203045"
  },
  "r286": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130543-203045"
  },
  "r287": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130545-203045"
  },
  "r288": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121604090&loc=SL49130549-203045"
  },
  "r289": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r29": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r290": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r291": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r292": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r293": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r294": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r295": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "91",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "606",
   "URI": "http://asc.fasb.org/extlink&oid=121551570&loc=SL49130690-203046-203046"
  },
  "r296": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "606",
   "URI": "http://asc.fasb.org/topic&trid=49130388"
  },
  "r297": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(i)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r298": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(ii)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r299": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(01)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r3": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r30": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r300": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r301": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(A)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r302": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(B)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r303": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(02)(C)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r304": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(d)(iv)(03)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r305": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(n)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118255775&loc=d3e1928-114920"
  },
  "r306": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=118257860&loc=d3e4179-114921"
  },
  "r307": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "80",
   "Subparagraph": "(d)",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947"
  },
  "r308": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "80",
   "Topic": "715",
   "URI": "http://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948"
  },
  "r309": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1D",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=SL116886442-113899"
  },
  "r31": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r310": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121326096&loc=d3e4549-113899"
  },
  "r311": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r312": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r313": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r314": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5047-113901"
  },
  "r315": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r316": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a),(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r317": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b),(f)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r318": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r319": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r32": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(3))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r320": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r321": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r322": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r323": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r324": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)(iv)(3)-(4)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r325": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(i)-(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r326": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r327": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r328": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(2)(iii)(3)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r329": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r33": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a)(4))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r330": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r331": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r332": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r333": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r334": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(e)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r335": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r336": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r337": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(ii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r338": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iii)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r339": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)(iv)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r34": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r340": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(g)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r341": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r342": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(h)(1)(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r343": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(i)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r344": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=d3e5070-113901"
  },
  "r345": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=120381028&loc=SL79508275-113901"
  },
  "r346": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r347": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(1)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r348": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(f)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r349": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(g)(2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=121322162&loc=SL121327923-165333"
  },
  "r35": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r350": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.D.2)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r351": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 14.F)",
   "Topic": "718",
   "URI": "http://asc.fasb.org/extlink&oid=115993241&loc=d3e301413-122809"
  },
  "r352": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "718",
   "URI": "http://asc.fasb.org/topic&trid=2228938"
  },
  "r353": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "35",
   "Subparagraph": "(a)",
   "Topic": "720",
   "URI": "http://asc.fasb.org/extlink&oid=6420018&loc=d3e36677-107848"
  },
  "r354": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "730",
   "URI": "http://asc.fasb.org/extlink&oid=6420194&loc=d3e21568-108373"
  },
  "r355": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32247-109318"
  },
  "r356": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120406818&loc=d3e32280-109318"
  },
  "r357": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32672-109319"
  },
  "r358": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32809-109319"
  },
  "r359": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32840-109319"
  },
  "r36": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(6)(c))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r360": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32847-109319"
  },
  "r361": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "9",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=84230637&loc=d3e32639-109319"
  },
  "r362": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(2)",
   "Topic": "740"
  },
  "r363": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "10",
   "Subparagraph": "(d)(3)",
   "Topic": "740"
  },
  "r364": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB TOPIC 6.I.7)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=116825942&loc=d3e330036-122817"
  },
  "r365": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "740",
   "URI": "http://asc.fasb.org/extlink&oid=120385591&loc=d3e38679-109324"
  },
  "r366": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5333-128473"
  },
  "r367": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "38",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=121598580&loc=d3e5504-128473"
  },
  "r368": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)(1)",
   "Topic": "805",
   "URI": "http://asc.fasb.org/extlink&oid=120321790&loc=d3e7008-128479"
  },
  "r369": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "19",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569616-111683"
  },
  "r37": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(7))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r370": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=108774443&loc=SL4569643-111683"
  },
  "r371": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r372": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988"
  },
  "r373": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684"
  },
  "r374": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r375": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c),(3)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684"
  },
  "r376": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r377": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "810",
   "URI": "http://asc.fasb.org/extlink&oid=121559654&loc=d3e5710-111685"
  },
  "r378": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "810",
   "URI": "http://asc.fasb.org/topic&trid=2197479"
  },
  "r379": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5B",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=107671284&loc=SL5844817-113951"
  },
  "r38": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02(8))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r380": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "10",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=77984636&loc=d3e40733-113955"
  },
  "r381": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5618551-113959"
  },
  "r382": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121590274&loc=SL5624163-113959"
  },
  "r383": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=121596415&loc=d3e48542-113965"
  },
  "r384": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "15",
   "Topic": "815",
   "URI": "http://asc.fasb.org/extlink&oid=56949186&loc=d3e50579-113967"
  },
  "r385": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r386": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r387": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r388": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r389": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r39": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.1)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r390": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(bbb)(2)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r391": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r392": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)(1)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r393": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19207-110258"
  },
  "r394": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r395": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=d3e19279-110258"
  },
  "r396": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "820",
   "URI": "http://asc.fasb.org/extlink&oid=117815213&loc=SL6742756-110258"
  },
  "r397": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13433-108611"
  },
  "r398": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13467-108611"
  },
  "r399": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13531-108611"
  },
  "r4": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r40": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r400": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=121572278&loc=d3e13537-108611"
  },
  "r401": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(f)",
   "Topic": "825",
   "URI": "http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612"
  },
  "r402": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=120253306&loc=d3e28228-110885"
  },
  "r403": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "35",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=121605123&loc=d3e30226-110892"
  },
  "r404": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=109240200&loc=d3e30690-110894"
  },
  "r405": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450222&loc=d3e30840-110895"
  },
  "r406": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "230",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=98513438&loc=d3e33268-110906"
  },
  "r407": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900"
  },
  "r408": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r409": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(b)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r41": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.13)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r410": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(c)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r411": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Subparagraph": "(d)",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900"
  },
  "r412": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Topic": "830",
   "URI": "http://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901"
  },
  "r413": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "830",
   "URI": "http://asc.fasb.org/topic&trid=2175825"
  },
  "r414": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=6450988&loc=d3e26243-108391"
  },
  "r415": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28541-108399"
  },
  "r416": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28551-108399"
  },
  "r417": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=119993939&loc=d3e28555-108399"
  },
  "r418": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "30",
   "Topic": "835",
   "URI": "http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400"
  },
  "r419": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r42": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.14)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r420": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918627-209977"
  },
  "r421": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918631-209977"
  },
  "r422": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918638-209977"
  },
  "r423": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r424": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r425": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121603541&loc=SL77918643-209977"
  },
  "r426": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918666-209980"
  },
  "r427": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r428": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918673-209980"
  },
  "r429": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(a)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r43": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.17)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r430": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r431": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(1)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r432": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(2)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r433": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(3)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r434": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(g)(4)",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r435": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918686-209980"
  },
  "r436": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121609121&loc=SL77918701-209980"
  },
  "r437": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "53",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/extlink&oid=121568110&loc=SL77918982-209971"
  },
  "r438": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "SubTopic": "20",
   "Topic": "842",
   "URI": "http://asc.fasb.org/subtopic&trid=77888251"
  },
  "r439": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r44": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r440": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r441": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r442": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r443": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864"
  },
  "r444": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864"
  },
  "r445": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "850",
   "URI": "http://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864"
  },
  "r446": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "850",
   "URI": "http://asc.fasb.org/topic&trid=2122745"
  },
  "r447": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r448": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)(ii)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r449": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r45": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19(b),22(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r450": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r451": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r452": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(bb)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r453": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r454": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r455": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719"
  },
  "r456": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r457": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r458": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(b)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r459": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719"
  },
  "r46": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.19-26)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r460": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "30",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728"
  },
  "r461": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "30",
   "Subparagraph": "(a)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729"
  },
  "r462": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r463": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r464": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r465": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)(i)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122625-111746"
  },
  "r466": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r467": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r468": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r469": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(4)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r47": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.20)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r470": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(5)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r471": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(6)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r472": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(a)(7)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r473": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(b)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r474": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(1)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r475": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(2)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r476": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "50",
   "Subparagraph": "(e)(3)",
   "Topic": "860",
   "URI": "http://asc.fasb.org/extlink&oid=116651436&loc=d3e122739-111746"
  },
  "r477": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "910",
   "URI": "http://asc.fasb.org/extlink&oid=119991564&loc=SL119991595-234733"
  },
  "r478": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SAB Topic 11.L)",
   "Topic": "924",
   "URI": "http://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856"
  },
  "r479": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "926",
   "URI": "http://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959"
  },
  "r48": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.21)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r480": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "340",
   "Topic": "928",
   "URI": "http://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004"
  },
  "r481": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r482": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61929-109447"
  },
  "r483": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r484": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62059-109447"
  },
  "r485": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r486": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62395-109447"
  },
  "r487": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r488": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "33",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e62479-109447"
  },
  "r489": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(a)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r49": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22(a)(1))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r490": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "35A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(b)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=SL6807758-109447"
  },
  "r491": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(1)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r492": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "235",
   "Subparagraph": "(c)(2)",
   "Topic": "932",
   "URI": "http://asc.fasb.org/extlink&oid=68064819&loc=d3e61872-109447"
  },
  "r493": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "25",
   "SubTopic": "20",
   "Topic": "940",
   "URI": "http://asc.fasb.org/extlink&oid=68072869&loc=d3e41242-110953"
  },
  "r494": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(10)(1))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r495": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(11))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r496": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(13))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r497": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r498": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(16))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r499": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03(23))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r5": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6676-107765"
  },
  "r50": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.22)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r500": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.9-03.17)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120398452&loc=d3e534808-122878"
  },
  "r501": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(15))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r502": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(22))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r503": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04(26))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r504": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.9-04.9)",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260"
  },
  "r505": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "235",
   "Subparagraph": "(SX 210.9-05(b)(2))",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884"
  },
  "r506": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "470",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823"
  },
  "r507": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "942",
   "URI": "http://asc.fasb.org/extlink&oid=108315417&loc=d3e61044-112788"
  },
  "r508": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r509": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(12))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r51": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.24)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r510": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(15))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r511": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(16))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r512": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r513": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r514": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(25))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r515": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(3))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r516": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03(a)(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r517": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "210",
   "Subparagraph": "(SX 210.7-03.(a),19)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400017&loc=d3e572229-122910"
  },
  "r518": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(18))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r519": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(22))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r52": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.25)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r520": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(8))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r521": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.7-04(9))",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263"
  },
  "r522": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "4H",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438"
  },
  "r523": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "7A",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "40",
   "Subparagraph": "(d)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121643868&loc=SL117782755-158439"
  },
  "r524": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(a)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r525": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(b)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r526": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13H",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Subparagraph": "(c)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117783719-158441"
  },
  "r527": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "29F",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "40",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121639165&loc=SL117819544-158441"
  },
  "r528": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(e)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r529": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(1)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r53": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.28,29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r530": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(f)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r531": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(i)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r532": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(g)(2)(ii)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r533": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "65",
   "SubTopic": "40",
   "Subparagraph": "(h)(2)",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=121370832&loc=SL117420844-207641"
  },
  "r534": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "825",
   "Topic": "944",
   "URI": "http://asc.fasb.org/extlink&oid=99380617&loc=SL75241803-196195"
  },
  "r535": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "20",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840"
  },
  "r536": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "21",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "210",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840"
  },
  "r537": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "220",
   "Subparagraph": "(SX 210.6-07.1(c))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272"
  },
  "r538": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column B)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r539": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column C)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r54": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r540": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column D)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r541": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column E)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r542": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column F)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r543": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "320",
   "Subparagraph": "(SX 210.12-13(Column G)(Footnote 1))",
   "Topic": "946",
   "URI": "http://asc.fasb.org/extlink&oid=120401592&loc=d3e611282-123010"
  },
  "r544": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "310",
   "Subparagraph": "(SX 210.12-29(Footnote 4))",
   "Topic": "948",
   "URI": "http://asc.fasb.org/extlink&oid=120402547&loc=d3e617274-123014"
  },
  "r545": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "740",
   "Topic": "954",
   "URI": "http://asc.fasb.org/extlink&oid=6491622&loc=d3e9504-115650"
  },
  "r546": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Subparagraph": "(d)",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99779-112916"
  },
  "r547": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "360",
   "Topic": "958",
   "URI": "http://asc.fasb.org/extlink&oid=120429125&loc=d3e99893-112916"
  },
  "r548": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column B))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r549": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column C))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r55": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29,30)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r550": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column D))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r551": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column E))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r552": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column F))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r553": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column G))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r554": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column H))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r555": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Column I))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r556": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "360",
   "Subparagraph": "(SX 210.12-28(Footnote 2))",
   "Topic": "970",
   "URI": "http://asc.fasb.org/extlink&oid=120402810&loc=d3e638233-123024"
  },
  "r557": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Topic": "985",
   "URI": "http://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756"
  },
  "r558": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r559": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r56": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.29-31)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r560": {
   "Name": "Form 10-Q",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r561": {
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r562": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r563": {
   "Name": "Regulation S-T",
   "Number": "232",
   "Publisher": "SEC",
   "Section": "405"
  },
  "r564": {
   "Name": "Securities Act",
   "Number": "7A",
   "Publisher": "SEC",
   "Section": "B",
   "Subsection": "2"
  },
  "r57": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(a))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r58": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.6(b))",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r59": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-02.9)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682"
  },
  "r6": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6801-107765"
  },
  "r60": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "3",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "20",
   "Subparagraph": "(c)",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=51824906&loc=SL20225862-175312"
  },
  "r61": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10",
   "Publisher": "FASB",
   "Section": "55",
   "SubTopic": "20",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=99393222&loc=SL20226008-175313"
  },
  "r62": {
   "Name": "Accounting Standards Codification",
   "Publisher": "FASB",
   "Topic": "210",
   "URI": "http://asc.fasb.org/topic&trid=2122208"
  },
  "r63": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "10A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669646-108580"
  },
  "r64": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "11",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e637-108580"
  },
  "r65": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e681-108580"
  },
  "r66": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669686-108580"
  },
  "r67": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL34724394-108580"
  },
  "r68": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r69": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r7": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6904-107765"
  },
  "r70": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1A",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580"
  },
  "r71": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r72": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1B",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580"
  },
  "r73": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "5",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=121641772&loc=d3e557-108580"
  },
  "r74": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "1",
   "Publisher": "FASB",
   "Section": "50",
   "SubTopic": "10",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=116657188&loc=SL116659661-227067"
  },
  "r75": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(210.5-03(11))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r76": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(10))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r77": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(20))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r78": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(24))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r79": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03(5))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r8": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "6",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6911-107765"
  },
  "r80": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1(e))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r81": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.1,2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r82": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.2)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r83": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.4)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r84": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.7(b))",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r85": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.8)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r86": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "2",
   "Publisher": "FASB",
   "Section": "S99",
   "SubTopic": "10",
   "Subparagraph": "(SX 210.5-03.9)",
   "Topic": "220",
   "URI": "http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227"
  },
  "r87": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "13",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(c)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3213-108585"
  },
  "r88": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r89": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "14",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3255-108585"
  },
  "r9": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "8",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "210",
   "URI": "http://asc.fasb.org/extlink&oid=121566466&loc=d3e6935-107765"
  },
  "r90": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "15",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3291-108585"
  },
  "r91": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r92": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r93": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "17",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(d)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3367-108585"
  },
  "r94": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "24",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3521-108585"
  },
  "r95": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(e)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r96": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "25",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3536-108585"
  },
  "r97": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(a)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r98": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Subparagraph": "(b)",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  },
  "r99": {
   "Name": "Accounting Standards Codification",
   "Paragraph": "28",
   "Publisher": "FASB",
   "Section": "45",
   "SubTopic": "10",
   "Topic": "230",
   "URI": "http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>86
<FILENAME>0001688757-21-000045-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001688757-21-000045-xbrl.zip
M4$L#!!0    ( (6 IE)FE%%<+@@# &6R&P 1    97-T82TR,#(Q,#,S,2YH
M=&WLO6M7&\G2)OI]?D4=WCDSW>M0=MXOWKT]"QMPTX,D&V3SPA>OO$*!+NR2
M9!"__D26)&X&&]L"25C=[;:DJLK*S(AXXI*1D7_]G_-V*_L2RE[1[?Q[!;]
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M) D",]EXCK"EAFO/D0I,>6TQEI$H$RQWD@BVY*-I\M&3) C,YD2B2#&77K
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M'X&5HNDL0JDCFN36T7%N'9I?K?_C;/'F>]MS%H(OOLZPHP_-L$-3RK##4=L
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M!P_02L("I8XL$*EGDN:!(^5@4,H0E&92!4V<$D%Q23'FE/KG)M4[H1?2D3-
MY&L'HX\I_!QE.8#3J!$*U+/1D:DR@">9ZFT+[H-ESTV69TG@F4AP0-%'91T)
M.#"DO<5,$HVQQ81YH18@X7[WR)3AC>D%_Z[;]3V@7+W;"9/032B_%"[TFN :
M]HQ+!'\SW!V<0J.AO&:)O>UV>H-6LE(7).B&.9C"Q@A1[1<73"&%0$2Q !]?
M,T\7"'EGN<(Y>X0%M>DD3=OH&&&<.VMP.E0XID.JI2)F@1!V;@@Y$R05WG"'
MN4[):DQ[9275B%@ 5$XE&$0+))'O4B M5+IR<*LLSQ7:OC?#*K4Q1=T.*Y4Z
M(?2T(K)SPT\S 08G%!,:,QP]26>M::4!)BSC2@C#S")EX"_Y:0[PR9#@'=<V
M.$Z91EHSI@7"S 1JN39D@?!I[DV^>4 /'WET43E%6<J>YQ*3M*W6,!ZTL N$
M'HM%[=G$89P0R!@6:10@T%$93-,):B8ES?LQM1=#MJ<&TG/*7X^M-*_U_3GB
M6DI-Y"18;9UEZ2!BC:TF1'"L Y+RMW27EIS^'#'=:!RM$MX9RYFR+I4B#PHA
MBV+ EIH%P/2[]D 5G0?L@?I5&7KTK,;9 Z%3"@5'C9#"LHB)02I82KA!!'Z*
MB\ >4R7B3S'C8VW(FSU[$*^<B$$II17#,IBD-"/G$8O .%\D;^_WE7%BHTM%
MHF,(I,K@<]1Q+QE2--7:HHMO[#PM$6<3%];<$1&)<IBR=%H5QA21@%("#*AS
ML4B2""WXHC5(:0V[P0W*HE^$WL:Y:PU\\)MEM_VVVSX=]*N%U4;<,&6GZ!SV
MWH=R9,<-[V[@>D;4V*"[99H^[T@ODDY)38.5-#*GE;*&,.<)"IPY*<0BB?FS
MYY#9')BB S="<(=89&#V&1ZU0> $: 6?#5MBR#?5RL=.T>_M['Y\CN#AK*4"
M>8X83GL&E8Z&(T(PY@A32>42/.:!-6:"&DQCSJ5V)FC-+.4&6[ ^0N"!8\3\
M(N7</@EKC'>0/$>4X,1+I9%17"A&I-%& [4]$I%%&<4BY>0^(U:8#2HX(F64
MWFIN4]*1\E00%IT&^P(9N4AGZ>V$%DR"?P_3-KP6MNZ]&5Z_<I.R6^UV\ 5<
MW#3MHC4<-=Z(-=,QH[!RHWQ?%AU7G)I6XZP3RN?( \IK;X.-4@3,/"=*1BUI
M0"Y2S3Q#"Z09G@,/S$0E "68P0%K*@5C,EJ+@".P5<YJ/]X9.M_;MA>4](^R
M[]M+XX.)R#)<'5T+?@ 1/*3U 2<)8O.?Q[WXU)QBV2HOA XD.H,4HQ99+XE5
M!&D6-59\5#U:3+8]BJ60/NZ.2?'P'9/BID3_ CY'!:*<TOLE$LQA,,V"X9Q(
MZB7'7(P.HUZ2_E$W,HOIU>70,:7A$4[!PK*>*F0):%VD+15"DG&8!I.QU;TD
MZV-;W4#8AUK=/R71+XOS5V7H=0>E"[W1UZ, .CIUWA=?7O\%_YMLHHS #\P2
MK3T#2]QPBUG$%%POQX5GGQ,G7#W3ZP];0/-VT<F/0JJ%\0JKT_Z_S@K?/WJ%
M$?I_5V[>9\I#N-5V^_UN^Y4X[</EWJGIO/[+EB^AW='G4?-?O20-)3>MXK#S
M*NU1#^7XX<EUUVUURU?_A:I__A5A['FL"/SJ?Z^5A6G][]4>\$?>@SF*H\N]
MXB*\P@PZ7'T]&XU PM.MHA,N1T32,#[6MYH;Z]EN<ZVYL7NSIW/3Q]V-MQ]W
MMII;&[O96GT]V_COMW^OU=]M9&\;M=K6[NY6HSZG'=\SO:.B<]CO=E:S]1=O
M7V0$<:;O[>Q7;/2O1^J^N-5[=F?O_]=_@?GSK]GW%M_N[MV3O=G8J65_ 01T
MNIWZH V-N&R,%#LAI@4>KX*1FFEF+".!@=6',99,18&(('?6R\\Z)H&_#\6K
M]:ZKZHRG!?:5L4- /PWM>O?+-MGYLD]K W^\\>7@G3YN'&^V#]H?+AKK.T7M
M^(0?K']@=7)P5-_;.J^_VS^O7:R=U4@-U]L?T#:MM_8ONN<'[8.3VL4AVC_>
MXHV]#ZBQ[MO[S4]%K;G3KC5K9[7U^G&]>7!2WU3GV^1@N+_G1'T=VMO[='3P
M[J!HO-MIU]?76./=%JE=?&K5CVOL8&^SW6BN\?J%^^+??6+^[W]:!Z3UQ1YW
M4>UX \/UDX/V%CMXMX]JZX=L_WC_HK[W$9X_:NWO[?/:^@FM8S6LK7\\^^R$
MMI%'FBOO1<Z,C+GE@N="6.RT4(([L_(:H_Q#!<175'C]0!:B0.;Q+_WN:?HZ
M'?Y1#^+V/VJF/,D:G?#GI+O38%WT*Y+VX"[L <CX%("]KQOX0=V8NO#$;MDV
M?7@:< &,IE>VVVU9TVIU^[9[?I=L?1B C1#*%E@YJ=S4[R=FP\\&1^$C4GED
MVN8L! T"%U2N$3+$2^P4P8ECM&3B7_=)VE.S[M?_GV)/] O^( 7PX>/:3G-C
M9WL_V]EXW]AI9N\_[NQ^7*LWLV8C QNB"89"AFG6V,DP_\/_F34VL^;?&]DU
M\^+2M%A[VTR7L:;L!Q3@J?%)#/-6B".+<4H*\&&DV.R66?\H9/^9"%$VLINS
MZL3VZ:O&:]+]RJ>*#]#BD3?#83!EZ-PEWN^K_FR,K/O?3;B/MSX+B42(0N2*
M()DS2>"3H3(W-EJJ*1%:@ JMI>(8(RFB>#5+$WY;SK/96V7Z03+9V'E$K79;
M+.[NPNRU6N7 %\E__TW5V@?RF7B##54J#]Z$'"9:Y=9QEUM+;'!$)M-RK-;8
MDZJUNYEFCM1:<V>MOKO5O.;E/IGT9C,8[N^MN_N74#%1WK'LMK//5_]D_>[U
MKP\<(2:/-\2'\5*JZUOT4I0SVRQ:(0/9MJ%\]9@>^T85J4QO&[WL]\-=^AF@
MU6#E71X%88"["+SVB&@N"(I*8RY(]"F(C7.JN*8/=MT?*];S,)!X=*;9"8=5
M<<%./Y43_?T8AWV6P8K(&<^%13IG\"4W1K!<L$"H0MI&&59>;_3ZQK:*WE&R
M<[)M8WO9W]U69;5E6QWW8M;\=#OV<S<[_;%Q;ER_8H*L&[,KXF>FE_5.@TNK
M.3XK.EG1[V7NJ/*O_ORAL:1I"I,;;+?TH<QA3"USV@NO)A_^Y8O>:<L,7Q6=
MJI/50__Z$LI^X4QKW&2_>SI>B-#ZA1(XB4._A#]^TOQXF>)%)2DO^_[K:XR_
M()C=>QF]P/=>^U:SX@61]S_YLZU6G>4/:O9E-1&CR8!)3?3Y]PI=F3PP5H"O
MR.EYAN]RC6[/]4A[/I&:1$_BK01_:,K3LOO%=0>=?CF\Z:F/T"^5<2S!4ZG2
M.ZMJCF]'-[_M^L4$P\W"OOLH:NL;PWKSGU9];__LX-UFN_[NGW9C;^/\8-T?
MP>>B?OP!U]<WH;V-\3.?X%V\<]#LGM6:6[C6_H@/CM^< %BB_?8^WV]NGM3)
M!GS>(O7UCZBVM\7V/ZFS[>9:O[:+SN'OS^#7&&W W3>8 8X:H7+M),H=MEI:
M$JEAH(#?I 39WE'VJ4A66[;5:YF.[]V+GF,Y^ :+H\3@*P^Z=8ZEH=X%"$[5
M$5Q"PAO#_XZHCR$V+23 V+)>MU7X;-++;XP\V<9W(.Z=Z[WCQF_:U?*%DM=^
M*T>C&_WX1$KN*Q>CFLM*CC/P,QK@:)39/X.RZ/FB2BM(2N][CL1B#?8&@E6#
M+@]-I[BHOM]:D)^*,#TJO]V8<_%"\J_F?/SC;.?\Q<Z+W1?9>/-@F6V-\V!&
M-8"S>O?%'1,_%N-)!\<-CM;^IH9P/WOKSYL3=Y'U$CX?W^R=D:UQVXY8\[X,
MO=[XKW0T-EY:#]^S'BZN60^WW3AXIE74+Z#?ZUL7^Q=KZ*"]V=IOUMMU4N/[
M>QN\OGYRWEC_,#S85.@SP=(HC@FP# ?3(S*2:^3!] A@>C L)-$63(]!43EL
MV1O,,[ Z,L)G[;7-+?N2)?L^%?O2ST*DT]4TSE&*7S%):6Z8$WGD.B(JE>*>
MI;CBL-O*-LL0LH-N)RQ9]SKKOH6/C1((V%DR[E,Q[GEM[;/$5$I$6,XI43GS
MV.4V&),;BH.T45'K^<KKM98Y'H26^4UY]G9D8AR02*Q\5U!BPM*CNY;\_'3\
M?/:9:>5<Y#XG.M <B,MSXX/(K3<26Q+2IID$Q;V^R7; Y/TV1R_#%[,-7RR&
M.SF6]Q2;N-RVD&V<!U=M*L\:,:9*FDM?_E$F_Z XS5*P]SZ/_66U-#'#M0_H
MY@LTTDL_NOB!U0N-[K_\L\L4RV9_K-D'!E>F&^89<]\D*^)'I'M>E,K_QY'(
M"*,,_H?0XRP)?#\*AOE\*.*')?=?K>C^K_]2!,M_];)F:(73(_ 8QYDHJVF]
MNC6H(B%K93 WX>_^4&7*6)B'6.5,(Z!+(7VXY;<4TGMLCDWP!T.9I82;U6S\
M96($IKCD^*?-H@>]S/:# 9DM8O;V*!4<]MDNV(@AVS:]?C9*LUT*[S<MM:]3
M(*^O]/''R@Z\&Z"W.CZM$X7,#C-W%-Q)UD[;L<Z.0K58F5(CRZNLG#_PGZ-T
MW"/3RV+1 NJ;5@ON2&3OP=__&10E_-CO9C:,;X"&=T.UVCEZ%-.T+#A*)@47
M([WAJE 5^!FN8JMLS?73Y91,FGFX"MHAW7I:!A<J78')J+UJ]T,O^P,:C?"G
M-W!'6>^HFS*%)JF<_2/3OSV4,W.SOZFSHX?'H_ESM6+^/\BU(=L0@"P#>PP#
M2@]5]\.3J3_CQE(^5J_J2=7=)!4:C5KP9MA[<2.I^;&CD6\'90G]&8DE=')T
M"L%"AG!^*:N.?S:<F71^;XX\BCGS2.16"Y\'&G'4G%FOU<KK_?!5ZL=/I9]_
M;P?%PXRGR[UFCY9]_F-;R^K='\U+_]%YN&]/P'ASPH-SRA]C-^MCX&G"%("3
M=M'O PJ!8>SZ9;>3C('6, M@& S!. 8@2T4HOH1LW?3-*(G[%M)>M7$Z*'N#
MU#1<V!FTPHAR#/%Q?N6@9:Z@>#=O9G^DCW),84+)B_&]_:.BRK@\31F73X+
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MYLK77Y-TFG#Z7>99].^FJ,FR1Q9TL;&3[0Z'C:TL'4(54)QO/;T462^Y8VJ
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MU-SKE'*0P7)H$6*.+B*Q)E:I9=;$[&J5P9Q2_WINN=-$"&#[5ZF 6P)[_IS
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MF*-",PG11]VCC^GT;@XZ?'+2(NE,0!PKCZQ/!)'(G)79I8R$&H8?CV"/]O5
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M/+CS7WL-/QX,8L^?-$:#_&&=22K]DVU#]3HLZX)OZN:;QY#2@C$$^ ;?@&_
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MVARDMK.W,=IIXV\5L6U\-"023A5&1E*%N.(!V40HHL)BGUTIHI)E(U*-(BJ
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M84YZ^C2M)%@*D0<;$*%2925A,#)$4L2$==KF&0!+M;8NS>,Z@^QQ(K06JW2
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MP)/&[1O,9_J9MF(;B!M9<N<1S3=J)%O6$>SV%%X.;&:$%#&:8VIX0-WH5R3
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MG/EV#&:BG<6Y+\*<)VGDOGCE+LGE-5K3VE(4E.'8\=TT3_.(L5S$W(D"*>+
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M21)N<^%D8(=1L;"?VC[C&8M]+V1)NB(7O$%E:'6L#?#A^L"'Z\<E[A"&KI5
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M:\1N[3DW&"T1VL]41__JDA8\UP6=O+(GS!V#]0T)0,S SYU3[[#I18-JU^D
MNQQ"LJ@?.43=$<[@+4S@:4J'[\'28?O?WIV$4L8A\X4=RRBWF<= KPWCQ$XR
M%OC E1T_\!&?[HNT+B2O%M'I&D@9 RK:::6\9>TVN'0-[73A%Q&-I>W_.0=.
M"E)['E*Q+N&7''$2>?M PO6<%H13JI'4<.L5H.9L0AAPA">'@*8CKKN# :&>
M5OR,2#GCDQI;)C?HG7@+/:,++=G%9528W^78 $BJUC8XG3/LYM5@ZU(#Y*EJ
M.Z 'C-W,^F@X\"AJH]9T\3+-PZAC_&DEZ?&P%B6UX1MHS)!F 7!R9CH*PY^
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MB8*W$YCU0B_0:_+'1]?O[([UCNOU^JLW;8@//IV>I%GBL)QY-JRMM+'7GIW
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M,KX=*QM! 6\:JG-68<B5-B+2A@JP%$*PUC(N.2WX5BX3WZZN+^.C;8?2C[&
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M+PWG/M1M<:_JN \L/3A3#>"5JTLX^UN_<!1\NA)@)0 ^$ "_7'%V"!!< 3-
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M/MN-'W&< _ _5X/[1F^ Q[=8!Z\RZ$^_9;82XH\@.LQ,"1G$7(L*G/@[S[I
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M60J)(".T0UD)25LOC>;QYL'M4^'?A#[&LA_%M@_BM&._R)7N'V;ML]/CXRP
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MM8G^491-V_PS@T$IL^VBAQ&IV9^VV2KVA=.3K%@.E#>;[QF:L_&?P3?^WRE
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ME52,< MS*UAA8)8)ADR,'D4LN XB!$+2VFNV?ND\L[U1-G]MF,C_1/0L'DR
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M4-SG5=9%:/H;Y%\4PUX;C/L""0$/E0%@S(80[#8) ()N4'FSPHB+QJJKQTP
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M_*I<]I.PK^13^&<QDX0W*P%7:LPTR96G3I0A\BQH<V<4/0"E2BYY5:=6H;O
M7.2?\+E71ZLP[B?@D3&W/6"/I@>,TM*"4/5BBZM.X(%]!FS2-%F#5HMPENB-
MW%56U!;,9HSK$90'&N=M C(R"6_N<4SJ!#&LLDGX?G6M]DINOJ&*$-T E:[
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MO3?O[/EV:O]^);F";=WL)C"E>^H;;>729K.D6VH2M6\GO>3T?.\:GOW1VS^
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ML6,Z+'+68F*1RR+.8BVP=&:%GN'YL>'8W&2.&[J&9M&)WH]WM2=ZTXEZ'J@
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M,2/VWFDTTDK)K4YV IR0T OP:AC:'Y]A#<I'^27ZF_Y'[5F8"?H$E8.#CG(
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M;5PNK% ODS8R)BL*NJ/GI&(&]GX1UB!EH49\ P:\AI"M1ORR?%=+2<_'==*
MI#8^*<51Q ,A2V4::65#PN/Q%,F(C7$*S8Q8\JF \B\U*GI J@N5P[*>;MH*
MFV<5-J"J<G1NU4ZD(W5D<IU5VO<8N(9:>XY.LBS2%W$F>*Z?C*4'K[+54'T*
MI<J(GE=4E=MS?\9SE_R9F#-&OR=">'"4^2PL#?]2"M!Y#E(8E9)<2\LG8A/6
M'N13'B3_F8C":S*&"X7L;#HH;&3A<Y%BO+*HR>Z1T8$O(TI%H.R3?-X2*;PU
M'/,SPA*P0@08:N]J#_X9;S!<S0F7?I.%B>YUHW0Z$KGQ/&IDSTO[&<4_L7E>
M!H1DDKRTQH=)3L70XPSM!*G3B=_Y!+UYE( OO#5HJ[:4\:2448"#EKX./-2R
M8*ITDPEDFH;_8X$70GH.*-NE/<0GO-[DY,&H7!%J PT\#[,DX#-1TN.]#T6D
MM'[')6^7>6I"S1K =V\(TTHIOR.@&N9#M/^OP(0EL >)L%!"T!2E8<JVA3Z+
M_:VE3 24K)QC32K!Z/*??0;:*SH]R)SM5]4U+)*%2>=@PU:5252 1><3,D)M
M1[XXGQ08E;'QC+9[^=Z]VFPN:WDVUQIU"OZ;-@7L-:2 /7Z.]XVU)D<76%3%
M+S>TX DK$/"O%-4!F0%LBRMG?*"" $'A@)<!'<Q#S M ?3#(&'%Y;)%!P'K*
M0?E9(BH.!4L8)SSDA01I8O 5ONJJ/A+3#B:8CB!J(LB3(!0-C#5=<)@,):FA
M.:G\*H/)LCY+:#>R'&*N'K1ART0@N=)((.-GTS-E)X*[G%"Z- 7>0)A]W-U!
M9SDO7D]Z[04&:.##OP]W,% SC:XH=1MGD/,!)D>0=HV-@UA5(5?]E4KP1A$"
MK5_)ZAIU.LY_$UG4TV"0Y'T"/:KJ2VFE&*4*65GK,K/A*'4NP>B^Q+>*"#B+
M@-Q @LE\MU\KZ8^1?:JY#-DXGV*&,L81,O+I%M7KPLXOW+X9KWP[OY6I;#)'
M6[0<P802=@%7' O;I91+\_+4BYP1D*64]5A\=]8Z*.F@3'(3*6Q4WSKA-0JJ
MULY%02H0)AP/C^I."@:J:Y^C]@J62HB:K'"!4X@"QVK&)P3)-2FT($?YFKR*
M>-)<L9E E=T',QABF4IU):("+)0"M1G5^GR5E?[2$8ZQ4:$-D(>-HGI9#5&R
M0.TG/!B9F[EXCO7R!98,!;G%TXQ&YZ-^D=@#)TF&NMR332W!K.U32G<'KLYY
MFLFL$W%\.?P?[@M8,!0$1W #F8M7BS,L()M.E8@2\#-<$MC%4CD^ J5/(K1J
MU7&5U9\C8 :R3!TQS+#Q!BF],W,HDP;IV\(GSD74I>XJS1+89>P7-.EGE.4_
MZT0OPC;!I/:WC6W<<52[585)L";X&G'37TRM:Y8=3@@\RP#[I_C++&@2PVP-
MK,01/.<7N^M7C\(T#+/K_[NK]*JCN\3BP%^<ZKFUIYL7K(_\(K_H;M>[VUA
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MYJ+<CJBQ3"F$0)@(%'>I&A63XY6I6Q2KECC'\H9ATP2**,K4%6FP-0A,6J=
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MJ:(H'W=W<'>*C%/=$_M6S&TVG5(@(V%*I<PYC9,,KE91?PDC[<#%&]!(7>4
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M>!;!WA[+#<?B='3O>8[E(2.F&^[\#SABIS::VVTAVVIC:_.7Q_7,M?TM&Q,
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MI8(\+,769X>55!EG.8^47^RNK\#X@R0==90T4PRSZ_^[HTQ2Y1=3ZYK%9U2
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ML8'XJ&_VI#[*R45D5H&FP?OQ@+:7<NS&]UE4Q:^EIK=PW3B\%@WPX3DMJK+
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MU^OVSQ-L9;B>YJS=X([&I8[0+=!?N!+.Q['IOPN4-9R"?]'/U3SSKON/AYY
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MX[CLWFO9O:"A16XN;0F'B[N2Q"?RA4PRQ,:BRQ>%"7X"();/Q*CT]9- -X_
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MQHCI.625[E98G2Y:[JFAH+CB0XO/M&TB\Q"?@E7MEGI^=^M&-%F8^S8&'CA
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M/UKS10Q)-CI)]NA%.5XNX6"[(T*_9?>]UD[O#<2N:6+Z1],.OW_],:6>?WJ
MC#C.=Z]<WIJT^B,0@L_V*,%G]RP%'Q*DF9. 3X(S=)XL6VY02*3AL:ATEJ]1
MB8_D9K=2?B]]'K8O[>[I7OT!:YWWD=H6L22H!/AD*S5A%4H&MU26E_KYO3Z#
M&WE1L@(@(E9/1I!N^R.W(^CF&M -$C,)@;ZP"Y$O0#9U6?CN&=M_&;=412"'
M%6,N2RA#T=>O0<$=9^=.LP-KU8)E1@I+P0*R5BOH@^W8I2DLQ#6+)&VL9Y!+
M&;6ES;,PAHYKL_XA[^DA>*WG?BN,5AK7PO-QZM@C :XNA/3..\!<'(!CW?.*
MVR(\^^"S7+/W)O++2U*)N+L=/42SZMR3Q4'XA%VS\.]/T3(>EV\S2)_99V/T
M[WB .?8'&>G;W"O40GHA40^2%9S@WME\F[/(%4-'[M/$I+LU$,&:TP]K=80X
M&;!L;H:W)*"6X[:^KVT=.[6T?N2Q-A*G6&F?B]P%V61G?6O:S'0#D>3=.3K#
M=(5%6%UWLBLV0(>XZID_RN..;8=M#GO\*P:Z'E?$?:+,A7=&S+G^0Y TY.K*
MWM:"X!R4-AM#/L'=9^1-MK<2,#"L^Y=-DA-) "=D0[D?(1-RT6P2^,:<Y(+^
M)<&8&4]:7&8,/%)SE2N0- 1R68SBLDDH5743N@J:%JO='?&\XTORZ9](DSO>
ML/-3O<@OFY:=8 W*PW3'EH_;M#?N)0N](]?%A]?WN'-7/5:E+@P_:.HQ),.Z
M,_2E^R2.6Z" >3OVZ0Q,U9W@ %!QWD!ER"<[-.O;+_I9/H&#(81 FWBC<VG#
MY5B?3ES&7\[C$D!A34 G\OJQ*I=/+O.VU/YDH2A5*$M<$'$3V^B$"T,DF^OE
MZGF$C1?:C=5[.)V\,&!>3O:&]B[_.BJM&.2$7;5U6X(];J=PG4U0UM+:H]#O
M*AA Q8[0Q]Q(:U393GYII@A^D>S;MA5@\,A%\;<,N<.M&PQ\Q:@)RE:T76<Q
MRSO+NPL>$7X&?2ZPA@N+\CF+!PI%#",?( HX1"R*^(C)*EMBIH<FSTQ*Q),/
M,.:'$P-Q1; E4Z^MCTT/U0) (38&65GEC*M:YSL)M_M9)878]T_]'F=!OV=-
M(_+H"?A# -7"Z FRRQT,$@7?!FOJ;YH[6JO;VI^G'[[ML_-]GQB/YSYC0T/Q
M;$ W14,)0_:CN= ?S7'DH&',P4(O07NS"P0LXVVCAEQ.4JE"G2:H/.7RHU6[
MH$?1;SF.*+:2813A&<R<DGB/-<8 <OE,V, DU\KHE5]Y?=**>_K%WZ]W3?^R
M((*G1Q#!$43P48 (/KPU?/KX[V:# K6H5RWN]LD6L^UY^ "!N@I3:H]I6E-+
M+IRTC7,;$&-C:V750B\0N;F"=9:CNHNXVD-UYX/ ;JT"F7J:;*2#78H<X<#Q
M[W_+P^=T\L9&9.2HN-49\?MFN??7/W'*@6X-JKW^O.W(KQP<MUGO!169T7EL
M-LO,%>+HH)BM,&BA18+3TT5Q4+E?"*76>;?AYI#UQ:XCKS*O0\4S^/OSADNY
MUB75Z^+B]_<DG73E19%O@IZCTC$QM)6I/U7TSSS\%!<A7JEHIB[Z1=D1>FI\
MU"<6HDM9X$0&D#LT(E.L,17;R,LTZ3!Q:&/2?XN$]CU.R<%68%_U(+SBCHED
MA7K[@XVF+J!,AO'=\YC+FS<*DTFX08/&ABI=)/GM[8:7BQ'%;IICP>\^,XV!
M%1L-V</Y"NT W68[U_;Z@2.>5L:-SW783:"]NY'4WF]]RSA 1I-WO8B@,^)8
M&=CL45.+,D$=O%M(@O++X]JXK[H$ZPUHA6VPSSN>%-,@T,P0G5)FY3-6OEH"
MZAT)Y913E&.\;4UFY5A&NK?IJD<4(OB8J48G,$U]BC4_SL9]S8;5-MX52($B
M>\G$3]Q%9XY)?R_H_"G] (HB ]N+="B IN18"=AG5>1(6=*1++[R@DRG2 HC
M]RG.J^-A,!,[NVA*%096ZWN<^ON:>LYR%;49SH0#>U3-1V,?>@S'!;8LT+>Z
MOBA].=Z<[K'+',^]^Z*?8E$(R9Y;)I)VVF7)AI4K'AR+ N\VZ6AW^BW)R,VB
M\#GUN04=K/,^(1OP[RU<GYDV6R?P0,.+*)@.X0WZP%4FY^6;5Y.S1X^_> )I
M2/;*OX\2Z&^XG<I@!$'M\1_<#]_,>S#$=<O-UM+U]<WW/V;)#QE\TQ7 N+2Q
MY_3KY^<!$V,/H'=]+2N2:QM?M?EO)9YZKR15&[Y]'4G:<=W>:=U*?Z DS"%X
MSZWG/-5)).YZ<*=&+#6EX);"44S[?$5'#COGAB93;%'/?SC.VWW&8/EE7E8A
M01/I8_+Y95YKJV5HWH#A</]T8F#A;T$5#,782K>>9H4TM0),(+!$O-^/LWF?
ML^D!=O"P0IV[00$74>Q)LSA9-[-W8F$MWY1OEPR2<=1A,XZ4M=$F1>@)#V)G
M$,A :BX_+%=3R&;SR<"DV2GATM%;N,?Y[I4I]:RK1OE(FG9)'OMO<8[Y E'$
M+%S%XP"NYY$\SMB=9BQR8[AD\-UWH%#;!"[ZLE>4UJ[ <8R2]M>+]CDC3I1@
MH=?U+SB9 =M^DG #0\55SJ!\M3!J;2+S_U?R<GITGYQ'68+S*$OP'<L2/$-'
MW'<J2\"^H2D3'&IEZ0WXD$)1)"@EMX45+507?=,V%1<F!MIROO3B%<.*&Y+;
M2:MPO)QV#.?,DU1+52:]+/UZ%<H'1NRFOY:+%@S*9#8HA4V&@HT#Y=[N\0!B
M*ZV[T>'&ZO=AM+PG^<Q#*_"^/<K^_D&ROQ^\[,S)&.WV+=YY\MJ$<Z7'&B9;
MMQM5U34"?:V ,5'H0L"0:KEK$2%,)R1 /:T6+E,-+W_R[ 5%\NV[O;>#P8J$
M6JK-^YMK8M:E\>*G+R<7S160I-P:$,K"^JR.;]5H*/&S\Z[,)S_F\AKRA4B,
M*HNKOS;(>&V1OY#EVA4T8DAJC*U;0=&&3>'.T$LP)H@@?2H^,V,N/)R."=UP
M+":)U'WLKN%6Q=!!X:QP6.68,;3C@S= :M[Y)OG%$2+6VSQ/'APA8D>(V$<!
M$?NSSQ7'"F.FFRPWD\6IP3DE.]X6#1OB80F]'61C+:L,3VO+<8)RJ8MAW"6^
M(M>)))38(]E>&N@^V-73R;E9X.DN>#7SIA >PZ+F+H#<?>?6E\X<;9S\U)/
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M,C.APG&&UEL:@RQ-;BF%+Y<'W!#O-0T>)<)]F?UUR).HX"TEGMO7_*G"8/-
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M3<($C:2L=U9CNKG6.C&)9;UEF\NHEH;+S]M:/ _69+P(SJ;T$"5ZUP+< 5G
M0%%]A%-6)WJ];;MM;\= "Y-,<=T)%@WF6DNUZ=<6;N5$J*V[JA5.9P@BRCQ8
MR=Y>XEB^*I1Y67+*.((B %BVK96M$^)A%0D:'8=)XQV%H <$1\S1V 6M.0-A
M)L!F+%,9 ;Z(#LS<_L9$;<ZVNP@Z6O>OVORW4B&'BGQ^L47V*'<:;(>\G!G3
MU$@]-Y@-<A%D@;!V8IZJ!:MU-2XK 6'#CMYN303NO!YU,E/00*65_Z LEUUO
M:4;RH"YARNM=JT^\YUZ"ZWO&<$>AV K3N5#V/3/B;/]96]?MBGV<SV;;"Z/"
M]CLI'@.L(M<GZX\A1<*[!4G?%1)&H.6NI0L )F0)<VG%EH /MPGQ]^59D8O%
MZ,U;XZN6XNH3VD\*0RC$8HL#3S,_+Z:;< (-[_P>\KEW[-&A4.\"<>\5%[3T
M^%1ZQ[J_HW=Q*6KN)]3,>Y>U!EYW_B3=+X8XB/A)T6MN:H/^69YO,(EA93LS
MII&L%<IXN5SG5HSVMH_P'^POS?OM9=Y$0D:I6[RWLP,GY0KM*0"4U5R/[38G
ML9@XS;NRV\=6B1M:MQ?7-.G6LW+-[QTE31?]?969X<U&# ANE9@/3IW+2M+=
MG?M7"7LT2L9R+SG7Y4$2"VBM@F:DVUT#(TVG2GZE1!50*%>O8(0NRD!)RA>X
M:*HY8V=?:@& P5!.RCW>J>PF8.2DU[AL4) $C'K<C*1N:N)G+EBI-QT('(D<
M8VZ#,N:>ER,C$;N= -\I0^]R*D(N:1OA[#P66_O%UL^/Q=9CL?58;!W9&B[%
M"TLE4.?$&[$\OV8XN"8K+0'J%$ADT[^.MY*!#)S[[-J5 ]P[?ZZ9;/WY=,B.
MMS;BP,-#Y5')WP?T2WT'4EW-<(AR[BYXD2%.<LF)G;"9.)@6?KP$H7+B6DMW
M R.\U,%(VKBUWK+CO']!OD2S*[QG@[0;H.E#K]RE0O*-P]YSEB#F1?@TQ\4#
MX-XY?IP.V=WTIIR T7,T%#-3^EUX.2=.<""XBXZ8-M[%H4VKDJX[YZJ,QHX<
M==K'T9\<+_G>,'5%?*5!:LEW=_=8S9P$S.1G741Y*E^SK9-45'"D,SR<<]$T
M"Q1#6Q'%Z:>;)#29^UC 8OAB)=&%N.FTTY>6I@P.;#[CH)A+;SRT64PRA=SI
M'G\RY,6#,WGEG4S-JSNSTRL4\;BO0)6HRMUPBB^ 9>QTN$)V7JKMG?JKWI(I
MU8&)WDH<8&6MCRFW:AUZL5+AJX-7W(XC_.NVTR+(;U;EY<JE!R/HSW($34M+
M"'[E#)#OPB>4(GG.M97W.P@A'7 Q2##N&)8+X7M"#A>C,1Q46D9-)WCV$"L*
M\EC\ES%N@E$^ ;1O]/J,Y 1P4%"^*'<8=GLOSGFW_L65Q:C(P_,I!_KH.^E"
M,4:*+3=_ #J%5A1TF"TMZ$Y@*X!HR0"8 F+>*346],U:J3W-4]D)RSE<6F1M
M+:\A(N;T0+KFXZ.RSS)9E1V[:=@( NA9:".+YVBE&9+H=+NV3F1?"&?A$T8T
MVU% 3YC6!*H=XVAEE&D+<)%'1TD';;2WTZHY@VF1 2GK7[9!?,4E^]W.3K)'
MKY/:^8J6.1^H/(; P37;#06B13:<4BDY:6+IR))^7T2R%"[PP3+W];O17:X3
MK#FI(]GS_>G9TQ;:&3[$=8UPBM\9G.#3@#LEC[6KXU3<UU3 WYRW^9505461
MFX2=WK@Q^%0@FUQ5(4VL'QTGY+XF9% T%JHB/L>DQ\K:08(_&*ISDI^U?>6K
MOT6^.D[1O4V1.^I7X"V%$TY;J)T+]4H%9&.Y6!QWQ;T-N>$A%5#$0L['P;U'
M9GUROF,B*J5#8]=HC$A-_:)#3@!&X#[J29._/7Q"X4=5:10]#*;&T*P1_V5Y
M4J<()GC:O$J<_B0R0(:D?U'N;I#\!KB5=S%_MJ]R']#8PR<4<B@16^*OX]A0
M9@!4<5?(!J4R9G1N=(L=SVQ\]Y@SH #Z]IV?'S[3,M*1G$EPVFZRD3RK0H4*
M#PI*BLVCK=YRS.[C#$3[Q_C/>%A-$]O1 G'/D<$. PPRBTTG6!.SS9C>Y!#W
M%?)C![H57S(]#%P159*T#B %1,R'8#G.L2!%/8LTCX)-#21#>[FMY8\O5_D2
MO$[TR0:9@S3Q6DR>EY=D]B:/GH.]7?GY)]VNVQ2KS),LC4TK[U.=(<4)".V2
M6R7\B#8S.F^2TNQQ=H%0[N&9 -.*70.%2X8KQI5JS YC>F[C$KP_:YG#2*;V
M+)@>!BS"O1R!N".2\L0N^VBU$X!T*O<F6-XYK>29_9XF9L:4F[=">24XSMXL
MA\S^7M4$7/L9><7S_)#/K#U8JSX%;5@220<YYQNK30E67R AU=)C+$;M39_T
MH$/)@I-5DE(;-9;CAM+91JL/P2H:EMI3NJ4[Z<?0]1ZWC1J\3A-_!N?AD'.,
MD#!SU1SCES)6Y@!5M!N5*V;4$GP0<X1&ZQU(5AS&RZROOS,GBZ2ZI6)1_O&Y
M"J9*QOE& 2QR_4'O3Q!6X9Z:O=@]A0YYL=8J4J6MQUZ-&:SVG$NGD^_*=P7
M5S>!99)+#"O#3AYE6!I.8/_H?H-KDNI76^OM#1HXD9B!FS7D508]I]%7$Q&
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MC'*UXU%)BS2L,DVE+PL53BOEH7CF2RB7KRI&=IN\N@* =L%(HQ>%?.,8Z""
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MEW#,SV3\U_B_SW]VQZYW/;*F:TV.<[#9Y,%'!6$>7(O7M=>F7L\-10@ZE'^
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M(_4BWSH=5S8HHN=*S7"LP]KF:W=NNGA,W=EXZ_S-"8JK"+H>KVJ"A&MP4.W
M_% _XN\^6M^="G@R8N;W34L3*.QP5_ >$E$DFTK#8>D1)Y=.Q>O>YL5H61E<
M^$%";V1<2IX3;:KD0Y'M%7^+T$G+>M<8/AJ$#@,R;3A+>F[:A$9]H2\B5BQF
MQ+#O)/^0]<<3DO>R%(^>29W)5^#PCFJEC$K"KBTHWH, (0D'0@A/UV*JCA3C
MPGT<7GFJ:Z?-$^N--F;GB^\JAK1CA(1@1);TSJ5KU"C$IF U)A<5H%]4YUW)
M:'H;[U9HES(W\'>]:='##KM ($Q>!(KIW>(AE)QNZ?I_O6%@;7A0Z8!Q8\-G
M,&_5/MPTHL;S+QW=J_E&974LHJH;-FFL'B^9S$9'!%E]WUT?,]/.9' U7SV'
MN5M[-\6=K'=T0PBM\QU*T*K"MC;'JJYL% :<%9(.-(QTMP[7#=>[#"MA4TNC
MKFPU=Y%"6STF2^N6,:82^["JES%MN#_L)!^+UQZUM8A9TY]_)N*B"]281&V'
MS\26R14X28F#V'BQ@PNYAD-_/"(B;GCH1H$^O1\DN_B^$G_,0C7D9J-0D<X^
MK7_9;3/C$*.;:P37TUN%-ZD46YXN$%,?B@_Q:(\ 5?%V6RU9#FZ/,'BD''0$
MG8X-S0__&:XI!%-Y\"CL$_2YL:Q3Y+.M2H( $(-H'+C";(Z/3=7P[" [R)<8
MAS0RF;O%J2R<EX6?G\K"I[+PDR@+_])F<#:8/H<@I#=%RL$I@=BR[I?CEITD
M=[)<''P?DH*V*>73A/W4EE-OR?MBL*#4/U.W:\+G,SE'VY)2U _.+V6LEMAL
MB2&IY[$961!K4/+!S'V%:F+BP$:]X!G/2%YYN2'X77#BK#BXI$8@D8C=,R/L
M6CE#YCV($E'M^>(=G8UVP4'*L:DG*Q55\6?9-Z/\5#A2Z3TT-[6I&O(T['V:
M*B5T8QG8+' $'R"&G ^;41F#PN>8,N_QCH,(#^>NKYM73CI!YOI8Q0/RN/0L
M(!@8^SD?-_4@,G<]=:C_5%]):,.J][@2&N&\BAWN%36VJ2PR6%-HPIFO[2&$
MP5+M[OCPNBST >GM1XXL>,UN:2L)Q7.8,G+=F"RXZUGHAER_]"<E:K1.4G:5
MQ6#>]PZ767=-W7GO.CGO'0=]=+:K#XQ:NRF L>>9GT[$^+?Y&O.IN/MDQWY]
MR=B9-)-%,&8OCHLGVZAS2IKZ9_?*$/1H?=^O)18)+T'*Z+8S5M4Z"0S0$*C\
M1D[<WLE*3=]:#6?XTJ:^J"6FCH*%4D!ZG9TNHV;Z_?$0K&(:=UTSMX4 ?U"W
M03*L6LW8$E?=Y#(69>]]NK)06'JAVHA@LK0%[PXB3W%+/.'TX,B,)0\T?08B
MGN/OR%+:NE,K'%7#ON]H].=/#ZVS17M3'F33S6!@;A@NP7I)>ON@>1*=9JTV
MID>0069N7/EN UD2A:NR9IE< 0'E13YTNAC;G"^^!:6S9=CPH,9V6J4PEO $
M8:=N\;[.,J<K^,9G5KKW5BE%DF&3/ =R<4R^@E2$!N$.8!-UX(A[6O[N7"#W
M59D!"&-RJ<ZM!T*;^:FX4P8W/?"1 " F &-2B"(C./<Y.8 %;3?-T@(F<8_7
MM<#3KR^KL-G/71I81M?127Y'2A;5"CK#D ^.YC1-$+K*5[J$<Q) ZKF@HB8K
M@ U[R=*:(+SJQ+-:L,A\\(H3,@-DL0V2\%-J.H_CU)*BI,=@:OXX&?2?<)RE
M2^NBBN:[8&_+Q&8+%N^-2K"/M="2GS>Z%5(7QQ>ZIS&!Z3?=;A8!@%6RYG3;
MT7A)BRQUL82#S^I=&1L^,FW)CU,N2U'_NTD,F!$[8M"-LV(8:+N4A'0(.R@R
MBNJ]>MUW )>0W]=Q>G%($ -R'7E-N8E>-9@>"G0N/5F&#;K"2FX:P*QHSIT3
M;BSB,B_@BH:CG//?%?6-"<1!S8PR=>")N5*@(17/2!))P1:"<);<$F]!!5 %
M6(8+DQ@8$6,6S0I*I\DE>%PC_:U?6^ECR3&!='5^U3 &6C2B:;4BM6=(/;C:
MCALAF<[=N$^PHG;H[(U(1.HH:;1I%8KP3PY)R;@G )1@C4K7MN;-=(S4-!%_
MB,L<!VKP*I<"W"%0]CQ PMY+P=]@ <%S8UR14Y\#FDW!91<,+ OS5P\,V7#
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M;'=>\Q^LRX;\"ONSFA<:V_WFX K4G#E<6S?+V,;LZ *E9:*JU6 Z7K&PI)^
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M&9-<KJ@UAG83M^31T3VD!+9HP0G+>E#;23G+L&ZED1X')?G 6KKV#R'FC1F
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MH(S28+Q>P!6\(683W(";ZG 7YL29RVT66A:0-[AB+I,L5;L17JP92 A.^H'
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MNWGIMQC((:S\/L%M$\9%?.:=?LC(NOO/&R?44SH^F'F,/K[[/U!+ P04
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M:OK,?QHO_&24DLO" B-,)XD+E//$\Z2(0]5Y(X4!(UH08 .>77C ?TP>U+!
M-3I\0/=FONPN;M,29&(<&>DYRT0&*TA0,1+PTE$9#8?8A GWH>Q" O&-!.1'
M8L&1BJ]&@'>P\.,II!>^FZ(S/'\2T?$M:H;T'/(XCA>CY"SX3!-QLOBN*C-B
M+?I@,4AGD*Q&4MN"$-NA[4(0^6/.$I7M4F_]^(;CS>(,.ES5/G5PA@[:^#.\
MPI#J'%[/YO-?8?$F?_!?1])YB!9!JHA+F^11$>^5)T%8*Q)/(&B;=64_G+LP
M2?V83&IIL7JTFL_1D7^V[#KT_T>0M+?1(Y6M#41ZBDNAB)H(Q[D)Z#+EE)J0
MYC:*HWUL/S\;1:.]!NJ(,A3?4>Z!..\YL=ER =8KVT:2,OB0?.G#[7O/C=Y7
MK36GOMERNIB_@PCCSQBN KXS-R(QK2SH1)(*G,BH+0D)(G$IF)!C0&"^T3RW
M$=20G.AZ!*AFAFK$>#7]C&//N@L$,G+4"Y.#PTF3:R(-FLSY$%&^S 7.H<&X
M)I'T;1![.LX_B.$/5G,U0[_MX!/&;"^^?BH;4D^FEPOJ]Q(:!4"MQ/52^X1+
MM0+TXJTF*:. - JC&&]A_QVP#<E=KD>+VD:IQI;78Q_&$XSU88ZHUGAU02M*
M.6,DV-6A@*'$,J\)Y5I!8DE*VV2JV :LHN C%JGE5N)*+;3']]2BM%D;HJD4
M62@O*6VR9WH+PY#\H*J<N/LF'*KW:HPO6YSC1=G"+](]FTT7&+K"-*X R2A]
M<HQ$4+@RR\B)3Y83JG0P3#H,952K'>8-F(;D'S4E1BV[5"/*.OE8IM8'2V2B
M&'9FSM%SPS]QASX=K@$@?)-(:=OT=UKOJ2DMCK1"BX5R%$3DAJ.E1,HX;Z'?
M3KRF0,#H9#V%##VO%T>)<^U_)!H4<##$^C(;"ZV)!5J^,,:-M8RGV%BJ/7S
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MM[[L?@J<PR2RTC*0/#8Y<MCF5!Y^LO+67Y3]_&L!J;9!"IN)2@J#$6\BL;9
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M*A6(5R(1IIV6E%KK5!//:Q.@(3GA0V55%6/6/.U9C7X33K" T25WQ!O (#.
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M)&=GM4HYR-RD*+Y7*0>U\O;X5JR-S =)K9HM%>]*=].IW6L1-"H)USF&X91
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M@(N!SH$XBFM#4#3B/REQV^009Q=P.U&JSVXM_6RA5;9:0SY=;_<5F9T5W+M
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M?%M'5P>,Y4OQ>_[QE_\/4$L#!!0    ( (6 IE*($UT;HU<  ,GA P 5
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MT1AUT 9L29[V-4&$Z@=XW/J^.M+U6">S]-GK)]5=FMT8+S0VG*Q^.KI<L+<
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MM9H0KZ=^RC*/0;+DLN(9N$^\23CY'DR/6TOZ(J/'B_N?MR(/L7B%&5E2F;;
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M I#/7U)F =RJ4$WRA=;PV*F]WG"V[)X#?')*?9::<W>&Z/.?(?_"&FNCSWS
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M)$52YU*@Q+G6TA(PQV5F.HO$0(98>/,Q1"M1J':)X[, [V$%2F/#[B'Z[;5
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M0L@LDN%,(Q(#T)IEXEX:"YC[7$B'SK^?*]H.T6+7$\J^S4_=&M]U;YIJS,)
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MG!+;!7WV]V$+[FI>J%?_N\W:'32XLYO7RW4^7Q9S^3>^V.@91MI0821 5!N
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MP7@=G/VZ(3O*,K*S\CK$CEV:5SXOC&>+?#W[X.)YZ_!-I6/*G)F*-48 \]B
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M'?>^7MYOUO;75C%[5[E+?/:P8Y32K?=B=<?GRQF.J8(X4\#$T!V_IJZI0FR
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M&$90ZU@G4 95@3X_U#0IJ1$Q=!,M5LO/P(Y]UX&23L.;2H&I,!QDAC#+_RY
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M, $LI10D@@N,N-:)"LH:"!Q_:OQ9B0]*^:.] E75]^(F*G6(JJ),3HNN#NS
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M5I  XSJQNF!SY+KJ]) KV@3>2IEOM&I4GZE[@<T8HE3&" &5Q!I@3AG@5&A
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MA'T_%$=8,F@2'M:AN4_AIO:=V$D:-43MZ';M=1+]/@=/-36CN&N"9R68OX>
MKT_^[E6^4?E["&0/^7N0,7HOA_?L85]PJCQH3[!,#=,$B 1:6YXQ:\&GQDT_
M990B@6,1U&TD8.P)LF]+/387"]JLR-;)\Q$P,9X>D&'@'IY1^T.ZSZ)WYS ;
MJ>#=T?!3*79W#I> 0G=G'W%M">66,0\J\@J"4ZB% $9F"<!(,\"T3 &WEBF"
MU@[5:<?RR=XR3(WSFL5[VU=EUZ+)_M/CQW@#@SXP\_GC/5*5Y& 0AZF0["_&
M$U5'#L;I?&7D\$=U;"O'BR^N'?A7OG"FY>WZ.<_S!VN55K4"H5()A=01(9(
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M5K>N86?QR56':?[>]2:ON,=5@?^\G/]3JX_KE?S]W7U9#'[&8HRTI!G0&=(
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M?6K\\CC;66VSG7FGM/6P>? CG,'0'9B"/'++G^=:S1TW%4-T^^D$7)]<%2;
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M!A)M *1& BR86X4B 21)LX0(B)$)<BD'C#TUTZ 6/2IECYK"AZW>$/C]EOA
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MZP#%O?#)7OJD$]\OP<I[0AP,S(%@'IB;.H0_/#?"'J;F0$B/9&U&1-S/X@R
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M*(0QJ<U;AE$I+A2A4ZH+?DZD<,T7V\VWY<HV])J5 BM"E0(09^8_F=2 %YD
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M&NW3_GK3T=Z[PEAF=P3YR?QW5=G=P&&*3--U[L<7ZWW=9\IKJK'"2H(2911
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M.L5BG!I7E^&(23$G(XS*&)>U.R6 *U<%1J#5WK.7C2M[%SF)5,JIS4\DN,
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M^^I=?FH:\7Q9?F%__+W:?/NVG,MJ\?7(Q#EZU2$K<VJ/.PDR^V,(RQRP4D&
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MS3#(90DADYAET.M4,(),4Z-DV\HA^6E5BVIV79Y'>S$FR='M.B[T0SMG:VU
MK4ZRUZ?)R;?':D^J;O=VJ-I#LM/*KI^-7HE5+*(?-Q[*4;V]$<0:UR<<#\<S
MSW'$1\<,"FK6@A<+(Y5MMFOD^VA>^?7'Y;P2/V:I)#C'*08I1PK 0A) RHP
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M^N"%CC_RFOB^RPX\[]NWW:PWYANT0>'+^?S-<F6OGZ52I!J6!>!IF9E%45/
M4"Y!43"5&YM;:;_FXZ-)/K55L7/U@,#VH<_\'@R\$@XYN]-?"HWVH%'_0F-:
MLU+N(4A^LR D+0J#)V\/.'.36 N]A?]S+(:A<Q)M-0P6(&PY?*6T6JV4?%,M
M;)?PE\OU9OU>;69$I=ANVT!*F%F\I*2 IF4.M*)(B5QHK;WB#*Z,,[6EYIWZ
MRN:!+?RN0>G&_Q$ &IBM7RF^2=ZNUULK7U(+:/A713Q+NX%!3-Z[-M2H+'5#
MWU-.N75YJ$%</3W9^LD+^7\,NY@KOW:AN+) &2'0&+#&^(+8&K"T0("B'$&*
M6<Y]O3I71IH:"W2"UAOK3E1?\_(:JJ[F8 2L!C??+L 4,7S9&8NX!M&UP48V
M8&[H?&YPW+KA>7S(!U9+7R,<:]'H;N.L,Y(5F &=EL1LG$L-",D+4.:*:(P%
M5;P8TYOLK\+4"&VW@_;LL#65-V(<9_*P\SS]O?3.K7P Q,WN;,,$A3[;3$YB
M;QVNQ9]CDWWW+,7V/=\A26APV7$ESK^LENOUZS_:TB)_62[E[]5\/LLI%#SG
MT"R"YO6"F$O \IR!G!<E8T@SD6F_N#*78:>V>M52)B_9:O6C[NOS: /]?,/*
MG/!VC2B+C>+@P63'!8,-Q3>8_K23.NG$OGZ>'!!'YH-3W! RIY%'CA[S0>,\
M<,SK[L!&</4!VP?]23TM5QM[Y/99?:U]C[,48]MINP""V%Z2!4& (UD"S3 M
M< X1S+W\@=>'FAK[[&,R5CM9DW4KK&=#M^OXNC%/'-0&9IL]8'LQD\^W //O
MOW83BZA]UJZ/-FX_M9M:G_5-NWU'&%O\LEU7"[5>&Y.+5XO:XGJY7-@H5AO
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M WHX.,%S=TN'_E%&[O#@I/)YPP>WV\(LG"[N9U\XYMURO9YE1<D@-J8,@E0
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MGMW6^ZQ,F<,M(Q?6_-#4/'NS7&E5V3KMZ[>+CW4 \RQC*=9*&$-"H!Q 7"K
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ML)[=BA#^@,#T\8.0Q@]Z5R[CY7*]6;]82&MDUTFHLYP32C.%&_Z'.<P 4Z(
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M1Z&]:T\>K=[>#=4.R^[=NC2Z\7&ADX0=]<OORYF4.4-E)H 6-N4^UQCPM&!
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MOTES>+6U9E?3=JH>:7TY,W.F5$9$7F0 *VYV\5Q;XC'F$M-:"I'FA'.O77R
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MB,;Q]4D)5=6E-6;&5BMQIB#0,"7&XE *4%Y@("%#$O'4&'ABMJC[-,LO'GX
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MG*(>ZG@)'O9X)P2+HX.>H)N['AF[*J6W8ED=37L?7^[>-*97OE(,?%NK%O6
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M*@U;ISH.?D>EK",]MF/-1OU#SQ:/;K$GO\\7L\7]<_W<)K<5,<92:1DW88I
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MP)P8!4F1))!QAB!/4EHP5*0X#8I[#!,_MJGHW6[;H2L:X'@ [S=]] =GSY/
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M[T/W*-CU3#QKE<!G+?7TASM=OP&O2ZVF*_#!+2+?_G*!O1K\YB;><LEGY_?
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MG:./W8&S"\$__\^_K7]C?[CCU__S;_\/4$L#!!0    ( (6 IE(V$_D7%9@
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M<O[KW^[\_E>Y^6WNO?]U\[>7O[J:;OM%^EC^Z__^X_7[] E/ DSGJW68I[K
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M4W4L..JH!0YRN?5C2G8#2_^9S:&$/?8UV%FF[>5TE<+L/S L+XK3BXL>9?6
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M*)IB.6MTH5WO:E\*2\Z-*S8ZS(7Y-C7&Q^1RY+K2(T-XQQTT/IXZWFPW=/,
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M$;QB=(B+A.!+BI!S]IYY'I-NXB@_2-6XB8#A432<"CK T^VI#>=<I(B%V^"
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MM2VY0<?(LWE:Z/I.]?[^@N\"-[7=T(?P[6RD=.4@&J5\-@Z<"$BNLO3@B@S
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MO\^GQ 6S)DCA"T@A#(F$=DIDJ(@?DWWTY,ON5))Q(+0NR-D-5D__KF$ 970
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M,QYLY&T2W2?.,_T8W@.1\-BXGT/YWO4LB_6,_6HE]VJ$N/.OQ[44CQVIK;U
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M1N!\U\T9&\+VWOUU[]^/[7(:[O_: DJV 6N#/'@G$P$E*0@B)_">4=+D*:C
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MLHC@2_U=L3KGXE1R1S!KCYQLFM2N&\#M*:)^,3=+R7DCHH"\SGF*2A#(0$/
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M?9_3[H14\Y=!ZOZ2/"&XSA+1I%V0(.L6;%4*<=*$ DYJ'JU*&=LTA.YZP)U
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M;E4Q3>; /'>H:?M&6@)H7\Z?F)?Z2)^^_([YPY(H#<L?5\2/ZK*>_XJ6_FL
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M'%-&E,)$DW[%8<><MJ#4#F7;UJ^A\-H;N\T/ZB^1HMS_[__Y_P%02P,$%
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M:]W;'N/^5E8L>$3Z=SS,\5"(7"_MEBZ+O<8_6+4?:?W^!W^4"21CQ86#!Q<
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MLXA*5:.?D$ 5[T,NJ-)#0ED,'.!,R@K<*J+;")\HZGHJGT0A-;T+#)@"R;=
M0@$5HQE3@I:L5!"S*?HCQ\. &P>PY_ KZ3VGP=:W3H-+O9:OY:0\OY34T2Q$
MY&Y<U%ELL'H0:]$%*<+CJ;S9Y9Z[/<4SOV:D+SSM_P=02P$"% ,4    " "%
M@*929I117"X( P!ELAL $0              @ $     97-T82TR,#(Q,#,S
M,2YH=&U02P$"% ,4    " "%@*92C@CSC[D0  "0MP  $0
M@ %=" , 97-T82TR,#(Q,#,S,2YX<V102P$"% ,4    " "%@*92YJ0J938F
M  !?F0$ %0              @ %%&0, 97-T82TR,#(Q,#,S,5]C86PN>&UL
M4$L! A0#%     @ A8"F4H@371NC5P  R>$# !4              ( !KC\#
M &5S=&$M,C R,3 S,S%?9&5F+GAM;%!+ 0(4 Q0    ( (6 IE)]4<)%/_X
M "W,"@ 5              "  827 P!E<W1A+3(P,C$P,S,Q7VQA8BYX;6Q0
M2P$"% ,4    " "%@*92-A/Y%Q68   =,@< %0              @ 'VE00
M97-T82TR,#(Q,#,S,5]P<F4N>&UL4$L! A0#%     @ A8"F4CM68AI-"
MFRH  !0              ( !/BX% &5X:&EB:70S,3%Q,3(P,C$N:'1M4$L!
M A0#%     @ A8"F4G7YB!(Z"   Z2H  !0              ( !O38% &5X
M:&EB:70S,3)Q,3(P,C$N:'1M4$L! A0#%     @ A8"F4OK6CH?%!@  2R4
M !0              ( !*3\% &5X:&EB:70S,C%Q,3(P,C$N:'1M4$L%!@
0   )  D 4 (  "!&!0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
